data_2i8l_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2i8l _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 44.0 t0 . . . . . 0 C--O 1.235 0.311 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.9 m -112.63 152.66 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 124.487 1.115 . . . . 0.0 109.891 -169.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 23.8 tp -125.29 107.45 10.73 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 177.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 62.5 tp -96.71 95.68 8.09 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 81.8 m -69.66 142.44 53.41 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 168.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.6 t -140.63 143.29 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 146.12 175.94 19.56 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.561 -1.015 . . . . 0.0 110.561 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -125.61 120.9 32.05 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.29 1.436 . . . . 0.0 107.813 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -59.59 -15.18 16.86 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.111 1.764 . . . . 0.0 115.377 -169.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -127.43 13.59 7.08 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.942 0.897 . . . . 0.0 111.119 -176.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.8 ttt -98.34 29.03 3.76 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.28 0.632 . . . . 0.0 109.771 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.23 -146.9 21.3 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 -177.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -58.34 -18.69 29.35 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 126.019 1.727 . . . . 0.0 112.171 175.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -51.97 -25.42 8.25 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.991 1.316 . . . . 0.0 112.645 173.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.13 24.01 0.56 Allowed Glycine 0 CA--C 1.534 1.278 0 CA-C-O 118.602 -1.11 . . . . 0.0 114.554 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.95 -52.25 63.75 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 119.559 1.68 . . . . 0.0 110.611 -171.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.41 -54.66 35.95 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 117.803 -1.554 . . . . 0.0 111.165 176.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -50.15 -40.16 51.26 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 CA-C-N 120.911 2.356 . . . . 0.0 114.99 177.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 62.9 tp -70.6 -39.88 73.54 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 119.89 1.223 . . . . 0.0 110.201 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.0 tp -61.29 -46.77 88.95 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 117.932 0.333 . . . . 0.0 110.346 175.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.67 -42.2 87.92 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.412 1.085 . . . . 0.0 110.939 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -60.81 -49.06 78.99 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 118.499 0.59 . . . . 0.0 109.778 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -62.87 -48.01 80.88 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.104 0.561 . . . . 0.0 110.749 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 89.2 m -63.75 -39.61 94.7 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.641 0.655 . . . . 0.0 111.437 177.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.45 -40.04 96.08 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.144 0.884 . . . . 0.0 110.871 177.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.35 -33.52 74.44 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.372 0.669 . . . . 0.0 111.773 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.79 92.08 2.45 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 124.861 1.264 . . . . 0.0 108.94 -171.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -51.73 161.91 1.93 Allowed 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 124.064 3.176 . . . . 0.0 114.795 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -140.25 157.21 45.94 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 126.256 1.822 . . . . 0.0 106.978 176.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 34.48 30.25 0.01 OUTLIER Glycine 0 CA--C 1.536 1.347 0 C-N-CA 128.332 2.872 . . . . 0.0 118.213 168.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 43.07 35.41 0.78 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.128 1.771 . . . . 0.0 112.837 -169.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -70.69 128.63 36.74 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 120.828 -1.17 . . . . 0.0 108.103 175.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.4 t -78.04 87.66 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 105.231 -2.137 . . . . 0.0 105.231 168.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.9 p -64.48 138.92 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 96.0 mt -137.95 144.94 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 103.454 -2.795 . . . . 0.0 103.454 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -126.85 109.02 11.54 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -66.08 -16.79 64.85 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 124.899 1.237 . . . . 0.0 113.394 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 57.0 39.85 90.24 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 119.303 1.551 . . . . 0.0 113.643 170.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . 0.258 78.3 p 62.73 12.36 5.58 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.698 2.399 . . . . 0.0 114.689 -175.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.86 59.7 13.97 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 125.447 1.499 . . . . 0.0 108.423 170.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -66.88 -19.31 52.64 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.832 2.355 . . . . 0.0 113.279 -168.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -58.02 -30.49 66.16 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.707 0.685 . . . . 0.0 112.334 177.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.43 -30.61 68.61 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.183 0.593 . . . . 0.0 111.931 175.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -94.32 -4.88 47.86 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.087 0.955 . . . . 0.0 111.501 -170.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.5 mt -54.22 -42.66 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 118.977 0.808 . . . . 0.0 109.167 173.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.7 t -62.44 -42.08 94.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 118.273 0.488 . . . . 0.0 109.99 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.24 -44.89 86.73 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.925 -0.485 . . . . 0.0 110.613 -177.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 78.2 mt -57.91 -48.04 84.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.823 0.849 . . . . 0.0 108.997 173.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -60.15 -35.3 75.0 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 118.097 -0.954 . . . . 0.0 111.994 -175.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -57.4 -31.9 66.29 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.544 1.065 . . . . 0.0 111.513 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 73.2 mt -86.12 -11.86 51.53 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.986 0.914 . . . . 0.0 112.544 -175.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 30.36 60.59 0.96 Allowed Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 126.43 1.892 . . . . 0.0 112.465 -168.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -56.52 151.65 44.83 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.977 2.451 . . . . 0.0 114.328 -169.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.1 m -69.11 -39.69 78.79 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.78 1.232 . . . . 0.0 109.642 169.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 58.2 mtm180 -144.69 166.11 26.13 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.061 0.944 . . . . 0.0 110.136 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.6 tp -145.01 141.66 29.12 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 125.312 1.445 . . . . 0.0 108.071 175.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 39.2 tp -128.15 135.43 49.75 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 173.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.4 mt -123.34 141.81 42.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 -176.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.3 t -140.51 132.83 31.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 118.566 0.621 . . . . 0.0 109.766 -173.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -162.78 173.8 13.31 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.075 2.15 . . . . 0.0 107.443 176.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.24 158.31 36.1 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 167.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 m -154.65 128.22 8.59 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 175.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -72.4 123.42 23.02 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 172.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 73.6 mtm -124.57 1.1 8.25 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.828 1.651 . . . . 0.0 110.957 -175.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.3 24.68 67.65 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-N 118.618 0.644 . . . . 0.0 112.368 -172.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.4 mt -95.85 -173.19 2.78 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.229 1.412 . . . . 0.0 109.417 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -74.84 141.23 75.1 Favored Pre-proline 0 N--CA 1.468 0.44 0 CA-C-O 117.551 -1.214 . . . . 0.0 108.338 170.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -43.44 136.74 5.94 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.202 2.602 . . . . 0.0 113.223 173.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.7 1.55 72.37 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-O 118.646 -1.085 . . . . 0.0 113.375 176.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -64.62 149.25 49.27 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 120.182 1.991 . . . . 0.0 108.307 168.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 91.5 mt -121.51 142.01 39.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 -172.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 83.9 mmt-85 -148.35 149.77 32.39 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 118.387 0.539 . . . . 0.0 111.362 169.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 49.0 mm -77.75 144.0 12.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 166.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.43 165.09 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -137.5 145.64 50.11 Favored Pre-proline 0 C--O 1.235 0.332 0 C-N-CA 126.747 2.019 . . . . 0.0 107.453 -170.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -53.64 -27.1 40.36 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.313 2.675 . . . . 0.0 115.398 -174.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -66.37 -21.69 66.24 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.032 0.833 . . . . 0.0 112.324 177.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -119.31 -29.73 5.1 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.912 1.285 . . . . 0.0 111.921 -171.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.1 mt -51.16 -38.81 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.325 1.45 . . . . 0.0 109.777 169.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.7 -29.01 61.96 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.272 1.029 . . . . 0.0 113.078 -177.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -99.32 -45.23 5.93 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 176.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 22.0 mmt -69.07 -29.31 67.41 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -168.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -70.99 -41.51 70.86 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-N 119.414 1.006 . . . . 0.0 111.393 175.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 CA--C 1.538 0.496 0 CA-C-N 118.791 0.723 . . . . 0.0 112.228 175.242 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.9 mt . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 117.528 2.418 . . . . 0.0 117.528 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.44 -23.39 9.85 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.354 0.979 . . . . 0.0 112.504 168.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -57.77 -39.67 77.99 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 119.271 0.941 . . . . 0.0 110.844 176.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.4 tt -70.15 -43.93 69.9 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 123.41 0.684 . . . . 0.0 109.622 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 95.4 mt -57.74 -41.66 80.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -63.98 -18.26 64.11 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 56.2 mm-40 -83.12 -5.43 59.11 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.941 0.792 . . . . 0.0 112.095 175.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 90.0 mt -132.89 -35.19 1.09 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.933 0.893 . . . . 0.0 112.274 -168.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 12.0 pttm -62.16 -19.76 63.41 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.413 1.085 . . . . 0.0 112.805 -176.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -72.56 -12.99 61.29 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.28 1.032 . . . . 0.0 111.805 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -136.23 -32.72 0.85 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.249 0.931 . . . . 0.0 113.014 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 22.9 mt -68.16 139.64 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 170.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.61 -37.5 92.57 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.097 0.856 . . . . 0.0 112.561 -176.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -149.45 136.66 19.87 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 118.429 1.114 . . . . 0.0 108.505 175.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 56.9 t -123.45 129.78 74.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 175.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.2 mt -129.78 152.0 36.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 -168.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -134.33 146.45 49.98 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 176.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.9 tt -127.19 130.98 50.73 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 170.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -113.23 157.51 14.9 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 175.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 68.0 mt -134.53 128.37 51.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -61.85 115.52 15.98 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-O 117.635 -1.174 . . . . 0.0 110.014 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -78.89 172.42 15.03 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.562 2.175 . . . . 0.0 111.249 170.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -136.54 -31.16 0.88 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 127.533 2.333 . . . . 0.0 110.978 173.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -127.25 122.41 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 -176.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 94.0 t -144.94 132.98 16.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 152.79 150.35 5.38 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -65.7 150.3 48.71 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.137 0.968 . . . . 0.0 110.838 -177.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 18.2 t80 56.29 47.2 19.68 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.595 1.958 . . . . 0.0 111.955 -174.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -130.6 141.65 42.71 Favored Pre-proline 0 C--O 1.236 0.362 0 C-N-CA 123.935 0.894 . . . . 0.0 109.199 168.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -75.84 164.52 31.68 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.909 2.406 . . . . 0.0 110.358 170.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 49.5 ttm -72.63 140.98 48.31 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 168.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 38.3 p -78.53 157.53 28.8 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.414 1.086 . . . . 0.0 110.497 176.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.1 tm0? -49.77 -46.63 80.26 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-O 117.089 -1.434 . . . . 0.0 114.034 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -68.59 -29.27 30.43 Favored 'Trans proline' 0 C--N 1.351 0.695 0 CA-C-N 122.62 1.971 . . . . 0.0 112.163 -174.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 mp -79.63 -35.14 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -56.62 -46.68 80.81 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.39 0.996 . . . . 0.0 109.956 170.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -62.19 -38.28 88.53 Favored 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 123.108 0.563 . . . . 0.0 111.402 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.83 -48.55 76.34 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 122.045 -0.409 . . . . 0.0 111.045 176.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 79.8 t -61.27 -40.58 86.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -60.87 -42.78 98.58 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.919 0.781 . . . . 0.0 110.364 174.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 46.6 m -62.35 -45.13 94.58 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.351 0.523 . . . . 0.0 110.129 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 84.7 t -62.47 -48.16 89.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 118.644 0.657 . . . . 0.0 109.3 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -53.95 -45.77 71.4 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.127 0.971 . . . . 0.0 111.197 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 68.3 mm-40 -68.4 -34.43 76.01 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.399 0.545 . . . . 0.0 111.777 177.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.18 -33.38 75.63 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.755 0.707 . . . . 0.0 111.346 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 38.0 mt -55.18 -24.19 25.55 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -168.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 CA--C 1.542 0.646 0 CA-C-N 120.515 1.507 . . . . 0.0 113.605 178.478 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 . . . . . 0 N--CA 1.45 -0.44 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -64.44 154.43 35.75 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.087 0.955 . . . . 0.0 109.509 177.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -105.45 122.8 46.75 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 -175.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 60.4 tp . . . . . 0 C--O 1.234 0.269 0 C-N-CA 125.301 1.44 . . . . 0.0 109.822 179.167 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.5 t0 . . . . . 0 C--O 1.234 0.28 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.8 t -141.15 145.71 24.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 118.982 0.81 . . . . 0.0 109.708 -167.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 36.5 tp -118.14 126.21 51.77 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 174.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.4 tp -113.43 101.62 9.55 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 176.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 95.3 m -76.73 142.52 40.43 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 169.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.2 t -139.92 142.56 31.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 125.112 1.365 . . . . 0.0 107.46 177.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 144.21 177.42 19.08 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.418 1.008 . . . . 0.0 112.046 176.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -125.45 122.39 36.53 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.302 1.441 . . . . 0.0 108.256 176.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 m -59.72 -17.01 31.37 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.306 1.842 . . . . 0.0 115.417 -169.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 27.4 ptm -126.13 15.81 7.86 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.091 0.956 . . . . 0.0 111.034 -175.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 11.8 tpt -94.93 25.99 3.85 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.657 1.183 . . . . 0.0 108.955 175.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.82 -142.56 23.59 Favored Glycine 0 C--N 1.338 0.642 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -61.72 -16.89 53.08 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.706 1.202 . . . . 0.0 112.552 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -53.1 -26.66 17.15 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.346 1.458 . . . . 0.0 112.819 175.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.62 25.47 0.62 Allowed Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.548 -1.14 . . . . 0.0 114.369 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.1 -48.08 80.1 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 119.461 1.631 . . . . 0.0 110.079 -171.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.28 -58.09 16.26 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-O 117.627 -1.652 . . . . 0.0 111.19 174.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -48.75 -41.07 38.94 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 CA-C-N 121.035 2.417 . . . . 0.0 115.735 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.3 tp -70.83 -39.4 73.02 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 120.209 1.368 . . . . 0.0 110.332 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.2 tp -61.56 -46.07 91.48 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.563 0.345 . . . . 0.0 110.342 176.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.09 -41.87 89.1 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.279 1.032 . . . . 0.0 111.033 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -60.86 -49.49 77.25 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 118.706 0.685 . . . . 0.0 109.784 178.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -62.66 -46.2 89.29 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.963 0.505 . . . . 0.0 110.849 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 79.1 m -68.04 -34.53 76.64 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.336 0.516 . . . . 0.0 111.265 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.36 -40.08 93.13 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.416 1.007 . . . . 0.0 110.736 174.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.43 -33.0 73.43 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.329 0.652 . . . . 0.0 111.723 178.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -151.3 89.27 4.24 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 125.315 1.446 . . . . 0.0 108.809 -174.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -53.29 151.09 23.68 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 123.634 2.889 . . . . 0.0 112.795 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.526 ' HE2' ' CE1' ' A' ' 136' ' ' TYR . 32.5 mmtt -127.28 163.96 22.78 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.723 1.209 . . . . 0.0 109.637 -178.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 40.16 -115.58 0.63 Allowed Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.253 1.406 . . . . 0.0 111.865 175.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -134.03 9.71 3.84 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.841 1.257 . . . . 0.0 111.107 174.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 2.8 m95 -71.26 121.58 18.69 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 121.316 -0.865 . . . . 0.0 110.149 -169.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.7 t -72.23 119.65 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 104.362 -2.458 . . . . 0.0 104.362 166.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 36.5 t -76.29 135.13 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 -178.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 62.8 mt -132.48 144.34 37.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 169.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -129.73 110.21 11.58 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.038 -1.468 . . . . 0.0 107.038 174.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.7 -2.1 90.41 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 119.08 -0.844 . . . . 0.0 112.463 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 56.51 -145.89 34.85 Favored Glycine 0 C--N 1.34 0.762 0 N-CA-C 108.357 -1.897 . . . . 0.0 108.357 -169.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.1 p -88.67 10.61 20.07 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.944 -0.739 . . . . 0.0 111.8 176.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.3 57.9 15.89 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 125.07 1.348 . . . . 0.0 110.664 -175.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -70.08 -21.84 31.45 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.899 2.399 . . . . 0.0 113.158 -172.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.51 -35.92 79.08 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.109 0.868 . . . . 0.0 112.174 -176.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -65.99 -10.3 38.18 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.744 0.818 . . . . 0.0 112.919 175.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -116.03 0.17 12.94 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.259 1.024 . . . . 0.0 112.427 -171.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 81.8 mt -48.17 -41.37 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 125.224 1.41 . . . . 0.0 110.683 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.6 t -56.36 -42.52 74.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.427 0.691 . . . . 0.0 110.248 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.07 -40.67 87.06 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 122.955 0.502 . . . . 0.0 110.874 -176.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 55.5 mt -57.86 -49.11 82.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 173.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -64.01 -35.21 79.95 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 118.082 -0.961 . . . . 0.0 111.994 -173.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -57.48 -28.8 63.71 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.432 1.015 . . . . 0.0 112.064 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 34.5 mt -76.41 -3.57 37.77 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.467 0.707 . . . . 0.0 112.639 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 41.47 53.8 7.45 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 126.307 1.843 . . . . 0.0 111.565 -171.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -57.91 135.01 66.2 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.203 1.936 . . . . 0.0 112.343 -169.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.7 m -78.32 -31.97 49.0 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.037 0.935 . . . . 0.0 108.577 168.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 20.7 ttp-105 -142.2 155.29 45.27 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.405 1.082 . . . . 0.0 109.79 173.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.4 tp -136.13 141.47 44.15 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 126.09 1.756 . . . . 0.0 107.66 169.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 24.0 tp -130.63 134.44 46.97 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 172.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.5 mt -121.29 145.17 28.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -171.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 38.3 t -141.37 135.65 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 118.938 0.79 . . . . 0.0 110.421 -175.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -163.22 169.79 18.71 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.583 2.353 . . . . 0.0 107.871 177.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.3 155.98 39.6 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.318 -0.864 . . . . 0.0 109.194 168.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.8 m -154.15 123.63 6.58 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -72.15 121.98 20.21 Favored 'General case' 0 N--CA 1.46 0.068 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 171.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 74.8 mtm -122.89 1.01 9.28 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.59 1.556 . . . . 0.0 110.736 -174.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.53 23.5 64.93 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-N 118.639 0.654 . . . . 0.0 112.341 -172.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.0 mt -96.6 -173.85 2.86 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.275 1.43 . . . . 0.0 109.052 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -73.82 140.55 77.91 Favored Pre-proline 0 N--CA 1.467 0.389 0 CA-C-O 117.744 -1.122 . . . . 0.0 108.429 172.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -43.58 137.29 6.05 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.364 2.709 . . . . 0.0 113.195 173.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.36 4.57 74.55 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 118.772 -1.015 . . . . 0.0 113.845 177.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -68.01 150.94 47.83 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 119.714 1.757 . . . . 0.0 108.13 168.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 74.1 mt -128.02 138.02 55.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 -171.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 90.1 mmt-85 -145.58 147.09 31.7 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 118.836 0.744 . . . . 0.0 112.081 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 51.0 mm -75.77 143.0 13.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 166.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mt -134.81 161.48 40.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 174.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -125.69 144.0 46.82 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 126.493 1.917 . . . . 0.0 108.312 -174.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -42.76 -37.82 6.12 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 124.726 3.618 . . . . 0.0 116.685 -178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -64.84 -22.17 66.94 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.367 0.667 . . . . 0.0 112.34 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -113.33 -32.05 6.38 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.123 1.369 . . . . 0.0 111.1 -174.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 34.5 mt -49.08 -40.44 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.776 1.63 . . . . 0.0 110.359 169.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.31 -21.93 16.82 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.097 1.359 . . . . 0.0 113.733 -176.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -115.97 -36.46 4.13 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 118.574 0.625 . . . . 0.0 110.336 174.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 86.2 mmm -72.15 -26.64 62.17 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 118.479 -0.772 . . . . 0.0 113.032 -171.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -64.53 -51.84 60.85 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 119.933 1.242 . . . . 0.0 109.801 170.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 CA--C 1.537 0.459 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -179.155 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 mt . . . . . 0 CA--C 1.533 0.302 0 N-CA-C 117.108 2.262 . . . . 0.0 117.108 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -52.56 -28.23 20.01 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.546 -0.721 . . . . 0.0 111.207 167.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -59.55 -39.18 83.17 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.118 0.567 . . . . 0.0 111.12 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.6 tt -70.12 -43.68 70.5 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 123.67 0.788 . . . . 0.0 109.471 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 94.0 mt -59.78 -39.05 78.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -63.9 -19.28 64.97 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -82.37 -9.33 59.5 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.537 -0.727 . . . . 0.0 112.009 175.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 68.9 mt -126.83 -30.69 2.73 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.318 1.047 . . . . 0.0 112.09 -168.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 12.5 pttm -63.59 -24.88 67.98 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.317 -0.864 . . . . 0.0 111.942 178.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -78.33 -5.54 52.48 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.772 1.229 . . . . 0.0 111.804 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -132.54 -3.66 3.35 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.867 1.267 . . . . 0.0 112.896 -168.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 65.7 mt -135.89 143.64 35.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 126.111 1.764 . . . . 0.0 106.878 -173.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.68 -37.48 76.78 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-O 119.396 -0.669 . . . . 0.0 112.823 -171.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -144.89 124.63 13.33 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 37.2 t -127.92 130.36 69.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 3.3 mt -136.24 154.17 32.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 -169.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -131.55 146.04 52.02 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 168.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.0 tt -126.67 122.11 34.02 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.759 1.624 . . . . 0.0 106.934 176.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -107.61 156.33 15.92 Favored Glycine 0 C--N 1.333 0.377 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -178.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 56.1 mt -133.79 125.85 49.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -175.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.5 tp60 -64.09 115.24 17.78 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-O 117.624 -1.179 . . . . 0.0 110.377 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -76.06 170.39 20.19 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.302 2.668 . . . . 0.0 111.352 170.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -131.03 -30.08 1.81 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.62 1.968 . . . . 0.0 111.056 170.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.1 pp -135.24 136.4 51.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 119.105 0.866 . . . . 0.0 108.708 173.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 65.1 t -142.02 136.91 30.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 176.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 156.03 152.85 6.37 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -67.04 154.0 42.27 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.611 0.72 . . . . 0.0 110.199 -176.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.8 t80 58.21 33.93 23.63 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.196 1.798 . . . . 0.0 111.682 -177.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -123.58 145.84 48.28 Favored Pre-proline 0 C--O 1.237 0.407 0 O-C-N 121.562 -0.711 . . . . 0.0 110.199 174.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -80.3 164.74 21.57 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.198 2.599 . . . . 0.0 110.657 174.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.9 ttm -68.45 134.53 50.29 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 168.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.94 159.6 31.62 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.329 1.052 . . . . 0.0 110.471 176.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.51 -46.62 99.59 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-O 117.196 -1.383 . . . . 0.0 113.316 -171.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -66.89 -26.12 44.57 Favored 'Trans proline' 0 C--N 1.35 0.613 0 CA-C-N 122.288 1.853 . . . . 0.0 112.717 -178.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 mp -80.66 -34.86 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 119.313 0.961 . . . . 0.0 108.666 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -56.99 -46.38 82.3 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 118.988 0.813 . . . . 0.0 109.745 169.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -63.09 -37.95 89.26 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 122.787 0.435 . . . . 0.0 111.356 178.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.55 -47.38 81.82 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 121.88 -0.513 . . . . 0.0 110.9 175.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.16 -39.17 82.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 118.702 0.683 . . . . 0.0 109.871 177.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -63.21 -33.77 76.21 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.193 0.906 . . . . 0.0 111.126 174.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 39.2 m -70.31 -43.17 70.88 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.678 0.791 . . . . 0.0 110.1 175.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 91.2 t -63.45 -45.93 96.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 119.363 0.983 . . . . 0.0 109.26 176.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.526 ' CE1' ' HE2' ' A' ' 31' ' ' LYS . 22.3 t80 -52.36 -50.97 61.32 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.155 0.982 . . . . 0.0 110.884 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -71.28 -34.74 70.94 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.873 0.761 . . . . 0.0 111.818 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.21 -32.51 74.11 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 118.926 0.784 . . . . 0.0 111.43 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 55.2 mt -57.52 -18.65 20.12 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.54 1.064 . . . . 0.0 112.708 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 . . . . . 0 CA--C 1.544 0.73 0 CA-C-N 119.403 1.001 . . . . 0.0 112.368 178.581 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 . . . . . 0 N--CA 1.452 -0.372 0 CA-C-O 121.769 0.795 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -84.24 146.91 27.54 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 172.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -78.89 131.77 36.53 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 169.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 56.7 tp . . . . . 0 N--CA 1.456 -0.166 0 C-N-CA 124.8 1.24 . . . . 0.0 110.887 179.344 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.4 t0 . . . . . 0 C--O 1.234 0.288 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.9 m -118.06 153.47 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 124.051 0.94 . . . . 0.0 110.561 -169.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 41.4 tp -124.09 101.54 7.27 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 56.5 tp -89.84 98.94 12.06 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.071 0.949 . . . . 0.0 108.938 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 95.9 m -75.01 141.09 43.98 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 169.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.5 t -141.38 143.31 27.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 125.328 1.451 . . . . 0.0 107.782 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 148.91 171.5 17.73 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.094 0.854 . . . . 0.0 112.231 175.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -109.0 117.1 33.33 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.919 1.288 . . . . 0.0 107.951 175.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -59.57 -13.83 10.88 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.109 1.764 . . . . 0.0 115.741 -169.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -129.57 13.55 5.96 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 119.436 1.016 . . . . 0.0 111.878 -174.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.2 ttt -100.64 40.12 1.3 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.49 0.662 . . . . 0.0 110.158 -176.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.51 -136.39 18.37 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -50.9 -30.26 14.21 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.901 1.281 . . . . 0.0 113.328 174.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -60.25 -17.91 45.21 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -167.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.34 25.58 0.71 Allowed Glycine 0 CA--C 1.533 1.187 0 CA-C-O 118.14 -1.366 . . . . 0.0 113.791 175.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.51 -49.14 77.92 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 119.944 1.872 . . . . 0.0 110.382 -170.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.19 -56.44 23.76 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-O 117.612 -1.66 . . . . 0.0 111.203 173.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -47.09 -42.47 26.13 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 CA-C-N 120.991 2.396 . . . . 0.0 115.659 177.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 62.6 tp -71.49 -37.43 71.27 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 120.173 1.351 . . . . 0.0 110.713 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.4 tp -61.34 -47.39 86.13 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.324 0.511 . . . . 0.0 110.283 174.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.96 -40.28 88.5 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 123.859 0.864 . . . . 0.0 110.903 177.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.6 tp10 -62.03 -49.29 76.58 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 118.659 0.663 . . . . 0.0 109.726 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -63.21 -45.9 89.53 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 119.166 -0.445 . . . . 0.0 110.477 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 78.4 m -63.5 -40.34 96.82 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.581 0.628 . . . . 0.0 111.228 177.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.91 -39.31 93.88 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.844 0.747 . . . . 0.0 111.146 177.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.37 -36.9 77.28 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.343 0.657 . . . . 0.0 111.467 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.89 95.58 2.19 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.113 1.365 . . . . 0.0 108.063 -172.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -53.04 170.19 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 124.907 3.738 . . . . 0.0 115.729 -176.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.55 ' HE2' ' CZ ' ' A' ' 136' ' ' TYR . 19.4 mmtm -138.85 157.04 46.79 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.342 1.457 . . . . 0.0 108.94 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 38.33 -115.1 0.38 Allowed Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.241 1.4 . . . . 0.0 111.625 177.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -140.71 22.29 2.31 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.473 1.109 . . . . 0.0 110.425 170.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 10.0 m95 -69.87 128.63 37.06 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 121.32 -0.862 . . . . 0.0 109.302 -173.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 86.4 t -76.88 106.72 7.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 168.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.7 t -64.02 136.67 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.0 mm -131.02 148.06 33.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 169.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -135.6 100.26 4.43 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.59 -8.33 80.88 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-O 118.88 -0.956 . . . . 0.0 112.419 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 51.48 -140.19 25.12 Favored Glycine 0 C--N 1.341 0.807 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -169.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.9 p -91.53 14.76 13.99 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.032 0.933 . . . . 0.0 111.799 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.48 57.06 6.8 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 125.291 1.437 . . . . 0.0 110.142 -176.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -68.46 -18.66 43.6 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.822 2.348 . . . . 0.0 113.648 -169.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -61.47 -32.14 72.13 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.338 0.972 . . . . 0.0 111.473 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.43 -31.31 71.25 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.189 0.595 . . . . 0.0 111.579 175.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.54 -9.56 49.44 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 123.645 0.778 . . . . 0.0 111.326 -169.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 95.6 mt -53.1 -42.17 44.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 170.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.6 t -58.1 -40.26 76.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.565 0.746 . . . . 0.0 110.241 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.81 -45.45 71.18 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.232 0.469 . . . . 0.0 110.249 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.3 mt -62.72 -37.5 79.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -64.07 -19.04 64.94 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 117.871 -1.061 . . . . 0.0 112.578 176.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -70.91 -46.79 61.9 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 120.483 1.492 . . . . 0.0 108.964 169.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.4 mt -69.9 -21.1 63.34 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.47 1.108 . . . . 0.0 112.657 -173.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.3 mtt85 41.92 54.63 8.76 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.04 1.736 . . . . 0.0 112.202 -177.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -57.87 153.86 41.57 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.768 2.312 . . . . 0.0 114.793 -169.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.8 m -72.35 -38.82 68.48 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.085 1.354 . . . . 0.0 109.536 168.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 53.3 mtm180 -143.99 164.57 30.24 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.036 0.934 . . . . 0.0 110.577 178.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.0 tp -146.01 141.69 27.91 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.345 1.458 . . . . 0.0 108.235 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 41.7 tp -128.49 135.35 49.32 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 172.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.5 mt -122.04 144.16 32.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -175.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.5 t -140.18 132.82 33.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 118.413 0.551 . . . . 0.0 109.663 -175.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -158.78 175.19 13.92 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.556 2.342 . . . . 0.0 106.742 169.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.68 162.74 28.46 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 121.028 -1.045 . . . . 0.0 110.628 169.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.7 m -157.24 128.22 6.7 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 176.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -73.42 116.63 14.21 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 170.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 77.1 mtm -114.64 1.55 14.25 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.767 1.627 . . . . 0.0 110.461 -176.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.48 13.6 45.32 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 123.948 0.785 . . . . 0.0 113.011 -172.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 72.3 mt -85.92 -176.31 5.94 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.904 1.681 . . . . 0.0 109.928 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -72.54 139.1 80.79 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 117.928 -1.034 . . . . 0.0 109.388 172.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -43.99 134.34 8.24 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.812 3.008 . . . . 0.0 114.224 177.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.87 4.73 86.03 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 118.858 -0.968 . . . . 0.0 113.547 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -66.75 152.67 45.05 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 119.722 1.761 . . . . 0.0 108.435 168.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 85.6 mt -127.78 139.92 50.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 -171.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 90.9 mmt-85 -148.64 151.81 35.62 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.624 0.647 . . . . 0.0 111.147 173.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 43.8 mm -78.41 146.13 8.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 167.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.402 HG21 ' H ' ' A' ' 77' ' ' ASP . 1.6 mt -135.17 165.19 31.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 177.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.402 ' H ' HG21 ' A' ' 76' ' ' ILE . 5.4 t70 -138.67 146.41 50.4 Favored Pre-proline 0 C--O 1.235 0.32 0 C-N-CA 126.925 2.09 . . . . 0.0 107.009 -170.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -53.08 -28.43 40.86 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.38 2.72 . . . . 0.0 114.982 -175.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -66.69 -21.38 66.09 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 118.943 0.792 . . . . 0.0 112.359 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -117.96 -30.18 5.43 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.873 1.269 . . . . 0.0 111.894 -172.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 69.5 mt -50.5 -40.89 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 124.658 1.183 . . . . 0.0 109.89 170.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.81 -27.36 50.88 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.857 0.863 . . . . 0.0 113.254 -176.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -99.23 -43.22 6.7 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 174.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 95.0 mmm -72.1 -25.52 61.78 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.631 -0.668 . . . . 0.0 112.708 -169.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -80.0 1.01 29.22 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 172.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 23.3 ptt? . . . . . 0 CA--C 1.537 0.454 0 C-N-CA 123.407 0.683 . . . . 0.0 111.846 167.612 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.6 mt . . . . . 0 N--CA 1.47 0.532 0 N-CA-C 116.66 2.096 . . . . 0.0 116.66 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -52.48 -26.77 13.81 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.202 0.91 . . . . 0.0 112.199 168.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -63.53 -33.82 76.44 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.713 1.142 . . . . 0.0 111.671 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.6 tt -69.59 -46.39 66.42 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.0 mt -60.5 -49.49 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -67.18 -14.14 62.63 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -171.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -106.04 7.96 32.11 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.675 1.19 . . . . 0.0 111.668 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 26.6 tp -138.5 -27.86 0.85 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.785 0.834 . . . . 0.0 111.167 -173.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -59.35 -19.77 49.34 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.849 1.26 . . . . 0.0 111.494 168.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -64.39 -16.77 62.93 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.288 1.435 . . . . 0.0 111.361 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -125.75 -40.41 2.06 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.477 1.111 . . . . 0.0 111.426 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 36.5 mt -71.82 139.04 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.76 -38.89 93.42 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.361 0.981 . . . . 0.0 112.747 -177.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -147.22 135.95 22.06 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 118.662 1.231 . . . . 0.0 108.395 176.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.8 t -126.11 127.57 71.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.2 mt -130.24 155.31 41.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -168.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -136.13 147.8 47.92 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.4 tt -129.68 135.48 48.56 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.043 1.337 . . . . 0.0 108.167 171.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -118.13 158.91 14.48 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 125.112 1.339 . . . . 0.0 111.117 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 92.3 mt -136.31 129.73 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 C-N-CA 125.444 1.498 . . . . 0.0 107.593 -175.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -66.74 119.47 63.69 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 117.513 -1.232 . . . . 0.0 111.245 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.11 170.15 17.68 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 124.755 3.636 . . . . 0.0 113.449 173.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -137.82 -36.73 0.61 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.453 1.101 . . . . 0.0 112.028 168.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.1 pp -136.67 138.06 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 170.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 89.8 t -139.98 136.46 38.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 175.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 160.5 151.81 6.34 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -65.37 151.35 46.5 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.7 0.762 . . . . 0.0 111.079 -174.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 54.86 38.29 30.07 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.733 2.013 . . . . 0.0 112.061 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -121.6 149.54 53.05 Favored Pre-proline 0 C--O 1.237 0.439 0 C-N-CA 124.026 0.93 . . . . 0.0 109.451 173.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -78.0 158.37 30.72 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.831 2.354 . . . . 0.0 110.68 177.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 59.5 ttm -64.88 132.57 49.76 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 168.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.0 151.17 47.41 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 123.913 0.885 . . . . 0.0 111.209 177.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -57.59 -47.13 99.5 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 117.198 -1.382 . . . . 0.0 112.925 -174.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -67.92 -25.48 38.7 Favored 'Trans proline' 0 C--N 1.35 0.657 0 CA-C-N 122.105 1.787 . . . . 0.0 112.166 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 mp -76.96 -38.67 28.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -57.01 -46.88 81.98 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.977 0.808 . . . . 0.0 109.863 171.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -61.91 -39.22 91.25 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 122.639 0.376 . . . . 0.0 111.144 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.51 -49.9 71.7 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.755 0.422 . . . . 0.0 110.929 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 76.4 t -59.2 -40.78 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 118.634 0.652 . . . . 0.0 109.618 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -68.73 -28.93 67.26 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.921 0.782 . . . . 0.0 111.742 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 46.7 m -69.27 -46.79 66.39 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.558 -0.713 . . . . 0.0 109.527 173.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 96.3 t -59.39 -46.32 92.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 118.965 0.802 . . . . 0.0 108.968 176.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.55 ' CZ ' ' HE2' ' A' ' 31' ' ' LYS . 37.6 t80 -52.33 -57.93 8.25 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.317 1.047 . . . . 0.0 110.637 178.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -69.27 -29.95 67.95 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.025 0.83 . . . . 0.0 111.852 -176.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -61.43 -33.7 74.16 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 118.777 0.717 . . . . 0.0 110.881 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 52.7 mt -57.99 -17.2 15.79 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -177.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 . . . . . 0 CA--C 1.539 0.543 0 CA-C-N 120.248 1.386 . . . . 0.0 112.793 177.372 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 . . . . . 0 N--CA 1.451 -0.42 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.62 155.77 40.14 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 123.811 0.844 . . . . 0.0 109.256 173.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -102.65 123.95 47.29 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.985 1.314 . . . . 0.0 108.196 -177.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 58.9 tp . . . . . 0 C--O 1.233 0.202 0 C-N-CA 126.226 1.81 . . . . 0.0 110.727 179.807 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 . . . . . 0 C--O 1.233 0.22 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.1 m -89.88 141.36 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 29.3 tp -109.37 126.48 53.46 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 105.18 -2.155 . . . . 0.0 105.18 171.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 48.9 tp -114.61 97.38 6.25 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 177.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 93.2 m -71.78 140.12 49.31 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.84 169.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.1 t -140.26 141.84 32.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 148.0 -175.52 27.27 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 118.43 0.559 . . . . 0.0 112.153 177.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -136.79 117.78 14.28 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.057 1.343 . . . . 0.0 107.983 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.7 m -58.74 -11.55 3.29 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.477 2.311 . . . . 0.0 115.798 -170.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 23.4 ptp -131.97 12.35 4.74 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.805 1.184 . . . . 0.0 111.425 -177.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 27.7 mmm -89.45 24.54 2.22 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.64 0.776 . . . . 0.0 110.261 173.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.58 -139.15 16.3 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -63.42 -14.98 56.14 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.407 1.083 . . . . 0.0 112.108 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -61.39 -5.84 1.93 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.629 1.571 . . . . 0.0 113.324 174.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.64 16.89 28.48 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 120.537 -1.352 . . . . 0.0 113.412 174.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.37 -50.33 74.04 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.4 1.6 . . . . 0.0 111.578 -169.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.54 -55.22 31.19 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 117.718 -1.601 . . . . 0.0 111.144 176.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -48.73 -40.08 38.66 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 CA-C-N 120.849 2.325 . . . . 0.0 115.24 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.6 tp -71.19 -38.93 72.09 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 119.975 1.261 . . . . 0.0 110.464 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.3 tp -60.9 -46.36 90.95 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.066 0.394 . . . . 0.0 110.187 175.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.41 -39.92 81.02 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 123.85 0.86 . . . . 0.0 110.956 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -62.67 -49.36 75.42 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 118.815 0.734 . . . . 0.0 109.829 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -62.84 -44.51 95.95 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.558 0.343 . . . . 0.0 110.515 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 79.5 m -65.0 -39.64 93.76 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 118.21 0.459 . . . . 0.0 111.157 177.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.52 -37.54 87.9 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.039 0.836 . . . . 0.0 111.199 177.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.07 -38.8 79.23 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.226 0.61 . . . . 0.0 111.116 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.5 90.2 2.9 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.765 1.226 . . . . 0.0 109.191 -173.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -55.24 160.19 8.92 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 124.07 3.18 . . . . 0.0 114.0 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 32.1 mmtt -117.39 168.12 10.64 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.871 1.268 . . . . 0.0 109.768 174.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 37.52 -112.3 0.17 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 126.193 1.854 . . . . 0.0 111.564 176.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -139.13 36.27 2.11 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.852 1.261 . . . . 0.0 108.886 169.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -67.47 144.94 55.45 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 121.591 -0.693 . . . . 0.0 110.653 -175.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.1 t -103.16 103.5 15.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 168.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.8 t -71.36 136.97 24.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -176.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 54.9 mt -136.96 142.19 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 104.55 -2.389 . . . . 0.0 104.55 172.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -131.01 110.07 10.97 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -88.83 0.65 82.67 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 118.811 -0.994 . . . . 0.0 112.879 -178.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 56.9 -144.29 38.87 Favored Glycine 0 C--N 1.34 0.766 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -171.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.1 p -94.19 1.63 56.02 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.693 0.797 . . . . 0.0 112.629 -175.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.02 64.16 40.13 Favored Pre-proline 0 C--O 1.238 0.454 0 C-N-CA 124.798 1.239 . . . . 0.0 109.458 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -65.06 -14.35 44.78 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.194 2.596 . . . . 0.0 112.875 -173.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.7 tp10 -43.1 -41.74 3.73 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.087 1.755 . . . . 0.0 111.536 168.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -69.64 -17.41 63.51 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.048 0.939 . . . . 0.0 112.655 -175.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -117.79 0.8 12.06 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.797 0.839 . . . . 0.0 113.251 -168.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 73.5 mt -48.96 -38.9 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 125.147 1.379 . . . . 0.0 110.62 172.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.9 t -55.35 -42.02 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 123.955 0.902 . . . . 0.0 110.453 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.0 -40.77 91.41 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.954 0.501 . . . . 0.0 110.799 -176.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.5 mt -60.8 -49.31 85.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.975 0.91 . . . . 0.0 108.608 173.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -61.21 -36.02 78.77 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 118.386 -0.816 . . . . 0.0 111.857 -173.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -55.79 -30.19 60.94 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.871 0.76 . . . . 0.0 111.994 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 68.6 mt -87.67 -9.48 54.05 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.085 0.954 . . . . 0.0 112.377 -174.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 30.75 59.87 1.01 Allowed Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 126.588 1.955 . . . . 0.0 112.504 -168.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -57.45 155.59 30.03 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.02 2.48 . . . . 0.0 114.242 -169.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.3 m -72.77 -42.01 64.45 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.889 0.476 . . . . 0.0 109.802 170.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 50.3 mtm180 -142.7 160.62 39.95 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.439 0.696 . . . . 0.0 109.91 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 26.3 tp -141.17 138.86 33.69 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 124.645 1.178 . . . . 0.0 108.583 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 62.3 tp -127.62 114.54 17.5 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 176.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 mm -86.39 148.6 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 172.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.9 t -140.7 133.5 31.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 118.459 0.572 . . . . 0.0 109.634 171.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -161.95 173.84 13.91 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.266 2.226 . . . . 0.0 107.351 169.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.18 157.54 37.98 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.052 -1.03 . . . . 0.0 109.734 169.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.7 m -151.55 126.44 9.7 Favored 'General case' 0 CA--C 1.527 0.09 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -77.42 80.51 3.91 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.994 0.902 . . . . 0.0 110.261 175.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 74.0 mtm -75.4 -6.55 50.61 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.012 1.725 . . . . 0.0 112.345 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.0 21.02 76.74 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 123.87 0.747 . . . . 0.0 111.943 -172.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.5 mt -93.49 -172.65 2.97 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.132 1.373 . . . . 0.0 109.706 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -74.2 140.45 76.55 Favored Pre-proline 0 N--CA 1.468 0.437 0 CA-C-O 117.695 -1.145 . . . . 0.0 108.434 169.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -43.01 137.99 4.25 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.423 2.749 . . . . 0.0 113.445 172.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.05 1.59 74.39 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 118.587 -1.118 . . . . 0.0 113.689 176.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -67.12 147.22 53.41 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.926 1.863 . . . . 0.0 107.891 168.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 55.2 mt -124.97 139.81 49.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 -173.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 91.3 mmt-85 -147.26 152.46 38.35 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 118.765 0.712 . . . . 0.0 111.734 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 48.5 mm -80.51 142.53 13.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 166.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.2 mt -134.99 164.3 34.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 124.871 1.268 . . . . 0.0 107.844 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -135.05 145.78 55.77 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 126.884 2.074 . . . . 0.0 107.974 -169.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -55.32 -25.04 45.48 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.292 2.662 . . . . 0.0 115.229 -173.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -66.33 -21.16 66.25 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.157 0.89 . . . . 0.0 112.271 176.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -122.16 -29.8 4.14 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.655 1.182 . . . . 0.0 112.149 -170.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.0 mt -50.8 -40.36 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.15 1.38 . . . . 0.0 109.675 169.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.91 -29.18 59.66 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.409 1.084 . . . . 0.0 112.989 -176.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -99.45 -43.91 6.37 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 20.8 mmt -68.06 -31.4 71.01 Favored 'General case' 0 CA--C 1.523 -0.087 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -169.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -70.33 -45.65 65.76 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 118.766 0.712 . . . . 0.0 111.491 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 CA--C 1.533 0.304 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.541 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.2 mt . . . . . 0 N--CA 1.476 0.834 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -52.48 -25.06 9.15 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.487 1.039 . . . . 0.0 112.128 167.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -59.11 -32.55 69.94 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.072 0.851 . . . . 0.0 111.529 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.8 tt -79.51 -44.6 20.91 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 85.0 mt -57.55 -42.39 81.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -59.63 -24.94 64.26 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -89.06 -4.0 58.5 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.151 0.98 . . . . 0.0 112.506 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -123.0 -30.87 3.71 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.449 1.022 . . . . 0.0 111.832 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -60.17 -20.66 59.59 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.103 0.961 . . . . 0.0 113.048 -176.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -69.62 -16.15 63.33 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.362 1.065 . . . . 0.0 112.094 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -140.2 -32.39 0.61 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.372 0.987 . . . . 0.0 113.621 -176.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 12.4 mt -69.53 138.78 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 170.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.62 -37.59 92.62 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.344 0.973 . . . . 0.0 112.483 -175.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -148.69 137.76 21.63 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 118.497 1.149 . . . . 0.0 108.462 175.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 45.2 t -129.63 124.45 59.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 25.8 mt -129.93 154.93 41.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -169.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -125.66 143.48 51.01 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 174.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.6 tt -122.23 124.08 42.95 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 169.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -110.71 156.73 15.39 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 57.7 mt -134.44 124.9 46.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 -176.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -64.89 118.14 45.81 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-O 117.448 -1.263 . . . . 0.0 110.447 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -76.18 171.68 17.66 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.703 2.935 . . . . 0.0 111.569 170.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -128.0 -31.96 2.34 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 125.765 1.626 . . . . 0.0 110.98 171.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -135.86 136.55 49.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.344 1.058 . . . . 0.0 108.161 175.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.9 t -140.79 132.2 29.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 174.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 162.83 154.76 7.75 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -70.11 153.18 43.48 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.898 0.856 . . . . 0.0 110.929 -171.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.9 t80 50.96 39.18 22.24 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.915 2.086 . . . . 0.0 112.222 -176.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.5 m-30 -120.29 148.04 46.42 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 123.793 0.837 . . . . 0.0 109.947 174.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -81.27 164.39 19.39 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.23 2.62 . . . . 0.0 111.162 177.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 52.0 ttm -72.74 140.54 47.85 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 168.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 71.4 p -81.25 159.81 24.42 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.374 1.07 . . . . 0.0 110.656 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.2 tm0? -51.04 -48.65 84.39 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-O 116.978 -1.487 . . . . 0.0 113.329 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -67.78 -30.01 34.55 Favored 'Trans proline' 0 C--N 1.352 0.731 0 CA-C-N 122.546 1.945 . . . . 0.0 112.368 -174.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.77 -35.88 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 119.092 0.86 . . . . 0.0 108.931 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -56.97 -47.13 81.49 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.46 1.027 . . . . 0.0 109.926 171.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -61.52 -42.49 98.9 Favored 'General case' 0 C--O 1.231 0.087 0 C-N-CA 122.995 0.518 . . . . 0.0 111.082 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.96 -48.47 80.23 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 119.04 -0.505 . . . . 0.0 110.952 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 55.5 t -60.01 -41.66 87.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 118.705 0.684 . . . . 0.0 109.617 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -69.58 -29.93 67.58 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.044 0.838 . . . . 0.0 111.568 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 38.0 m -69.58 -45.48 68.55 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.325 -0.86 . . . . 0.0 109.776 174.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 78.7 t -59.23 -47.15 91.29 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 175.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -52.08 -48.11 64.86 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.008 0.923 . . . . 0.0 110.811 177.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -64.0 -44.0 93.98 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 118.564 0.62 . . . . 0.0 110.991 177.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.6 tpp85 -64.11 -26.54 68.59 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 118.736 -0.65 . . . . 0.0 112.234 -175.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 61.0 mt -57.2 -23.68 49.39 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.412 1.006 . . . . 0.0 112.317 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 . . . . . 0 CA--C 1.538 0.487 0 CA-C-N 119.325 0.966 . . . . 0.0 112.558 178.121 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 . . . . . 0 C--O 1.236 0.343 0 CA-C-O 121.338 0.59 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.81 151.13 39.09 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -91.98 120.47 32.67 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 59.0 tp . . . . . 0 C--O 1.233 0.236 0 C-N-CA 124.486 1.115 . . . . 0.0 109.794 178.482 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 29.8 t0 . . . . . 0 C--O 1.235 0.315 0 N-CA-C 105.056 -2.202 . . . . 0.0 105.056 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.4 t -121.84 147.45 25.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.431 0.634 . . . . 0.0 109.995 -165.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 28.6 tp -116.27 127.95 55.16 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 56.8 tp -117.45 94.49 4.57 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 94.5 m -71.14 143.51 50.54 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.459 -0.791 . . . . 0.0 108.918 170.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.9 t -141.38 141.46 30.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 125.23 1.412 . . . . 0.0 107.655 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 143.38 176.34 17.33 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 124.494 1.045 . . . . 0.0 111.949 176.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -120.83 121.49 38.25 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 125.017 1.327 . . . . 0.0 108.124 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 m -59.07 -16.86 21.19 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.438 1.895 . . . . 0.0 115.342 -169.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -126.38 14.27 7.69 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.958 0.903 . . . . 0.0 111.03 -175.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.6 ttt -97.84 32.77 2.26 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.274 0.63 . . . . 0.0 109.586 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.2 -146.3 27.66 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -174.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -60.31 -17.39 42.45 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 126.028 1.731 . . . . 0.0 112.377 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -51.72 -28.03 13.75 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.022 1.329 . . . . 0.0 112.681 175.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.28 26.61 0.56 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.845 1.212 . . . . 0.0 114.456 178.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.77 -50.19 73.38 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 119.291 1.545 . . . . 0.0 110.297 -173.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.95 -56.69 23.33 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-O 117.75 -1.584 . . . . 0.0 111.111 175.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -48.78 -41.04 39.2 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 CA-C-N 120.972 2.386 . . . . 0.0 115.214 178.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.0 tp -71.24 -37.91 71.98 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-N 119.962 1.255 . . . . 0.0 110.605 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.6 tp -60.97 -48.35 82.23 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.308 0.504 . . . . 0.0 109.934 175.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.19 -40.01 88.56 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.773 0.829 . . . . 0.0 111.046 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.6 tp10 -61.06 -49.54 76.96 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 118.492 0.587 . . . . 0.0 109.535 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -63.51 -44.83 93.15 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 119.192 -0.433 . . . . 0.0 110.742 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 75.4 m -63.71 -42.25 97.99 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.716 0.689 . . . . 0.0 111.039 178.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.83 -41.15 99.21 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.417 0.553 . . . . 0.0 110.788 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.92 -32.86 72.78 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.379 0.672 . . . . 0.0 111.99 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.7 88.53 3.29 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 124.707 1.203 . . . . 0.0 109.014 -171.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -51.39 160.92 2.07 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 123.967 3.111 . . . . 0.0 114.329 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -135.75 164.26 28.31 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.473 1.509 . . . . 0.0 108.964 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 41.8 -120.18 2.03 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.491 1.52 . . . . 0.0 111.374 175.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -140.91 34.99 1.76 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.844 1.257 . . . . 0.0 109.443 170.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -69.3 162.21 27.68 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.636 0.774 . . . . 0.0 111.99 -174.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.2 t -116.61 119.13 61.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 103.728 -2.693 . . . . 0.0 103.728 165.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.4 t -88.1 136.79 22.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -172.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 73.0 mt -133.08 143.99 37.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 104.705 -2.332 . . . . 0.0 104.705 169.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -128.03 106.96 9.43 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 172.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.14 -2.98 80.63 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-O 118.929 -0.928 . . . . 0.0 112.807 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 56.83 -147.29 33.7 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 -168.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.6 p -86.61 10.38 15.71 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.732 -0.863 . . . . 0.0 111.876 177.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.76 59.76 17.19 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 125.138 1.375 . . . . 0.0 110.519 -175.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -67.75 -15.4 44.22 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.824 2.35 . . . . 0.0 113.355 -172.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -57.25 -30.75 64.91 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.824 0.738 . . . . 0.0 112.126 173.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.0 -28.46 70.11 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.185 0.594 . . . . 0.0 111.97 175.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.18 -4.12 36.19 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.954 1.301 . . . . 0.0 111.894 -169.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.8 mt -48.57 -43.73 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 124.265 1.026 . . . . 0.0 109.79 170.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 52.5 t -59.5 -38.73 76.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 118.591 0.632 . . . . 0.0 110.644 -177.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.69 -44.53 81.48 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 121.918 -0.489 . . . . 0.0 110.21 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 77.6 mt -60.02 -39.62 80.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 123.489 0.716 . . . . 0.0 109.507 176.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -65.8 -20.33 66.21 Favored 'General case' 0 N--CA 1.462 0.145 0 O-C-N 121.024 -1.048 . . . . 0.0 112.311 178.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -75.55 -48.18 23.56 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 120.122 1.328 . . . . 0.0 109.087 169.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.8 mt -66.04 -26.94 67.75 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.402 0.681 . . . . 0.0 112.368 -175.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 42.77 59.61 10.76 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 125.87 1.668 . . . . 0.0 110.863 -175.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -53.92 146.35 47.23 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.691 2.26 . . . . 0.0 113.413 -169.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.3 m -74.75 -35.1 62.6 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 167.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -147.98 152.5 37.58 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.78 1.232 . . . . 0.0 109.086 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 51.3 tp -140.9 141.37 34.57 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.433 1.093 . . . . 0.0 108.862 -177.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 58.8 tp -125.54 136.92 53.83 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 170.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.5 mt -121.17 143.67 32.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.5 t -140.58 135.41 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 118.586 0.63 . . . . 0.0 110.018 -173.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -162.9 170.37 18.27 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.727 2.411 . . . . 0.0 107.454 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.48 154.94 39.71 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 168.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.9 m -153.23 124.13 7.37 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -69.64 120.99 16.25 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 169.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 76.7 mtm -119.04 1.29 11.41 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.636 1.575 . . . . 0.0 110.704 -177.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.94 34.2 89.24 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 118.929 0.786 . . . . 0.0 111.577 -172.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.3 mt -111.54 -172.14 1.98 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.774 1.63 . . . . 0.0 109.446 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -75.28 140.18 72.62 Favored Pre-proline 0 N--CA 1.468 0.453 0 CA-C-O 117.456 -1.259 . . . . 0.0 108.681 173.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -43.64 136.55 6.55 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.198 2.599 . . . . 0.0 112.896 172.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.65 1.79 83.95 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-O 118.584 -1.12 . . . . 0.0 113.758 177.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -65.75 147.24 53.71 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 120.02 1.91 . . . . 0.0 108.68 168.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 66.9 mt -126.82 133.12 69.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 C-N-CA 125.403 1.481 . . . . 0.0 107.077 -172.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.3 mmt-85 -143.42 151.81 40.81 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.864 0.756 . . . . 0.0 109.691 174.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 48.7 mm -80.83 145.72 8.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 168.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 11.1 mt -131.81 123.39 51.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -175.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -76.81 140.69 67.51 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-O 117.87 -1.062 . . . . 0.0 109.716 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_exo -46.81 -35.24 17.4 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 124.264 3.309 . . . . 0.0 116.677 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -68.59 -23.96 64.53 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.648 0.658 . . . . 0.0 111.687 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -98.81 -31.46 11.86 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.279 1.431 . . . . 0.0 111.116 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 68.0 mt -50.11 -40.82 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.796 1.238 . . . . 0.0 109.569 169.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.93 -19.97 7.9 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.887 1.675 . . . . 0.0 114.327 -175.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -124.33 -37.0 2.58 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 118.72 0.691 . . . . 0.0 110.553 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 21.3 mmt -66.85 -29.43 69.34 Favored 'General case' 0 N--CA 1.46 0.063 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -175.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -69.35 -45.4 69.52 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 119.155 0.889 . . . . 0.0 110.487 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 21.7 ptp . . . . . 0 CA--C 1.537 0.469 0 CA-C-O 118.923 -0.56 . . . . 0.0 112.468 176.564 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.7 mt . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 116.854 2.168 . . . . 0.0 116.854 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.04 -22.59 6.11 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.188 0.995 . . . . 0.0 112.608 168.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -59.51 -33.77 71.77 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.336 0.971 . . . . 0.0 111.755 175.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.9 tt -73.41 -44.49 58.26 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 74.4 mt -60.55 -42.29 90.93 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.107 0 C-N-CA 123.258 0.623 . . . . 0.0 109.63 -177.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -60.5 -24.37 65.25 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -176.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -85.03 -11.42 55.41 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.754 0.822 . . . . 0.0 112.063 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.4 mp -121.14 -31.28 4.16 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.32 1.448 . . . . 0.0 111.855 -168.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -60.57 -21.1 62.22 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.68 1.192 . . . . 0.0 112.611 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -71.78 -11.31 60.75 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.593 1.157 . . . . 0.0 111.694 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -134.35 -38.55 0.84 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.092 0.957 . . . . 0.0 112.138 -176.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 53.3 mt -72.17 139.96 18.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 174.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.08 -41.64 94.96 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.052 0.834 . . . . 0.0 111.972 -178.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -149.41 137.63 20.67 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 118.564 1.182 . . . . 0.0 108.612 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 41.4 t -131.13 123.98 54.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 19.9 mt -127.09 154.79 37.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 -171.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -129.74 141.84 50.81 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 173.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.1 tt -121.76 128.42 51.73 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 173.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -114.67 156.29 15.75 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 72.5 mt -131.98 128.09 59.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -177.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.1 tp60 -62.55 115.48 16.91 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 117.579 -1.201 . . . . 0.0 110.157 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -78.76 172.91 14.35 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.143 2.562 . . . . 0.0 111.552 171.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -137.29 -30.7 0.84 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 127.811 2.444 . . . . 0.0 111.045 173.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -129.74 124.14 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 -176.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.7 t -145.27 132.91 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 151.63 150.56 5.37 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -63.8 149.95 45.76 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 118.155 0.978 . . . . 0.0 110.901 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 57.95 43.62 21.03 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.601 1.96 . . . . 0.0 111.951 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -127.72 140.65 38.7 Favored Pre-proline 0 C--O 1.236 0.345 0 C-N-CA 124.116 0.967 . . . . 0.0 108.78 168.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -73.97 161.66 40.74 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.462 2.108 . . . . 0.0 110.041 170.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 52.1 ttm -70.27 139.49 52.17 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 168.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 33.1 p -76.32 156.49 33.31 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.134 0.974 . . . . 0.0 110.504 176.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.1 tm0? -49.32 -46.79 77.5 Favored Pre-proline 0 CA--C 1.544 0.733 0 CA-C-O 117.009 -1.472 . . . . 0.0 113.912 -178.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.46 -28.0 32.87 Favored 'Trans proline' 0 C--N 1.35 0.645 0 CA-C-N 122.616 1.97 . . . . 0.0 112.257 -175.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 mp -80.41 -35.55 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 119.358 0.981 . . . . 0.0 108.64 177.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -56.91 -47.23 81.03 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.405 1.002 . . . . 0.0 109.913 170.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -61.3 -41.81 97.6 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 123.303 0.641 . . . . 0.0 111.013 178.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.98 -48.99 77.89 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 119.121 -0.466 . . . . 0.0 110.929 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 56.0 t -59.48 -41.04 83.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 118.712 0.687 . . . . 0.0 109.728 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -68.94 -30.48 68.95 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.028 0.831 . . . . 0.0 111.483 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 32.9 m -69.41 -40.97 76.98 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.062 -1.024 . . . . 0.0 109.981 174.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 77.4 t -61.25 -50.08 81.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -56.28 -35.66 67.72 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.517 1.127 . . . . 0.0 112.156 177.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -67.9 -43.52 79.08 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.524 1.056 . . . . 0.0 110.685 171.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -58.91 -31.39 68.59 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 118.568 -0.729 . . . . 0.0 112.441 176.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.7 mp -56.52 -22.96 36.5 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.449 1.022 . . . . 0.0 111.973 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 . . . . . 0 CA--C 1.542 0.669 0 CA-C-N 119.449 1.022 . . . . 0.0 112.795 178.835 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 . . . . . 0 C--O 1.236 0.387 0 CA-C-O 121.73 0.776 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.9 153.41 38.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.574 176.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -93.42 121.88 35.27 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 50.1 tp . . . . . 0 CA--C 1.532 0.282 0 C-N-CA 125.663 1.585 . . . . 0.0 109.837 178.68 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.6 t0 . . . . . 0 C--O 1.233 0.206 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 56.3 t -93.93 146.69 6.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.556 0.693 . . . . 0.0 109.655 -169.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 58.5 tp -115.76 114.75 25.21 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 170.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 55.3 tp -103.59 102.29 12.16 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.456 1.102 . . . . 0.0 108.03 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 90.6 m -76.63 142.3 40.7 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 170.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.5 t -141.0 142.63 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 143.49 178.77 19.57 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -132.53 121.0 22.63 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 124.613 1.165 . . . . 0.0 108.443 177.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 m -58.58 -5.33 0.53 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.957 2.503 . . . . 0.0 116.391 -169.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -133.03 10.36 4.19 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.294 0.952 . . . . 0.0 111.446 -176.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 63.8 mtp -95.71 27.97 3.24 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.599 0.76 . . . . 0.0 110.581 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.6 -139.34 19.39 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 -177.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -62.9 -15.81 56.59 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.321 1.048 . . . . 0.0 112.148 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -58.29 -18.6 28.11 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.922 1.289 . . . . 0.0 112.755 174.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.54 19.67 0.86 Allowed Glycine 0 CA--C 1.535 1.3 0 O-C-N 120.626 -1.296 . . . . 0.0 114.237 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.85 -53.3 57.72 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 119.865 1.832 . . . . 0.0 111.157 -169.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.92 -53.93 41.7 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-O 117.953 -1.471 . . . . 0.0 111.21 176.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -50.57 -38.97 55.92 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 CA-C-N 120.907 2.353 . . . . 0.0 115.188 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.1 tp -70.3 -38.7 75.05 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 120.029 1.286 . . . . 0.0 110.243 177.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 51.1 tp -61.89 -48.89 78.43 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.001 0.364 . . . . 0.0 110.219 175.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.66 -41.05 80.73 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 124.302 1.041 . . . . 0.0 111.115 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -61.7 -48.74 79.4 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.771 0.714 . . . . 0.0 109.995 178.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -61.13 -46.24 91.38 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 122.817 0.447 . . . . 0.0 110.518 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 85.6 m -64.0 -40.38 96.23 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.278 0.49 . . . . 0.0 111.117 178.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.44 -38.9 92.92 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.334 0.516 . . . . 0.0 110.947 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.64 -37.65 76.86 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.3 0.64 . . . . 0.0 111.244 178.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.72 98.81 1.69 Allowed Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 125.122 1.369 . . . . 0.0 108.549 -172.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.52 167.36 25.64 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.305 2.004 . . . . 0.0 111.679 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -128.62 177.41 7.05 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.927 1.691 . . . . 0.0 108.654 177.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 41.16 -124.65 2.95 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.054 1.311 . . . . 0.0 112.317 175.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -141.44 37.91 1.69 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.25 1.42 . . . . 0.0 109.337 172.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -72.63 167.83 19.93 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.374 1.07 . . . . 0.0 111.85 -174.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.0 t -123.57 110.31 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 167.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.6 t -75.21 139.32 19.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -175.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 22.9 mm -134.59 147.95 29.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 169.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -130.72 112.2 12.87 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 176.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.52 -11.49 80.18 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 118.79 -1.005 . . . . 0.0 112.982 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.65 35.51 81.44 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 119.017 1.408 . . . . 0.0 113.667 170.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 66.92 10.26 7.49 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.772 1.629 . . . . 0.0 113.5 -177.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.79 53.68 4.84 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 125.341 1.457 . . . . 0.0 108.794 173.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -64.02 -24.63 66.79 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.488 2.125 . . . . 0.0 112.7 -169.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -63.49 -33.53 75.77 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.974 0.806 . . . . 0.0 111.741 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.52 -22.57 67.0 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.569 0.748 . . . . 0.0 111.552 174.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -105.59 -2.2 23.77 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.444 1.098 . . . . 0.0 112.653 -169.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.8 mt -47.24 -42.73 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.989 1.315 . . . . 0.0 110.372 173.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.3 t -56.42 -42.32 74.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.068 0.547 . . . . 0.0 110.167 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.12 -35.55 76.54 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.072 0.549 . . . . 0.0 111.525 -177.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 68.6 mt -63.83 -46.88 93.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 173.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 37.0 mtp180 -69.37 -22.43 63.73 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 117.888 -1.053 . . . . 0.0 112.624 -174.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -56.33 -32.45 64.67 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 120.535 1.516 . . . . 0.0 110.847 170.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 55.1 mt -86.64 -10.85 52.94 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.11 0.964 . . . . 0.0 112.773 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 28.68 61.85 0.72 Allowed Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 126.825 2.05 . . . . 0.0 112.54 -167.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.53 149.15 40.33 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.294 2.663 . . . . 0.0 113.873 -169.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.0 m -71.81 -37.59 70.36 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 168.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -147.97 156.61 42.86 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.059 0.944 . . . . 0.0 109.537 -176.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 41.7 tp -143.75 139.09 29.25 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 124.805 1.242 . . . . 0.0 108.653 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 57.1 tp -124.1 137.17 54.6 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 169.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.7 mt -120.58 143.21 33.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.4 t -140.58 134.03 33.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 118.442 0.565 . . . . 0.0 109.83 -175.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -161.87 172.57 15.86 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.241 2.217 . . . . 0.0 107.39 170.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.49 157.51 36.98 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 121.288 -0.883 . . . . 0.0 108.753 167.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.2 m -152.8 129.38 10.75 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -77.52 82.78 3.94 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 118.921 0.782 . . . . 0.0 109.731 176.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 77.5 mtm -76.82 -6.45 52.38 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.281 1.433 . . . . 0.0 111.806 -177.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.36 25.61 72.43 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.091 0.853 . . . . 0.0 111.752 -174.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 47.5 mt -107.84 -168.56 1.39 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.512 1.125 . . . . 0.0 109.873 -176.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -79.31 138.47 55.82 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-O 117.738 -1.125 . . . . 0.0 109.263 175.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -45.51 134.93 12.68 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.474 2.782 . . . . 0.0 113.864 177.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.13 1.82 90.17 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-O 118.597 -1.113 . . . . 0.0 113.238 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -64.1 145.79 55.32 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 119.767 1.784 . . . . 0.0 107.804 167.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 59.0 mt -126.74 137.33 58.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 -175.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.2 mmt-85 -147.59 150.19 33.98 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 118.792 0.724 . . . . 0.0 111.445 175.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 50.2 mm -72.97 149.38 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 164.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.6 mt -133.41 133.62 57.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -80.91 142.75 52.52 Favored Pre-proline 0 N--CA 1.471 0.614 0 CA-C-O 117.508 -1.234 . . . . 0.0 109.37 174.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -46.59 -37.48 20.35 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 123.997 3.131 . . . . 0.0 116.435 177.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -69.57 -22.32 63.54 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.552 0.614 . . . . 0.0 111.603 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -97.13 -34.1 11.26 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.956 1.303 . . . . 0.0 110.75 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 83.7 mt -50.81 -42.15 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 125.513 1.525 . . . . 0.0 109.111 169.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.55 -23.61 51.49 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.611 1.164 . . . . 0.0 113.571 -175.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -107.39 -40.76 5.27 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 123.184 0.593 . . . . 0.0 109.613 176.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 22.4 mmt -71.71 -29.49 64.62 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -169.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -71.09 -43.03 68.54 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 119.458 1.026 . . . . 0.0 110.981 175.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 28.9 ptm . . . . . 0 CA--C 1.537 0.454 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 176.376 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.8 mt . . . . . 0 N--CA 1.474 0.755 0 N-CA-C 118.116 2.636 . . . . 0.0 118.116 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.06 -23.6 8.07 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.333 0.969 . . . . 0.0 112.821 168.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -59.19 -33.07 70.51 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.351 0.978 . . . . 0.0 111.883 175.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.6 tt -74.58 -43.23 56.63 Favored 'General case' 0 C--N 1.338 0.071 0 O-C-N 121.719 -0.613 . . . . 0.0 109.399 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 87.7 mt -61.73 -40.14 85.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.544 0.738 . . . . 0.0 109.728 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -57.39 -30.61 65.05 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.262 0.625 . . . . 0.0 112.264 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -84.74 -1.62 56.51 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.427 1.091 . . . . 0.0 112.27 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 70.7 mt -126.53 -26.13 3.33 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.457 1.103 . . . . 0.0 112.061 -175.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -58.69 -29.45 66.64 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.805 1.184 . . . . 0.0 111.82 170.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -66.97 -11.93 58.16 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.992 0.917 . . . . 0.0 113.132 173.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -129.84 -11.42 4.33 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.382 1.073 . . . . 0.0 113.701 -168.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 46.7 mt -132.33 143.41 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 125.488 1.515 . . . . 0.0 107.995 -169.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -68.52 -40.77 86.14 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-O 119.211 -0.772 . . . . 0.0 112.261 -175.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -147.46 138.75 23.77 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 118.686 1.243 . . . . 0.0 108.52 177.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 51.3 t -134.25 121.62 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 -176.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 18.2 mt -127.41 154.66 38.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 -170.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -130.32 144.19 51.23 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 174.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.3 tt -124.96 128.21 48.25 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 173.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -111.14 156.48 15.52 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 74.4 mt -133.44 126.39 52.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -66.12 117.27 41.21 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 117.368 -1.301 . . . . 0.0 110.296 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -76.84 172.06 16.88 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.515 2.81 . . . . 0.0 111.499 170.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -128.44 -32.27 2.21 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.882 1.673 . . . . 0.0 111.103 171.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -135.55 135.21 51.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 176.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.3 t -141.22 134.85 31.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 175.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 157.81 155.1 7.38 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 177.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -64.96 153.62 40.01 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.941 0.877 . . . . 0.0 111.339 -174.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 52.88 39.64 29.42 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.036 2.134 . . . . 0.0 112.127 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -123.41 148.76 56.32 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 123.828 0.851 . . . . 0.0 109.943 173.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -82.15 163.02 17.76 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.262 2.641 . . . . 0.0 111.184 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 53.1 ttm -71.47 139.41 49.6 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 168.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 72.5 p -79.65 159.27 26.79 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.356 1.063 . . . . 0.0 110.538 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.3 tp60 -53.06 -44.54 97.31 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 116.565 -1.683 . . . . 0.0 114.197 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -68.42 -30.46 29.65 Favored 'Trans proline' 0 C--N 1.352 0.717 0 CA-C-N 122.888 2.067 . . . . 0.0 112.176 -176.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.8 -35.45 16.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 119.026 0.83 . . . . 0.0 108.788 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -56.5 -46.85 80.29 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.318 0.963 . . . . 0.0 110.074 170.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -63.94 -37.98 89.41 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 123.039 0.536 . . . . 0.0 111.203 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.69 -47.28 78.97 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 119.108 -0.472 . . . . 0.0 111.045 175.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 76.5 t -61.5 -38.56 80.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 118.915 0.779 . . . . 0.0 109.688 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -63.65 -39.2 93.74 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 119.361 0.982 . . . . 0.0 110.926 174.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 41.2 m -64.76 -45.01 88.21 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.55 -0.719 . . . . 0.0 110.092 177.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 73.8 t -62.26 -44.48 99.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.32 0.648 . . . . 0.0 109.574 176.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -55.41 -47.44 75.9 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.032 0.933 . . . . 0.0 110.521 177.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -63.77 -38.98 93.14 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 121.827 -0.546 . . . . 0.0 111.248 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -61.12 -25.57 67.07 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 118.27 -0.872 . . . . 0.0 112.534 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 94.5 mt -57.7 -23.36 51.3 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.99 1.268 . . . . 0.0 112.195 178.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 . . . . . 0 CA--C 1.546 0.803 0 CA-C-N 118.973 0.806 . . . . 0.0 112.428 -178.511 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 . . . . . 0 N--CA 1.454 -0.253 0 CA-C-O 121.902 0.858 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.29 153.69 21.79 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 169.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -91.29 134.61 34.44 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 173.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 56.8 tp . . . . . 0 N--CA 1.45 -0.442 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 175.971 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 . . . . . 0 C--O 1.234 0.288 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 79.8 t -137.35 146.91 27.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 36.1 tp -121.55 128.32 51.89 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 56.0 tp -118.83 95.98 5.06 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 89.1 m -70.39 142.96 52.03 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 169.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.8 t -140.64 142.08 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.314 1.446 . . . . 0.0 107.327 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 143.53 172.61 14.5 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 123.976 0.798 . . . . 0.0 112.059 175.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -110.2 118.56 36.67 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.537 1.135 . . . . 0.0 108.16 177.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -60.53 -13.88 16.55 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.235 1.814 . . . . 0.0 115.14 -170.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 26.0 ptm -127.94 18.13 6.68 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.584 1.153 . . . . 0.0 111.246 -173.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.2 ttt -110.72 37.95 2.63 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.101 0.864 . . . . 0.0 110.055 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.83 -141.37 26.24 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -61.35 -16.77 49.47 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.498 1.519 . . . . 0.0 112.198 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -60.51 -16.06 33.33 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.17 0.988 . . . . 0.0 112.127 174.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.64 17.16 2.77 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-O 118.35 -1.25 . . . . 0.0 113.649 174.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.09 -50.43 71.96 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 119.891 1.846 . . . . 0.0 111.123 -170.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.84 -54.96 32.59 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-O 117.789 -1.562 . . . . 0.0 110.825 175.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -48.51 -40.1 37.01 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 CA-C-N 120.758 2.279 . . . . 0.0 115.206 175.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.6 tp -71.4 -37.94 71.5 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.931 1.242 . . . . 0.0 110.466 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.8 tp -61.22 -46.89 88.58 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.235 0.47 . . . . 0.0 110.033 174.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.09 -40.74 86.2 Favored 'General case' 0 C--O 1.226 -0.159 0 C-N-CA 123.71 0.804 . . . . 0.0 111.036 178.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.8 tp10 -61.71 -49.52 76.12 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.601 0.637 . . . . 0.0 109.549 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -63.74 -45.6 89.12 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.87 0.468 . . . . 0.0 110.71 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 74.0 m -65.05 -37.84 88.87 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.703 0.683 . . . . 0.0 111.172 178.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.37 -40.38 95.73 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.263 0.938 . . . . 0.0 110.876 176.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.36 -34.05 75.38 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.277 0.631 . . . . 0.0 111.705 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.12 90.52 3.51 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 125.164 1.386 . . . . 0.0 108.792 -173.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -51.64 162.01 1.8 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 124.127 3.218 . . . . 0.0 114.486 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.403 ' HE2' ' CE1' ' A' ' 136' ' ' TYR . 36.7 mmtm -134.81 156.43 48.89 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 124.538 1.135 . . . . 0.0 110.052 -178.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 38.57 -111.45 0.17 Allowed Glycine 0 CA--C 1.527 0.817 0 C-N-CA 126.394 1.949 . . . . 0.0 113.096 170.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -137.74 9.68 2.86 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.392 1.477 . . . . 0.0 111.018 -171.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -81.77 126.41 31.8 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 121.33 -0.856 . . . . 0.0 111.205 -168.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.9 t -75.27 117.77 20.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 165.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.1 t -80.13 134.51 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -177.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 84.7 mt -133.54 146.19 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 170.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -127.57 110.47 12.74 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 173.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.5 -1.38 90.2 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 119.105 -0.83 . . . . 0.0 112.864 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 56.34 -147.57 31.24 Favored Glycine 0 C--N 1.339 0.737 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 -169.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.9 p -88.66 6.78 36.8 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.522 0.729 . . . . 0.0 112.155 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.37 58.2 20.24 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.179 1.392 . . . . 0.0 109.856 -177.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -68.68 -16.15 41.85 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.844 2.363 . . . . 0.0 113.237 -169.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -57.37 -31.07 65.41 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.479 0.711 . . . . 0.0 111.882 175.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.24 -28.26 69.04 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.256 0.622 . . . . 0.0 112.157 175.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.4 -2.48 45.46 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.967 1.307 . . . . 0.0 111.936 -169.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 87.9 mt -51.71 -43.72 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 123.923 0.889 . . . . 0.0 109.915 176.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.5 t -58.26 -41.05 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.265 0.626 . . . . 0.0 110.192 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.0 -44.96 75.36 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.241 0.473 . . . . 0.0 110.674 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.2 mt -59.11 -42.26 86.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -59.88 -31.17 69.54 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 118.061 -0.971 . . . . 0.0 111.847 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -59.97 -31.76 70.19 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.985 1.266 . . . . 0.0 111.133 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.6 mt -81.99 -13.0 58.04 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.176 0.99 . . . . 0.0 112.095 -175.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 72.8 mtp180 33.15 61.79 1.56 Allowed Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 126.552 1.941 . . . . 0.0 111.721 -169.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -53.88 143.2 61.14 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.008 2.472 . . . . 0.0 113.074 -169.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.4 m -72.81 -38.8 67.07 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 167.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 71.4 mtm180 -144.45 156.87 44.4 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 124.455 1.102 . . . . 0.0 108.969 176.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 45.6 tp -137.72 140.24 40.61 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.4 tp -126.24 136.38 52.73 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 174.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.0 mt -125.07 142.06 43.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 -174.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.1 t -141.56 133.77 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 118.806 0.73 . . . . 0.0 110.846 -174.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -161.36 172.21 16.96 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.565 2.346 . . . . 0.0 107.647 169.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.45 156.81 38.26 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.011 -1.056 . . . . 0.0 108.895 168.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.0 m -156.15 129.18 8.0 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 177.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -71.84 124.64 25.26 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 173.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 74.2 mtm -123.6 1.51 8.88 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.16 1.784 . . . . 0.0 110.766 -177.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.64 24.45 66.2 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-N 118.683 0.674 . . . . 0.0 112.423 -172.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.9 mt -95.74 -173.69 2.93 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.223 1.409 . . . . 0.0 109.333 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -73.38 140.4 79.27 Favored Pre-proline 0 N--CA 1.466 0.355 0 CA-C-O 117.72 -1.133 . . . . 0.0 108.18 170.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -44.23 136.59 8.07 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.258 2.639 . . . . 0.0 112.748 173.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.27 1.97 82.36 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-O 118.501 -1.166 . . . . 0.0 113.796 177.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -67.89 152.21 45.92 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 120.135 1.968 . . . . 0.0 108.257 168.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 51.5 mt -131.5 134.67 60.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -169.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.6 mmt-85 -147.01 148.85 32.11 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 118.721 0.691 . . . . 0.0 109.772 175.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 44.3 mm -73.79 152.85 7.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 166.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.9 mt -135.18 134.74 52.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 176.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -79.02 143.4 61.38 Favored Pre-proline 0 N--CA 1.472 0.661 0 CA-C-O 117.4 -1.286 . . . . 0.0 109.256 173.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo -45.47 -38.22 15.73 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 124.029 3.152 . . . . 0.0 116.439 176.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -68.04 -26.34 65.82 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.363 0.529 . . . . 0.0 111.523 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -94.35 -29.91 14.78 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.786 1.235 . . . . 0.0 111.232 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 59.9 mt -51.71 -45.59 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.15 1.38 . . . . 0.0 109.339 170.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -52.96 -31.35 40.0 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.292 1.037 . . . . 0.0 112.898 -177.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -96.8 -37.63 10.19 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.328 0.651 . . . . 0.0 110.328 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 24.8 mmt -80.64 -27.08 37.32 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 119.09 -0.481 . . . . 0.0 112.249 -170.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -64.8 -45.9 84.31 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 119.187 0.903 . . . . 0.0 110.286 175.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 20.2 ptt? . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -179.535 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.1 mt . . . . . 0 N--CA 1.466 0.331 0 N-CA-C 117.836 2.532 . . . . 0.0 117.836 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.95 -20.34 6.01 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.31 0.959 . . . . 0.0 112.055 167.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -59.91 -27.18 66.52 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.557 1.071 . . . . 0.0 112.582 173.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.7 tt -63.35 -49.42 73.98 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 119.141 0.882 . . . . 0.0 108.909 172.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 84.1 mt -64.82 -43.21 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -63.54 -19.65 64.97 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -175.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -102.55 8.77 39.78 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.176 1.39 . . . . 0.0 111.781 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.6 tp -140.31 -25.77 0.78 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.826 0.851 . . . . 0.0 112.163 -170.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 50.5 pttt -56.01 -24.66 40.4 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.51 1.524 . . . . 0.0 112.271 172.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -62.4 -17.07 58.31 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.996 1.318 . . . . 0.0 112.635 -172.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -130.15 9.12 5.21 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.646 0.778 . . . . 0.0 112.584 -175.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 56.3 mt -122.96 143.14 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.894 1.278 . . . . 0.0 108.409 -175.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -73.43 -37.01 54.14 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.868 0.747 . . . . 0.0 112.027 -177.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -149.43 136.56 19.83 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 118.226 1.013 . . . . 0.0 108.508 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 43.8 t -122.24 128.92 75.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 171.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.8 mt -126.64 149.26 31.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 -169.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -131.31 144.46 51.28 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 169.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.1 tt -124.56 127.79 47.94 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.45 1.5 . . . . 0.0 107.045 174.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -109.77 155.82 15.9 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 78.4 mt -133.78 127.69 52.82 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 -178.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 69.1 tp60 -61.77 114.79 12.28 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-O 117.467 -1.254 . . . . 0.0 110.517 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -77.34 171.46 17.66 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.402 2.735 . . . . 0.0 111.188 170.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -138.24 -26.93 0.9 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 127.088 2.155 . . . . 0.0 111.536 173.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -136.77 120.12 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 -173.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.5 t -143.22 129.4 16.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 156.76 151.75 6.07 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -63.21 145.28 55.84 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.421 0.629 . . . . 0.0 110.765 -174.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 64.83 0.08 1.1 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 128.199 2.6 . . . . 0.0 113.834 -175.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 19.3 m-30 -77.28 142.51 67.88 Favored Pre-proline 0 C--O 1.237 0.418 0 CA-C-N 120.309 1.413 . . . . 0.0 109.133 174.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -73.61 158.29 47.58 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.48 2.12 . . . . 0.0 109.914 169.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 47.3 ttm -73.88 142.78 46.0 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 168.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 29.9 p -81.12 155.09 26.42 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.082 0.953 . . . . 0.0 110.798 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -53.69 -40.43 80.64 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-O 116.529 -1.7 . . . . 0.0 114.729 -178.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -63.68 -39.68 33.57 Favored 'Trans proline' 0 C--N 1.35 0.647 0 CA-C-N 122.819 2.043 . . . . 0.0 111.291 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.6 mp -73.21 -37.53 52.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -57.19 -47.06 82.21 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.35 0.977 . . . . 0.0 110.305 172.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -63.99 -39.25 93.7 Favored 'General case' 0 C--N 1.334 -0.095 0 C-N-CA 122.959 0.504 . . . . 0.0 110.903 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.59 -46.68 84.72 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 122.994 0.517 . . . . 0.0 111.095 176.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 52.7 t -59.94 -41.31 85.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -67.69 -27.88 67.21 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 118.843 0.747 . . . . 0.0 111.858 177.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 36.7 m -71.13 -41.86 69.95 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.366 -0.833 . . . . 0.0 109.952 174.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 98.2 t -62.73 -48.7 86.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 119.2 0.909 . . . . 0.0 108.761 173.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.403 ' CE1' ' HE2' ' A' ' 31' ' ' LYS . 18.0 t80 -50.91 -50.17 57.99 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.655 1.182 . . . . 0.0 111.301 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -73.18 -31.71 64.38 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.915 0.779 . . . . 0.0 111.988 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -61.3 -38.01 85.27 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.077 0.853 . . . . 0.0 110.642 176.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 75.7 mt -55.7 -20.48 14.47 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -174.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 . . . . . 0 CA--C 1.54 0.581 0 CA-C-N 119.649 1.113 . . . . 0.0 112.352 177.17 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 . . . . . 0 N--CA 1.446 -0.654 0 CA-C-O 121.484 0.659 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.88 155.65 37.26 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.784 0.834 . . . . 0.0 109.0 170.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -92.18 140.8 29.26 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 173.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 52.0 tp . . . . . 0 N--CA 1.449 -0.5 0 C-N-CA 124.969 1.308 . . . . 0.0 107.806 173.86 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.6 t0 . . . . . 0 C--O 1.231 0.129 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 55.4 t -92.74 145.96 6.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -169.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 50.4 tp -119.76 98.19 5.99 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 172.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.9 tp -90.07 106.12 18.27 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -75.49 150.41 38.22 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 172.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.9 t -142.27 140.05 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 143.66 172.6 14.59 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.017 0.818 . . . . 0.0 112.135 176.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -116.67 120.25 38.05 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.92 1.288 . . . . 0.0 108.257 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 m -59.43 -13.72 9.69 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.644 1.977 . . . . 0.0 115.529 -169.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.1 ptt? -129.83 12.36 5.74 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 119.239 0.927 . . . . 0.0 111.485 -176.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.6 ttt -96.99 34.27 1.76 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.718 0.69 . . . . 0.0 110.002 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.37 -140.81 22.4 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -178.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -62.73 -15.98 55.47 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 124.387 1.075 . . . . 0.0 112.293 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -59.1 -17.81 29.79 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.961 1.304 . . . . 0.0 112.729 175.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.08 19.02 1.07 Allowed Glycine 0 CA--C 1.534 1.248 0 O-C-N 120.693 -1.254 . . . . 0.0 114.033 176.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.14 -49.98 73.69 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.572 1.686 . . . . 0.0 110.819 -170.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.68 -55.78 28.57 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.076 -1.402 . . . . 0.0 111.191 175.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -48.58 -42.75 35.17 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 CA-C-N 120.275 2.037 . . . . 0.0 115.487 176.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.6 tp -70.68 -37.15 73.6 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 120.217 1.371 . . . . 0.0 110.448 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 51.1 tp -61.41 -49.56 76.38 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.159 0.436 . . . . 0.0 110.108 175.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.79 -36.87 82.35 Favored 'General case' 0 C--O 1.227 -0.12 0 CA-C-O 118.594 -0.717 . . . . 0.0 111.774 178.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -60.59 -48.59 81.12 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 119.058 0.845 . . . . 0.0 109.682 176.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -62.01 -44.59 96.39 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 122.938 0.495 . . . . 0.0 110.605 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 75.0 m -62.62 -43.85 97.78 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 118.495 0.589 . . . . 0.0 111.023 177.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.44 -40.3 96.14 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.085 0.554 . . . . 0.0 110.787 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.21 -31.88 70.76 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.387 0.675 . . . . 0.0 111.951 177.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.73 93.09 2.17 Favored Pre-proline 0 CA--C 1.537 0.481 0 C-N-CA 124.93 1.292 . . . . 0.0 108.742 -171.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -55.64 158.13 14.0 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.819 2.346 . . . . 0.0 112.486 177.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -131.67 173.47 11.1 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.467 1.507 . . . . 0.0 108.892 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 37.93 -119.48 0.76 Allowed Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.216 1.389 . . . . 0.0 111.929 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -142.91 40.89 1.53 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.092 1.357 . . . . 0.0 108.592 169.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -76.54 165.06 25.31 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.705 0.764 . . . . 0.0 111.573 -170.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.3 t -120.41 84.41 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 104.478 -2.416 . . . . 0.0 104.478 167.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.2 p -64.97 143.57 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 O-C-N 121.596 -0.69 . . . . 0.0 109.386 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.2 mt -132.12 128.15 58.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -83.92 78.78 9.67 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.05 0.94 . . . . 0.0 109.312 172.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -66.35 -29.69 75.31 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.604 -0.599 . . . . 0.0 111.604 176.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 55.65 -140.03 41.44 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 175.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.9 p -88.18 1.54 54.19 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.726 0.81 . . . . 0.0 112.949 -171.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -145.18 61.46 7.97 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 124.583 1.153 . . . . 0.0 110.183 178.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -66.22 -15.37 48.06 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 122.679 2.253 . . . . 0.0 112.646 -175.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -47.88 -40.37 21.45 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.751 1.621 . . . . 0.0 111.011 169.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -64.65 -31.2 72.32 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 122.097 -0.377 . . . . 0.0 111.959 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -89.28 -9.17 51.61 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.2 1.0 . . . . 0.0 111.329 -169.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.7 mt -52.86 -40.07 34.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 123.811 0.845 . . . . 0.0 109.211 169.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.1 t -60.21 -40.84 84.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.041 0.537 . . . . 0.0 110.145 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.53 -47.49 63.56 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.836 0.454 . . . . 0.0 110.102 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 95.4 mt -53.55 -41.58 46.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.222 1.009 . . . . 0.0 110.079 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -66.34 -18.99 65.68 Favored 'General case' 0 CA--C 1.53 0.173 0 O-C-N 121.05 -1.031 . . . . 0.0 112.725 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -72.64 -40.7 66.21 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 120.228 1.376 . . . . 0.0 109.379 169.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 60.2 mt -73.72 -29.05 62.02 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.434 1.094 . . . . 0.0 111.934 -174.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 39.6 60.18 6.29 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 125.941 1.696 . . . . 0.0 111.877 -169.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.02 153.56 31.52 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.757 2.305 . . . . 0.0 114.043 -170.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.5 m -70.9 -37.81 72.98 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 168.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -148.59 155.5 41.18 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.038 0.935 . . . . 0.0 109.454 -174.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.6 tp -144.67 136.56 25.87 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.651 1.181 . . . . 0.0 108.347 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 58.5 tp -122.4 140.02 53.17 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 169.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.3 mt -124.06 143.17 38.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 41.4 t -141.07 135.33 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 118.571 0.623 . . . . 0.0 109.778 -173.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -163.96 171.8 14.79 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.52 2.328 . . . . 0.0 107.495 173.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.03 157.66 37.84 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.575 -0.703 . . . . 0.0 109.16 168.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.6 m -152.32 127.89 10.07 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -78.07 80.1 4.51 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 119.099 0.863 . . . . 0.0 110.222 176.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 73.7 mtm -75.47 -6.45 50.22 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.033 1.733 . . . . 0.0 112.379 -177.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.62 23.25 78.27 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-N 118.621 0.646 . . . . 0.0 111.822 -172.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.9 mt -100.33 -171.66 2.07 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.889 1.276 . . . . 0.0 109.948 -178.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -74.89 139.99 73.85 Favored Pre-proline 0 N--CA 1.468 0.451 0 CA-C-O 117.431 -1.271 . . . . 0.0 108.612 170.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -43.07 137.44 4.66 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.316 2.677 . . . . 0.0 113.31 172.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.45 0.58 79.32 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 118.641 -1.089 . . . . 0.0 113.646 176.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -65.05 146.57 54.83 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 119.82 1.81 . . . . 0.0 108.243 168.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.6 mt -125.94 138.44 54.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -175.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 91.0 mmt-85 -147.69 152.49 37.9 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 118.69 0.677 . . . . 0.0 111.442 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 37.3 mm -78.78 145.33 9.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 105.828 -1.915 . . . . 0.0 105.828 165.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.5 mt -129.61 124.14 58.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -76.8 140.68 67.56 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 117.859 -1.067 . . . . 0.0 109.586 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -47.42 -34.28 18.94 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 124.086 3.191 . . . . 0.0 116.581 179.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -67.74 -22.91 65.2 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.596 0.634 . . . . 0.0 111.806 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -101.54 -30.9 11.13 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.177 1.391 . . . . 0.0 111.35 -178.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 68.8 mt -50.41 -38.59 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.707 1.203 . . . . 0.0 109.547 169.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.22 -20.19 6.48 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.917 1.687 . . . . 0.0 114.285 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -124.76 -38.76 2.34 Favored 'General case' 0 C--N 1.334 -0.067 0 CA-C-N 118.811 0.732 . . . . 0.0 110.638 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 10.9 mmt -68.12 -24.48 65.02 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -172.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -74.78 -45.35 44.25 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 119.358 0.981 . . . . 0.0 111.066 173.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 25.7 ptt? . . . . . 0 CA--C 1.535 0.389 0 O-C-N 121.732 -0.605 . . . . 0.0 112.583 177.004 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 mt . . . . . 0 N--CA 1.474 0.765 0 N-CA-C 117.235 2.309 . . . . 0.0 117.235 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.1 -21.13 4.37 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.093 0.957 . . . . 0.0 112.783 168.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -59.57 -29.49 67.97 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.453 1.024 . . . . 0.0 112.04 174.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.7 tt -76.62 -43.57 37.76 Favored 'General case' 0 C--N 1.338 0.103 0 O-C-N 121.399 -0.813 . . . . 0.0 109.667 175.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 77.7 mt -60.47 -43.93 95.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 C-N-CA 123.409 0.684 . . . . 0.0 109.299 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -60.79 -25.43 66.54 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -177.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -82.68 -3.09 55.82 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.879 0.872 . . . . 0.0 112.47 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.0 mt -134.89 -28.4 1.21 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.099 0.959 . . . . 0.0 112.626 -171.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -60.63 -22.04 63.38 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.149 0.98 . . . . 0.0 112.668 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -72.03 -10.25 59.52 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.623 1.169 . . . . 0.0 111.834 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -133.08 -42.57 0.88 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.433 1.093 . . . . 0.0 111.949 -173.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 29.0 mt -72.26 141.4 16.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -64.69 -41.86 97.5 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.119 0.866 . . . . 0.0 112.037 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -149.47 138.37 21.14 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.635 1.218 . . . . 0.0 108.906 176.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 54.0 t -131.28 124.98 56.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 16.9 mt -129.79 154.45 40.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -171.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -129.82 140.63 50.98 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 173.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.0 tt -120.09 129.72 54.32 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 174.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -112.58 156.55 15.52 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 68.8 mt -134.07 124.78 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 -177.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -65.28 118.1 46.69 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-O 117.423 -1.275 . . . . 0.0 110.363 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -77.15 172.05 16.77 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.656 2.904 . . . . 0.0 111.572 171.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -128.84 -31.96 2.14 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.785 1.634 . . . . 0.0 110.974 172.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.15 136.38 49.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.415 1.086 . . . . 0.0 108.269 175.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.1 t -141.1 134.36 31.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 175.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 159.7 151.55 6.2 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -64.71 157.98 25.91 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 117.642 0.721 . . . . 0.0 111.608 -175.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . 0.253 44.1 p90 44.37 41.4 4.49 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.333 2.253 . . . . 0.0 113.072 -174.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -121.51 148.41 50.12 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 123.95 0.9 . . . . 0.0 109.919 172.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -81.06 163.06 20.38 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.238 2.625 . . . . 0.0 111.259 177.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 54.2 ttm -72.22 139.66 48.28 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 168.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 68.3 p -80.6 159.88 25.28 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.365 1.066 . . . . 0.0 110.603 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.1 tm0? -51.23 -48.6 85.18 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-O 117.011 -1.471 . . . . 0.0 113.303 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -67.7 -29.64 35.65 Favored 'Trans proline' 0 C--N 1.352 0.727 0 CA-C-N 122.55 1.946 . . . . 0.0 112.423 -174.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -80.35 -35.32 15.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 119.046 0.839 . . . . 0.0 108.937 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -56.67 -46.78 80.93 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.418 1.008 . . . . 0.0 109.89 170.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -62.98 -38.57 91.66 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 122.961 0.504 . . . . 0.0 111.517 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.84 -46.74 80.62 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 119.193 -0.432 . . . . 0.0 111.017 176.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 73.8 t -62.25 -39.41 83.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 118.883 0.765 . . . . 0.0 109.81 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 34.6 tp10 -61.69 -40.98 96.92 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.031 0.832 . . . . 0.0 110.56 174.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 50.2 m -63.84 -45.87 87.59 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.06 0.544 . . . . 0.0 110.063 177.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 76.6 t -62.56 -44.17 99.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 118.831 0.741 . . . . 0.0 109.605 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -55.05 -46.95 75.4 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.317 1.047 . . . . 0.0 110.611 176.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -63.72 -39.7 94.94 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.659 0.663 . . . . 0.0 110.989 175.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.13 -26.06 67.43 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.421 0.688 . . . . 0.0 112.647 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 91.3 mt -57.11 -22.81 42.53 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.184 0.902 . . . . 0.0 112.231 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 . . . . . 0 CA--C 1.546 0.795 0 C-N-CA 124.277 1.031 . . . . 0.0 112.166 -178.911 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 . . . . . 0 C--O 1.233 0.218 0 CA-C-O 121.948 0.88 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -80.81 149.71 29.47 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 171.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -88.98 123.07 32.97 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 173.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 62.9 tp . . . . . 0 C--O 1.233 0.205 0 C-N-CA 125.158 1.383 . . . . 0.0 109.925 177.693 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.3 t70 . . . . . 0 C--O 1.232 0.178 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.8 m -132.92 154.73 40.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 124.002 0.921 . . . . 0.0 110.541 -169.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 30.6 tp -125.66 117.21 23.03 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 174.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 64.8 tp -104.74 97.52 7.39 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 96.9 m -73.15 143.73 47.16 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 169.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.0 t -142.16 144.47 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 175.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 147.64 174.48 19.6 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 124.653 1.121 . . . . 0.0 110.335 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -121.83 120.22 33.92 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 174.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 m -58.93 -12.95 5.13 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.446 1.898 . . . . 0.0 115.545 -169.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -129.61 12.82 5.91 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 119.321 0.964 . . . . 0.0 111.226 -177.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.8 ttt -94.32 32.17 1.59 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.868 0.758 . . . . 0.0 109.589 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.05 -145.12 26.75 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 -175.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -59.34 -18.06 34.88 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 125.952 1.701 . . . . 0.0 112.308 178.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -53.89 -25.58 20.77 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.819 1.248 . . . . 0.0 112.676 175.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.76 25.01 0.64 Allowed Glycine 0 CA--C 1.532 1.148 0 CA-C-O 118.7 -1.055 . . . . 0.0 114.277 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.08 -50.67 67.44 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 119.474 1.637 . . . . 0.0 110.432 -170.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.24 -55.64 29.0 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-O 117.881 -1.511 . . . . 0.0 110.98 175.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -50.65 -37.98 54.61 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 CA-C-N 121.106 2.453 . . . . 0.0 114.77 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.9 tp -71.75 -38.88 70.33 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 120.014 1.279 . . . . 0.0 110.509 176.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.1 tp -60.44 -47.65 85.19 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.341 0.518 . . . . 0.0 110.216 175.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.67 -40.96 85.05 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.479 1.111 . . . . 0.0 110.975 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.0 tp10 -61.97 -49.68 75.11 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-N 118.717 0.69 . . . . 0.0 109.693 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -63.64 -45.3 90.87 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.729 0.412 . . . . 0.0 110.81 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 75.5 m -65.32 -38.35 89.89 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.566 0.621 . . . . 0.0 111.094 178.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.91 -39.84 95.1 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.248 0.931 . . . . 0.0 110.906 176.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.41 -33.87 75.0 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.261 0.624 . . . . 0.0 111.805 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.47 91.08 3.35 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 125.141 1.376 . . . . 0.0 108.767 -173.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -51.66 161.32 2.13 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 124.035 3.157 . . . . 0.0 114.852 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -137.98 158.78 43.63 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.345 1.458 . . . . 0.0 108.969 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 41.44 -120.15 1.86 Allowed Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.362 1.458 . . . . 0.0 111.737 175.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -136.79 16.26 3.09 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.685 1.194 . . . . 0.0 110.787 174.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 2.0 m95 -75.0 120.29 20.34 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 121.324 -0.86 . . . . 0.0 109.018 -170.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.7 t -71.02 111.12 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 168.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.3 t -71.33 138.33 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -177.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 98.5 mt -135.91 142.73 38.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 104.03 -2.581 . . . . 0.0 104.03 173.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -126.37 107.04 9.92 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 175.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.3 -11.38 71.29 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 118.523 -1.154 . . . . 0.0 113.391 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.17 34.64 80.7 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-N 119.425 1.612 . . . . 0.0 113.713 170.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 63.23 14.04 7.43 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.007 1.723 . . . . 0.0 114.242 -174.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.79 56.88 12.11 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 125.385 1.474 . . . . 0.0 108.057 169.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -68.58 -15.41 41.37 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.396 2.064 . . . . 0.0 113.128 -168.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -51.45 -34.14 33.99 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.086 0.857 . . . . 0.0 112.074 170.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.17 -26.4 68.31 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.215 0.606 . . . . 0.0 112.289 177.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -103.0 -5.66 23.18 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.956 1.302 . . . . 0.0 111.403 -170.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 73.9 mt -55.47 -41.63 64.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 119.112 0.869 . . . . 0.0 109.604 174.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.6 t -60.3 -41.21 86.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 118.524 0.602 . . . . 0.0 109.797 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.76 -45.19 83.47 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.87 0.468 . . . . 0.0 110.38 -178.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 90.2 mt -56.43 -48.38 80.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -63.02 -34.52 77.73 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 118.206 -0.902 . . . . 0.0 112.005 -174.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -58.01 -32.2 67.71 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.482 1.037 . . . . 0.0 111.537 175.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 78.9 mt -84.75 -8.65 58.75 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.174 0.99 . . . . 0.0 112.703 -175.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 27.74 62.26 0.64 Allowed Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 126.892 2.077 . . . . 0.0 112.794 -168.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.33 149.62 63.89 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.246 1.964 . . . . 0.0 113.543 -173.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.49 -26.43 35.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.784 168.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -145.21 151.32 38.22 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.811 0.844 . . . . 0.0 109.841 177.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 25.1 tp -140.91 141.31 34.56 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 125.551 1.54 . . . . 0.0 108.132 172.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 34.3 tp -129.34 138.88 51.81 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 171.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.8 mt -124.66 141.37 44.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 -174.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.9 t -140.86 133.47 30.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 118.728 0.694 . . . . 0.0 109.898 -174.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -161.28 172.44 16.63 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.442 2.297 . . . . 0.0 107.122 174.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.27 158.28 36.16 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.157 -0.965 . . . . 0.0 108.622 167.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.5 m -153.23 129.22 10.3 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 174.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -77.03 80.59 3.56 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.705 0.764 . . . . 0.0 109.94 175.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 76.3 mtm -76.46 -6.76 53.13 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.313 1.445 . . . . 0.0 112.241 -174.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.58 31.28 60.89 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -172.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 77.3 mt -110.97 -170.8 1.7 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.745 1.218 . . . . 0.0 109.722 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -81.14 140.82 49.61 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 117.668 -1.158 . . . . 0.0 108.84 174.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -46.51 132.94 16.34 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.198 2.599 . . . . 0.0 113.614 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.58 1.33 90.1 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 118.506 -1.164 . . . . 0.0 113.412 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -65.65 153.79 40.65 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 119.902 1.851 . . . . 0.0 108.49 168.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 62.3 mt -132.74 140.95 46.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -170.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 82.3 mmt-85 -149.44 152.98 36.59 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.365 0.666 . . . . 0.0 109.981 170.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 35.8 mm -77.29 145.33 10.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 165.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.3 mt -129.57 161.97 38.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 176.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -131.14 144.78 54.95 Favored Pre-proline 0 C--O 1.234 0.288 0 C-N-CA 126.519 1.928 . . . . 0.0 107.181 -171.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -54.28 -27.97 50.43 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 123.18 2.586 . . . . 0.0 115.139 -174.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -68.96 -19.98 64.18 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.948 0.794 . . . . 0.0 112.197 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -117.01 -30.88 5.56 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.164 1.386 . . . . 0.0 111.771 -171.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 65.6 mt -50.15 -40.87 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.268 1.427 . . . . 0.0 109.78 169.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.25 -26.13 37.92 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.822 1.249 . . . . 0.0 113.458 -176.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -108.14 -39.42 5.5 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 123.337 0.655 . . . . 0.0 110.021 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 21.4 mmt -69.21 -26.32 64.76 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -174.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -72.13 -46.37 56.83 Favored 'General case' 0 C--O 1.228 -0.052 0 CA-C-N 119.109 0.868 . . . . 0.0 110.799 174.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 27.6 ptm . . . . . 0 CA--C 1.541 0.598 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -176.502 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.1 mt . . . . . 0 N--CA 1.47 0.534 0 N-CA-C 116.939 2.2 . . . . 0.0 116.939 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.47 -20.31 4.62 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 117.878 -1.058 . . . . 0.0 113.02 168.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -54.77 -35.74 64.12 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 119.967 1.258 . . . . 0.0 111.517 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.8 tt -75.38 -44.09 46.7 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.329 0.652 . . . . 0.0 109.592 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 94.3 mt -62.95 -44.11 99.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -64.67 -17.65 64.26 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -171.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -109.6 13.68 23.76 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.306 1.043 . . . . 0.0 112.085 178.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 72.8 mt -129.5 -34.48 1.8 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.178 1.391 . . . . 0.0 110.783 177.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -57.5 -22.17 42.39 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.265 1.426 . . . . 0.0 112.693 176.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -70.16 -14.84 62.82 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.656 1.182 . . . . 0.0 111.931 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -137.52 -32.31 0.77 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.144 0.883 . . . . 0.0 113.045 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 32.5 mt -70.46 138.26 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 174.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -64.24 -42.87 97.71 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.268 0.937 . . . . 0.0 112.385 -176.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -144.75 134.62 23.72 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.664 1.232 . . . . 0.0 108.336 175.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 47.8 t -125.95 127.8 71.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 177.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.9 mt -130.84 153.29 38.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 -168.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -133.17 145.56 50.75 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 175.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.1 tt -127.87 133.46 49.34 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 171.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -114.16 157.06 15.22 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 80.8 mt -134.47 126.88 49.31 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -65.04 116.52 30.71 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-O 117.583 -1.199 . . . . 0.0 110.372 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -79.17 173.5 13.29 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.247 2.631 . . . . 0.0 111.789 171.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -136.71 -28.7 0.97 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.373 2.269 . . . . 0.0 111.382 172.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -132.42 119.63 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 -173.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.3 t -143.67 131.78 18.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 153.54 152.82 6.16 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -67.12 150.89 48.54 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.974 0.893 . . . . 0.0 111.27 -174.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 13.0 t80 51.69 40.67 27.9 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.839 2.055 . . . . 0.0 112.107 -174.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.4 m-30 -115.79 142.54 29.18 Favored Pre-proline 0 C--O 1.237 0.434 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 170.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -74.27 160.44 42.22 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.636 2.224 . . . . 0.0 110.46 170.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.1 ttm -74.69 141.98 44.49 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 169.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 39.9 p -79.53 157.42 27.42 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.426 1.091 . . . . 0.0 110.653 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -52.55 -42.47 88.39 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-O 116.579 -1.677 . . . . 0.0 114.721 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -70.81 -28.55 20.08 Favored 'Trans proline' 0 C--N 1.351 0.707 0 CA-C-N 123.043 2.123 . . . . 0.0 111.883 -175.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.23 -36.53 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -56.68 -45.93 81.43 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.297 0.953 . . . . 0.0 110.091 170.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -63.34 -41.6 98.89 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 123.064 0.546 . . . . 0.0 111.117 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.69 -47.09 85.13 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.833 0.453 . . . . 0.0 111.043 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.0 t -60.81 -42.33 91.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 177.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -68.26 -28.27 67.06 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.874 0.761 . . . . 0.0 111.602 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 42.9 m -69.03 -46.29 68.3 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.214 -0.929 . . . . 0.0 109.492 173.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 90.1 t -61.65 -43.43 97.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 119.111 0.869 . . . . 0.0 109.597 176.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -52.96 -46.12 68.07 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.209 1.004 . . . . 0.0 111.227 175.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -66.11 -42.43 89.23 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.628 0.649 . . . . 0.0 111.003 175.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -58.4 -37.31 75.05 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.882 0.873 . . . . 0.0 111.76 -175.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 72.1 mt -57.21 -18.59 16.49 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.154 0.982 . . . . 0.0 113.137 -175.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 . . . . . 0 CA--C 1.542 0.635 0 CA-C-N 119.671 1.123 . . . . 0.0 112.431 177.161 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 . . . . . 0 N--CA 1.448 -0.537 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -78.24 151.86 32.87 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 172.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -98.19 119.74 37.38 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 55.1 tp . . . . . 0 C--O 1.233 0.207 0 C-N-CA 125.262 1.425 . . . . 0.0 110.301 -179.152 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.5 t0 . . . . . 0 C--O 1.233 0.184 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 51.2 t -139.42 151.8 22.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 119.003 0.82 . . . . 0.0 109.921 -167.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 33.7 tp -126.2 129.86 49.82 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 126.069 1.748 . . . . 0.0 106.402 176.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.9 tp -117.31 100.95 8.03 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 124.915 1.286 . . . . 0.0 107.886 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 89.4 m -76.04 141.23 42.15 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 169.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 50.9 t -139.96 142.93 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 143.18 174.39 15.43 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.252 0.93 . . . . 0.0 111.709 176.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -118.32 120.16 36.8 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.7 1.2 . . . . 0.0 108.869 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -59.67 -15.97 23.12 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.356 1.862 . . . . 0.0 115.228 -170.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 27.7 ptm -126.88 14.47 7.42 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.206 1.003 . . . . 0.0 111.167 -175.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.2 ttt -101.78 31.58 3.78 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.41 0.684 . . . . 0.0 110.048 -177.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.29 -142.49 21.3 Favored Glycine 0 C--N 1.337 0.584 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -60.26 -17.68 43.82 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.784 1.234 . . . . 0.0 112.352 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -57.09 -19.75 21.36 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.88 1.272 . . . . 0.0 112.557 176.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.13 21.17 0.85 Allowed Glycine 0 CA--C 1.534 1.238 0 O-C-N 120.761 -1.212 . . . . 0.0 114.278 176.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.25 -53.18 58.86 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.588 1.694 . . . . 0.0 110.943 -170.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.59 -53.94 41.86 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 117.791 -1.561 . . . . 0.0 111.02 175.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -48.97 -41.02 40.63 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 CA-C-N 120.78 2.29 . . . . 0.0 115.217 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.7 tp -71.51 -37.74 71.19 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 120.265 1.393 . . . . 0.0 110.372 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.9 tp -61.91 -46.98 87.02 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.047 0.385 . . . . 0.0 110.252 175.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.53 -40.6 87.69 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 124.021 0.929 . . . . 0.0 111.111 177.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -60.94 -48.81 80.1 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 118.833 0.742 . . . . 0.0 109.789 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -62.34 -46.13 90.07 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 122.959 0.504 . . . . 0.0 110.569 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 79.6 m -64.57 -38.36 90.74 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.271 0.487 . . . . 0.0 111.219 178.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.54 -38.64 91.72 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.886 0.766 . . . . 0.0 110.988 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.36 -38.28 78.02 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.203 0.601 . . . . 0.0 111.157 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.32 94.57 2.16 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 125.205 1.402 . . . . 0.0 108.497 -173.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -56.01 159.67 11.75 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 123.526 2.817 . . . . 0.0 113.328 178.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -135.74 167.51 21.01 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 126.053 1.741 . . . . 0.0 108.336 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 44.23 -127.32 6.54 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.509 1.052 . . . . 0.0 111.831 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -136.16 9.89 3.26 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.854 1.261 . . . . 0.0 111.699 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -71.33 125.12 26.13 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 123.986 0.914 . . . . 0.0 109.252 -172.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 51.1 t -69.9 123.79 24.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 166.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.4 t -77.45 135.38 26.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -178.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.6 mm -130.65 145.9 34.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 104.292 -2.484 . . . . 0.0 104.292 168.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -134.33 107.92 7.9 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 177.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.54 -1.9 89.06 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 118.966 -0.908 . . . . 0.0 112.49 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 54.22 -145.1 27.23 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -169.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.8 p -89.71 13.75 13.48 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 122.01 -0.7 . . . . 0.0 111.869 177.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.54 58.63 10.42 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 124.995 1.318 . . . . 0.0 110.498 -177.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -72.25 -22.09 22.57 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.873 2.382 . . . . 0.0 112.967 -171.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.72 -36.19 78.22 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.847 0.749 . . . . 0.0 111.856 -177.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -65.0 -11.89 44.06 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.867 0.867 . . . . 0.0 112.931 175.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -113.75 -0.25 14.3 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.305 1.042 . . . . 0.0 112.29 -172.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 62.5 mt -48.17 -41.19 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 125.124 1.37 . . . . 0.0 110.732 174.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.0 t -56.77 -44.02 80.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.313 0.645 . . . . 0.0 110.198 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.32 93.03 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.974 0.51 . . . . 0.0 110.966 -177.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 64.7 mt -64.27 -45.53 95.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.1 mtp180 -64.89 -31.29 72.45 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.512 -176.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -57.92 -33.06 68.38 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.667 1.121 . . . . 0.0 111.558 174.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 33.0 mt -76.22 -8.23 56.61 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 118.571 -0.728 . . . . 0.0 112.778 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.1 mtp180 31.8 62.12 1.23 Allowed Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 126.994 2.118 . . . . 0.0 112.359 -169.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -55.07 142.67 76.63 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.835 2.357 . . . . 0.0 112.305 -172.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.2 m -81.68 -31.84 32.04 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.682 0.793 . . . . 0.0 108.913 168.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -142.55 150.76 40.82 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.611 1.564 . . . . 0.0 107.721 174.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 56.4 tp -138.81 142.89 38.7 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.645 1.178 . . . . 0.0 108.088 173.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 35.0 tp -128.49 138.93 52.52 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 173.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.1 mt -125.31 142.07 43.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 -175.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.4 t -140.83 134.11 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 118.593 0.633 . . . . 0.0 110.08 -174.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -161.52 171.18 18.54 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.252 2.221 . . . . 0.0 107.739 171.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.4 156.84 39.01 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.133 -0.979 . . . . 0.0 108.621 168.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.3 m -155.86 127.74 7.45 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 176.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -71.48 123.76 23.12 Favored 'General case' 0 N--CA 1.461 0.097 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 171.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 75.4 mtm -123.24 1.73 9.12 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.032 1.733 . . . . 0.0 110.705 -175.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.83 25.21 68.97 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-N 118.747 0.703 . . . . 0.0 112.332 -173.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.0 mt -99.92 -172.25 2.2 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.332 1.453 . . . . 0.0 109.292 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -75.36 140.22 72.34 Favored Pre-proline 0 N--CA 1.469 0.49 0 CA-C-O 117.539 -1.219 . . . . 0.0 108.667 173.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -43.43 136.32 6.1 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 123.343 2.695 . . . . 0.0 113.081 172.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.31 3.48 76.91 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 118.779 -1.012 . . . . 0.0 113.75 178.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -64.74 148.57 50.88 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 119.754 1.777 . . . . 0.0 108.581 168.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 76.5 mt -125.89 136.09 61.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 -173.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 90.1 mmt-85 -148.18 152.64 37.59 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 118.512 0.596 . . . . 0.0 111.101 175.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 41.5 mm -81.58 144.74 9.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 166.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.8 mt -126.79 129.33 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -73.5 139.14 77.86 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 118.185 -0.912 . . . . 0.0 109.36 172.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -45.37 -36.26 12.81 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 124.46 3.44 . . . . 0.0 116.4 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -66.67 -26.78 67.2 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.445 0.566 . . . . 0.0 111.687 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -97.7 -28.57 13.84 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.515 1.126 . . . . 0.0 111.149 -178.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 45.9 mt -51.04 -43.38 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.613 1.165 . . . . 0.0 110.229 170.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -52.99 -31.49 41.17 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.593 1.157 . . . . 0.0 112.804 -177.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -97.58 -42.33 7.72 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.314 0.646 . . . . 0.0 109.843 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 22.5 mmt -67.3 -33.38 75.17 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -171.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -62.43 -43.37 98.97 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 118.454 0.57 . . . . 0.0 110.655 176.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 27.8 ptm . . . . . 0 CA--C 1.538 0.498 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -179.751 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.6 mt . . . . . 0 N--CA 1.464 0.258 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -52.84 -23.32 6.75 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.256 0.934 . . . . 0.0 112.045 167.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -60.64 -27.08 67.52 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.828 0.74 . . . . 0.0 112.583 175.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.5 tt -69.64 -43.78 71.95 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 119.023 0.829 . . . . 0.0 109.372 175.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 76.7 mt -61.95 -43.48 97.58 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.093 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -64.38 -16.46 62.33 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -105.54 16.98 24.6 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.33 1.452 . . . . 0.0 111.18 177.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.6 mt -136.06 -37.5 0.72 Allowed 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.703 1.201 . . . . 0.0 110.994 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -55.59 -22.32 21.63 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.569 1.148 . . . . 0.0 112.742 176.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -60.23 -24.71 65.08 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.504 1.522 . . . . 0.0 112.122 -177.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -134.05 7.42 3.7 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.681 0.792 . . . . 0.0 112.488 -171.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 76.5 mt -122.41 141.51 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.977 1.311 . . . . 0.0 108.291 -174.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.27 -39.64 81.88 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 123.864 0.745 . . . . 0.0 111.809 -176.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -147.38 132.86 18.65 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 118.307 1.054 . . . . 0.0 108.256 176.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 41.5 t -122.65 129.38 75.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 172.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 15.1 mt -129.24 148.68 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 -169.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -129.6 141.18 51.0 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 170.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.5 tt -123.53 127.98 49.11 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 175.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -109.48 155.63 16.0 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 83.4 mt -133.06 126.01 52.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.103 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -62.76 114.47 12.32 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-O 117.778 -1.106 . . . . 0.0 110.453 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -75.96 170.48 20.02 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.171 2.581 . . . . 0.0 111.111 170.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -129.75 -30.11 2.08 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.493 1.917 . . . . 0.0 111.025 169.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.1 pp -136.03 137.02 49.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 123.891 0.876 . . . . 0.0 109.025 176.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 75.7 t -146.36 139.64 20.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 153.9 151.51 5.78 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 108.776 -1.729 . . . . 0.0 108.776 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -64.27 149.11 48.73 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 118.086 0.943 . . . . 0.0 110.597 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.6 t80 58.43 46.08 15.7 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.292 1.837 . . . . 0.0 111.577 -175.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -132.81 147.27 64.8 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 123.853 0.861 . . . . 0.0 109.759 168.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -81.87 166.12 17.23 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.554 2.836 . . . . 0.0 110.827 176.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.1 ttm -70.0 134.64 48.52 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 169.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.04 159.66 31.46 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.557 1.143 . . . . 0.0 110.57 175.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.63 -46.39 99.59 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-O 117.233 -1.365 . . . . 0.0 113.538 -171.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -67.07 -26.8 42.74 Favored 'Trans proline' 0 C--N 1.35 0.615 0 CA-C-N 122.209 1.824 . . . . 0.0 112.593 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.24 -35.7 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -56.24 -46.79 79.45 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.138 0.881 . . . . 0.0 109.984 170.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -63.11 -38.09 89.8 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 122.722 0.409 . . . . 0.0 111.444 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.49 -47.78 77.67 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 122.033 -0.417 . . . . 0.0 111.056 175.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 71.4 t -61.21 -39.28 81.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 118.672 0.669 . . . . 0.0 109.719 178.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 32.6 tp10 -63.91 -39.09 93.36 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.13 0.877 . . . . 0.0 110.927 175.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 51.7 m -63.9 -48.07 78.08 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.763 -0.586 . . . . 0.0 109.854 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 79.2 t -60.3 -46.08 95.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -54.62 -48.78 71.82 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.05 0.94 . . . . 0.0 110.849 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -65.06 -38.16 89.91 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.456 0.571 . . . . 0.0 111.194 177.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -62.14 -29.25 70.21 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 118.367 -0.825 . . . . 0.0 111.552 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 83.9 mt -55.01 -21.28 11.54 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.3 0.954 . . . . 0.0 112.909 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 . . . . . 0 CA--C 1.539 0.55 0 CA-C-N 119.309 0.959 . . . . 0.0 112.595 -179.514 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 . . . . . 0 N--CA 1.448 -0.533 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.95 146.41 47.79 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -92.3 121.02 33.39 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 177.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 62.5 tp . . . . . 0 C--O 1.233 0.203 0 C-N-CA 125.791 1.637 . . . . 0.0 110.631 178.566 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 . . . . . 0 C--O 1.235 0.291 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 78.4 t -136.77 149.11 26.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -175.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 37.0 tp -127.93 112.06 14.26 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.415 1.486 . . . . 0.0 107.066 -175.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 51.9 tp -101.45 97.22 7.71 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 125.129 1.372 . . . . 0.0 107.883 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 87.3 m -73.11 143.03 47.51 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 169.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.0 t -141.71 144.82 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 176.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.79 174.34 17.87 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -124.76 119.31 28.55 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.128 1.371 . . . . 0.0 107.846 176.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 m -60.44 -14.2 17.87 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.185 1.794 . . . . 0.0 115.313 -169.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 27.9 ptm -125.22 13.14 8.29 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.153 0.981 . . . . 0.0 111.067 -176.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.3 ttt -100.7 29.68 4.38 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.567 0.747 . . . . 0.0 109.83 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.78 -142.26 20.75 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -61.86 -17.04 55.02 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.592 1.157 . . . . 0.0 112.221 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -54.87 -24.53 23.67 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.433 1.493 . . . . 0.0 113.236 176.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.21 24.49 0.71 Allowed Glycine 0 CA--C 1.533 1.191 0 CA-C-O 118.575 -1.125 . . . . 0.0 114.447 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.31 -51.45 65.98 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 119.468 1.634 . . . . 0.0 110.826 -169.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.17 -54.8 34.33 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-O 117.809 -1.55 . . . . 0.0 111.021 175.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -50.22 -37.68 49.73 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 CA-C-N 121.085 2.442 . . . . 0.0 114.841 178.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.7 tp -71.05 -39.79 72.04 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 120.117 1.326 . . . . 0.0 110.546 176.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.7 tp -60.9 -46.74 89.43 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.225 0.466 . . . . 0.0 110.479 175.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.48 -41.74 90.51 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 124.222 1.009 . . . . 0.0 110.913 176.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -61.06 -48.36 82.09 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 118.932 0.787 . . . . 0.0 110.046 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -61.2 -47.55 85.6 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 122.917 0.487 . . . . 0.0 110.513 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 80.9 m -64.5 -38.16 90.06 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.252 0.478 . . . . 0.0 111.183 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.7 -38.45 91.05 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.857 0.753 . . . . 0.0 111.077 177.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.78 -37.58 76.39 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.349 0.659 . . . . 0.0 111.218 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.31 98.56 1.97 Allowed Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 125.448 1.499 . . . . 0.0 107.856 -174.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -56.08 167.39 2.48 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 123.93 3.087 . . . . 0.0 114.664 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.493 ' HE2' ' CZ ' ' A' ' 136' ' ' TYR . 71.4 mmtt -135.93 160.14 39.51 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 126.055 1.742 . . . . 0.0 107.858 176.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 42.29 -121.19 2.6 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.861 1.22 . . . . 0.0 111.867 175.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -137.25 15.76 3.0 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.036 1.734 . . . . 0.0 111.142 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 13.0 m95 -72.26 131.27 42.49 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.565 0.746 . . . . 0.0 110.243 -171.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.0 t -75.73 118.03 21.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 104.273 -2.491 . . . . 0.0 104.273 165.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.0 t -72.81 134.82 29.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.7 mm -133.33 148.1 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 171.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -135.45 113.82 11.53 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 176.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.04 -13.27 83.21 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 118.613 -1.104 . . . . 0.0 112.81 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.56 34.05 79.69 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-N 119.62 1.71 . . . . 0.0 113.784 172.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 61.87 14.03 5.98 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.951 1.7 . . . . 0.0 114.261 -172.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -135.54 58.05 23.0 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 125.807 1.643 . . . . 0.0 107.657 169.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -71.26 -25.41 22.05 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.018 1.812 . . . . 0.0 111.873 -169.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.42 -30.69 71.77 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.668 0.787 . . . . 0.0 111.867 -179.068 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -63.02 -15.34 56.1 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.029 0.932 . . . . 0.0 112.419 172.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -117.32 1.07 12.37 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.369 1.068 . . . . 0.0 112.568 -169.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 78.7 mt -48.82 -37.29 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.869 1.268 . . . . 0.0 110.512 171.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.8 t -55.93 -41.26 66.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 123.683 0.793 . . . . 0.0 110.333 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.78 -41.96 82.41 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 118.479 0.582 . . . . 0.0 110.562 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.6 mt -61.06 -41.57 89.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 176.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -67.33 -19.99 65.53 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 117.693 -1.146 . . . . 0.0 112.505 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -72.25 -44.97 62.06 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 120.655 1.57 . . . . 0.0 108.894 169.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 56.5 mt -69.04 -26.4 64.96 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 118.489 -0.767 . . . . 0.0 112.703 -176.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 37.43 63.65 3.19 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 125.778 1.631 . . . . 0.0 111.443 -169.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.45 144.55 31.57 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.214 2.609 . . . . 0.0 113.774 -170.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.4 m -67.08 -42.18 85.1 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 167.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 73.0 mtm180 -144.08 153.82 42.57 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 124.769 1.228 . . . . 0.0 108.105 174.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 56.9 tp -133.16 137.01 46.07 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 35.0 tp -124.01 133.71 53.61 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.715 -1.958 . . . . 0.0 105.715 174.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.2 mt -122.22 139.75 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 -175.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.4 t -140.24 133.36 34.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 118.203 0.456 . . . . 0.0 109.828 -172.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -162.32 172.9 14.92 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.24 2.216 . . . . 0.0 107.397 176.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.73 157.73 37.4 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.112 -0.993 . . . . 0.0 108.326 167.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.0 m -154.66 130.18 9.86 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 174.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -74.55 124.19 26.17 Favored 'General case' 0 N--CA 1.461 0.105 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 172.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 77.1 mtm -122.18 0.44 9.57 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.547 1.539 . . . . 0.0 110.814 -175.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.55 24.83 68.19 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-N 118.576 0.626 . . . . 0.0 112.364 -172.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 58.8 mt -100.67 -169.61 1.74 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.964 1.305 . . . . 0.0 108.568 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -82.2 147.01 56.06 Favored Pre-proline 0 N--CA 1.471 0.62 0 CA-C-O 118.466 -0.778 . . . . 0.0 109.747 174.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -46.81 136.1 17.02 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.379 2.719 . . . . 0.0 112.348 176.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.56 1.87 90.3 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 118.483 -1.176 . . . . 0.0 113.45 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -64.53 148.54 50.5 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 119.906 1.853 . . . . 0.0 108.356 168.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 69.3 mt -128.76 135.95 61.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 -172.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 -148.7 150.84 33.87 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 118.666 0.666 . . . . 0.0 111.926 177.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 51.4 mm -79.45 143.61 12.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 166.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.8 mt -128.63 125.61 63.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -74.87 140.54 74.34 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.266 172.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -45.66 -34.57 11.69 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 124.369 3.379 . . . . 0.0 116.628 177.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -68.58 -24.99 64.66 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.57 0.623 . . . . 0.0 111.807 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -98.69 -30.37 12.49 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.865 1.266 . . . . 0.0 111.076 -177.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 63.7 mt -49.91 -40.91 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.692 1.197 . . . . 0.0 109.189 169.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.0 -19.72 19.99 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.161 1.384 . . . . 0.0 114.454 -174.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -117.91 -36.24 3.69 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 118.699 0.682 . . . . 0.0 110.084 176.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 38.4 mmt -69.19 -25.46 64.34 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -176.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -70.21 -47.15 62.71 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 119.164 0.893 . . . . 0.0 111.238 173.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 20.1 ptp . . . . . 0 CA--C 1.532 0.271 0 CA-C-O 118.608 -0.711 . . . . 0.0 112.881 179.361 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 mt . . . . . 0 N--CA 1.468 0.452 0 N-CA-C 117.694 2.479 . . . . 0.0 117.694 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -54.42 -21.79 10.71 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.21 -0.931 . . . . 0.0 112.192 167.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -60.0 -31.77 70.24 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.445 1.02 . . . . 0.0 111.751 174.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.9 tt -73.91 -45.71 48.9 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.758 0.708 . . . . 0.0 109.114 174.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 85.4 mt -57.22 -42.81 80.7 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -62.41 -21.58 65.5 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -85.42 -2.33 57.99 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.829 0.852 . . . . 0.0 112.226 177.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -129.95 -33.93 1.74 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.316 1.047 . . . . 0.0 112.51 -178.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 13.4 pttm -62.92 -19.72 64.5 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.658 0.783 . . . . 0.0 112.983 -171.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -72.09 -12.17 61.08 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.389 1.075 . . . . 0.0 111.814 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -133.26 -34.05 1.09 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.226 0.921 . . . . 0.0 112.915 -177.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 23.8 mt -67.87 143.19 15.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 171.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.81 -39.9 93.6 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 123.954 0.788 . . . . 0.0 112.39 -177.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -150.49 138.72 20.3 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 118.379 1.089 . . . . 0.0 108.442 174.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 39.0 t -122.41 132.07 71.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 174.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.2 mt -130.92 147.35 33.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 -169.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -132.68 140.74 48.27 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 175.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.9 tt -125.5 133.85 52.24 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 174.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -116.71 156.83 15.4 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 177.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 87.1 mt -134.39 127.53 50.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 -177.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -63.9 114.34 13.25 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 117.38 -1.295 . . . . 0.0 110.151 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -76.09 170.56 19.83 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.152 2.568 . . . . 0.0 111.154 170.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -128.81 -32.04 2.14 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.031 1.732 . . . . 0.0 110.986 171.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -135.58 136.23 50.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 177.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.4 t -141.73 135.55 30.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 176.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 157.47 150.73 5.8 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -66.14 152.67 44.25 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.78 0.8 . . . . 0.0 111.08 -176.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 25.0 t80 55.05 39.88 31.74 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.536 1.934 . . . . 0.0 111.648 -175.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -125.06 147.96 58.67 Favored Pre-proline 0 C--O 1.237 0.427 0 C-N-CA 123.669 0.787 . . . . 0.0 109.815 169.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -82.4 164.47 16.78 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.38 2.72 . . . . 0.0 111.087 176.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 53.0 ttm -71.83 138.0 47.97 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 168.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 71.5 p -78.41 159.49 28.28 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.153 0.981 . . . . 0.0 110.494 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.3 tp60 -53.09 -44.42 97.08 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-O 116.533 -1.699 . . . . 0.0 114.23 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -68.58 -30.53 28.45 Favored 'Trans proline' 0 C--N 1.351 0.683 0 CA-C-N 122.914 2.076 . . . . 0.0 112.164 -176.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.81 -35.31 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 119.021 0.828 . . . . 0.0 108.841 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -56.56 -46.64 80.63 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.3 0.955 . . . . 0.0 110.056 170.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -63.97 -37.14 86.33 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.055 0.542 . . . . 0.0 111.434 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.38 -47.25 77.02 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.919 -0.488 . . . . 0.0 111.17 175.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 78.9 t -61.74 -39.66 84.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 118.564 0.62 . . . . 0.0 109.525 177.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -61.37 -42.31 98.5 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.911 0.778 . . . . 0.0 110.534 174.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 52.2 m -62.19 -45.74 92.02 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.747 -0.596 . . . . 0.0 110.237 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 80.3 t -61.9 -47.53 92.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 176.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.493 ' CZ ' ' HE2' ' A' ' 31' ' ' LYS . 38.7 t80 -55.42 -49.66 71.82 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.913 0.885 . . . . 0.0 110.923 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 48.7 mm-40 -68.78 -23.35 64.29 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.734 -0.604 . . . . 0.0 112.102 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.18 -29.24 64.93 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.66 1.118 . . . . 0.0 111.583 175.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 67.6 mt -58.58 -20.38 46.34 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -168.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 . . . . . 0 CA--C 1.54 0.562 0 CA-C-N 120.254 1.388 . . . . 0.0 113.297 177.118 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.02 151.37 47.77 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.774 0.829 . . . . 0.0 109.527 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -92.59 123.98 36.28 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 62.0 tp . . . . . 0 C--O 1.234 0.266 0 C-N-CA 125.381 1.472 . . . . 0.0 109.741 176.858 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.2 t0 . . . . . 0 C--O 1.233 0.223 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 70.8 t -124.0 148.61 28.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 121.409 0.623 . . . . 0.0 110.709 -167.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 33.7 tp -114.37 129.56 56.65 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.628 -1.989 . . . . 0.0 105.628 168.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.8 tp -120.63 100.82 7.35 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 92.7 m -75.33 143.03 43.11 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 171.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 51.9 t -141.01 142.04 30.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.285 1.434 . . . . 0.0 107.306 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 144.57 176.88 18.97 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.336 0.969 . . . . 0.0 111.873 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -126.55 122.54 35.42 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.8 1.24 . . . . 0.0 108.844 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 m -60.82 -15.33 29.0 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.572 1.949 . . . . 0.0 115.661 -169.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 25.8 ptm -127.4 11.01 6.82 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.074 0.95 . . . . 0.0 110.989 -176.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.6 ttt -88.68 14.32 10.33 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.225 1.01 . . . . 0.0 110.098 176.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.54 -140.96 15.34 Favored Glycine 0 C--N 1.337 0.637 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -60.44 -17.42 44.45 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.504 1.121 . . . . 0.0 112.224 176.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -55.81 -20.68 16.01 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.614 1.566 . . . . 0.0 113.207 174.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.44 21.5 0.7 Allowed Glycine 0 CA--C 1.534 1.253 0 O-C-N 120.823 -1.173 . . . . 0.0 114.286 177.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.4 -51.0 67.64 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 119.477 1.639 . . . . 0.0 110.788 -169.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.64 -54.91 33.74 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-O 117.76 -1.578 . . . . 0.0 111.073 175.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -49.75 -41.08 47.21 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 CA-C-N 120.826 2.313 . . . . 0.0 115.282 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.9 tp -71.34 -39.08 71.56 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 120.135 1.334 . . . . 0.0 110.267 178.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.8 tp -61.18 -46.15 91.69 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 122.055 -0.403 . . . . 0.0 110.314 175.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.14 -40.2 84.76 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 124.08 0.952 . . . . 0.0 111.167 177.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -61.41 -48.52 80.86 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 118.918 0.781 . . . . 0.0 109.866 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -61.87 -46.39 89.61 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.895 0.478 . . . . 0.0 110.506 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 80.1 m -64.59 -39.05 93.04 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.191 0.451 . . . . 0.0 111.209 178.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.47 -37.62 88.19 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.774 0.715 . . . . 0.0 111.052 177.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.88 -37.45 79.04 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.172 0.589 . . . . 0.0 111.058 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.0 96.24 1.72 Allowed Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 124.985 1.314 . . . . 0.0 108.553 -173.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -55.93 164.34 4.86 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.869 3.046 . . . . 0.0 113.969 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -134.02 166.1 23.51 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.383 1.473 . . . . 0.0 109.011 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 44.76 -113.25 0.82 Allowed Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.767 1.175 . . . . 0.0 111.418 175.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -144.57 8.94 1.35 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.795 1.238 . . . . 0.0 111.741 176.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 3.9 m95 -68.13 131.54 45.6 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.951 0.901 . . . . 0.0 110.201 -169.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 62.1 t -77.58 119.04 25.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 166.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.5 t -82.55 136.52 22.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -174.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 70.0 mt -133.74 145.29 33.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 169.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -129.58 107.91 9.82 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 175.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.98 -2.16 90.49 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-O 118.892 -0.949 . . . . 0.0 112.95 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 55.28 -144.93 31.88 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 108.441 -1.863 . . . . 0.0 108.441 -169.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.4 p -88.52 9.13 24.88 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.738 -0.86 . . . . 0.0 112.084 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -135.86 57.19 17.42 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 124.991 1.316 . . . . 0.0 110.493 -176.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -68.74 -14.37 39.02 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.735 2.29 . . . . 0.0 113.197 -171.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -55.48 -32.5 62.88 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.074 0.852 . . . . 0.0 112.001 173.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.99 -27.31 66.75 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.192 0.597 . . . . 0.0 112.119 176.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -99.38 -2.74 35.49 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.804 1.242 . . . . 0.0 111.458 -171.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 77.3 mt -54.56 -43.09 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 119.405 1.002 . . . . 0.0 109.641 175.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.3 t -61.6 -42.29 93.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 118.348 0.522 . . . . 0.0 109.737 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.68 -46.31 79.57 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 122.948 0.499 . . . . 0.0 110.666 -177.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 67.5 mt -55.16 -48.05 76.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 172.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -68.18 -23.28 64.83 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 117.865 -1.064 . . . . 0.0 112.778 -174.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -62.96 -37.56 87.57 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 120.519 1.509 . . . . 0.0 110.34 169.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 39.2 mt -77.19 -16.55 59.05 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.851 0.86 . . . . 0.0 111.917 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 26.89 64.6 0.56 Allowed Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 127.883 2.473 . . . . 0.0 113.538 -169.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -58.67 151.25 64.53 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.704 2.936 . . . . 0.0 113.912 -169.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.9 m -69.85 -36.1 75.25 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.085 0.954 . . . . 0.0 108.736 167.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -146.68 153.94 40.86 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.394 1.078 . . . . 0.0 110.402 -175.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 46.7 tp -142.77 136.85 29.28 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 125.301 1.44 . . . . 0.0 108.373 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 27.1 tp -125.32 135.33 52.36 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 172.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.5 mt -123.25 145.17 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 -172.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 44.0 t -141.06 135.53 32.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 118.74 0.7 . . . . 0.0 110.043 -175.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -163.99 172.26 14.13 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.598 2.359 . . . . 0.0 107.544 173.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.58 158.49 36.11 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.366 -0.834 . . . . 0.0 109.17 167.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.7 m -154.41 128.67 9.04 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -75.98 83.88 2.88 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 119.004 0.82 . . . . 0.0 109.925 174.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 74.6 mtm -77.44 -8.98 58.59 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.45 1.5 . . . . 0.0 112.212 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.04 29.26 67.1 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-N 118.914 0.779 . . . . 0.0 111.362 -171.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.3 mt -106.07 -172.36 2.07 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.965 1.306 . . . . 0.0 109.721 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -74.6 141.16 75.84 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-O 117.749 -1.12 . . . . 0.0 108.58 169.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -43.19 137.95 4.72 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 123.445 2.763 . . . . 0.0 113.395 172.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.29 1.02 79.94 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-O 118.625 -1.097 . . . . 0.0 113.82 176.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -68.2 149.34 49.64 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 119.875 1.838 . . . . 0.0 108.299 168.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 48.2 mt -128.82 135.07 63.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 125.607 1.563 . . . . 0.0 106.952 -172.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.2 mmt-85 -144.99 152.12 39.65 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.068 0.849 . . . . 0.0 109.653 175.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 42.6 mm -78.12 146.57 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 167.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.3 mt -128.49 118.18 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -71.88 139.85 83.15 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-O 117.926 -1.035 . . . . 0.0 109.172 174.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -47.56 -33.22 17.47 Favored 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 124.22 3.28 . . . . 0.0 116.654 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -67.95 -24.27 65.15 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.763 0.71 . . . . 0.0 111.641 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -100.64 -28.85 12.63 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.284 1.434 . . . . 0.0 111.307 -177.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 61.0 mt -49.34 -45.87 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.69 1.196 . . . . 0.0 109.044 169.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.68 -14.89 15.88 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.257 1.423 . . . . 0.0 113.969 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -126.2 4.89 7.08 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.226 1.01 . . . . 0.0 111.637 -177.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 20.9 mmt -121.64 -25.71 5.05 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -176.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -73.79 -40.89 63.08 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.835 1.198 . . . . 0.0 111.449 -178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.448 0 O-C-N 121.773 -0.58 . . . . 0.0 112.397 175.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 mt . . . . . 0 N--CA 1.475 0.817 0 N-CA-C 117.642 2.46 . . . . 0.0 117.642 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.06 -20.97 4.05 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.053 0.842 . . . . 0.0 112.641 168.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -58.39 -32.4 68.57 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.641 1.11 . . . . 0.0 112.083 174.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.4 tt -74.77 -43.5 54.51 Favored 'General case' 0 N--CA 1.462 0.125 0 O-C-N 121.623 -0.673 . . . . 0.0 109.669 176.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 74.5 mt -62.0 -40.28 86.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 123.946 0.898 . . . . 0.0 109.705 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.1 -27.89 65.99 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.505 0.722 . . . . 0.0 112.386 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -91.47 8.49 36.14 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.816 1.246 . . . . 0.0 111.943 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 88.4 mt -133.47 -29.81 1.34 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.223 1.009 . . . . 0.0 111.865 -176.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 45.0 mttm -56.16 -19.14 12.25 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.095 0.958 . . . . 0.0 112.779 170.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -59.02 -18.81 37.94 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.423 1.089 . . . . 0.0 112.205 175.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -138.23 -42.93 0.51 Allowed 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.868 0.867 . . . . 0.0 112.012 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 20.3 mt -68.62 133.4 31.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -173.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -75.97 -34.07 48.61 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.203 0.906 . . . . 0.0 112.432 -173.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -143.62 125.75 15.47 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.4 t -127.07 128.85 70.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 3.8 mt -131.55 150.11 33.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 -169.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -130.96 141.04 50.23 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 169.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.9 tt -120.62 128.74 53.3 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 174.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -111.94 156.23 15.7 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -178.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 62.6 mt -133.92 124.52 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 -176.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -65.47 117.84 44.7 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-O 117.389 -1.291 . . . . 0.0 110.4 -178.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -77.21 171.99 16.82 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.662 2.908 . . . . 0.0 111.485 170.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -128.11 -31.43 2.35 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.669 1.587 . . . . 0.0 111.073 170.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.1 pp -136.52 135.54 49.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.309 1.044 . . . . 0.0 108.751 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.3 t -143.77 145.92 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 176.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 173.28 -120.58 0.81 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -156.21 154.18 30.36 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.647 1.224 . . . . 0.0 108.33 175.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 3.0 t80 53.73 33.07 15.97 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.691 1.197 . . . . 0.0 110.861 -171.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 12.5 m-30 -118.96 140.38 28.57 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 124.816 1.246 . . . . 0.0 109.84 -173.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -82.72 165.22 15.81 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.433 2.755 . . . . 0.0 111.215 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.3 ttm -75.71 139.35 41.86 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 168.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 73.0 p -80.74 160.5 24.91 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.484 1.114 . . . . 0.0 110.475 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -53.1 -45.04 98.44 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-O 116.493 -1.718 . . . . 0.0 114.117 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -68.52 -30.56 28.83 Favored 'Trans proline' 0 C--N 1.35 0.653 0 CA-C-N 122.847 2.052 . . . . 0.0 112.215 -176.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -80.56 -35.47 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -56.3 -46.42 79.8 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.366 0.985 . . . . 0.0 109.946 170.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -64.05 -38.62 91.74 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 122.937 0.495 . . . . 0.0 111.254 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.53 -46.49 82.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 119.013 -0.518 . . . . 0.0 111.09 175.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 79.7 t -62.87 -38.92 83.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 119.147 0.885 . . . . 0.0 109.793 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -62.79 -42.29 99.64 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.396 0.998 . . . . 0.0 110.355 174.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 57.3 m -61.14 -49.75 75.97 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 71.1 t -60.66 -42.17 90.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 123.646 0.779 . . . . 0.0 109.893 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -57.1 -48.3 78.96 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.465 0.575 . . . . 0.0 110.575 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 63.9 mm-40 -64.53 -38.57 91.47 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.992 0.815 . . . . 0.0 110.895 175.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -63.92 -27.43 69.14 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 123.436 0.695 . . . . 0.0 112.414 -177.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 75.1 mt -59.11 -18.5 36.19 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.376 0.989 . . . . 0.0 112.16 175.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 . . . . . 0 CA--C 1.544 0.739 0 CA-C-N 119.149 0.886 . . . . 0.0 111.947 178.708 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 . . . . . 0 N--CA 1.452 -0.367 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -88.75 148.56 23.89 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 170.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.6 121.9 29.77 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 174.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 52.3 tp . . . . . 0 CA--C 1.532 0.281 0 C-N-CA 125.612 1.565 . . . . 0.0 109.793 178.49 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 C--O 1.235 0.315 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 69.6 t -136.33 148.38 27.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 39.3 tp -123.36 119.15 29.24 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.9 tp -109.95 96.91 6.54 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 99.4 m -71.29 142.39 50.48 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 169.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.3 t -140.82 143.12 29.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 177.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.02 174.54 17.36 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -122.71 121.05 35.43 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.365 1.466 . . . . 0.0 107.422 177.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 m -59.56 -14.78 14.52 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.934 1.693 . . . . 0.0 115.495 -169.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -128.86 14.12 6.35 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.839 0.856 . . . . 0.0 111.243 -176.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.2 ttt -97.73 30.6 2.9 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 118.682 0.674 . . . . 0.0 109.898 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.26 -142.39 20.45 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -178.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -61.2 -17.31 52.48 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.593 1.157 . . . . 0.0 112.111 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -56.63 -19.97 18.84 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.217 1.407 . . . . 0.0 112.871 174.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.36 20.26 0.77 Allowed Glycine 0 CA--C 1.534 1.258 0 O-C-N 120.691 -1.256 . . . . 0.0 114.311 177.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.8 -52.7 63.14 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 119.571 1.685 . . . . 0.0 110.862 -169.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.62 -54.81 34.55 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-O 117.88 -1.511 . . . . 0.0 111.214 175.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -49.67 -40.76 46.75 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 CA-C-N 120.818 2.309 . . . . 0.0 115.077 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 65.6 tp -70.65 -39.27 73.72 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-N 119.963 1.256 . . . . 0.0 110.311 178.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.0 tp -61.28 -46.87 88.54 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.065 0.393 . . . . 0.0 110.348 175.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.38 -42.23 86.58 Favored 'General case' 0 C--O 1.227 -0.125 0 C-N-CA 124.134 0.974 . . . . 0.0 110.829 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -60.72 -49.15 78.68 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.476 0.58 . . . . 0.0 110.0 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -61.75 -49.83 74.83 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 122.99 0.516 . . . . 0.0 110.723 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 75.7 m -64.02 -37.79 88.71 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.549 0.613 . . . . 0.0 111.399 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.46 -40.65 96.12 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.112 0.869 . . . . 0.0 111.073 176.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.64 -33.05 73.34 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.511 0.724 . . . . 0.0 111.704 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.44 96.08 2.66 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.544 1.537 . . . . 0.0 107.762 -173.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -53.31 159.5 5.87 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 123.439 2.759 . . . . 0.0 113.939 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -134.53 155.54 50.23 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.638 1.575 . . . . 0.0 108.085 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 40.71 -119.08 1.32 Allowed Glycine 0 CA--C 1.532 1.104 0 C-N-CA 125.128 1.346 . . . . 0.0 111.88 176.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -137.14 14.87 3.04 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.913 1.685 . . . . 0.0 111.309 177.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -72.52 128.17 34.77 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.337 0.655 . . . . 0.0 109.791 -173.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.2 t -72.86 120.45 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 166.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.0 t -76.22 133.72 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 24.4 mm -133.15 147.94 31.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 104.967 -2.235 . . . . 0.0 104.967 171.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -134.7 114.06 12.32 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 177.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.79 -16.28 76.19 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 118.654 -1.081 . . . . 0.0 113.003 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 57.95 39.0 91.14 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-N 119.264 1.532 . . . . 0.0 113.722 170.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . 0.252 75.3 p 60.71 14.29 4.95 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.502 2.321 . . . . 0.0 114.69 -173.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.2 56.29 6.22 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 125.632 1.573 . . . . 0.0 108.995 172.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -67.05 -28.75 41.11 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.395 2.063 . . . . 0.0 112.258 -169.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.59 -36.19 77.96 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.592 0.757 . . . . 0.0 111.892 -178.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -64.43 -13.59 52.2 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.702 0.801 . . . . 0.0 112.574 176.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -112.66 -0.36 15.12 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.314 1.046 . . . . 0.0 112.38 -172.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 87.5 mt -50.01 -36.92 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 124.577 1.151 . . . . 0.0 110.518 172.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 51.3 t -56.41 -40.82 69.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 123.646 0.778 . . . . 0.0 110.455 178.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.46 -41.85 83.99 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.498 0.59 . . . . 0.0 110.504 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 51.1 mt -61.91 -40.29 86.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -66.23 -20.25 66.06 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 117.785 -1.103 . . . . 0.0 112.528 176.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -72.45 -43.94 63.07 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 120.677 1.581 . . . . 0.0 109.097 169.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 49.0 mt -68.75 -27.91 66.33 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 118.671 -0.681 . . . . 0.0 112.568 -177.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 39.12 64.74 3.69 Favored Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 125.589 1.556 . . . . 0.0 111.306 -169.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -49.69 141.04 28.23 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.269 2.646 . . . . 0.0 113.402 -172.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.1 m -66.99 -41.29 87.01 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 167.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.2 mtm-85 -146.72 149.97 34.47 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.115 1.766 . . . . 0.0 106.789 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 52.9 tp -134.59 137.76 43.99 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 33.6 tp -125.6 133.8 52.13 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 175.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.4 mt -121.96 142.38 38.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -174.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.5 t -141.01 133.56 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 118.764 0.711 . . . . 0.0 110.056 -174.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -161.42 171.24 18.55 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.39 2.276 . . . . 0.0 107.464 172.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.54 156.28 39.6 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.951 -1.093 . . . . 0.0 108.583 168.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.8 m -155.9 132.56 10.38 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -78.13 122.73 26.01 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 73.5 mtm -121.43 1.49 10.14 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.209 1.803 . . . . 0.0 110.699 -176.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.24 18.17 60.24 Favored Glycine 0 CA--C 1.537 1.412 0 CA-C-N 118.676 0.671 . . . . 0.0 112.579 -171.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.6 mt -87.47 -176.1 5.47 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.487 1.515 . . . . 0.0 109.744 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -76.08 140.26 69.76 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-O 117.871 -1.062 . . . . 0.0 108.818 171.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -45.86 134.93 14.0 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.417 2.744 . . . . 0.0 113.71 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.01 2.27 88.54 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.574 -1.126 . . . . 0.0 113.359 177.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -65.99 151.93 45.72 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 119.867 1.833 . . . . 0.0 108.025 168.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 81.0 mt -128.12 141.91 45.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -171.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 84.2 mmt-85 -151.04 154.19 36.55 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 123.326 0.651 . . . . 0.0 110.858 172.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 35.8 mm -81.6 144.68 9.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 165.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.7 mt -125.53 128.12 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 176.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -72.87 140.1 80.67 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-O 118.084 -0.96 . . . . 0.0 109.655 173.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -46.98 -32.55 13.05 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 124.356 3.37 . . . . 0.0 116.79 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -67.49 -26.48 66.38 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.778 0.717 . . . . 0.0 111.782 178.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -101.66 -25.08 13.99 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.991 1.316 . . . . 0.0 111.446 -176.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 45.0 mt -50.17 -41.21 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.54 1.136 . . . . 0.0 109.512 169.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.33 -30.67 52.11 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.53 1.132 . . . . 0.0 113.15 -177.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -100.38 -39.16 8.12 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.052 0.541 . . . . 0.0 110.06 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 26.1 mmt -73.47 -27.85 61.62 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 121.714 -0.616 . . . . 0.0 112.256 -173.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -68.59 -49.95 55.39 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 118.838 0.745 . . . . 0.0 110.306 171.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 27.6 ptm . . . . . 0 CA--C 1.535 0.384 0 CA-C-N 119.206 0.912 . . . . 0.0 111.911 -178.556 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.1 mt . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 117.363 2.357 . . . . 0.0 117.363 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -54.08 -19.42 4.89 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.437 1.017 . . . . 0.0 112.243 166.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -59.35 -28.46 66.87 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.608 1.095 . . . . 0.0 112.125 173.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.7 tt -70.78 -45.6 64.41 Favored 'General case' 0 N--CA 1.463 0.18 0 O-C-N 121.334 -0.854 . . . . 0.0 109.625 173.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 90.0 mt -61.5 -42.11 92.66 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.137 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -60.38 -24.85 65.43 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -85.89 0.11 53.94 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.921 0.888 . . . . 0.0 112.453 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 65.3 mt -135.89 -31.34 0.93 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.21 1.004 . . . . 0.0 112.401 -171.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -59.29 -21.84 60.29 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.895 1.278 . . . . 0.0 112.712 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -71.44 -13.06 61.71 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.513 1.125 . . . . 0.0 111.916 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -134.67 -32.98 0.97 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.219 0.918 . . . . 0.0 112.983 -176.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 53.7 mt -68.55 143.58 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 172.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -67.17 -41.66 92.05 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 123.96 0.791 . . . . 0.0 112.236 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -150.63 143.15 24.42 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 118.582 1.191 . . . . 0.0 108.999 173.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.0 t -127.66 129.44 70.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 177.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.6 mt -129.93 148.86 33.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 -169.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -132.86 142.38 48.91 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 171.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.4 tt -122.44 127.8 50.09 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.434 1.494 . . . . 0.0 107.124 174.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -109.16 156.09 15.78 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 77.8 mt -133.93 126.98 51.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -61.28 114.95 12.19 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-O 117.346 -1.311 . . . . 0.0 110.34 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -76.52 171.4 18.13 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.184 2.589 . . . . 0.0 111.174 170.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -129.59 -31.81 1.98 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.915 1.686 . . . . 0.0 111.041 171.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -135.84 135.85 50.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 124.282 1.033 . . . . 0.0 108.215 176.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.6 t -141.58 135.4 30.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 158.4 151.16 5.99 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 178.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -65.99 153.33 42.45 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.844 0.831 . . . . 0.0 111.344 -175.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 54.62 38.79 30.55 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.92 2.088 . . . . 0.0 112.141 -176.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -123.4 148.32 55.06 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 123.961 0.904 . . . . 0.0 109.996 172.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -81.74 163.83 18.48 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.19 2.594 . . . . 0.0 111.161 176.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 52.2 ttm -72.24 138.94 47.84 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 168.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 68.8 p -79.07 159.27 27.61 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.153 0.981 . . . . 0.0 110.529 178.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -52.9 -44.1 95.63 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-O 116.569 -1.681 . . . . 0.0 114.277 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -68.67 -31.26 26.49 Favored 'Trans proline' 0 C--N 1.351 0.667 0 CA-C-N 122.892 2.069 . . . . 0.0 112.215 -176.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.09 -35.28 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -56.3 -46.02 80.0 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.196 0.907 . . . . 0.0 110.172 170.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -64.15 -37.92 89.2 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 122.987 0.515 . . . . 0.0 111.41 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.58 -47.33 79.08 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 121.944 -0.473 . . . . 0.0 110.986 175.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 72.4 t -62.71 -39.37 84.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 118.552 0.615 . . . . 0.0 109.789 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -60.31 -43.26 96.51 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.022 0.828 . . . . 0.0 110.265 173.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 55.2 m -61.52 -47.5 85.33 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.959 -0.463 . . . . 0.0 109.971 178.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 87.8 t -61.44 -45.65 98.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 118.552 0.615 . . . . 0.0 109.648 178.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -54.4 -48.84 71.11 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.802 0.841 . . . . 0.0 110.71 177.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 48.2 mm-40 -65.58 -37.34 86.37 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.642 0.656 . . . . 0.0 111.41 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.1 -35.54 71.6 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.545 0.738 . . . . 0.0 111.843 -178.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 77.6 mt -59.07 -16.88 21.27 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -172.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 . . . . . 0 CA--C 1.54 0.576 0 CA-C-N 120.042 1.292 . . . . 0.0 112.54 177.164 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 . . . . . 0 N--CA 1.45 -0.455 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -76.7 148.08 37.02 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 174.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -91.3 120.54 32.27 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 176.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 44.9 tp . . . . . 0 C--O 1.233 0.219 0 C-N-CA 125.819 1.647 . . . . 0.0 109.883 177.334 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 . . . . . 0 C--O 1.234 0.259 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.6 t -138.02 148.19 25.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -175.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 31.7 tp -122.71 119.55 31.01 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.3 tp -109.02 97.68 7.27 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 125.405 1.482 . . . . 0.0 107.487 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 87.7 m -73.53 143.17 46.63 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 169.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.8 t -140.21 142.11 32.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 142.37 178.92 18.83 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 124.214 0.912 . . . . 0.0 111.861 177.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -127.95 123.59 35.23 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.768 1.227 . . . . 0.0 108.619 177.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 m -58.74 -16.05 14.93 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.631 1.972 . . . . 0.0 115.461 -169.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.0 ptp -128.7 15.98 6.42 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 119.197 0.908 . . . . 0.0 111.259 -178.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 11.3 tpt -92.19 25.48 2.89 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.621 0.768 . . . . 0.0 109.397 176.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.75 -142.64 20.21 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -176.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -61.0 -16.82 47.68 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.695 1.198 . . . . 0.0 112.221 178.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -55.58 -20.56 13.87 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.483 1.513 . . . . 0.0 112.906 173.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.14 17.91 0.94 Allowed Glycine 0 CA--C 1.534 1.257 0 O-C-N 120.789 -1.194 . . . . 0.0 114.437 177.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.19 -51.29 69.63 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 119.566 1.683 . . . . 0.0 110.838 -170.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.77 -55.96 27.52 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-O 117.794 -1.559 . . . . 0.0 111.136 175.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -49.77 -40.78 47.66 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 CA-C-N 120.784 2.292 . . . . 0.0 115.113 178.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 62.6 tp -70.61 -39.89 73.51 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 119.862 1.21 . . . . 0.0 109.986 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.2 tp -61.47 -46.37 90.33 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.443 0.297 . . . . 0.0 110.388 176.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.69 -42.6 88.93 Favored 'General case' 0 C--O 1.227 -0.127 0 C-N-CA 123.838 0.855 . . . . 0.0 110.883 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -60.93 -48.98 79.3 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 118.616 0.643 . . . . 0.0 109.871 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -63.62 -48.69 76.28 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 123.016 0.526 . . . . 0.0 110.907 -178.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 93.0 m -65.39 -34.56 78.6 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.732 0.696 . . . . 0.0 111.478 178.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.99 -40.64 95.26 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.689 1.132 . . . . 0.0 110.848 174.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.14 -33.05 72.83 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.434 0.693 . . . . 0.0 111.8 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.57 89.54 4.42 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.394 1.478 . . . . 0.0 108.548 -174.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -52.6 155.8 9.7 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.955 3.103 . . . . 0.0 113.606 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -133.37 156.65 47.27 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.635 1.174 . . . . 0.0 109.479 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 40.84 -111.95 0.3 Allowed Glycine 0 CA--C 1.527 0.844 0 C-N-CA 125.85 1.691 . . . . 0.0 112.612 172.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -138.04 9.91 2.8 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.145 1.378 . . . . 0.0 111.295 -173.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 1.5 m95 -85.07 123.07 30.18 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 121.286 -0.884 . . . . 0.0 110.753 -168.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.7 t -70.68 119.88 17.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 166.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.6 t -74.04 132.6 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.1 mm -133.98 148.0 30.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 172.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -135.61 111.66 9.6 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.23 -1.99 88.05 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-O 118.991 -0.894 . . . . 0.0 112.727 179.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 56.16 -147.52 30.63 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -169.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 p -90.08 10.95 22.31 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.841 0.856 . . . . 0.0 111.94 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.83 55.17 7.43 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.267 1.427 . . . . 0.0 109.77 -177.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -66.36 -20.35 55.06 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.825 2.35 . . . . 0.0 113.479 -169.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.3 pm0 -61.6 -30.39 70.65 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 119.05 0.841 . . . . 0.0 111.911 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.02 -25.85 67.89 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.373 0.669 . . . . 0.0 112.084 175.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -102.84 -2.51 27.79 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.106 0.962 . . . . 0.0 113.06 -168.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.9 mt -48.52 -40.4 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.518 1.127 . . . . 0.0 110.288 174.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.1 t -56.19 -40.26 64.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.926 0.89 . . . . 0.0 110.582 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.32 -42.26 83.94 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 118.318 0.508 . . . . 0.0 110.398 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 35.3 mt -64.97 -37.48 80.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.38 -21.05 66.05 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 117.855 -1.069 . . . . 0.0 112.397 175.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -70.91 -39.74 72.57 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 120.613 1.552 . . . . 0.0 109.745 170.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 59.5 mt -70.48 -26.55 63.67 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.499 0.72 . . . . 0.0 112.187 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 40.89 65.71 4.08 Favored Pre-proline 0 N--CA 1.472 0.668 0 C-N-CA 125.698 1.599 . . . . 0.0 110.932 -171.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -52.14 137.4 54.39 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 123.253 2.635 . . . . 0.0 112.79 -169.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.0 m -69.53 -38.67 77.61 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 167.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -144.45 157.7 44.11 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 124.889 1.276 . . . . 0.0 107.885 171.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 53.5 tp -136.74 136.16 38.72 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 32.5 tp -123.67 134.92 53.66 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 175.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.0 mt -123.29 141.82 42.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 -173.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 44.6 t -140.87 134.36 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 118.773 0.715 . . . . 0.0 110.642 -174.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -162.82 171.22 17.04 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.783 2.433 . . . . 0.0 107.481 172.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.75 157.69 37.59 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 120.989 -1.069 . . . . 0.0 108.54 167.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.0 m -156.2 127.79 7.23 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 175.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -70.74 124.21 23.74 Favored 'General case' 0 C--O 1.23 0.058 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 172.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 73.6 mtm -122.39 2.2 9.66 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.142 1.777 . . . . 0.0 110.562 -177.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.11 24.64 68.9 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-N 118.66 0.664 . . . . 0.0 112.195 -172.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.6 mt -98.04 -172.71 2.42 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.398 1.479 . . . . 0.0 109.24 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -79.6 140.4 55.37 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-O 117.746 -1.121 . . . . 0.0 108.931 173.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -45.64 134.0 13.26 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.343 2.695 . . . . 0.0 113.705 178.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.49 2.08 89.27 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-O 118.254 -1.303 . . . . 0.0 113.345 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -66.29 150.24 49.15 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 120.156 1.978 . . . . 0.0 107.728 167.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 34.4 mt -131.52 135.14 59.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -169.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.4 mmt-85 -146.6 153.3 40.17 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.504 0.593 . . . . 0.0 109.984 176.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 29.4 mm -83.0 143.36 12.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 167.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.6 mt -126.11 124.17 65.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -71.39 141.09 85.33 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.419 173.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -46.99 -32.5 13.01 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 124.133 3.222 . . . . 0.0 116.594 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -67.19 -25.54 66.18 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.803 0.728 . . . . 0.0 111.799 177.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -101.42 -26.21 13.67 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.915 1.286 . . . . 0.0 111.447 -177.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 51.6 mt -50.19 -41.36 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.478 1.111 . . . . 0.0 109.109 168.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.39 -22.1 18.44 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.425 1.49 . . . . 0.0 114.075 -177.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -115.2 -33.75 5.24 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 118.68 0.673 . . . . 0.0 110.387 177.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 23.3 mmt -72.28 -28.51 63.15 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -177.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -66.39 -46.29 77.12 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 119.241 0.928 . . . . 0.0 110.92 176.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 CA--C 1.541 0.629 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 -178.818 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.468 0.447 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -55.46 -17.31 4.93 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 120.997 -1.065 . . . . 0.0 112.179 166.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -59.29 -32.15 69.77 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 120.155 1.343 . . . . 0.0 111.924 173.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.3 tt -67.59 -48.92 65.46 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 174.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 74.5 mt -61.27 -45.31 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -174.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.56 -21.08 66.56 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.014 -1.054 . . . . 0.0 113.38 -174.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -91.84 5.64 49.18 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.149 0.98 . . . . 0.0 111.852 177.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 40.5 tp -140.89 -32.88 0.55 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.593 0.757 . . . . 0.0 112.311 -169.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.0 pttm -61.68 -25.28 67.31 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 125.63 1.572 . . . . 0.0 112.62 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -62.6 -18.04 61.41 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.315 1.046 . . . . 0.0 112.275 -175.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -114.12 6.21 16.27 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.231 1.012 . . . . 0.0 112.155 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 79.9 mt -120.6 146.42 25.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.848 1.259 . . . . 0.0 108.522 -171.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -75.19 -36.25 46.22 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.774 0.702 . . . . 0.0 112.143 -177.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -152.12 141.05 21.11 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.107 0.954 . . . . 0.0 108.679 175.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.6 t -124.99 135.23 64.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 171.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.0 mp -129.49 149.72 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 -177.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -130.75 141.8 50.39 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 169.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.4 tt -120.28 130.54 54.52 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.313 1.445 . . . . 0.0 107.544 173.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -111.41 155.01 16.4 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 176.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 77.1 mt -133.24 127.37 54.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -60.93 114.63 10.98 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-O 117.351 -1.309 . . . . 0.0 110.179 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -76.2 171.5 17.99 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.158 2.572 . . . . 0.0 111.116 170.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -129.42 -31.56 2.04 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.053 1.741 . . . . 0.0 111.012 171.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -135.85 136.03 50.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.237 1.015 . . . . 0.0 108.309 176.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.8 t -141.45 134.84 30.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 175.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 159.47 153.94 7.06 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -69.52 153.46 43.47 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.882 0.849 . . . . 0.0 110.775 -173.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.4 t80 51.8 39.16 25.02 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.846 2.058 . . . . 0.0 112.296 -176.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 23.0 m-30 -121.97 147.63 49.34 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 124.067 0.947 . . . . 0.0 109.961 173.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -81.15 164.09 19.77 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.153 2.568 . . . . 0.0 111.15 177.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.3 ttm -72.59 139.41 47.44 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 168.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 68.6 p -79.08 159.36 27.55 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.191 0.996 . . . . 0.0 110.522 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.2 tp60 -52.87 -44.26 95.88 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-O 116.579 -1.677 . . . . 0.0 114.232 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -68.78 -30.55 27.08 Favored 'Trans proline' 0 C--N 1.35 0.647 0 CA-C-N 122.869 2.06 . . . . 0.0 112.295 -176.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.97 -35.26 15.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 119.072 0.851 . . . . 0.0 108.706 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -56.29 -46.91 79.56 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.136 0.88 . . . . 0.0 109.977 169.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -63.28 -38.27 90.5 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.037 0.535 . . . . 0.0 111.248 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.35 -47.14 80.44 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 121.967 -0.458 . . . . 0.0 111.133 176.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.5 t -61.4 -41.27 89.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 118.581 0.628 . . . . 0.0 109.655 177.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -62.36 -33.86 75.55 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.863 0.865 . . . . 0.0 111.074 175.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 44.3 m -69.52 -46.23 67.02 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.462 -0.774 . . . . 0.0 109.926 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 92.3 t -61.97 -44.35 98.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 119.203 0.911 . . . . 0.0 109.592 178.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -53.37 -43.82 68.09 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.32 1.048 . . . . 0.0 111.172 176.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -68.73 -45.02 72.61 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.527 0.603 . . . . 0.0 111.119 175.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -58.7 -36.66 74.58 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.133 0.573 . . . . 0.0 111.221 -174.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 56.9 mt -56.27 -19.06 12.47 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -175.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 . . . . . 0 CA--C 1.538 0.481 0 CA-C-N 120.09 1.314 . . . . 0.0 112.211 176.31 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 . . . . . 0 N--CA 1.447 -0.595 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.87 148.47 42.29 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.196 176.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -92.15 119.85 32.19 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 60.4 tp . . . . . 0 CA--C 1.53 0.199 0 C-N-CA 126.024 1.729 . . . . 0.0 110.104 178.749 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.1 t0 . . . . . 0 C--O 1.234 0.265 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.8 m -86.41 150.72 3.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 123.758 0.823 . . . . 0.0 110.04 -172.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 52.6 tp -115.32 124.51 51.47 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 171.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 67.2 tp -112.95 97.41 6.51 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 92.2 m -72.97 141.97 47.78 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 169.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.4 t -141.23 142.03 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 125.216 1.407 . . . . 0.0 107.734 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 148.91 178.04 23.61 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 123.971 0.796 . . . . 0.0 112.272 175.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -124.93 117.17 23.46 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 125.387 1.475 . . . . 0.0 107.908 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 m -56.13 -21.63 23.63 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 126.5 1.92 . . . . 0.0 115.339 -170.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 25.7 ptp -123.91 20.48 9.2 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.665 0.666 . . . . 0.0 110.794 -174.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.411 ' HA ' ' HA ' ' A' ' 120' ' ' PHE . 24.9 ttt -102.34 29.23 5.31 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.38 1.072 . . . . 0.0 110.29 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.33 -142.07 21.83 Favored Glycine 0 N--CA 1.441 -1.021 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -63.17 -15.44 56.89 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.37 1.068 . . . . 0.0 112.223 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -56.17 -21.49 23.24 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.15 1.38 . . . . 0.0 112.987 175.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.33 21.29 0.69 Allowed Glycine 0 CA--C 1.534 1.246 0 CA-C-O 118.491 -1.172 . . . . 0.0 114.475 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.1 -51.88 67.27 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 119.545 1.673 . . . . 0.0 110.758 -169.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.28 -55.32 30.81 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 117.502 -1.721 . . . . 0.0 111.423 177.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -50.47 -40.14 54.23 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 CA-C-N 120.921 2.36 . . . . 0.0 115.076 178.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.6 tp -71.07 -39.48 72.18 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 119.878 1.217 . . . . 0.0 110.039 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 51.1 tp -61.53 -48.85 79.13 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 176.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.26 -41.7 80.14 Favored 'General case' 0 C--O 1.227 -0.107 0 C-N-CA 124.054 0.942 . . . . 0.0 111.283 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -60.77 -49.1 78.86 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.661 0.664 . . . . 0.0 109.897 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -62.66 -47.74 82.37 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 122.983 0.513 . . . . 0.0 110.702 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 73.8 m -64.74 -37.95 89.33 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.574 0.624 . . . . 0.0 111.458 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.81 -40.91 97.77 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.991 0.814 . . . . 0.0 110.806 176.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.67 -32.53 72.42 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.483 0.713 . . . . 0.0 111.837 178.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.86 92.6 2.85 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 125.268 1.427 . . . . 0.0 108.461 -172.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -53.8 158.85 7.8 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.34 2.693 . . . . 0.0 113.567 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.414 ' HE2' ' CE1' ' A' ' 136' ' ' TYR . 74.7 mmtt -129.36 166.39 19.61 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.481 1.512 . . . . 0.0 108.474 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 41.17 -124.37 2.88 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.478 1.513 . . . . 0.0 112.139 175.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -138.47 35.98 2.26 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.185 1.394 . . . . 0.0 109.028 170.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -70.49 167.02 19.25 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.146 0.978 . . . . 0.0 111.441 -175.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 68.7 t -122.29 101.95 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 168.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.9 t -72.43 136.91 24.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -175.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 90.9 mt -135.33 142.31 40.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 172.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -127.01 105.29 8.5 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.55 -6.36 80.76 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 118.973 -0.904 . . . . 0.0 112.69 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 54.22 -140.7 35.42 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 -169.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.4 p -93.2 7.89 42.43 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.624 0.77 . . . . 0.0 112.469 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.72 64.22 42.52 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 124.875 1.27 . . . . 0.0 109.528 177.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -65.17 -15.63 51.15 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.668 2.245 . . . . 0.0 112.183 -177.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -46.92 -42.37 17.55 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.703 1.601 . . . . 0.0 111.161 168.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.96 -27.29 68.73 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.93 -5.43 41.4 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.854 1.261 . . . . 0.0 111.33 -169.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.8 mt -52.86 -44.9 49.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 118.919 0.781 . . . . 0.0 109.18 171.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.7 t -60.99 -42.29 92.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.22 -44.69 87.48 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 123.192 0.597 . . . . 0.0 110.854 -177.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 72.9 mt -55.39 -48.15 77.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.091 0.956 . . . . 0.0 108.504 173.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 49.7 mtp180 -67.83 -19.17 65.03 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 117.598 -1.192 . . . . 0.0 113.135 -176.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -58.97 -27.39 65.33 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 121.023 1.738 . . . . 0.0 110.977 171.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 58.6 mt -95.93 -9.52 31.05 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.582 1.153 . . . . 0.0 112.33 -172.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 48.7 mmm-85 32.85 58.48 1.47 Allowed Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 126.423 1.889 . . . . 0.0 111.764 -169.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -56.09 152.49 37.14 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.073 2.515 . . . . 0.0 114.867 -168.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.1 m -71.97 -39.06 69.6 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.089 0.955 . . . . 0.0 109.244 168.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -148.67 160.12 43.46 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.633 0.773 . . . . 0.0 111.126 -177.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 24.1 tp -141.91 139.52 32.57 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 125.304 1.442 . . . . 0.0 109.074 177.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 54.4 tp -124.17 135.98 53.86 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 168.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.9 mt -119.49 144.97 26.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -178.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 46.3 t -139.92 133.68 36.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 123.148 0.579 . . . . 0.0 109.649 -175.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -162.65 171.68 16.52 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 127.335 2.254 . . . . 0.0 107.245 173.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.07 155.31 40.58 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 167.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.1 m -153.86 135.56 14.44 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 177.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -81.09 84.45 6.51 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.945 0.793 . . . . 0.0 109.873 176.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -69.48 -8.88 50.79 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.698 0.799 . . . . 0.0 112.121 173.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.36 24.89 76.39 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 119.434 1.016 . . . . 0.0 111.634 -171.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 98.0 mt -100.01 -173.26 2.39 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.232 1.413 . . . . 0.0 110.477 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -69.66 139.76 89.01 Favored Pre-proline 0 N--CA 1.467 0.407 0 CA-C-O 117.606 -1.188 . . . . 0.0 108.72 169.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -43.04 138.92 3.88 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.544 2.829 . . . . 0.0 113.57 172.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.17 0.27 76.42 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 118.6 -1.111 . . . . 0.0 113.679 176.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -65.72 154.78 38.0 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 119.794 1.797 . . . . 0.0 108.815 168.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 77.4 mt -134.7 132.87 54.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 125.825 1.65 . . . . 0.0 106.699 -170.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.2 mmt-85 -143.39 148.11 35.69 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.291 0.95 . . . . 0.0 109.733 177.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 47.1 mm -77.92 144.68 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 169.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -135.5 165.63 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 124.777 1.231 . . . . 0.0 108.205 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -139.42 146.16 47.21 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 127.086 2.155 . . . . 0.0 107.619 -169.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -54.12 -27.97 48.88 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.399 2.733 . . . . 0.0 115.088 -174.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -67.29 -20.02 65.57 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.862 0.755 . . . . 0.0 112.123 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -119.85 -31.2 4.56 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.91 1.284 . . . . 0.0 111.84 -171.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 67.2 mt -50.74 -39.98 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.373 1.469 . . . . 0.0 109.938 169.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.45 -28.28 53.36 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.359 1.064 . . . . 0.0 113.129 -177.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -102.24 -43.83 5.6 Favored 'General case' 0 C--O 1.23 0.078 0 C-N-CA 123.202 0.601 . . . . 0.0 109.53 176.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 21.2 mmt -69.06 -28.76 66.83 Favored 'General case' 0 C--O 1.23 0.057 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -169.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -68.06 -48.36 65.82 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 119.038 0.835 . . . . 0.0 110.724 175.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 28.8 ptm . . . . . 0 CA--C 1.535 0.385 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 179.631 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.3 mt . . . . . 0 N--CA 1.471 0.579 0 N-CA-C 117.087 2.255 . . . . 0.0 117.087 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -52.78 -23.24 6.46 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.318 -0.864 . . . . 0.0 112.278 167.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -58.83 -34.4 71.49 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.396 0.998 . . . . 0.0 111.593 175.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.3 tt -75.83 -44.29 41.73 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 86.7 mt -60.96 -42.0 91.18 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.175 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -60.84 -26.01 67.04 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.853 0.751 . . . . 0.0 112.606 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -85.06 -3.57 58.84 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.753 0.821 . . . . 0.0 112.211 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 80.3 mt -130.01 -26.59 2.37 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.22 1.008 . . . . 0.0 111.946 -173.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -63.44 -23.11 67.26 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.221 -0.924 . . . . 0.0 112.286 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -80.09 -6.06 57.0 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.148 0.979 . . . . 0.0 111.789 175.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -132.51 -3.06 3.38 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.689 1.195 . . . . 0.0 113.038 -168.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.3 mt -134.85 143.41 37.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 126.549 1.94 . . . . 0.0 106.163 -175.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -70.37 -37.15 70.2 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-O 119.464 -0.631 . . . . 0.0 112.539 -172.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -146.53 130.88 17.59 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 -177.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 48.6 t -132.12 124.31 52.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 21.3 mt -130.19 156.68 42.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 -169.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -130.82 147.47 52.48 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 174.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.8 tt -126.37 126.5 43.99 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 170.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -107.69 156.16 15.98 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 82.5 mt -131.82 126.32 56.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 71.1 tp60 -64.64 116.03 25.44 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-O 117.201 -1.381 . . . . 0.0 110.438 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -76.51 170.59 19.64 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.268 2.645 . . . . 0.0 111.377 170.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -128.08 -31.9 2.32 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.978 1.711 . . . . 0.0 110.984 171.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.1 pp -137.14 139.77 43.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 124.369 1.068 . . . . 0.0 108.531 178.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 92.8 t -143.22 138.55 26.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 175.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 163.01 140.06 2.78 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 175.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 13' ' ' MET . 13.0 t80 -74.1 42.71 0.15 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.806 2.042 . . . . 0.0 113.759 -169.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -161.39 26.1 0.13 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.608 1.563 . . . . 0.0 110.731 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -135.04 153.24 78.33 Favored Pre-proline 0 CA--C 1.536 0.421 0 O-C-N 121.517 -0.74 . . . . 0.0 112.15 -174.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -83.75 166.1 13.52 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.601 2.867 . . . . 0.0 110.854 172.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.4 ttm -69.83 140.87 53.32 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 168.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 71.7 p -81.32 160.45 24.17 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.509 1.124 . . . . 0.0 110.682 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 6.9 tm0? -50.91 -48.81 83.32 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-O 117.004 -1.474 . . . . 0.0 113.351 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -67.53 -29.3 37.26 Favored 'Trans proline' 0 C--N 1.352 0.753 0 CA-C-N 122.575 1.955 . . . . 0.0 112.573 -175.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -81.63 -34.76 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 119.134 0.879 . . . . 0.0 108.865 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -56.65 -46.61 80.95 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 119.183 0.901 . . . . 0.0 109.782 169.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -62.36 -38.74 90.7 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 123.092 0.557 . . . . 0.0 111.525 177.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.41 -46.93 81.13 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 122.036 -0.415 . . . . 0.0 111.094 176.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 62.7 t -62.38 -40.32 87.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 118.81 0.732 . . . . 0.0 109.782 178.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -61.48 -40.06 93.17 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.625 0.648 . . . . 0.0 110.52 174.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 49.5 m -63.94 -46.92 82.6 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.785 -0.626 . . . . 0.0 109.962 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 85.4 t -58.83 -47.6 88.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 119.209 0.913 . . . . 0.0 109.133 177.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.414 ' CE1' ' HE2' ' A' ' 31' ' ' LYS . 24.4 t80 -53.83 -46.87 71.31 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.939 0.896 . . . . 0.0 111.2 177.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -72.36 -4.96 33.05 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 178.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.38 -11.4 10.57 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.17 1.388 . . . . 0.0 109.452 -175.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 59.5 mt -59.72 -25.45 64.83 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 119.348 -2.095 . . . . 0.0 111.449 170.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 . . . . . 0 CA--C 1.544 0.716 0 C-N-CA 124.668 1.187 . . . . 0.0 113.555 177.413 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 . . . . . 0 C--O 1.232 0.168 0 CA-C-O 121.815 0.816 . . . . 0.0 110.049 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.36 144.65 44.33 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -87.88 119.81 28.59 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 48.4 tp . . . . . 0 C--O 1.233 0.236 0 C-N-CA 125.322 1.449 . . . . 0.0 110.255 -179.579 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.8 t0 . . . . . 0 C--O 1.234 0.242 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 49.1 t -88.42 143.56 10.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-O 121.518 0.675 . . . . 0.0 109.357 -170.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.2 tp -113.22 108.67 17.59 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 169.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.1 tp -98.09 103.14 15.06 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 99.8 m -77.58 141.67 39.4 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 169.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 54.3 t -140.84 141.67 31.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 152.73 176.48 25.34 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-N 118.44 0.563 . . . . 0.0 112.9 174.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -120.15 115.65 24.08 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.73 1.612 . . . . 0.0 108.494 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -66.5 -10.39 44.18 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 -170.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 21.9 ptp -117.34 2.0 12.46 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.912 1.233 . . . . 0.0 111.267 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.3 ttt -95.75 39.85 1.13 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 122.087 0.946 . . . . 0.0 109.227 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 57.66 -121.83 27.13 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 124.327 0.965 . . . . 0.0 110.759 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -61.43 -19.67 62.22 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.096 0.959 . . . . 0.0 112.502 -174.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -65.61 -13.02 58.23 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.614 0.765 . . . . 0.0 112.274 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.19 17.4 1.4 Allowed Glycine 0 CA--C 1.531 1.039 0 O-C-N 120.743 -1.223 . . . . 0.0 113.097 176.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.26 -52.22 65.67 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.604 1.702 . . . . 0.0 110.821 -169.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.59 -55.6 29.02 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-O 117.745 -1.586 . . . . 0.0 111.024 175.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -49.73 -40.98 47.27 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 CA-C-N 120.878 2.339 . . . . 0.0 115.217 177.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.7 tp -71.98 -36.66 69.85 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 119.876 1.216 . . . . 0.0 110.408 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 49.4 tp -61.74 -49.94 74.41 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.332 0.515 . . . . 0.0 109.936 174.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.73 -39.49 77.43 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.923 0.889 . . . . 0.0 111.102 177.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.9 tp10 -62.05 -49.48 75.82 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 118.778 0.717 . . . . 0.0 109.87 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -62.24 -44.49 96.43 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.816 0.446 . . . . 0.0 110.614 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 84.9 m -63.64 -42.34 98.15 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.298 0.499 . . . . 0.0 110.997 178.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.18 -39.53 94.91 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.309 0.504 . . . . 0.0 111.046 178.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.37 -36.36 76.75 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.258 0.623 . . . . 0.0 111.486 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.01 91.61 2.43 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 124.8 1.24 . . . . 0.0 108.877 -171.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -55.65 163.26 5.51 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.633 2.889 . . . . 0.0 113.811 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -133.71 174.42 10.46 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 126.033 1.733 . . . . 0.0 108.87 176.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 40.1 -125.4 2.46 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.228 1.394 . . . . 0.0 112.336 177.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -141.25 38.4 1.73 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.319 1.447 . . . . 0.0 109.169 172.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -74.93 168.38 20.05 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.341 1.057 . . . . 0.0 111.904 -172.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 67.9 t -120.38 105.6 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 167.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.0 t -70.44 137.77 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -178.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.0 mm -134.59 148.21 29.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 169.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -130.66 109.81 10.92 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 175.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.22 -1.91 88.12 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 118.868 -0.962 . . . . 0.0 112.833 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 60.93 -146.5 47.54 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -170.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.8 p -94.44 -1.78 53.02 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.15 0.98 . . . . 0.0 112.917 -172.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.66 70.0 31.07 Favored Pre-proline 0 C--O 1.235 0.303 0 C-N-CA 125.138 1.375 . . . . 0.0 107.993 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -66.1 -12.42 35.37 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.777 2.318 . . . . 0.0 112.77 -169.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.8 tp10 -44.57 -41.15 6.3 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.592 1.557 . . . . 0.0 110.938 168.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -62.86 -23.71 67.45 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -177.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -113.86 -2.22 13.68 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -168.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 79.6 mt -50.59 -37.7 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.154 0.981 . . . . 0.0 110.311 172.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 53.1 t -55.92 -40.28 61.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 123.852 0.861 . . . . 0.0 110.395 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.81 -43.29 84.19 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.431 0.56 . . . . 0.0 110.406 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.3 mt -62.36 -39.5 84.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -65.91 -18.99 65.71 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 117.724 -1.131 . . . . 0.0 112.513 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -69.19 -42.95 75.14 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 120.702 1.592 . . . . 0.0 109.241 169.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.4 mt -72.6 -25.75 61.44 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.648 0.779 . . . . 0.0 112.447 -175.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 38.22 60.32 4.83 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.703 1.601 . . . . 0.0 111.929 -169.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.37 151.02 38.73 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.862 2.374 . . . . 0.0 113.501 -170.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.6 m -71.66 -37.28 70.81 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 168.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -147.4 155.86 42.34 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.201 1.0 . . . . 0.0 109.31 -176.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 37.1 tp -144.51 136.22 25.79 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.63 1.172 . . . . 0.0 108.633 -177.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 56.9 tp -122.14 137.85 54.67 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 169.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.2 mt -122.21 143.19 35.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 -177.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.9 t -140.97 134.07 31.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 118.294 0.497 . . . . 0.0 110.013 -174.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -161.92 173.15 14.9 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 127.11 2.164 . . . . 0.0 107.456 169.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.69 156.58 39.29 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.055 -1.028 . . . . 0.0 109.906 169.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.8 m -152.92 129.49 10.74 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -178.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -79.85 83.63 5.75 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 119.031 0.832 . . . . 0.0 109.561 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 74.9 mtm -77.26 -7.28 55.7 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.583 1.553 . . . . 0.0 112.018 -177.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.33 26.67 72.98 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 123.816 0.722 . . . . 0.0 111.672 -172.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.4 mt -104.88 -171.24 1.88 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.936 1.294 . . . . 0.0 110.004 -177.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -73.66 140.2 78.17 Favored Pre-proline 0 N--CA 1.468 0.467 0 CA-C-O 117.47 -1.252 . . . . 0.0 108.676 171.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -42.96 137.59 4.37 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.303 2.668 . . . . 0.0 113.378 172.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.66 2.74 76.87 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 118.692 -1.06 . . . . 0.0 113.7 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -66.11 148.1 52.34 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.743 1.771 . . . . 0.0 108.348 168.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.13 136.32 59.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -173.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 89.4 mmt-85 -145.9 151.16 37.41 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 118.8 0.727 . . . . 0.0 110.703 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 49.0 mm -75.9 144.09 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 167.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.418 HG21 ' H ' ' A' ' 77' ' ' ASP . 1.4 mt -133.64 165.79 30.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 124.55 1.14 . . . . 0.0 107.989 177.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.418 ' H ' HG21 ' A' ' 76' ' ' ILE . 5.9 t70 -135.63 145.89 55.12 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 127.116 2.166 . . . . 0.0 107.681 -170.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -54.46 -26.6 45.54 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.395 2.73 . . . . 0.0 115.147 -174.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -66.51 -21.37 66.17 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.012 0.824 . . . . 0.0 112.273 177.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -120.39 -28.52 4.99 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.708 1.203 . . . . 0.0 112.14 -171.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 72.0 mt -51.23 -39.78 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.845 1.258 . . . . 0.0 109.743 169.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.9 -28.6 51.91 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.53 1.132 . . . . 0.0 113.261 -177.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -100.9 -44.27 5.81 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 123.068 0.547 . . . . 0.0 109.657 175.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 21.3 mmt -67.26 -26.77 66.73 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -171.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -76.85 -43.33 36.64 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.741 0.701 . . . . 0.0 111.502 174.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 22.0 ptt? . . . . . 0 CA--C 1.533 0.307 0 CA-C-N 119.102 0.864 . . . . 0.0 112.044 178.938 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 18.8 mt . . . . . 0 N--CA 1.468 0.452 0 N-CA-C 116.903 2.186 . . . . 0.0 116.903 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -52.42 -24.94 8.71 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.406 1.003 . . . . 0.0 112.578 168.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -59.18 -33.05 70.48 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 119.32 0.964 . . . . 0.0 111.803 176.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.6 tt -75.61 -41.77 53.49 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 -177.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 92.2 mt -61.4 -48.59 88.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -61.7 -29.44 70.1 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.392 0.542 . . . . 0.0 112.395 -177.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -82.28 -2.69 53.41 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.002 0.921 . . . . 0.0 113.246 178.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 64.4 mt -133.08 -25.71 1.77 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.676 1.125 . . . . 0.0 112.549 -174.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -59.02 -21.62 59.34 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.353 1.061 . . . . 0.0 112.862 177.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -72.8 -11.19 60.51 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.415 1.086 . . . . 0.0 112.051 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -133.09 -42.54 0.88 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.349 1.06 . . . . 0.0 111.733 -173.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 28.2 mt -73.65 140.42 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 175.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.05 -40.89 95.34 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.185 0.897 . . . . 0.0 112.141 -177.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -148.49 137.14 21.47 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 118.633 1.216 . . . . 0.0 108.429 177.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.8 t -131.9 123.06 50.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -178.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 18.2 mt -129.54 155.39 41.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 -171.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -127.99 147.13 50.49 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 175.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.6 tt -129.1 130.36 46.39 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 172.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -115.19 156.96 15.31 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 77.6 mt -133.49 127.53 53.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 125.215 1.406 . . . . 0.0 107.269 -176.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 69.1 tp60 -67.25 117.6 48.05 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-O 117.607 -1.187 . . . . 0.0 111.129 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.35 175.04 11.78 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 124.27 3.313 . . . . 0.0 111.887 170.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -134.12 -29.16 1.29 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.257 1.423 . . . . 0.0 112.78 175.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.2 pp -132.29 4.22 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 119.362 0.983 . . . . 0.0 113.408 -171.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 8.5 p -38.43 118.49 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 125.929 1.692 . . . . 0.0 113.713 -167.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 170.31 158.37 14.09 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -175.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -67.17 152.56 45.53 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.996 0.919 . . . . 0.0 111.647 -173.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 56.32 41.76 28.67 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.883 2.073 . . . . 0.0 112.046 177.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -127.33 152.59 76.46 Favored Pre-proline 0 C--O 1.236 0.356 0 C-N-CA 124.287 1.035 . . . . 0.0 109.176 172.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -77.76 157.57 31.58 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.031 2.487 . . . . 0.0 109.875 168.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 56.5 ttm -66.25 136.64 56.14 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 169.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 18.1 p -77.75 154.45 31.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.588 0.709 . . . . 0.0 111.318 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -49.33 -47.25 77.17 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-O 116.916 -1.516 . . . . 0.0 113.443 -177.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -66.98 -28.13 42.11 Favored 'Trans proline' 0 C--N 1.351 0.69 0 CA-C-N 122.46 1.914 . . . . 0.0 112.407 -177.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 mp -78.12 -37.81 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 119.29 0.95 . . . . 0.0 108.564 177.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -57.28 -47.42 81.51 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.44 1.018 . . . . 0.0 110.074 172.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.18 -41.81 97.46 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 123.347 0.659 . . . . 0.0 111.053 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.94 -47.82 81.58 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 118.997 -0.525 . . . . 0.0 111.15 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.2 t -59.22 -41.21 83.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 118.886 0.766 . . . . 0.0 109.467 178.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -69.49 -27.83 65.54 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.861 0.755 . . . . 0.0 111.776 177.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 40.1 m -72.2 -42.39 65.86 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 120.982 -1.074 . . . . 0.0 109.944 174.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 88.0 t -61.18 -44.38 98.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 174.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -54.31 -47.04 72.91 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.163 0.985 . . . . 0.0 110.875 175.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -62.73 -40.72 98.09 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 118.869 0.758 . . . . 0.0 111.461 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -60.32 -25.39 65.76 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 118.368 -0.825 . . . . 0.0 112.463 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 93.0 mt -57.18 -22.66 42.07 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.852 1.205 . . . . 0.0 112.421 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 . . . . . 0 CA--C 1.544 0.745 0 C-N-CA 123.731 0.812 . . . . 0.0 112.411 -178.91 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 . . . . . 0 C--O 1.233 0.224 0 CA-C-O 121.799 0.809 . . . . 0.0 110.685 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -90.55 153.4 20.38 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 170.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -91.79 123.12 34.94 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 177.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 58.3 tp . . . . . 0 CA--C 1.53 0.206 0 C-N-CA 124.986 1.314 . . . . 0.0 109.809 178.493 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.3 t70 . . . . . 0 C--O 1.232 0.166 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 88.4 t -135.47 146.2 30.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 121.425 0.631 . . . . 0.0 110.284 -168.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 17.1 tp -115.03 126.94 55.31 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 104.889 -2.263 . . . . 0.0 104.889 168.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.8 tp -116.29 99.36 7.15 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 87.9 m -72.68 142.76 48.25 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 169.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.4 t -143.79 144.75 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 147.17 172.17 17.11 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -121.96 114.37 20.88 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 123.818 0.847 . . . . 0.0 109.138 -176.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -59.87 -11.76 6.17 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.624 1.97 . . . . 0.0 115.197 -170.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 22.5 ptp -127.72 10.13 6.54 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 119.212 0.915 . . . . 0.0 111.303 -178.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.4 ttt -98.04 31.33 2.75 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.072 0.851 . . . . 0.0 109.665 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.22 -140.49 20.67 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -178.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -62.04 -16.92 55.38 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.681 1.192 . . . . 0.0 112.389 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -58.19 -16.55 14.07 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.89 1.276 . . . . 0.0 112.995 176.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.32 21.86 0.84 Allowed Glycine 0 CA--C 1.535 1.324 0 O-C-N 120.288 -1.507 . . . . 0.0 114.451 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.94 -50.55 70.37 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 119.522 1.661 . . . . 0.0 111.363 -169.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.26 -54.43 37.96 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 117.555 -1.692 . . . . 0.0 111.322 177.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -48.37 -41.72 35.3 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 CA-C-N 120.656 2.228 . . . . 0.0 115.1 175.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.3 tp -72.54 -37.59 68.23 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.848 1.204 . . . . 0.0 110.706 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.6 tp -61.74 -45.95 91.74 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.605 0.639 . . . . 0.0 109.998 174.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.89 -38.55 86.05 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.903 0.881 . . . . 0.0 111.09 179.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.4 tp10 -61.86 -49.08 77.69 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 118.7 0.682 . . . . 0.0 109.541 178.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -63.84 -44.85 91.95 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.781 0.432 . . . . 0.0 110.501 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 73.3 m -63.69 -39.47 94.39 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.487 0.585 . . . . 0.0 111.444 177.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.22 -37.51 87.73 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.89 0.768 . . . . 0.0 111.113 177.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.48 -36.65 76.74 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.089 0.556 . . . . 0.0 111.245 178.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.71 98.51 1.53 Allowed Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 125.023 1.329 . . . . 0.0 108.163 -173.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -55.14 169.18 1.02 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 124.316 3.344 . . . . 0.0 114.983 -178.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.536 ' HE2' ' CZ ' ' A' ' 136' ' ' TYR . 14.9 mmtm -140.52 158.9 43.31 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.758 1.623 . . . . 0.0 108.28 -177.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 42.79 -126.33 4.71 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.007 1.289 . . . . 0.0 111.95 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -136.53 12.1 3.21 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.036 1.334 . . . . 0.0 111.164 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -73.64 131.03 41.22 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.942 0.897 . . . . 0.0 108.806 -173.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 97.5 t -69.85 112.86 5.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 166.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.3 t -71.56 133.16 32.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 60.4 mt -132.84 145.13 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 104.258 -2.497 . . . . 0.0 104.258 169.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -128.42 98.48 5.06 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 177.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.43 -14.07 71.54 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-O 119.136 -0.814 . . . . 0.0 112.121 175.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 51.71 -135.66 33.66 Favored Glycine 0 C--N 1.34 0.795 0 CA-C-N 118.208 1.004 . . . . 0.0 110.591 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.6 t -88.4 7.21 33.69 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.109 0.964 . . . . 0.0 111.554 -175.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.47 60.56 5.61 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.666 1.186 . . . . 0.0 110.12 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -69.7 -18.2 37.41 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.723 2.282 . . . . 0.0 112.929 -169.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -56.66 -31.69 64.65 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.44 0.696 . . . . 0.0 112.267 177.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.47 -30.32 69.6 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.296 0.639 . . . . 0.0 111.982 176.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -94.16 -6.4 44.96 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.022 0.929 . . . . 0.0 111.496 -169.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.2 mt -53.19 -43.85 50.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 118.964 0.802 . . . . 0.0 109.2 173.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.0 t -61.14 -42.11 92.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 122.981 0.512 . . . . 0.0 110.012 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.0 -46.87 73.21 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 122.923 0.489 . . . . 0.0 110.689 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.6 mt -55.09 -45.72 77.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.258 1.023 . . . . 0.0 109.179 174.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -60.86 -30.96 70.44 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 117.846 -1.073 . . . . 0.0 112.357 -177.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -59.46 -30.73 68.73 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 120.083 1.31 . . . . 0.0 111.265 176.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 56.5 mt -87.07 -9.06 56.37 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.666 1.186 . . . . 0.0 112.374 -173.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 27.34 61.73 0.6 Allowed Pre-proline 0 N--CA 1.475 0.811 0 C-N-CA 127.084 2.154 . . . . 0.0 112.229 -168.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.22 142.99 66.05 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.75 2.3 . . . . 0.0 114.203 -169.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.2 m -74.39 -30.37 61.92 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 168.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -146.54 151.66 37.7 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.007 0.923 . . . . 0.0 110.023 177.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 46.0 tp -141.24 136.11 31.36 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.674 1.59 . . . . 0.0 107.83 174.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 20.8 tp -126.8 133.42 50.79 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 105.674 -1.972 . . . . 0.0 105.674 172.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.4 mt -119.36 144.7 27.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -172.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.6 t -140.46 134.76 34.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 118.557 0.617 . . . . 0.0 109.875 -174.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -161.4 175.94 11.66 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 127.347 2.259 . . . . 0.0 107.082 172.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.44 160.4 30.28 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 120.805 -1.184 . . . . 0.0 108.494 167.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.0 m -156.29 125.27 6.02 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -70.72 122.3 19.57 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 169.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 77.1 mtm -122.46 1.39 9.56 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.53 1.532 . . . . 0.0 110.896 -175.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.87 26.05 71.01 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 118.568 0.622 . . . . 0.0 112.071 -173.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 74.9 mt -103.68 -171.1 1.88 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.479 1.512 . . . . 0.0 109.026 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -81.29 138.67 48.5 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-O 117.649 -1.167 . . . . 0.0 109.34 176.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -45.32 132.72 12.13 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.417 2.745 . . . . 0.0 113.814 177.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.95 3.22 90.65 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 118.502 -1.166 . . . . 0.0 113.241 179.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -64.58 145.71 55.73 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 119.895 1.847 . . . . 0.0 107.664 167.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 41.7 mt -126.72 138.84 53.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 -173.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 -148.94 148.96 30.41 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 118.236 0.471 . . . . 0.0 111.764 -179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 41.3 mm -76.11 144.63 11.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 165.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.4 mt -135.38 163.79 34.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 176.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -136.72 145.73 52.32 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 126.36 1.864 . . . . 0.0 107.688 -170.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -52.17 -28.1 32.28 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.448 2.766 . . . . 0.0 115.197 -174.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -66.53 -23.23 66.2 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.817 0.735 . . . . 0.0 112.567 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -117.41 -29.51 5.81 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.659 1.184 . . . . 0.0 111.701 -173.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 53.5 mt -50.14 -41.02 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.322 1.449 . . . . 0.0 110.12 169.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.8 -24.43 57.25 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -173.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -103.34 -44.15 5.23 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 172.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 33.8 mmt -65.04 -34.44 78.43 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -170.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -66.79 -22.12 66.03 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -178.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 CA--C 1.535 0.369 0 C-N-CA 123.773 0.829 . . . . 0.0 111.208 174.701 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.5 mt . . . . . 0 N--CA 1.468 0.467 0 N-CA-C 117.343 2.349 . . . . 0.0 117.343 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.12 -26.43 16.57 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 119.298 0.954 . . . . 0.0 111.614 167.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -60.36 -34.46 73.9 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.827 0.74 . . . . 0.0 111.604 176.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.5 tt -77.22 -43.35 33.93 Favored 'General case' 0 C--N 1.338 0.087 0 C-N-CA 123.334 0.654 . . . . 0.0 109.374 177.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 85.8 mt -59.78 -43.75 92.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -178.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -61.98 -23.94 66.72 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -84.71 0.68 49.59 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.723 0.809 . . . . 0.0 112.314 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 84.5 mt -133.58 -35.7 0.99 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.071 0.948 . . . . 0.0 111.626 -173.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -58.83 -22.77 59.42 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.307 1.043 . . . . 0.0 113.07 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -71.32 -13.37 61.85 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.061 0.944 . . . . 0.0 111.988 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -134.84 -30.35 1.09 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.175 0.898 . . . . 0.0 112.931 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 28.9 mt -69.19 138.92 21.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 174.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -63.95 -42.86 98.15 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 123.763 0.697 . . . . 0.0 112.442 -177.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -146.94 134.14 20.53 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.404 1.102 . . . . 0.0 108.367 177.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.8 t -126.09 133.59 68.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 176.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.9 mp -132.01 154.66 40.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 -176.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -128.69 146.52 50.86 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 170.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.0 tt -126.94 132.73 50.78 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 170.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -118.58 159.28 14.43 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 124.571 1.081 . . . . 0.0 110.853 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 82.1 mt -133.85 126.14 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 -177.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -62.48 115.42 16.42 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-O 117.463 -1.256 . . . . 0.0 110.199 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -75.45 171.13 18.83 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 123.394 2.73 . . . . 0.0 111.196 169.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -125.21 -30.91 3.12 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 125.867 1.667 . . . . 0.0 110.734 170.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -136.01 134.32 50.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 176.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.3 t -140.27 135.49 36.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 174.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 158.08 150.8 5.86 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -66.9 154.42 41.05 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.952 0.882 . . . . 0.0 111.522 -175.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 54.81 38.65 30.6 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.048 2.139 . . . . 0.0 112.273 -176.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -124.79 149.09 61.53 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 123.899 0.88 . . . . 0.0 110.281 172.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -83.13 165.16 14.98 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.437 2.758 . . . . 0.0 111.461 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.4 ttm -72.73 139.92 47.47 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 168.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 82.4 p -80.64 159.82 25.24 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.816 1.246 . . . . 0.0 110.549 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.3 tp60 -53.78 -44.79 98.61 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-O 116.675 -1.631 . . . . 0.0 114.298 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -68.29 -30.47 30.49 Favored 'Trans proline' 0 C--N 1.351 0.71 0 CA-C-N 122.86 2.057 . . . . 0.0 112.034 -176.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.6 mp -78.94 -35.79 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -56.82 -46.36 81.71 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.549 1.068 . . . . 0.0 110.044 171.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -63.21 -41.67 99.18 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 122.965 0.506 . . . . 0.0 111.07 178.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.98 -47.97 82.44 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 118.958 -0.544 . . . . 0.0 110.974 176.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 76.5 t -60.76 -40.01 83.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 118.98 0.809 . . . . 0.0 109.705 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -69.93 -30.62 68.06 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.583 1.083 . . . . 0.0 111.551 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 28.1 m -68.68 -46.87 67.94 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.36 -0.837 . . . . 0.0 109.443 173.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 53.9 t -58.73 -45.52 91.07 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.163 0 C-N-CA 123.875 0.87 . . . . 0.0 109.152 176.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.536 ' CZ ' ' HE2' ' A' ' 31' ' ' LYS . 33.5 t80 -52.37 -48.64 65.47 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.275 1.03 . . . . 0.0 110.861 177.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -64.39 -38.74 92.11 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.568 0.622 . . . . 0.0 110.838 176.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 9.2 tpp85 -65.46 -23.25 66.87 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 118.145 -0.931 . . . . 0.0 112.862 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -59.2 -17.27 26.23 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 120.431 1.469 . . . . 0.0 111.036 172.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 . . . . . 0 CA--C 1.541 0.624 0 CA-C-N 120.167 1.349 . . . . 0.0 112.706 176.938 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 . . . . . 0 C--O 1.235 0.314 0 CA-C-O 121.231 0.539 . . . . 0.0 109.835 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -87.69 155.46 19.92 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 169.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -88.53 125.72 34.91 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 174.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 67.7 tp . . . . . 0 C--O 1.234 0.246 0 C-N-CA 124.941 1.296 . . . . 0.0 109.785 176.753 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.0 t70 . . . . . 0 CA--C 1.522 -0.129 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 74.0 t -135.73 145.52 31.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 123.3 0.64 . . . . 0.0 109.986 -170.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 25.8 tp -114.14 124.89 53.2 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 169.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 56.7 tp -114.2 96.26 5.7 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 178.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 91.5 m -72.54 142.22 48.48 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.131 169.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.4 t -140.4 142.94 30.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 125.176 1.39 . . . . 0.0 107.517 178.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 144.76 172.26 15.14 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 124.657 1.122 . . . . 0.0 111.442 176.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -113.77 121.14 43.16 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 107.832 -1.174 . . . . 0.0 107.832 174.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -59.2 -13.63 8.09 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.401 1.88 . . . . 0.0 115.423 -169.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.0 ptt? -130.78 12.79 5.31 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.976 0.91 . . . . 0.0 111.172 -176.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.9 ttt -92.95 35.24 1.06 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.816 0.734 . . . . 0.0 109.311 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.28 -143.89 30.08 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -173.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -60.24 -18.01 45.79 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 126.016 1.726 . . . . 0.0 112.445 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -54.02 -26.96 29.06 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.649 1.18 . . . . 0.0 112.57 176.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.18 27.83 0.68 Allowed Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.643 -1.087 . . . . 0.0 114.165 178.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.45 -47.97 74.32 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 119.45 1.625 . . . . 0.0 110.253 -172.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.03 -55.82 28.78 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 117.692 -1.616 . . . . 0.0 111.071 174.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -48.21 -41.82 34.07 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 CA-C-N 121.01 2.405 . . . . 0.0 115.372 176.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.3 tp -70.78 -38.28 73.38 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.889 1.222 . . . . 0.0 110.495 178.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.4 tp -61.99 -46.6 88.51 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.936 -0.477 . . . . 0.0 110.291 175.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.35 -40.57 82.55 Favored 'General case' 0 C--O 1.227 -0.088 0 C-N-CA 124.025 0.93 . . . . 0.0 110.978 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -60.72 -48.82 80.1 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 118.594 0.634 . . . . 0.0 109.821 178.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -63.37 -48.8 76.4 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.171 0.589 . . . . 0.0 110.515 -178.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 70.7 m -64.32 -36.74 85.11 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.45 0.568 . . . . 0.0 111.449 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.74 -37.56 88.02 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.166 0.894 . . . . 0.0 111.151 176.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.75 -34.27 75.31 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.18 0.592 . . . . 0.0 111.406 178.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.72 98.89 1.87 Allowed Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 125.325 1.45 . . . . 0.0 108.156 -174.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -54.89 161.02 6.82 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 123.483 2.789 . . . . 0.0 113.854 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.426 ' HE2' ' CE1' ' A' ' 136' ' ' TYR . 72.8 mmtt -135.08 162.21 33.13 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.912 1.685 . . . . 0.0 108.137 178.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 43.53 -121.73 3.56 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.96 1.267 . . . . 0.0 111.614 176.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -134.07 10.7 3.89 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.672 1.189 . . . . 0.0 111.136 174.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -72.86 117.71 14.91 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 121.469 -0.77 . . . . 0.0 109.31 -169.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 89.4 t -67.98 118.31 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 167.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.1 t -73.9 134.13 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -177.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 56.1 mt -132.45 141.34 45.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 103.875 -2.639 . . . . 0.0 103.875 169.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -125.98 106.19 9.45 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 175.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.36 -1.89 82.63 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 118.997 -0.89 . . . . 0.0 112.919 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 56.52 -146.99 33.04 Favored Glycine 0 C--N 1.34 0.76 0 N-CA-C 108.17 -1.972 . . . . 0.0 108.17 -168.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.2 p -88.5 10.49 20.06 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.772 -0.84 . . . . 0.0 111.867 177.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.37 57.96 15.91 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 125.151 1.38 . . . . 0.0 110.393 -176.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -68.87 -14.29 38.52 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.834 2.356 . . . . 0.0 112.978 -171.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -56.7 -32.21 65.25 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.05 0.841 . . . . 0.0 112.03 175.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -61.64 -27.88 68.98 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.4 0.68 . . . . 0.0 112.258 175.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -98.25 -1.88 40.89 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.945 1.298 . . . . 0.0 111.575 -169.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.7 mt -53.86 -42.4 52.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 118.866 0.757 . . . . 0.0 109.783 175.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 43.2 t -61.08 -41.04 87.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 118.378 0.535 . . . . 0.0 110.065 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.33 -43.91 84.82 Favored 'General case' 0 N--CA 1.456 -0.159 0 O-C-N 121.842 -0.536 . . . . 0.0 110.757 -177.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 63.3 mt -58.84 -48.99 84.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 173.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -60.82 -35.88 77.66 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 118.163 -0.922 . . . . 0.0 111.947 -174.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -57.07 -29.73 63.7 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.521 1.055 . . . . 0.0 111.794 177.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 55.2 mt -87.15 -9.78 54.39 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.883 0.873 . . . . 0.0 112.457 -177.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 29.14 61.06 0.78 Allowed Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 126.768 2.027 . . . . 0.0 112.464 -168.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -56.33 145.99 75.16 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.86 2.374 . . . . 0.0 112.589 -171.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.8 m -73.13 -30.35 63.55 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.938 0.895 . . . . 0.0 108.937 168.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -145.36 151.88 38.99 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.28 1.032 . . . . 0.0 109.954 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 41.9 tp -143.17 134.0 25.35 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.329 1.452 . . . . 0.0 107.862 176.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 23.5 tp -126.65 135.27 50.97 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 172.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.0 mt -121.33 143.76 32.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 -171.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.5 t -142.14 135.64 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 119.117 0.871 . . . . 0.0 110.296 -175.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -164.89 170.93 14.73 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 127.372 2.269 . . . . 0.0 107.871 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.82 155.42 37.59 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 121.437 -0.789 . . . . 0.0 108.963 168.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.2 m -154.67 125.08 6.88 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -72.66 121.75 20.3 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 172.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 74.2 mtm -121.53 1.73 10.11 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.168 1.787 . . . . 0.0 110.709 -176.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.43 23.87 67.06 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 118.686 0.675 . . . . 0.0 112.317 -172.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.0 mt -96.2 -174.32 3.05 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.315 1.446 . . . . 0.0 109.43 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -73.7 140.43 78.22 Favored Pre-proline 0 N--CA 1.467 0.393 0 CA-C-O 117.645 -1.169 . . . . 0.0 108.286 170.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -44.29 137.52 7.73 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.216 2.611 . . . . 0.0 112.962 173.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.41 2.32 79.24 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 118.695 -1.058 . . . . 0.0 113.83 176.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -67.12 147.85 52.6 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.911 1.855 . . . . 0.0 108.23 168.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 70.4 mt -124.39 135.92 62.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -172.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.3 mmt-85 -145.26 147.76 32.74 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 118.853 0.751 . . . . 0.0 110.513 176.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 42.3 mm -78.05 142.81 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 167.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.7 mt -129.02 136.38 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 119.98 1.264 . . . . 0.0 108.729 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -80.66 141.29 51.83 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 124.536 1.134 . . . . 0.0 109.761 175.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -47.62 -34.35 20.37 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 124.162 3.241 . . . . 0.0 116.216 178.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -66.54 -26.27 67.05 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.528 0.604 . . . . 0.0 111.719 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -101.09 -29.05 12.36 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.541 1.137 . . . . 0.0 111.094 -176.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 24.9 mt -49.34 -41.08 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.317 1.447 . . . . 0.0 110.839 169.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.9 -24.4 15.97 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.138 1.375 . . . . 0.0 113.601 -177.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -113.61 -37.35 4.62 Favored 'General case' 0 C--O 1.228 -0.063 0 C-N-CA 123.304 0.642 . . . . 0.0 110.381 175.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 22.3 mmt -66.89 -31.86 72.74 Favored 'General case' 0 C--N 1.334 -0.096 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -173.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -63.77 -53.02 57.5 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 119.053 0.842 . . . . 0.0 109.869 174.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.3 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -176.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.3 mt . . . . . 0 N--CA 1.466 0.36 0 N-CA-C 118.822 2.897 . . . . 0.0 118.822 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.49 -25.92 39.72 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 120.006 1.276 . . . . 0.0 110.762 166.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -62.03 -29.64 70.42 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.618 0.767 . . . . 0.0 112.171 174.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.2 tt -74.68 -45.86 41.69 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.175 0.898 . . . . 0.0 108.858 174.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 98.5 mt -58.59 -42.14 83.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -178.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.11 -23.88 64.2 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -87.94 -1.77 58.19 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.993 0.917 . . . . 0.0 112.449 178.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -123.63 -34.93 2.98 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.102 0.961 . . . . 0.0 111.789 178.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -60.68 -21.78 63.21 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.859 0.864 . . . . 0.0 113.063 -173.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -72.34 -12.11 60.99 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.079 0.952 . . . . 0.0 112.012 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -136.31 -32.62 0.85 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.265 0.939 . . . . 0.0 113.082 -178.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 15.3 mt -69.6 138.83 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 172.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -65.91 -41.14 95.58 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.111 0.862 . . . . 0.0 112.397 -176.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -145.9 137.57 25.04 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 118.582 1.191 . . . . 0.0 109.113 175.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.5 t -130.22 129.4 65.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.9 mp -130.52 154.12 40.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -174.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -133.35 144.5 49.65 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 168.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.3 tt -126.32 123.31 37.74 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.641 1.576 . . . . 0.0 106.966 177.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -109.65 155.6 16.01 Favored Glycine 0 C--N 1.334 0.436 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 64.6 mt -133.97 124.19 46.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 -173.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.7 tp60 -61.64 115.94 17.9 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-O 117.547 -1.216 . . . . 0.0 110.619 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -79.12 172.47 14.77 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.308 2.672 . . . . 0.0 111.582 170.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -135.95 -29.2 1.03 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 127.263 2.225 . . . . 0.0 111.317 173.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -132.97 120.42 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 -173.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 64.5 t -143.56 132.62 20.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 153.54 152.39 6.03 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -67.73 150.15 49.04 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.882 0.849 . . . . 0.0 111.441 -173.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 14.2 t80 51.24 41.41 27.86 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.884 2.074 . . . . 0.0 112.101 -173.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.3 m-30 -115.19 142.9 29.29 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 169.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.03 159.44 44.54 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.596 2.197 . . . . 0.0 110.531 171.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.7 ttm -73.98 142.45 45.83 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 168.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 37.3 p -81.71 157.61 24.52 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.367 1.067 . . . . 0.0 110.701 178.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -52.1 -42.6 86.67 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-O 116.52 -1.705 . . . . 0.0 114.697 -178.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.37 -29.07 21.53 Favored 'Trans proline' 0 C--N 1.35 0.628 0 CA-C-N 123.087 2.138 . . . . 0.0 111.878 -176.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.63 -36.11 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -56.52 -46.15 80.74 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.166 0.893 . . . . 0.0 109.986 170.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -64.61 -37.83 88.9 Favored 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 123.302 0.641 . . . . 0.0 111.435 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.25 -47.24 80.39 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 121.933 -0.479 . . . . 0.0 110.706 175.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 61.0 t -62.6 -39.91 86.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 118.643 0.656 . . . . 0.0 109.842 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -60.7 -42.88 98.09 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.136 0.88 . . . . 0.0 110.283 173.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 54.2 m -61.35 -48.76 79.82 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 79.3 t -60.39 -45.97 95.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 118.762 0.71 . . . . 0.0 109.654 179.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.426 ' CE1' ' HE2' ' A' ' 31' ' ' LYS . 19.3 t80 -54.06 -49.7 68.4 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.92 0.888 . . . . 0.0 110.578 177.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -69.83 -26.8 64.4 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.525 -0.734 . . . . 0.0 112.114 178.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -73.48 -24.36 60.18 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.23 -0.919 . . . . 0.0 112.065 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 33.4 mt -61.1 -21.94 64.17 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.393 0.997 . . . . 0.0 113.454 -172.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 . . . . . 0 CA--C 1.54 0.573 0 CA-C-N 119.833 1.197 . . . . 0.0 112.794 176.693 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 . . . . . 0 N--CA 1.452 -0.363 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -89.42 147.08 24.23 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 172.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -93.22 119.91 32.92 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 44.1 tp . . . . . 0 CA--C 1.532 0.267 0 C-N-CA 124.913 1.285 . . . . 0.0 109.797 -179.786 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.5 t0 . . . . . 0 C--O 1.234 0.266 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 53.1 t -124.87 141.1 46.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.624 0.726 . . . . 0.0 109.541 -170.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 34.8 tp -107.42 128.1 54.18 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 168.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 56.5 tp -116.18 97.81 6.27 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 177.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 93.2 m -73.18 142.19 47.38 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 170.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.8 t -140.34 141.58 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 125.31 1.444 . . . . 0.0 107.274 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.74 174.94 18.39 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 123.988 0.804 . . . . 0.0 112.219 175.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -117.13 121.25 40.74 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.94 1.296 . . . . 0.0 108.25 176.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 m -59.39 -14.87 13.55 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.458 1.903 . . . . 0.0 115.524 -169.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -130.0 13.98 5.75 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.983 0.913 . . . . 0.0 111.282 -175.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.9 ttt -97.24 34.42 1.78 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.599 0.636 . . . . 0.0 109.756 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.86 -140.95 22.98 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -177.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -62.77 -15.77 55.04 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.474 1.11 . . . . 0.0 112.279 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -59.4 -16.51 23.56 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.035 1.334 . . . . 0.0 112.669 174.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.64 17.84 1.47 Allowed Glycine 0 CA--C 1.533 1.208 0 O-C-N 120.568 -1.332 . . . . 0.0 114.01 175.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.45 -51.16 68.61 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 119.682 1.741 . . . . 0.0 111.032 -169.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.84 -55.18 31.82 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-O 117.806 -1.552 . . . . 0.0 110.984 175.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -48.96 -40.94 40.63 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 CA-C-N 120.687 2.243 . . . . 0.0 115.298 176.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.9 tp -71.97 -37.84 69.85 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 120.254 1.388 . . . . 0.0 110.443 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.2 tp -62.18 -45.63 92.53 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.899 -0.501 . . . . 0.0 110.315 175.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.43 -40.55 87.13 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 123.894 0.878 . . . . 0.0 111.023 177.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.4 tp10 -60.85 -48.66 80.77 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.792 0.723 . . . . 0.0 109.661 178.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -62.28 -46.69 87.65 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.062 0.545 . . . . 0.0 110.639 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 81.1 m -64.98 -37.89 89.17 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.267 0.485 . . . . 0.0 111.237 179.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.66 -37.83 88.93 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.853 0.751 . . . . 0.0 111.107 176.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.13 -37.95 78.57 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.204 0.602 . . . . 0.0 111.092 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.63 95.81 2.03 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 125.166 1.386 . . . . 0.0 108.489 -173.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -55.78 164.32 4.67 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 123.813 3.009 . . . . 0.0 114.182 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.419 ' HE2' ' CZ ' ' A' ' 136' ' ' TYR . 21.0 mmtt -131.56 167.54 19.22 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.625 1.57 . . . . 0.0 109.058 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 40.08 -116.63 0.75 Allowed Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.048 1.309 . . . . 0.0 111.513 175.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -140.65 28.45 1.98 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.62 1.168 . . . . 0.0 109.843 169.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -73.58 125.66 28.5 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.372 -0.83 . . . . 0.0 109.514 -173.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.9 t -78.14 115.32 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 104.103 -2.555 . . . . 0.0 104.103 166.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.4 t -75.77 136.2 25.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -175.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.9 mm -131.38 145.35 35.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 103.972 -2.603 . . . . 0.0 103.972 169.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -132.85 103.79 6.26 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 178.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.5 -4.54 87.44 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-O 118.855 -0.969 . . . . 0.0 112.743 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 54.71 -143.72 31.75 Favored Glycine 0 C--N 1.34 0.754 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 -169.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.2 p -89.67 6.74 40.04 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.985 -0.714 . . . . 0.0 112.41 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.28 64.59 47.22 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 124.866 1.266 . . . . 0.0 109.749 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -64.51 -16.39 54.94 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.732 2.288 . . . . 0.0 112.505 -177.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -47.71 -42.28 24.72 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.51 1.524 . . . . 0.0 111.164 169.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.26 -24.99 66.67 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.015 0.526 . . . . 0.0 112.342 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.04 -3.8 31.27 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 125.071 1.348 . . . . 0.0 111.821 -169.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 84.0 mt -51.2 -41.09 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.866 0.866 . . . . 0.0 110.423 175.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 49.0 t -58.46 -42.04 83.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 118.844 0.747 . . . . 0.0 110.319 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.39 -32.99 73.45 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.212 0.605 . . . . 0.0 111.227 -175.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 58.5 mt -67.33 -50.57 61.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 170.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -66.65 -33.24 75.22 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 118.247 -0.882 . . . . 0.0 112.464 -169.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -62.91 -20.74 65.46 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.979 1.263 . . . . 0.0 112.03 178.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 62.5 mt -86.03 -10.18 55.47 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.391 1.076 . . . . 0.0 113.067 174.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 28.91 61.79 0.75 Allowed Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 127.231 2.212 . . . . 0.0 112.856 -167.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -58.05 150.38 65.21 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.383 2.722 . . . . 0.0 113.549 -169.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.3 m -71.13 -36.27 72.03 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.221 1.009 . . . . 0.0 109.359 168.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 21.3 mtm180 -144.52 162.2 37.17 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.346 1.059 . . . . 0.0 110.199 179.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.5 tp -146.19 134.8 22.16 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 125.256 1.422 . . . . 0.0 107.836 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 37.7 tp -125.78 131.1 52.55 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 173.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.0 mt -115.95 143.2 26.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -175.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.5 t -140.27 134.07 34.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 118.64 0.654 . . . . 0.0 109.91 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -161.7 173.46 14.64 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.275 2.23 . . . . 0.0 107.304 170.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.89 157.78 35.88 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 166.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.3 m -154.6 124.47 6.67 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 176.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -71.57 125.63 27.56 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 172.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 72.9 mtm -127.01 1.96 6.54 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.445 1.898 . . . . 0.0 110.427 -175.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.66 23.74 67.36 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-N 118.693 0.679 . . . . 0.0 112.553 -172.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.2 mt -96.41 -172.47 2.53 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.251 1.421 . . . . 0.0 109.41 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -76.02 139.33 69.18 Favored Pre-proline 0 N--CA 1.468 0.426 0 CA-C-O 117.669 -1.158 . . . . 0.0 108.338 171.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -43.38 137.5 5.41 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.411 2.741 . . . . 0.0 113.131 172.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.93 2.11 81.0 Favored Glycine 0 CA--C 1.534 1.234 0 CA-C-O 118.528 -1.151 . . . . 0.0 113.739 176.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -66.57 144.16 56.6 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 119.909 1.855 . . . . 0.0 107.786 168.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 51.8 mt -121.05 140.71 44.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 -174.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 90.3 mmt-85 -148.4 147.67 29.46 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 118.522 0.601 . . . . 0.0 112.131 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 50.6 mm -77.94 143.28 13.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 164.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.6 mt -128.57 123.84 60.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 176.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -75.16 139.89 72.83 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-O 117.739 -1.124 . . . . 0.0 109.433 175.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_exo -46.75 -36.39 19.33 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 124.235 3.29 . . . . 0.0 116.609 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -69.32 -25.83 64.42 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 118.532 0.605 . . . . 0.0 111.38 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -93.35 -34.46 13.48 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.87 1.268 . . . . 0.0 110.985 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 71.6 mt -48.78 -46.48 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.901 1.28 . . . . 0.0 108.956 169.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.46 -19.54 37.63 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.609 1.164 . . . . 0.0 114.002 -174.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -115.01 -25.34 8.18 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.469 0.708 . . . . 0.0 110.867 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 22.7 mmt -80.5 -36.68 32.98 Favored 'General case' 0 C--O 1.231 0.079 0 CA-C-N 118.238 0.472 . . . . 0.0 112.005 -178.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.64 -37.7 88.48 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 118.906 0.775 . . . . 0.0 112.584 -169.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.6 ppp? . . . . . 0 CA--C 1.538 0.482 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 178.965 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.2 mt . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 117.435 2.383 . . . . 0.0 117.435 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.73 -20.04 4.99 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.333 -0.854 . . . . 0.0 112.554 167.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -58.88 -31.3 68.45 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.517 1.053 . . . . 0.0 111.71 174.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.4 tt -72.95 -45.95 55.2 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 174.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 83.8 mt -58.84 -39.48 77.43 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 123.196 0.599 . . . . 0.0 109.881 -177.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -58.33 -24.72 60.58 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.677 0.671 . . . . 0.0 112.805 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -89.79 -6.71 55.68 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.231 1.012 . . . . 0.0 112.086 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -118.63 -28.15 5.72 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.252 1.021 . . . . 0.0 111.703 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -63.46 -24.18 67.72 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 119.379 0.991 . . . . 0.0 112.403 -175.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -79.27 -4.78 52.33 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.47 1.108 . . . . 0.0 111.843 176.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -134.33 -1.81 2.85 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.33 1.452 . . . . 0.0 112.688 -168.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 20.0 mt -137.29 145.41 29.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 126.094 1.758 . . . . 0.0 107.15 -173.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -71.46 -37.68 62.41 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-O 119.236 -0.758 . . . . 0.0 112.45 -174.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -146.75 135.37 22.09 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.56 1.18 . . . . 0.0 108.076 174.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.2 t -124.68 132.62 71.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 175.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 5.4 mt -133.49 152.29 34.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 -168.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -130.43 142.02 50.51 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 169.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.8 tt -124.31 129.05 50.05 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 174.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -112.88 156.46 15.59 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 77.6 mt -132.75 123.71 49.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -178.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -60.63 115.94 15.95 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-O 117.43 -1.271 . . . . 0.0 110.439 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -76.05 171.53 17.97 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.59 2.86 . . . . 0.0 111.416 170.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -127.96 -32.45 2.31 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.976 1.71 . . . . 0.0 110.932 171.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.69 137.03 47.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.296 1.038 . . . . 0.0 108.333 176.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 90.1 t -141.41 134.93 30.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 175.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 159.21 150.93 5.96 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -65.29 152.55 43.47 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.865 0.84 . . . . 0.0 111.308 -175.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 54.87 38.96 31.21 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.852 2.061 . . . . 0.0 112.09 -177.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -123.14 148.41 54.53 Favored Pre-proline 0 C--O 1.237 0.399 0 C-N-CA 123.987 0.915 . . . . 0.0 109.794 172.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.99 162.5 20.67 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.164 2.576 . . . . 0.0 111.13 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 52.5 ttm -71.43 138.91 49.45 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 168.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 67.4 p -79.85 159.51 26.43 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.285 1.034 . . . . 0.0 110.496 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 21.8 tp60 -53.03 -44.8 97.93 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 116.565 -1.683 . . . . 0.0 114.101 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -68.63 -30.53 28.09 Favored 'Trans proline' 0 C--N 1.351 0.695 0 CA-C-N 122.912 2.076 . . . . 0.0 112.144 -176.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.6 mp -80.05 -35.61 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 118.971 0.805 . . . . 0.0 108.889 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -56.26 -46.56 79.62 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.354 0.979 . . . . 0.0 109.941 170.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -63.92 -38.58 91.6 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.024 0.53 . . . . 0.0 111.319 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.9 -46.19 82.75 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 119.097 -0.478 . . . . 0.0 111.164 175.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 71.8 t -62.68 -39.5 84.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 118.994 0.816 . . . . 0.0 109.658 178.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -62.35 -42.46 99.41 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.191 0.905 . . . . 0.0 110.508 173.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 59.0 m -61.48 -49.4 76.93 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 72.7 t -60.09 -44.25 94.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 123.539 0.736 . . . . 0.0 109.642 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.419 ' CZ ' ' HE2' ' A' ' 31' ' ' LYS . 43.1 t80 -55.96 -48.59 75.53 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.184 0.594 . . . . 0.0 110.631 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 60.0 mm-40 -64.89 -39.09 93.0 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.038 0.836 . . . . 0.0 110.903 176.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -62.3 -29.42 70.42 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 118.732 -0.651 . . . . 0.0 112.263 -177.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 76.8 mt -57.52 -21.78 40.19 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.11 0.868 . . . . 0.0 112.389 177.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 . . . . . 0 CA--C 1.544 0.714 0 CA-C-N 119.105 0.866 . . . . 0.0 112.21 179.278 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 . . . . . 0 N--CA 1.452 -0.342 0 CA-C-O 121.761 0.791 . . . . 0.0 109.794 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.28 144.68 30.45 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 172.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -81.42 123.97 29.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 170.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 67.0 tp . . . . . 0 C--O 1.234 0.258 0 C-N-CA 124.004 0.922 . . . . 0.0 109.914 176.731 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 53.4 t0 . . . . . 0 C--O 1.235 0.315 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.4 m -108.76 146.48 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 123.977 0.911 . . . . 0.0 109.78 -169.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 54.7 tp -119.47 104.35 10.25 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 179.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.3 tp -93.71 97.61 10.56 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 98.5 m -72.89 140.83 47.79 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 169.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.5 t -141.0 141.84 30.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 125.063 1.345 . . . . 0.0 107.768 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.59 176.68 19.72 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.248 0.928 . . . . 0.0 111.862 176.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -118.84 121.55 40.28 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.737 1.215 . . . . 0.0 108.253 176.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -59.97 -14.67 17.06 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.65 1.98 . . . . 0.0 115.469 -169.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.8 ptt? -126.91 13.53 7.35 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.115 0.966 . . . . 0.0 111.065 -177.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 27.0 ttt -97.68 33.54 2.04 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.038 0.835 . . . . 0.0 110.25 -177.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.46 -139.71 21.96 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -178.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -63.26 -15.47 57.25 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.251 1.02 . . . . 0.0 111.977 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -59.79 -16.61 29.31 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.933 1.293 . . . . 0.0 112.651 174.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.1 17.63 1.32 Allowed Glycine 0 CA--C 1.534 1.221 0 O-C-N 120.562 -1.336 . . . . 0.0 114.015 175.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.83 -53.3 59.58 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 119.562 1.681 . . . . 0.0 111.096 -169.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.83 -55.04 32.03 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-O 117.812 -1.549 . . . . 0.0 111.152 176.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -49.44 -39.63 44.7 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 CA-C-N 120.787 2.294 . . . . 0.0 115.381 177.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.8 tp -71.18 -38.86 72.11 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 120.083 1.311 . . . . 0.0 110.394 177.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 52.5 tp -61.21 -47.58 85.46 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 122.002 -0.436 . . . . 0.0 110.277 175.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.71 -41.04 85.4 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.862 0.865 . . . . 0.0 111.082 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -60.94 -48.52 81.42 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 118.858 0.753 . . . . 0.0 109.963 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -61.47 -47.15 87.02 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 122.907 0.483 . . . . 0.0 110.668 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 75.7 m -63.88 -40.69 97.12 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.209 0.459 . . . . 0.0 110.938 179.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.8 -39.63 94.72 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.383 0.538 . . . . 0.0 111.094 178.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.18 -35.9 76.76 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.374 0.669 . . . . 0.0 111.457 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.23 95.71 2.11 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 125.086 1.354 . . . . 0.0 108.296 -172.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -55.45 165.53 3.19 Favored 'Trans proline' 0 CA--C 1.537 0.625 0 C-N-CA 123.674 2.916 . . . . 0.0 114.445 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.442 ' HE2' ' CZ ' ' A' ' 136' ' ' TYR . 68.5 mmtt -133.3 170.77 14.96 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 126.327 1.851 . . . . 0.0 108.215 176.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 38.16 -121.93 1.1 Allowed Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.366 1.46 . . . . 0.0 112.307 177.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -140.22 38.21 1.92 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.242 1.417 . . . . 0.0 108.763 169.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -71.59 160.93 31.82 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.912 0.885 . . . . 0.0 111.565 -172.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 98.8 t -115.12 99.26 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 167.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.8 t -68.17 138.3 22.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -178.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 87.7 mt -136.23 141.16 42.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 172.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -125.64 104.36 8.34 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 177.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.22 -4.02 83.02 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.939 -0.923 . . . . 0.0 112.835 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 54.61 -143.8 31.2 Favored Glycine 0 C--N 1.341 0.82 0 N-CA-C 108.427 -1.869 . . . . 0.0 108.427 -169.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.0 p -91.46 10.98 25.47 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 122.064 -0.668 . . . . 0.0 111.891 177.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.52 58.57 21.02 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 125.352 1.461 . . . . 0.0 110.131 -177.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -70.24 -15.44 35.29 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.61 2.207 . . . . 0.0 113.784 -169.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -55.89 -32.07 63.4 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.22 0.918 . . . . 0.0 111.877 174.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.17 -28.59 68.05 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.284 0.634 . . . . 0.0 112.036 177.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -96.45 -3.29 43.71 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.386 1.075 . . . . 0.0 111.607 -170.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 90.0 mt -54.72 -41.74 57.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 118.898 0.772 . . . . 0.0 109.386 173.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.0 t -61.79 -41.7 91.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 O-C-N 121.869 -0.519 . . . . 0.0 110.063 178.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.38 -44.88 86.18 Favored 'General case' 0 N--CA 1.457 -0.1 0 O-C-N 121.972 -0.455 . . . . 0.0 110.512 -178.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 80.8 mt -57.11 -47.89 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.787 0.835 . . . . 0.0 109.237 173.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -60.58 -34.65 74.5 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 118.131 -0.938 . . . . 0.0 112.048 -174.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -57.82 -31.24 66.41 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.481 1.037 . . . . 0.0 111.638 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 70.1 mt -86.26 -12.18 50.29 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.319 1.048 . . . . 0.0 112.339 -174.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 30.53 60.09 0.98 Allowed Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 126.512 1.925 . . . . 0.0 112.57 -168.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -56.78 154.79 30.05 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.923 2.416 . . . . 0.0 114.766 -170.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.7 m -74.83 -37.28 62.32 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.401 1.08 . . . . 0.0 109.874 169.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 36.2 mtm180 -144.03 159.66 42.21 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.355 1.062 . . . . 0.0 109.872 -177.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 30.8 tp -147.38 141.81 26.41 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.748 1.219 . . . . 0.0 108.472 176.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.5 123.59 26.89 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 177.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.4 mm -98.79 144.4 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 175.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.9 t -137.56 132.9 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 119.093 0.86 . . . . 0.0 110.0 175.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -160.91 173.5 15.21 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.35 2.26 . . . . 0.0 107.222 169.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.09 157.34 37.04 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.071 -1.018 . . . . 0.0 109.181 168.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.9 m -156.23 127.15 6.89 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 176.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -71.55 124.55 24.92 Favored 'General case' 0 C--O 1.231 0.096 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 172.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 76.2 mtm -122.15 0.8 9.66 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.805 1.642 . . . . 0.0 111.058 -176.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.03 34.22 88.25 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 119.162 0.892 . . . . 0.0 111.5 -171.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.5 mt -109.53 -176.66 3.07 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.405 1.482 . . . . 0.0 109.676 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -70.34 141.22 88.24 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-O 117.988 -1.006 . . . . 0.0 108.832 170.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -42.99 138.12 4.15 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.53 2.82 . . . . 0.0 113.453 172.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.41 3.14 70.23 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-O 118.733 -1.037 . . . . 0.0 113.451 175.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -66.25 148.6 51.6 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 120.101 1.951 . . . . 0.0 108.335 168.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 65.3 mt -124.44 134.5 66.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 -172.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.1 mmt-85 -143.16 151.08 40.26 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.934 0.788 . . . . 0.0 109.747 173.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 50.7 mm -79.11 145.53 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 169.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.1 mt -132.81 163.42 37.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 124.612 1.165 . . . . 0.0 107.89 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -133.07 144.93 54.83 Favored Pre-proline 0 C--O 1.236 0.345 0 C-N-CA 126.868 2.067 . . . . 0.0 107.617 -170.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -54.81 -27.04 50.81 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 123.24 2.626 . . . . 0.0 115.141 -173.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -66.76 -20.58 65.98 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.006 0.821 . . . . 0.0 112.249 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -119.25 -31.1 4.77 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.794 1.238 . . . . 0.0 111.875 -171.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 79.7 mt -50.77 -40.58 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.09 1.356 . . . . 0.0 109.869 170.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.02 -25.59 31.38 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.7 1.2 . . . . 0.0 113.446 -176.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -111.35 -35.66 5.78 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.362 0.665 . . . . 0.0 110.215 177.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 22.1 mmt -67.1 -29.71 69.53 Favored 'General case' 0 C--N 1.334 -0.1 0 O-C-N 121.757 -0.589 . . . . 0.0 112.412 -178.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -71.72 -42.67 67.05 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 119.095 0.861 . . . . 0.0 111.598 177.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 19.0 ptp . . . . . 0 CA--C 1.537 0.451 0 CA-C-N 119.134 0.879 . . . . 0.0 113.01 -179.666 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.471 0.585 0 N-CA-C 117.782 2.512 . . . . 0.0 117.782 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -52.8 -22.02 4.86 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.979 0.911 . . . . 0.0 112.957 168.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -56.86 -32.37 65.74 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 119.402 1.001 . . . . 0.0 111.664 176.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.5 tt -73.23 -44.32 59.75 Favored 'General case' 0 C--N 1.339 0.118 0 O-C-N 121.845 -0.535 . . . . 0.0 109.58 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 98.0 mt -60.31 -45.4 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -64.32 -21.25 66.55 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -175.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -88.17 1.58 54.08 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.245 1.018 . . . . 0.0 112.425 177.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 79.1 mt -135.52 -33.3 0.88 Allowed 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.042 0.937 . . . . 0.0 112.128 -171.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -59.85 -20.63 58.15 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.471 1.108 . . . . 0.0 112.676 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -68.2 -17.2 64.26 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.45 1.1 . . . . 0.0 111.813 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -136.51 -31.18 0.88 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.066 0.848 . . . . 0.0 113.12 -177.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 30.4 mt -69.65 140.89 17.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 172.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -62.58 -42.56 99.68 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 124.105 0.86 . . . . 0.0 112.218 -177.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -149.5 142.28 24.64 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.742 1.271 . . . . 0.0 109.221 175.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 43.5 t -134.06 121.36 38.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 21.5 mt -127.91 154.45 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 C-N-CA 125.094 1.358 . . . . 0.0 107.914 -171.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -125.04 145.14 50.05 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 174.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.7 tt -125.12 128.0 47.75 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 171.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -113.35 155.44 16.3 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 73.9 mt -131.98 126.92 57.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 -178.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.8 tp60 -61.36 114.87 12.07 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-O 117.282 -1.342 . . . . 0.0 110.062 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -76.31 170.28 20.3 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.917 2.412 . . . . 0.0 111.041 170.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -130.04 -32.06 1.86 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.924 1.69 . . . . 0.0 111.014 172.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -135.43 136.04 51.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 175.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 90.9 t -141.55 134.87 30.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 175.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 158.83 149.04 5.39 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -68.67 157.5 36.1 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 122.065 0.936 . . . . 0.0 111.353 -173.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 14.1 t80 48.88 41.38 18.47 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.769 2.028 . . . . 0.0 112.391 -172.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -123.73 148.39 56.2 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 124.067 0.947 . . . . 0.0 109.759 170.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -81.44 160.88 19.75 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.053 2.502 . . . . 0.0 111.157 177.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 52.0 ttm -70.05 138.22 51.92 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 168.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 68.7 p -78.06 158.98 28.98 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 123.967 0.907 . . . . 0.0 110.459 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -52.84 -44.46 96.24 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-O 116.629 -1.653 . . . . 0.0 114.211 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -68.22 -31.86 28.15 Favored 'Trans proline' 0 C--N 1.351 0.702 0 CA-C-N 122.906 2.074 . . . . 0.0 112.065 -176.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.92 -33.91 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 119.074 0.852 . . . . 0.0 108.872 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -56.89 -46.63 81.76 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.477 1.035 . . . . 0.0 110.059 169.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -63.65 -37.01 85.73 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 122.977 0.511 . . . . 0.0 111.228 178.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.56 -49.31 73.94 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 119.172 -0.442 . . . . 0.0 110.895 175.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 75.8 t -61.46 -38.37 79.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 118.743 0.701 . . . . 0.0 109.837 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -61.61 -43.24 99.22 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.09 0.859 . . . . 0.0 110.486 173.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 29.2 m -63.31 -43.46 97.78 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.602 -0.687 . . . . 0.0 110.331 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 78.2 t -62.01 -45.71 98.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 123.3 0.64 . . . . 0.0 109.406 176.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.442 ' CZ ' ' HE2' ' A' ' 31' ' ' LYS . 48.7 t80 -56.68 -48.06 78.47 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.788 0.835 . . . . 0.0 110.624 178.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -66.62 -26.85 67.28 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.589 -0.695 . . . . 0.0 112.17 178.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -68.0 -23.54 65.02 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 119.203 0.91 . . . . 0.0 112.694 176.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.44 -24.25 66.41 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -169.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 . . . . . 0 CA--C 1.541 0.601 0 CA-C-N 119.649 1.113 . . . . 0.0 112.966 178.103 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 . . . . . 0 C--O 1.237 0.413 0 CA-C-O 121.889 0.852 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -76.22 155.75 34.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.325 176.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -97.56 121.78 39.86 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.789 1.236 . . . . 0.0 107.756 -178.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 52.3 tp . . . . . 0 CA--C 1.533 0.322 0 C-N-CA 125.564 1.546 . . . . 0.0 110.044 179.672 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 mmt . . . . . 0 N--CA 1.484 1.26 0 CA-C-O 118.872 -0.585 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.4 m -140.91 147.96 39.69 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -177.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -142.02 124.85 16.04 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -177.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.9 m -112.63 152.66 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 124.487 1.115 . . . . 0.0 109.891 -169.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 23.8 tp -125.29 107.45 10.73 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 177.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 62.5 tp -96.71 95.68 8.09 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 81.8 m -69.66 142.44 53.41 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 168.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.6 t -140.63 143.29 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 146.12 175.94 19.56 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.561 -1.015 . . . . 0.0 110.561 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -125.61 120.9 32.05 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.29 1.436 . . . . 0.0 107.813 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -59.59 -15.18 16.86 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.111 1.764 . . . . 0.0 115.377 -169.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -127.43 13.59 7.08 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.942 0.897 . . . . 0.0 111.119 -176.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.8 ttt -98.34 29.03 3.76 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.28 0.632 . . . . 0.0 109.771 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.23 -146.9 21.3 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 -177.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -58.34 -18.69 29.35 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 126.019 1.727 . . . . 0.0 112.171 175.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -51.97 -25.42 8.25 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.991 1.316 . . . . 0.0 112.645 173.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.13 24.01 0.56 Allowed Glycine 0 CA--C 1.534 1.278 0 CA-C-O 118.602 -1.11 . . . . 0.0 114.554 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.95 -52.25 63.75 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 119.559 1.68 . . . . 0.0 110.611 -171.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.41 -54.66 35.95 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 117.803 -1.554 . . . . 0.0 111.165 176.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -50.15 -40.16 51.26 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 CA-C-N 120.911 2.356 . . . . 0.0 114.99 177.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 62.9 tp -70.6 -39.88 73.54 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 119.89 1.223 . . . . 0.0 110.201 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.0 tp -61.29 -46.77 88.95 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 117.932 0.333 . . . . 0.0 110.346 175.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.67 -42.2 87.92 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.412 1.085 . . . . 0.0 110.939 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -60.81 -49.06 78.99 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 118.499 0.59 . . . . 0.0 109.778 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -62.87 -48.01 80.88 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.104 0.561 . . . . 0.0 110.749 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 89.2 m -63.75 -39.61 94.7 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.641 0.655 . . . . 0.0 111.437 177.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.45 -40.04 96.08 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.144 0.884 . . . . 0.0 110.871 177.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.35 -33.52 74.44 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.372 0.669 . . . . 0.0 111.773 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.79 92.08 2.45 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 124.861 1.264 . . . . 0.0 108.94 -171.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -51.73 161.91 1.93 Allowed 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 124.064 3.176 . . . . 0.0 114.795 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -140.25 157.21 45.94 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 126.256 1.822 . . . . 0.0 106.978 176.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 34.48 30.25 0.01 OUTLIER Glycine 0 CA--C 1.536 1.347 0 C-N-CA 128.332 2.872 . . . . 0.0 118.213 168.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 43.07 35.41 0.78 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.128 1.771 . . . . 0.0 112.837 -169.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -70.69 128.63 36.74 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 120.828 -1.17 . . . . 0.0 108.103 175.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.4 t -78.04 87.66 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 105.231 -2.137 . . . . 0.0 105.231 168.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.9 p -64.48 138.92 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 96.0 mt -137.95 144.94 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 103.454 -2.795 . . . . 0.0 103.454 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -126.85 109.02 11.54 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -66.08 -16.79 64.85 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 124.899 1.237 . . . . 0.0 113.394 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 57.0 39.85 90.24 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 119.303 1.551 . . . . 0.0 113.643 170.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . 0.258 78.3 p 62.73 12.36 5.58 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.698 2.399 . . . . 0.0 114.689 -175.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.86 59.7 13.97 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 125.447 1.499 . . . . 0.0 108.423 170.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -66.88 -19.31 52.64 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.832 2.355 . . . . 0.0 113.279 -168.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -58.02 -30.49 66.16 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.707 0.685 . . . . 0.0 112.334 177.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.43 -30.61 68.61 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.183 0.593 . . . . 0.0 111.931 175.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -94.32 -4.88 47.86 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.087 0.955 . . . . 0.0 111.501 -170.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.5 mt -54.22 -42.66 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 118.977 0.808 . . . . 0.0 109.167 173.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.7 t -62.44 -42.08 94.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 118.273 0.488 . . . . 0.0 109.99 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.24 -44.89 86.73 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.925 -0.485 . . . . 0.0 110.613 -177.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 78.2 mt -57.91 -48.04 84.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.823 0.849 . . . . 0.0 108.997 173.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -60.15 -35.3 75.0 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 118.097 -0.954 . . . . 0.0 111.994 -175.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -57.4 -31.9 66.29 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.544 1.065 . . . . 0.0 111.513 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 73.2 mt -86.12 -11.86 51.53 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.986 0.914 . . . . 0.0 112.544 -175.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 30.36 60.59 0.96 Allowed Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 126.43 1.892 . . . . 0.0 112.465 -168.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -56.52 151.65 44.83 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.977 2.451 . . . . 0.0 114.328 -169.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.1 m -69.11 -39.69 78.79 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.78 1.232 . . . . 0.0 109.642 169.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 58.2 mtm180 -144.69 166.11 26.13 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.061 0.944 . . . . 0.0 110.136 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.6 tp -145.01 141.66 29.12 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 125.312 1.445 . . . . 0.0 108.071 175.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 39.2 tp -128.15 135.43 49.75 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 173.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.4 mt -123.34 141.81 42.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 -176.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.3 t -140.51 132.83 31.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 118.566 0.621 . . . . 0.0 109.766 -173.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -162.78 173.8 13.31 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.075 2.15 . . . . 0.0 107.443 176.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.24 158.31 36.1 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 167.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 m -154.65 128.22 8.59 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 175.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -72.4 123.42 23.02 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 172.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 73.6 mtm -124.57 1.1 8.25 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.828 1.651 . . . . 0.0 110.957 -175.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.3 24.68 67.65 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-N 118.618 0.644 . . . . 0.0 112.368 -172.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.4 mt -95.85 -173.19 2.78 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.229 1.412 . . . . 0.0 109.417 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -74.84 141.23 75.1 Favored Pre-proline 0 N--CA 1.468 0.44 0 CA-C-O 117.551 -1.214 . . . . 0.0 108.338 170.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -43.44 136.74 5.94 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.202 2.602 . . . . 0.0 113.223 173.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.7 1.55 72.37 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-O 118.646 -1.085 . . . . 0.0 113.375 176.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -64.62 149.25 49.27 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 120.182 1.991 . . . . 0.0 108.307 168.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 91.5 mt -121.51 142.01 39.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 -172.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 83.9 mmt-85 -148.35 149.77 32.39 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 118.387 0.539 . . . . 0.0 111.362 169.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 49.0 mm -77.75 144.0 12.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 166.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.43 165.09 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -137.5 145.64 50.11 Favored Pre-proline 0 C--O 1.235 0.332 0 C-N-CA 126.747 2.019 . . . . 0.0 107.453 -170.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -53.64 -27.1 40.36 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.313 2.675 . . . . 0.0 115.398 -174.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -66.37 -21.69 66.24 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.032 0.833 . . . . 0.0 112.324 177.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -119.31 -29.73 5.1 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.912 1.285 . . . . 0.0 111.921 -171.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.1 mt -51.16 -38.81 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.325 1.45 . . . . 0.0 109.777 169.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.7 -29.01 61.96 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.272 1.029 . . . . 0.0 113.078 -177.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -99.32 -45.23 5.93 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 176.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 22.0 mmt -69.07 -29.31 67.41 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -168.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -70.99 -41.51 70.86 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-N 119.414 1.006 . . . . 0.0 111.393 175.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -81.15 10.0 6.0 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.791 0.723 . . . . 0.0 112.228 175.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 50.5 tpp -61.71 -25.31 67.34 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.516 1.053 . . . . 0.0 109.648 167.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 74.2 p -61.28 -8.19 3.57 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.71 2.004 . . . . 0.0 112.729 169.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.6 m 65.87 9.2 5.89 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.157 2.183 . . . . 0.0 112.095 -172.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 51.5 p-80 -155.31 -26.61 0.11 Allowed 'General case' 0 C--N 1.349 0.583 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -65.0 146.16 55.39 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 120.784 1.629 . . . . 0.0 109.885 -174.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 40.7 tpp -57.45 138.31 81.37 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 173.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -74.19 81.72 1.94 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.977 3.118 . . . . 0.0 109.197 178.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.9 mt -49.63 -9.56 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 117.528 2.418 . . . . 0.0 117.528 -168.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.44 -23.39 9.85 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.354 0.979 . . . . 0.0 112.504 168.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -57.77 -39.67 77.99 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 119.271 0.941 . . . . 0.0 110.844 176.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.4 tt -70.15 -43.93 69.9 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 123.41 0.684 . . . . 0.0 109.622 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 95.4 mt -57.74 -41.66 80.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -63.98 -18.26 64.11 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 56.2 mm-40 -83.12 -5.43 59.11 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.941 0.792 . . . . 0.0 112.095 175.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 90.0 mt -132.89 -35.19 1.09 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.933 0.893 . . . . 0.0 112.274 -168.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 12.0 pttm -62.16 -19.76 63.41 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.413 1.085 . . . . 0.0 112.805 -176.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -72.56 -12.99 61.29 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.28 1.032 . . . . 0.0 111.805 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -136.23 -32.72 0.85 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.249 0.931 . . . . 0.0 113.014 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 22.9 mt -68.16 139.64 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 170.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.61 -37.5 92.57 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.097 0.856 . . . . 0.0 112.561 -176.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -149.45 136.66 19.87 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 118.429 1.114 . . . . 0.0 108.505 175.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 56.9 t -123.45 129.78 74.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 175.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.2 mt -129.78 152.0 36.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 -168.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -134.33 146.45 49.98 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 176.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.9 tt -127.19 130.98 50.73 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 170.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -113.23 157.51 14.9 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 175.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 68.0 mt -134.53 128.37 51.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -61.85 115.52 15.98 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-O 117.635 -1.174 . . . . 0.0 110.014 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -78.89 172.42 15.03 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.562 2.175 . . . . 0.0 111.249 170.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -136.54 -31.16 0.88 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 127.533 2.333 . . . . 0.0 110.978 173.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -127.25 122.41 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 -176.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 94.0 t -144.94 132.98 16.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 152.79 150.35 5.38 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -65.7 150.3 48.71 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.137 0.968 . . . . 0.0 110.838 -177.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 18.2 t80 56.29 47.2 19.68 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.595 1.958 . . . . 0.0 111.955 -174.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -130.6 141.65 42.71 Favored Pre-proline 0 C--O 1.236 0.362 0 C-N-CA 123.935 0.894 . . . . 0.0 109.199 168.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -75.84 164.52 31.68 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.909 2.406 . . . . 0.0 110.358 170.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 49.5 ttm -72.63 140.98 48.31 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 168.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 38.3 p -78.53 157.53 28.8 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.414 1.086 . . . . 0.0 110.497 176.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.1 tm0? -49.77 -46.63 80.26 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-O 117.089 -1.434 . . . . 0.0 114.034 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -68.59 -29.27 30.43 Favored 'Trans proline' 0 C--N 1.351 0.695 0 CA-C-N 122.62 1.971 . . . . 0.0 112.163 -174.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 mp -79.63 -35.14 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -56.62 -46.68 80.81 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.39 0.996 . . . . 0.0 109.956 170.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -62.19 -38.28 88.53 Favored 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 123.108 0.563 . . . . 0.0 111.402 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.83 -48.55 76.34 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 122.045 -0.409 . . . . 0.0 111.045 176.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 79.8 t -61.27 -40.58 86.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -60.87 -42.78 98.58 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.919 0.781 . . . . 0.0 110.364 174.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 46.6 m -62.35 -45.13 94.58 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.351 0.523 . . . . 0.0 110.129 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 84.7 t -62.47 -48.16 89.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 118.644 0.657 . . . . 0.0 109.3 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -53.95 -45.77 71.4 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.127 0.971 . . . . 0.0 111.197 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 68.3 mm-40 -68.4 -34.43 76.01 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.399 0.545 . . . . 0.0 111.777 177.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.18 -33.38 75.63 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.755 0.707 . . . . 0.0 111.346 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 38.0 mt -55.18 -24.19 25.55 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -168.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -83.72 -5.74 59.26 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 120.515 1.507 . . . . 0.0 113.605 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -143.77 18.46 2.19 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.12 1.343 . . . . 0.0 112.166 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 4.3 t-105 -62.46 -37.66 86.77 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.892 1.677 . . . . 0.0 112.067 -174.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 67.78 -48.67 0.52 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 128.554 2.741 . . . . 0.0 114.895 174.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -160.84 -41.78 0.02 OUTLIER Glycine 0 CA--C 1.523 0.577 0 CA-C-O 118.815 -0.992 . . . . 0.0 112.025 -178.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -143.59 7.95 1.52 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 118.72 1.26 . . . . 0.0 113.368 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 61.41 15.2 44.83 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-O 119.038 -0.868 . . . . 0.0 114.498 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 65.09 7.85 33.06 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-N 118.8 1.3 . . . . 0.0 113.604 -175.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -69.23 141.6 54.41 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 119.367 1.584 . . . . 0.0 109.123 177.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -64.44 154.43 35.75 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.087 0.955 . . . . 0.0 109.509 177.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -105.45 122.8 46.75 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 -175.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 60.4 tp -56.94 118.59 5.11 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.301 1.44 . . . . 0.0 109.822 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.57 38.96 0.87 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.757 0.423 . . . . 0.0 111.173 -175.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 6.8 t 57.88 17.4 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 125.289 1.436 . . . . 0.0 110.839 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 47.18 40.77 10.67 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 128.193 2.597 . . . . 0.0 113.082 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -142.58 169.11 18.19 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.381 1.472 . . . . 0.0 109.394 175.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 . . . . . 0 C--O 1.25 1.113 0 C-N-CA 125.697 1.599 . . . . 0.0 106.931 179.514 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.8 mtt . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.3 m -146.04 154.19 41.58 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -131.81 144.84 51.21 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 176.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.8 t -141.15 145.71 24.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 118.982 0.81 . . . . 0.0 109.708 -167.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 36.5 tp -118.14 126.21 51.77 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 174.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.4 tp -113.43 101.62 9.55 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 176.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 95.3 m -76.73 142.52 40.43 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 169.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.2 t -139.92 142.56 31.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 125.112 1.365 . . . . 0.0 107.46 177.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 144.21 177.42 19.08 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.418 1.008 . . . . 0.0 112.046 176.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -125.45 122.39 36.53 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.302 1.441 . . . . 0.0 108.256 176.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 m -59.72 -17.01 31.37 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.306 1.842 . . . . 0.0 115.417 -169.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 27.4 ptm -126.13 15.81 7.86 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.091 0.956 . . . . 0.0 111.034 -175.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 11.8 tpt -94.93 25.99 3.85 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.657 1.183 . . . . 0.0 108.955 175.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.82 -142.56 23.59 Favored Glycine 0 C--N 1.338 0.642 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -61.72 -16.89 53.08 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.706 1.202 . . . . 0.0 112.552 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -53.1 -26.66 17.15 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.346 1.458 . . . . 0.0 112.819 175.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.62 25.47 0.62 Allowed Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.548 -1.14 . . . . 0.0 114.369 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.1 -48.08 80.1 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 119.461 1.631 . . . . 0.0 110.079 -171.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.28 -58.09 16.26 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-O 117.627 -1.652 . . . . 0.0 111.19 174.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -48.75 -41.07 38.94 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 CA-C-N 121.035 2.417 . . . . 0.0 115.735 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.3 tp -70.83 -39.4 73.02 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 120.209 1.368 . . . . 0.0 110.332 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.2 tp -61.56 -46.07 91.48 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.563 0.345 . . . . 0.0 110.342 176.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.09 -41.87 89.1 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.279 1.032 . . . . 0.0 111.033 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -60.86 -49.49 77.25 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 118.706 0.685 . . . . 0.0 109.784 178.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -62.66 -46.2 89.29 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.963 0.505 . . . . 0.0 110.849 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 79.1 m -68.04 -34.53 76.64 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.336 0.516 . . . . 0.0 111.265 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.36 -40.08 93.13 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.416 1.007 . . . . 0.0 110.736 174.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.43 -33.0 73.43 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.329 0.652 . . . . 0.0 111.723 178.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -151.3 89.27 4.24 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 125.315 1.446 . . . . 0.0 108.809 -174.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -53.29 151.09 23.68 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 123.634 2.889 . . . . 0.0 112.795 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.526 ' HE2' ' CE1' ' A' ' 136' ' ' TYR . 32.5 mmtt -127.28 163.96 22.78 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.723 1.209 . . . . 0.0 109.637 -178.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 40.16 -115.58 0.63 Allowed Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.253 1.406 . . . . 0.0 111.865 175.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -134.03 9.71 3.84 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.841 1.257 . . . . 0.0 111.107 174.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 2.8 m95 -71.26 121.58 18.69 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 121.316 -0.865 . . . . 0.0 110.149 -169.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.7 t -72.23 119.65 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 104.362 -2.458 . . . . 0.0 104.362 166.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 36.5 t -76.29 135.13 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 -178.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 62.8 mt -132.48 144.34 37.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 169.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -129.73 110.21 11.58 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.038 -1.468 . . . . 0.0 107.038 174.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.7 -2.1 90.41 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 119.08 -0.844 . . . . 0.0 112.463 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 56.51 -145.89 34.85 Favored Glycine 0 C--N 1.34 0.762 0 N-CA-C 108.357 -1.897 . . . . 0.0 108.357 -169.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.1 p -88.67 10.61 20.07 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.944 -0.739 . . . . 0.0 111.8 176.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.3 57.9 15.89 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 125.07 1.348 . . . . 0.0 110.664 -175.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -70.08 -21.84 31.45 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.899 2.399 . . . . 0.0 113.158 -172.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.51 -35.92 79.08 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.109 0.868 . . . . 0.0 112.174 -176.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -65.99 -10.3 38.18 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.744 0.818 . . . . 0.0 112.919 175.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -116.03 0.17 12.94 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.259 1.024 . . . . 0.0 112.427 -171.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 81.8 mt -48.17 -41.37 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 125.224 1.41 . . . . 0.0 110.683 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.6 t -56.36 -42.52 74.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.427 0.691 . . . . 0.0 110.248 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.07 -40.67 87.06 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 122.955 0.502 . . . . 0.0 110.874 -176.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 55.5 mt -57.86 -49.11 82.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 173.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -64.01 -35.21 79.95 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 118.082 -0.961 . . . . 0.0 111.994 -173.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -57.48 -28.8 63.71 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.432 1.015 . . . . 0.0 112.064 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 34.5 mt -76.41 -3.57 37.77 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.467 0.707 . . . . 0.0 112.639 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 41.47 53.8 7.45 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 126.307 1.843 . . . . 0.0 111.565 -171.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -57.91 135.01 66.2 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.203 1.936 . . . . 0.0 112.343 -169.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.7 m -78.32 -31.97 49.0 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.037 0.935 . . . . 0.0 108.577 168.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 20.7 ttp-105 -142.2 155.29 45.27 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.405 1.082 . . . . 0.0 109.79 173.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.4 tp -136.13 141.47 44.15 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 126.09 1.756 . . . . 0.0 107.66 169.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 24.0 tp -130.63 134.44 46.97 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 172.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.5 mt -121.29 145.17 28.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -171.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 38.3 t -141.37 135.65 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 118.938 0.79 . . . . 0.0 110.421 -175.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -163.22 169.79 18.71 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.583 2.353 . . . . 0.0 107.871 177.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.3 155.98 39.6 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.318 -0.864 . . . . 0.0 109.194 168.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.8 m -154.15 123.63 6.58 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -72.15 121.98 20.21 Favored 'General case' 0 N--CA 1.46 0.068 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 171.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 74.8 mtm -122.89 1.01 9.28 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.59 1.556 . . . . 0.0 110.736 -174.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.53 23.5 64.93 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-N 118.639 0.654 . . . . 0.0 112.341 -172.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.0 mt -96.6 -173.85 2.86 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.275 1.43 . . . . 0.0 109.052 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -73.82 140.55 77.91 Favored Pre-proline 0 N--CA 1.467 0.389 0 CA-C-O 117.744 -1.122 . . . . 0.0 108.429 172.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -43.58 137.29 6.05 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.364 2.709 . . . . 0.0 113.195 173.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.36 4.57 74.55 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 118.772 -1.015 . . . . 0.0 113.845 177.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -68.01 150.94 47.83 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 119.714 1.757 . . . . 0.0 108.13 168.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 74.1 mt -128.02 138.02 55.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 -171.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 90.1 mmt-85 -145.58 147.09 31.7 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 118.836 0.744 . . . . 0.0 112.081 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 51.0 mm -75.77 143.0 13.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 166.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mt -134.81 161.48 40.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 174.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -125.69 144.0 46.82 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 126.493 1.917 . . . . 0.0 108.312 -174.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -42.76 -37.82 6.12 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 124.726 3.618 . . . . 0.0 116.685 -178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -64.84 -22.17 66.94 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.367 0.667 . . . . 0.0 112.34 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -113.33 -32.05 6.38 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.123 1.369 . . . . 0.0 111.1 -174.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 34.5 mt -49.08 -40.44 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.776 1.63 . . . . 0.0 110.359 169.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.31 -21.93 16.82 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.097 1.359 . . . . 0.0 113.733 -176.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -115.97 -36.46 4.13 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 118.574 0.625 . . . . 0.0 110.336 174.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 86.2 mmm -72.15 -26.64 62.17 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 118.479 -0.772 . . . . 0.0 113.032 -171.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -64.53 -51.84 60.85 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 119.933 1.242 . . . . 0.0 109.801 170.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -75.86 6.82 4.55 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 51.6 tpp -61.88 -25.36 67.51 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.585 1.084 . . . . 0.0 109.748 167.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 70.0 p -63.05 -6.89 4.46 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.92 1.688 . . . . 0.0 112.685 168.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.4 m 68.73 4.12 4.24 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 127.43 2.292 . . . . 0.0 112.371 -171.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 49.2 p-80 -155.7 -25.56 0.11 Allowed 'General case' 0 C--N 1.35 0.616 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -63.51 139.99 58.83 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 120.776 1.626 . . . . 0.0 108.447 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -64.38 146.73 97.8 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-O 118.566 -0.73 . . . . 0.0 109.501 -174.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -72.68 63.72 3.85 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 125.166 3.91 . . . . 0.0 110.449 175.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 mt -53.11 -3.14 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 129.577 3.151 . . . . 0.0 117.108 -168.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -52.56 -28.23 20.01 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.546 -0.721 . . . . 0.0 111.207 167.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -59.55 -39.18 83.17 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.118 0.567 . . . . 0.0 111.12 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.6 tt -70.12 -43.68 70.5 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 123.67 0.788 . . . . 0.0 109.471 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 94.0 mt -59.78 -39.05 78.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -63.9 -19.28 64.97 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -82.37 -9.33 59.5 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.537 -0.727 . . . . 0.0 112.009 175.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 68.9 mt -126.83 -30.69 2.73 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.318 1.047 . . . . 0.0 112.09 -168.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 12.5 pttm -63.59 -24.88 67.98 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.317 -0.864 . . . . 0.0 111.942 178.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -78.33 -5.54 52.48 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.772 1.229 . . . . 0.0 111.804 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -132.54 -3.66 3.35 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.867 1.267 . . . . 0.0 112.896 -168.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 65.7 mt -135.89 143.64 35.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 126.111 1.764 . . . . 0.0 106.878 -173.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.68 -37.48 76.78 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-O 119.396 -0.669 . . . . 0.0 112.823 -171.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -144.89 124.63 13.33 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 37.2 t -127.92 130.36 69.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 3.3 mt -136.24 154.17 32.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 -169.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -131.55 146.04 52.02 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 168.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.0 tt -126.67 122.11 34.02 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.759 1.624 . . . . 0.0 106.934 176.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -107.61 156.33 15.92 Favored Glycine 0 C--N 1.333 0.377 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -178.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 56.1 mt -133.79 125.85 49.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -175.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.5 tp60 -64.09 115.24 17.78 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-O 117.624 -1.179 . . . . 0.0 110.377 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -76.06 170.39 20.19 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.302 2.668 . . . . 0.0 111.352 170.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -131.03 -30.08 1.81 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.62 1.968 . . . . 0.0 111.056 170.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.1 pp -135.24 136.4 51.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 119.105 0.866 . . . . 0.0 108.708 173.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 65.1 t -142.02 136.91 30.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 176.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 156.03 152.85 6.37 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -67.04 154.0 42.27 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.611 0.72 . . . . 0.0 110.199 -176.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.8 t80 58.21 33.93 23.63 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.196 1.798 . . . . 0.0 111.682 -177.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -123.58 145.84 48.28 Favored Pre-proline 0 C--O 1.237 0.407 0 O-C-N 121.562 -0.711 . . . . 0.0 110.199 174.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -80.3 164.74 21.57 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.198 2.599 . . . . 0.0 110.657 174.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.9 ttm -68.45 134.53 50.29 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 168.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.94 159.6 31.62 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.329 1.052 . . . . 0.0 110.471 176.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.51 -46.62 99.59 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-O 117.196 -1.383 . . . . 0.0 113.316 -171.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -66.89 -26.12 44.57 Favored 'Trans proline' 0 C--N 1.35 0.613 0 CA-C-N 122.288 1.853 . . . . 0.0 112.717 -178.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 mp -80.66 -34.86 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 119.313 0.961 . . . . 0.0 108.666 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -56.99 -46.38 82.3 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 118.988 0.813 . . . . 0.0 109.745 169.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -63.09 -37.95 89.26 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 122.787 0.435 . . . . 0.0 111.356 178.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.55 -47.38 81.82 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 121.88 -0.513 . . . . 0.0 110.9 175.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.16 -39.17 82.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 118.702 0.683 . . . . 0.0 109.871 177.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -63.21 -33.77 76.21 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.193 0.906 . . . . 0.0 111.126 174.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 39.2 m -70.31 -43.17 70.88 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.678 0.791 . . . . 0.0 110.1 175.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 91.2 t -63.45 -45.93 96.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 119.363 0.983 . . . . 0.0 109.26 176.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.526 ' CE1' ' HE2' ' A' ' 31' ' ' LYS . 22.3 t80 -52.36 -50.97 61.32 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.155 0.982 . . . . 0.0 110.884 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -71.28 -34.74 70.94 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.873 0.761 . . . . 0.0 111.818 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.21 -32.51 74.11 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 118.926 0.784 . . . . 0.0 111.43 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 55.2 mt -57.52 -18.65 20.12 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.54 1.064 . . . . 0.0 112.708 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -83.69 -12.64 55.6 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 119.403 1.001 . . . . 0.0 112.368 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -145.71 7.13 1.47 Allowed Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.151 0.881 . . . . 0.0 114.39 -173.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -55.51 146.72 19.45 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.447 1.499 . . . . 0.0 109.405 172.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -150.8 100.28 2.8 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 171.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 79.41 -41.51 2.29 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.691 1.615 . . . . 0.0 114.165 169.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -146.2 -16.91 0.45 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.323 1.449 . . . . 0.0 112.111 -169.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 64.7 17.08 62.16 Favored Glycine 0 CA--C 1.531 1.084 0 O-C-N 121.429 -0.795 . . . . 0.0 113.464 175.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.61 5.03 55.06 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 118.614 -1.103 . . . . 0.0 113.275 -176.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -74.14 159.51 32.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 119.578 1.689 . . . . 0.0 109.601 176.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -84.24 146.91 27.54 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 172.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -78.89 131.77 36.53 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 169.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 56.7 tp -54.39 144.92 19.37 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.8 1.24 . . . . 0.0 110.887 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 71.86 -47.93 0.67 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 130.423 3.489 . . . . 0.0 112.734 170.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 60.5 t -81.38 55.13 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 127.651 2.38 . . . . 0.0 104.849 168.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -58.28 154.83 12.64 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.325 1.85 . . . . 0.0 111.437 -169.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -133.73 28.78 3.89 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.732 1.213 . . . . 0.0 110.188 -171.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 . . . . . 0 C--O 1.25 1.115 0 C-N-CA 124.646 1.178 . . . . 0.0 109.33 174.38 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.6 ttp . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 119.078 -0.487 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 22.8 m -145.53 149.3 34.35 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -173.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -144.6 128.09 16.99 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 -176.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.9 m -118.06 153.47 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 124.051 0.94 . . . . 0.0 110.561 -169.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 41.4 tp -124.09 101.54 7.27 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 56.5 tp -89.84 98.94 12.06 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.071 0.949 . . . . 0.0 108.938 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 95.9 m -75.01 141.09 43.98 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 169.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.5 t -141.38 143.31 27.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 125.328 1.451 . . . . 0.0 107.782 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 148.91 171.5 17.73 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.094 0.854 . . . . 0.0 112.231 175.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -109.0 117.1 33.33 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.919 1.288 . . . . 0.0 107.951 175.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -59.57 -13.83 10.88 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.109 1.764 . . . . 0.0 115.741 -169.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -129.57 13.55 5.96 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 119.436 1.016 . . . . 0.0 111.878 -174.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.2 ttt -100.64 40.12 1.3 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.49 0.662 . . . . 0.0 110.158 -176.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.51 -136.39 18.37 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -50.9 -30.26 14.21 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.901 1.281 . . . . 0.0 113.328 174.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -60.25 -17.91 45.21 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -167.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.34 25.58 0.71 Allowed Glycine 0 CA--C 1.533 1.187 0 CA-C-O 118.14 -1.366 . . . . 0.0 113.791 175.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.51 -49.14 77.92 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 119.944 1.872 . . . . 0.0 110.382 -170.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.19 -56.44 23.76 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-O 117.612 -1.66 . . . . 0.0 111.203 173.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -47.09 -42.47 26.13 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 CA-C-N 120.991 2.396 . . . . 0.0 115.659 177.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 62.6 tp -71.49 -37.43 71.27 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 120.173 1.351 . . . . 0.0 110.713 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.4 tp -61.34 -47.39 86.13 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.324 0.511 . . . . 0.0 110.283 174.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.96 -40.28 88.5 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 123.859 0.864 . . . . 0.0 110.903 177.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.6 tp10 -62.03 -49.29 76.58 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 118.659 0.663 . . . . 0.0 109.726 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -63.21 -45.9 89.53 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 119.166 -0.445 . . . . 0.0 110.477 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 78.4 m -63.5 -40.34 96.82 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.581 0.628 . . . . 0.0 111.228 177.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.91 -39.31 93.88 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.844 0.747 . . . . 0.0 111.146 177.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.37 -36.9 77.28 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.343 0.657 . . . . 0.0 111.467 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.89 95.58 2.19 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.113 1.365 . . . . 0.0 108.063 -172.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -53.04 170.19 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 124.907 3.738 . . . . 0.0 115.729 -176.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.55 ' HE2' ' CZ ' ' A' ' 136' ' ' TYR . 19.4 mmtm -138.85 157.04 46.79 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.342 1.457 . . . . 0.0 108.94 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 38.33 -115.1 0.38 Allowed Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.241 1.4 . . . . 0.0 111.625 177.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -140.71 22.29 2.31 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.473 1.109 . . . . 0.0 110.425 170.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 10.0 m95 -69.87 128.63 37.06 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 121.32 -0.862 . . . . 0.0 109.302 -173.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 86.4 t -76.88 106.72 7.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 168.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.7 t -64.02 136.67 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.0 mm -131.02 148.06 33.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 169.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -135.6 100.26 4.43 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.59 -8.33 80.88 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-O 118.88 -0.956 . . . . 0.0 112.419 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 51.48 -140.19 25.12 Favored Glycine 0 C--N 1.341 0.807 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -169.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.9 p -91.53 14.76 13.99 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.032 0.933 . . . . 0.0 111.799 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.48 57.06 6.8 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 125.291 1.437 . . . . 0.0 110.142 -176.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -68.46 -18.66 43.6 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.822 2.348 . . . . 0.0 113.648 -169.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -61.47 -32.14 72.13 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.338 0.972 . . . . 0.0 111.473 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.43 -31.31 71.25 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.189 0.595 . . . . 0.0 111.579 175.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.54 -9.56 49.44 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 123.645 0.778 . . . . 0.0 111.326 -169.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 95.6 mt -53.1 -42.17 44.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 170.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.6 t -58.1 -40.26 76.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.565 0.746 . . . . 0.0 110.241 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.81 -45.45 71.18 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.232 0.469 . . . . 0.0 110.249 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.3 mt -62.72 -37.5 79.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -64.07 -19.04 64.94 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 117.871 -1.061 . . . . 0.0 112.578 176.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -70.91 -46.79 61.9 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 120.483 1.492 . . . . 0.0 108.964 169.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.4 mt -69.9 -21.1 63.34 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.47 1.108 . . . . 0.0 112.657 -173.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.3 mtt85 41.92 54.63 8.76 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.04 1.736 . . . . 0.0 112.202 -177.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -57.87 153.86 41.57 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.768 2.312 . . . . 0.0 114.793 -169.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.8 m -72.35 -38.82 68.48 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.085 1.354 . . . . 0.0 109.536 168.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 53.3 mtm180 -143.99 164.57 30.24 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.036 0.934 . . . . 0.0 110.577 178.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.0 tp -146.01 141.69 27.91 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.345 1.458 . . . . 0.0 108.235 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 41.7 tp -128.49 135.35 49.32 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 172.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.5 mt -122.04 144.16 32.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -175.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.5 t -140.18 132.82 33.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 118.413 0.551 . . . . 0.0 109.663 -175.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -158.78 175.19 13.92 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.556 2.342 . . . . 0.0 106.742 169.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.68 162.74 28.46 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 121.028 -1.045 . . . . 0.0 110.628 169.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.7 m -157.24 128.22 6.7 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 176.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -73.42 116.63 14.21 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 170.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 77.1 mtm -114.64 1.55 14.25 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.767 1.627 . . . . 0.0 110.461 -176.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.48 13.6 45.32 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 123.948 0.785 . . . . 0.0 113.011 -172.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 72.3 mt -85.92 -176.31 5.94 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.904 1.681 . . . . 0.0 109.928 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -72.54 139.1 80.79 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 117.928 -1.034 . . . . 0.0 109.388 172.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -43.99 134.34 8.24 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.812 3.008 . . . . 0.0 114.224 177.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.87 4.73 86.03 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 118.858 -0.968 . . . . 0.0 113.547 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -66.75 152.67 45.05 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 119.722 1.761 . . . . 0.0 108.435 168.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 85.6 mt -127.78 139.92 50.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 -171.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 90.9 mmt-85 -148.64 151.81 35.62 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.624 0.647 . . . . 0.0 111.147 173.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 43.8 mm -78.41 146.13 8.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 167.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.402 HG21 ' H ' ' A' ' 77' ' ' ASP . 1.6 mt -135.17 165.19 31.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 177.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.402 ' H ' HG21 ' A' ' 76' ' ' ILE . 5.4 t70 -138.67 146.41 50.4 Favored Pre-proline 0 C--O 1.235 0.32 0 C-N-CA 126.925 2.09 . . . . 0.0 107.009 -170.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -53.08 -28.43 40.86 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.38 2.72 . . . . 0.0 114.982 -175.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -66.69 -21.38 66.09 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 118.943 0.792 . . . . 0.0 112.359 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -117.96 -30.18 5.43 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.873 1.269 . . . . 0.0 111.894 -172.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 69.5 mt -50.5 -40.89 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 124.658 1.183 . . . . 0.0 109.89 170.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.81 -27.36 50.88 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.857 0.863 . . . . 0.0 113.254 -176.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -99.23 -43.22 6.7 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 174.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 95.0 mmm -72.1 -25.52 61.78 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.631 -0.668 . . . . 0.0 112.708 -169.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -80.0 1.01 29.22 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 172.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 23.3 ptt? -121.06 -3.12 9.59 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.407 0.683 . . . . 0.0 111.846 167.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 15.8 tpt -61.93 -29.27 70.11 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.213 0.915 . . . . 0.0 109.804 168.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.4 p -54.37 -28.55 43.92 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 127.988 2.515 . . . . 0.0 113.023 169.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.8 m 118.72 -52.38 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.446 1 C-N-CA 133.537 4.735 . . . . 0.0 104.091 -168.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -168.87 154.59 6.41 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.713 2.005 . . . . 0.0 107.449 168.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -140.45 -77.86 0.3 Allowed 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 168.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 36.3 mtt -164.44 133.82 2.92 Favored Pre-proline 0 C--N 1.329 -0.302 0 C-N-CA 129.376 3.071 . . . . 0.0 102.78 168.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -73.97 61.0 4.69 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.521 2.814 . . . . 0.0 110.631 177.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.6 mt -47.69 -12.46 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 129.608 3.163 . . . . 0.0 116.66 -168.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -52.48 -26.77 13.81 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.202 0.91 . . . . 0.0 112.199 168.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -63.53 -33.82 76.44 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.713 1.142 . . . . 0.0 111.671 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.6 tt -69.59 -46.39 66.42 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.0 mt -60.5 -49.49 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -67.18 -14.14 62.63 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -171.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -106.04 7.96 32.11 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.675 1.19 . . . . 0.0 111.668 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 26.6 tp -138.5 -27.86 0.85 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.785 0.834 . . . . 0.0 111.167 -173.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -59.35 -19.77 49.34 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.849 1.26 . . . . 0.0 111.494 168.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -64.39 -16.77 62.93 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.288 1.435 . . . . 0.0 111.361 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -125.75 -40.41 2.06 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.477 1.111 . . . . 0.0 111.426 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 36.5 mt -71.82 139.04 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.76 -38.89 93.42 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.361 0.981 . . . . 0.0 112.747 -177.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -147.22 135.95 22.06 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 118.662 1.231 . . . . 0.0 108.395 176.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.8 t -126.11 127.57 71.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.2 mt -130.24 155.31 41.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -168.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -136.13 147.8 47.92 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.4 tt -129.68 135.48 48.56 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.043 1.337 . . . . 0.0 108.167 171.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -118.13 158.91 14.48 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 125.112 1.339 . . . . 0.0 111.117 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 92.3 mt -136.31 129.73 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 C-N-CA 125.444 1.498 . . . . 0.0 107.593 -175.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -66.74 119.47 63.69 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 117.513 -1.232 . . . . 0.0 111.245 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.11 170.15 17.68 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 124.755 3.636 . . . . 0.0 113.449 173.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -137.82 -36.73 0.61 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.453 1.101 . . . . 0.0 112.028 168.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.1 pp -136.67 138.06 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 170.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 89.8 t -139.98 136.46 38.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 175.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 160.5 151.81 6.34 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -65.37 151.35 46.5 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.7 0.762 . . . . 0.0 111.079 -174.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 54.86 38.29 30.07 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.733 2.013 . . . . 0.0 112.061 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -121.6 149.54 53.05 Favored Pre-proline 0 C--O 1.237 0.439 0 C-N-CA 124.026 0.93 . . . . 0.0 109.451 173.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -78.0 158.37 30.72 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.831 2.354 . . . . 0.0 110.68 177.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 59.5 ttm -64.88 132.57 49.76 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 168.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.0 151.17 47.41 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 123.913 0.885 . . . . 0.0 111.209 177.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -57.59 -47.13 99.5 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 117.198 -1.382 . . . . 0.0 112.925 -174.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -67.92 -25.48 38.7 Favored 'Trans proline' 0 C--N 1.35 0.657 0 CA-C-N 122.105 1.787 . . . . 0.0 112.166 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 mp -76.96 -38.67 28.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -57.01 -46.88 81.98 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.977 0.808 . . . . 0.0 109.863 171.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -61.91 -39.22 91.25 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 122.639 0.376 . . . . 0.0 111.144 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.51 -49.9 71.7 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.755 0.422 . . . . 0.0 110.929 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 76.4 t -59.2 -40.78 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 118.634 0.652 . . . . 0.0 109.618 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -68.73 -28.93 67.26 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.921 0.782 . . . . 0.0 111.742 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 46.7 m -69.27 -46.79 66.39 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.558 -0.713 . . . . 0.0 109.527 173.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 96.3 t -59.39 -46.32 92.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 118.965 0.802 . . . . 0.0 108.968 176.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.55 ' CZ ' ' HE2' ' A' ' 31' ' ' LYS . 37.6 t80 -52.33 -57.93 8.25 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.317 1.047 . . . . 0.0 110.637 178.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -69.27 -29.95 67.95 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.025 0.83 . . . . 0.0 111.852 -176.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -61.43 -33.7 74.16 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 118.777 0.717 . . . . 0.0 110.881 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 52.7 mt -57.99 -17.2 15.79 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -177.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -79.46 -14.88 58.61 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 120.248 1.386 . . . . 0.0 112.793 177.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -135.23 -5.14 2.42 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.609 1.099 . . . . 0.0 113.328 -178.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -54.16 135.26 44.03 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 126.135 1.774 . . . . 0.0 109.048 174.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -143.96 151.41 39.73 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 167.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.01 -107.75 0.93 Allowed Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 -172.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -108.27 11.18 27.48 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.861 1.264 . . . . 0.0 112.463 -177.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 73.42 6.19 69.57 Favored Glycine 0 CA--C 1.528 0.887 0 O-C-N 121.379 -0.826 . . . . 0.0 113.395 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 73.17 5.71 66.91 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-N 119.024 1.412 . . . . 0.0 113.303 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -67.0 151.83 46.92 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 119.209 1.504 . . . . 0.0 108.83 170.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.62 155.77 40.14 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 123.811 0.844 . . . . 0.0 109.256 173.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -102.65 123.95 47.29 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.985 1.314 . . . . 0.0 108.196 -177.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 58.9 tp -56.05 129.31 39.35 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 126.226 1.81 . . . . 0.0 110.727 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -143.54 56.18 1.35 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.047 0.939 . . . . 0.0 110.139 178.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 6.9 t 53.78 51.69 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 125.201 1.401 . . . . 0.0 110.013 176.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -75.67 177.0 7.16 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.73 1.212 . . . . 0.0 110.913 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -145.32 153.25 41.05 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.048 1.739 . . . . 0.0 106.909 169.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 . . . . . 0 C--O 1.25 1.127 0 C-N-CA 124.781 1.232 . . . . 0.0 109.713 169.95 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.4 tpp . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 91.4 m -130.99 126.19 35.32 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 171.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -119.53 101.58 8.04 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 -175.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.1 m -89.88 141.36 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 29.3 tp -109.37 126.48 53.46 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 105.18 -2.155 . . . . 0.0 105.18 171.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 48.9 tp -114.61 97.38 6.25 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 177.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 93.2 m -71.78 140.12 49.31 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.84 169.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.1 t -140.26 141.84 32.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 148.0 -175.52 27.27 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 118.43 0.559 . . . . 0.0 112.153 177.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -136.79 117.78 14.28 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.057 1.343 . . . . 0.0 107.983 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.7 m -58.74 -11.55 3.29 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.477 2.311 . . . . 0.0 115.798 -170.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 23.4 ptp -131.97 12.35 4.74 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.805 1.184 . . . . 0.0 111.425 -177.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 27.7 mmm -89.45 24.54 2.22 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.64 0.776 . . . . 0.0 110.261 173.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.58 -139.15 16.3 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -63.42 -14.98 56.14 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.407 1.083 . . . . 0.0 112.108 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -61.39 -5.84 1.93 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.629 1.571 . . . . 0.0 113.324 174.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.64 16.89 28.48 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 120.537 -1.352 . . . . 0.0 113.412 174.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.37 -50.33 74.04 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.4 1.6 . . . . 0.0 111.578 -169.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.54 -55.22 31.19 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 117.718 -1.601 . . . . 0.0 111.144 176.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -48.73 -40.08 38.66 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 CA-C-N 120.849 2.325 . . . . 0.0 115.24 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.6 tp -71.19 -38.93 72.09 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 119.975 1.261 . . . . 0.0 110.464 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.3 tp -60.9 -46.36 90.95 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.066 0.394 . . . . 0.0 110.187 175.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.41 -39.92 81.02 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 123.85 0.86 . . . . 0.0 110.956 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -62.67 -49.36 75.42 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 118.815 0.734 . . . . 0.0 109.829 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -62.84 -44.51 95.95 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.558 0.343 . . . . 0.0 110.515 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 79.5 m -65.0 -39.64 93.76 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 118.21 0.459 . . . . 0.0 111.157 177.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.52 -37.54 87.9 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.039 0.836 . . . . 0.0 111.199 177.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.07 -38.8 79.23 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.226 0.61 . . . . 0.0 111.116 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.5 90.2 2.9 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.765 1.226 . . . . 0.0 109.191 -173.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -55.24 160.19 8.92 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 124.07 3.18 . . . . 0.0 114.0 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 32.1 mmtt -117.39 168.12 10.64 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.871 1.268 . . . . 0.0 109.768 174.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 37.52 -112.3 0.17 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 126.193 1.854 . . . . 0.0 111.564 176.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -139.13 36.27 2.11 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.852 1.261 . . . . 0.0 108.886 169.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -67.47 144.94 55.45 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 121.591 -0.693 . . . . 0.0 110.653 -175.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.1 t -103.16 103.5 15.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 168.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.8 t -71.36 136.97 24.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -176.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 54.9 mt -136.96 142.19 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 104.55 -2.389 . . . . 0.0 104.55 172.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -131.01 110.07 10.97 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -88.83 0.65 82.67 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 118.811 -0.994 . . . . 0.0 112.879 -178.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 56.9 -144.29 38.87 Favored Glycine 0 C--N 1.34 0.766 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -171.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.1 p -94.19 1.63 56.02 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.693 0.797 . . . . 0.0 112.629 -175.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.02 64.16 40.13 Favored Pre-proline 0 C--O 1.238 0.454 0 C-N-CA 124.798 1.239 . . . . 0.0 109.458 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -65.06 -14.35 44.78 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.194 2.596 . . . . 0.0 112.875 -173.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.7 tp10 -43.1 -41.74 3.73 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.087 1.755 . . . . 0.0 111.536 168.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -69.64 -17.41 63.51 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.048 0.939 . . . . 0.0 112.655 -175.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -117.79 0.8 12.06 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.797 0.839 . . . . 0.0 113.251 -168.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 73.5 mt -48.96 -38.9 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 125.147 1.379 . . . . 0.0 110.62 172.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.9 t -55.35 -42.02 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 123.955 0.902 . . . . 0.0 110.453 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.0 -40.77 91.41 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.954 0.501 . . . . 0.0 110.799 -176.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.5 mt -60.8 -49.31 85.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.975 0.91 . . . . 0.0 108.608 173.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -61.21 -36.02 78.77 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 118.386 -0.816 . . . . 0.0 111.857 -173.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -55.79 -30.19 60.94 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.871 0.76 . . . . 0.0 111.994 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 68.6 mt -87.67 -9.48 54.05 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.085 0.954 . . . . 0.0 112.377 -174.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 30.75 59.87 1.01 Allowed Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 126.588 1.955 . . . . 0.0 112.504 -168.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -57.45 155.59 30.03 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.02 2.48 . . . . 0.0 114.242 -169.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.3 m -72.77 -42.01 64.45 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.889 0.476 . . . . 0.0 109.802 170.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 50.3 mtm180 -142.7 160.62 39.95 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.439 0.696 . . . . 0.0 109.91 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 26.3 tp -141.17 138.86 33.69 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 124.645 1.178 . . . . 0.0 108.583 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 62.3 tp -127.62 114.54 17.5 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 176.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 mm -86.39 148.6 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 172.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.9 t -140.7 133.5 31.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 118.459 0.572 . . . . 0.0 109.634 171.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -161.95 173.84 13.91 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.266 2.226 . . . . 0.0 107.351 169.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.18 157.54 37.98 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.052 -1.03 . . . . 0.0 109.734 169.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.7 m -151.55 126.44 9.7 Favored 'General case' 0 CA--C 1.527 0.09 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -77.42 80.51 3.91 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.994 0.902 . . . . 0.0 110.261 175.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 74.0 mtm -75.4 -6.55 50.61 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.012 1.725 . . . . 0.0 112.345 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.0 21.02 76.74 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 123.87 0.747 . . . . 0.0 111.943 -172.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.5 mt -93.49 -172.65 2.97 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.132 1.373 . . . . 0.0 109.706 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -74.2 140.45 76.55 Favored Pre-proline 0 N--CA 1.468 0.437 0 CA-C-O 117.695 -1.145 . . . . 0.0 108.434 169.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -43.01 137.99 4.25 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.423 2.749 . . . . 0.0 113.445 172.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.05 1.59 74.39 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 118.587 -1.118 . . . . 0.0 113.689 176.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -67.12 147.22 53.41 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.926 1.863 . . . . 0.0 107.891 168.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 55.2 mt -124.97 139.81 49.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 -173.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 91.3 mmt-85 -147.26 152.46 38.35 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 118.765 0.712 . . . . 0.0 111.734 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 48.5 mm -80.51 142.53 13.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 166.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.2 mt -134.99 164.3 34.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 124.871 1.268 . . . . 0.0 107.844 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -135.05 145.78 55.77 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 126.884 2.074 . . . . 0.0 107.974 -169.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -55.32 -25.04 45.48 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.292 2.662 . . . . 0.0 115.229 -173.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -66.33 -21.16 66.25 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.157 0.89 . . . . 0.0 112.271 176.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -122.16 -29.8 4.14 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.655 1.182 . . . . 0.0 112.149 -170.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.0 mt -50.8 -40.36 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.15 1.38 . . . . 0.0 109.675 169.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.91 -29.18 59.66 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.409 1.084 . . . . 0.0 112.989 -176.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -99.45 -43.91 6.37 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 20.8 mmt -68.06 -31.4 71.01 Favored 'General case' 0 CA--C 1.523 -0.087 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -169.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -70.33 -45.65 65.76 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 118.766 0.712 . . . . 0.0 111.491 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -83.33 8.48 13.45 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 15.3 tpt -60.49 -26.53 66.89 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.174 0.897 . . . . 0.0 109.589 167.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 55.4 p -59.76 -15.86 23.37 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.963 1.705 . . . . 0.0 112.916 169.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.0 m 56.6 31.95 20.07 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.956 1.703 . . . . 0.0 109.845 -168.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -153.37 -60.05 0.14 Allowed 'General case' 0 C--N 1.345 0.37 0 O-C-N 121.411 -0.806 . . . . 0.0 112.724 -170.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -71.63 147.0 47.97 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 122.796 0.438 . . . . 0.0 109.884 -169.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 77.6 mtm -67.35 145.96 98.65 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 122.963 0.505 . . . . 0.0 109.981 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.8 81.44 1.89 Allowed 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 123.99 3.127 . . . . 0.0 110.139 177.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.2 mt -50.95 -8.47 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 127.257 2.223 . . . . 0.0 116.779 -169.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -52.48 -25.06 9.15 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.487 1.039 . . . . 0.0 112.128 167.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -59.11 -32.55 69.94 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.072 0.851 . . . . 0.0 111.529 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.8 tt -79.51 -44.6 20.91 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 85.0 mt -57.55 -42.39 81.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -59.63 -24.94 64.26 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -89.06 -4.0 58.5 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.151 0.98 . . . . 0.0 112.506 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -123.0 -30.87 3.71 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.449 1.022 . . . . 0.0 111.832 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -60.17 -20.66 59.59 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.103 0.961 . . . . 0.0 113.048 -176.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -69.62 -16.15 63.33 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.362 1.065 . . . . 0.0 112.094 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -140.2 -32.39 0.61 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.372 0.987 . . . . 0.0 113.621 -176.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 12.4 mt -69.53 138.78 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 170.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.62 -37.59 92.62 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.344 0.973 . . . . 0.0 112.483 -175.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -148.69 137.76 21.63 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 118.497 1.149 . . . . 0.0 108.462 175.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 45.2 t -129.63 124.45 59.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 25.8 mt -129.93 154.93 41.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -169.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -125.66 143.48 51.01 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 174.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.6 tt -122.23 124.08 42.95 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 169.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -110.71 156.73 15.39 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 57.7 mt -134.44 124.9 46.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 -176.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -64.89 118.14 45.81 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-O 117.448 -1.263 . . . . 0.0 110.447 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -76.18 171.68 17.66 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.703 2.935 . . . . 0.0 111.569 170.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -128.0 -31.96 2.34 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 125.765 1.626 . . . . 0.0 110.98 171.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -135.86 136.55 49.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.344 1.058 . . . . 0.0 108.161 175.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.9 t -140.79 132.2 29.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 174.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 162.83 154.76 7.75 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -70.11 153.18 43.48 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.898 0.856 . . . . 0.0 110.929 -171.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.9 t80 50.96 39.18 22.24 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.915 2.086 . . . . 0.0 112.222 -176.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.5 m-30 -120.29 148.04 46.42 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 123.793 0.837 . . . . 0.0 109.947 174.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -81.27 164.39 19.39 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.23 2.62 . . . . 0.0 111.162 177.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 52.0 ttm -72.74 140.54 47.85 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 168.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 71.4 p -81.25 159.81 24.42 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.374 1.07 . . . . 0.0 110.656 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.2 tm0? -51.04 -48.65 84.39 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-O 116.978 -1.487 . . . . 0.0 113.329 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -67.78 -30.01 34.55 Favored 'Trans proline' 0 C--N 1.352 0.731 0 CA-C-N 122.546 1.945 . . . . 0.0 112.368 -174.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.77 -35.88 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 119.092 0.86 . . . . 0.0 108.931 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -56.97 -47.13 81.49 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.46 1.027 . . . . 0.0 109.926 171.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -61.52 -42.49 98.9 Favored 'General case' 0 C--O 1.231 0.087 0 C-N-CA 122.995 0.518 . . . . 0.0 111.082 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.96 -48.47 80.23 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 119.04 -0.505 . . . . 0.0 110.952 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 55.5 t -60.01 -41.66 87.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 118.705 0.684 . . . . 0.0 109.617 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -69.58 -29.93 67.58 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.044 0.838 . . . . 0.0 111.568 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 38.0 m -69.58 -45.48 68.55 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.325 -0.86 . . . . 0.0 109.776 174.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 78.7 t -59.23 -47.15 91.29 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 175.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -52.08 -48.11 64.86 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.008 0.923 . . . . 0.0 110.811 177.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -64.0 -44.0 93.98 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 118.564 0.62 . . . . 0.0 110.991 177.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.6 tpp85 -64.11 -26.54 68.59 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 118.736 -0.65 . . . . 0.0 112.234 -175.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 61.0 mt -57.2 -23.68 49.39 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.412 1.006 . . . . 0.0 112.317 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -67.69 -19.03 65.12 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.325 0.966 . . . . 0.0 112.558 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -136.97 6.41 3.73 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.725 1.155 . . . . 0.0 113.361 -174.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 21.0 t90 -62.36 141.53 58.26 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 118.485 1.142 . . . . 0.0 108.822 172.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -151.3 70.34 0.97 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 80.69 -45.28 3.09 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.448 1.023 . . . . 0.0 110.945 -172.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -148.84 96.08 2.51 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 169.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -60.61 7.97 0.08 OUTLIER Glycine 0 CA--C 1.532 1.114 0 C-N-CA 125.865 1.698 . . . . 0.0 116.541 171.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 110.81 42.39 1.12 Allowed Glycine 0 CA--C 1.522 0.51 0 CA-C-N 120.034 1.917 . . . . 0.0 112.877 168.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -112.19 154.6 25.29 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 118.332 1.066 . . . . 0.0 110.121 169.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.81 151.13 39.09 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -91.98 120.47 32.67 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 59.0 tp -59.47 125.33 23.2 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.486 1.115 . . . . 0.0 109.794 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -139.82 -47.59 0.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.719 0.808 . . . . 0.0 111.133 173.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -164.09 -55.52 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 125.254 1.422 . . . . 0.0 109.022 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 47.91 31.83 2.52 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.822 2.049 . . . . 0.0 112.898 -170.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -139.48 27.74 2.27 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.395 1.878 . . . . 0.0 108.937 175.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 . . . . . 0 C--O 1.247 0.956 0 C-N-CA 126.913 2.085 . . . . 0.0 106.9 -176.806 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 tpt . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.4 m -137.47 135.54 36.92 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 172.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -129.94 118.53 21.8 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 105.056 -2.202 . . . . 0.0 105.056 -174.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.4 t -121.84 147.45 25.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.431 0.634 . . . . 0.0 109.995 -165.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 28.6 tp -116.27 127.95 55.16 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 56.8 tp -117.45 94.49 4.57 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 94.5 m -71.14 143.51 50.54 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.459 -0.791 . . . . 0.0 108.918 170.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.9 t -141.38 141.46 30.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 125.23 1.412 . . . . 0.0 107.655 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 143.38 176.34 17.33 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 124.494 1.045 . . . . 0.0 111.949 176.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -120.83 121.49 38.25 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 125.017 1.327 . . . . 0.0 108.124 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 m -59.07 -16.86 21.19 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.438 1.895 . . . . 0.0 115.342 -169.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -126.38 14.27 7.69 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.958 0.903 . . . . 0.0 111.03 -175.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.6 ttt -97.84 32.77 2.26 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.274 0.63 . . . . 0.0 109.586 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.2 -146.3 27.66 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -174.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -60.31 -17.39 42.45 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 126.028 1.731 . . . . 0.0 112.377 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -51.72 -28.03 13.75 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.022 1.329 . . . . 0.0 112.681 175.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.28 26.61 0.56 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.845 1.212 . . . . 0.0 114.456 178.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.77 -50.19 73.38 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 119.291 1.545 . . . . 0.0 110.297 -173.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.95 -56.69 23.33 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-O 117.75 -1.584 . . . . 0.0 111.111 175.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -48.78 -41.04 39.2 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 CA-C-N 120.972 2.386 . . . . 0.0 115.214 178.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.0 tp -71.24 -37.91 71.98 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-N 119.962 1.255 . . . . 0.0 110.605 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.6 tp -60.97 -48.35 82.23 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.308 0.504 . . . . 0.0 109.934 175.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.19 -40.01 88.56 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.773 0.829 . . . . 0.0 111.046 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.6 tp10 -61.06 -49.54 76.96 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 118.492 0.587 . . . . 0.0 109.535 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -63.51 -44.83 93.15 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 119.192 -0.433 . . . . 0.0 110.742 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 75.4 m -63.71 -42.25 97.99 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.716 0.689 . . . . 0.0 111.039 178.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.83 -41.15 99.21 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.417 0.553 . . . . 0.0 110.788 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.92 -32.86 72.78 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.379 0.672 . . . . 0.0 111.99 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.7 88.53 3.29 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 124.707 1.203 . . . . 0.0 109.014 -171.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -51.39 160.92 2.07 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 123.967 3.111 . . . . 0.0 114.329 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -135.75 164.26 28.31 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.473 1.509 . . . . 0.0 108.964 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 41.8 -120.18 2.03 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.491 1.52 . . . . 0.0 111.374 175.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -140.91 34.99 1.76 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.844 1.257 . . . . 0.0 109.443 170.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -69.3 162.21 27.68 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.636 0.774 . . . . 0.0 111.99 -174.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.2 t -116.61 119.13 61.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 103.728 -2.693 . . . . 0.0 103.728 165.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.4 t -88.1 136.79 22.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -172.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 73.0 mt -133.08 143.99 37.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 104.705 -2.332 . . . . 0.0 104.705 169.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -128.03 106.96 9.43 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 172.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.14 -2.98 80.63 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-O 118.929 -0.928 . . . . 0.0 112.807 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 56.83 -147.29 33.7 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 -168.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.6 p -86.61 10.38 15.71 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.732 -0.863 . . . . 0.0 111.876 177.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.76 59.76 17.19 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 125.138 1.375 . . . . 0.0 110.519 -175.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -67.75 -15.4 44.22 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.824 2.35 . . . . 0.0 113.355 -172.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -57.25 -30.75 64.91 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.824 0.738 . . . . 0.0 112.126 173.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.0 -28.46 70.11 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.185 0.594 . . . . 0.0 111.97 175.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.18 -4.12 36.19 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.954 1.301 . . . . 0.0 111.894 -169.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.8 mt -48.57 -43.73 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 124.265 1.026 . . . . 0.0 109.79 170.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 52.5 t -59.5 -38.73 76.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 118.591 0.632 . . . . 0.0 110.644 -177.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.69 -44.53 81.48 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 121.918 -0.489 . . . . 0.0 110.21 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 77.6 mt -60.02 -39.62 80.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 123.489 0.716 . . . . 0.0 109.507 176.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -65.8 -20.33 66.21 Favored 'General case' 0 N--CA 1.462 0.145 0 O-C-N 121.024 -1.048 . . . . 0.0 112.311 178.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -75.55 -48.18 23.56 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 120.122 1.328 . . . . 0.0 109.087 169.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.8 mt -66.04 -26.94 67.75 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.402 0.681 . . . . 0.0 112.368 -175.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 42.77 59.61 10.76 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 125.87 1.668 . . . . 0.0 110.863 -175.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -53.92 146.35 47.23 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.691 2.26 . . . . 0.0 113.413 -169.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.3 m -74.75 -35.1 62.6 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 167.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -147.98 152.5 37.58 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.78 1.232 . . . . 0.0 109.086 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 51.3 tp -140.9 141.37 34.57 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.433 1.093 . . . . 0.0 108.862 -177.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 58.8 tp -125.54 136.92 53.83 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 170.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.5 mt -121.17 143.67 32.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.5 t -140.58 135.41 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 118.586 0.63 . . . . 0.0 110.018 -173.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -162.9 170.37 18.27 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.727 2.411 . . . . 0.0 107.454 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.48 154.94 39.71 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 168.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.9 m -153.23 124.13 7.37 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -69.64 120.99 16.25 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 169.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 76.7 mtm -119.04 1.29 11.41 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.636 1.575 . . . . 0.0 110.704 -177.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.94 34.2 89.24 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 118.929 0.786 . . . . 0.0 111.577 -172.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.3 mt -111.54 -172.14 1.98 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.774 1.63 . . . . 0.0 109.446 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -75.28 140.18 72.62 Favored Pre-proline 0 N--CA 1.468 0.453 0 CA-C-O 117.456 -1.259 . . . . 0.0 108.681 173.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -43.64 136.55 6.55 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.198 2.599 . . . . 0.0 112.896 172.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.65 1.79 83.95 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-O 118.584 -1.12 . . . . 0.0 113.758 177.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -65.75 147.24 53.71 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 120.02 1.91 . . . . 0.0 108.68 168.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 66.9 mt -126.82 133.12 69.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 C-N-CA 125.403 1.481 . . . . 0.0 107.077 -172.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.3 mmt-85 -143.42 151.81 40.81 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.864 0.756 . . . . 0.0 109.691 174.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 48.7 mm -80.83 145.72 8.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 168.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 11.1 mt -131.81 123.39 51.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -175.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -76.81 140.69 67.51 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-O 117.87 -1.062 . . . . 0.0 109.716 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_exo -46.81 -35.24 17.4 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 124.264 3.309 . . . . 0.0 116.677 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -68.59 -23.96 64.53 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.648 0.658 . . . . 0.0 111.687 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -98.81 -31.46 11.86 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.279 1.431 . . . . 0.0 111.116 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 68.0 mt -50.11 -40.82 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.796 1.238 . . . . 0.0 109.569 169.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.93 -19.97 7.9 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.887 1.675 . . . . 0.0 114.327 -175.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -124.33 -37.0 2.58 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 118.72 0.691 . . . . 0.0 110.553 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 21.3 mmt -66.85 -29.43 69.34 Favored 'General case' 0 N--CA 1.46 0.063 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -175.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -69.35 -45.4 69.52 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 119.155 0.889 . . . . 0.0 110.487 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 21.7 ptp -78.31 8.02 5.61 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 118.923 -0.56 . . . . 0.0 112.468 176.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 50.0 tpp -61.24 -27.51 68.5 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.945 1.248 . . . . 0.0 109.743 168.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 68.4 p -62.16 -12.69 21.16 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.914 1.686 . . . . 0.0 113.008 169.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.8 m 57.48 30.6 18.93 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.919 1.687 . . . . 0.0 109.963 -168.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -152.64 -57.63 0.14 Allowed 'General case' 0 C--N 1.345 0.391 0 O-C-N 121.344 -0.847 . . . . 0.0 113.12 -172.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -67.46 146.35 54.08 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 122.838 0.455 . . . . 0.0 109.899 -169.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 94.8 mmm -67.13 148.95 98.73 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 123.228 0.611 . . . . 0.0 109.565 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -71.9 72.66 2.58 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 124.273 3.315 . . . . 0.0 109.433 171.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.7 mt -48.94 -11.47 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 128.532 2.733 . . . . 0.0 116.854 -168.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.04 -22.59 6.11 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.188 0.995 . . . . 0.0 112.608 168.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -59.51 -33.77 71.77 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.336 0.971 . . . . 0.0 111.755 175.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.9 tt -73.41 -44.49 58.26 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 74.4 mt -60.55 -42.29 90.93 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.107 0 C-N-CA 123.258 0.623 . . . . 0.0 109.63 -177.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -60.5 -24.37 65.25 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -176.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -85.03 -11.42 55.41 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.754 0.822 . . . . 0.0 112.063 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.4 mp -121.14 -31.28 4.16 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.32 1.448 . . . . 0.0 111.855 -168.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -60.57 -21.1 62.22 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.68 1.192 . . . . 0.0 112.611 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -71.78 -11.31 60.75 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.593 1.157 . . . . 0.0 111.694 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -134.35 -38.55 0.84 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.092 0.957 . . . . 0.0 112.138 -176.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 53.3 mt -72.17 139.96 18.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 174.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.08 -41.64 94.96 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.052 0.834 . . . . 0.0 111.972 -178.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -149.41 137.63 20.67 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 118.564 1.182 . . . . 0.0 108.612 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 41.4 t -131.13 123.98 54.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 19.9 mt -127.09 154.79 37.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 -171.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -129.74 141.84 50.81 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 173.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.1 tt -121.76 128.42 51.73 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 173.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -114.67 156.29 15.75 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 72.5 mt -131.98 128.09 59.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -177.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.1 tp60 -62.55 115.48 16.91 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 117.579 -1.201 . . . . 0.0 110.157 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -78.76 172.91 14.35 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.143 2.562 . . . . 0.0 111.552 171.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -137.29 -30.7 0.84 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 127.811 2.444 . . . . 0.0 111.045 173.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -129.74 124.14 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 -176.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.7 t -145.27 132.91 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 151.63 150.56 5.37 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -63.8 149.95 45.76 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 118.155 0.978 . . . . 0.0 110.901 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 57.95 43.62 21.03 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.601 1.96 . . . . 0.0 111.951 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -127.72 140.65 38.7 Favored Pre-proline 0 C--O 1.236 0.345 0 C-N-CA 124.116 0.967 . . . . 0.0 108.78 168.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -73.97 161.66 40.74 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.462 2.108 . . . . 0.0 110.041 170.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 52.1 ttm -70.27 139.49 52.17 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 168.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 33.1 p -76.32 156.49 33.31 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.134 0.974 . . . . 0.0 110.504 176.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.1 tm0? -49.32 -46.79 77.5 Favored Pre-proline 0 CA--C 1.544 0.733 0 CA-C-O 117.009 -1.472 . . . . 0.0 113.912 -178.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.46 -28.0 32.87 Favored 'Trans proline' 0 C--N 1.35 0.645 0 CA-C-N 122.616 1.97 . . . . 0.0 112.257 -175.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 mp -80.41 -35.55 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 119.358 0.981 . . . . 0.0 108.64 177.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -56.91 -47.23 81.03 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.405 1.002 . . . . 0.0 109.913 170.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -61.3 -41.81 97.6 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 123.303 0.641 . . . . 0.0 111.013 178.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.98 -48.99 77.89 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 119.121 -0.466 . . . . 0.0 110.929 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 56.0 t -59.48 -41.04 83.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 118.712 0.687 . . . . 0.0 109.728 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -68.94 -30.48 68.95 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.028 0.831 . . . . 0.0 111.483 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 32.9 m -69.41 -40.97 76.98 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.062 -1.024 . . . . 0.0 109.981 174.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 77.4 t -61.25 -50.08 81.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -56.28 -35.66 67.72 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.517 1.127 . . . . 0.0 112.156 177.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -67.9 -43.52 79.08 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.524 1.056 . . . . 0.0 110.685 171.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -58.91 -31.39 68.59 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 118.568 -0.729 . . . . 0.0 112.441 176.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.7 mp -56.52 -22.96 36.5 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.449 1.022 . . . . 0.0 111.973 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 -71.84 -16.3 62.15 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 119.449 1.022 . . . . 0.0 112.795 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -149.71 -0.36 0.41 Allowed Glycine 0 CA--C 1.533 1.213 0 N-CA-C 115.512 0.965 . . . . 0.0 115.512 -171.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 25.8 t90 -58.72 140.37 54.86 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.239 1.519 . . . . 0.0 109.022 170.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -138.49 10.63 2.72 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.44 1.096 . . . . 0.0 111.577 173.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 165.62 -47.93 0.28 Allowed Glycine 0 C--N 1.338 0.679 0 O-C-N 121.403 -0.811 . . . . 0.0 111.234 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -123.12 -24.36 4.73 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 54.86 26.27 40.09 Favored Glycine 0 CA--C 1.536 1.359 0 CA-C-N 119.267 0.94 . . . . 0.0 112.755 -172.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.38 -8.84 51.9 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 118.159 -1.356 . . . . 0.0 114.104 -176.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -69.23 145.46 53.15 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 120.362 2.081 . . . . 0.0 110.26 175.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.9 153.41 38.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.574 176.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -93.42 121.88 35.27 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 50.1 tp -56.47 124.45 18.22 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.663 1.585 . . . . 0.0 109.837 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.56 62.2 1.49 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.458 1.103 . . . . 0.0 109.006 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.6 t 52.86 42.01 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 125.463 1.505 . . . . 0.0 110.115 -176.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -73.01 157.67 36.92 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.001 0.92 . . . . 0.0 108.804 172.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -154.67 158.12 39.15 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.264 1.426 . . . . 0.0 107.685 169.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 . . . . . 0 C--O 1.248 1.005 0 C-N-CA 124.519 1.128 . . . . 0.0 108.062 175.843 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.482 1.135 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.8 m -134.97 138.05 43.65 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 173.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -137.85 101.01 4.33 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -168.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 56.3 t -93.93 146.69 6.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.556 0.693 . . . . 0.0 109.655 -169.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 58.5 tp -115.76 114.75 25.21 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 170.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 55.3 tp -103.59 102.29 12.16 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.456 1.102 . . . . 0.0 108.03 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 90.6 m -76.63 142.3 40.7 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 170.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.5 t -141.0 142.63 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 143.49 178.77 19.57 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -132.53 121.0 22.63 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 124.613 1.165 . . . . 0.0 108.443 177.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 m -58.58 -5.33 0.53 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.957 2.503 . . . . 0.0 116.391 -169.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -133.03 10.36 4.19 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.294 0.952 . . . . 0.0 111.446 -176.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 63.8 mtp -95.71 27.97 3.24 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.599 0.76 . . . . 0.0 110.581 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.6 -139.34 19.39 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 -177.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -62.9 -15.81 56.59 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.321 1.048 . . . . 0.0 112.148 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -58.29 -18.6 28.11 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.922 1.289 . . . . 0.0 112.755 174.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.54 19.67 0.86 Allowed Glycine 0 CA--C 1.535 1.3 0 O-C-N 120.626 -1.296 . . . . 0.0 114.237 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.85 -53.3 57.72 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 119.865 1.832 . . . . 0.0 111.157 -169.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.92 -53.93 41.7 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-O 117.953 -1.471 . . . . 0.0 111.21 176.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -50.57 -38.97 55.92 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 CA-C-N 120.907 2.353 . . . . 0.0 115.188 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.1 tp -70.3 -38.7 75.05 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 120.029 1.286 . . . . 0.0 110.243 177.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 51.1 tp -61.89 -48.89 78.43 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.001 0.364 . . . . 0.0 110.219 175.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.66 -41.05 80.73 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 124.302 1.041 . . . . 0.0 111.115 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -61.7 -48.74 79.4 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.771 0.714 . . . . 0.0 109.995 178.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -61.13 -46.24 91.38 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 122.817 0.447 . . . . 0.0 110.518 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 85.6 m -64.0 -40.38 96.23 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.278 0.49 . . . . 0.0 111.117 178.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.44 -38.9 92.92 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.334 0.516 . . . . 0.0 110.947 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.64 -37.65 76.86 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.3 0.64 . . . . 0.0 111.244 178.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.72 98.81 1.69 Allowed Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 125.122 1.369 . . . . 0.0 108.549 -172.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.52 167.36 25.64 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.305 2.004 . . . . 0.0 111.679 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -128.62 177.41 7.05 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.927 1.691 . . . . 0.0 108.654 177.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 41.16 -124.65 2.95 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.054 1.311 . . . . 0.0 112.317 175.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -141.44 37.91 1.69 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.25 1.42 . . . . 0.0 109.337 172.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -72.63 167.83 19.93 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.374 1.07 . . . . 0.0 111.85 -174.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.0 t -123.57 110.31 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 167.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.6 t -75.21 139.32 19.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -175.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 22.9 mm -134.59 147.95 29.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 169.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -130.72 112.2 12.87 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 176.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.52 -11.49 80.18 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 118.79 -1.005 . . . . 0.0 112.982 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.65 35.51 81.44 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 119.017 1.408 . . . . 0.0 113.667 170.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 66.92 10.26 7.49 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.772 1.629 . . . . 0.0 113.5 -177.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.79 53.68 4.84 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 125.341 1.457 . . . . 0.0 108.794 173.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -64.02 -24.63 66.79 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.488 2.125 . . . . 0.0 112.7 -169.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -63.49 -33.53 75.77 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.974 0.806 . . . . 0.0 111.741 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.52 -22.57 67.0 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.569 0.748 . . . . 0.0 111.552 174.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -105.59 -2.2 23.77 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.444 1.098 . . . . 0.0 112.653 -169.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.8 mt -47.24 -42.73 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.989 1.315 . . . . 0.0 110.372 173.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.3 t -56.42 -42.32 74.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.068 0.547 . . . . 0.0 110.167 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.12 -35.55 76.54 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.072 0.549 . . . . 0.0 111.525 -177.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 68.6 mt -63.83 -46.88 93.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 173.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 37.0 mtp180 -69.37 -22.43 63.73 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 117.888 -1.053 . . . . 0.0 112.624 -174.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -56.33 -32.45 64.67 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 120.535 1.516 . . . . 0.0 110.847 170.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 55.1 mt -86.64 -10.85 52.94 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.11 0.964 . . . . 0.0 112.773 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 28.68 61.85 0.72 Allowed Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 126.825 2.05 . . . . 0.0 112.54 -167.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.53 149.15 40.33 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.294 2.663 . . . . 0.0 113.873 -169.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.0 m -71.81 -37.59 70.36 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 168.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -147.97 156.61 42.86 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.059 0.944 . . . . 0.0 109.537 -176.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 41.7 tp -143.75 139.09 29.25 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 124.805 1.242 . . . . 0.0 108.653 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 57.1 tp -124.1 137.17 54.6 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 169.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.7 mt -120.58 143.21 33.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.4 t -140.58 134.03 33.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 118.442 0.565 . . . . 0.0 109.83 -175.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -161.87 172.57 15.86 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.241 2.217 . . . . 0.0 107.39 170.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.49 157.51 36.98 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 121.288 -0.883 . . . . 0.0 108.753 167.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.2 m -152.8 129.38 10.75 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -77.52 82.78 3.94 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 118.921 0.782 . . . . 0.0 109.731 176.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 77.5 mtm -76.82 -6.45 52.38 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.281 1.433 . . . . 0.0 111.806 -177.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.36 25.61 72.43 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.091 0.853 . . . . 0.0 111.752 -174.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 47.5 mt -107.84 -168.56 1.39 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.512 1.125 . . . . 0.0 109.873 -176.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -79.31 138.47 55.82 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-O 117.738 -1.125 . . . . 0.0 109.263 175.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -45.51 134.93 12.68 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.474 2.782 . . . . 0.0 113.864 177.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.13 1.82 90.17 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-O 118.597 -1.113 . . . . 0.0 113.238 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -64.1 145.79 55.32 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 119.767 1.784 . . . . 0.0 107.804 167.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 59.0 mt -126.74 137.33 58.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 -175.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.2 mmt-85 -147.59 150.19 33.98 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 118.792 0.724 . . . . 0.0 111.445 175.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 50.2 mm -72.97 149.38 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 164.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.6 mt -133.41 133.62 57.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -80.91 142.75 52.52 Favored Pre-proline 0 N--CA 1.471 0.614 0 CA-C-O 117.508 -1.234 . . . . 0.0 109.37 174.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -46.59 -37.48 20.35 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 123.997 3.131 . . . . 0.0 116.435 177.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -69.57 -22.32 63.54 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.552 0.614 . . . . 0.0 111.603 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -97.13 -34.1 11.26 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.956 1.303 . . . . 0.0 110.75 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 83.7 mt -50.81 -42.15 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 125.513 1.525 . . . . 0.0 109.111 169.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.55 -23.61 51.49 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.611 1.164 . . . . 0.0 113.571 -175.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -107.39 -40.76 5.27 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 123.184 0.593 . . . . 0.0 109.613 176.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 22.4 mmt -71.71 -29.49 64.62 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -169.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -71.09 -43.03 68.54 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 119.458 1.026 . . . . 0.0 110.981 175.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 28.9 ptm -81.21 10.74 4.98 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 176.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 51.3 tpp -61.78 -24.77 67.06 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.417 1.008 . . . . 0.0 109.862 168.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 45.0 p -62.16 -15.65 47.46 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.347 1.859 . . . . 0.0 112.81 169.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.6 m 60.57 22.03 11.81 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.139 1.776 . . . . 0.0 110.344 -168.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -142.15 -53.61 0.43 Allowed 'General case' 0 C--N 1.343 0.324 0 O-C-N 121.208 -0.932 . . . . 0.0 112.161 -169.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -69.61 147.88 50.11 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 118.272 0.487 . . . . 0.0 110.719 -168.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 12.7 tpt -61.76 140.92 95.34 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 171.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.96 81.34 1.95 Allowed 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 124.044 3.163 . . . . 0.0 109.686 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.8 mt -47.2 -11.12 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 128.326 2.65 . . . . 0.0 118.116 -168.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.06 -23.6 8.07 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.333 0.969 . . . . 0.0 112.821 168.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -59.19 -33.07 70.51 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.351 0.978 . . . . 0.0 111.883 175.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.6 tt -74.58 -43.23 56.63 Favored 'General case' 0 C--N 1.338 0.071 0 O-C-N 121.719 -0.613 . . . . 0.0 109.399 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 87.7 mt -61.73 -40.14 85.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.544 0.738 . . . . 0.0 109.728 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -57.39 -30.61 65.05 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.262 0.625 . . . . 0.0 112.264 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -84.74 -1.62 56.51 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.427 1.091 . . . . 0.0 112.27 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 70.7 mt -126.53 -26.13 3.33 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.457 1.103 . . . . 0.0 112.061 -175.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -58.69 -29.45 66.64 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.805 1.184 . . . . 0.0 111.82 170.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -66.97 -11.93 58.16 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.992 0.917 . . . . 0.0 113.132 173.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -129.84 -11.42 4.33 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.382 1.073 . . . . 0.0 113.701 -168.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 46.7 mt -132.33 143.41 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 125.488 1.515 . . . . 0.0 107.995 -169.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -68.52 -40.77 86.14 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-O 119.211 -0.772 . . . . 0.0 112.261 -175.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -147.46 138.75 23.77 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 118.686 1.243 . . . . 0.0 108.52 177.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 51.3 t -134.25 121.62 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 -176.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 18.2 mt -127.41 154.66 38.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 -170.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -130.32 144.19 51.23 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 174.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.3 tt -124.96 128.21 48.25 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 173.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -111.14 156.48 15.52 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 74.4 mt -133.44 126.39 52.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -66.12 117.27 41.21 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 117.368 -1.301 . . . . 0.0 110.296 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -76.84 172.06 16.88 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.515 2.81 . . . . 0.0 111.499 170.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -128.44 -32.27 2.21 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.882 1.673 . . . . 0.0 111.103 171.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -135.55 135.21 51.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 176.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.3 t -141.22 134.85 31.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 175.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 157.81 155.1 7.38 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 177.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -64.96 153.62 40.01 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.941 0.877 . . . . 0.0 111.339 -174.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 52.88 39.64 29.42 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.036 2.134 . . . . 0.0 112.127 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -123.41 148.76 56.32 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 123.828 0.851 . . . . 0.0 109.943 173.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -82.15 163.02 17.76 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.262 2.641 . . . . 0.0 111.184 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 53.1 ttm -71.47 139.41 49.6 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 168.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 72.5 p -79.65 159.27 26.79 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.356 1.063 . . . . 0.0 110.538 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.3 tp60 -53.06 -44.54 97.31 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 116.565 -1.683 . . . . 0.0 114.197 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -68.42 -30.46 29.65 Favored 'Trans proline' 0 C--N 1.352 0.717 0 CA-C-N 122.888 2.067 . . . . 0.0 112.176 -176.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.8 -35.45 16.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 119.026 0.83 . . . . 0.0 108.788 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -56.5 -46.85 80.29 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.318 0.963 . . . . 0.0 110.074 170.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -63.94 -37.98 89.41 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 123.039 0.536 . . . . 0.0 111.203 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.69 -47.28 78.97 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 119.108 -0.472 . . . . 0.0 111.045 175.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 76.5 t -61.5 -38.56 80.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 118.915 0.779 . . . . 0.0 109.688 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -63.65 -39.2 93.74 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 119.361 0.982 . . . . 0.0 110.926 174.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 41.2 m -64.76 -45.01 88.21 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.55 -0.719 . . . . 0.0 110.092 177.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 73.8 t -62.26 -44.48 99.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.32 0.648 . . . . 0.0 109.574 176.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -55.41 -47.44 75.9 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.032 0.933 . . . . 0.0 110.521 177.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -63.77 -38.98 93.14 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 121.827 -0.546 . . . . 0.0 111.248 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -61.12 -25.57 67.07 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 118.27 -0.872 . . . . 0.0 112.534 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 94.5 mt -57.7 -23.36 51.3 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.99 1.268 . . . . 0.0 112.195 178.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -84.4 0.56 48.98 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 118.973 0.806 . . . . 0.0 112.428 -178.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -151.15 -14.51 0.08 OUTLIER Glycine 0 CA--C 1.533 1.171 0 N-CA-C 115.331 0.892 . . . . 0.0 115.331 -174.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 24.8 t90 -57.85 142.25 46.49 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.969 1.384 . . . . 0.0 109.261 172.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -140.8 15.7 2.31 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.704 1.202 . . . . 0.0 110.184 177.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 149.89 -33.89 1.04 Allowed Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.876 1.227 . . . . 0.0 111.648 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -135.51 -28.14 1.14 Allowed 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -172.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 61.07 13.35 34.22 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-N 118.931 0.787 . . . . 0.0 115.038 175.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 83.96 2.18 89.61 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-O 118.411 -1.216 . . . . 0.0 112.984 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -72.36 160.68 31.95 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 119.92 1.86 . . . . 0.0 110.159 174.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.29 153.69 21.79 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 169.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -91.29 134.61 34.44 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 173.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 56.8 tp -62.36 127.23 30.36 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 175.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -150.66 79.34 1.33 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . 0.285 27.0 m 43.89 39.08 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 127.589 2.356 . . . . 0.0 114.158 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -70.27 166.21 20.62 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.12 0.968 . . . . 0.0 110.323 172.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -144.27 155.57 43.9 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.327 1.851 . . . . 0.0 106.533 171.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 . . . . . 0 C--O 1.247 0.974 0 C-N-CA 123.528 0.731 . . . . 0.0 109.578 169.763 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.7 tpp . . . . . 0 N--CA 1.483 1.19 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 51.0 m -101.7 100.89 11.31 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 170.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -84.54 147.03 27.25 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 170.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 79.8 t -137.35 146.91 27.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 36.1 tp -121.55 128.32 51.89 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 56.0 tp -118.83 95.98 5.06 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 89.1 m -70.39 142.96 52.03 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 169.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.8 t -140.64 142.08 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.314 1.446 . . . . 0.0 107.327 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 143.53 172.61 14.5 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 123.976 0.798 . . . . 0.0 112.059 175.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -110.2 118.56 36.67 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.537 1.135 . . . . 0.0 108.16 177.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -60.53 -13.88 16.55 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.235 1.814 . . . . 0.0 115.14 -170.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 26.0 ptm -127.94 18.13 6.68 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.584 1.153 . . . . 0.0 111.246 -173.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.2 ttt -110.72 37.95 2.63 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.101 0.864 . . . . 0.0 110.055 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.83 -141.37 26.24 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -61.35 -16.77 49.47 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.498 1.519 . . . . 0.0 112.198 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -60.51 -16.06 33.33 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.17 0.988 . . . . 0.0 112.127 174.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.64 17.16 2.77 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-O 118.35 -1.25 . . . . 0.0 113.649 174.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.09 -50.43 71.96 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 119.891 1.846 . . . . 0.0 111.123 -170.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.84 -54.96 32.59 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-O 117.789 -1.562 . . . . 0.0 110.825 175.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -48.51 -40.1 37.01 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 CA-C-N 120.758 2.279 . . . . 0.0 115.206 175.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.6 tp -71.4 -37.94 71.5 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.931 1.242 . . . . 0.0 110.466 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.8 tp -61.22 -46.89 88.58 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.235 0.47 . . . . 0.0 110.033 174.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.09 -40.74 86.2 Favored 'General case' 0 C--O 1.226 -0.159 0 C-N-CA 123.71 0.804 . . . . 0.0 111.036 178.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.8 tp10 -61.71 -49.52 76.12 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.601 0.637 . . . . 0.0 109.549 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -63.74 -45.6 89.12 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.87 0.468 . . . . 0.0 110.71 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 74.0 m -65.05 -37.84 88.87 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.703 0.683 . . . . 0.0 111.172 178.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.37 -40.38 95.73 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.263 0.938 . . . . 0.0 110.876 176.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.36 -34.05 75.38 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.277 0.631 . . . . 0.0 111.705 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.12 90.52 3.51 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 125.164 1.386 . . . . 0.0 108.792 -173.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -51.64 162.01 1.8 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 124.127 3.218 . . . . 0.0 114.486 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.403 ' HE2' ' CE1' ' A' ' 136' ' ' TYR . 36.7 mmtm -134.81 156.43 48.89 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 124.538 1.135 . . . . 0.0 110.052 -178.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 38.57 -111.45 0.17 Allowed Glycine 0 CA--C 1.527 0.817 0 C-N-CA 126.394 1.949 . . . . 0.0 113.096 170.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -137.74 9.68 2.86 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.392 1.477 . . . . 0.0 111.018 -171.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -81.77 126.41 31.8 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 121.33 -0.856 . . . . 0.0 111.205 -168.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.9 t -75.27 117.77 20.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 165.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.1 t -80.13 134.51 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -177.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 84.7 mt -133.54 146.19 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 170.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -127.57 110.47 12.74 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 173.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.5 -1.38 90.2 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 119.105 -0.83 . . . . 0.0 112.864 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 56.34 -147.57 31.24 Favored Glycine 0 C--N 1.339 0.737 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 -169.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.9 p -88.66 6.78 36.8 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.522 0.729 . . . . 0.0 112.155 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.37 58.2 20.24 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.179 1.392 . . . . 0.0 109.856 -177.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -68.68 -16.15 41.85 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.844 2.363 . . . . 0.0 113.237 -169.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -57.37 -31.07 65.41 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.479 0.711 . . . . 0.0 111.882 175.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.24 -28.26 69.04 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.256 0.622 . . . . 0.0 112.157 175.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.4 -2.48 45.46 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.967 1.307 . . . . 0.0 111.936 -169.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 87.9 mt -51.71 -43.72 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 123.923 0.889 . . . . 0.0 109.915 176.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.5 t -58.26 -41.05 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.265 0.626 . . . . 0.0 110.192 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.0 -44.96 75.36 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.241 0.473 . . . . 0.0 110.674 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.2 mt -59.11 -42.26 86.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -59.88 -31.17 69.54 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 118.061 -0.971 . . . . 0.0 111.847 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -59.97 -31.76 70.19 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.985 1.266 . . . . 0.0 111.133 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.6 mt -81.99 -13.0 58.04 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.176 0.99 . . . . 0.0 112.095 -175.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 72.8 mtp180 33.15 61.79 1.56 Allowed Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 126.552 1.941 . . . . 0.0 111.721 -169.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -53.88 143.2 61.14 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.008 2.472 . . . . 0.0 113.074 -169.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.4 m -72.81 -38.8 67.07 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 167.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 71.4 mtm180 -144.45 156.87 44.4 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 124.455 1.102 . . . . 0.0 108.969 176.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 45.6 tp -137.72 140.24 40.61 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.4 tp -126.24 136.38 52.73 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 174.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.0 mt -125.07 142.06 43.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 -174.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.1 t -141.56 133.77 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 118.806 0.73 . . . . 0.0 110.846 -174.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -161.36 172.21 16.96 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.565 2.346 . . . . 0.0 107.647 169.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.45 156.81 38.26 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.011 -1.056 . . . . 0.0 108.895 168.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.0 m -156.15 129.18 8.0 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 177.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -71.84 124.64 25.26 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 173.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 74.2 mtm -123.6 1.51 8.88 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.16 1.784 . . . . 0.0 110.766 -177.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.64 24.45 66.2 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-N 118.683 0.674 . . . . 0.0 112.423 -172.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.9 mt -95.74 -173.69 2.93 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.223 1.409 . . . . 0.0 109.333 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -73.38 140.4 79.27 Favored Pre-proline 0 N--CA 1.466 0.355 0 CA-C-O 117.72 -1.133 . . . . 0.0 108.18 170.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -44.23 136.59 8.07 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.258 2.639 . . . . 0.0 112.748 173.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.27 1.97 82.36 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-O 118.501 -1.166 . . . . 0.0 113.796 177.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -67.89 152.21 45.92 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 120.135 1.968 . . . . 0.0 108.257 168.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 51.5 mt -131.5 134.67 60.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -169.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.6 mmt-85 -147.01 148.85 32.11 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 118.721 0.691 . . . . 0.0 109.772 175.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 44.3 mm -73.79 152.85 7.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 166.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.9 mt -135.18 134.74 52.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 176.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -79.02 143.4 61.38 Favored Pre-proline 0 N--CA 1.472 0.661 0 CA-C-O 117.4 -1.286 . . . . 0.0 109.256 173.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo -45.47 -38.22 15.73 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 124.029 3.152 . . . . 0.0 116.439 176.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -68.04 -26.34 65.82 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.363 0.529 . . . . 0.0 111.523 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -94.35 -29.91 14.78 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.786 1.235 . . . . 0.0 111.232 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 59.9 mt -51.71 -45.59 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.15 1.38 . . . . 0.0 109.339 170.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -52.96 -31.35 40.0 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.292 1.037 . . . . 0.0 112.898 -177.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -96.8 -37.63 10.19 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.328 0.651 . . . . 0.0 110.328 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 24.8 mmt -80.64 -27.08 37.32 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 119.09 -0.481 . . . . 0.0 112.249 -170.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -64.8 -45.9 84.31 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 119.187 0.903 . . . . 0.0 110.286 175.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 20.2 ptt? -71.4 -7.63 48.51 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 45.0 tpp -59.18 -26.81 65.11 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.888 0.875 . . . . 0.0 112.106 -175.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 22.6 p -59.51 -55.53 33.36 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.163 0.985 . . . . 0.0 110.286 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -165.98 -46.51 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.776 1.63 . . . . 0.0 110.334 174.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -157.41 -44.39 0.07 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.728 0.811 . . . . 0.0 110.452 -179.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 47.8 -138.87 0.71 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.9 1.28 . . . . 0.0 110.567 176.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 71.0 mtm -139.66 144.15 38.07 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 169.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.21 55.48 5.08 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 124.233 3.289 . . . . 0.0 111.046 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.1 mt -48.68 -9.84 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 129.182 2.993 . . . . 0.0 117.836 -167.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.95 -20.34 6.01 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.31 0.959 . . . . 0.0 112.055 167.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -59.91 -27.18 66.52 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.557 1.071 . . . . 0.0 112.582 173.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.7 tt -63.35 -49.42 73.98 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 119.141 0.882 . . . . 0.0 108.909 172.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 84.1 mt -64.82 -43.21 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -63.54 -19.65 64.97 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -175.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -102.55 8.77 39.78 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.176 1.39 . . . . 0.0 111.781 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.6 tp -140.31 -25.77 0.78 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.826 0.851 . . . . 0.0 112.163 -170.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 50.5 pttt -56.01 -24.66 40.4 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.51 1.524 . . . . 0.0 112.271 172.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -62.4 -17.07 58.31 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.996 1.318 . . . . 0.0 112.635 -172.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -130.15 9.12 5.21 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.646 0.778 . . . . 0.0 112.584 -175.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 56.3 mt -122.96 143.14 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.894 1.278 . . . . 0.0 108.409 -175.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -73.43 -37.01 54.14 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.868 0.747 . . . . 0.0 112.027 -177.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -149.43 136.56 19.83 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 118.226 1.013 . . . . 0.0 108.508 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 43.8 t -122.24 128.92 75.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 171.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.8 mt -126.64 149.26 31.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 -169.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -131.31 144.46 51.28 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 169.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.1 tt -124.56 127.79 47.94 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.45 1.5 . . . . 0.0 107.045 174.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -109.77 155.82 15.9 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 78.4 mt -133.78 127.69 52.82 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 -178.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 69.1 tp60 -61.77 114.79 12.28 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-O 117.467 -1.254 . . . . 0.0 110.517 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -77.34 171.46 17.66 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.402 2.735 . . . . 0.0 111.188 170.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -138.24 -26.93 0.9 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 127.088 2.155 . . . . 0.0 111.536 173.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -136.77 120.12 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 -173.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.5 t -143.22 129.4 16.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 156.76 151.75 6.07 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -63.21 145.28 55.84 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.421 0.629 . . . . 0.0 110.765 -174.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 64.83 0.08 1.1 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 128.199 2.6 . . . . 0.0 113.834 -175.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 19.3 m-30 -77.28 142.51 67.88 Favored Pre-proline 0 C--O 1.237 0.418 0 CA-C-N 120.309 1.413 . . . . 0.0 109.133 174.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -73.61 158.29 47.58 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.48 2.12 . . . . 0.0 109.914 169.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 47.3 ttm -73.88 142.78 46.0 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 168.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 29.9 p -81.12 155.09 26.42 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.082 0.953 . . . . 0.0 110.798 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -53.69 -40.43 80.64 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-O 116.529 -1.7 . . . . 0.0 114.729 -178.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -63.68 -39.68 33.57 Favored 'Trans proline' 0 C--N 1.35 0.647 0 CA-C-N 122.819 2.043 . . . . 0.0 111.291 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.6 mp -73.21 -37.53 52.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -57.19 -47.06 82.21 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.35 0.977 . . . . 0.0 110.305 172.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -63.99 -39.25 93.7 Favored 'General case' 0 C--N 1.334 -0.095 0 C-N-CA 122.959 0.504 . . . . 0.0 110.903 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.59 -46.68 84.72 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 122.994 0.517 . . . . 0.0 111.095 176.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 52.7 t -59.94 -41.31 85.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -67.69 -27.88 67.21 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 118.843 0.747 . . . . 0.0 111.858 177.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 36.7 m -71.13 -41.86 69.95 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.366 -0.833 . . . . 0.0 109.952 174.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 98.2 t -62.73 -48.7 86.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 119.2 0.909 . . . . 0.0 108.761 173.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.403 ' CE1' ' HE2' ' A' ' 31' ' ' LYS . 18.0 t80 -50.91 -50.17 57.99 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.655 1.182 . . . . 0.0 111.301 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -73.18 -31.71 64.38 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.915 0.779 . . . . 0.0 111.988 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -61.3 -38.01 85.27 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.077 0.853 . . . . 0.0 110.642 176.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 75.7 mt -55.7 -20.48 14.47 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -174.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -72.57 -29.07 63.22 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.649 1.113 . . . . 0.0 112.352 177.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -131.13 1.87 5.44 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.544 1.069 . . . . 0.0 113.561 -171.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -52.21 136.9 29.44 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 126.297 1.839 . . . . 0.0 109.561 173.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -146.19 149.95 34.93 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 167.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 50.47 -118.21 5.9 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.157 0.884 . . . . 0.0 111.666 -177.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -76.47 -0.49 23.15 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.574 1.149 . . . . 0.0 113.134 -176.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 74.37 16.56 79.85 Favored Glycine 0 CA--C 1.527 0.811 0 O-C-N 121.347 -0.846 . . . . 0.0 113.066 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.66 -15.94 2.02 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-N 118.368 1.084 . . . . 0.0 113.471 -176.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -66.54 147.37 53.37 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.987 1.315 . . . . 0.0 109.412 174.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.88 155.65 37.26 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.784 0.834 . . . . 0.0 109.0 170.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -92.18 140.8 29.26 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 173.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 52.0 tp -64.44 117.25 7.03 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.969 1.308 . . . . 0.0 107.806 173.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -152.61 50.45 0.75 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.9 t 50.79 37.4 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 126.052 1.741 . . . . 0.0 111.241 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 51.03 34.18 10.34 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.116 1.767 . . . . 0.0 113.356 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -134.38 34.95 3.23 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.659 1.584 . . . . 0.0 109.846 174.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 . . . . . 0 C--O 1.252 1.212 0 C-N-CA 125.378 1.471 . . . . 0.0 109.87 169.895 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ttt . . . . . 0 N--CA 1.482 1.164 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 44.4 m -129.19 136.94 50.81 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 169.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -139.54 101.02 4.12 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -168.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 55.4 t -92.74 145.96 6.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -169.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 50.4 tp -119.76 98.19 5.99 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 172.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.9 tp -90.07 106.12 18.27 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -75.49 150.41 38.22 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 172.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.9 t -142.27 140.05 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 143.66 172.6 14.59 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.017 0.818 . . . . 0.0 112.135 176.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -116.67 120.25 38.05 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.92 1.288 . . . . 0.0 108.257 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 m -59.43 -13.72 9.69 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.644 1.977 . . . . 0.0 115.529 -169.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.1 ptt? -129.83 12.36 5.74 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 119.239 0.927 . . . . 0.0 111.485 -176.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.6 ttt -96.99 34.27 1.76 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.718 0.69 . . . . 0.0 110.002 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.37 -140.81 22.4 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -178.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -62.73 -15.98 55.47 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 124.387 1.075 . . . . 0.0 112.293 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -59.1 -17.81 29.79 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.961 1.304 . . . . 0.0 112.729 175.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.08 19.02 1.07 Allowed Glycine 0 CA--C 1.534 1.248 0 O-C-N 120.693 -1.254 . . . . 0.0 114.033 176.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.14 -49.98 73.69 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.572 1.686 . . . . 0.0 110.819 -170.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.68 -55.78 28.57 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.076 -1.402 . . . . 0.0 111.191 175.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -48.58 -42.75 35.17 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 CA-C-N 120.275 2.037 . . . . 0.0 115.487 176.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.6 tp -70.68 -37.15 73.6 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 120.217 1.371 . . . . 0.0 110.448 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 51.1 tp -61.41 -49.56 76.38 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.159 0.436 . . . . 0.0 110.108 175.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.79 -36.87 82.35 Favored 'General case' 0 C--O 1.227 -0.12 0 CA-C-O 118.594 -0.717 . . . . 0.0 111.774 178.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -60.59 -48.59 81.12 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 119.058 0.845 . . . . 0.0 109.682 176.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -62.01 -44.59 96.39 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 122.938 0.495 . . . . 0.0 110.605 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 75.0 m -62.62 -43.85 97.78 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 118.495 0.589 . . . . 0.0 111.023 177.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.44 -40.3 96.14 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.085 0.554 . . . . 0.0 110.787 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.21 -31.88 70.76 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.387 0.675 . . . . 0.0 111.951 177.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.73 93.09 2.17 Favored Pre-proline 0 CA--C 1.537 0.481 0 C-N-CA 124.93 1.292 . . . . 0.0 108.742 -171.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -55.64 158.13 14.0 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.819 2.346 . . . . 0.0 112.486 177.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -131.67 173.47 11.1 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.467 1.507 . . . . 0.0 108.892 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 37.93 -119.48 0.76 Allowed Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.216 1.389 . . . . 0.0 111.929 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -142.91 40.89 1.53 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.092 1.357 . . . . 0.0 108.592 169.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -76.54 165.06 25.31 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.705 0.764 . . . . 0.0 111.573 -170.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.3 t -120.41 84.41 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 104.478 -2.416 . . . . 0.0 104.478 167.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.2 p -64.97 143.57 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 O-C-N 121.596 -0.69 . . . . 0.0 109.386 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.2 mt -132.12 128.15 58.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -83.92 78.78 9.67 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.05 0.94 . . . . 0.0 109.312 172.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -66.35 -29.69 75.31 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.604 -0.599 . . . . 0.0 111.604 176.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 55.65 -140.03 41.44 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 175.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.9 p -88.18 1.54 54.19 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.726 0.81 . . . . 0.0 112.949 -171.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -145.18 61.46 7.97 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 124.583 1.153 . . . . 0.0 110.183 178.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -66.22 -15.37 48.06 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 122.679 2.253 . . . . 0.0 112.646 -175.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -47.88 -40.37 21.45 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.751 1.621 . . . . 0.0 111.011 169.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -64.65 -31.2 72.32 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 122.097 -0.377 . . . . 0.0 111.959 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -89.28 -9.17 51.61 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.2 1.0 . . . . 0.0 111.329 -169.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.7 mt -52.86 -40.07 34.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 123.811 0.845 . . . . 0.0 109.211 169.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.1 t -60.21 -40.84 84.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.041 0.537 . . . . 0.0 110.145 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.53 -47.49 63.56 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.836 0.454 . . . . 0.0 110.102 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 95.4 mt -53.55 -41.58 46.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.222 1.009 . . . . 0.0 110.079 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -66.34 -18.99 65.68 Favored 'General case' 0 CA--C 1.53 0.173 0 O-C-N 121.05 -1.031 . . . . 0.0 112.725 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -72.64 -40.7 66.21 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 120.228 1.376 . . . . 0.0 109.379 169.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 60.2 mt -73.72 -29.05 62.02 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.434 1.094 . . . . 0.0 111.934 -174.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 39.6 60.18 6.29 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 125.941 1.696 . . . . 0.0 111.877 -169.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.02 153.56 31.52 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.757 2.305 . . . . 0.0 114.043 -170.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.5 m -70.9 -37.81 72.98 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 168.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -148.59 155.5 41.18 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.038 0.935 . . . . 0.0 109.454 -174.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.6 tp -144.67 136.56 25.87 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.651 1.181 . . . . 0.0 108.347 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 58.5 tp -122.4 140.02 53.17 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 169.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.3 mt -124.06 143.17 38.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 41.4 t -141.07 135.33 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 118.571 0.623 . . . . 0.0 109.778 -173.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -163.96 171.8 14.79 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.52 2.328 . . . . 0.0 107.495 173.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.03 157.66 37.84 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.575 -0.703 . . . . 0.0 109.16 168.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.6 m -152.32 127.89 10.07 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -78.07 80.1 4.51 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 119.099 0.863 . . . . 0.0 110.222 176.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 73.7 mtm -75.47 -6.45 50.22 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.033 1.733 . . . . 0.0 112.379 -177.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.62 23.25 78.27 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-N 118.621 0.646 . . . . 0.0 111.822 -172.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.9 mt -100.33 -171.66 2.07 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.889 1.276 . . . . 0.0 109.948 -178.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -74.89 139.99 73.85 Favored Pre-proline 0 N--CA 1.468 0.451 0 CA-C-O 117.431 -1.271 . . . . 0.0 108.612 170.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -43.07 137.44 4.66 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.316 2.677 . . . . 0.0 113.31 172.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.45 0.58 79.32 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 118.641 -1.089 . . . . 0.0 113.646 176.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -65.05 146.57 54.83 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 119.82 1.81 . . . . 0.0 108.243 168.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.6 mt -125.94 138.44 54.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -175.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 91.0 mmt-85 -147.69 152.49 37.9 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 118.69 0.677 . . . . 0.0 111.442 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 37.3 mm -78.78 145.33 9.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 105.828 -1.915 . . . . 0.0 105.828 165.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.5 mt -129.61 124.14 58.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -76.8 140.68 67.56 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 117.859 -1.067 . . . . 0.0 109.586 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -47.42 -34.28 18.94 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 124.086 3.191 . . . . 0.0 116.581 179.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -67.74 -22.91 65.2 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.596 0.634 . . . . 0.0 111.806 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -101.54 -30.9 11.13 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.177 1.391 . . . . 0.0 111.35 -178.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 68.8 mt -50.41 -38.59 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.707 1.203 . . . . 0.0 109.547 169.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.22 -20.19 6.48 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.917 1.687 . . . . 0.0 114.285 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -124.76 -38.76 2.34 Favored 'General case' 0 C--N 1.334 -0.067 0 CA-C-N 118.811 0.732 . . . . 0.0 110.638 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 10.9 mmt -68.12 -24.48 65.02 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -172.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -74.78 -45.35 44.25 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 119.358 0.981 . . . . 0.0 111.066 173.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -78.56 6.23 9.13 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.732 -0.605 . . . . 0.0 112.583 177.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 50.4 tpp -58.7 -26.39 63.84 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.197 0.908 . . . . 0.0 110.115 168.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 42.4 p -59.22 -14.89 12.36 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.23 1.812 . . . . 0.0 113.059 169.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.7 m 61.4 23.25 13.53 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 126.325 1.85 . . . . 0.0 110.734 -168.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 59.8 m80 -147.43 -53.84 0.22 Allowed 'General case' 0 C--N 1.344 0.355 0 O-C-N 121.409 -0.807 . . . . 0.0 112.929 -171.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -68.23 150.0 48.83 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 118.155 0.434 . . . . 0.0 110.412 -169.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 90.8 mmm -63.12 150.53 88.51 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 171.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -73.06 82.32 1.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.708 2.939 . . . . 0.0 108.639 170.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 mt -50.05 -10.43 0.05 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 117.235 2.309 . . . . 0.0 117.235 -168.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.1 -21.13 4.37 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.093 0.957 . . . . 0.0 112.783 168.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -59.57 -29.49 67.97 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.453 1.024 . . . . 0.0 112.04 174.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.7 tt -76.62 -43.57 37.76 Favored 'General case' 0 C--N 1.338 0.103 0 O-C-N 121.399 -0.813 . . . . 0.0 109.667 175.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 77.7 mt -60.47 -43.93 95.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 C-N-CA 123.409 0.684 . . . . 0.0 109.299 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -60.79 -25.43 66.54 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -177.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -82.68 -3.09 55.82 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.879 0.872 . . . . 0.0 112.47 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.0 mt -134.89 -28.4 1.21 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.099 0.959 . . . . 0.0 112.626 -171.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -60.63 -22.04 63.38 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.149 0.98 . . . . 0.0 112.668 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -72.03 -10.25 59.52 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.623 1.169 . . . . 0.0 111.834 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -133.08 -42.57 0.88 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.433 1.093 . . . . 0.0 111.949 -173.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 29.0 mt -72.26 141.4 16.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -64.69 -41.86 97.5 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.119 0.866 . . . . 0.0 112.037 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -149.47 138.37 21.14 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.635 1.218 . . . . 0.0 108.906 176.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 54.0 t -131.28 124.98 56.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 16.9 mt -129.79 154.45 40.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -171.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -129.82 140.63 50.98 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 173.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.0 tt -120.09 129.72 54.32 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 174.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -112.58 156.55 15.52 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 68.8 mt -134.07 124.78 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 -177.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -65.28 118.1 46.69 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-O 117.423 -1.275 . . . . 0.0 110.363 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -77.15 172.05 16.77 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.656 2.904 . . . . 0.0 111.572 171.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -128.84 -31.96 2.14 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.785 1.634 . . . . 0.0 110.974 172.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.15 136.38 49.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.415 1.086 . . . . 0.0 108.269 175.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.1 t -141.1 134.36 31.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 175.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 159.7 151.55 6.2 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -64.71 157.98 25.91 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 117.642 0.721 . . . . 0.0 111.608 -175.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . 0.253 44.1 p90 44.37 41.4 4.49 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.333 2.253 . . . . 0.0 113.072 -174.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -121.51 148.41 50.12 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 123.95 0.9 . . . . 0.0 109.919 172.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -81.06 163.06 20.38 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.238 2.625 . . . . 0.0 111.259 177.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 54.2 ttm -72.22 139.66 48.28 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 168.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 68.3 p -80.6 159.88 25.28 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.365 1.066 . . . . 0.0 110.603 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.1 tm0? -51.23 -48.6 85.18 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-O 117.011 -1.471 . . . . 0.0 113.303 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -67.7 -29.64 35.65 Favored 'Trans proline' 0 C--N 1.352 0.727 0 CA-C-N 122.55 1.946 . . . . 0.0 112.423 -174.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -80.35 -35.32 15.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 119.046 0.839 . . . . 0.0 108.937 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -56.67 -46.78 80.93 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.418 1.008 . . . . 0.0 109.89 170.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -62.98 -38.57 91.66 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 122.961 0.504 . . . . 0.0 111.517 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.84 -46.74 80.62 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 119.193 -0.432 . . . . 0.0 111.017 176.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 73.8 t -62.25 -39.41 83.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 118.883 0.765 . . . . 0.0 109.81 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 34.6 tp10 -61.69 -40.98 96.92 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.031 0.832 . . . . 0.0 110.56 174.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 50.2 m -63.84 -45.87 87.59 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.06 0.544 . . . . 0.0 110.063 177.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 76.6 t -62.56 -44.17 99.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 118.831 0.741 . . . . 0.0 109.605 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -55.05 -46.95 75.4 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.317 1.047 . . . . 0.0 110.611 176.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -63.72 -39.7 94.94 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.659 0.663 . . . . 0.0 110.989 175.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.13 -26.06 67.43 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.421 0.688 . . . . 0.0 112.647 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 91.3 mt -57.11 -22.81 42.53 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.184 0.902 . . . . 0.0 112.231 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -81.43 -3.07 51.81 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.277 1.031 . . . . 0.0 112.166 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -152.01 -14.71 0.07 OUTLIER Glycine 0 CA--C 1.535 1.307 0 N-CA-C 115.962 1.145 . . . . 0.0 115.962 -172.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 15.7 t90 -59.71 141.66 54.7 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.573 1.686 . . . . 0.0 109.031 170.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -138.84 15.09 2.68 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.614 1.165 . . . . 0.0 111.407 173.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 156.53 -37.8 0.58 Allowed Glycine 0 CA--C 1.525 0.699 0 O-C-N 121.361 -0.837 . . . . 0.0 111.618 176.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -130.77 -26.76 2.18 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.781 0.659 . . . . 0.0 112.781 -174.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 57.45 17.08 24.36 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-N 118.675 0.671 . . . . 0.0 114.5 178.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.36 2.96 81.43 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-N 118.814 1.307 . . . . 0.0 113.531 -177.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -71.89 158.85 35.3 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 120.101 1.95 . . . . 0.0 110.153 175.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -80.81 149.71 29.47 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 171.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -88.98 123.07 32.97 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 173.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 62.9 tp -53.9 118.09 3.71 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.158 1.383 . . . . 0.0 109.925 177.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -151.66 102.85 2.9 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.642 0.777 . . . . 0.0 109.558 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . 0.263 33.9 m 40.64 46.56 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 127.27 2.228 . . . . 0.0 114.261 171.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -79.45 62.11 3.68 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.891 1.276 . . . . 0.0 109.924 -177.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 57.51 32.06 21.23 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.544 1.938 . . . . 0.0 112.271 -177.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 . . . . . 0 C--O 1.248 0.976 0 C-N-CA 126.676 1.99 . . . . 0.0 105.783 171.546 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.1 mtp . . . . . 0 N--CA 1.484 1.261 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.0 m -146.73 164.95 31.11 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.94 1.296 . . . . 0.0 107.82 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -144.44 133.34 22.56 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.8 m -132.92 154.73 40.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 124.002 0.921 . . . . 0.0 110.541 -169.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 30.6 tp -125.66 117.21 23.03 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 174.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 64.8 tp -104.74 97.52 7.39 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 96.9 m -73.15 143.73 47.16 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 169.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.0 t -142.16 144.47 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 175.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 147.64 174.48 19.6 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 124.653 1.121 . . . . 0.0 110.335 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -121.83 120.22 33.92 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 174.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 m -58.93 -12.95 5.13 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.446 1.898 . . . . 0.0 115.545 -169.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -129.61 12.82 5.91 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 119.321 0.964 . . . . 0.0 111.226 -177.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.8 ttt -94.32 32.17 1.59 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.868 0.758 . . . . 0.0 109.589 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.05 -145.12 26.75 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 -175.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -59.34 -18.06 34.88 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 125.952 1.701 . . . . 0.0 112.308 178.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -53.89 -25.58 20.77 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.819 1.248 . . . . 0.0 112.676 175.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.76 25.01 0.64 Allowed Glycine 0 CA--C 1.532 1.148 0 CA-C-O 118.7 -1.055 . . . . 0.0 114.277 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.08 -50.67 67.44 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 119.474 1.637 . . . . 0.0 110.432 -170.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.24 -55.64 29.0 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-O 117.881 -1.511 . . . . 0.0 110.98 175.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -50.65 -37.98 54.61 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 CA-C-N 121.106 2.453 . . . . 0.0 114.77 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.9 tp -71.75 -38.88 70.33 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 120.014 1.279 . . . . 0.0 110.509 176.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.1 tp -60.44 -47.65 85.19 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.341 0.518 . . . . 0.0 110.216 175.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.67 -40.96 85.05 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.479 1.111 . . . . 0.0 110.975 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.0 tp10 -61.97 -49.68 75.11 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-N 118.717 0.69 . . . . 0.0 109.693 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -63.64 -45.3 90.87 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.729 0.412 . . . . 0.0 110.81 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 75.5 m -65.32 -38.35 89.89 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.566 0.621 . . . . 0.0 111.094 178.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.91 -39.84 95.1 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.248 0.931 . . . . 0.0 110.906 176.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.41 -33.87 75.0 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.261 0.624 . . . . 0.0 111.805 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.47 91.08 3.35 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 125.141 1.376 . . . . 0.0 108.767 -173.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -51.66 161.32 2.13 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 124.035 3.157 . . . . 0.0 114.852 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -137.98 158.78 43.63 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.345 1.458 . . . . 0.0 108.969 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 41.44 -120.15 1.86 Allowed Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.362 1.458 . . . . 0.0 111.737 175.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -136.79 16.26 3.09 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.685 1.194 . . . . 0.0 110.787 174.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 2.0 m95 -75.0 120.29 20.34 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 121.324 -0.86 . . . . 0.0 109.018 -170.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.7 t -71.02 111.12 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 168.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.3 t -71.33 138.33 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -177.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 98.5 mt -135.91 142.73 38.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 104.03 -2.581 . . . . 0.0 104.03 173.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -126.37 107.04 9.92 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 175.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.3 -11.38 71.29 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 118.523 -1.154 . . . . 0.0 113.391 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.17 34.64 80.7 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-N 119.425 1.612 . . . . 0.0 113.713 170.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 63.23 14.04 7.43 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.007 1.723 . . . . 0.0 114.242 -174.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.79 56.88 12.11 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 125.385 1.474 . . . . 0.0 108.057 169.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -68.58 -15.41 41.37 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.396 2.064 . . . . 0.0 113.128 -168.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -51.45 -34.14 33.99 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.086 0.857 . . . . 0.0 112.074 170.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.17 -26.4 68.31 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.215 0.606 . . . . 0.0 112.289 177.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -103.0 -5.66 23.18 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.956 1.302 . . . . 0.0 111.403 -170.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 73.9 mt -55.47 -41.63 64.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 119.112 0.869 . . . . 0.0 109.604 174.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.6 t -60.3 -41.21 86.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 118.524 0.602 . . . . 0.0 109.797 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.76 -45.19 83.47 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.87 0.468 . . . . 0.0 110.38 -178.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 90.2 mt -56.43 -48.38 80.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -63.02 -34.52 77.73 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 118.206 -0.902 . . . . 0.0 112.005 -174.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -58.01 -32.2 67.71 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.482 1.037 . . . . 0.0 111.537 175.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 78.9 mt -84.75 -8.65 58.75 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.174 0.99 . . . . 0.0 112.703 -175.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 27.74 62.26 0.64 Allowed Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 126.892 2.077 . . . . 0.0 112.794 -168.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.33 149.62 63.89 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.246 1.964 . . . . 0.0 113.543 -173.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.49 -26.43 35.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.784 168.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -145.21 151.32 38.22 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.811 0.844 . . . . 0.0 109.841 177.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 25.1 tp -140.91 141.31 34.56 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 125.551 1.54 . . . . 0.0 108.132 172.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 34.3 tp -129.34 138.88 51.81 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 171.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.8 mt -124.66 141.37 44.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 -174.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.9 t -140.86 133.47 30.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 118.728 0.694 . . . . 0.0 109.898 -174.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -161.28 172.44 16.63 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.442 2.297 . . . . 0.0 107.122 174.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.27 158.28 36.16 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.157 -0.965 . . . . 0.0 108.622 167.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.5 m -153.23 129.22 10.3 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 174.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -77.03 80.59 3.56 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.705 0.764 . . . . 0.0 109.94 175.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 76.3 mtm -76.46 -6.76 53.13 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.313 1.445 . . . . 0.0 112.241 -174.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.58 31.28 60.89 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -172.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 77.3 mt -110.97 -170.8 1.7 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.745 1.218 . . . . 0.0 109.722 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -81.14 140.82 49.61 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 117.668 -1.158 . . . . 0.0 108.84 174.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -46.51 132.94 16.34 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.198 2.599 . . . . 0.0 113.614 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.58 1.33 90.1 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 118.506 -1.164 . . . . 0.0 113.412 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -65.65 153.79 40.65 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 119.902 1.851 . . . . 0.0 108.49 168.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 62.3 mt -132.74 140.95 46.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -170.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 82.3 mmt-85 -149.44 152.98 36.59 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.365 0.666 . . . . 0.0 109.981 170.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 35.8 mm -77.29 145.33 10.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 165.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.3 mt -129.57 161.97 38.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 176.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -131.14 144.78 54.95 Favored Pre-proline 0 C--O 1.234 0.288 0 C-N-CA 126.519 1.928 . . . . 0.0 107.181 -171.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -54.28 -27.97 50.43 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 123.18 2.586 . . . . 0.0 115.139 -174.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -68.96 -19.98 64.18 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.948 0.794 . . . . 0.0 112.197 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -117.01 -30.88 5.56 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.164 1.386 . . . . 0.0 111.771 -171.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 65.6 mt -50.15 -40.87 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.268 1.427 . . . . 0.0 109.78 169.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.25 -26.13 37.92 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.822 1.249 . . . . 0.0 113.458 -176.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -108.14 -39.42 5.5 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 123.337 0.655 . . . . 0.0 110.021 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 21.4 mmt -69.21 -26.32 64.76 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -174.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -72.13 -46.37 56.83 Favored 'General case' 0 C--O 1.228 -0.052 0 CA-C-N 119.109 0.868 . . . . 0.0 110.799 174.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 27.6 ptm -74.94 9.23 2.01 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -176.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 76.7 mmm -53.88 -28.41 36.15 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.635 1.174 . . . . 0.0 111.977 171.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 30.9 p -76.56 32.69 0.13 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.361 1.864 . . . . 0.0 112.064 -178.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.4 m 68.87 -41.5 0.47 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 128.644 2.778 . . . . 0.0 112.081 -169.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -152.01 152.52 32.55 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.925 1.69 . . . . 0.0 107.084 169.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -163.44 175.37 10.85 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.828 1.251 . . . . 0.0 107.933 174.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 65.9 mtt -70.37 127.01 92.48 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 168.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -76.91 71.6 6.12 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 123.312 2.675 . . . . 0.0 108.603 173.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.1 mt -49.3 -14.86 0.1 Allowed 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 116.939 2.2 . . . . 0.0 116.939 -167.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.47 -20.31 4.62 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 117.878 -1.058 . . . . 0.0 113.02 168.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -54.77 -35.74 64.12 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 119.967 1.258 . . . . 0.0 111.517 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.8 tt -75.38 -44.09 46.7 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.329 0.652 . . . . 0.0 109.592 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 94.3 mt -62.95 -44.11 99.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -64.67 -17.65 64.26 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -171.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -109.6 13.68 23.76 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.306 1.043 . . . . 0.0 112.085 178.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 72.8 mt -129.5 -34.48 1.8 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.178 1.391 . . . . 0.0 110.783 177.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -57.5 -22.17 42.39 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.265 1.426 . . . . 0.0 112.693 176.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -70.16 -14.84 62.82 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.656 1.182 . . . . 0.0 111.931 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -137.52 -32.31 0.77 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.144 0.883 . . . . 0.0 113.045 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 32.5 mt -70.46 138.26 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 174.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -64.24 -42.87 97.71 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.268 0.937 . . . . 0.0 112.385 -176.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -144.75 134.62 23.72 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.664 1.232 . . . . 0.0 108.336 175.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 47.8 t -125.95 127.8 71.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 177.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.9 mt -130.84 153.29 38.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 -168.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -133.17 145.56 50.75 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 175.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.1 tt -127.87 133.46 49.34 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 171.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -114.16 157.06 15.22 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 80.8 mt -134.47 126.88 49.31 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -65.04 116.52 30.71 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-O 117.583 -1.199 . . . . 0.0 110.372 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -79.17 173.5 13.29 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.247 2.631 . . . . 0.0 111.789 171.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -136.71 -28.7 0.97 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.373 2.269 . . . . 0.0 111.382 172.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -132.42 119.63 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 -173.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.3 t -143.67 131.78 18.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 153.54 152.82 6.16 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -67.12 150.89 48.54 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.974 0.893 . . . . 0.0 111.27 -174.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 13.0 t80 51.69 40.67 27.9 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.839 2.055 . . . . 0.0 112.107 -174.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.4 m-30 -115.79 142.54 29.18 Favored Pre-proline 0 C--O 1.237 0.434 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 170.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -74.27 160.44 42.22 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.636 2.224 . . . . 0.0 110.46 170.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.1 ttm -74.69 141.98 44.49 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 169.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 39.9 p -79.53 157.42 27.42 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.426 1.091 . . . . 0.0 110.653 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -52.55 -42.47 88.39 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-O 116.579 -1.677 . . . . 0.0 114.721 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -70.81 -28.55 20.08 Favored 'Trans proline' 0 C--N 1.351 0.707 0 CA-C-N 123.043 2.123 . . . . 0.0 111.883 -175.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.23 -36.53 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -56.68 -45.93 81.43 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.297 0.953 . . . . 0.0 110.091 170.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -63.34 -41.6 98.89 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 123.064 0.546 . . . . 0.0 111.117 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.69 -47.09 85.13 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.833 0.453 . . . . 0.0 111.043 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.0 t -60.81 -42.33 91.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 177.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -68.26 -28.27 67.06 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.874 0.761 . . . . 0.0 111.602 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 42.9 m -69.03 -46.29 68.3 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.214 -0.929 . . . . 0.0 109.492 173.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 90.1 t -61.65 -43.43 97.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 119.111 0.869 . . . . 0.0 109.597 176.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -52.96 -46.12 68.07 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.209 1.004 . . . . 0.0 111.227 175.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -66.11 -42.43 89.23 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.628 0.649 . . . . 0.0 111.003 175.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -58.4 -37.31 75.05 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.882 0.873 . . . . 0.0 111.76 -175.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 72.1 mt -57.21 -18.59 16.49 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.154 0.982 . . . . 0.0 113.137 -175.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -77.29 -24.12 50.99 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.671 1.123 . . . . 0.0 112.431 177.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -139.14 3.0 2.7 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-N 118.93 0.786 . . . . 0.0 114.45 -169.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -54.43 133.74 45.71 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.699 1.6 . . . . 0.0 109.208 173.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -139.14 149.4 44.45 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 169.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 51.38 -121.67 12.86 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 123.995 0.807 . . . . 0.0 111.749 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -76.29 5.53 6.88 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.768 1.227 . . . . 0.0 112.957 -178.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 68.96 15.16 69.03 Favored Glycine 0 CA--C 1.528 0.856 0 O-C-N 121.068 -1.02 . . . . 0.0 112.529 -176.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 69.06 -9.47 2.07 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-N 118.642 1.221 . . . . 0.0 113.844 -174.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -68.81 156.44 38.37 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.103 1.451 . . . . 0.0 109.27 173.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -78.24 151.86 32.87 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 172.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -98.19 119.74 37.38 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 55.1 tp -57.05 130.42 46.04 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.262 1.425 . . . . 0.0 110.301 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.91 -50.4 0.65 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.073 0.949 . . . . 0.0 111.86 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 8.5 p -157.53 -0.97 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 123.74 0.816 . . . . 0.0 112.47 -169.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -63.95 155.05 32.13 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.337 -0.852 . . . . 0.0 111.617 -170.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -148.21 141.89 25.57 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 169.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 . . . . . 0 C--O 1.249 1.066 0 C-N-CA 124.791 1.236 . . . . 0.0 107.733 -175.966 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 N--CA 1.483 1.194 0 CA-C-O 118.616 -0.707 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.5 m -145.8 159.83 42.63 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.374 0.988 . . . . 0.0 108.413 -176.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -134.91 137.68 43.4 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 174.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 51.2 t -139.42 151.8 22.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 119.003 0.82 . . . . 0.0 109.921 -167.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 33.7 tp -126.2 129.86 49.82 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 126.069 1.748 . . . . 0.0 106.402 176.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.9 tp -117.31 100.95 8.03 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 124.915 1.286 . . . . 0.0 107.886 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 89.4 m -76.04 141.23 42.15 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 169.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 50.9 t -139.96 142.93 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 143.18 174.39 15.43 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.252 0.93 . . . . 0.0 111.709 176.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -118.32 120.16 36.8 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.7 1.2 . . . . 0.0 108.869 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -59.67 -15.97 23.12 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.356 1.862 . . . . 0.0 115.228 -170.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 27.7 ptm -126.88 14.47 7.42 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.206 1.003 . . . . 0.0 111.167 -175.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.2 ttt -101.78 31.58 3.78 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.41 0.684 . . . . 0.0 110.048 -177.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.29 -142.49 21.3 Favored Glycine 0 C--N 1.337 0.584 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -60.26 -17.68 43.82 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.784 1.234 . . . . 0.0 112.352 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -57.09 -19.75 21.36 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.88 1.272 . . . . 0.0 112.557 176.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.13 21.17 0.85 Allowed Glycine 0 CA--C 1.534 1.238 0 O-C-N 120.761 -1.212 . . . . 0.0 114.278 176.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.25 -53.18 58.86 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.588 1.694 . . . . 0.0 110.943 -170.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.59 -53.94 41.86 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 117.791 -1.561 . . . . 0.0 111.02 175.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -48.97 -41.02 40.63 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 CA-C-N 120.78 2.29 . . . . 0.0 115.217 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.7 tp -71.51 -37.74 71.19 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 120.265 1.393 . . . . 0.0 110.372 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.9 tp -61.91 -46.98 87.02 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.047 0.385 . . . . 0.0 110.252 175.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.53 -40.6 87.69 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 124.021 0.929 . . . . 0.0 111.111 177.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -60.94 -48.81 80.1 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 118.833 0.742 . . . . 0.0 109.789 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -62.34 -46.13 90.07 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 122.959 0.504 . . . . 0.0 110.569 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 79.6 m -64.57 -38.36 90.74 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.271 0.487 . . . . 0.0 111.219 178.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.54 -38.64 91.72 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.886 0.766 . . . . 0.0 110.988 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.36 -38.28 78.02 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.203 0.601 . . . . 0.0 111.157 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.32 94.57 2.16 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 125.205 1.402 . . . . 0.0 108.497 -173.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -56.01 159.67 11.75 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 123.526 2.817 . . . . 0.0 113.328 178.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -135.74 167.51 21.01 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 126.053 1.741 . . . . 0.0 108.336 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 44.23 -127.32 6.54 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.509 1.052 . . . . 0.0 111.831 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -136.16 9.89 3.26 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.854 1.261 . . . . 0.0 111.699 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -71.33 125.12 26.13 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 123.986 0.914 . . . . 0.0 109.252 -172.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 51.1 t -69.9 123.79 24.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 166.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.4 t -77.45 135.38 26.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -178.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.6 mm -130.65 145.9 34.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 104.292 -2.484 . . . . 0.0 104.292 168.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -134.33 107.92 7.9 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 177.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.54 -1.9 89.06 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 118.966 -0.908 . . . . 0.0 112.49 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 54.22 -145.1 27.23 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -169.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.8 p -89.71 13.75 13.48 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 122.01 -0.7 . . . . 0.0 111.869 177.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.54 58.63 10.42 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 124.995 1.318 . . . . 0.0 110.498 -177.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -72.25 -22.09 22.57 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.873 2.382 . . . . 0.0 112.967 -171.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.72 -36.19 78.22 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.847 0.749 . . . . 0.0 111.856 -177.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -65.0 -11.89 44.06 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.867 0.867 . . . . 0.0 112.931 175.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -113.75 -0.25 14.3 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.305 1.042 . . . . 0.0 112.29 -172.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 62.5 mt -48.17 -41.19 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 125.124 1.37 . . . . 0.0 110.732 174.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.0 t -56.77 -44.02 80.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.313 0.645 . . . . 0.0 110.198 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.32 93.03 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.974 0.51 . . . . 0.0 110.966 -177.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 64.7 mt -64.27 -45.53 95.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.1 mtp180 -64.89 -31.29 72.45 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.512 -176.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -57.92 -33.06 68.38 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.667 1.121 . . . . 0.0 111.558 174.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 33.0 mt -76.22 -8.23 56.61 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 118.571 -0.728 . . . . 0.0 112.778 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.1 mtp180 31.8 62.12 1.23 Allowed Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 126.994 2.118 . . . . 0.0 112.359 -169.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -55.07 142.67 76.63 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.835 2.357 . . . . 0.0 112.305 -172.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.2 m -81.68 -31.84 32.04 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.682 0.793 . . . . 0.0 108.913 168.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -142.55 150.76 40.82 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.611 1.564 . . . . 0.0 107.721 174.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 56.4 tp -138.81 142.89 38.7 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.645 1.178 . . . . 0.0 108.088 173.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 35.0 tp -128.49 138.93 52.52 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 173.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.1 mt -125.31 142.07 43.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 -175.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.4 t -140.83 134.11 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 118.593 0.633 . . . . 0.0 110.08 -174.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -161.52 171.18 18.54 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.252 2.221 . . . . 0.0 107.739 171.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.4 156.84 39.01 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.133 -0.979 . . . . 0.0 108.621 168.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.3 m -155.86 127.74 7.45 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 176.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -71.48 123.76 23.12 Favored 'General case' 0 N--CA 1.461 0.097 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 171.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 75.4 mtm -123.24 1.73 9.12 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.032 1.733 . . . . 0.0 110.705 -175.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.83 25.21 68.97 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-N 118.747 0.703 . . . . 0.0 112.332 -173.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.0 mt -99.92 -172.25 2.2 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.332 1.453 . . . . 0.0 109.292 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -75.36 140.22 72.34 Favored Pre-proline 0 N--CA 1.469 0.49 0 CA-C-O 117.539 -1.219 . . . . 0.0 108.667 173.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -43.43 136.32 6.1 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 123.343 2.695 . . . . 0.0 113.081 172.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.31 3.48 76.91 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 118.779 -1.012 . . . . 0.0 113.75 178.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -64.74 148.57 50.88 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 119.754 1.777 . . . . 0.0 108.581 168.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 76.5 mt -125.89 136.09 61.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 -173.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 90.1 mmt-85 -148.18 152.64 37.59 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 118.512 0.596 . . . . 0.0 111.101 175.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 41.5 mm -81.58 144.74 9.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 166.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.8 mt -126.79 129.33 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -73.5 139.14 77.86 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 118.185 -0.912 . . . . 0.0 109.36 172.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -45.37 -36.26 12.81 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 124.46 3.44 . . . . 0.0 116.4 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -66.67 -26.78 67.2 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.445 0.566 . . . . 0.0 111.687 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -97.7 -28.57 13.84 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.515 1.126 . . . . 0.0 111.149 -178.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 45.9 mt -51.04 -43.38 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.613 1.165 . . . . 0.0 110.229 170.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -52.99 -31.49 41.17 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.593 1.157 . . . . 0.0 112.804 -177.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -97.58 -42.33 7.72 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.314 0.646 . . . . 0.0 109.843 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 22.5 mmt -67.3 -33.38 75.17 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -171.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -62.43 -43.37 98.97 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 118.454 0.57 . . . . 0.0 110.655 176.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 27.8 ptm -80.43 15.61 1.58 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 26.2 mmt -74.0 -29.0 61.73 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.896 -1.127 . . . . 0.0 109.675 168.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 67.1 p -74.34 -45.87 44.4 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 122.937 0.495 . . . . 0.0 110.846 -173.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.5 p -164.82 -172.03 2.48 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 128.808 2.843 . . . . 0.0 105.194 -167.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -73.2 51.8 0.33 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.359 1.064 . . . . 0.0 109.448 167.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -65.34 161.05 20.43 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 126.985 2.114 . . . . 0.0 110.45 -171.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.2 mmt -63.3 136.27 96.62 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-O 118.402 -0.809 . . . . 0.0 109.075 172.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.87 61.48 6.33 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 123.946 3.097 . . . . 0.0 109.188 169.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.6 mt -52.63 -7.08 0.06 Allowed 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 128.016 2.526 . . . . 0.0 117.061 -167.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -52.84 -23.32 6.75 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.256 0.934 . . . . 0.0 112.045 167.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -60.64 -27.08 67.52 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.828 0.74 . . . . 0.0 112.583 175.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.5 tt -69.64 -43.78 71.95 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 119.023 0.829 . . . . 0.0 109.372 175.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 76.7 mt -61.95 -43.48 97.58 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.093 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -64.38 -16.46 62.33 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -105.54 16.98 24.6 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.33 1.452 . . . . 0.0 111.18 177.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.6 mt -136.06 -37.5 0.72 Allowed 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.703 1.201 . . . . 0.0 110.994 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -55.59 -22.32 21.63 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.569 1.148 . . . . 0.0 112.742 176.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -60.23 -24.71 65.08 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.504 1.522 . . . . 0.0 112.122 -177.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -134.05 7.42 3.7 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.681 0.792 . . . . 0.0 112.488 -171.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 76.5 mt -122.41 141.51 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.977 1.311 . . . . 0.0 108.291 -174.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.27 -39.64 81.88 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 123.864 0.745 . . . . 0.0 111.809 -176.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -147.38 132.86 18.65 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 118.307 1.054 . . . . 0.0 108.256 176.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 41.5 t -122.65 129.38 75.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 172.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 15.1 mt -129.24 148.68 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 -169.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -129.6 141.18 51.0 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 170.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.5 tt -123.53 127.98 49.11 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 175.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -109.48 155.63 16.0 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 83.4 mt -133.06 126.01 52.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.103 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -62.76 114.47 12.32 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-O 117.778 -1.106 . . . . 0.0 110.453 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -75.96 170.48 20.02 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.171 2.581 . . . . 0.0 111.111 170.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -129.75 -30.11 2.08 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.493 1.917 . . . . 0.0 111.025 169.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.1 pp -136.03 137.02 49.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 123.891 0.876 . . . . 0.0 109.025 176.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 75.7 t -146.36 139.64 20.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 153.9 151.51 5.78 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 108.776 -1.729 . . . . 0.0 108.776 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -64.27 149.11 48.73 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 118.086 0.943 . . . . 0.0 110.597 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.6 t80 58.43 46.08 15.7 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.292 1.837 . . . . 0.0 111.577 -175.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -132.81 147.27 64.8 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 123.853 0.861 . . . . 0.0 109.759 168.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -81.87 166.12 17.23 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.554 2.836 . . . . 0.0 110.827 176.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.1 ttm -70.0 134.64 48.52 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 169.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.04 159.66 31.46 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.557 1.143 . . . . 0.0 110.57 175.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.63 -46.39 99.59 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-O 117.233 -1.365 . . . . 0.0 113.538 -171.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -67.07 -26.8 42.74 Favored 'Trans proline' 0 C--N 1.35 0.615 0 CA-C-N 122.209 1.824 . . . . 0.0 112.593 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.24 -35.7 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -56.24 -46.79 79.45 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.138 0.881 . . . . 0.0 109.984 170.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -63.11 -38.09 89.8 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 122.722 0.409 . . . . 0.0 111.444 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.49 -47.78 77.67 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 122.033 -0.417 . . . . 0.0 111.056 175.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 71.4 t -61.21 -39.28 81.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 118.672 0.669 . . . . 0.0 109.719 178.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 32.6 tp10 -63.91 -39.09 93.36 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.13 0.877 . . . . 0.0 110.927 175.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 51.7 m -63.9 -48.07 78.08 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.763 -0.586 . . . . 0.0 109.854 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 79.2 t -60.3 -46.08 95.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -54.62 -48.78 71.82 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.05 0.94 . . . . 0.0 110.849 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -65.06 -38.16 89.91 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.456 0.571 . . . . 0.0 111.194 177.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -62.14 -29.25 70.21 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 118.367 -0.825 . . . . 0.0 111.552 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 83.9 mt -55.01 -21.28 11.54 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.3 0.954 . . . . 0.0 112.909 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -80.06 -21.94 42.84 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.309 0.959 . . . . 0.0 112.595 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -143.61 5.53 1.81 Allowed Glycine 0 CA--C 1.532 1.104 0 CA-C-N 118.859 0.754 . . . . 0.0 114.726 -169.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.8 t-105 -52.81 138.46 29.33 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.809 1.643 . . . . 0.0 109.266 171.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -141.52 145.34 35.05 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 170.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 58.09 -106.4 0.81 Allowed Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -174.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -110.2 14.28 22.86 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.28 1.432 . . . . 0.0 112.097 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 79.19 2.65 87.63 Favored Glycine 0 CA--C 1.526 0.748 0 O-C-N 121.535 -0.728 . . . . 0.0 112.65 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.32 6.13 64.6 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 118.965 1.382 . . . . 0.0 112.67 -176.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -67.22 148.8 51.3 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 118.829 1.315 . . . . 0.0 108.48 171.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.95 146.41 47.79 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -92.3 121.02 33.39 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 177.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 62.5 tp -55.12 130.52 42.27 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.791 1.637 . . . . 0.0 110.631 178.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -145.34 53.9 1.19 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.314 1.046 . . . . 0.0 109.522 176.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 57.1 t 71.75 -44.4 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 128.567 2.747 . . . . 0.0 113.026 176.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 53.47 30.92 11.28 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.693 1.997 . . . . 0.0 113.362 174.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -153.22 170.69 19.95 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.168 1.787 . . . . 0.0 108.217 169.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 . . . . . 0 C--O 1.246 0.917 0 C-N-CA 125.541 1.537 . . . . 0.0 106.889 178.376 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.3 mmt . . . . . 0 N--CA 1.484 1.254 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.6 m -135.09 93.17 2.96 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -174.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -78.5 143.58 36.47 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 169.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 78.4 t -136.77 149.11 26.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -175.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 37.0 tp -127.93 112.06 14.26 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.415 1.486 . . . . 0.0 107.066 -175.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 51.9 tp -101.45 97.22 7.71 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 125.129 1.372 . . . . 0.0 107.883 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 87.3 m -73.11 143.03 47.51 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 169.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.0 t -141.71 144.82 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 176.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.79 174.34 17.87 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -124.76 119.31 28.55 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.128 1.371 . . . . 0.0 107.846 176.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 m -60.44 -14.2 17.87 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.185 1.794 . . . . 0.0 115.313 -169.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 27.9 ptm -125.22 13.14 8.29 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.153 0.981 . . . . 0.0 111.067 -176.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.3 ttt -100.7 29.68 4.38 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.567 0.747 . . . . 0.0 109.83 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.78 -142.26 20.75 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -61.86 -17.04 55.02 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.592 1.157 . . . . 0.0 112.221 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -54.87 -24.53 23.67 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.433 1.493 . . . . 0.0 113.236 176.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.21 24.49 0.71 Allowed Glycine 0 CA--C 1.533 1.191 0 CA-C-O 118.575 -1.125 . . . . 0.0 114.447 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.31 -51.45 65.98 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 119.468 1.634 . . . . 0.0 110.826 -169.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.17 -54.8 34.33 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-O 117.809 -1.55 . . . . 0.0 111.021 175.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -50.22 -37.68 49.73 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 CA-C-N 121.085 2.442 . . . . 0.0 114.841 178.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.7 tp -71.05 -39.79 72.04 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 120.117 1.326 . . . . 0.0 110.546 176.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.7 tp -60.9 -46.74 89.43 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.225 0.466 . . . . 0.0 110.479 175.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.48 -41.74 90.51 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 124.222 1.009 . . . . 0.0 110.913 176.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -61.06 -48.36 82.09 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 118.932 0.787 . . . . 0.0 110.046 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -61.2 -47.55 85.6 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 122.917 0.487 . . . . 0.0 110.513 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 80.9 m -64.5 -38.16 90.06 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.252 0.478 . . . . 0.0 111.183 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.7 -38.45 91.05 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.857 0.753 . . . . 0.0 111.077 177.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.78 -37.58 76.39 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.349 0.659 . . . . 0.0 111.218 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.31 98.56 1.97 Allowed Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 125.448 1.499 . . . . 0.0 107.856 -174.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -56.08 167.39 2.48 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 123.93 3.087 . . . . 0.0 114.664 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.493 ' HE2' ' CZ ' ' A' ' 136' ' ' TYR . 71.4 mmtt -135.93 160.14 39.51 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 126.055 1.742 . . . . 0.0 107.858 176.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 42.29 -121.19 2.6 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.861 1.22 . . . . 0.0 111.867 175.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -137.25 15.76 3.0 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.036 1.734 . . . . 0.0 111.142 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 13.0 m95 -72.26 131.27 42.49 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.565 0.746 . . . . 0.0 110.243 -171.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.0 t -75.73 118.03 21.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 104.273 -2.491 . . . . 0.0 104.273 165.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.0 t -72.81 134.82 29.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.7 mm -133.33 148.1 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 171.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -135.45 113.82 11.53 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 176.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.04 -13.27 83.21 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 118.613 -1.104 . . . . 0.0 112.81 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.56 34.05 79.69 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-N 119.62 1.71 . . . . 0.0 113.784 172.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 61.87 14.03 5.98 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.951 1.7 . . . . 0.0 114.261 -172.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -135.54 58.05 23.0 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 125.807 1.643 . . . . 0.0 107.657 169.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -71.26 -25.41 22.05 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.018 1.812 . . . . 0.0 111.873 -169.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.42 -30.69 71.77 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.668 0.787 . . . . 0.0 111.867 -179.068 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -63.02 -15.34 56.1 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.029 0.932 . . . . 0.0 112.419 172.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -117.32 1.07 12.37 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.369 1.068 . . . . 0.0 112.568 -169.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 78.7 mt -48.82 -37.29 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.869 1.268 . . . . 0.0 110.512 171.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.8 t -55.93 -41.26 66.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 123.683 0.793 . . . . 0.0 110.333 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.78 -41.96 82.41 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 118.479 0.582 . . . . 0.0 110.562 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.6 mt -61.06 -41.57 89.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 176.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -67.33 -19.99 65.53 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 117.693 -1.146 . . . . 0.0 112.505 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -72.25 -44.97 62.06 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 120.655 1.57 . . . . 0.0 108.894 169.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 56.5 mt -69.04 -26.4 64.96 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 118.489 -0.767 . . . . 0.0 112.703 -176.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 37.43 63.65 3.19 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 125.778 1.631 . . . . 0.0 111.443 -169.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.45 144.55 31.57 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.214 2.609 . . . . 0.0 113.774 -170.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.4 m -67.08 -42.18 85.1 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 167.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 73.0 mtm180 -144.08 153.82 42.57 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 124.769 1.228 . . . . 0.0 108.105 174.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 56.9 tp -133.16 137.01 46.07 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 35.0 tp -124.01 133.71 53.61 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.715 -1.958 . . . . 0.0 105.715 174.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.2 mt -122.22 139.75 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 -175.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.4 t -140.24 133.36 34.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 118.203 0.456 . . . . 0.0 109.828 -172.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -162.32 172.9 14.92 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.24 2.216 . . . . 0.0 107.397 176.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.73 157.73 37.4 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.112 -0.993 . . . . 0.0 108.326 167.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.0 m -154.66 130.18 9.86 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 174.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -74.55 124.19 26.17 Favored 'General case' 0 N--CA 1.461 0.105 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 172.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 77.1 mtm -122.18 0.44 9.57 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.547 1.539 . . . . 0.0 110.814 -175.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.55 24.83 68.19 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-N 118.576 0.626 . . . . 0.0 112.364 -172.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 58.8 mt -100.67 -169.61 1.74 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.964 1.305 . . . . 0.0 108.568 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -82.2 147.01 56.06 Favored Pre-proline 0 N--CA 1.471 0.62 0 CA-C-O 118.466 -0.778 . . . . 0.0 109.747 174.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -46.81 136.1 17.02 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.379 2.719 . . . . 0.0 112.348 176.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.56 1.87 90.3 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 118.483 -1.176 . . . . 0.0 113.45 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -64.53 148.54 50.5 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 119.906 1.853 . . . . 0.0 108.356 168.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 69.3 mt -128.76 135.95 61.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 -172.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 -148.7 150.84 33.87 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 118.666 0.666 . . . . 0.0 111.926 177.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 51.4 mm -79.45 143.61 12.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 166.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.8 mt -128.63 125.61 63.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -74.87 140.54 74.34 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.266 172.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -45.66 -34.57 11.69 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 124.369 3.379 . . . . 0.0 116.628 177.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -68.58 -24.99 64.66 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.57 0.623 . . . . 0.0 111.807 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -98.69 -30.37 12.49 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.865 1.266 . . . . 0.0 111.076 -177.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 63.7 mt -49.91 -40.91 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.692 1.197 . . . . 0.0 109.189 169.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.0 -19.72 19.99 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.161 1.384 . . . . 0.0 114.454 -174.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -117.91 -36.24 3.69 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 118.699 0.682 . . . . 0.0 110.084 176.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 38.4 mmt -69.19 -25.46 64.34 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -176.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -70.21 -47.15 62.71 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 119.164 0.893 . . . . 0.0 111.238 173.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 20.1 ptp -70.48 -13.4 62.1 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 118.608 -0.711 . . . . 0.0 112.881 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 27.9 ttt -58.49 -24.24 59.96 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.051 0.841 . . . . 0.0 111.663 175.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 44.0 p -61.85 -82.29 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.414 1.086 . . . . 0.0 110.082 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.3 p -155.7 54.31 0.6 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.556 2.343 . . . . 0.0 107.544 178.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 56.59 39.18 29.95 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.554 1.142 . . . . 0.0 112.52 -176.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -60.02 150.68 28.47 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 167.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -58.67 140.88 85.13 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 123.654 0.781 . . . . 0.0 109.735 -176.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -72.55 79.01 1.92 Allowed 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 125.101 3.868 . . . . 0.0 108.881 178.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 mt -50.87 -7.29 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 117.694 2.479 . . . . 0.0 117.694 -167.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -54.42 -21.79 10.71 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.21 -0.931 . . . . 0.0 112.192 167.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -60.0 -31.77 70.24 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.445 1.02 . . . . 0.0 111.751 174.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.9 tt -73.91 -45.71 48.9 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.758 0.708 . . . . 0.0 109.114 174.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 85.4 mt -57.22 -42.81 80.7 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -62.41 -21.58 65.5 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -85.42 -2.33 57.99 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.829 0.852 . . . . 0.0 112.226 177.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -129.95 -33.93 1.74 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.316 1.047 . . . . 0.0 112.51 -178.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 13.4 pttm -62.92 -19.72 64.5 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.658 0.783 . . . . 0.0 112.983 -171.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -72.09 -12.17 61.08 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.389 1.075 . . . . 0.0 111.814 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -133.26 -34.05 1.09 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.226 0.921 . . . . 0.0 112.915 -177.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 23.8 mt -67.87 143.19 15.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 171.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.81 -39.9 93.6 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 123.954 0.788 . . . . 0.0 112.39 -177.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -150.49 138.72 20.3 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 118.379 1.089 . . . . 0.0 108.442 174.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 39.0 t -122.41 132.07 71.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 174.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.2 mt -130.92 147.35 33.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 -169.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -132.68 140.74 48.27 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 175.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.9 tt -125.5 133.85 52.24 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 174.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -116.71 156.83 15.4 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 177.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 87.1 mt -134.39 127.53 50.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 -177.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -63.9 114.34 13.25 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 117.38 -1.295 . . . . 0.0 110.151 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -76.09 170.56 19.83 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.152 2.568 . . . . 0.0 111.154 170.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -128.81 -32.04 2.14 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.031 1.732 . . . . 0.0 110.986 171.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -135.58 136.23 50.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 177.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.4 t -141.73 135.55 30.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 176.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 157.47 150.73 5.8 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -66.14 152.67 44.25 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.78 0.8 . . . . 0.0 111.08 -176.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 25.0 t80 55.05 39.88 31.74 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.536 1.934 . . . . 0.0 111.648 -175.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -125.06 147.96 58.67 Favored Pre-proline 0 C--O 1.237 0.427 0 C-N-CA 123.669 0.787 . . . . 0.0 109.815 169.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -82.4 164.47 16.78 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.38 2.72 . . . . 0.0 111.087 176.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 53.0 ttm -71.83 138.0 47.97 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 168.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 71.5 p -78.41 159.49 28.28 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.153 0.981 . . . . 0.0 110.494 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.3 tp60 -53.09 -44.42 97.08 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-O 116.533 -1.699 . . . . 0.0 114.23 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -68.58 -30.53 28.45 Favored 'Trans proline' 0 C--N 1.351 0.683 0 CA-C-N 122.914 2.076 . . . . 0.0 112.164 -176.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.81 -35.31 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 119.021 0.828 . . . . 0.0 108.841 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -56.56 -46.64 80.63 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.3 0.955 . . . . 0.0 110.056 170.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -63.97 -37.14 86.33 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.055 0.542 . . . . 0.0 111.434 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.38 -47.25 77.02 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.919 -0.488 . . . . 0.0 111.17 175.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 78.9 t -61.74 -39.66 84.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 118.564 0.62 . . . . 0.0 109.525 177.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -61.37 -42.31 98.5 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.911 0.778 . . . . 0.0 110.534 174.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 52.2 m -62.19 -45.74 92.02 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.747 -0.596 . . . . 0.0 110.237 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 80.3 t -61.9 -47.53 92.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 176.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.493 ' CZ ' ' HE2' ' A' ' 31' ' ' LYS . 38.7 t80 -55.42 -49.66 71.82 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.913 0.885 . . . . 0.0 110.923 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 48.7 mm-40 -68.78 -23.35 64.29 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.734 -0.604 . . . . 0.0 112.102 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.18 -29.24 64.93 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.66 1.118 . . . . 0.0 111.583 175.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 67.6 mt -58.58 -20.38 46.34 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -168.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -83.81 -12.66 55.31 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 120.254 1.388 . . . . 0.0 113.297 177.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -131.56 -3.13 4.27 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.822 1.201 . . . . 0.0 113.092 -175.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 -56.62 111.94 1.14 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.428 1.891 . . . . 0.0 108.753 173.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -83.15 -36.0 25.11 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 122.66 0.384 . . . . 0.0 110.98 -177.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -165.79 -38.56 0.02 OUTLIER Glycine 0 CA--C 1.526 0.731 0 CA-C-O 118.804 -0.998 . . . . 0.0 112.377 -175.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -136.97 13.41 3.1 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.709 1.255 . . . . 0.0 113.015 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 61.43 12.74 33.94 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 119.188 -0.785 . . . . 0.0 114.437 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 65.61 8.45 39.7 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-N 118.793 1.297 . . . . 0.0 113.277 -173.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -72.03 143.3 49.19 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 119.335 1.567 . . . . 0.0 108.932 177.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.02 151.37 47.77 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.774 0.829 . . . . 0.0 109.527 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -92.59 123.98 36.28 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 62.0 tp -54.73 127.62 29.11 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.381 1.472 . . . . 0.0 109.741 176.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -141.83 34.36 1.59 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.545 1.138 . . . . 0.0 109.686 175.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.3 t 52.06 52.16 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 126.338 1.855 . . . . 0.0 110.391 175.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -56.06 150.0 14.6 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.568 0.747 . . . . 0.0 110.843 176.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -137.12 30.1 2.74 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.299 1.44 . . . . 0.0 109.128 175.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 . . . . . 0 C--O 1.251 1.182 0 C-N-CA 126.754 2.022 . . . . 0.0 108.154 -177.225 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.5 mmm . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 118.937 -0.554 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.9 m -143.09 151.87 41.22 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 -173.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -144.97 128.65 17.18 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 -171.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 70.8 t -124.0 148.61 28.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 121.409 0.623 . . . . 0.0 110.709 -167.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 33.7 tp -114.37 129.56 56.65 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.628 -1.989 . . . . 0.0 105.628 168.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.8 tp -120.63 100.82 7.35 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 92.7 m -75.33 143.03 43.11 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 171.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 51.9 t -141.01 142.04 30.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.285 1.434 . . . . 0.0 107.306 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 144.57 176.88 18.97 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.336 0.969 . . . . 0.0 111.873 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -126.55 122.54 35.42 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.8 1.24 . . . . 0.0 108.844 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 m -60.82 -15.33 29.0 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.572 1.949 . . . . 0.0 115.661 -169.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 25.8 ptm -127.4 11.01 6.82 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.074 0.95 . . . . 0.0 110.989 -176.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.6 ttt -88.68 14.32 10.33 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.225 1.01 . . . . 0.0 110.098 176.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.54 -140.96 15.34 Favored Glycine 0 C--N 1.337 0.637 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -60.44 -17.42 44.45 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.504 1.121 . . . . 0.0 112.224 176.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -55.81 -20.68 16.01 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.614 1.566 . . . . 0.0 113.207 174.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.44 21.5 0.7 Allowed Glycine 0 CA--C 1.534 1.253 0 O-C-N 120.823 -1.173 . . . . 0.0 114.286 177.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.4 -51.0 67.64 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 119.477 1.639 . . . . 0.0 110.788 -169.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.64 -54.91 33.74 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-O 117.76 -1.578 . . . . 0.0 111.073 175.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -49.75 -41.08 47.21 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 CA-C-N 120.826 2.313 . . . . 0.0 115.282 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.9 tp -71.34 -39.08 71.56 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 120.135 1.334 . . . . 0.0 110.267 178.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.8 tp -61.18 -46.15 91.69 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 122.055 -0.403 . . . . 0.0 110.314 175.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.14 -40.2 84.76 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 124.08 0.952 . . . . 0.0 111.167 177.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -61.41 -48.52 80.86 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 118.918 0.781 . . . . 0.0 109.866 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -61.87 -46.39 89.61 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.895 0.478 . . . . 0.0 110.506 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 80.1 m -64.59 -39.05 93.04 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.191 0.451 . . . . 0.0 111.209 178.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.47 -37.62 88.19 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.774 0.715 . . . . 0.0 111.052 177.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.88 -37.45 79.04 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.172 0.589 . . . . 0.0 111.058 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.0 96.24 1.72 Allowed Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 124.985 1.314 . . . . 0.0 108.553 -173.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -55.93 164.34 4.86 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.869 3.046 . . . . 0.0 113.969 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -134.02 166.1 23.51 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.383 1.473 . . . . 0.0 109.011 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 44.76 -113.25 0.82 Allowed Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.767 1.175 . . . . 0.0 111.418 175.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -144.57 8.94 1.35 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.795 1.238 . . . . 0.0 111.741 176.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 3.9 m95 -68.13 131.54 45.6 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.951 0.901 . . . . 0.0 110.201 -169.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 62.1 t -77.58 119.04 25.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 166.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.5 t -82.55 136.52 22.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -174.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 70.0 mt -133.74 145.29 33.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 169.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -129.58 107.91 9.82 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 175.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.98 -2.16 90.49 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-O 118.892 -0.949 . . . . 0.0 112.95 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 55.28 -144.93 31.88 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 108.441 -1.863 . . . . 0.0 108.441 -169.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.4 p -88.52 9.13 24.88 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.738 -0.86 . . . . 0.0 112.084 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -135.86 57.19 17.42 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 124.991 1.316 . . . . 0.0 110.493 -176.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -68.74 -14.37 39.02 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.735 2.29 . . . . 0.0 113.197 -171.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -55.48 -32.5 62.88 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.074 0.852 . . . . 0.0 112.001 173.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.99 -27.31 66.75 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.192 0.597 . . . . 0.0 112.119 176.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -99.38 -2.74 35.49 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.804 1.242 . . . . 0.0 111.458 -171.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 77.3 mt -54.56 -43.09 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 119.405 1.002 . . . . 0.0 109.641 175.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.3 t -61.6 -42.29 93.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 118.348 0.522 . . . . 0.0 109.737 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.68 -46.31 79.57 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 122.948 0.499 . . . . 0.0 110.666 -177.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 67.5 mt -55.16 -48.05 76.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 172.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -68.18 -23.28 64.83 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 117.865 -1.064 . . . . 0.0 112.778 -174.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -62.96 -37.56 87.57 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 120.519 1.509 . . . . 0.0 110.34 169.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 39.2 mt -77.19 -16.55 59.05 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.851 0.86 . . . . 0.0 111.917 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 26.89 64.6 0.56 Allowed Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 127.883 2.473 . . . . 0.0 113.538 -169.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -58.67 151.25 64.53 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.704 2.936 . . . . 0.0 113.912 -169.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.9 m -69.85 -36.1 75.25 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.085 0.954 . . . . 0.0 108.736 167.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -146.68 153.94 40.86 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.394 1.078 . . . . 0.0 110.402 -175.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 46.7 tp -142.77 136.85 29.28 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 125.301 1.44 . . . . 0.0 108.373 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 27.1 tp -125.32 135.33 52.36 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 172.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.5 mt -123.25 145.17 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 -172.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 44.0 t -141.06 135.53 32.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 118.74 0.7 . . . . 0.0 110.043 -175.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -163.99 172.26 14.13 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.598 2.359 . . . . 0.0 107.544 173.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.58 158.49 36.11 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.366 -0.834 . . . . 0.0 109.17 167.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.7 m -154.41 128.67 9.04 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -75.98 83.88 2.88 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 119.004 0.82 . . . . 0.0 109.925 174.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 74.6 mtm -77.44 -8.98 58.59 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.45 1.5 . . . . 0.0 112.212 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.04 29.26 67.1 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-N 118.914 0.779 . . . . 0.0 111.362 -171.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.3 mt -106.07 -172.36 2.07 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.965 1.306 . . . . 0.0 109.721 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -74.6 141.16 75.84 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-O 117.749 -1.12 . . . . 0.0 108.58 169.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -43.19 137.95 4.72 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 123.445 2.763 . . . . 0.0 113.395 172.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.29 1.02 79.94 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-O 118.625 -1.097 . . . . 0.0 113.82 176.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -68.2 149.34 49.64 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 119.875 1.838 . . . . 0.0 108.299 168.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 48.2 mt -128.82 135.07 63.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 125.607 1.563 . . . . 0.0 106.952 -172.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.2 mmt-85 -144.99 152.12 39.65 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.068 0.849 . . . . 0.0 109.653 175.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 42.6 mm -78.12 146.57 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 167.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.3 mt -128.49 118.18 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -71.88 139.85 83.15 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-O 117.926 -1.035 . . . . 0.0 109.172 174.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -47.56 -33.22 17.47 Favored 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 124.22 3.28 . . . . 0.0 116.654 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -67.95 -24.27 65.15 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.763 0.71 . . . . 0.0 111.641 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -100.64 -28.85 12.63 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.284 1.434 . . . . 0.0 111.307 -177.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 61.0 mt -49.34 -45.87 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.69 1.196 . . . . 0.0 109.044 169.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.68 -14.89 15.88 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.257 1.423 . . . . 0.0 113.969 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -126.2 4.89 7.08 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.226 1.01 . . . . 0.0 111.637 -177.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 20.9 mmt -121.64 -25.71 5.05 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -176.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -73.79 -40.89 63.08 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.835 1.198 . . . . 0.0 111.449 -178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.05 6.15 10.13 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.773 -0.58 . . . . 0.0 112.397 175.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 54.0 tpp -59.53 -26.13 65.08 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.573 1.079 . . . . 0.0 110.096 169.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 48.7 p -59.06 -14.05 8.65 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.207 1.803 . . . . 0.0 113.062 169.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.8 m 61.37 22.85 13.18 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.383 1.873 . . . . 0.0 110.751 -168.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 63.5 m80 -146.84 -55.08 0.25 Allowed 'General case' 0 C--N 1.346 0.42 0 O-C-N 121.349 -0.844 . . . . 0.0 112.804 -172.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -69.77 146.05 51.74 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 118.241 0.473 . . . . 0.0 110.399 -169.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 25.1 mmt -68.49 154.33 94.55 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 173.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.8 80.72 2.31 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 124.336 3.357 . . . . 0.0 109.876 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 mt -47.23 -11.72 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 127.994 2.518 . . . . 0.0 117.642 -168.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.06 -20.97 4.05 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.053 0.842 . . . . 0.0 112.641 168.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -58.39 -32.4 68.57 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.641 1.11 . . . . 0.0 112.083 174.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.4 tt -74.77 -43.5 54.51 Favored 'General case' 0 N--CA 1.462 0.125 0 O-C-N 121.623 -0.673 . . . . 0.0 109.669 176.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 74.5 mt -62.0 -40.28 86.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 123.946 0.898 . . . . 0.0 109.705 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.1 -27.89 65.99 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.505 0.722 . . . . 0.0 112.386 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -91.47 8.49 36.14 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.816 1.246 . . . . 0.0 111.943 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 88.4 mt -133.47 -29.81 1.34 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.223 1.009 . . . . 0.0 111.865 -176.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 45.0 mttm -56.16 -19.14 12.25 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.095 0.958 . . . . 0.0 112.779 170.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -59.02 -18.81 37.94 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.423 1.089 . . . . 0.0 112.205 175.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -138.23 -42.93 0.51 Allowed 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.868 0.867 . . . . 0.0 112.012 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 20.3 mt -68.62 133.4 31.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -173.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -75.97 -34.07 48.61 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.203 0.906 . . . . 0.0 112.432 -173.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -143.62 125.75 15.47 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.4 t -127.07 128.85 70.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 3.8 mt -131.55 150.11 33.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 -169.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -130.96 141.04 50.23 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 169.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.9 tt -120.62 128.74 53.3 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 174.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -111.94 156.23 15.7 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -178.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 62.6 mt -133.92 124.52 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 -176.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -65.47 117.84 44.7 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-O 117.389 -1.291 . . . . 0.0 110.4 -178.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -77.21 171.99 16.82 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.662 2.908 . . . . 0.0 111.485 170.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -128.11 -31.43 2.35 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.669 1.587 . . . . 0.0 111.073 170.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.1 pp -136.52 135.54 49.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.309 1.044 . . . . 0.0 108.751 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.3 t -143.77 145.92 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 176.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 173.28 -120.58 0.81 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -156.21 154.18 30.36 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.647 1.224 . . . . 0.0 108.33 175.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 3.0 t80 53.73 33.07 15.97 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.691 1.197 . . . . 0.0 110.861 -171.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 12.5 m-30 -118.96 140.38 28.57 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 124.816 1.246 . . . . 0.0 109.84 -173.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -82.72 165.22 15.81 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.433 2.755 . . . . 0.0 111.215 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.3 ttm -75.71 139.35 41.86 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 168.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 73.0 p -80.74 160.5 24.91 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.484 1.114 . . . . 0.0 110.475 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -53.1 -45.04 98.44 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-O 116.493 -1.718 . . . . 0.0 114.117 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -68.52 -30.56 28.83 Favored 'Trans proline' 0 C--N 1.35 0.653 0 CA-C-N 122.847 2.052 . . . . 0.0 112.215 -176.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -80.56 -35.47 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -56.3 -46.42 79.8 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.366 0.985 . . . . 0.0 109.946 170.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -64.05 -38.62 91.74 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 122.937 0.495 . . . . 0.0 111.254 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.53 -46.49 82.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 119.013 -0.518 . . . . 0.0 111.09 175.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 79.7 t -62.87 -38.92 83.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 119.147 0.885 . . . . 0.0 109.793 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -62.79 -42.29 99.64 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.396 0.998 . . . . 0.0 110.355 174.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 57.3 m -61.14 -49.75 75.97 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 71.1 t -60.66 -42.17 90.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 123.646 0.779 . . . . 0.0 109.893 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -57.1 -48.3 78.96 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.465 0.575 . . . . 0.0 110.575 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 63.9 mm-40 -64.53 -38.57 91.47 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.992 0.815 . . . . 0.0 110.895 175.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -63.92 -27.43 69.14 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 123.436 0.695 . . . . 0.0 112.414 -177.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 75.1 mt -59.11 -18.5 36.19 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.376 0.989 . . . . 0.0 112.16 175.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -91.44 2.11 56.65 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.149 0.886 . . . . 0.0 111.947 178.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -149.69 -3.74 0.26 Allowed Glycine 0 CA--C 1.535 1.323 0 CA-C-O 119.017 -0.879 . . . . 0.0 115.272 -173.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -53.94 144.13 19.74 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.169 1.387 . . . . 0.0 108.803 169.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.09 -27.51 1.61 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.282 1.433 . . . . 0.0 112.604 -169.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 178.4 -26.81 0.06 OUTLIER Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.15 1.357 . . . . 0.0 112.303 -176.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -145.52 4.78 1.04 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.792 1.296 . . . . 0.0 112.282 178.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 63.32 13.68 50.67 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.497 1.522 . . . . 0.0 112.495 -171.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 61.56 6.79 9.1 Favored Glycine 0 CA--C 1.538 1.508 0 CA-C-N 118.543 1.172 . . . . 0.0 112.914 -168.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -72.29 167.31 20.68 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.997 1.399 . . . . 0.0 109.076 172.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -88.75 148.56 23.89 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 170.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.6 121.9 29.77 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 174.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 52.3 tp -53.77 124.38 15.08 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.612 1.565 . . . . 0.0 109.793 178.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -139.3 57.28 1.65 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.638 1.175 . . . . 0.0 109.295 -175.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.5 t 53.2 40.18 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 125.429 1.492 . . . . 0.0 110.048 -175.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -72.76 152.38 41.64 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.22 1.008 . . . . 0.0 108.395 172.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -141.2 150.7 43.04 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 169.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 . . . . . 0 C--O 1.247 0.965 0 C-N-CA 124.545 1.138 . . . . 0.0 108.161 179.039 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.485 1.309 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 24.6 m -102.71 86.32 2.73 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -177.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -75.78 145.58 40.64 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 168.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 69.6 t -136.33 148.38 27.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 39.3 tp -123.36 119.15 29.24 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.9 tp -109.95 96.91 6.54 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 99.4 m -71.29 142.39 50.48 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 169.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.3 t -140.82 143.12 29.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 177.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.02 174.54 17.36 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -122.71 121.05 35.43 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.365 1.466 . . . . 0.0 107.422 177.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 m -59.56 -14.78 14.52 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.934 1.693 . . . . 0.0 115.495 -169.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -128.86 14.12 6.35 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.839 0.856 . . . . 0.0 111.243 -176.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.2 ttt -97.73 30.6 2.9 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 118.682 0.674 . . . . 0.0 109.898 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.26 -142.39 20.45 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -178.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -61.2 -17.31 52.48 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.593 1.157 . . . . 0.0 112.111 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -56.63 -19.97 18.84 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.217 1.407 . . . . 0.0 112.871 174.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.36 20.26 0.77 Allowed Glycine 0 CA--C 1.534 1.258 0 O-C-N 120.691 -1.256 . . . . 0.0 114.311 177.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.8 -52.7 63.14 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 119.571 1.685 . . . . 0.0 110.862 -169.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.62 -54.81 34.55 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-O 117.88 -1.511 . . . . 0.0 111.214 175.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -49.67 -40.76 46.75 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 CA-C-N 120.818 2.309 . . . . 0.0 115.077 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 65.6 tp -70.65 -39.27 73.72 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-N 119.963 1.256 . . . . 0.0 110.311 178.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.0 tp -61.28 -46.87 88.54 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.065 0.393 . . . . 0.0 110.348 175.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.38 -42.23 86.58 Favored 'General case' 0 C--O 1.227 -0.125 0 C-N-CA 124.134 0.974 . . . . 0.0 110.829 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -60.72 -49.15 78.68 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.476 0.58 . . . . 0.0 110.0 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -61.75 -49.83 74.83 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 122.99 0.516 . . . . 0.0 110.723 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 75.7 m -64.02 -37.79 88.71 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.549 0.613 . . . . 0.0 111.399 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.46 -40.65 96.12 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.112 0.869 . . . . 0.0 111.073 176.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.64 -33.05 73.34 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.511 0.724 . . . . 0.0 111.704 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.44 96.08 2.66 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.544 1.537 . . . . 0.0 107.762 -173.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -53.31 159.5 5.87 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 123.439 2.759 . . . . 0.0 113.939 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -134.53 155.54 50.23 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.638 1.575 . . . . 0.0 108.085 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 40.71 -119.08 1.32 Allowed Glycine 0 CA--C 1.532 1.104 0 C-N-CA 125.128 1.346 . . . . 0.0 111.88 176.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -137.14 14.87 3.04 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.913 1.685 . . . . 0.0 111.309 177.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -72.52 128.17 34.77 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.337 0.655 . . . . 0.0 109.791 -173.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.2 t -72.86 120.45 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 166.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.0 t -76.22 133.72 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 24.4 mm -133.15 147.94 31.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 104.967 -2.235 . . . . 0.0 104.967 171.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -134.7 114.06 12.32 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 177.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.79 -16.28 76.19 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 118.654 -1.081 . . . . 0.0 113.003 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 57.95 39.0 91.14 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-N 119.264 1.532 . . . . 0.0 113.722 170.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . 0.252 75.3 p 60.71 14.29 4.95 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.502 2.321 . . . . 0.0 114.69 -173.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.2 56.29 6.22 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 125.632 1.573 . . . . 0.0 108.995 172.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -67.05 -28.75 41.11 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.395 2.063 . . . . 0.0 112.258 -169.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.59 -36.19 77.96 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.592 0.757 . . . . 0.0 111.892 -178.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -64.43 -13.59 52.2 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.702 0.801 . . . . 0.0 112.574 176.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -112.66 -0.36 15.12 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.314 1.046 . . . . 0.0 112.38 -172.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 87.5 mt -50.01 -36.92 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 124.577 1.151 . . . . 0.0 110.518 172.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 51.3 t -56.41 -40.82 69.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 123.646 0.778 . . . . 0.0 110.455 178.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.46 -41.85 83.99 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.498 0.59 . . . . 0.0 110.504 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 51.1 mt -61.91 -40.29 86.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -66.23 -20.25 66.06 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 117.785 -1.103 . . . . 0.0 112.528 176.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -72.45 -43.94 63.07 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 120.677 1.581 . . . . 0.0 109.097 169.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 49.0 mt -68.75 -27.91 66.33 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 118.671 -0.681 . . . . 0.0 112.568 -177.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 39.12 64.74 3.69 Favored Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 125.589 1.556 . . . . 0.0 111.306 -169.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -49.69 141.04 28.23 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.269 2.646 . . . . 0.0 113.402 -172.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.1 m -66.99 -41.29 87.01 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 167.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.2 mtm-85 -146.72 149.97 34.47 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.115 1.766 . . . . 0.0 106.789 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 52.9 tp -134.59 137.76 43.99 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 33.6 tp -125.6 133.8 52.13 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 175.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.4 mt -121.96 142.38 38.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -174.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.5 t -141.01 133.56 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 118.764 0.711 . . . . 0.0 110.056 -174.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -161.42 171.24 18.55 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.39 2.276 . . . . 0.0 107.464 172.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.54 156.28 39.6 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.951 -1.093 . . . . 0.0 108.583 168.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.8 m -155.9 132.56 10.38 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -78.13 122.73 26.01 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 73.5 mtm -121.43 1.49 10.14 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.209 1.803 . . . . 0.0 110.699 -176.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.24 18.17 60.24 Favored Glycine 0 CA--C 1.537 1.412 0 CA-C-N 118.676 0.671 . . . . 0.0 112.579 -171.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.6 mt -87.47 -176.1 5.47 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.487 1.515 . . . . 0.0 109.744 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -76.08 140.26 69.76 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-O 117.871 -1.062 . . . . 0.0 108.818 171.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -45.86 134.93 14.0 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.417 2.744 . . . . 0.0 113.71 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.01 2.27 88.54 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.574 -1.126 . . . . 0.0 113.359 177.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -65.99 151.93 45.72 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 119.867 1.833 . . . . 0.0 108.025 168.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 81.0 mt -128.12 141.91 45.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -171.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 84.2 mmt-85 -151.04 154.19 36.55 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 123.326 0.651 . . . . 0.0 110.858 172.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 35.8 mm -81.6 144.68 9.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 165.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.7 mt -125.53 128.12 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 176.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -72.87 140.1 80.67 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-O 118.084 -0.96 . . . . 0.0 109.655 173.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -46.98 -32.55 13.05 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 124.356 3.37 . . . . 0.0 116.79 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -67.49 -26.48 66.38 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.778 0.717 . . . . 0.0 111.782 178.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -101.66 -25.08 13.99 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.991 1.316 . . . . 0.0 111.446 -176.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 45.0 mt -50.17 -41.21 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.54 1.136 . . . . 0.0 109.512 169.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.33 -30.67 52.11 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.53 1.132 . . . . 0.0 113.15 -177.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -100.38 -39.16 8.12 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.052 0.541 . . . . 0.0 110.06 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 26.1 mmt -73.47 -27.85 61.62 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 121.714 -0.616 . . . . 0.0 112.256 -173.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -68.59 -49.95 55.39 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 118.838 0.745 . . . . 0.0 110.306 171.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 27.6 ptm -63.21 -20.78 65.74 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.206 0.912 . . . . 0.0 111.911 -178.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 10.7 tpt -58.4 -25.28 61.93 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.935 0.894 . . . . 0.0 112.249 173.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 82.4 p -68.99 -7.08 32.07 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 119.378 0.99 . . . . 0.0 113.136 176.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.4 m 118.68 81.33 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 130.929 3.692 . . . . 0.0 108.188 169.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 24.5 m80 56.29 26.58 10.68 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.914 1.686 . . . . 0.0 113.388 176.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -63.17 157.42 22.5 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.222 1.009 . . . . 0.0 109.543 172.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 63.4 mtt -67.43 146.22 98.65 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -76.61 73.46 5.2 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 124.285 3.323 . . . . 0.0 109.827 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.1 mt -51.85 -6.83 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 117.363 2.357 . . . . 0.0 117.363 -168.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -54.08 -19.42 4.89 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.437 1.017 . . . . 0.0 112.243 166.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -59.35 -28.46 66.87 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.608 1.095 . . . . 0.0 112.125 173.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.7 tt -70.78 -45.6 64.41 Favored 'General case' 0 N--CA 1.463 0.18 0 O-C-N 121.334 -0.854 . . . . 0.0 109.625 173.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 90.0 mt -61.5 -42.11 92.66 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.137 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -60.38 -24.85 65.43 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -85.89 0.11 53.94 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.921 0.888 . . . . 0.0 112.453 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 65.3 mt -135.89 -31.34 0.93 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.21 1.004 . . . . 0.0 112.401 -171.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -59.29 -21.84 60.29 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.895 1.278 . . . . 0.0 112.712 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -71.44 -13.06 61.71 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.513 1.125 . . . . 0.0 111.916 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -134.67 -32.98 0.97 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.219 0.918 . . . . 0.0 112.983 -176.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 53.7 mt -68.55 143.58 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 172.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -67.17 -41.66 92.05 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 123.96 0.791 . . . . 0.0 112.236 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -150.63 143.15 24.42 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 118.582 1.191 . . . . 0.0 108.999 173.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.0 t -127.66 129.44 70.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 177.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.6 mt -129.93 148.86 33.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 -169.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -132.86 142.38 48.91 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 171.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.4 tt -122.44 127.8 50.09 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.434 1.494 . . . . 0.0 107.124 174.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -109.16 156.09 15.78 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 77.8 mt -133.93 126.98 51.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -61.28 114.95 12.19 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-O 117.346 -1.311 . . . . 0.0 110.34 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -76.52 171.4 18.13 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.184 2.589 . . . . 0.0 111.174 170.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -129.59 -31.81 1.98 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.915 1.686 . . . . 0.0 111.041 171.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -135.84 135.85 50.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 124.282 1.033 . . . . 0.0 108.215 176.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.6 t -141.58 135.4 30.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 158.4 151.16 5.99 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 178.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -65.99 153.33 42.45 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.844 0.831 . . . . 0.0 111.344 -175.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 54.62 38.79 30.55 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.92 2.088 . . . . 0.0 112.141 -176.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -123.4 148.32 55.06 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 123.961 0.904 . . . . 0.0 109.996 172.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -81.74 163.83 18.48 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.19 2.594 . . . . 0.0 111.161 176.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 52.2 ttm -72.24 138.94 47.84 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 168.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 68.8 p -79.07 159.27 27.61 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.153 0.981 . . . . 0.0 110.529 178.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -52.9 -44.1 95.63 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-O 116.569 -1.681 . . . . 0.0 114.277 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -68.67 -31.26 26.49 Favored 'Trans proline' 0 C--N 1.351 0.667 0 CA-C-N 122.892 2.069 . . . . 0.0 112.215 -176.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.09 -35.28 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -56.3 -46.02 80.0 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.196 0.907 . . . . 0.0 110.172 170.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -64.15 -37.92 89.2 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 122.987 0.515 . . . . 0.0 111.41 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.58 -47.33 79.08 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 121.944 -0.473 . . . . 0.0 110.986 175.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 72.4 t -62.71 -39.37 84.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 118.552 0.615 . . . . 0.0 109.789 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -60.31 -43.26 96.51 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.022 0.828 . . . . 0.0 110.265 173.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 55.2 m -61.52 -47.5 85.33 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.959 -0.463 . . . . 0.0 109.971 178.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 87.8 t -61.44 -45.65 98.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 118.552 0.615 . . . . 0.0 109.648 178.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -54.4 -48.84 71.11 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.802 0.841 . . . . 0.0 110.71 177.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 48.2 mm-40 -65.58 -37.34 86.37 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.642 0.656 . . . . 0.0 111.41 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.1 -35.54 71.6 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.545 0.738 . . . . 0.0 111.843 -178.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 77.6 mt -59.07 -16.88 21.27 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -172.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -77.52 -20.34 54.39 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 120.042 1.292 . . . . 0.0 112.54 177.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -145.76 5.81 1.35 Allowed Glycine 0 CA--C 1.532 1.145 0 CA-C-O 119.393 -0.67 . . . . 0.0 114.713 -169.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -52.06 138.19 25.81 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.647 1.579 . . . . 0.0 108.907 170.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -143.61 145.78 32.76 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 170.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 53.59 -121.27 16.94 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 123.971 0.796 . . . . 0.0 111.581 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -75.33 5.09 6.07 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.71 1.204 . . . . 0.0 112.916 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 70.8 13.76 72.28 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 124.213 0.911 . . . . 0.0 112.398 -174.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.54 -4.5 3.88 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-N 118.413 1.107 . . . . 0.0 113.526 -172.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -71.82 152.22 42.84 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 119.094 1.447 . . . . 0.0 109.023 174.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -76.7 148.08 37.02 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 174.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -91.3 120.54 32.27 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 176.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 44.9 tp -55.89 124.31 17.2 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.819 1.647 . . . . 0.0 109.883 177.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.98 -42.51 0.16 Allowed 'General case' 0 C--O 1.233 0.189 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -177.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 16.4 t -151.27 -47.9 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 118.711 0.687 . . . . 0.0 110.172 -169.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 57.83 28.79 16.51 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.487 1.915 . . . . 0.0 113.128 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -143.35 162.67 35.12 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.377 1.871 . . . . 0.0 107.357 174.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 . . . . . 0 C--O 1.25 1.111 0 C-N-CA 125.897 1.679 . . . . 0.0 107.035 179.86 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ttt . . . . . 0 N--CA 1.483 1.209 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.8 m -104.04 93.77 5.03 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 -177.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -77.38 151.99 34.6 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 169.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.6 t -138.02 148.19 25.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -175.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 31.7 tp -122.71 119.55 31.01 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.3 tp -109.02 97.68 7.27 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 125.405 1.482 . . . . 0.0 107.487 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 87.7 m -73.53 143.17 46.63 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 169.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.8 t -140.21 142.11 32.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 142.37 178.92 18.83 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 124.214 0.912 . . . . 0.0 111.861 177.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -127.95 123.59 35.23 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.768 1.227 . . . . 0.0 108.619 177.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 m -58.74 -16.05 14.93 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.631 1.972 . . . . 0.0 115.461 -169.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.0 ptp -128.7 15.98 6.42 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 119.197 0.908 . . . . 0.0 111.259 -178.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 11.3 tpt -92.19 25.48 2.89 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.621 0.768 . . . . 0.0 109.397 176.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.75 -142.64 20.21 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -176.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -61.0 -16.82 47.68 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.695 1.198 . . . . 0.0 112.221 178.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -55.58 -20.56 13.87 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.483 1.513 . . . . 0.0 112.906 173.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.14 17.91 0.94 Allowed Glycine 0 CA--C 1.534 1.257 0 O-C-N 120.789 -1.194 . . . . 0.0 114.437 177.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.19 -51.29 69.63 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 119.566 1.683 . . . . 0.0 110.838 -170.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.77 -55.96 27.52 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-O 117.794 -1.559 . . . . 0.0 111.136 175.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -49.77 -40.78 47.66 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 CA-C-N 120.784 2.292 . . . . 0.0 115.113 178.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 62.6 tp -70.61 -39.89 73.51 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 119.862 1.21 . . . . 0.0 109.986 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.2 tp -61.47 -46.37 90.33 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.443 0.297 . . . . 0.0 110.388 176.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.69 -42.6 88.93 Favored 'General case' 0 C--O 1.227 -0.127 0 C-N-CA 123.838 0.855 . . . . 0.0 110.883 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -60.93 -48.98 79.3 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 118.616 0.643 . . . . 0.0 109.871 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -63.62 -48.69 76.28 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 123.016 0.526 . . . . 0.0 110.907 -178.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 93.0 m -65.39 -34.56 78.6 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.732 0.696 . . . . 0.0 111.478 178.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.99 -40.64 95.26 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.689 1.132 . . . . 0.0 110.848 174.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.14 -33.05 72.83 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.434 0.693 . . . . 0.0 111.8 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.57 89.54 4.42 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.394 1.478 . . . . 0.0 108.548 -174.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -52.6 155.8 9.7 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.955 3.103 . . . . 0.0 113.606 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -133.37 156.65 47.27 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.635 1.174 . . . . 0.0 109.479 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 40.84 -111.95 0.3 Allowed Glycine 0 CA--C 1.527 0.844 0 C-N-CA 125.85 1.691 . . . . 0.0 112.612 172.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -138.04 9.91 2.8 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.145 1.378 . . . . 0.0 111.295 -173.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 1.5 m95 -85.07 123.07 30.18 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 121.286 -0.884 . . . . 0.0 110.753 -168.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.7 t -70.68 119.88 17.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 166.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.6 t -74.04 132.6 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.1 mm -133.98 148.0 30.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 172.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -135.61 111.66 9.6 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.23 -1.99 88.05 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-O 118.991 -0.894 . . . . 0.0 112.727 179.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 56.16 -147.52 30.63 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -169.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 p -90.08 10.95 22.31 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.841 0.856 . . . . 0.0 111.94 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.83 55.17 7.43 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.267 1.427 . . . . 0.0 109.77 -177.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -66.36 -20.35 55.06 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.825 2.35 . . . . 0.0 113.479 -169.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.3 pm0 -61.6 -30.39 70.65 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 119.05 0.841 . . . . 0.0 111.911 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.02 -25.85 67.89 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.373 0.669 . . . . 0.0 112.084 175.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -102.84 -2.51 27.79 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.106 0.962 . . . . 0.0 113.06 -168.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.9 mt -48.52 -40.4 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.518 1.127 . . . . 0.0 110.288 174.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.1 t -56.19 -40.26 64.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.926 0.89 . . . . 0.0 110.582 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.32 -42.26 83.94 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 118.318 0.508 . . . . 0.0 110.398 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 35.3 mt -64.97 -37.48 80.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.38 -21.05 66.05 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 117.855 -1.069 . . . . 0.0 112.397 175.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -70.91 -39.74 72.57 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 120.613 1.552 . . . . 0.0 109.745 170.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 59.5 mt -70.48 -26.55 63.67 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.499 0.72 . . . . 0.0 112.187 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 40.89 65.71 4.08 Favored Pre-proline 0 N--CA 1.472 0.668 0 C-N-CA 125.698 1.599 . . . . 0.0 110.932 -171.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -52.14 137.4 54.39 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 123.253 2.635 . . . . 0.0 112.79 -169.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.0 m -69.53 -38.67 77.61 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 167.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -144.45 157.7 44.11 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 124.889 1.276 . . . . 0.0 107.885 171.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 53.5 tp -136.74 136.16 38.72 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 32.5 tp -123.67 134.92 53.66 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 175.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.0 mt -123.29 141.82 42.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 -173.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 44.6 t -140.87 134.36 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 118.773 0.715 . . . . 0.0 110.642 -174.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -162.82 171.22 17.04 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.783 2.433 . . . . 0.0 107.481 172.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.75 157.69 37.59 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 120.989 -1.069 . . . . 0.0 108.54 167.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.0 m -156.2 127.79 7.23 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 175.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -70.74 124.21 23.74 Favored 'General case' 0 C--O 1.23 0.058 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 172.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 73.6 mtm -122.39 2.2 9.66 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.142 1.777 . . . . 0.0 110.562 -177.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.11 24.64 68.9 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-N 118.66 0.664 . . . . 0.0 112.195 -172.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.6 mt -98.04 -172.71 2.42 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.398 1.479 . . . . 0.0 109.24 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -79.6 140.4 55.37 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-O 117.746 -1.121 . . . . 0.0 108.931 173.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -45.64 134.0 13.26 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.343 2.695 . . . . 0.0 113.705 178.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.49 2.08 89.27 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-O 118.254 -1.303 . . . . 0.0 113.345 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -66.29 150.24 49.15 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 120.156 1.978 . . . . 0.0 107.728 167.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 34.4 mt -131.52 135.14 59.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -169.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.4 mmt-85 -146.6 153.3 40.17 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.504 0.593 . . . . 0.0 109.984 176.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 29.4 mm -83.0 143.36 12.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 167.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.6 mt -126.11 124.17 65.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -71.39 141.09 85.33 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.419 173.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -46.99 -32.5 13.01 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 124.133 3.222 . . . . 0.0 116.594 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -67.19 -25.54 66.18 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.803 0.728 . . . . 0.0 111.799 177.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -101.42 -26.21 13.67 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.915 1.286 . . . . 0.0 111.447 -177.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 51.6 mt -50.19 -41.36 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.478 1.111 . . . . 0.0 109.109 168.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.39 -22.1 18.44 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.425 1.49 . . . . 0.0 114.075 -177.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -115.2 -33.75 5.24 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 118.68 0.673 . . . . 0.0 110.387 177.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 23.3 mmt -72.28 -28.51 63.15 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -177.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -66.39 -46.29 77.12 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 119.241 0.928 . . . . 0.0 110.92 176.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -69.55 1.34 4.16 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 -178.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 87.2 mmm -62.7 -40.06 95.94 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 166.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 63.4 p -72.2 134.69 45.8 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 169.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.6 m -49.47 114.61 1.08 Allowed 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.813 1.645 . . . . 0.0 111.428 -166.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 30.1 m170 55.78 20.77 4.24 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.422 1.489 . . . . 0.0 113.905 173.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -67.51 148.0 52.07 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.369 -0.832 . . . . 0.0 109.471 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 26.4 mmt -72.19 151.36 92.37 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -74.9 74.56 3.91 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 124.321 3.347 . . . . 0.0 109.433 175.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.83 -6.78 0.06 Allowed 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 -167.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -55.46 -17.31 4.93 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 120.997 -1.065 . . . . 0.0 112.179 166.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -59.29 -32.15 69.77 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 120.155 1.343 . . . . 0.0 111.924 173.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.3 tt -67.59 -48.92 65.46 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 174.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 74.5 mt -61.27 -45.31 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -174.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.56 -21.08 66.56 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.014 -1.054 . . . . 0.0 113.38 -174.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -91.84 5.64 49.18 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.149 0.98 . . . . 0.0 111.852 177.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 40.5 tp -140.89 -32.88 0.55 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.593 0.757 . . . . 0.0 112.311 -169.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.0 pttm -61.68 -25.28 67.31 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 125.63 1.572 . . . . 0.0 112.62 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -62.6 -18.04 61.41 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.315 1.046 . . . . 0.0 112.275 -175.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -114.12 6.21 16.27 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.231 1.012 . . . . 0.0 112.155 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 79.9 mt -120.6 146.42 25.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.848 1.259 . . . . 0.0 108.522 -171.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -75.19 -36.25 46.22 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.774 0.702 . . . . 0.0 112.143 -177.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -152.12 141.05 21.11 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.107 0.954 . . . . 0.0 108.679 175.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.6 t -124.99 135.23 64.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 171.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.0 mp -129.49 149.72 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 -177.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -130.75 141.8 50.39 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 169.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.4 tt -120.28 130.54 54.52 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.313 1.445 . . . . 0.0 107.544 173.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -111.41 155.01 16.4 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 176.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 77.1 mt -133.24 127.37 54.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -60.93 114.63 10.98 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-O 117.351 -1.309 . . . . 0.0 110.179 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -76.2 171.5 17.99 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.158 2.572 . . . . 0.0 111.116 170.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -129.42 -31.56 2.04 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.053 1.741 . . . . 0.0 111.012 171.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -135.85 136.03 50.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.237 1.015 . . . . 0.0 108.309 176.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.8 t -141.45 134.84 30.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 175.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 159.47 153.94 7.06 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -69.52 153.46 43.47 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.882 0.849 . . . . 0.0 110.775 -173.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.4 t80 51.8 39.16 25.02 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.846 2.058 . . . . 0.0 112.296 -176.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 23.0 m-30 -121.97 147.63 49.34 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 124.067 0.947 . . . . 0.0 109.961 173.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -81.15 164.09 19.77 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.153 2.568 . . . . 0.0 111.15 177.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.3 ttm -72.59 139.41 47.44 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 168.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 68.6 p -79.08 159.36 27.55 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.191 0.996 . . . . 0.0 110.522 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.2 tp60 -52.87 -44.26 95.88 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-O 116.579 -1.677 . . . . 0.0 114.232 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -68.78 -30.55 27.08 Favored 'Trans proline' 0 C--N 1.35 0.647 0 CA-C-N 122.869 2.06 . . . . 0.0 112.295 -176.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.97 -35.26 15.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 119.072 0.851 . . . . 0.0 108.706 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -56.29 -46.91 79.56 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.136 0.88 . . . . 0.0 109.977 169.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -63.28 -38.27 90.5 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.037 0.535 . . . . 0.0 111.248 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.35 -47.14 80.44 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 121.967 -0.458 . . . . 0.0 111.133 176.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.5 t -61.4 -41.27 89.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 118.581 0.628 . . . . 0.0 109.655 177.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -62.36 -33.86 75.55 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.863 0.865 . . . . 0.0 111.074 175.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 44.3 m -69.52 -46.23 67.02 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.462 -0.774 . . . . 0.0 109.926 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 92.3 t -61.97 -44.35 98.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 119.203 0.911 . . . . 0.0 109.592 178.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -53.37 -43.82 68.09 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.32 1.048 . . . . 0.0 111.172 176.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -68.73 -45.02 72.61 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.527 0.603 . . . . 0.0 111.119 175.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -58.7 -36.66 74.58 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.133 0.573 . . . . 0.0 111.221 -174.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 56.9 mt -56.27 -19.06 12.47 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -175.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -72.92 -25.65 61.12 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 120.09 1.314 . . . . 0.0 112.211 176.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -132.21 1.8 4.99 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.416 1.008 . . . . 0.0 113.72 -173.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -54.42 113.0 1.11 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.342 1.857 . . . . 0.0 109.09 175.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -80.09 -43.45 21.73 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.621 0.368 . . . . 0.0 110.721 -177.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -168.77 -39.2 0.02 OUTLIER Glycine 0 CA--C 1.529 0.91 0 CA-C-O 118.822 -0.988 . . . . 0.0 112.671 -178.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -113.38 3.73 16.01 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 118.406 1.103 . . . . 0.0 112.209 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 61.3 15.8 46.54 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.187 0.899 . . . . 0.0 113.832 -176.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 63.99 2.22 6.3 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-N 118.625 1.212 . . . . 0.0 113.574 -171.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -75.17 148.55 39.49 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 119.202 1.501 . . . . 0.0 108.818 177.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.87 148.47 42.29 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.196 176.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -92.15 119.85 32.19 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 60.4 tp -56.66 124.31 17.9 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.024 1.729 . . . . 0.0 110.104 178.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -145.78 44.34 1.27 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.103 0.961 . . . . 0.0 110.653 -174.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 4.5 t 52.72 49.11 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 125.295 1.438 . . . . 0.0 109.792 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -65.14 163.14 15.59 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.933 0.893 . . . . 0.0 111.108 176.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -143.15 163.49 32.75 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.804 1.642 . . . . 0.0 107.892 177.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 . . . . . 0 C--O 1.248 0.989 0 C-N-CA 125.659 1.583 . . . . 0.0 106.891 177.395 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.6 mmt . . . . . 0 N--CA 1.484 1.23 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 15.2 m -145.6 139.11 26.43 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -176.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -136.54 97.07 3.47 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 -172.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.8 m -86.41 150.72 3.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 123.758 0.823 . . . . 0.0 110.04 -172.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 52.6 tp -115.32 124.51 51.47 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 171.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 67.2 tp -112.95 97.41 6.51 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 92.2 m -72.97 141.97 47.78 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 169.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.4 t -141.23 142.03 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 125.216 1.407 . . . . 0.0 107.734 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 148.91 178.04 23.61 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 123.971 0.796 . . . . 0.0 112.272 175.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -124.93 117.17 23.46 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 125.387 1.475 . . . . 0.0 107.908 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 m -56.13 -21.63 23.63 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 126.5 1.92 . . . . 0.0 115.339 -170.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 25.7 ptp -123.91 20.48 9.2 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.665 0.666 . . . . 0.0 110.794 -174.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.411 ' HA ' ' HA ' ' A' ' 120' ' ' PHE . 24.9 ttt -102.34 29.23 5.31 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.38 1.072 . . . . 0.0 110.29 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.33 -142.07 21.83 Favored Glycine 0 N--CA 1.441 -1.021 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -63.17 -15.44 56.89 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.37 1.068 . . . . 0.0 112.223 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -56.17 -21.49 23.24 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.15 1.38 . . . . 0.0 112.987 175.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.33 21.29 0.69 Allowed Glycine 0 CA--C 1.534 1.246 0 CA-C-O 118.491 -1.172 . . . . 0.0 114.475 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.1 -51.88 67.27 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 119.545 1.673 . . . . 0.0 110.758 -169.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.28 -55.32 30.81 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 117.502 -1.721 . . . . 0.0 111.423 177.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -50.47 -40.14 54.23 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 CA-C-N 120.921 2.36 . . . . 0.0 115.076 178.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.6 tp -71.07 -39.48 72.18 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 119.878 1.217 . . . . 0.0 110.039 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 51.1 tp -61.53 -48.85 79.13 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 176.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.26 -41.7 80.14 Favored 'General case' 0 C--O 1.227 -0.107 0 C-N-CA 124.054 0.942 . . . . 0.0 111.283 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -60.77 -49.1 78.86 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.661 0.664 . . . . 0.0 109.897 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -62.66 -47.74 82.37 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 122.983 0.513 . . . . 0.0 110.702 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 73.8 m -64.74 -37.95 89.33 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.574 0.624 . . . . 0.0 111.458 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.81 -40.91 97.77 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.991 0.814 . . . . 0.0 110.806 176.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.67 -32.53 72.42 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.483 0.713 . . . . 0.0 111.837 178.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.86 92.6 2.85 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 125.268 1.427 . . . . 0.0 108.461 -172.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -53.8 158.85 7.8 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.34 2.693 . . . . 0.0 113.567 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.414 ' HE2' ' CE1' ' A' ' 136' ' ' TYR . 74.7 mmtt -129.36 166.39 19.61 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.481 1.512 . . . . 0.0 108.474 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 41.17 -124.37 2.88 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.478 1.513 . . . . 0.0 112.139 175.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -138.47 35.98 2.26 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.185 1.394 . . . . 0.0 109.028 170.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -70.49 167.02 19.25 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.146 0.978 . . . . 0.0 111.441 -175.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 68.7 t -122.29 101.95 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 168.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.9 t -72.43 136.91 24.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -175.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 90.9 mt -135.33 142.31 40.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 172.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -127.01 105.29 8.5 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.55 -6.36 80.76 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 118.973 -0.904 . . . . 0.0 112.69 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 54.22 -140.7 35.42 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 -169.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.4 p -93.2 7.89 42.43 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.624 0.77 . . . . 0.0 112.469 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.72 64.22 42.52 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 124.875 1.27 . . . . 0.0 109.528 177.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -65.17 -15.63 51.15 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.668 2.245 . . . . 0.0 112.183 -177.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -46.92 -42.37 17.55 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.703 1.601 . . . . 0.0 111.161 168.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.96 -27.29 68.73 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.93 -5.43 41.4 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.854 1.261 . . . . 0.0 111.33 -169.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.8 mt -52.86 -44.9 49.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 118.919 0.781 . . . . 0.0 109.18 171.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.7 t -60.99 -42.29 92.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.22 -44.69 87.48 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 123.192 0.597 . . . . 0.0 110.854 -177.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 72.9 mt -55.39 -48.15 77.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.091 0.956 . . . . 0.0 108.504 173.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 49.7 mtp180 -67.83 -19.17 65.03 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 117.598 -1.192 . . . . 0.0 113.135 -176.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -58.97 -27.39 65.33 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 121.023 1.738 . . . . 0.0 110.977 171.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 58.6 mt -95.93 -9.52 31.05 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.582 1.153 . . . . 0.0 112.33 -172.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 48.7 mmm-85 32.85 58.48 1.47 Allowed Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 126.423 1.889 . . . . 0.0 111.764 -169.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -56.09 152.49 37.14 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.073 2.515 . . . . 0.0 114.867 -168.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.1 m -71.97 -39.06 69.6 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.089 0.955 . . . . 0.0 109.244 168.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -148.67 160.12 43.46 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.633 0.773 . . . . 0.0 111.126 -177.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 24.1 tp -141.91 139.52 32.57 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 125.304 1.442 . . . . 0.0 109.074 177.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 54.4 tp -124.17 135.98 53.86 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 168.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.9 mt -119.49 144.97 26.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -178.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 46.3 t -139.92 133.68 36.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 123.148 0.579 . . . . 0.0 109.649 -175.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -162.65 171.68 16.52 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 127.335 2.254 . . . . 0.0 107.245 173.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.07 155.31 40.58 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 167.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.1 m -153.86 135.56 14.44 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 177.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -81.09 84.45 6.51 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.945 0.793 . . . . 0.0 109.873 176.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -69.48 -8.88 50.79 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.698 0.799 . . . . 0.0 112.121 173.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.36 24.89 76.39 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 119.434 1.016 . . . . 0.0 111.634 -171.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 98.0 mt -100.01 -173.26 2.39 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.232 1.413 . . . . 0.0 110.477 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -69.66 139.76 89.01 Favored Pre-proline 0 N--CA 1.467 0.407 0 CA-C-O 117.606 -1.188 . . . . 0.0 108.72 169.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -43.04 138.92 3.88 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.544 2.829 . . . . 0.0 113.57 172.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.17 0.27 76.42 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 118.6 -1.111 . . . . 0.0 113.679 176.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -65.72 154.78 38.0 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 119.794 1.797 . . . . 0.0 108.815 168.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 77.4 mt -134.7 132.87 54.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 125.825 1.65 . . . . 0.0 106.699 -170.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.2 mmt-85 -143.39 148.11 35.69 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.291 0.95 . . . . 0.0 109.733 177.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 47.1 mm -77.92 144.68 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 169.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -135.5 165.63 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 124.777 1.231 . . . . 0.0 108.205 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -139.42 146.16 47.21 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 127.086 2.155 . . . . 0.0 107.619 -169.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -54.12 -27.97 48.88 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.399 2.733 . . . . 0.0 115.088 -174.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -67.29 -20.02 65.57 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.862 0.755 . . . . 0.0 112.123 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -119.85 -31.2 4.56 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.91 1.284 . . . . 0.0 111.84 -171.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 67.2 mt -50.74 -39.98 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.373 1.469 . . . . 0.0 109.938 169.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.45 -28.28 53.36 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.359 1.064 . . . . 0.0 113.129 -177.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -102.24 -43.83 5.6 Favored 'General case' 0 C--O 1.23 0.078 0 C-N-CA 123.202 0.601 . . . . 0.0 109.53 176.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 21.2 mmt -69.06 -28.76 66.83 Favored 'General case' 0 C--O 1.23 0.057 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -169.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -68.06 -48.36 65.82 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 119.038 0.835 . . . . 0.0 110.724 175.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 28.8 ptm -80.64 9.86 5.59 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 15.1 tpt -60.8 -27.37 67.98 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.432 1.015 . . . . 0.0 109.488 167.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 45.4 p -59.81 -15.56 21.59 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.096 1.758 . . . . 0.0 112.9 169.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.9 m 56.78 31.34 19.31 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.941 1.696 . . . . 0.0 109.961 -168.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -153.52 -54.58 0.11 Allowed 'General case' 0 C--N 1.345 0.404 0 O-C-N 121.393 -0.817 . . . . 0.0 112.988 -171.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -70.5 150.92 45.66 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 118.113 0.415 . . . . 0.0 110.321 -169.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 26.3 mmt -68.34 145.47 97.39 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 123.31 0.644 . . . . 0.0 109.632 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -73.83 76.58 2.87 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 124.463 3.442 . . . . 0.0 109.057 176.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.3 mt -52.03 -7.56 0.06 Allowed 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 117.087 2.255 . . . . 0.0 117.087 -167.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -52.78 -23.24 6.46 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.318 -0.864 . . . . 0.0 112.278 167.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -58.83 -34.4 71.49 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.396 0.998 . . . . 0.0 111.593 175.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.3 tt -75.83 -44.29 41.73 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 86.7 mt -60.96 -42.0 91.18 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.175 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -60.84 -26.01 67.04 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.853 0.751 . . . . 0.0 112.606 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -85.06 -3.57 58.84 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.753 0.821 . . . . 0.0 112.211 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 80.3 mt -130.01 -26.59 2.37 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.22 1.008 . . . . 0.0 111.946 -173.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -63.44 -23.11 67.26 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.221 -0.924 . . . . 0.0 112.286 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -80.09 -6.06 57.0 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.148 0.979 . . . . 0.0 111.789 175.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -132.51 -3.06 3.38 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.689 1.195 . . . . 0.0 113.038 -168.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.3 mt -134.85 143.41 37.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 126.549 1.94 . . . . 0.0 106.163 -175.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -70.37 -37.15 70.2 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-O 119.464 -0.631 . . . . 0.0 112.539 -172.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -146.53 130.88 17.59 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 -177.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 48.6 t -132.12 124.31 52.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 21.3 mt -130.19 156.68 42.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 -169.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -130.82 147.47 52.48 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 174.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.8 tt -126.37 126.5 43.99 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 170.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -107.69 156.16 15.98 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 82.5 mt -131.82 126.32 56.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 71.1 tp60 -64.64 116.03 25.44 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-O 117.201 -1.381 . . . . 0.0 110.438 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -76.51 170.59 19.64 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.268 2.645 . . . . 0.0 111.377 170.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -128.08 -31.9 2.32 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.978 1.711 . . . . 0.0 110.984 171.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.1 pp -137.14 139.77 43.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 124.369 1.068 . . . . 0.0 108.531 178.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 92.8 t -143.22 138.55 26.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 175.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 163.01 140.06 2.78 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 175.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 13' ' ' MET . 13.0 t80 -74.1 42.71 0.15 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.806 2.042 . . . . 0.0 113.759 -169.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -161.39 26.1 0.13 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.608 1.563 . . . . 0.0 110.731 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -135.04 153.24 78.33 Favored Pre-proline 0 CA--C 1.536 0.421 0 O-C-N 121.517 -0.74 . . . . 0.0 112.15 -174.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -83.75 166.1 13.52 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.601 2.867 . . . . 0.0 110.854 172.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.4 ttm -69.83 140.87 53.32 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 168.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 71.7 p -81.32 160.45 24.17 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.509 1.124 . . . . 0.0 110.682 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 6.9 tm0? -50.91 -48.81 83.32 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-O 117.004 -1.474 . . . . 0.0 113.351 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -67.53 -29.3 37.26 Favored 'Trans proline' 0 C--N 1.352 0.753 0 CA-C-N 122.575 1.955 . . . . 0.0 112.573 -175.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -81.63 -34.76 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 119.134 0.879 . . . . 0.0 108.865 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -56.65 -46.61 80.95 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 119.183 0.901 . . . . 0.0 109.782 169.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -62.36 -38.74 90.7 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 123.092 0.557 . . . . 0.0 111.525 177.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.41 -46.93 81.13 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 122.036 -0.415 . . . . 0.0 111.094 176.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 62.7 t -62.38 -40.32 87.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 118.81 0.732 . . . . 0.0 109.782 178.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -61.48 -40.06 93.17 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.625 0.648 . . . . 0.0 110.52 174.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 49.5 m -63.94 -46.92 82.6 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.785 -0.626 . . . . 0.0 109.962 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 85.4 t -58.83 -47.6 88.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 119.209 0.913 . . . . 0.0 109.133 177.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.414 ' CE1' ' HE2' ' A' ' 31' ' ' LYS . 24.4 t80 -53.83 -46.87 71.31 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.939 0.896 . . . . 0.0 111.2 177.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -72.36 -4.96 33.05 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 178.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.38 -11.4 10.57 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.17 1.388 . . . . 0.0 109.452 -175.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 59.5 mt -59.72 -25.45 64.83 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 119.348 -2.095 . . . . 0.0 111.449 170.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -81.33 -1.05 43.83 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.668 1.187 . . . . 0.0 113.555 177.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -137.4 -19.29 0.6 Allowed Glycine 0 CA--C 1.532 1.138 0 CA-C-N 119.182 0.901 . . . . 0.0 114.476 -172.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 17.1 t90 -60.26 149.62 32.74 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 118.422 1.111 . . . . 0.0 110.527 172.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.48 -2.36 2.47 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.391 1.876 . . . . 0.0 111.646 -175.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 150.93 -25.28 1.02 Allowed Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.725 1.631 . . . . 0.0 111.616 -173.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -142.79 -29.75 0.55 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.563 1.182 . . . . 0.0 112.652 -177.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 56.74 29.0 57.74 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.025 1.298 . . . . 0.0 113.751 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 78.76 4.87 88.39 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-O 118.204 -1.331 . . . . 0.0 114.265 173.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -87.74 150.87 23.33 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 119.874 1.837 . . . . 0.0 110.049 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.36 144.65 44.33 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -87.88 119.81 28.59 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 48.4 tp -57.96 137.91 56.35 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.322 1.449 . . . . 0.0 110.255 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -137.19 -63.9 0.58 Allowed 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.253 0.621 . . . . 0.0 111.431 173.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 8.1 p -156.26 9.0 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 C-N-CA 124.243 1.017 . . . . 0.0 111.121 -173.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -68.43 146.13 53.47 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.188 -0.945 . . . . 0.0 109.472 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -143.5 163.84 32.01 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.617 1.567 . . . . 0.0 108.109 177.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 . . . . . 0 C--O 1.252 1.204 0 C-N-CA 125.166 1.386 . . . . 0.0 109.874 173.491 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 44.4 m -128.2 135.98 50.46 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 170.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -137.81 96.68 3.27 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 -168.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 49.1 t -88.42 143.56 10.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-O 121.518 0.675 . . . . 0.0 109.357 -170.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.2 tp -113.22 108.67 17.59 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 169.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.1 tp -98.09 103.14 15.06 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 99.8 m -77.58 141.67 39.4 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 169.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 54.3 t -140.84 141.67 31.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 152.73 176.48 25.34 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-N 118.44 0.563 . . . . 0.0 112.9 174.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -120.15 115.65 24.08 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.73 1.612 . . . . 0.0 108.494 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -66.5 -10.39 44.18 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 -170.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 21.9 ptp -117.34 2.0 12.46 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.912 1.233 . . . . 0.0 111.267 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.3 ttt -95.75 39.85 1.13 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 122.087 0.946 . . . . 0.0 109.227 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 57.66 -121.83 27.13 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 124.327 0.965 . . . . 0.0 110.759 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -61.43 -19.67 62.22 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.096 0.959 . . . . 0.0 112.502 -174.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -65.61 -13.02 58.23 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.614 0.765 . . . . 0.0 112.274 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.19 17.4 1.4 Allowed Glycine 0 CA--C 1.531 1.039 0 O-C-N 120.743 -1.223 . . . . 0.0 113.097 176.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.26 -52.22 65.67 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.604 1.702 . . . . 0.0 110.821 -169.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.59 -55.6 29.02 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-O 117.745 -1.586 . . . . 0.0 111.024 175.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -49.73 -40.98 47.27 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 CA-C-N 120.878 2.339 . . . . 0.0 115.217 177.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.7 tp -71.98 -36.66 69.85 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 119.876 1.216 . . . . 0.0 110.408 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 49.4 tp -61.74 -49.94 74.41 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.332 0.515 . . . . 0.0 109.936 174.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.73 -39.49 77.43 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.923 0.889 . . . . 0.0 111.102 177.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.9 tp10 -62.05 -49.48 75.82 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 118.778 0.717 . . . . 0.0 109.87 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -62.24 -44.49 96.43 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.816 0.446 . . . . 0.0 110.614 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 84.9 m -63.64 -42.34 98.15 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.298 0.499 . . . . 0.0 110.997 178.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.18 -39.53 94.91 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.309 0.504 . . . . 0.0 111.046 178.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.37 -36.36 76.75 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.258 0.623 . . . . 0.0 111.486 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.01 91.61 2.43 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 124.8 1.24 . . . . 0.0 108.877 -171.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -55.65 163.26 5.51 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.633 2.889 . . . . 0.0 113.811 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -133.71 174.42 10.46 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 126.033 1.733 . . . . 0.0 108.87 176.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 40.1 -125.4 2.46 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.228 1.394 . . . . 0.0 112.336 177.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -141.25 38.4 1.73 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.319 1.447 . . . . 0.0 109.169 172.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -74.93 168.38 20.05 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.341 1.057 . . . . 0.0 111.904 -172.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 67.9 t -120.38 105.6 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 167.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.0 t -70.44 137.77 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -178.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.0 mm -134.59 148.21 29.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 169.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -130.66 109.81 10.92 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 175.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.22 -1.91 88.12 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 118.868 -0.962 . . . . 0.0 112.833 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 60.93 -146.5 47.54 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -170.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.8 p -94.44 -1.78 53.02 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.15 0.98 . . . . 0.0 112.917 -172.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.66 70.0 31.07 Favored Pre-proline 0 C--O 1.235 0.303 0 C-N-CA 125.138 1.375 . . . . 0.0 107.993 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -66.1 -12.42 35.37 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.777 2.318 . . . . 0.0 112.77 -169.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.8 tp10 -44.57 -41.15 6.3 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.592 1.557 . . . . 0.0 110.938 168.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -62.86 -23.71 67.45 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -177.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -113.86 -2.22 13.68 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -168.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 79.6 mt -50.59 -37.7 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.154 0.981 . . . . 0.0 110.311 172.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 53.1 t -55.92 -40.28 61.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 123.852 0.861 . . . . 0.0 110.395 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.81 -43.29 84.19 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.431 0.56 . . . . 0.0 110.406 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.3 mt -62.36 -39.5 84.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -65.91 -18.99 65.71 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 117.724 -1.131 . . . . 0.0 112.513 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -69.19 -42.95 75.14 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 120.702 1.592 . . . . 0.0 109.241 169.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.4 mt -72.6 -25.75 61.44 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.648 0.779 . . . . 0.0 112.447 -175.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 38.22 60.32 4.83 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.703 1.601 . . . . 0.0 111.929 -169.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.37 151.02 38.73 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.862 2.374 . . . . 0.0 113.501 -170.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.6 m -71.66 -37.28 70.81 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 168.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -147.4 155.86 42.34 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.201 1.0 . . . . 0.0 109.31 -176.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 37.1 tp -144.51 136.22 25.79 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.63 1.172 . . . . 0.0 108.633 -177.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 56.9 tp -122.14 137.85 54.67 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 169.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.2 mt -122.21 143.19 35.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 -177.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.9 t -140.97 134.07 31.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 118.294 0.497 . . . . 0.0 110.013 -174.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -161.92 173.15 14.9 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 127.11 2.164 . . . . 0.0 107.456 169.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.69 156.58 39.29 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.055 -1.028 . . . . 0.0 109.906 169.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.8 m -152.92 129.49 10.74 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -178.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -79.85 83.63 5.75 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 119.031 0.832 . . . . 0.0 109.561 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 74.9 mtm -77.26 -7.28 55.7 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.583 1.553 . . . . 0.0 112.018 -177.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.33 26.67 72.98 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 123.816 0.722 . . . . 0.0 111.672 -172.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.4 mt -104.88 -171.24 1.88 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.936 1.294 . . . . 0.0 110.004 -177.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -73.66 140.2 78.17 Favored Pre-proline 0 N--CA 1.468 0.467 0 CA-C-O 117.47 -1.252 . . . . 0.0 108.676 171.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -42.96 137.59 4.37 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.303 2.668 . . . . 0.0 113.378 172.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.66 2.74 76.87 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 118.692 -1.06 . . . . 0.0 113.7 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -66.11 148.1 52.34 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.743 1.771 . . . . 0.0 108.348 168.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.13 136.32 59.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -173.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 89.4 mmt-85 -145.9 151.16 37.41 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 118.8 0.727 . . . . 0.0 110.703 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 49.0 mm -75.9 144.09 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 167.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.418 HG21 ' H ' ' A' ' 77' ' ' ASP . 1.4 mt -133.64 165.79 30.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 124.55 1.14 . . . . 0.0 107.989 177.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.418 ' H ' HG21 ' A' ' 76' ' ' ILE . 5.9 t70 -135.63 145.89 55.12 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 127.116 2.166 . . . . 0.0 107.681 -170.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -54.46 -26.6 45.54 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.395 2.73 . . . . 0.0 115.147 -174.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -66.51 -21.37 66.17 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.012 0.824 . . . . 0.0 112.273 177.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -120.39 -28.52 4.99 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.708 1.203 . . . . 0.0 112.14 -171.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 72.0 mt -51.23 -39.78 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.845 1.258 . . . . 0.0 109.743 169.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.9 -28.6 51.91 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.53 1.132 . . . . 0.0 113.261 -177.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -100.9 -44.27 5.81 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 123.068 0.547 . . . . 0.0 109.657 175.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 21.3 mmt -67.26 -26.77 66.73 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -171.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -76.85 -43.33 36.64 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.741 0.701 . . . . 0.0 111.502 174.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 22.0 ptt? -71.15 -17.79 62.53 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.102 0.864 . . . . 0.0 112.044 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 14.4 tpt -55.35 -27.22 45.78 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.347 1.059 . . . . 0.0 112.229 173.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 75.9 p -59.67 -31.15 69.29 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.63 0.772 . . . . 0.0 112.501 176.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.3 m 139.07 -41.89 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.605 1 C-N-CA 133.43 4.692 . . . . 0.0 105.849 -168.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -166.66 -46.25 0.02 OUTLIER 'General case' 0 C--N 1.347 0.481 0 C-N-CA 123.414 0.686 . . . . 0.0 112.144 174.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 42.77 -105.72 0.07 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.681 1.592 . . . . 0.0 108.332 -165.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 17.3 mmt -149.34 141.79 15.38 Favored Pre-proline 0 N--CA 1.452 -0.364 0 N-CA-C 104.036 -2.579 . . . . 0.0 104.036 168.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -74.83 59.05 4.95 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.786 2.991 . . . . 0.0 110.613 175.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 18.8 mt -47.86 -14.36 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 129.148 2.979 . . . . 0.0 116.903 -168.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -52.42 -24.94 8.71 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.406 1.003 . . . . 0.0 112.578 168.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -59.18 -33.05 70.48 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 119.32 0.964 . . . . 0.0 111.803 176.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.6 tt -75.61 -41.77 53.49 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 -177.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 92.2 mt -61.4 -48.59 88.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -61.7 -29.44 70.1 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.392 0.542 . . . . 0.0 112.395 -177.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -82.28 -2.69 53.41 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.002 0.921 . . . . 0.0 113.246 178.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 64.4 mt -133.08 -25.71 1.77 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.676 1.125 . . . . 0.0 112.549 -174.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -59.02 -21.62 59.34 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.353 1.061 . . . . 0.0 112.862 177.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -72.8 -11.19 60.51 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.415 1.086 . . . . 0.0 112.051 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -133.09 -42.54 0.88 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.349 1.06 . . . . 0.0 111.733 -173.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 28.2 mt -73.65 140.42 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 175.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.05 -40.89 95.34 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.185 0.897 . . . . 0.0 112.141 -177.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -148.49 137.14 21.47 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 118.633 1.216 . . . . 0.0 108.429 177.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.8 t -131.9 123.06 50.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -178.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 18.2 mt -129.54 155.39 41.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 -171.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -127.99 147.13 50.49 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 175.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.6 tt -129.1 130.36 46.39 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 172.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -115.19 156.96 15.31 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 77.6 mt -133.49 127.53 53.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 125.215 1.406 . . . . 0.0 107.269 -176.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 69.1 tp60 -67.25 117.6 48.05 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-O 117.607 -1.187 . . . . 0.0 111.129 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.35 175.04 11.78 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 124.27 3.313 . . . . 0.0 111.887 170.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -134.12 -29.16 1.29 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.257 1.423 . . . . 0.0 112.78 175.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.2 pp -132.29 4.22 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 119.362 0.983 . . . . 0.0 113.408 -171.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 8.5 p -38.43 118.49 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 125.929 1.692 . . . . 0.0 113.713 -167.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 170.31 158.37 14.09 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -175.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -67.17 152.56 45.53 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.996 0.919 . . . . 0.0 111.647 -173.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 56.32 41.76 28.67 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.883 2.073 . . . . 0.0 112.046 177.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -127.33 152.59 76.46 Favored Pre-proline 0 C--O 1.236 0.356 0 C-N-CA 124.287 1.035 . . . . 0.0 109.176 172.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -77.76 157.57 31.58 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.031 2.487 . . . . 0.0 109.875 168.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 56.5 ttm -66.25 136.64 56.14 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 169.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 18.1 p -77.75 154.45 31.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.588 0.709 . . . . 0.0 111.318 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -49.33 -47.25 77.17 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-O 116.916 -1.516 . . . . 0.0 113.443 -177.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -66.98 -28.13 42.11 Favored 'Trans proline' 0 C--N 1.351 0.69 0 CA-C-N 122.46 1.914 . . . . 0.0 112.407 -177.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 mp -78.12 -37.81 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 119.29 0.95 . . . . 0.0 108.564 177.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -57.28 -47.42 81.51 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.44 1.018 . . . . 0.0 110.074 172.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.18 -41.81 97.46 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 123.347 0.659 . . . . 0.0 111.053 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.94 -47.82 81.58 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 118.997 -0.525 . . . . 0.0 111.15 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.2 t -59.22 -41.21 83.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 118.886 0.766 . . . . 0.0 109.467 178.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -69.49 -27.83 65.54 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.861 0.755 . . . . 0.0 111.776 177.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 40.1 m -72.2 -42.39 65.86 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 120.982 -1.074 . . . . 0.0 109.944 174.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 88.0 t -61.18 -44.38 98.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 174.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -54.31 -47.04 72.91 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.163 0.985 . . . . 0.0 110.875 175.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -62.73 -40.72 98.09 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 118.869 0.758 . . . . 0.0 111.461 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -60.32 -25.39 65.76 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 118.368 -0.825 . . . . 0.0 112.463 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 93.0 mt -57.18 -22.66 42.07 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.852 1.205 . . . . 0.0 112.421 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -79.13 -9.45 59.56 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.731 0.812 . . . . 0.0 112.411 -178.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -150.99 -10.85 0.1 OUTLIER Glycine 0 CA--C 1.535 1.291 0 N-CA-C 115.884 1.114 . . . . 0.0 115.884 -171.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 17.7 t90 -58.17 139.53 54.69 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 119.175 1.487 . . . . 0.0 108.772 170.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -137.65 14.07 2.94 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.007 1.323 . . . . 0.0 111.058 172.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 158.05 -34.58 0.52 Allowed Glycine 0 CA--C 1.527 0.801 0 C-N-CA 123.866 0.746 . . . . 0.0 111.762 177.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -133.64 -26.32 1.61 Allowed 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -171.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 58.73 13.7 19.18 Favored Glycine 0 CA--C 1.537 1.423 0 N-CA-C 115.389 0.916 . . . . 0.0 115.389 176.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 85.14 1.27 88.58 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-N 118.793 1.296 . . . . 0.0 113.239 -178.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -74.57 165.87 24.49 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 119.721 1.76 . . . . 0.0 110.685 176.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -90.55 153.4 20.38 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 170.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -91.79 123.12 34.94 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 177.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 58.3 tp -59.02 116.75 4.02 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.986 1.314 . . . . 0.0 109.809 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -149.56 55.62 0.97 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.088 0.955 . . . . 0.0 109.379 -174.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . 0.272 35.1 m 42.62 47.84 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 127.017 2.127 . . . . 0.0 113.292 178.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -61.61 149.9 37.87 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.623 1.169 . . . . 0.0 110.916 176.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -142.09 31.34 1.58 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.461 1.504 . . . . 0.0 109.352 -178.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 . . . . . 0 C--O 1.25 1.079 0 C-N-CA 126.261 1.824 . . . . 0.0 108.486 -177.637 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 N--CA 1.482 1.15 0 N-CA-C 110.705 -0.109 . . . . 0.0 110.705 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.42 158.34 44.04 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -146.68 138.13 24.37 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -176.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 88.4 t -135.47 146.2 30.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 121.425 0.631 . . . . 0.0 110.284 -168.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 17.1 tp -115.03 126.94 55.31 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 104.889 -2.263 . . . . 0.0 104.889 168.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.8 tp -116.29 99.36 7.15 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 87.9 m -72.68 142.76 48.25 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 169.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.4 t -143.79 144.75 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 147.17 172.17 17.11 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -121.96 114.37 20.88 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 123.818 0.847 . . . . 0.0 109.138 -176.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -59.87 -11.76 6.17 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.624 1.97 . . . . 0.0 115.197 -170.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 22.5 ptp -127.72 10.13 6.54 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 119.212 0.915 . . . . 0.0 111.303 -178.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.4 ttt -98.04 31.33 2.75 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.072 0.851 . . . . 0.0 109.665 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.22 -140.49 20.67 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -178.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -62.04 -16.92 55.38 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.681 1.192 . . . . 0.0 112.389 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -58.19 -16.55 14.07 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.89 1.276 . . . . 0.0 112.995 176.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.32 21.86 0.84 Allowed Glycine 0 CA--C 1.535 1.324 0 O-C-N 120.288 -1.507 . . . . 0.0 114.451 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.94 -50.55 70.37 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 119.522 1.661 . . . . 0.0 111.363 -169.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.26 -54.43 37.96 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 117.555 -1.692 . . . . 0.0 111.322 177.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -48.37 -41.72 35.3 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 CA-C-N 120.656 2.228 . . . . 0.0 115.1 175.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.3 tp -72.54 -37.59 68.23 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.848 1.204 . . . . 0.0 110.706 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.6 tp -61.74 -45.95 91.74 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.605 0.639 . . . . 0.0 109.998 174.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.89 -38.55 86.05 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.903 0.881 . . . . 0.0 111.09 179.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.4 tp10 -61.86 -49.08 77.69 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 118.7 0.682 . . . . 0.0 109.541 178.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -63.84 -44.85 91.95 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.781 0.432 . . . . 0.0 110.501 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 73.3 m -63.69 -39.47 94.39 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.487 0.585 . . . . 0.0 111.444 177.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.22 -37.51 87.73 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.89 0.768 . . . . 0.0 111.113 177.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.48 -36.65 76.74 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.089 0.556 . . . . 0.0 111.245 178.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.71 98.51 1.53 Allowed Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 125.023 1.329 . . . . 0.0 108.163 -173.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -55.14 169.18 1.02 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 124.316 3.344 . . . . 0.0 114.983 -178.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.536 ' HE2' ' CZ ' ' A' ' 136' ' ' TYR . 14.9 mmtm -140.52 158.9 43.31 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.758 1.623 . . . . 0.0 108.28 -177.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 42.79 -126.33 4.71 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.007 1.289 . . . . 0.0 111.95 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -136.53 12.1 3.21 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.036 1.334 . . . . 0.0 111.164 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -73.64 131.03 41.22 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.942 0.897 . . . . 0.0 108.806 -173.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 97.5 t -69.85 112.86 5.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 166.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.3 t -71.56 133.16 32.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 60.4 mt -132.84 145.13 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 104.258 -2.497 . . . . 0.0 104.258 169.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -128.42 98.48 5.06 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 177.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.43 -14.07 71.54 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-O 119.136 -0.814 . . . . 0.0 112.121 175.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 51.71 -135.66 33.66 Favored Glycine 0 C--N 1.34 0.795 0 CA-C-N 118.208 1.004 . . . . 0.0 110.591 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.6 t -88.4 7.21 33.69 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.109 0.964 . . . . 0.0 111.554 -175.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.47 60.56 5.61 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.666 1.186 . . . . 0.0 110.12 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -69.7 -18.2 37.41 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.723 2.282 . . . . 0.0 112.929 -169.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -56.66 -31.69 64.65 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.44 0.696 . . . . 0.0 112.267 177.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.47 -30.32 69.6 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.296 0.639 . . . . 0.0 111.982 176.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -94.16 -6.4 44.96 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.022 0.929 . . . . 0.0 111.496 -169.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.2 mt -53.19 -43.85 50.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 118.964 0.802 . . . . 0.0 109.2 173.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.0 t -61.14 -42.11 92.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 122.981 0.512 . . . . 0.0 110.012 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.0 -46.87 73.21 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 122.923 0.489 . . . . 0.0 110.689 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.6 mt -55.09 -45.72 77.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.258 1.023 . . . . 0.0 109.179 174.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -60.86 -30.96 70.44 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 117.846 -1.073 . . . . 0.0 112.357 -177.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -59.46 -30.73 68.73 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 120.083 1.31 . . . . 0.0 111.265 176.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 56.5 mt -87.07 -9.06 56.37 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.666 1.186 . . . . 0.0 112.374 -173.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 27.34 61.73 0.6 Allowed Pre-proline 0 N--CA 1.475 0.811 0 C-N-CA 127.084 2.154 . . . . 0.0 112.229 -168.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.22 142.99 66.05 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.75 2.3 . . . . 0.0 114.203 -169.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.2 m -74.39 -30.37 61.92 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 168.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -146.54 151.66 37.7 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.007 0.923 . . . . 0.0 110.023 177.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 46.0 tp -141.24 136.11 31.36 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.674 1.59 . . . . 0.0 107.83 174.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 20.8 tp -126.8 133.42 50.79 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 105.674 -1.972 . . . . 0.0 105.674 172.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.4 mt -119.36 144.7 27.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -172.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.6 t -140.46 134.76 34.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 118.557 0.617 . . . . 0.0 109.875 -174.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -161.4 175.94 11.66 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 127.347 2.259 . . . . 0.0 107.082 172.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.44 160.4 30.28 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 120.805 -1.184 . . . . 0.0 108.494 167.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.0 m -156.29 125.27 6.02 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -70.72 122.3 19.57 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 169.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 77.1 mtm -122.46 1.39 9.56 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.53 1.532 . . . . 0.0 110.896 -175.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.87 26.05 71.01 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 118.568 0.622 . . . . 0.0 112.071 -173.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 74.9 mt -103.68 -171.1 1.88 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.479 1.512 . . . . 0.0 109.026 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -81.29 138.67 48.5 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-O 117.649 -1.167 . . . . 0.0 109.34 176.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -45.32 132.72 12.13 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.417 2.745 . . . . 0.0 113.814 177.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.95 3.22 90.65 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 118.502 -1.166 . . . . 0.0 113.241 179.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -64.58 145.71 55.73 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 119.895 1.847 . . . . 0.0 107.664 167.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 41.7 mt -126.72 138.84 53.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 -173.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 -148.94 148.96 30.41 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 118.236 0.471 . . . . 0.0 111.764 -179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 41.3 mm -76.11 144.63 11.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 165.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.4 mt -135.38 163.79 34.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 176.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -136.72 145.73 52.32 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 126.36 1.864 . . . . 0.0 107.688 -170.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -52.17 -28.1 32.28 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.448 2.766 . . . . 0.0 115.197 -174.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -66.53 -23.23 66.2 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.817 0.735 . . . . 0.0 112.567 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -117.41 -29.51 5.81 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.659 1.184 . . . . 0.0 111.701 -173.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 53.5 mt -50.14 -41.02 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.322 1.449 . . . . 0.0 110.12 169.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.8 -24.43 57.25 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -173.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -103.34 -44.15 5.23 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 172.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 33.8 mmt -65.04 -34.44 78.43 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -170.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -66.79 -22.12 66.03 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -178.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -121.29 30.68 6.68 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.773 0.829 . . . . 0.0 111.208 174.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 15.1 tpt -61.38 -31.94 71.85 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 167.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.1 t -102.06 161.2 13.86 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.111 1.764 . . . . 0.0 107.547 169.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.6 p -76.02 37.44 0.15 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.631 1.972 . . . . 0.0 112.523 -176.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -145.62 177.86 8.57 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.862 1.265 . . . . 0.0 110.714 -167.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 52.75 -157.0 0.16 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.991 1.716 . . . . 0.0 110.765 -178.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 66.4 mtt -140.23 153.3 68.82 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 125.445 1.498 . . . . 0.0 107.672 176.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -70.94 72.86 1.98 Allowed 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 124.581 3.521 . . . . 0.0 110.822 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.5 mt -50.63 -6.36 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 129.228 3.011 . . . . 0.0 117.343 -168.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.12 -26.43 16.57 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 119.298 0.954 . . . . 0.0 111.614 167.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -60.36 -34.46 73.9 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.827 0.74 . . . . 0.0 111.604 176.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.5 tt -77.22 -43.35 33.93 Favored 'General case' 0 C--N 1.338 0.087 0 C-N-CA 123.334 0.654 . . . . 0.0 109.374 177.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 85.8 mt -59.78 -43.75 92.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -178.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -61.98 -23.94 66.72 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -84.71 0.68 49.59 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.723 0.809 . . . . 0.0 112.314 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 84.5 mt -133.58 -35.7 0.99 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.071 0.948 . . . . 0.0 111.626 -173.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -58.83 -22.77 59.42 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.307 1.043 . . . . 0.0 113.07 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -71.32 -13.37 61.85 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.061 0.944 . . . . 0.0 111.988 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -134.84 -30.35 1.09 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.175 0.898 . . . . 0.0 112.931 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 28.9 mt -69.19 138.92 21.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 174.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -63.95 -42.86 98.15 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 123.763 0.697 . . . . 0.0 112.442 -177.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -146.94 134.14 20.53 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.404 1.102 . . . . 0.0 108.367 177.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.8 t -126.09 133.59 68.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 176.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.9 mp -132.01 154.66 40.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 -176.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -128.69 146.52 50.86 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 170.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.0 tt -126.94 132.73 50.78 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 170.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -118.58 159.28 14.43 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 124.571 1.081 . . . . 0.0 110.853 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 82.1 mt -133.85 126.14 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 -177.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -62.48 115.42 16.42 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-O 117.463 -1.256 . . . . 0.0 110.199 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -75.45 171.13 18.83 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 123.394 2.73 . . . . 0.0 111.196 169.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -125.21 -30.91 3.12 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 125.867 1.667 . . . . 0.0 110.734 170.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -136.01 134.32 50.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 176.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.3 t -140.27 135.49 36.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 174.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 158.08 150.8 5.86 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -66.9 154.42 41.05 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.952 0.882 . . . . 0.0 111.522 -175.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 54.81 38.65 30.6 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.048 2.139 . . . . 0.0 112.273 -176.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -124.79 149.09 61.53 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 123.899 0.88 . . . . 0.0 110.281 172.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -83.13 165.16 14.98 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.437 2.758 . . . . 0.0 111.461 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.4 ttm -72.73 139.92 47.47 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 168.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 82.4 p -80.64 159.82 25.24 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.816 1.246 . . . . 0.0 110.549 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.3 tp60 -53.78 -44.79 98.61 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-O 116.675 -1.631 . . . . 0.0 114.298 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -68.29 -30.47 30.49 Favored 'Trans proline' 0 C--N 1.351 0.71 0 CA-C-N 122.86 2.057 . . . . 0.0 112.034 -176.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.6 mp -78.94 -35.79 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -56.82 -46.36 81.71 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.549 1.068 . . . . 0.0 110.044 171.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -63.21 -41.67 99.18 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 122.965 0.506 . . . . 0.0 111.07 178.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.98 -47.97 82.44 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 118.958 -0.544 . . . . 0.0 110.974 176.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 76.5 t -60.76 -40.01 83.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 118.98 0.809 . . . . 0.0 109.705 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -69.93 -30.62 68.06 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.583 1.083 . . . . 0.0 111.551 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 28.1 m -68.68 -46.87 67.94 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.36 -0.837 . . . . 0.0 109.443 173.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 53.9 t -58.73 -45.52 91.07 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.163 0 C-N-CA 123.875 0.87 . . . . 0.0 109.152 176.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.536 ' CZ ' ' HE2' ' A' ' 31' ' ' LYS . 33.5 t80 -52.37 -48.64 65.47 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.275 1.03 . . . . 0.0 110.861 177.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -64.39 -38.74 92.11 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.568 0.622 . . . . 0.0 110.838 176.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 9.2 tpp85 -65.46 -23.25 66.87 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 118.145 -0.931 . . . . 0.0 112.862 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -59.2 -17.27 26.23 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 120.431 1.469 . . . . 0.0 111.036 172.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -91.97 -2.07 56.94 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 120.167 1.349 . . . . 0.0 112.706 176.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -152.43 13.44 0.7 Allowed Glycine 0 CA--C 1.531 1.06 0 CA-C-N 119.083 0.856 . . . . 0.0 114.922 -169.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 6.7 t90 -58.07 140.93 51.55 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.567 1.183 . . . . 0.0 108.347 169.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -138.35 10.48 2.75 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -168.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 140.97 -34.28 1.95 Allowed Glycine 0 CA--C 1.524 0.637 0 C-N-CA 124.186 0.898 . . . . 0.0 112.211 175.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -136.86 20.62 3.05 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.644 1.178 . . . . 0.0 109.983 177.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 59.47 7.04 5.19 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.802 1.668 . . . . 0.0 115.17 -175.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.76 -0.2 29.46 Favored Glycine 0 CA--C 1.538 1.496 0 CA-C-N 119.364 1.582 . . . . 0.0 112.025 -168.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -80.72 169.78 17.16 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.891 1.276 . . . . 0.0 109.835 172.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -87.69 155.46 19.92 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 169.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -88.53 125.72 34.91 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 174.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 67.7 tp -54.87 127.37 28.31 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.941 1.296 . . . . 0.0 109.785 176.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -142.16 36.47 1.54 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.934 0.894 . . . . 0.0 109.598 171.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.8 t 53.03 52.79 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 126.198 1.799 . . . . 0.0 110.296 174.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -54.25 149.39 9.89 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.486 0.714 . . . . 0.0 110.489 174.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -154.17 169.18 24.2 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.402 1.481 . . . . 0.0 108.543 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 . . . . . 0 C--O 1.247 0.921 0 C-N-CA 125.953 1.701 . . . . 0.0 106.972 178.854 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ptm . . . . . 0 N--CA 1.484 1.243 0 CA-C-O 120.629 0.252 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.5 m -136.37 152.33 50.52 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 173.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -150.37 141.63 23.22 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -169.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 74.0 t -135.73 145.52 31.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 123.3 0.64 . . . . 0.0 109.986 -170.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 25.8 tp -114.14 124.89 53.2 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 169.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 56.7 tp -114.2 96.26 5.7 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 178.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 91.5 m -72.54 142.22 48.48 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.131 169.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.4 t -140.4 142.94 30.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 125.176 1.39 . . . . 0.0 107.517 178.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 144.76 172.26 15.14 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 124.657 1.122 . . . . 0.0 111.442 176.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -113.77 121.14 43.16 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 107.832 -1.174 . . . . 0.0 107.832 174.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -59.2 -13.63 8.09 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.401 1.88 . . . . 0.0 115.423 -169.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.0 ptt? -130.78 12.79 5.31 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.976 0.91 . . . . 0.0 111.172 -176.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.9 ttt -92.95 35.24 1.06 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.816 0.734 . . . . 0.0 109.311 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.28 -143.89 30.08 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -173.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -60.24 -18.01 45.79 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 126.016 1.726 . . . . 0.0 112.445 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -54.02 -26.96 29.06 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.649 1.18 . . . . 0.0 112.57 176.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.18 27.83 0.68 Allowed Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.643 -1.087 . . . . 0.0 114.165 178.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.45 -47.97 74.32 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 119.45 1.625 . . . . 0.0 110.253 -172.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.03 -55.82 28.78 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 117.692 -1.616 . . . . 0.0 111.071 174.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -48.21 -41.82 34.07 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 CA-C-N 121.01 2.405 . . . . 0.0 115.372 176.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.3 tp -70.78 -38.28 73.38 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.889 1.222 . . . . 0.0 110.495 178.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.4 tp -61.99 -46.6 88.51 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.936 -0.477 . . . . 0.0 110.291 175.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.35 -40.57 82.55 Favored 'General case' 0 C--O 1.227 -0.088 0 C-N-CA 124.025 0.93 . . . . 0.0 110.978 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -60.72 -48.82 80.1 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 118.594 0.634 . . . . 0.0 109.821 178.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -63.37 -48.8 76.4 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.171 0.589 . . . . 0.0 110.515 -178.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 70.7 m -64.32 -36.74 85.11 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.45 0.568 . . . . 0.0 111.449 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.74 -37.56 88.02 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.166 0.894 . . . . 0.0 111.151 176.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.75 -34.27 75.31 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.18 0.592 . . . . 0.0 111.406 178.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.72 98.89 1.87 Allowed Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 125.325 1.45 . . . . 0.0 108.156 -174.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -54.89 161.02 6.82 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 123.483 2.789 . . . . 0.0 113.854 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.426 ' HE2' ' CE1' ' A' ' 136' ' ' TYR . 72.8 mmtt -135.08 162.21 33.13 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.912 1.685 . . . . 0.0 108.137 178.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 43.53 -121.73 3.56 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.96 1.267 . . . . 0.0 111.614 176.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -134.07 10.7 3.89 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.672 1.189 . . . . 0.0 111.136 174.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -72.86 117.71 14.91 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 121.469 -0.77 . . . . 0.0 109.31 -169.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 89.4 t -67.98 118.31 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 167.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.1 t -73.9 134.13 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -177.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 56.1 mt -132.45 141.34 45.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 103.875 -2.639 . . . . 0.0 103.875 169.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -125.98 106.19 9.45 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 175.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.36 -1.89 82.63 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 118.997 -0.89 . . . . 0.0 112.919 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 56.52 -146.99 33.04 Favored Glycine 0 C--N 1.34 0.76 0 N-CA-C 108.17 -1.972 . . . . 0.0 108.17 -168.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.2 p -88.5 10.49 20.06 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.772 -0.84 . . . . 0.0 111.867 177.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.37 57.96 15.91 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 125.151 1.38 . . . . 0.0 110.393 -176.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -68.87 -14.29 38.52 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.834 2.356 . . . . 0.0 112.978 -171.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -56.7 -32.21 65.25 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.05 0.841 . . . . 0.0 112.03 175.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -61.64 -27.88 68.98 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.4 0.68 . . . . 0.0 112.258 175.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -98.25 -1.88 40.89 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.945 1.298 . . . . 0.0 111.575 -169.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.7 mt -53.86 -42.4 52.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 118.866 0.757 . . . . 0.0 109.783 175.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 43.2 t -61.08 -41.04 87.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 118.378 0.535 . . . . 0.0 110.065 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.33 -43.91 84.82 Favored 'General case' 0 N--CA 1.456 -0.159 0 O-C-N 121.842 -0.536 . . . . 0.0 110.757 -177.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 63.3 mt -58.84 -48.99 84.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 173.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -60.82 -35.88 77.66 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 118.163 -0.922 . . . . 0.0 111.947 -174.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -57.07 -29.73 63.7 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.521 1.055 . . . . 0.0 111.794 177.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 55.2 mt -87.15 -9.78 54.39 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.883 0.873 . . . . 0.0 112.457 -177.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 29.14 61.06 0.78 Allowed Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 126.768 2.027 . . . . 0.0 112.464 -168.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -56.33 145.99 75.16 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.86 2.374 . . . . 0.0 112.589 -171.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.8 m -73.13 -30.35 63.55 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.938 0.895 . . . . 0.0 108.937 168.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -145.36 151.88 38.99 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.28 1.032 . . . . 0.0 109.954 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 41.9 tp -143.17 134.0 25.35 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.329 1.452 . . . . 0.0 107.862 176.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 23.5 tp -126.65 135.27 50.97 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 172.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.0 mt -121.33 143.76 32.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 -171.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.5 t -142.14 135.64 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 119.117 0.871 . . . . 0.0 110.296 -175.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -164.89 170.93 14.73 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 127.372 2.269 . . . . 0.0 107.871 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.82 155.42 37.59 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 121.437 -0.789 . . . . 0.0 108.963 168.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.2 m -154.67 125.08 6.88 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -72.66 121.75 20.3 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 172.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 74.2 mtm -121.53 1.73 10.11 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.168 1.787 . . . . 0.0 110.709 -176.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.43 23.87 67.06 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 118.686 0.675 . . . . 0.0 112.317 -172.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.0 mt -96.2 -174.32 3.05 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.315 1.446 . . . . 0.0 109.43 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -73.7 140.43 78.22 Favored Pre-proline 0 N--CA 1.467 0.393 0 CA-C-O 117.645 -1.169 . . . . 0.0 108.286 170.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -44.29 137.52 7.73 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.216 2.611 . . . . 0.0 112.962 173.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.41 2.32 79.24 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 118.695 -1.058 . . . . 0.0 113.83 176.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -67.12 147.85 52.6 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.911 1.855 . . . . 0.0 108.23 168.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 70.4 mt -124.39 135.92 62.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -172.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.3 mmt-85 -145.26 147.76 32.74 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 118.853 0.751 . . . . 0.0 110.513 176.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 42.3 mm -78.05 142.81 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 167.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.7 mt -129.02 136.38 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 119.98 1.264 . . . . 0.0 108.729 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -80.66 141.29 51.83 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 124.536 1.134 . . . . 0.0 109.761 175.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -47.62 -34.35 20.37 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 124.162 3.241 . . . . 0.0 116.216 178.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -66.54 -26.27 67.05 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.528 0.604 . . . . 0.0 111.719 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -101.09 -29.05 12.36 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.541 1.137 . . . . 0.0 111.094 -176.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 24.9 mt -49.34 -41.08 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.317 1.447 . . . . 0.0 110.839 169.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.9 -24.4 15.97 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.138 1.375 . . . . 0.0 113.601 -177.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -113.61 -37.35 4.62 Favored 'General case' 0 C--O 1.228 -0.063 0 C-N-CA 123.304 0.642 . . . . 0.0 110.381 175.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 22.3 mmt -66.89 -31.86 72.74 Favored 'General case' 0 C--N 1.334 -0.096 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -173.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -63.77 -53.02 57.5 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 119.053 0.842 . . . . 0.0 109.869 174.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.55 4.82 17.17 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -176.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 14.3 tpt -60.31 -26.64 66.68 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.323 -0.861 . . . . 0.0 110.021 168.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 65.6 p -62.5 -13.39 30.02 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.511 1.524 . . . . 0.0 113.042 169.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.6 m 61.22 21.85 12.26 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.462 1.905 . . . . 0.0 110.54 -168.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -142.88 -58.05 0.43 Allowed 'General case' 0 C--N 1.344 0.369 0 O-C-N 121.046 -1.034 . . . . 0.0 112.101 -170.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -68.43 149.37 49.4 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 123.168 0.587 . . . . 0.0 110.002 -169.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 64.3 mtt -77.5 149.93 78.94 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-O 118.404 -0.808 . . . . 0.0 109.522 -175.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -73.88 56.23 3.53 Favored 'Trans proline' 0 CA--C 1.538 0.684 1 C-N-CA 125.683 4.256 . . . . 0.0 112.667 -177.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.3 mt -49.66 -1.06 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 130.36 3.464 . . . . 0.0 118.822 -168.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.49 -25.92 39.72 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 120.006 1.276 . . . . 0.0 110.762 166.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -62.03 -29.64 70.42 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.618 0.767 . . . . 0.0 112.171 174.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.2 tt -74.68 -45.86 41.69 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.175 0.898 . . . . 0.0 108.858 174.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 98.5 mt -58.59 -42.14 83.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -178.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.11 -23.88 64.2 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -87.94 -1.77 58.19 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.993 0.917 . . . . 0.0 112.449 178.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -123.63 -34.93 2.98 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.102 0.961 . . . . 0.0 111.789 178.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -60.68 -21.78 63.21 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.859 0.864 . . . . 0.0 113.063 -173.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -72.34 -12.11 60.99 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.079 0.952 . . . . 0.0 112.012 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -136.31 -32.62 0.85 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.265 0.939 . . . . 0.0 113.082 -178.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 15.3 mt -69.6 138.83 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 172.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -65.91 -41.14 95.58 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.111 0.862 . . . . 0.0 112.397 -176.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -145.9 137.57 25.04 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 118.582 1.191 . . . . 0.0 109.113 175.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.5 t -130.22 129.4 65.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.9 mp -130.52 154.12 40.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -174.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -133.35 144.5 49.65 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 168.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.3 tt -126.32 123.31 37.74 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.641 1.576 . . . . 0.0 106.966 177.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -109.65 155.6 16.01 Favored Glycine 0 C--N 1.334 0.436 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 64.6 mt -133.97 124.19 46.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 -173.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.7 tp60 -61.64 115.94 17.9 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-O 117.547 -1.216 . . . . 0.0 110.619 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -79.12 172.47 14.77 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.308 2.672 . . . . 0.0 111.582 170.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -135.95 -29.2 1.03 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 127.263 2.225 . . . . 0.0 111.317 173.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -132.97 120.42 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 -173.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 64.5 t -143.56 132.62 20.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 153.54 152.39 6.03 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -67.73 150.15 49.04 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.882 0.849 . . . . 0.0 111.441 -173.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 14.2 t80 51.24 41.41 27.86 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.884 2.074 . . . . 0.0 112.101 -173.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.3 m-30 -115.19 142.9 29.29 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 169.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.03 159.44 44.54 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.596 2.197 . . . . 0.0 110.531 171.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.7 ttm -73.98 142.45 45.83 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 168.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 37.3 p -81.71 157.61 24.52 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.367 1.067 . . . . 0.0 110.701 178.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -52.1 -42.6 86.67 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-O 116.52 -1.705 . . . . 0.0 114.697 -178.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.37 -29.07 21.53 Favored 'Trans proline' 0 C--N 1.35 0.628 0 CA-C-N 123.087 2.138 . . . . 0.0 111.878 -176.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.63 -36.11 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -56.52 -46.15 80.74 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.166 0.893 . . . . 0.0 109.986 170.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -64.61 -37.83 88.9 Favored 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 123.302 0.641 . . . . 0.0 111.435 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.25 -47.24 80.39 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 121.933 -0.479 . . . . 0.0 110.706 175.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 61.0 t -62.6 -39.91 86.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 118.643 0.656 . . . . 0.0 109.842 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -60.7 -42.88 98.09 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.136 0.88 . . . . 0.0 110.283 173.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 54.2 m -61.35 -48.76 79.82 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 79.3 t -60.39 -45.97 95.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 118.762 0.71 . . . . 0.0 109.654 179.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.426 ' CE1' ' HE2' ' A' ' 31' ' ' LYS . 19.3 t80 -54.06 -49.7 68.4 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.92 0.888 . . . . 0.0 110.578 177.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -69.83 -26.8 64.4 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.525 -0.734 . . . . 0.0 112.114 178.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -73.48 -24.36 60.18 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.23 -0.919 . . . . 0.0 112.065 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 33.4 mt -61.1 -21.94 64.17 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.393 0.997 . . . . 0.0 113.454 -172.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -88.69 -1.94 58.34 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.833 1.197 . . . . 0.0 112.794 176.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -137.58 5.83 3.5 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.479 1.037 . . . . 0.0 113.754 -172.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -59.4 139.49 57.01 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.405 1.082 . . . . 0.0 108.259 169.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -143.88 23.11 1.74 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.572 0.749 . . . . 0.0 111.315 -170.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 146.08 -34.65 1.41 Allowed Glycine 0 C--N 1.339 0.704 0 O-C-N 121.427 -0.796 . . . . 0.0 112.64 171.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -153.33 16.4 0.54 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.221 1.008 . . . . 0.0 111.327 173.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 69.23 3.1 36.3 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.652 1.12 . . . . 0.0 114.246 -177.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.81 10.25 60.82 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-N 119.422 1.611 . . . . 0.0 112.09 -170.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -69.63 167.7 16.38 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 118.371 1.085 . . . . 0.0 109.133 170.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -89.42 147.08 24.23 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 172.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -93.22 119.91 32.92 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 44.1 tp -60.82 126.56 27.86 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.913 1.285 . . . . 0.0 109.797 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.31 56.38 1.61 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.35 1.06 . . . . 0.0 109.207 -179.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 6.5 t 50.79 51.96 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 125.434 1.493 . . . . 0.0 109.007 -173.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 -64.77 136.51 56.99 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.234 1.014 . . . . 0.0 109.77 -176.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -146.19 163.56 35.03 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.179 1.792 . . . . 0.0 107.416 175.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 . . . . . 0 C--O 1.25 1.108 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 176.34 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 119.062 -0.494 . . . . 0.0 110.82 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.2 m -143.51 152.14 41.11 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 -172.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -140.1 139.2 35.79 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 53.1 t -124.87 141.1 46.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.624 0.726 . . . . 0.0 109.541 -170.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 34.8 tp -107.42 128.1 54.18 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 168.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 56.5 tp -116.18 97.81 6.27 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 177.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 93.2 m -73.18 142.19 47.38 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 170.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.8 t -140.34 141.58 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 125.31 1.444 . . . . 0.0 107.274 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.74 174.94 18.39 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 123.988 0.804 . . . . 0.0 112.219 175.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -117.13 121.25 40.74 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.94 1.296 . . . . 0.0 108.25 176.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 m -59.39 -14.87 13.55 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.458 1.903 . . . . 0.0 115.524 -169.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -130.0 13.98 5.75 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.983 0.913 . . . . 0.0 111.282 -175.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.9 ttt -97.24 34.42 1.78 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.599 0.636 . . . . 0.0 109.756 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.86 -140.95 22.98 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -177.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -62.77 -15.77 55.04 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.474 1.11 . . . . 0.0 112.279 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -59.4 -16.51 23.56 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.035 1.334 . . . . 0.0 112.669 174.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.64 17.84 1.47 Allowed Glycine 0 CA--C 1.533 1.208 0 O-C-N 120.568 -1.332 . . . . 0.0 114.01 175.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.45 -51.16 68.61 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 119.682 1.741 . . . . 0.0 111.032 -169.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.84 -55.18 31.82 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-O 117.806 -1.552 . . . . 0.0 110.984 175.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -48.96 -40.94 40.63 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 CA-C-N 120.687 2.243 . . . . 0.0 115.298 176.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.9 tp -71.97 -37.84 69.85 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 120.254 1.388 . . . . 0.0 110.443 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.2 tp -62.18 -45.63 92.53 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.899 -0.501 . . . . 0.0 110.315 175.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.43 -40.55 87.13 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 123.894 0.878 . . . . 0.0 111.023 177.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.4 tp10 -60.85 -48.66 80.77 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.792 0.723 . . . . 0.0 109.661 178.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -62.28 -46.69 87.65 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.062 0.545 . . . . 0.0 110.639 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 81.1 m -64.98 -37.89 89.17 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.267 0.485 . . . . 0.0 111.237 179.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.66 -37.83 88.93 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.853 0.751 . . . . 0.0 111.107 176.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.13 -37.95 78.57 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.204 0.602 . . . . 0.0 111.092 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.63 95.81 2.03 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 125.166 1.386 . . . . 0.0 108.489 -173.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -55.78 164.32 4.67 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 123.813 3.009 . . . . 0.0 114.182 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.419 ' HE2' ' CZ ' ' A' ' 136' ' ' TYR . 21.0 mmtt -131.56 167.54 19.22 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.625 1.57 . . . . 0.0 109.058 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 40.08 -116.63 0.75 Allowed Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.048 1.309 . . . . 0.0 111.513 175.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -140.65 28.45 1.98 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.62 1.168 . . . . 0.0 109.843 169.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -73.58 125.66 28.5 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.372 -0.83 . . . . 0.0 109.514 -173.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.9 t -78.14 115.32 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 104.103 -2.555 . . . . 0.0 104.103 166.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.4 t -75.77 136.2 25.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -175.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.9 mm -131.38 145.35 35.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 103.972 -2.603 . . . . 0.0 103.972 169.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -132.85 103.79 6.26 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 178.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.5 -4.54 87.44 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-O 118.855 -0.969 . . . . 0.0 112.743 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 54.71 -143.72 31.75 Favored Glycine 0 C--N 1.34 0.754 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 -169.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.2 p -89.67 6.74 40.04 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.985 -0.714 . . . . 0.0 112.41 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.28 64.59 47.22 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 124.866 1.266 . . . . 0.0 109.749 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -64.51 -16.39 54.94 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.732 2.288 . . . . 0.0 112.505 -177.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -47.71 -42.28 24.72 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.51 1.524 . . . . 0.0 111.164 169.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.26 -24.99 66.67 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.015 0.526 . . . . 0.0 112.342 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.04 -3.8 31.27 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 125.071 1.348 . . . . 0.0 111.821 -169.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 84.0 mt -51.2 -41.09 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.866 0.866 . . . . 0.0 110.423 175.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 49.0 t -58.46 -42.04 83.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 118.844 0.747 . . . . 0.0 110.319 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.39 -32.99 73.45 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.212 0.605 . . . . 0.0 111.227 -175.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 58.5 mt -67.33 -50.57 61.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 170.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -66.65 -33.24 75.22 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 118.247 -0.882 . . . . 0.0 112.464 -169.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -62.91 -20.74 65.46 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.979 1.263 . . . . 0.0 112.03 178.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 62.5 mt -86.03 -10.18 55.47 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.391 1.076 . . . . 0.0 113.067 174.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 28.91 61.79 0.75 Allowed Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 127.231 2.212 . . . . 0.0 112.856 -167.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -58.05 150.38 65.21 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.383 2.722 . . . . 0.0 113.549 -169.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.3 m -71.13 -36.27 72.03 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.221 1.009 . . . . 0.0 109.359 168.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 21.3 mtm180 -144.52 162.2 37.17 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.346 1.059 . . . . 0.0 110.199 179.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.5 tp -146.19 134.8 22.16 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 125.256 1.422 . . . . 0.0 107.836 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 37.7 tp -125.78 131.1 52.55 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 173.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.0 mt -115.95 143.2 26.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -175.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.5 t -140.27 134.07 34.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 118.64 0.654 . . . . 0.0 109.91 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -161.7 173.46 14.64 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.275 2.23 . . . . 0.0 107.304 170.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.89 157.78 35.88 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 166.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.3 m -154.6 124.47 6.67 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 176.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -71.57 125.63 27.56 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 172.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 72.9 mtm -127.01 1.96 6.54 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.445 1.898 . . . . 0.0 110.427 -175.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.66 23.74 67.36 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-N 118.693 0.679 . . . . 0.0 112.553 -172.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.2 mt -96.41 -172.47 2.53 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.251 1.421 . . . . 0.0 109.41 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -76.02 139.33 69.18 Favored Pre-proline 0 N--CA 1.468 0.426 0 CA-C-O 117.669 -1.158 . . . . 0.0 108.338 171.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -43.38 137.5 5.41 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.411 2.741 . . . . 0.0 113.131 172.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.93 2.11 81.0 Favored Glycine 0 CA--C 1.534 1.234 0 CA-C-O 118.528 -1.151 . . . . 0.0 113.739 176.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -66.57 144.16 56.6 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 119.909 1.855 . . . . 0.0 107.786 168.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 51.8 mt -121.05 140.71 44.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 -174.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 90.3 mmt-85 -148.4 147.67 29.46 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 118.522 0.601 . . . . 0.0 112.131 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 50.6 mm -77.94 143.28 13.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 164.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.6 mt -128.57 123.84 60.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 176.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -75.16 139.89 72.83 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-O 117.739 -1.124 . . . . 0.0 109.433 175.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_exo -46.75 -36.39 19.33 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 124.235 3.29 . . . . 0.0 116.609 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -69.32 -25.83 64.42 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 118.532 0.605 . . . . 0.0 111.38 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -93.35 -34.46 13.48 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.87 1.268 . . . . 0.0 110.985 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 71.6 mt -48.78 -46.48 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.901 1.28 . . . . 0.0 108.956 169.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.46 -19.54 37.63 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.609 1.164 . . . . 0.0 114.002 -174.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -115.01 -25.34 8.18 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.469 0.708 . . . . 0.0 110.867 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 22.7 mmt -80.5 -36.68 32.98 Favored 'General case' 0 C--O 1.231 0.079 0 CA-C-N 118.238 0.472 . . . . 0.0 112.005 -178.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.64 -37.7 88.48 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 118.906 0.775 . . . . 0.0 112.584 -169.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -63.27 -10.43 15.95 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 178.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.6 ttt -62.14 -23.0 66.31 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.501 1.046 . . . . 0.0 111.064 172.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 55.9 p -76.86 47.51 0.52 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.348 1.059 . . . . 0.0 111.107 169.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.5 m 61.62 65.67 0.92 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.971 1.708 . . . . 0.0 111.931 174.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 21.0 t-80 58.84 32.59 22.38 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.673 1.589 . . . . 0.0 111.986 175.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -60.84 159.85 10.52 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 123.784 0.834 . . . . 0.0 110.004 169.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 26.4 mmt -64.18 145.59 98.01 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 123.149 0.579 . . . . 0.0 109.969 178.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -75.25 78.33 2.99 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 124.708 3.605 . . . . 0.0 108.213 174.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.2 mt -48.89 -11.2 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 117.435 2.383 . . . . 0.0 117.435 -167.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.73 -20.04 4.99 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.333 -0.854 . . . . 0.0 112.554 167.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -58.88 -31.3 68.45 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.517 1.053 . . . . 0.0 111.71 174.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.4 tt -72.95 -45.95 55.2 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 174.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 83.8 mt -58.84 -39.48 77.43 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 123.196 0.599 . . . . 0.0 109.881 -177.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -58.33 -24.72 60.58 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.677 0.671 . . . . 0.0 112.805 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -89.79 -6.71 55.68 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.231 1.012 . . . . 0.0 112.086 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -118.63 -28.15 5.72 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.252 1.021 . . . . 0.0 111.703 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -63.46 -24.18 67.72 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 119.379 0.991 . . . . 0.0 112.403 -175.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -79.27 -4.78 52.33 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.47 1.108 . . . . 0.0 111.843 176.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -134.33 -1.81 2.85 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.33 1.452 . . . . 0.0 112.688 -168.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 20.0 mt -137.29 145.41 29.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 126.094 1.758 . . . . 0.0 107.15 -173.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -71.46 -37.68 62.41 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-O 119.236 -0.758 . . . . 0.0 112.45 -174.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -146.75 135.37 22.09 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.56 1.18 . . . . 0.0 108.076 174.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.2 t -124.68 132.62 71.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 175.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 5.4 mt -133.49 152.29 34.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 -168.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -130.43 142.02 50.51 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 169.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.8 tt -124.31 129.05 50.05 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 174.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -112.88 156.46 15.59 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 77.6 mt -132.75 123.71 49.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -178.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -60.63 115.94 15.95 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-O 117.43 -1.271 . . . . 0.0 110.439 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -76.05 171.53 17.97 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.59 2.86 . . . . 0.0 111.416 170.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -127.96 -32.45 2.31 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.976 1.71 . . . . 0.0 110.932 171.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.69 137.03 47.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.296 1.038 . . . . 0.0 108.333 176.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 90.1 t -141.41 134.93 30.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 175.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 159.21 150.93 5.96 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -65.29 152.55 43.47 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.865 0.84 . . . . 0.0 111.308 -175.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 54.87 38.96 31.21 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.852 2.061 . . . . 0.0 112.09 -177.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -123.14 148.41 54.53 Favored Pre-proline 0 C--O 1.237 0.399 0 C-N-CA 123.987 0.915 . . . . 0.0 109.794 172.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.99 162.5 20.67 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.164 2.576 . . . . 0.0 111.13 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 52.5 ttm -71.43 138.91 49.45 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 168.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 67.4 p -79.85 159.51 26.43 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.285 1.034 . . . . 0.0 110.496 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 21.8 tp60 -53.03 -44.8 97.93 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 116.565 -1.683 . . . . 0.0 114.101 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -68.63 -30.53 28.09 Favored 'Trans proline' 0 C--N 1.351 0.695 0 CA-C-N 122.912 2.076 . . . . 0.0 112.144 -176.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.6 mp -80.05 -35.61 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 118.971 0.805 . . . . 0.0 108.889 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -56.26 -46.56 79.62 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.354 0.979 . . . . 0.0 109.941 170.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -63.92 -38.58 91.6 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.024 0.53 . . . . 0.0 111.319 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.9 -46.19 82.75 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 119.097 -0.478 . . . . 0.0 111.164 175.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 71.8 t -62.68 -39.5 84.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 118.994 0.816 . . . . 0.0 109.658 178.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -62.35 -42.46 99.41 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.191 0.905 . . . . 0.0 110.508 173.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 59.0 m -61.48 -49.4 76.93 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 72.7 t -60.09 -44.25 94.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 123.539 0.736 . . . . 0.0 109.642 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.419 ' CZ ' ' HE2' ' A' ' 31' ' ' LYS . 43.1 t80 -55.96 -48.59 75.53 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.184 0.594 . . . . 0.0 110.631 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 60.0 mm-40 -64.89 -39.09 93.0 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.038 0.836 . . . . 0.0 110.903 176.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -62.3 -29.42 70.42 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 118.732 -0.651 . . . . 0.0 112.263 -177.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 76.8 mt -57.52 -21.78 40.19 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.11 0.868 . . . . 0.0 112.389 177.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -81.49 -13.6 57.96 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.105 0.866 . . . . 0.0 112.21 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -134.79 -9.88 1.67 Allowed Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.215 0.912 . . . . 0.0 114.342 -171.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 17.5 t90 -55.18 141.83 33.53 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.177 1.391 . . . . 0.0 109.253 171.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -145.08 12.28 1.39 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.085 0.954 . . . . 0.0 112.705 -178.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 159.96 -36.16 0.46 Allowed Glycine 0 CA--C 1.529 0.919 0 O-C-N 121.653 -0.654 . . . . 0.0 112.264 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -148.5 -17.03 0.33 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.318 1.047 . . . . 0.0 112.495 -175.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 67.89 7.93 51.21 Favored Glycine 0 CA--C 1.531 1.043 0 O-C-N 121.257 -0.902 . . . . 0.0 113.661 177.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 76.61 5.5 83.15 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 118.319 -1.267 . . . . 0.0 112.728 -174.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -71.06 157.64 37.86 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 119.98 1.89 . . . . 0.0 109.794 175.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.28 144.68 30.45 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 172.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -81.42 123.97 29.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 170.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 67.0 tp -53.53 121.08 7.01 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.004 0.922 . . . . 0.0 109.914 176.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -150.38 29.38 0.71 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.911 1.285 . . . . 0.0 109.346 173.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . 0.332 24.6 m 42.94 28.92 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 128.512 2.725 . . . . 0.0 114.31 -169.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 36.96 56.08 1.22 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 129.821 3.248 . . . . 0.0 113.561 168.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -133.92 24.35 3.93 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.804 1.242 . . . . 0.0 111.098 174.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 . . . . . 0 C--O 1.247 0.96 0 C-N-CA 126.744 2.017 . . . . 0.0 106.82 178.127 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.8 ttm . . . . . 0 N--CA 1.482 1.15 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 27.6 m -133.19 139.8 47.22 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 169.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -142.44 117.44 9.99 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -171.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.4 m -108.76 146.48 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 123.977 0.911 . . . . 0.0 109.78 -169.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 54.7 tp -119.47 104.35 10.25 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 179.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.3 tp -93.71 97.61 10.56 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 98.5 m -72.89 140.83 47.79 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 169.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.5 t -141.0 141.84 30.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 125.063 1.345 . . . . 0.0 107.768 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.59 176.68 19.72 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.248 0.928 . . . . 0.0 111.862 176.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -118.84 121.55 40.28 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.737 1.215 . . . . 0.0 108.253 176.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -59.97 -14.67 17.06 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.65 1.98 . . . . 0.0 115.469 -169.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.8 ptt? -126.91 13.53 7.35 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.115 0.966 . . . . 0.0 111.065 -177.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 27.0 ttt -97.68 33.54 2.04 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.038 0.835 . . . . 0.0 110.25 -177.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.46 -139.71 21.96 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -178.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -63.26 -15.47 57.25 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.251 1.02 . . . . 0.0 111.977 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -59.79 -16.61 29.31 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.933 1.293 . . . . 0.0 112.651 174.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.1 17.63 1.32 Allowed Glycine 0 CA--C 1.534 1.221 0 O-C-N 120.562 -1.336 . . . . 0.0 114.015 175.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.83 -53.3 59.58 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 119.562 1.681 . . . . 0.0 111.096 -169.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.83 -55.04 32.03 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-O 117.812 -1.549 . . . . 0.0 111.152 176.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -49.44 -39.63 44.7 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 CA-C-N 120.787 2.294 . . . . 0.0 115.381 177.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.8 tp -71.18 -38.86 72.11 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 120.083 1.311 . . . . 0.0 110.394 177.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 52.5 tp -61.21 -47.58 85.46 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 122.002 -0.436 . . . . 0.0 110.277 175.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.71 -41.04 85.4 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.862 0.865 . . . . 0.0 111.082 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -60.94 -48.52 81.42 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 118.858 0.753 . . . . 0.0 109.963 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -61.47 -47.15 87.02 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 122.907 0.483 . . . . 0.0 110.668 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 75.7 m -63.88 -40.69 97.12 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.209 0.459 . . . . 0.0 110.938 179.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.8 -39.63 94.72 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.383 0.538 . . . . 0.0 111.094 178.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.18 -35.9 76.76 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.374 0.669 . . . . 0.0 111.457 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.23 95.71 2.11 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 125.086 1.354 . . . . 0.0 108.296 -172.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -55.45 165.53 3.19 Favored 'Trans proline' 0 CA--C 1.537 0.625 0 C-N-CA 123.674 2.916 . . . . 0.0 114.445 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.442 ' HE2' ' CZ ' ' A' ' 136' ' ' TYR . 68.5 mmtt -133.3 170.77 14.96 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 126.327 1.851 . . . . 0.0 108.215 176.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 38.16 -121.93 1.1 Allowed Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.366 1.46 . . . . 0.0 112.307 177.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -140.22 38.21 1.92 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.242 1.417 . . . . 0.0 108.763 169.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -71.59 160.93 31.82 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.912 0.885 . . . . 0.0 111.565 -172.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 98.8 t -115.12 99.26 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 167.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.8 t -68.17 138.3 22.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -178.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 87.7 mt -136.23 141.16 42.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 172.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -125.64 104.36 8.34 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 177.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.22 -4.02 83.02 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.939 -0.923 . . . . 0.0 112.835 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 54.61 -143.8 31.2 Favored Glycine 0 C--N 1.341 0.82 0 N-CA-C 108.427 -1.869 . . . . 0.0 108.427 -169.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.0 p -91.46 10.98 25.47 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 122.064 -0.668 . . . . 0.0 111.891 177.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.52 58.57 21.02 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 125.352 1.461 . . . . 0.0 110.131 -177.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -70.24 -15.44 35.29 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.61 2.207 . . . . 0.0 113.784 -169.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -55.89 -32.07 63.4 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.22 0.918 . . . . 0.0 111.877 174.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.17 -28.59 68.05 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.284 0.634 . . . . 0.0 112.036 177.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -96.45 -3.29 43.71 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.386 1.075 . . . . 0.0 111.607 -170.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 90.0 mt -54.72 -41.74 57.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 118.898 0.772 . . . . 0.0 109.386 173.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.0 t -61.79 -41.7 91.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 O-C-N 121.869 -0.519 . . . . 0.0 110.063 178.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.38 -44.88 86.18 Favored 'General case' 0 N--CA 1.457 -0.1 0 O-C-N 121.972 -0.455 . . . . 0.0 110.512 -178.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 80.8 mt -57.11 -47.89 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.787 0.835 . . . . 0.0 109.237 173.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -60.58 -34.65 74.5 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 118.131 -0.938 . . . . 0.0 112.048 -174.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -57.82 -31.24 66.41 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.481 1.037 . . . . 0.0 111.638 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 70.1 mt -86.26 -12.18 50.29 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.319 1.048 . . . . 0.0 112.339 -174.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 30.53 60.09 0.98 Allowed Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 126.512 1.925 . . . . 0.0 112.57 -168.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -56.78 154.79 30.05 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.923 2.416 . . . . 0.0 114.766 -170.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.7 m -74.83 -37.28 62.32 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.401 1.08 . . . . 0.0 109.874 169.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 36.2 mtm180 -144.03 159.66 42.21 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.355 1.062 . . . . 0.0 109.872 -177.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 30.8 tp -147.38 141.81 26.41 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.748 1.219 . . . . 0.0 108.472 176.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.5 123.59 26.89 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 177.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.4 mm -98.79 144.4 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 175.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.9 t -137.56 132.9 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 119.093 0.86 . . . . 0.0 110.0 175.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -160.91 173.5 15.21 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.35 2.26 . . . . 0.0 107.222 169.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.09 157.34 37.04 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.071 -1.018 . . . . 0.0 109.181 168.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.9 m -156.23 127.15 6.89 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 176.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -71.55 124.55 24.92 Favored 'General case' 0 C--O 1.231 0.096 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 172.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 76.2 mtm -122.15 0.8 9.66 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.805 1.642 . . . . 0.0 111.058 -176.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.03 34.22 88.25 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 119.162 0.892 . . . . 0.0 111.5 -171.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.5 mt -109.53 -176.66 3.07 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.405 1.482 . . . . 0.0 109.676 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -70.34 141.22 88.24 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-O 117.988 -1.006 . . . . 0.0 108.832 170.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -42.99 138.12 4.15 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.53 2.82 . . . . 0.0 113.453 172.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.41 3.14 70.23 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-O 118.733 -1.037 . . . . 0.0 113.451 175.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -66.25 148.6 51.6 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 120.101 1.951 . . . . 0.0 108.335 168.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 65.3 mt -124.44 134.5 66.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 -172.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.1 mmt-85 -143.16 151.08 40.26 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.934 0.788 . . . . 0.0 109.747 173.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 50.7 mm -79.11 145.53 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 169.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.1 mt -132.81 163.42 37.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 124.612 1.165 . . . . 0.0 107.89 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -133.07 144.93 54.83 Favored Pre-proline 0 C--O 1.236 0.345 0 C-N-CA 126.868 2.067 . . . . 0.0 107.617 -170.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -54.81 -27.04 50.81 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 123.24 2.626 . . . . 0.0 115.141 -173.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -66.76 -20.58 65.98 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.006 0.821 . . . . 0.0 112.249 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -119.25 -31.1 4.77 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.794 1.238 . . . . 0.0 111.875 -171.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 79.7 mt -50.77 -40.58 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.09 1.356 . . . . 0.0 109.869 170.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.02 -25.59 31.38 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.7 1.2 . . . . 0.0 113.446 -176.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -111.35 -35.66 5.78 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.362 0.665 . . . . 0.0 110.215 177.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 22.1 mmt -67.1 -29.71 69.53 Favored 'General case' 0 C--N 1.334 -0.1 0 O-C-N 121.757 -0.589 . . . . 0.0 112.412 -178.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -71.72 -42.67 67.05 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 119.095 0.861 . . . . 0.0 111.598 177.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 19.0 ptp -66.47 -9.01 29.98 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.134 0.879 . . . . 0.0 113.01 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 24.0 mmt -58.04 -28.98 64.99 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.318 0.963 . . . . 0.0 110.987 168.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 74.5 p -79.92 51.16 1.29 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.675 1.19 . . . . 0.0 110.64 177.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.0 m 58.58 67.91 0.88 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.662 1.985 . . . . 0.0 111.958 178.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 57.3 34.64 25.03 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.556 1.542 . . . . 0.0 111.936 174.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -61.17 159.47 11.94 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.794 0.838 . . . . 0.0 110.653 174.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 17.1 ptt? -61.14 138.93 94.46 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 124.366 1.066 . . . . 0.0 110.587 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -79.57 72.86 6.3 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 124.691 3.594 . . . . 0.0 109.827 -175.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -46.33 -13.24 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 128.124 2.57 . . . . 0.0 117.782 -168.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -52.8 -22.02 4.86 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.979 0.911 . . . . 0.0 112.957 168.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -56.86 -32.37 65.74 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 119.402 1.001 . . . . 0.0 111.664 176.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.5 tt -73.23 -44.32 59.75 Favored 'General case' 0 C--N 1.339 0.118 0 O-C-N 121.845 -0.535 . . . . 0.0 109.58 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 98.0 mt -60.31 -45.4 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -64.32 -21.25 66.55 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -175.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -88.17 1.58 54.08 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.245 1.018 . . . . 0.0 112.425 177.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 79.1 mt -135.52 -33.3 0.88 Allowed 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.042 0.937 . . . . 0.0 112.128 -171.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -59.85 -20.63 58.15 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.471 1.108 . . . . 0.0 112.676 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -68.2 -17.2 64.26 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.45 1.1 . . . . 0.0 111.813 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -136.51 -31.18 0.88 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.066 0.848 . . . . 0.0 113.12 -177.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 30.4 mt -69.65 140.89 17.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 172.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -62.58 -42.56 99.68 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 124.105 0.86 . . . . 0.0 112.218 -177.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -149.5 142.28 24.64 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.742 1.271 . . . . 0.0 109.221 175.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 43.5 t -134.06 121.36 38.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 21.5 mt -127.91 154.45 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 C-N-CA 125.094 1.358 . . . . 0.0 107.914 -171.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -125.04 145.14 50.05 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 174.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.7 tt -125.12 128.0 47.75 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 171.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -113.35 155.44 16.3 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 73.9 mt -131.98 126.92 57.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 -178.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.8 tp60 -61.36 114.87 12.07 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-O 117.282 -1.342 . . . . 0.0 110.062 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -76.31 170.28 20.3 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.917 2.412 . . . . 0.0 111.041 170.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -130.04 -32.06 1.86 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.924 1.69 . . . . 0.0 111.014 172.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -135.43 136.04 51.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 175.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 90.9 t -141.55 134.87 30.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 175.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 158.83 149.04 5.39 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -68.67 157.5 36.1 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 122.065 0.936 . . . . 0.0 111.353 -173.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 14.1 t80 48.88 41.38 18.47 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.769 2.028 . . . . 0.0 112.391 -172.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -123.73 148.39 56.2 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 124.067 0.947 . . . . 0.0 109.759 170.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -81.44 160.88 19.75 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.053 2.502 . . . . 0.0 111.157 177.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 52.0 ttm -70.05 138.22 51.92 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 168.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 68.7 p -78.06 158.98 28.98 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 123.967 0.907 . . . . 0.0 110.459 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -52.84 -44.46 96.24 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-O 116.629 -1.653 . . . . 0.0 114.211 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -68.22 -31.86 28.15 Favored 'Trans proline' 0 C--N 1.351 0.702 0 CA-C-N 122.906 2.074 . . . . 0.0 112.065 -176.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.92 -33.91 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 119.074 0.852 . . . . 0.0 108.872 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -56.89 -46.63 81.76 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.477 1.035 . . . . 0.0 110.059 169.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -63.65 -37.01 85.73 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 122.977 0.511 . . . . 0.0 111.228 178.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.56 -49.31 73.94 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 119.172 -0.442 . . . . 0.0 110.895 175.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 75.8 t -61.46 -38.37 79.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 118.743 0.701 . . . . 0.0 109.837 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -61.61 -43.24 99.22 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.09 0.859 . . . . 0.0 110.486 173.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 29.2 m -63.31 -43.46 97.78 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.602 -0.687 . . . . 0.0 110.331 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 78.2 t -62.01 -45.71 98.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 123.3 0.64 . . . . 0.0 109.406 176.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.442 ' CZ ' ' HE2' ' A' ' 31' ' ' LYS . 48.7 t80 -56.68 -48.06 78.47 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.788 0.835 . . . . 0.0 110.624 178.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -66.62 -26.85 67.28 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.589 -0.695 . . . . 0.0 112.17 178.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -68.0 -23.54 65.02 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 119.203 0.91 . . . . 0.0 112.694 176.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.44 -24.25 66.41 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -169.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -82.87 -2.74 55.59 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.649 1.113 . . . . 0.0 112.966 178.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -136.39 -18.36 0.72 Allowed Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.378 0.99 . . . . 0.0 114.143 -172.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 51.1 t90 -57.11 140.87 48.02 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 118.707 1.254 . . . . 0.0 109.78 172.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -146.02 17.18 1.4 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.513 1.125 . . . . 0.0 110.543 170.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 162.43 -48.2 0.34 Allowed Glycine 0 C--N 1.34 0.802 0 O-C-N 121.193 -0.942 . . . . 0.0 111.104 178.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -125.02 -23.36 4.25 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 55.68 26.43 46.4 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 119.507 1.048 . . . . 0.0 112.636 -172.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 78.82 -8.24 44.79 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.292 -1.282 . . . . 0.0 113.994 -176.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -69.73 147.44 50.51 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 120.192 1.996 . . . . 0.0 110.312 176.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -76.22 155.75 34.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.325 176.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -97.56 121.78 39.86 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.789 1.236 . . . . 0.0 107.756 -178.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 52.3 tp -58.28 123.76 17.17 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.564 1.546 . . . . 0.0 110.044 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -141.62 62.89 1.44 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.422 1.089 . . . . 0.0 108.998 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.6 t 52.64 43.72 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 125.554 1.542 . . . . 0.0 110.066 -176.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -71.09 155.4 40.83 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.917 0.887 . . . . 0.0 108.846 172.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -144.79 158.97 43.59 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.806 1.642 . . . . 0.0 106.821 170.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 . . . . . 0 C--O 1.248 0.977 0 C-N-CA 124.376 1.071 . . . . 0.0 108.61 -177.295 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 44.0 t0 . . . . . 0 C--O 1.235 0.311 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.9 m -112.63 152.66 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 124.487 1.115 . . . . 0.0 109.891 -169.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 23.8 tp -125.29 107.45 10.73 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 177.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 62.5 tp -96.71 95.68 8.09 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 81.8 m -69.66 142.44 53.41 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 168.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.6 t -140.63 143.29 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 146.12 175.94 19.56 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.561 -1.015 . . . . 0.0 110.561 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -125.61 120.9 32.05 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.29 1.436 . . . . 0.0 107.813 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -59.59 -15.18 16.86 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.111 1.764 . . . . 0.0 115.377 -169.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -127.43 13.59 7.08 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.942 0.897 . . . . 0.0 111.119 -176.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.8 ttt -98.34 29.03 3.76 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.28 0.632 . . . . 0.0 109.771 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.23 -146.9 21.3 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 -177.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -58.34 -18.69 29.35 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 126.019 1.727 . . . . 0.0 112.171 175.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -51.97 -25.42 8.25 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.991 1.316 . . . . 0.0 112.645 173.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.13 24.01 0.56 Allowed Glycine 0 CA--C 1.534 1.278 0 CA-C-O 118.602 -1.11 . . . . 0.0 114.554 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.95 -52.25 63.75 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 119.559 1.68 . . . . 0.0 110.611 -171.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.41 -54.66 35.95 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 117.803 -1.554 . . . . 0.0 111.165 176.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -50.15 -40.16 51.26 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 CA-C-N 120.911 2.356 . . . . 0.0 114.99 177.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 62.9 tp -70.6 -39.88 73.54 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 119.89 1.223 . . . . 0.0 110.201 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.0 tp -61.29 -46.77 88.95 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 117.932 0.333 . . . . 0.0 110.346 175.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.67 -42.2 87.92 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.412 1.085 . . . . 0.0 110.939 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -60.81 -49.06 78.99 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 118.499 0.59 . . . . 0.0 109.778 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -62.87 -48.01 80.88 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.104 0.561 . . . . 0.0 110.749 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 89.2 m -63.75 -39.61 94.7 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.641 0.655 . . . . 0.0 111.437 177.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.45 -40.04 96.08 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.144 0.884 . . . . 0.0 110.871 177.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.35 -33.52 74.44 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.372 0.669 . . . . 0.0 111.773 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.79 92.08 2.45 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 124.861 1.264 . . . . 0.0 108.94 -171.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -51.73 161.91 1.93 Allowed 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 124.064 3.176 . . . . 0.0 114.795 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -140.25 157.21 45.94 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 126.256 1.822 . . . . 0.0 106.978 176.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 34.48 30.25 0.01 OUTLIER Glycine 0 CA--C 1.536 1.347 0 C-N-CA 128.332 2.872 . . . . 0.0 118.213 168.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 43.07 35.41 0.78 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.128 1.771 . . . . 0.0 112.837 -169.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -70.69 128.63 36.74 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 120.828 -1.17 . . . . 0.0 108.103 175.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.4 t -78.04 87.66 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 105.231 -2.137 . . . . 0.0 105.231 168.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.9 p -64.48 138.92 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 96.0 mt -137.95 144.94 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 103.454 -2.795 . . . . 0.0 103.454 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -126.85 109.02 11.54 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -66.08 -16.79 64.85 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 124.899 1.237 . . . . 0.0 113.394 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 57.0 39.85 90.24 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 119.303 1.551 . . . . 0.0 113.643 170.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . 0.258 78.3 p 62.73 12.36 5.58 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.698 2.399 . . . . 0.0 114.689 -175.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.86 59.7 13.97 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 125.447 1.499 . . . . 0.0 108.423 170.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -66.88 -19.31 52.64 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.832 2.355 . . . . 0.0 113.279 -168.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -58.02 -30.49 66.16 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.707 0.685 . . . . 0.0 112.334 177.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.43 -30.61 68.61 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.183 0.593 . . . . 0.0 111.931 175.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -94.32 -4.88 47.86 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.087 0.955 . . . . 0.0 111.501 -170.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.5 mt -54.22 -42.66 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 118.977 0.808 . . . . 0.0 109.167 173.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.7 t -62.44 -42.08 94.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 118.273 0.488 . . . . 0.0 109.99 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.24 -44.89 86.73 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.925 -0.485 . . . . 0.0 110.613 -177.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 78.2 mt -57.91 -48.04 84.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.823 0.849 . . . . 0.0 108.997 173.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -60.15 -35.3 75.0 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 118.097 -0.954 . . . . 0.0 111.994 -175.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -57.4 -31.9 66.29 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.544 1.065 . . . . 0.0 111.513 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 73.2 mt -86.12 -11.86 51.53 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.986 0.914 . . . . 0.0 112.544 -175.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 30.36 60.59 0.96 Allowed Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 126.43 1.892 . . . . 0.0 112.465 -168.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -56.52 151.65 44.83 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.977 2.451 . . . . 0.0 114.328 -169.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.1 m -69.11 -39.69 78.79 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.78 1.232 . . . . 0.0 109.642 169.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 58.2 mtm180 -144.69 166.11 26.13 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.061 0.944 . . . . 0.0 110.136 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.6 tp -145.01 141.66 29.12 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 125.312 1.445 . . . . 0.0 108.071 175.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 39.2 tp -128.15 135.43 49.75 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 173.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.4 mt -123.34 141.81 42.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 -176.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.3 t -140.51 132.83 31.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 118.566 0.621 . . . . 0.0 109.766 -173.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -162.78 173.8 13.31 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.075 2.15 . . . . 0.0 107.443 176.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.24 158.31 36.1 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 167.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 m -154.65 128.22 8.59 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 175.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -72.4 123.42 23.02 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 172.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 73.6 mtm -124.57 1.1 8.25 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.828 1.651 . . . . 0.0 110.957 -175.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.3 24.68 67.65 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-N 118.618 0.644 . . . . 0.0 112.368 -172.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.4 mt -95.85 -173.19 2.78 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.229 1.412 . . . . 0.0 109.417 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -74.84 141.23 75.1 Favored Pre-proline 0 N--CA 1.468 0.44 0 CA-C-O 117.551 -1.214 . . . . 0.0 108.338 170.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -43.44 136.74 5.94 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.202 2.602 . . . . 0.0 113.223 173.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.7 1.55 72.37 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-O 118.646 -1.085 . . . . 0.0 113.375 176.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -64.62 149.25 49.27 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 120.182 1.991 . . . . 0.0 108.307 168.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 91.5 mt -121.51 142.01 39.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 -172.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 83.9 mmt-85 -148.35 149.77 32.39 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 118.387 0.539 . . . . 0.0 111.362 169.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 49.0 mm -77.75 144.0 12.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 166.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.43 165.09 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -137.5 145.64 50.11 Favored Pre-proline 0 C--O 1.235 0.332 0 C-N-CA 126.747 2.019 . . . . 0.0 107.453 -170.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -53.64 -27.1 40.36 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.313 2.675 . . . . 0.0 115.398 -174.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -66.37 -21.69 66.24 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.032 0.833 . . . . 0.0 112.324 177.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -119.31 -29.73 5.1 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.912 1.285 . . . . 0.0 111.921 -171.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.1 mt -51.16 -38.81 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.325 1.45 . . . . 0.0 109.777 169.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.7 -29.01 61.96 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.272 1.029 . . . . 0.0 113.078 -177.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -99.32 -45.23 5.93 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 176.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 22.0 mmt -69.07 -29.31 67.41 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -168.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -70.99 -41.51 70.86 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-N 119.414 1.006 . . . . 0.0 111.393 175.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 CA--C 1.538 0.496 0 CA-C-N 118.791 0.723 . . . . 0.0 112.228 175.242 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.9 mt . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 117.528 2.418 . . . . 0.0 117.528 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.44 -23.39 9.85 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.354 0.979 . . . . 0.0 112.504 168.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -57.77 -39.67 77.99 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 119.271 0.941 . . . . 0.0 110.844 176.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.4 tt -70.15 -43.93 69.9 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 123.41 0.684 . . . . 0.0 109.622 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 95.4 mt -57.74 -41.66 80.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -63.98 -18.26 64.11 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 56.2 mm-40 -83.12 -5.43 59.11 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.941 0.792 . . . . 0.0 112.095 175.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 90.0 mt -132.89 -35.19 1.09 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.933 0.893 . . . . 0.0 112.274 -168.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 12.0 pttm -62.16 -19.76 63.41 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.413 1.085 . . . . 0.0 112.805 -176.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -72.56 -12.99 61.29 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.28 1.032 . . . . 0.0 111.805 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -136.23 -32.72 0.85 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.249 0.931 . . . . 0.0 113.014 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 22.9 mt -68.16 139.64 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 170.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.61 -37.5 92.57 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.097 0.856 . . . . 0.0 112.561 -176.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -149.45 136.66 19.87 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 118.429 1.114 . . . . 0.0 108.505 175.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 56.9 t -123.45 129.78 74.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 175.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.2 mt -129.78 152.0 36.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 -168.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -134.33 146.45 49.98 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 176.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.9 tt -127.19 130.98 50.73 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 170.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -113.23 157.51 14.9 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 175.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 68.0 mt -134.53 128.37 51.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -61.85 115.52 15.98 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-O 117.635 -1.174 . . . . 0.0 110.014 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -78.89 172.42 15.03 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.562 2.175 . . . . 0.0 111.249 170.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -136.54 -31.16 0.88 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 127.533 2.333 . . . . 0.0 110.978 173.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -127.25 122.41 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 -176.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 94.0 t -144.94 132.98 16.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 152.79 150.35 5.38 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -65.7 150.3 48.71 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.137 0.968 . . . . 0.0 110.838 -177.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 18.2 t80 56.29 47.2 19.68 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.595 1.958 . . . . 0.0 111.955 -174.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -130.6 141.65 42.71 Favored Pre-proline 0 C--O 1.236 0.362 0 C-N-CA 123.935 0.894 . . . . 0.0 109.199 168.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -75.84 164.52 31.68 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.909 2.406 . . . . 0.0 110.358 170.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 49.5 ttm -72.63 140.98 48.31 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 168.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 38.3 p -78.53 157.53 28.8 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.414 1.086 . . . . 0.0 110.497 176.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.1 tm0? -49.77 -46.63 80.26 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-O 117.089 -1.434 . . . . 0.0 114.034 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -68.59 -29.27 30.43 Favored 'Trans proline' 0 C--N 1.351 0.695 0 CA-C-N 122.62 1.971 . . . . 0.0 112.163 -174.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 mp -79.63 -35.14 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -56.62 -46.68 80.81 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.39 0.996 . . . . 0.0 109.956 170.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -62.19 -38.28 88.53 Favored 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 123.108 0.563 . . . . 0.0 111.402 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.83 -48.55 76.34 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 122.045 -0.409 . . . . 0.0 111.045 176.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 79.8 t -61.27 -40.58 86.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -60.87 -42.78 98.58 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.919 0.781 . . . . 0.0 110.364 174.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 46.6 m -62.35 -45.13 94.58 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.351 0.523 . . . . 0.0 110.129 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 84.7 t -62.47 -48.16 89.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 118.644 0.657 . . . . 0.0 109.3 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -53.95 -45.77 71.4 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.127 0.971 . . . . 0.0 111.197 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 68.3 mm-40 -68.4 -34.43 76.01 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.399 0.545 . . . . 0.0 111.777 177.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.18 -33.38 75.63 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.755 0.707 . . . . 0.0 111.346 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 38.0 mt -55.18 -24.19 25.55 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -168.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 CA--C 1.542 0.646 0 CA-C-N 120.515 1.507 . . . . 0.0 113.605 178.478 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 . . . . . 0 N--CA 1.45 -0.44 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -64.44 154.43 35.75 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.087 0.955 . . . . 0.0 109.509 177.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -105.45 122.8 46.75 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 -175.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 60.4 tp . . . . . 0 C--O 1.234 0.269 0 C-N-CA 125.301 1.44 . . . . 0.0 109.822 179.167 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.5 t0 . . . . . 0 C--O 1.234 0.28 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.8 t -141.15 145.71 24.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 118.982 0.81 . . . . 0.0 109.708 -167.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 36.5 tp -118.14 126.21 51.77 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 174.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.4 tp -113.43 101.62 9.55 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 176.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 95.3 m -76.73 142.52 40.43 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 169.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.2 t -139.92 142.56 31.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 125.112 1.365 . . . . 0.0 107.46 177.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 144.21 177.42 19.08 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.418 1.008 . . . . 0.0 112.046 176.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -125.45 122.39 36.53 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.302 1.441 . . . . 0.0 108.256 176.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 m -59.72 -17.01 31.37 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.306 1.842 . . . . 0.0 115.417 -169.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 27.4 ptm -126.13 15.81 7.86 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.091 0.956 . . . . 0.0 111.034 -175.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 11.8 tpt -94.93 25.99 3.85 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.657 1.183 . . . . 0.0 108.955 175.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.82 -142.56 23.59 Favored Glycine 0 C--N 1.338 0.642 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -61.72 -16.89 53.08 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.706 1.202 . . . . 0.0 112.552 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -53.1 -26.66 17.15 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.346 1.458 . . . . 0.0 112.819 175.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.62 25.47 0.62 Allowed Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.548 -1.14 . . . . 0.0 114.369 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.1 -48.08 80.1 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 119.461 1.631 . . . . 0.0 110.079 -171.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.28 -58.09 16.26 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-O 117.627 -1.652 . . . . 0.0 111.19 174.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -48.75 -41.07 38.94 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 CA-C-N 121.035 2.417 . . . . 0.0 115.735 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.3 tp -70.83 -39.4 73.02 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 120.209 1.368 . . . . 0.0 110.332 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.2 tp -61.56 -46.07 91.48 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.563 0.345 . . . . 0.0 110.342 176.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.09 -41.87 89.1 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.279 1.032 . . . . 0.0 111.033 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -60.86 -49.49 77.25 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 118.706 0.685 . . . . 0.0 109.784 178.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -62.66 -46.2 89.29 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.963 0.505 . . . . 0.0 110.849 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 79.1 m -68.04 -34.53 76.64 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.336 0.516 . . . . 0.0 111.265 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.36 -40.08 93.13 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.416 1.007 . . . . 0.0 110.736 174.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.43 -33.0 73.43 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.329 0.652 . . . . 0.0 111.723 178.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -151.3 89.27 4.24 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 125.315 1.446 . . . . 0.0 108.809 -174.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -53.29 151.09 23.68 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 123.634 2.889 . . . . 0.0 112.795 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.528 ' HE2' ' CE1' ' A' ' 136' ' ' TYR . 32.5 mmtt -127.28 163.96 22.78 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.723 1.209 . . . . 0.0 109.637 -178.158 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 40.16 -115.58 0.63 Allowed Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.253 1.406 . . . . 0.0 111.865 175.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -134.03 9.71 3.84 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.841 1.257 . . . . 0.0 111.107 174.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 2.8 m95 -71.26 121.58 18.69 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 121.316 -0.865 . . . . 0.0 110.149 -169.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.7 t -72.23 119.65 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 104.362 -2.458 . . . . 0.0 104.362 166.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 36.5 t -76.29 135.13 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 -178.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 62.8 mt -132.48 144.34 37.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 169.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -129.73 110.21 11.58 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.038 -1.468 . . . . 0.0 107.038 174.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.7 -2.1 90.41 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 119.08 -0.844 . . . . 0.0 112.463 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 56.51 -145.89 34.85 Favored Glycine 0 C--N 1.34 0.762 0 N-CA-C 108.357 -1.897 . . . . 0.0 108.357 -169.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.1 p -88.67 10.61 20.07 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.944 -0.739 . . . . 0.0 111.8 176.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.3 57.9 15.89 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 125.07 1.348 . . . . 0.0 110.664 -175.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -70.08 -21.84 31.45 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.899 2.399 . . . . 0.0 113.158 -172.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.51 -35.92 79.08 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.109 0.868 . . . . 0.0 112.174 -176.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -65.99 -10.3 38.18 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.744 0.818 . . . . 0.0 112.919 175.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -116.03 0.17 12.94 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.259 1.024 . . . . 0.0 112.427 -171.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 81.8 mt -48.17 -41.37 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 125.224 1.41 . . . . 0.0 110.683 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.6 t -56.36 -42.52 74.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.427 0.691 . . . . 0.0 110.248 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.07 -40.67 87.06 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 122.955 0.502 . . . . 0.0 110.874 -176.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 55.5 mt -57.86 -49.11 82.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 173.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -64.01 -35.21 79.95 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 118.082 -0.961 . . . . 0.0 111.994 -173.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -57.48 -28.8 63.71 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.432 1.015 . . . . 0.0 112.064 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 34.5 mt -76.41 -3.57 37.77 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.467 0.707 . . . . 0.0 112.639 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 41.47 53.8 7.45 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 126.307 1.843 . . . . 0.0 111.565 -171.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -57.91 135.01 66.2 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.203 1.936 . . . . 0.0 112.343 -169.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.7 m -78.32 -31.97 49.0 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.037 0.935 . . . . 0.0 108.577 168.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 20.7 ttp-105 -142.2 155.29 45.27 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.405 1.082 . . . . 0.0 109.79 173.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.4 tp -136.13 141.47 44.15 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 126.09 1.756 . . . . 0.0 107.66 169.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 24.0 tp -130.63 134.44 46.97 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 172.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.5 mt -121.29 145.17 28.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -171.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 38.3 t -141.37 135.65 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 118.938 0.79 . . . . 0.0 110.421 -175.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -163.22 169.79 18.71 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.583 2.353 . . . . 0.0 107.871 177.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.3 155.98 39.6 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.318 -0.864 . . . . 0.0 109.194 168.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.8 m -154.15 123.63 6.58 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -72.15 121.98 20.21 Favored 'General case' 0 N--CA 1.46 0.068 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 171.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 74.8 mtm -122.89 1.01 9.28 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.59 1.556 . . . . 0.0 110.736 -174.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.53 23.5 64.93 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-N 118.639 0.654 . . . . 0.0 112.341 -172.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.0 mt -96.6 -173.85 2.86 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.275 1.43 . . . . 0.0 109.052 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -73.82 140.55 77.91 Favored Pre-proline 0 N--CA 1.467 0.389 0 CA-C-O 117.744 -1.122 . . . . 0.0 108.429 172.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -43.58 137.29 6.05 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.364 2.709 . . . . 0.0 113.195 173.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.36 4.57 74.55 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 118.772 -1.015 . . . . 0.0 113.845 177.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -68.01 150.94 47.83 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 119.714 1.757 . . . . 0.0 108.13 168.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 74.1 mt -128.02 138.02 55.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 -171.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 90.1 mmt-85 -145.58 147.09 31.7 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 118.836 0.744 . . . . 0.0 112.081 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 51.0 mm -75.77 143.0 13.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 166.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mt -134.81 161.48 40.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 174.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -125.69 144.0 46.82 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 126.493 1.917 . . . . 0.0 108.312 -174.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -42.76 -37.82 6.12 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 124.726 3.618 . . . . 0.0 116.685 -178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -64.84 -22.17 66.94 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.367 0.667 . . . . 0.0 112.34 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -113.33 -32.05 6.38 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.123 1.369 . . . . 0.0 111.1 -174.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.4 HD11 ' HB3' ' A' ' 110' ' ' PHE . 34.5 mt -49.08 -40.44 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.776 1.63 . . . . 0.0 110.359 169.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.31 -21.93 16.82 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.097 1.359 . . . . 0.0 113.733 -176.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -115.97 -36.46 4.13 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 118.574 0.625 . . . . 0.0 110.336 174.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 86.2 mmm -72.15 -26.64 62.17 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 118.479 -0.772 . . . . 0.0 113.032 -171.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -64.53 -51.84 60.85 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 119.933 1.242 . . . . 0.0 109.801 170.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 CA--C 1.537 0.459 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -179.155 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 mt . . . . . 0 CA--C 1.533 0.302 0 N-CA-C 117.108 2.262 . . . . 0.0 117.108 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -52.56 -28.23 20.01 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.546 -0.721 . . . . 0.0 111.207 167.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -59.55 -39.18 83.17 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.118 0.567 . . . . 0.0 111.12 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.6 tt -70.12 -43.68 70.5 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 123.67 0.788 . . . . 0.0 109.471 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 94.0 mt -59.78 -39.05 78.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -63.9 -19.28 64.97 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -82.37 -9.33 59.5 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.537 -0.727 . . . . 0.0 112.009 175.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 68.9 mt -126.83 -30.69 2.73 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.318 1.047 . . . . 0.0 112.09 -168.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 12.5 pttm -63.59 -24.88 67.98 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.317 -0.864 . . . . 0.0 111.942 178.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -78.33 -5.54 52.48 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.772 1.229 . . . . 0.0 111.804 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -132.54 -3.66 3.35 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.867 1.267 . . . . 0.0 112.896 -168.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 65.7 mt -135.89 143.64 35.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 126.111 1.764 . . . . 0.0 106.878 -173.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.68 -37.48 76.78 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-O 119.396 -0.669 . . . . 0.0 112.823 -171.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -144.89 124.63 13.33 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 37.2 t -127.92 130.36 69.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 3.3 mt -136.24 154.17 32.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 -169.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.4 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.2 t80 -131.55 146.04 52.02 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 168.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.0 tt -126.67 122.11 34.02 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.759 1.624 . . . . 0.0 106.934 176.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -107.61 156.33 15.92 Favored Glycine 0 C--N 1.333 0.377 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -178.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 56.1 mt -133.79 125.85 49.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -175.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.5 tp60 -64.09 115.24 17.78 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-O 117.624 -1.179 . . . . 0.0 110.377 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -76.06 170.39 20.19 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.302 2.668 . . . . 0.0 111.352 170.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -131.03 -30.08 1.81 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.62 1.968 . . . . 0.0 111.056 170.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.1 pp -135.24 136.4 51.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 119.105 0.866 . . . . 0.0 108.708 173.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 65.1 t -142.02 136.91 30.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 176.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 156.03 152.85 6.37 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -67.04 154.0 42.27 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.611 0.72 . . . . 0.0 110.199 -176.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.8 t80 58.21 33.93 23.63 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.196 1.798 . . . . 0.0 111.682 -177.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -123.58 145.84 48.28 Favored Pre-proline 0 C--O 1.237 0.407 0 O-C-N 121.562 -0.711 . . . . 0.0 110.199 174.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -80.3 164.74 21.57 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.198 2.599 . . . . 0.0 110.657 174.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.9 ttm -68.45 134.53 50.29 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 168.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.94 159.6 31.62 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.329 1.052 . . . . 0.0 110.471 176.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.51 -46.62 99.59 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-O 117.196 -1.383 . . . . 0.0 113.316 -171.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -66.89 -26.12 44.57 Favored 'Trans proline' 0 C--N 1.35 0.613 0 CA-C-N 122.288 1.853 . . . . 0.0 112.717 -178.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 mp -80.66 -34.86 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 119.313 0.961 . . . . 0.0 108.666 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -56.99 -46.38 82.3 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 118.988 0.813 . . . . 0.0 109.745 169.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -63.09 -37.95 89.26 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 122.787 0.435 . . . . 0.0 111.356 178.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.55 -47.38 81.82 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 121.88 -0.513 . . . . 0.0 110.9 175.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.16 -39.17 82.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 118.702 0.683 . . . . 0.0 109.871 177.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -63.21 -33.77 76.21 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.193 0.906 . . . . 0.0 111.126 174.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 39.2 m -70.31 -43.17 70.88 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.678 0.791 . . . . 0.0 110.1 175.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 91.2 t -63.45 -45.93 96.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 119.363 0.983 . . . . 0.0 109.26 176.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.528 ' CE1' ' HE2' ' A' ' 31' ' ' LYS . 22.3 t80 -52.36 -50.97 61.32 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.155 0.982 . . . . 0.0 110.884 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -71.28 -34.74 70.94 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.873 0.761 . . . . 0.0 111.818 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.21 -32.51 74.11 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 118.926 0.784 . . . . 0.0 111.43 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 55.2 mt -57.52 -18.65 20.12 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.54 1.064 . . . . 0.0 112.708 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 . . . . . 0 CA--C 1.544 0.73 0 CA-C-N 119.403 1.001 . . . . 0.0 112.368 178.581 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 . . . . . 0 N--CA 1.452 -0.372 0 CA-C-O 121.769 0.795 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -84.24 146.91 27.54 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 172.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -78.89 131.77 36.53 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 169.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 56.7 tp . . . . . 0 N--CA 1.456 -0.166 0 C-N-CA 124.8 1.24 . . . . 0.0 110.887 179.344 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.4 t0 . . . . . 0 C--O 1.234 0.288 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.9 m -118.06 153.47 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 124.051 0.94 . . . . 0.0 110.561 -169.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 41.4 tp -124.09 101.54 7.27 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 56.5 tp -89.84 98.94 12.06 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.071 0.949 . . . . 0.0 108.938 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 95.9 m -75.01 141.09 43.98 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 169.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.5 t -141.38 143.31 27.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 125.328 1.451 . . . . 0.0 107.782 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 148.91 171.5 17.73 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.094 0.854 . . . . 0.0 112.231 175.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -109.0 117.1 33.33 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.919 1.288 . . . . 0.0 107.951 175.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -59.57 -13.83 10.88 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.109 1.764 . . . . 0.0 115.741 -169.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -129.57 13.55 5.96 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 119.436 1.016 . . . . 0.0 111.878 -174.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.2 ttt -100.64 40.12 1.3 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.49 0.662 . . . . 0.0 110.158 -176.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.51 -136.39 18.37 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -50.9 -30.26 14.21 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.901 1.281 . . . . 0.0 113.328 174.132 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -60.25 -17.91 45.21 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -167.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.34 25.58 0.71 Allowed Glycine 0 CA--C 1.533 1.187 0 CA-C-O 118.14 -1.366 . . . . 0.0 113.791 175.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.51 -49.14 77.92 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 119.944 1.872 . . . . 0.0 110.382 -170.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.19 -56.44 23.76 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-O 117.612 -1.66 . . . . 0.0 111.203 173.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -47.09 -42.47 26.13 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 CA-C-N 120.991 2.396 . . . . 0.0 115.659 177.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 62.6 tp -71.49 -37.43 71.27 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 120.173 1.351 . . . . 0.0 110.713 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.4 tp -61.34 -47.39 86.13 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.324 0.511 . . . . 0.0 110.283 174.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.96 -40.28 88.5 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 123.859 0.864 . . . . 0.0 110.903 177.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.6 tp10 -62.03 -49.29 76.58 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 118.659 0.663 . . . . 0.0 109.726 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -63.21 -45.9 89.53 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 119.166 -0.445 . . . . 0.0 110.477 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 78.4 m -63.5 -40.34 96.82 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.581 0.628 . . . . 0.0 111.228 177.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.91 -39.31 93.88 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.844 0.747 . . . . 0.0 111.146 177.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.37 -36.9 77.28 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.343 0.657 . . . . 0.0 111.467 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.89 95.58 2.19 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.113 1.365 . . . . 0.0 108.063 -172.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -53.04 170.19 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 124.907 3.738 . . . . 0.0 115.729 -176.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.562 ' HE2' ' CZ ' ' A' ' 136' ' ' TYR . 19.4 mmtm -138.85 157.04 46.79 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.342 1.457 . . . . 0.0 108.94 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 38.33 -115.1 0.38 Allowed Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.241 1.4 . . . . 0.0 111.625 177.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -140.71 22.29 2.31 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.473 1.109 . . . . 0.0 110.425 170.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 10.0 m95 -69.87 128.63 37.06 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 121.32 -0.862 . . . . 0.0 109.302 -173.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 86.4 t -76.88 106.72 7.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 168.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.7 t -64.02 136.67 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.0 mm -131.02 148.06 33.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 169.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -135.6 100.26 4.43 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.59 -8.33 80.88 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-O 118.88 -0.956 . . . . 0.0 112.419 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 51.48 -140.19 25.12 Favored Glycine 0 C--N 1.341 0.807 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -169.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.9 p -91.53 14.76 13.99 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.032 0.933 . . . . 0.0 111.799 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.48 57.06 6.8 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 125.291 1.437 . . . . 0.0 110.142 -176.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -68.46 -18.66 43.6 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.822 2.348 . . . . 0.0 113.648 -169.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -61.47 -32.14 72.13 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.338 0.972 . . . . 0.0 111.473 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.43 -31.31 71.25 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.189 0.595 . . . . 0.0 111.579 175.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.54 -9.56 49.44 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 123.645 0.778 . . . . 0.0 111.326 -169.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 95.6 mt -53.1 -42.17 44.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 170.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.6 t -58.1 -40.26 76.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.565 0.746 . . . . 0.0 110.241 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.81 -45.45 71.18 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.232 0.469 . . . . 0.0 110.249 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.3 mt -62.72 -37.5 79.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -64.07 -19.04 64.94 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 117.871 -1.061 . . . . 0.0 112.578 176.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -70.91 -46.79 61.9 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 120.483 1.492 . . . . 0.0 108.964 169.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.4 mt -69.9 -21.1 63.34 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.47 1.108 . . . . 0.0 112.657 -173.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.3 mtt85 41.92 54.63 8.76 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.04 1.736 . . . . 0.0 112.202 -177.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -57.87 153.86 41.57 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.768 2.312 . . . . 0.0 114.793 -169.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.8 m -72.35 -38.82 68.48 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.085 1.354 . . . . 0.0 109.536 168.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 53.3 mtm180 -143.99 164.57 30.24 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.036 0.934 . . . . 0.0 110.577 178.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.0 tp -146.01 141.69 27.91 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.345 1.458 . . . . 0.0 108.235 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 41.7 tp -128.49 135.35 49.32 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 172.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.5 mt -122.04 144.16 32.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -175.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.5 t -140.18 132.82 33.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 118.413 0.551 . . . . 0.0 109.663 -175.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -158.78 175.19 13.92 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.556 2.342 . . . . 0.0 106.742 169.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.68 162.74 28.46 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 121.028 -1.045 . . . . 0.0 110.628 169.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.7 m -157.24 128.22 6.7 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 176.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -73.42 116.63 14.21 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 170.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 77.1 mtm -114.64 1.55 14.25 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.767 1.627 . . . . 0.0 110.461 -176.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.48 13.6 45.32 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 123.948 0.785 . . . . 0.0 113.011 -172.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 72.3 mt -85.92 -176.31 5.94 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.904 1.681 . . . . 0.0 109.928 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -72.54 139.1 80.79 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 117.928 -1.034 . . . . 0.0 109.388 172.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -43.99 134.34 8.24 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.812 3.008 . . . . 0.0 114.224 177.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.87 4.73 86.03 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 118.858 -0.968 . . . . 0.0 113.547 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -66.75 152.67 45.05 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 119.722 1.761 . . . . 0.0 108.435 168.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 85.6 mt -127.78 139.92 50.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 -171.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 90.9 mmt-85 -148.64 151.81 35.62 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.624 0.647 . . . . 0.0 111.147 173.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 43.8 mm -78.41 146.13 8.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 167.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.6 mt -135.17 165.19 31.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 177.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -138.67 146.41 50.4 Favored Pre-proline 0 C--O 1.235 0.32 0 C-N-CA 126.925 2.09 . . . . 0.0 107.009 -170.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -53.08 -28.43 40.86 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.38 2.72 . . . . 0.0 114.982 -175.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -66.69 -21.38 66.09 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 118.943 0.792 . . . . 0.0 112.359 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -117.96 -30.18 5.43 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.873 1.269 . . . . 0.0 111.894 -172.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 69.5 mt -50.5 -40.89 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 124.658 1.183 . . . . 0.0 109.89 170.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.81 -27.36 50.88 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.857 0.863 . . . . 0.0 113.254 -176.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -99.23 -43.22 6.7 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 174.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 95.0 mmm -72.1 -25.52 61.78 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.631 -0.668 . . . . 0.0 112.708 -169.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -80.0 1.01 29.22 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 172.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 23.3 ptt? . . . . . 0 CA--C 1.537 0.454 0 C-N-CA 123.407 0.683 . . . . 0.0 111.846 167.612 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.6 mt . . . . . 0 N--CA 1.47 0.532 0 N-CA-C 116.66 2.096 . . . . 0.0 116.66 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -52.48 -26.77 13.81 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.202 0.91 . . . . 0.0 112.199 168.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -63.53 -33.82 76.44 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.713 1.142 . . . . 0.0 111.671 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.6 tt -69.59 -46.39 66.42 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.0 mt -60.5 -49.49 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -67.18 -14.14 62.63 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -171.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -106.04 7.96 32.11 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.675 1.19 . . . . 0.0 111.668 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 26.6 tp -138.5 -27.86 0.85 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.785 0.834 . . . . 0.0 111.167 -173.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -59.35 -19.77 49.34 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.849 1.26 . . . . 0.0 111.494 168.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -64.39 -16.77 62.93 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.288 1.435 . . . . 0.0 111.361 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -125.75 -40.41 2.06 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.477 1.111 . . . . 0.0 111.426 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 36.5 mt -71.82 139.04 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.76 -38.89 93.42 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.361 0.981 . . . . 0.0 112.747 -177.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -147.22 135.95 22.06 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 118.662 1.231 . . . . 0.0 108.395 176.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.8 t -126.11 127.57 71.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.2 mt -130.24 155.31 41.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -168.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -136.13 147.8 47.92 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.4 tt -129.68 135.48 48.56 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.043 1.337 . . . . 0.0 108.167 171.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -118.13 158.91 14.48 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 125.112 1.339 . . . . 0.0 111.117 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 92.3 mt -136.31 129.73 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 C-N-CA 125.444 1.498 . . . . 0.0 107.593 -175.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -66.74 119.47 63.69 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 117.513 -1.232 . . . . 0.0 111.245 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.11 170.15 17.68 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 124.755 3.636 . . . . 0.0 113.449 173.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -137.82 -36.73 0.61 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.453 1.101 . . . . 0.0 112.028 168.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.1 pp -136.67 138.06 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 170.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 89.8 t -139.98 136.46 38.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 175.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 160.5 151.81 6.34 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -65.37 151.35 46.5 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.7 0.762 . . . . 0.0 111.079 -174.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 54.86 38.29 30.07 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.733 2.013 . . . . 0.0 112.061 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -121.6 149.54 53.05 Favored Pre-proline 0 C--O 1.237 0.439 0 C-N-CA 124.026 0.93 . . . . 0.0 109.451 173.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -78.0 158.37 30.72 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.831 2.354 . . . . 0.0 110.68 177.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 59.5 ttm -64.88 132.57 49.76 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 168.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.0 151.17 47.41 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 123.913 0.885 . . . . 0.0 111.209 177.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -57.59 -47.13 99.5 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 117.198 -1.382 . . . . 0.0 112.925 -174.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -67.92 -25.48 38.7 Favored 'Trans proline' 0 C--N 1.35 0.657 0 CA-C-N 122.105 1.787 . . . . 0.0 112.166 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 mp -76.96 -38.67 28.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -57.01 -46.88 81.98 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.977 0.808 . . . . 0.0 109.863 171.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -61.91 -39.22 91.25 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 122.639 0.376 . . . . 0.0 111.144 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.51 -49.9 71.7 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.755 0.422 . . . . 0.0 110.929 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 76.4 t -59.2 -40.78 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 118.634 0.652 . . . . 0.0 109.618 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -68.73 -28.93 67.26 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.921 0.782 . . . . 0.0 111.742 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 46.7 m -69.27 -46.79 66.39 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.558 -0.713 . . . . 0.0 109.527 173.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 96.3 t -59.39 -46.32 92.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 118.965 0.802 . . . . 0.0 108.968 176.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.562 ' CZ ' ' HE2' ' A' ' 31' ' ' LYS . 37.6 t80 -52.33 -57.93 8.25 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.317 1.047 . . . . 0.0 110.637 178.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -69.27 -29.95 67.95 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.025 0.83 . . . . 0.0 111.852 -176.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -61.43 -33.7 74.16 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 118.777 0.717 . . . . 0.0 110.881 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 52.7 mt -57.99 -17.2 15.79 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -177.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 . . . . . 0 CA--C 1.539 0.543 0 CA-C-N 120.248 1.386 . . . . 0.0 112.793 177.372 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 . . . . . 0 N--CA 1.451 -0.42 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.62 155.77 40.14 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 123.811 0.844 . . . . 0.0 109.256 173.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -102.65 123.95 47.29 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.985 1.314 . . . . 0.0 108.196 -177.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 58.9 tp . . . . . 0 C--O 1.233 0.202 0 C-N-CA 126.226 1.81 . . . . 0.0 110.727 179.807 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 . . . . . 0 C--O 1.233 0.22 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.1 m -89.88 141.36 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 29.3 tp -109.37 126.48 53.46 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 105.18 -2.155 . . . . 0.0 105.18 171.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 48.9 tp -114.61 97.38 6.25 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 177.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 93.2 m -71.78 140.12 49.31 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.84 169.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.1 t -140.26 141.84 32.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 148.0 -175.52 27.27 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 118.43 0.559 . . . . 0.0 112.153 177.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -136.79 117.78 14.28 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.057 1.343 . . . . 0.0 107.983 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.7 m -58.74 -11.55 3.29 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.477 2.311 . . . . 0.0 115.798 -170.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 23.4 ptp -131.97 12.35 4.74 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.805 1.184 . . . . 0.0 111.425 -177.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 27.7 mmm -89.45 24.54 2.22 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.64 0.776 . . . . 0.0 110.261 173.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.58 -139.15 16.3 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -63.42 -14.98 56.14 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.407 1.083 . . . . 0.0 112.108 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -61.39 -5.84 1.93 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.629 1.571 . . . . 0.0 113.324 174.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.64 16.89 28.48 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 120.537 -1.352 . . . . 0.0 113.412 174.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.37 -50.33 74.04 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.4 1.6 . . . . 0.0 111.578 -169.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.54 -55.22 31.19 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 117.718 -1.601 . . . . 0.0 111.144 176.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -48.73 -40.08 38.66 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 CA-C-N 120.849 2.325 . . . . 0.0 115.24 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.6 tp -71.19 -38.93 72.09 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 119.975 1.261 . . . . 0.0 110.464 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.3 tp -60.9 -46.36 90.95 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.066 0.394 . . . . 0.0 110.187 175.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.41 -39.92 81.02 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 123.85 0.86 . . . . 0.0 110.956 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -62.67 -49.36 75.42 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 118.815 0.734 . . . . 0.0 109.829 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -62.84 -44.51 95.95 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.558 0.343 . . . . 0.0 110.515 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 79.5 m -65.0 -39.64 93.76 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 118.21 0.459 . . . . 0.0 111.157 177.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.52 -37.54 87.9 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.039 0.836 . . . . 0.0 111.199 177.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.07 -38.8 79.23 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.226 0.61 . . . . 0.0 111.116 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.5 90.2 2.9 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.765 1.226 . . . . 0.0 109.191 -173.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -55.24 160.19 8.92 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 124.07 3.18 . . . . 0.0 114.0 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 32.1 mmtt -117.39 168.12 10.64 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.871 1.268 . . . . 0.0 109.768 174.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 37.52 -112.3 0.17 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 126.193 1.854 . . . . 0.0 111.564 176.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -139.13 36.27 2.11 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.852 1.261 . . . . 0.0 108.886 169.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -67.47 144.94 55.45 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 121.591 -0.693 . . . . 0.0 110.653 -175.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.1 t -103.16 103.5 15.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 168.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.8 t -71.36 136.97 24.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -176.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 54.9 mt -136.96 142.19 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 104.55 -2.389 . . . . 0.0 104.55 172.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -131.01 110.07 10.97 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -88.83 0.65 82.67 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 118.811 -0.994 . . . . 0.0 112.879 -178.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 56.9 -144.29 38.87 Favored Glycine 0 C--N 1.34 0.766 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -171.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.1 p -94.19 1.63 56.02 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.693 0.797 . . . . 0.0 112.629 -175.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.02 64.16 40.13 Favored Pre-proline 0 C--O 1.238 0.454 0 C-N-CA 124.798 1.239 . . . . 0.0 109.458 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -65.06 -14.35 44.78 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.194 2.596 . . . . 0.0 112.875 -173.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.7 tp10 -43.1 -41.74 3.73 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.087 1.755 . . . . 0.0 111.536 168.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -69.64 -17.41 63.51 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.048 0.939 . . . . 0.0 112.655 -175.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -117.79 0.8 12.06 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.797 0.839 . . . . 0.0 113.251 -168.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 73.5 mt -48.96 -38.9 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 125.147 1.379 . . . . 0.0 110.62 172.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.9 t -55.35 -42.02 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 123.955 0.902 . . . . 0.0 110.453 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.0 -40.77 91.41 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.954 0.501 . . . . 0.0 110.799 -176.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.5 mt -60.8 -49.31 85.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.975 0.91 . . . . 0.0 108.608 173.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -61.21 -36.02 78.77 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 118.386 -0.816 . . . . 0.0 111.857 -173.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -55.79 -30.19 60.94 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.871 0.76 . . . . 0.0 111.994 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 68.6 mt -87.67 -9.48 54.05 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.085 0.954 . . . . 0.0 112.377 -174.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 30.75 59.87 1.01 Allowed Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 126.588 1.955 . . . . 0.0 112.504 -168.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -57.45 155.59 30.03 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.02 2.48 . . . . 0.0 114.242 -169.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.3 m -72.77 -42.01 64.45 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.889 0.476 . . . . 0.0 109.802 170.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 50.3 mtm180 -142.7 160.62 39.95 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.439 0.696 . . . . 0.0 109.91 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 26.3 tp -141.17 138.86 33.69 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 124.645 1.178 . . . . 0.0 108.583 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 62.3 tp -127.62 114.54 17.5 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 176.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 mm -86.39 148.6 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 172.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.9 t -140.7 133.5 31.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 118.459 0.572 . . . . 0.0 109.634 171.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -161.95 173.84 13.91 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.266 2.226 . . . . 0.0 107.351 169.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.18 157.54 37.98 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.052 -1.03 . . . . 0.0 109.734 169.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.7 m -151.55 126.44 9.7 Favored 'General case' 0 CA--C 1.527 0.09 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -77.42 80.51 3.91 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.994 0.902 . . . . 0.0 110.261 175.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 74.0 mtm -75.4 -6.55 50.61 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.012 1.725 . . . . 0.0 112.345 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.0 21.02 76.74 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 123.87 0.747 . . . . 0.0 111.943 -172.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.5 mt -93.49 -172.65 2.97 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.132 1.373 . . . . 0.0 109.706 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -74.2 140.45 76.55 Favored Pre-proline 0 N--CA 1.468 0.437 0 CA-C-O 117.695 -1.145 . . . . 0.0 108.434 169.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -43.01 137.99 4.25 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.423 2.749 . . . . 0.0 113.445 172.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.05 1.59 74.39 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 118.587 -1.118 . . . . 0.0 113.689 176.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -67.12 147.22 53.41 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.926 1.863 . . . . 0.0 107.891 168.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 55.2 mt -124.97 139.81 49.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 -173.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 91.3 mmt-85 -147.26 152.46 38.35 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 118.765 0.712 . . . . 0.0 111.734 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 48.5 mm -80.51 142.53 13.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 166.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.2 mt -134.99 164.3 34.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 124.871 1.268 . . . . 0.0 107.844 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -135.05 145.78 55.77 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 126.884 2.074 . . . . 0.0 107.974 -169.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -55.32 -25.04 45.48 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.292 2.662 . . . . 0.0 115.229 -173.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -66.33 -21.16 66.25 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.157 0.89 . . . . 0.0 112.271 176.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -122.16 -29.8 4.14 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.655 1.182 . . . . 0.0 112.149 -170.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.0 mt -50.8 -40.36 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.15 1.38 . . . . 0.0 109.675 169.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.91 -29.18 59.66 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.409 1.084 . . . . 0.0 112.989 -176.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -99.45 -43.91 6.37 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 20.8 mmt -68.06 -31.4 71.01 Favored 'General case' 0 CA--C 1.523 -0.087 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -169.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -70.33 -45.65 65.76 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 118.766 0.712 . . . . 0.0 111.491 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 CA--C 1.533 0.304 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.541 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.2 mt . . . . . 0 N--CA 1.476 0.834 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -52.48 -25.06 9.15 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.487 1.039 . . . . 0.0 112.128 167.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -59.11 -32.55 69.94 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.072 0.851 . . . . 0.0 111.529 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.8 tt -79.51 -44.6 20.91 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 85.0 mt -57.55 -42.39 81.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -59.63 -24.94 64.26 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -89.06 -4.0 58.5 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.151 0.98 . . . . 0.0 112.506 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -123.0 -30.87 3.71 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.449 1.022 . . . . 0.0 111.832 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -60.17 -20.66 59.59 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.103 0.961 . . . . 0.0 113.048 -176.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -69.62 -16.15 63.33 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.362 1.065 . . . . 0.0 112.094 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -140.2 -32.39 0.61 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.372 0.987 . . . . 0.0 113.621 -176.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 12.4 mt -69.53 138.78 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 170.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.62 -37.59 92.62 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.344 0.973 . . . . 0.0 112.483 -175.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -148.69 137.76 21.63 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 118.497 1.149 . . . . 0.0 108.462 175.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 45.2 t -129.63 124.45 59.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 25.8 mt -129.93 154.93 41.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -169.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -125.66 143.48 51.01 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 174.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.6 tt -122.23 124.08 42.95 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 169.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -110.71 156.73 15.39 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 57.7 mt -134.44 124.9 46.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 -176.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -64.89 118.14 45.81 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-O 117.448 -1.263 . . . . 0.0 110.447 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -76.18 171.68 17.66 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.703 2.935 . . . . 0.0 111.569 170.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -128.0 -31.96 2.34 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 125.765 1.626 . . . . 0.0 110.98 171.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -135.86 136.55 49.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.344 1.058 . . . . 0.0 108.161 175.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.9 t -140.79 132.2 29.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 174.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 162.83 154.76 7.75 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -70.11 153.18 43.48 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.898 0.856 . . . . 0.0 110.929 -171.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.9 t80 50.96 39.18 22.24 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.915 2.086 . . . . 0.0 112.222 -176.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.5 m-30 -120.29 148.04 46.42 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 123.793 0.837 . . . . 0.0 109.947 174.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -81.27 164.39 19.39 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.23 2.62 . . . . 0.0 111.162 177.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 52.0 ttm -72.74 140.54 47.85 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 168.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 71.4 p -81.25 159.81 24.42 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.374 1.07 . . . . 0.0 110.656 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.2 tm0? -51.04 -48.65 84.39 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-O 116.978 -1.487 . . . . 0.0 113.329 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -67.78 -30.01 34.55 Favored 'Trans proline' 0 C--N 1.352 0.731 0 CA-C-N 122.546 1.945 . . . . 0.0 112.368 -174.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.77 -35.88 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 119.092 0.86 . . . . 0.0 108.931 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -56.97 -47.13 81.49 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.46 1.027 . . . . 0.0 109.926 171.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -61.52 -42.49 98.9 Favored 'General case' 0 C--O 1.231 0.087 0 C-N-CA 122.995 0.518 . . . . 0.0 111.082 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.96 -48.47 80.23 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 119.04 -0.505 . . . . 0.0 110.952 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 55.5 t -60.01 -41.66 87.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 118.705 0.684 . . . . 0.0 109.617 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -69.58 -29.93 67.58 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.044 0.838 . . . . 0.0 111.568 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 38.0 m -69.58 -45.48 68.55 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.325 -0.86 . . . . 0.0 109.776 174.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 78.7 t -59.23 -47.15 91.29 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 175.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -52.08 -48.11 64.86 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.008 0.923 . . . . 0.0 110.811 177.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -64.0 -44.0 93.98 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 118.564 0.62 . . . . 0.0 110.991 177.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.6 tpp85 -64.11 -26.54 68.59 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 118.736 -0.65 . . . . 0.0 112.234 -175.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 61.0 mt -57.2 -23.68 49.39 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.412 1.006 . . . . 0.0 112.317 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 . . . . . 0 CA--C 1.538 0.487 0 CA-C-N 119.325 0.966 . . . . 0.0 112.558 178.121 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 . . . . . 0 C--O 1.236 0.343 0 CA-C-O 121.338 0.59 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.81 151.13 39.09 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -91.98 120.47 32.67 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 59.0 tp . . . . . 0 C--O 1.233 0.236 0 C-N-CA 124.486 1.115 . . . . 0.0 109.794 178.482 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 29.8 t0 . . . . . 0 C--O 1.235 0.315 0 N-CA-C 105.056 -2.202 . . . . 0.0 105.056 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.4 t -121.84 147.45 25.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.431 0.634 . . . . 0.0 109.995 -165.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 28.6 tp -116.27 127.95 55.16 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 56.8 tp -117.45 94.49 4.57 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 94.5 m -71.14 143.51 50.54 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.459 -0.791 . . . . 0.0 108.918 170.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.9 t -141.38 141.46 30.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 125.23 1.412 . . . . 0.0 107.655 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 143.38 176.34 17.33 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 124.494 1.045 . . . . 0.0 111.949 176.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -120.83 121.49 38.25 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 125.017 1.327 . . . . 0.0 108.124 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 m -59.07 -16.86 21.19 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.438 1.895 . . . . 0.0 115.342 -169.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -126.38 14.27 7.69 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.958 0.903 . . . . 0.0 111.03 -175.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.6 ttt -97.84 32.77 2.26 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.274 0.63 . . . . 0.0 109.586 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.2 -146.3 27.66 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -174.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -60.31 -17.39 42.45 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 126.028 1.731 . . . . 0.0 112.377 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -51.72 -28.03 13.75 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.022 1.329 . . . . 0.0 112.681 175.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.28 26.61 0.56 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.845 1.212 . . . . 0.0 114.456 178.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.77 -50.19 73.38 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 119.291 1.545 . . . . 0.0 110.297 -173.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.95 -56.69 23.33 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-O 117.75 -1.584 . . . . 0.0 111.111 175.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -48.78 -41.04 39.2 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 CA-C-N 120.972 2.386 . . . . 0.0 115.214 178.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.0 tp -71.24 -37.91 71.98 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-N 119.962 1.255 . . . . 0.0 110.605 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.6 tp -60.97 -48.35 82.23 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.308 0.504 . . . . 0.0 109.934 175.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.19 -40.01 88.56 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.773 0.829 . . . . 0.0 111.046 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.6 tp10 -61.06 -49.54 76.96 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 118.492 0.587 . . . . 0.0 109.535 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -63.51 -44.83 93.15 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 119.192 -0.433 . . . . 0.0 110.742 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 75.4 m -63.71 -42.25 97.99 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.716 0.689 . . . . 0.0 111.039 178.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.83 -41.15 99.21 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.417 0.553 . . . . 0.0 110.788 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.92 -32.86 72.78 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.379 0.672 . . . . 0.0 111.99 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.7 88.53 3.29 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 124.707 1.203 . . . . 0.0 109.014 -171.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -51.39 160.92 2.07 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 123.967 3.111 . . . . 0.0 114.329 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -135.75 164.26 28.31 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.473 1.509 . . . . 0.0 108.964 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 41.8 -120.18 2.03 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.491 1.52 . . . . 0.0 111.374 175.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -140.91 34.99 1.76 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.844 1.257 . . . . 0.0 109.443 170.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -69.3 162.21 27.68 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.636 0.774 . . . . 0.0 111.99 -174.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.2 t -116.61 119.13 61.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 103.728 -2.693 . . . . 0.0 103.728 165.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.4 t -88.1 136.79 22.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -172.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 73.0 mt -133.08 143.99 37.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 104.705 -2.332 . . . . 0.0 104.705 169.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -128.03 106.96 9.43 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 172.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.14 -2.98 80.63 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-O 118.929 -0.928 . . . . 0.0 112.807 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 56.83 -147.29 33.7 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 -168.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.6 p -86.61 10.38 15.71 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.732 -0.863 . . . . 0.0 111.876 177.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.76 59.76 17.19 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 125.138 1.375 . . . . 0.0 110.519 -175.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -67.75 -15.4 44.22 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.824 2.35 . . . . 0.0 113.355 -172.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -57.25 -30.75 64.91 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.824 0.738 . . . . 0.0 112.126 173.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.0 -28.46 70.11 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.185 0.594 . . . . 0.0 111.97 175.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.18 -4.12 36.19 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.954 1.301 . . . . 0.0 111.894 -169.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.8 mt -48.57 -43.73 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 124.265 1.026 . . . . 0.0 109.79 170.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 52.5 t -59.5 -38.73 76.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 118.591 0.632 . . . . 0.0 110.644 -177.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.69 -44.53 81.48 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 121.918 -0.489 . . . . 0.0 110.21 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 77.6 mt -60.02 -39.62 80.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 123.489 0.716 . . . . 0.0 109.507 176.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -65.8 -20.33 66.21 Favored 'General case' 0 N--CA 1.462 0.145 0 O-C-N 121.024 -1.048 . . . . 0.0 112.311 178.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -75.55 -48.18 23.56 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 120.122 1.328 . . . . 0.0 109.087 169.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.8 mt -66.04 -26.94 67.75 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.402 0.681 . . . . 0.0 112.368 -175.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 42.77 59.61 10.76 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 125.87 1.668 . . . . 0.0 110.863 -175.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -53.92 146.35 47.23 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.691 2.26 . . . . 0.0 113.413 -169.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.3 m -74.75 -35.1 62.6 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 167.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -147.98 152.5 37.58 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.78 1.232 . . . . 0.0 109.086 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 51.3 tp -140.9 141.37 34.57 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.433 1.093 . . . . 0.0 108.862 -177.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 58.8 tp -125.54 136.92 53.83 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 170.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.5 mt -121.17 143.67 32.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.5 t -140.58 135.41 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 118.586 0.63 . . . . 0.0 110.018 -173.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -162.9 170.37 18.27 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.727 2.411 . . . . 0.0 107.454 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.48 154.94 39.71 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 168.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.9 m -153.23 124.13 7.37 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -69.64 120.99 16.25 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 169.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 76.7 mtm -119.04 1.29 11.41 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.636 1.575 . . . . 0.0 110.704 -177.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.94 34.2 89.24 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 118.929 0.786 . . . . 0.0 111.577 -172.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.3 mt -111.54 -172.14 1.98 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.774 1.63 . . . . 0.0 109.446 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -75.28 140.18 72.62 Favored Pre-proline 0 N--CA 1.468 0.453 0 CA-C-O 117.456 -1.259 . . . . 0.0 108.681 173.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -43.64 136.55 6.55 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.198 2.599 . . . . 0.0 112.896 172.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.65 1.79 83.95 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-O 118.584 -1.12 . . . . 0.0 113.758 177.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -65.75 147.24 53.71 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 120.02 1.91 . . . . 0.0 108.68 168.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 66.9 mt -126.82 133.12 69.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 C-N-CA 125.403 1.481 . . . . 0.0 107.077 -172.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.3 mmt-85 -143.42 151.81 40.81 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.864 0.756 . . . . 0.0 109.691 174.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 48.7 mm -80.83 145.72 8.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 168.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 11.1 mt -131.81 123.39 51.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -175.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -76.81 140.69 67.51 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-O 117.87 -1.062 . . . . 0.0 109.716 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_exo -46.81 -35.24 17.4 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 124.264 3.309 . . . . 0.0 116.677 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -68.59 -23.96 64.53 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.648 0.658 . . . . 0.0 111.687 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -98.81 -31.46 11.86 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.279 1.431 . . . . 0.0 111.116 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 68.0 mt -50.11 -40.82 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.796 1.238 . . . . 0.0 109.569 169.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.93 -19.97 7.9 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.887 1.675 . . . . 0.0 114.327 -175.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -124.33 -37.0 2.58 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 118.72 0.691 . . . . 0.0 110.553 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 21.3 mmt -66.85 -29.43 69.34 Favored 'General case' 0 N--CA 1.46 0.063 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -175.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -69.35 -45.4 69.52 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 119.155 0.889 . . . . 0.0 110.487 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 21.7 ptp . . . . . 0 CA--C 1.537 0.469 0 CA-C-O 118.923 -0.56 . . . . 0.0 112.468 176.564 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.7 mt . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 116.854 2.168 . . . . 0.0 116.854 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.04 -22.59 6.11 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.188 0.995 . . . . 0.0 112.608 168.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -59.51 -33.77 71.77 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.336 0.971 . . . . 0.0 111.755 175.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.9 tt -73.41 -44.49 58.26 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 74.4 mt -60.55 -42.29 90.93 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.107 0 C-N-CA 123.258 0.623 . . . . 0.0 109.63 -177.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -60.5 -24.37 65.25 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -176.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -85.03 -11.42 55.41 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.754 0.822 . . . . 0.0 112.063 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.4 mp -121.14 -31.28 4.16 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.32 1.448 . . . . 0.0 111.855 -168.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -60.57 -21.1 62.22 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.68 1.192 . . . . 0.0 112.611 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -71.78 -11.31 60.75 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.593 1.157 . . . . 0.0 111.694 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -134.35 -38.55 0.84 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.092 0.957 . . . . 0.0 112.138 -176.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 53.3 mt -72.17 139.96 18.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 174.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.08 -41.64 94.96 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.052 0.834 . . . . 0.0 111.972 -178.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -149.41 137.63 20.67 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 118.564 1.182 . . . . 0.0 108.612 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 41.4 t -131.13 123.98 54.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 19.9 mt -127.09 154.79 37.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 -171.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -129.74 141.84 50.81 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 173.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.1 tt -121.76 128.42 51.73 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 173.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -114.67 156.29 15.75 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 72.5 mt -131.98 128.09 59.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -177.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.1 tp60 -62.55 115.48 16.91 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 117.579 -1.201 . . . . 0.0 110.157 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -78.76 172.91 14.35 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.143 2.562 . . . . 0.0 111.552 171.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -137.29 -30.7 0.84 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 127.811 2.444 . . . . 0.0 111.045 173.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -129.74 124.14 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 -176.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.7 t -145.27 132.91 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 151.63 150.56 5.37 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -63.8 149.95 45.76 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 118.155 0.978 . . . . 0.0 110.901 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 57.95 43.62 21.03 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.601 1.96 . . . . 0.0 111.951 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -127.72 140.65 38.7 Favored Pre-proline 0 C--O 1.236 0.345 0 C-N-CA 124.116 0.967 . . . . 0.0 108.78 168.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -73.97 161.66 40.74 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.462 2.108 . . . . 0.0 110.041 170.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 52.1 ttm -70.27 139.49 52.17 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 168.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 33.1 p -76.32 156.49 33.31 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.134 0.974 . . . . 0.0 110.504 176.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.1 tm0? -49.32 -46.79 77.5 Favored Pre-proline 0 CA--C 1.544 0.733 0 CA-C-O 117.009 -1.472 . . . . 0.0 113.912 -178.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.46 -28.0 32.87 Favored 'Trans proline' 0 C--N 1.35 0.645 0 CA-C-N 122.616 1.97 . . . . 0.0 112.257 -175.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 mp -80.41 -35.55 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 119.358 0.981 . . . . 0.0 108.64 177.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -56.91 -47.23 81.03 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.405 1.002 . . . . 0.0 109.913 170.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -61.3 -41.81 97.6 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 123.303 0.641 . . . . 0.0 111.013 178.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.98 -48.99 77.89 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 119.121 -0.466 . . . . 0.0 110.929 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 56.0 t -59.48 -41.04 83.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 118.712 0.687 . . . . 0.0 109.728 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -68.94 -30.48 68.95 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.028 0.831 . . . . 0.0 111.483 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 32.9 m -69.41 -40.97 76.98 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.062 -1.024 . . . . 0.0 109.981 174.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 77.4 t -61.25 -50.08 81.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -56.28 -35.66 67.72 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.517 1.127 . . . . 0.0 112.156 177.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -67.9 -43.52 79.08 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.524 1.056 . . . . 0.0 110.685 171.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -58.91 -31.39 68.59 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 118.568 -0.729 . . . . 0.0 112.441 176.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.7 mp -56.52 -22.96 36.5 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.449 1.022 . . . . 0.0 111.973 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 . . . . . 0 CA--C 1.542 0.669 0 CA-C-N 119.449 1.022 . . . . 0.0 112.795 178.835 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 . . . . . 0 C--O 1.236 0.387 0 CA-C-O 121.73 0.776 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.9 153.41 38.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.574 176.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -93.42 121.88 35.27 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 50.1 tp . . . . . 0 CA--C 1.532 0.282 0 C-N-CA 125.663 1.585 . . . . 0.0 109.837 178.68 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.6 t0 . . . . . 0 C--O 1.233 0.206 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 56.3 t -93.93 146.69 6.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.556 0.693 . . . . 0.0 109.655 -169.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 58.5 tp -115.76 114.75 25.21 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 170.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 55.3 tp -103.59 102.29 12.16 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.456 1.102 . . . . 0.0 108.03 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 90.6 m -76.63 142.3 40.7 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 170.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.5 t -141.0 142.63 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 143.49 178.77 19.57 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -132.53 121.0 22.63 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 124.613 1.165 . . . . 0.0 108.443 177.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 m -58.58 -5.33 0.53 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.957 2.503 . . . . 0.0 116.391 -169.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -133.03 10.36 4.19 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.294 0.952 . . . . 0.0 111.446 -176.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 63.8 mtp -95.71 27.97 3.24 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.599 0.76 . . . . 0.0 110.581 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.6 -139.34 19.39 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 -177.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -62.9 -15.81 56.59 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.321 1.048 . . . . 0.0 112.148 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -58.29 -18.6 28.11 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.922 1.289 . . . . 0.0 112.755 174.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.54 19.67 0.86 Allowed Glycine 0 CA--C 1.535 1.3 0 O-C-N 120.626 -1.296 . . . . 0.0 114.237 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.85 -53.3 57.72 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 119.865 1.832 . . . . 0.0 111.157 -169.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.92 -53.93 41.7 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-O 117.953 -1.471 . . . . 0.0 111.21 176.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -50.57 -38.97 55.92 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 CA-C-N 120.907 2.353 . . . . 0.0 115.188 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.1 tp -70.3 -38.7 75.05 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 120.029 1.286 . . . . 0.0 110.243 177.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 51.1 tp -61.89 -48.89 78.43 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.001 0.364 . . . . 0.0 110.219 175.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.66 -41.05 80.73 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 124.302 1.041 . . . . 0.0 111.115 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -61.7 -48.74 79.4 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.771 0.714 . . . . 0.0 109.995 178.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -61.13 -46.24 91.38 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 122.817 0.447 . . . . 0.0 110.518 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 85.6 m -64.0 -40.38 96.23 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.278 0.49 . . . . 0.0 111.117 178.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.44 -38.9 92.92 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.334 0.516 . . . . 0.0 110.947 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.64 -37.65 76.86 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.3 0.64 . . . . 0.0 111.244 178.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.72 98.81 1.69 Allowed Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 125.122 1.369 . . . . 0.0 108.549 -172.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.52 167.36 25.64 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.305 2.004 . . . . 0.0 111.679 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -128.62 177.41 7.05 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.927 1.691 . . . . 0.0 108.654 177.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 41.16 -124.65 2.95 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.054 1.311 . . . . 0.0 112.317 175.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -141.44 37.91 1.69 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.25 1.42 . . . . 0.0 109.337 172.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -72.63 167.83 19.93 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.374 1.07 . . . . 0.0 111.85 -174.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.0 t -123.57 110.31 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 167.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.6 t -75.21 139.32 19.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -175.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 22.9 mm -134.59 147.95 29.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 169.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -130.72 112.2 12.87 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 176.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.52 -11.49 80.18 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 118.79 -1.005 . . . . 0.0 112.982 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.65 35.51 81.44 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 119.017 1.408 . . . . 0.0 113.667 170.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 66.92 10.26 7.49 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.772 1.629 . . . . 0.0 113.5 -177.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.79 53.68 4.84 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 125.341 1.457 . . . . 0.0 108.794 173.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -64.02 -24.63 66.79 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.488 2.125 . . . . 0.0 112.7 -169.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -63.49 -33.53 75.77 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.974 0.806 . . . . 0.0 111.741 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.52 -22.57 67.0 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.569 0.748 . . . . 0.0 111.552 174.15 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -105.59 -2.2 23.77 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.444 1.098 . . . . 0.0 112.653 -169.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.8 mt -47.24 -42.73 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.989 1.315 . . . . 0.0 110.372 173.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.3 t -56.42 -42.32 74.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.068 0.547 . . . . 0.0 110.167 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.12 -35.55 76.54 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.072 0.549 . . . . 0.0 111.525 -177.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 68.6 mt -63.83 -46.88 93.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 173.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 37.0 mtp180 -69.37 -22.43 63.73 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 117.888 -1.053 . . . . 0.0 112.624 -174.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -56.33 -32.45 64.67 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 120.535 1.516 . . . . 0.0 110.847 170.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 55.1 mt -86.64 -10.85 52.94 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.11 0.964 . . . . 0.0 112.773 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 28.68 61.85 0.72 Allowed Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 126.825 2.05 . . . . 0.0 112.54 -167.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.53 149.15 40.33 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.294 2.663 . . . . 0.0 113.873 -169.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.0 m -71.81 -37.59 70.36 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 168.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -147.97 156.61 42.86 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.059 0.944 . . . . 0.0 109.537 -176.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 41.7 tp -143.75 139.09 29.25 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 124.805 1.242 . . . . 0.0 108.653 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 57.1 tp -124.1 137.17 54.6 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 169.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.7 mt -120.58 143.21 33.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.4 t -140.58 134.03 33.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 118.442 0.565 . . . . 0.0 109.83 -175.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -161.87 172.57 15.86 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.241 2.217 . . . . 0.0 107.39 170.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.49 157.51 36.98 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 121.288 -0.883 . . . . 0.0 108.753 167.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.2 m -152.8 129.38 10.75 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -77.52 82.78 3.94 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 118.921 0.782 . . . . 0.0 109.731 176.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 77.5 mtm -76.82 -6.45 52.38 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.281 1.433 . . . . 0.0 111.806 -177.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.36 25.61 72.43 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.091 0.853 . . . . 0.0 111.752 -174.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 47.5 mt -107.84 -168.56 1.39 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.512 1.125 . . . . 0.0 109.873 -176.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -79.31 138.47 55.82 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-O 117.738 -1.125 . . . . 0.0 109.263 175.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -45.51 134.93 12.68 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.474 2.782 . . . . 0.0 113.864 177.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.13 1.82 90.17 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-O 118.597 -1.113 . . . . 0.0 113.238 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -64.1 145.79 55.32 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 119.767 1.784 . . . . 0.0 107.804 167.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 59.0 mt -126.74 137.33 58.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 -175.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.2 mmt-85 -147.59 150.19 33.98 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 118.792 0.724 . . . . 0.0 111.445 175.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 50.2 mm -72.97 149.38 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 164.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.6 mt -133.41 133.62 57.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -80.91 142.75 52.52 Favored Pre-proline 0 N--CA 1.471 0.614 0 CA-C-O 117.508 -1.234 . . . . 0.0 109.37 174.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -46.59 -37.48 20.35 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 123.997 3.131 . . . . 0.0 116.435 177.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -69.57 -22.32 63.54 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.552 0.614 . . . . 0.0 111.603 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -97.13 -34.1 11.26 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.956 1.303 . . . . 0.0 110.75 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.407 HD11 ' CB ' ' A' ' 110' ' ' PHE . 83.7 mt -50.81 -42.15 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 125.513 1.525 . . . . 0.0 109.111 169.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.55 -23.61 51.49 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.611 1.164 . . . . 0.0 113.571 -175.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -107.39 -40.76 5.27 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 123.184 0.593 . . . . 0.0 109.613 176.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 22.4 mmt -71.71 -29.49 64.62 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -169.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -71.09 -43.03 68.54 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 119.458 1.026 . . . . 0.0 110.981 175.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 28.9 ptm . . . . . 0 CA--C 1.537 0.454 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 176.376 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.8 mt . . . . . 0 N--CA 1.474 0.755 0 N-CA-C 118.116 2.636 . . . . 0.0 118.116 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.06 -23.6 8.07 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.333 0.969 . . . . 0.0 112.821 168.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -59.19 -33.07 70.51 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.351 0.978 . . . . 0.0 111.883 175.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.6 tt -74.58 -43.23 56.63 Favored 'General case' 0 C--N 1.338 0.071 0 O-C-N 121.719 -0.613 . . . . 0.0 109.399 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 87.7 mt -61.73 -40.14 85.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.544 0.738 . . . . 0.0 109.728 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -57.39 -30.61 65.05 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.262 0.625 . . . . 0.0 112.264 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -84.74 -1.62 56.51 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.427 1.091 . . . . 0.0 112.27 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 70.7 mt -126.53 -26.13 3.33 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.457 1.103 . . . . 0.0 112.061 -175.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -58.69 -29.45 66.64 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.805 1.184 . . . . 0.0 111.82 170.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -66.97 -11.93 58.16 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.992 0.917 . . . . 0.0 113.132 173.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -129.84 -11.42 4.33 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.382 1.073 . . . . 0.0 113.701 -168.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 46.7 mt -132.33 143.41 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 125.488 1.515 . . . . 0.0 107.995 -169.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -68.52 -40.77 86.14 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-O 119.211 -0.772 . . . . 0.0 112.261 -175.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -147.46 138.75 23.77 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 118.686 1.243 . . . . 0.0 108.52 177.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 51.3 t -134.25 121.62 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 -176.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 18.2 mt -127.41 154.66 38.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 -170.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.407 ' CB ' HD11 ' A' ' 81' ' ' ILE . 4.8 t80 -130.32 144.19 51.23 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 174.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.3 tt -124.96 128.21 48.25 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 173.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -111.14 156.48 15.52 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 74.4 mt -133.44 126.39 52.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -66.12 117.27 41.21 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 117.368 -1.301 . . . . 0.0 110.296 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -76.84 172.06 16.88 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.515 2.81 . . . . 0.0 111.499 170.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -128.44 -32.27 2.21 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.882 1.673 . . . . 0.0 111.103 171.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -135.55 135.21 51.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 176.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.3 t -141.22 134.85 31.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 175.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 157.81 155.1 7.38 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 177.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -64.96 153.62 40.01 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.941 0.877 . . . . 0.0 111.339 -174.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 52.88 39.64 29.42 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.036 2.134 . . . . 0.0 112.127 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -123.41 148.76 56.32 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 123.828 0.851 . . . . 0.0 109.943 173.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -82.15 163.02 17.76 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.262 2.641 . . . . 0.0 111.184 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 53.1 ttm -71.47 139.41 49.6 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 168.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 72.5 p -79.65 159.27 26.79 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.356 1.063 . . . . 0.0 110.538 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.3 tp60 -53.06 -44.54 97.31 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 116.565 -1.683 . . . . 0.0 114.197 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -68.42 -30.46 29.65 Favored 'Trans proline' 0 C--N 1.352 0.717 0 CA-C-N 122.888 2.067 . . . . 0.0 112.176 -176.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.8 -35.45 16.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 119.026 0.83 . . . . 0.0 108.788 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -56.5 -46.85 80.29 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.318 0.963 . . . . 0.0 110.074 170.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -63.94 -37.98 89.41 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 123.039 0.536 . . . . 0.0 111.203 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.69 -47.28 78.97 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 119.108 -0.472 . . . . 0.0 111.045 175.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 76.5 t -61.5 -38.56 80.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 118.915 0.779 . . . . 0.0 109.688 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -63.65 -39.2 93.74 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 119.361 0.982 . . . . 0.0 110.926 174.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 41.2 m -64.76 -45.01 88.21 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.55 -0.719 . . . . 0.0 110.092 177.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 73.8 t -62.26 -44.48 99.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.32 0.648 . . . . 0.0 109.574 176.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -55.41 -47.44 75.9 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.032 0.933 . . . . 0.0 110.521 177.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -63.77 -38.98 93.14 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 121.827 -0.546 . . . . 0.0 111.248 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -61.12 -25.57 67.07 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 118.27 -0.872 . . . . 0.0 112.534 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 94.5 mt -57.7 -23.36 51.3 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.99 1.268 . . . . 0.0 112.195 178.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 . . . . . 0 CA--C 1.546 0.803 0 CA-C-N 118.973 0.806 . . . . 0.0 112.428 -178.511 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 . . . . . 0 N--CA 1.454 -0.253 0 CA-C-O 121.902 0.858 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.29 153.69 21.79 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 169.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -91.29 134.61 34.44 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 173.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 56.8 tp . . . . . 0 N--CA 1.45 -0.442 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 175.971 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 . . . . . 0 C--O 1.234 0.288 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 79.8 t -137.35 146.91 27.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 36.1 tp -121.55 128.32 51.89 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 56.0 tp -118.83 95.98 5.06 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 89.1 m -70.39 142.96 52.03 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 169.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.8 t -140.64 142.08 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.314 1.446 . . . . 0.0 107.327 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 143.53 172.61 14.5 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 123.976 0.798 . . . . 0.0 112.059 175.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -110.2 118.56 36.67 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.537 1.135 . . . . 0.0 108.16 177.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -60.53 -13.88 16.55 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.235 1.814 . . . . 0.0 115.14 -170.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 26.0 ptm -127.94 18.13 6.68 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.584 1.153 . . . . 0.0 111.246 -173.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.2 ttt -110.72 37.95 2.63 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.101 0.864 . . . . 0.0 110.055 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.83 -141.37 26.24 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -61.35 -16.77 49.47 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.498 1.519 . . . . 0.0 112.198 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -60.51 -16.06 33.33 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.17 0.988 . . . . 0.0 112.127 174.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.64 17.16 2.77 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-O 118.35 -1.25 . . . . 0.0 113.649 174.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.09 -50.43 71.96 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 119.891 1.846 . . . . 0.0 111.123 -170.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.84 -54.96 32.59 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-O 117.789 -1.562 . . . . 0.0 110.825 175.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -48.51 -40.1 37.01 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 CA-C-N 120.758 2.279 . . . . 0.0 115.206 175.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.6 tp -71.4 -37.94 71.5 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.931 1.242 . . . . 0.0 110.466 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.8 tp -61.22 -46.89 88.58 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.235 0.47 . . . . 0.0 110.033 174.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.09 -40.74 86.2 Favored 'General case' 0 C--O 1.226 -0.159 0 C-N-CA 123.71 0.804 . . . . 0.0 111.036 178.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.8 tp10 -61.71 -49.52 76.12 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.601 0.637 . . . . 0.0 109.549 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -63.74 -45.6 89.12 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.87 0.468 . . . . 0.0 110.71 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 74.0 m -65.05 -37.84 88.87 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.703 0.683 . . . . 0.0 111.172 178.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.37 -40.38 95.73 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.263 0.938 . . . . 0.0 110.876 176.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.36 -34.05 75.38 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.277 0.631 . . . . 0.0 111.705 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.12 90.52 3.51 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 125.164 1.386 . . . . 0.0 108.792 -173.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -51.64 162.01 1.8 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 124.127 3.218 . . . . 0.0 114.486 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.417 ' HE2' ' CE1' ' A' ' 136' ' ' TYR . 36.7 mmtm -134.81 156.43 48.89 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 124.538 1.135 . . . . 0.0 110.052 -178.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 38.57 -111.45 0.17 Allowed Glycine 0 CA--C 1.527 0.817 0 C-N-CA 126.394 1.949 . . . . 0.0 113.096 170.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -137.74 9.68 2.86 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.392 1.477 . . . . 0.0 111.018 -171.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -81.77 126.41 31.8 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 121.33 -0.856 . . . . 0.0 111.205 -168.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.9 t -75.27 117.77 20.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 165.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.1 t -80.13 134.51 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -177.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 84.7 mt -133.54 146.19 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 170.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -127.57 110.47 12.74 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 173.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.5 -1.38 90.2 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 119.105 -0.83 . . . . 0.0 112.864 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 56.34 -147.57 31.24 Favored Glycine 0 C--N 1.339 0.737 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 -169.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.9 p -88.66 6.78 36.8 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.522 0.729 . . . . 0.0 112.155 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.37 58.2 20.24 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.179 1.392 . . . . 0.0 109.856 -177.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -68.68 -16.15 41.85 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.844 2.363 . . . . 0.0 113.237 -169.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -57.37 -31.07 65.41 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.479 0.711 . . . . 0.0 111.882 175.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.24 -28.26 69.04 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.256 0.622 . . . . 0.0 112.157 175.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.4 -2.48 45.46 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.967 1.307 . . . . 0.0 111.936 -169.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 87.9 mt -51.71 -43.72 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 123.923 0.889 . . . . 0.0 109.915 176.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.5 t -58.26 -41.05 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.265 0.626 . . . . 0.0 110.192 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.0 -44.96 75.36 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.241 0.473 . . . . 0.0 110.674 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.2 mt -59.11 -42.26 86.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -59.88 -31.17 69.54 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 118.061 -0.971 . . . . 0.0 111.847 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -59.97 -31.76 70.19 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.985 1.266 . . . . 0.0 111.133 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.6 mt -81.99 -13.0 58.04 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.176 0.99 . . . . 0.0 112.095 -175.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 72.8 mtp180 33.15 61.79 1.56 Allowed Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 126.552 1.941 . . . . 0.0 111.721 -169.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -53.88 143.2 61.14 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.008 2.472 . . . . 0.0 113.074 -169.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.4 m -72.81 -38.8 67.07 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 167.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 71.4 mtm180 -144.45 156.87 44.4 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 124.455 1.102 . . . . 0.0 108.969 176.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 45.6 tp -137.72 140.24 40.61 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.4 tp -126.24 136.38 52.73 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 174.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.0 mt -125.07 142.06 43.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 -174.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.1 t -141.56 133.77 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 118.806 0.73 . . . . 0.0 110.846 -174.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -161.36 172.21 16.96 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.565 2.346 . . . . 0.0 107.647 169.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.45 156.81 38.26 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.011 -1.056 . . . . 0.0 108.895 168.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.0 m -156.15 129.18 8.0 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 177.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -71.84 124.64 25.26 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 173.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 74.2 mtm -123.6 1.51 8.88 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.16 1.784 . . . . 0.0 110.766 -177.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.64 24.45 66.2 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-N 118.683 0.674 . . . . 0.0 112.423 -172.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.9 mt -95.74 -173.69 2.93 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.223 1.409 . . . . 0.0 109.333 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -73.38 140.4 79.27 Favored Pre-proline 0 N--CA 1.466 0.355 0 CA-C-O 117.72 -1.133 . . . . 0.0 108.18 170.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -44.23 136.59 8.07 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.258 2.639 . . . . 0.0 112.748 173.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.27 1.97 82.36 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-O 118.501 -1.166 . . . . 0.0 113.796 177.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -67.89 152.21 45.92 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 120.135 1.968 . . . . 0.0 108.257 168.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 51.5 mt -131.5 134.67 60.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -169.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.6 mmt-85 -147.01 148.85 32.11 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 118.721 0.691 . . . . 0.0 109.772 175.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 44.3 mm -73.79 152.85 7.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 166.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.9 mt -135.18 134.74 52.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 176.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -79.02 143.4 61.38 Favored Pre-proline 0 N--CA 1.472 0.661 0 CA-C-O 117.4 -1.286 . . . . 0.0 109.256 173.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo -45.47 -38.22 15.73 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 124.029 3.152 . . . . 0.0 116.439 176.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -68.04 -26.34 65.82 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.363 0.529 . . . . 0.0 111.523 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -94.35 -29.91 14.78 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.786 1.235 . . . . 0.0 111.232 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.487 HD11 ' HB3' ' A' ' 110' ' ' PHE . 59.9 mt -51.71 -45.59 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.15 1.38 . . . . 0.0 109.339 170.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -52.96 -31.35 40.0 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.292 1.037 . . . . 0.0 112.898 -177.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -96.8 -37.63 10.19 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.328 0.651 . . . . 0.0 110.328 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 24.8 mmt -80.64 -27.08 37.32 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 119.09 -0.481 . . . . 0.0 112.249 -170.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -64.8 -45.9 84.31 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 119.187 0.903 . . . . 0.0 110.286 175.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 20.2 ptt? . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -179.535 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.1 mt . . . . . 0 N--CA 1.466 0.331 0 N-CA-C 117.836 2.532 . . . . 0.0 117.836 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.95 -20.34 6.01 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.31 0.959 . . . . 0.0 112.055 167.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -59.91 -27.18 66.52 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.557 1.071 . . . . 0.0 112.582 173.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.7 tt -63.35 -49.42 73.98 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 119.141 0.882 . . . . 0.0 108.909 172.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 84.1 mt -64.82 -43.21 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -63.54 -19.65 64.97 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -175.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -102.55 8.77 39.78 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.176 1.39 . . . . 0.0 111.781 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.6 tp -140.31 -25.77 0.78 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.826 0.851 . . . . 0.0 112.163 -170.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 50.5 pttt -56.01 -24.66 40.4 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.51 1.524 . . . . 0.0 112.271 172.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -62.4 -17.07 58.31 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.996 1.318 . . . . 0.0 112.635 -172.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -130.15 9.12 5.21 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.646 0.778 . . . . 0.0 112.584 -175.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 56.3 mt -122.96 143.14 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.894 1.278 . . . . 0.0 108.409 -175.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -73.43 -37.01 54.14 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.868 0.747 . . . . 0.0 112.027 -177.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -149.43 136.56 19.83 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 118.226 1.013 . . . . 0.0 108.508 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 43.8 t -122.24 128.92 75.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 171.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.8 mt -126.64 149.26 31.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 -169.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.487 ' HB3' HD11 ' A' ' 81' ' ' ILE . 60.0 t80 -131.31 144.46 51.28 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 169.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.1 tt -124.56 127.79 47.94 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.45 1.5 . . . . 0.0 107.045 174.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -109.77 155.82 15.9 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 78.4 mt -133.78 127.69 52.82 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 -178.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 69.1 tp60 -61.77 114.79 12.28 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-O 117.467 -1.254 . . . . 0.0 110.517 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -77.34 171.46 17.66 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.402 2.735 . . . . 0.0 111.188 170.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -138.24 -26.93 0.9 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 127.088 2.155 . . . . 0.0 111.536 173.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -136.77 120.12 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 -173.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.5 t -143.22 129.4 16.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 156.76 151.75 6.07 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -63.21 145.28 55.84 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.421 0.629 . . . . 0.0 110.765 -174.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 64.83 0.08 1.1 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 128.199 2.6 . . . . 0.0 113.834 -175.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 19.3 m-30 -77.28 142.51 67.88 Favored Pre-proline 0 C--O 1.237 0.418 0 CA-C-N 120.309 1.413 . . . . 0.0 109.133 174.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -73.61 158.29 47.58 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.48 2.12 . . . . 0.0 109.914 169.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 47.3 ttm -73.88 142.78 46.0 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 168.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 29.9 p -81.12 155.09 26.42 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.082 0.953 . . . . 0.0 110.798 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -53.69 -40.43 80.64 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-O 116.529 -1.7 . . . . 0.0 114.729 -178.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -63.68 -39.68 33.57 Favored 'Trans proline' 0 C--N 1.35 0.647 0 CA-C-N 122.819 2.043 . . . . 0.0 111.291 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.6 mp -73.21 -37.53 52.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -57.19 -47.06 82.21 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.35 0.977 . . . . 0.0 110.305 172.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -63.99 -39.25 93.7 Favored 'General case' 0 C--N 1.334 -0.095 0 C-N-CA 122.959 0.504 . . . . 0.0 110.903 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.59 -46.68 84.72 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 122.994 0.517 . . . . 0.0 111.095 176.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 52.7 t -59.94 -41.31 85.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -67.69 -27.88 67.21 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 118.843 0.747 . . . . 0.0 111.858 177.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 36.7 m -71.13 -41.86 69.95 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.366 -0.833 . . . . 0.0 109.952 174.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 98.2 t -62.73 -48.7 86.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 119.2 0.909 . . . . 0.0 108.761 173.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.417 ' CE1' ' HE2' ' A' ' 31' ' ' LYS . 18.0 t80 -50.91 -50.17 57.99 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.655 1.182 . . . . 0.0 111.301 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -73.18 -31.71 64.38 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.915 0.779 . . . . 0.0 111.988 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -61.3 -38.01 85.27 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.077 0.853 . . . . 0.0 110.642 176.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 75.7 mt -55.7 -20.48 14.47 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -174.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 . . . . . 0 CA--C 1.54 0.581 0 CA-C-N 119.649 1.113 . . . . 0.0 112.352 177.17 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 . . . . . 0 N--CA 1.446 -0.654 0 CA-C-O 121.484 0.659 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.88 155.65 37.26 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.784 0.834 . . . . 0.0 109.0 170.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -92.18 140.8 29.26 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 173.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 52.0 tp . . . . . 0 N--CA 1.449 -0.5 0 C-N-CA 124.969 1.308 . . . . 0.0 107.806 173.86 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.6 t0 . . . . . 0 C--O 1.231 0.129 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 55.4 t -92.74 145.96 6.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -169.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 50.4 tp -119.76 98.19 5.99 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 172.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.9 tp -90.07 106.12 18.27 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -75.49 150.41 38.22 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 172.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.9 t -142.27 140.05 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 143.66 172.6 14.59 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.017 0.818 . . . . 0.0 112.135 176.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -116.67 120.25 38.05 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.92 1.288 . . . . 0.0 108.257 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 m -59.43 -13.72 9.69 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.644 1.977 . . . . 0.0 115.529 -169.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.1 ptt? -129.83 12.36 5.74 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 119.239 0.927 . . . . 0.0 111.485 -176.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.6 ttt -96.99 34.27 1.76 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.718 0.69 . . . . 0.0 110.002 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.37 -140.81 22.4 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -178.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -62.73 -15.98 55.47 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 124.387 1.075 . . . . 0.0 112.293 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -59.1 -17.81 29.79 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.961 1.304 . . . . 0.0 112.729 175.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.08 19.02 1.07 Allowed Glycine 0 CA--C 1.534 1.248 0 O-C-N 120.693 -1.254 . . . . 0.0 114.033 176.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.14 -49.98 73.69 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.572 1.686 . . . . 0.0 110.819 -170.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.68 -55.78 28.57 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.076 -1.402 . . . . 0.0 111.191 175.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -48.58 -42.75 35.17 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 CA-C-N 120.275 2.037 . . . . 0.0 115.487 176.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.6 tp -70.68 -37.15 73.6 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 120.217 1.371 . . . . 0.0 110.448 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 51.1 tp -61.41 -49.56 76.38 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.159 0.436 . . . . 0.0 110.108 175.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.79 -36.87 82.35 Favored 'General case' 0 C--O 1.227 -0.12 0 CA-C-O 118.594 -0.717 . . . . 0.0 111.774 178.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -60.59 -48.59 81.12 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 119.058 0.845 . . . . 0.0 109.682 176.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -62.01 -44.59 96.39 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 122.938 0.495 . . . . 0.0 110.605 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 75.0 m -62.62 -43.85 97.78 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 118.495 0.589 . . . . 0.0 111.023 177.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.44 -40.3 96.14 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.085 0.554 . . . . 0.0 110.787 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.21 -31.88 70.76 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.387 0.675 . . . . 0.0 111.951 177.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.73 93.09 2.17 Favored Pre-proline 0 CA--C 1.537 0.481 0 C-N-CA 124.93 1.292 . . . . 0.0 108.742 -171.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -55.64 158.13 14.0 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.819 2.346 . . . . 0.0 112.486 177.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -131.67 173.47 11.1 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.467 1.507 . . . . 0.0 108.892 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 37.93 -119.48 0.76 Allowed Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.216 1.389 . . . . 0.0 111.929 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -142.91 40.89 1.53 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.092 1.357 . . . . 0.0 108.592 169.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -76.54 165.06 25.31 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.705 0.764 . . . . 0.0 111.573 -170.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.3 t -120.41 84.41 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 104.478 -2.416 . . . . 0.0 104.478 167.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.2 p -64.97 143.57 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 O-C-N 121.596 -0.69 . . . . 0.0 109.386 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.2 mt -132.12 128.15 58.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -83.92 78.78 9.67 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.05 0.94 . . . . 0.0 109.312 172.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -66.35 -29.69 75.31 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.604 -0.599 . . . . 0.0 111.604 176.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 55.65 -140.03 41.44 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 175.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.9 p -88.18 1.54 54.19 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.726 0.81 . . . . 0.0 112.949 -171.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -145.18 61.46 7.97 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 124.583 1.153 . . . . 0.0 110.183 178.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -66.22 -15.37 48.06 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 122.679 2.253 . . . . 0.0 112.646 -175.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -47.88 -40.37 21.45 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.751 1.621 . . . . 0.0 111.011 169.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -64.65 -31.2 72.32 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 122.097 -0.377 . . . . 0.0 111.959 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -89.28 -9.17 51.61 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.2 1.0 . . . . 0.0 111.329 -169.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.7 mt -52.86 -40.07 34.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 123.811 0.845 . . . . 0.0 109.211 169.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.1 t -60.21 -40.84 84.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.041 0.537 . . . . 0.0 110.145 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.53 -47.49 63.56 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.836 0.454 . . . . 0.0 110.102 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 95.4 mt -53.55 -41.58 46.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.222 1.009 . . . . 0.0 110.079 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -66.34 -18.99 65.68 Favored 'General case' 0 CA--C 1.53 0.173 0 O-C-N 121.05 -1.031 . . . . 0.0 112.725 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -72.64 -40.7 66.21 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 120.228 1.376 . . . . 0.0 109.379 169.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 60.2 mt -73.72 -29.05 62.02 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.434 1.094 . . . . 0.0 111.934 -174.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 39.6 60.18 6.29 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 125.941 1.696 . . . . 0.0 111.877 -169.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.02 153.56 31.52 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.757 2.305 . . . . 0.0 114.043 -170.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.5 m -70.9 -37.81 72.98 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 168.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -148.59 155.5 41.18 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.038 0.935 . . . . 0.0 109.454 -174.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.6 tp -144.67 136.56 25.87 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.651 1.181 . . . . 0.0 108.347 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 58.5 tp -122.4 140.02 53.17 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 169.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.3 mt -124.06 143.17 38.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 41.4 t -141.07 135.33 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 118.571 0.623 . . . . 0.0 109.778 -173.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -163.96 171.8 14.79 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.52 2.328 . . . . 0.0 107.495 173.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.03 157.66 37.84 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.575 -0.703 . . . . 0.0 109.16 168.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.6 m -152.32 127.89 10.07 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -78.07 80.1 4.51 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 119.099 0.863 . . . . 0.0 110.222 176.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 73.7 mtm -75.47 -6.45 50.22 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.033 1.733 . . . . 0.0 112.379 -177.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.62 23.25 78.27 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-N 118.621 0.646 . . . . 0.0 111.822 -172.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.9 mt -100.33 -171.66 2.07 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.889 1.276 . . . . 0.0 109.948 -178.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -74.89 139.99 73.85 Favored Pre-proline 0 N--CA 1.468 0.451 0 CA-C-O 117.431 -1.271 . . . . 0.0 108.612 170.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -43.07 137.44 4.66 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.316 2.677 . . . . 0.0 113.31 172.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.45 0.58 79.32 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 118.641 -1.089 . . . . 0.0 113.646 176.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -65.05 146.57 54.83 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 119.82 1.81 . . . . 0.0 108.243 168.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.6 mt -125.94 138.44 54.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -175.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 91.0 mmt-85 -147.69 152.49 37.9 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 118.69 0.677 . . . . 0.0 111.442 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 37.3 mm -78.78 145.33 9.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 105.828 -1.915 . . . . 0.0 105.828 165.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.5 mt -129.61 124.14 58.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -76.8 140.68 67.56 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 117.859 -1.067 . . . . 0.0 109.586 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -47.42 -34.28 18.94 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 124.086 3.191 . . . . 0.0 116.581 179.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -67.74 -22.91 65.2 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.596 0.634 . . . . 0.0 111.806 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -101.54 -30.9 11.13 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.177 1.391 . . . . 0.0 111.35 -178.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 68.8 mt -50.41 -38.59 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.707 1.203 . . . . 0.0 109.547 169.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.22 -20.19 6.48 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.917 1.687 . . . . 0.0 114.285 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -124.76 -38.76 2.34 Favored 'General case' 0 C--N 1.334 -0.067 0 CA-C-N 118.811 0.732 . . . . 0.0 110.638 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 10.9 mmt -68.12 -24.48 65.02 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -172.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -74.78 -45.35 44.25 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 119.358 0.981 . . . . 0.0 111.066 173.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 25.7 ptt? . . . . . 0 CA--C 1.535 0.389 0 O-C-N 121.732 -0.605 . . . . 0.0 112.583 177.004 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 mt . . . . . 0 N--CA 1.474 0.765 0 N-CA-C 117.235 2.309 . . . . 0.0 117.235 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.1 -21.13 4.37 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.093 0.957 . . . . 0.0 112.783 168.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -59.57 -29.49 67.97 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.453 1.024 . . . . 0.0 112.04 174.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.7 tt -76.62 -43.57 37.76 Favored 'General case' 0 C--N 1.338 0.103 0 O-C-N 121.399 -0.813 . . . . 0.0 109.667 175.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 77.7 mt -60.47 -43.93 95.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 C-N-CA 123.409 0.684 . . . . 0.0 109.299 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -60.79 -25.43 66.54 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -177.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -82.68 -3.09 55.82 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.879 0.872 . . . . 0.0 112.47 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.0 mt -134.89 -28.4 1.21 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.099 0.959 . . . . 0.0 112.626 -171.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -60.63 -22.04 63.38 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.149 0.98 . . . . 0.0 112.668 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -72.03 -10.25 59.52 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.623 1.169 . . . . 0.0 111.834 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -133.08 -42.57 0.88 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.433 1.093 . . . . 0.0 111.949 -173.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 29.0 mt -72.26 141.4 16.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -64.69 -41.86 97.5 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.119 0.866 . . . . 0.0 112.037 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -149.47 138.37 21.14 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.635 1.218 . . . . 0.0 108.906 176.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 54.0 t -131.28 124.98 56.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 16.9 mt -129.79 154.45 40.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -171.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -129.82 140.63 50.98 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 173.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.0 tt -120.09 129.72 54.32 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 174.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -112.58 156.55 15.52 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 68.8 mt -134.07 124.78 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 -177.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -65.28 118.1 46.69 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-O 117.423 -1.275 . . . . 0.0 110.363 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -77.15 172.05 16.77 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.656 2.904 . . . . 0.0 111.572 171.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -128.84 -31.96 2.14 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.785 1.634 . . . . 0.0 110.974 172.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.15 136.38 49.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.415 1.086 . . . . 0.0 108.269 175.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.1 t -141.1 134.36 31.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 175.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 159.7 151.55 6.2 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -64.71 157.98 25.91 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 117.642 0.721 . . . . 0.0 111.608 -175.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . 0.253 44.1 p90 44.37 41.4 4.49 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.333 2.253 . . . . 0.0 113.072 -174.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -121.51 148.41 50.12 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 123.95 0.9 . . . . 0.0 109.919 172.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -81.06 163.06 20.38 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.238 2.625 . . . . 0.0 111.259 177.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 54.2 ttm -72.22 139.66 48.28 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 168.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 68.3 p -80.6 159.88 25.28 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.365 1.066 . . . . 0.0 110.603 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.1 tm0? -51.23 -48.6 85.18 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-O 117.011 -1.471 . . . . 0.0 113.303 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -67.7 -29.64 35.65 Favored 'Trans proline' 0 C--N 1.352 0.727 0 CA-C-N 122.55 1.946 . . . . 0.0 112.423 -174.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -80.35 -35.32 15.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 119.046 0.839 . . . . 0.0 108.937 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -56.67 -46.78 80.93 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.418 1.008 . . . . 0.0 109.89 170.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -62.98 -38.57 91.66 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 122.961 0.504 . . . . 0.0 111.517 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.84 -46.74 80.62 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 119.193 -0.432 . . . . 0.0 111.017 176.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 73.8 t -62.25 -39.41 83.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 118.883 0.765 . . . . 0.0 109.81 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 34.6 tp10 -61.69 -40.98 96.92 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.031 0.832 . . . . 0.0 110.56 174.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 50.2 m -63.84 -45.87 87.59 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.06 0.544 . . . . 0.0 110.063 177.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 76.6 t -62.56 -44.17 99.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 118.831 0.741 . . . . 0.0 109.605 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -55.05 -46.95 75.4 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.317 1.047 . . . . 0.0 110.611 176.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -63.72 -39.7 94.94 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.659 0.663 . . . . 0.0 110.989 175.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.13 -26.06 67.43 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.421 0.688 . . . . 0.0 112.647 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 91.3 mt -57.11 -22.81 42.53 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.184 0.902 . . . . 0.0 112.231 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 . . . . . 0 CA--C 1.546 0.795 0 C-N-CA 124.277 1.031 . . . . 0.0 112.166 -178.911 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 . . . . . 0 C--O 1.233 0.218 0 CA-C-O 121.948 0.88 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -80.81 149.71 29.47 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 171.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -88.98 123.07 32.97 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 173.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 62.9 tp . . . . . 0 C--O 1.233 0.205 0 C-N-CA 125.158 1.383 . . . . 0.0 109.925 177.693 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.3 t70 . . . . . 0 C--O 1.232 0.178 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.8 m -132.92 154.73 40.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 124.002 0.921 . . . . 0.0 110.541 -169.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 30.6 tp -125.66 117.21 23.03 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 174.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 64.8 tp -104.74 97.52 7.39 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 96.9 m -73.15 143.73 47.16 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 169.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.0 t -142.16 144.47 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 175.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 147.64 174.48 19.6 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 124.653 1.121 . . . . 0.0 110.335 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -121.83 120.22 33.92 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 174.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 m -58.93 -12.95 5.13 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.446 1.898 . . . . 0.0 115.545 -169.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -129.61 12.82 5.91 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 119.321 0.964 . . . . 0.0 111.226 -177.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.8 ttt -94.32 32.17 1.59 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.868 0.758 . . . . 0.0 109.589 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.05 -145.12 26.75 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 -175.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -59.34 -18.06 34.88 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 125.952 1.701 . . . . 0.0 112.308 178.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -53.89 -25.58 20.77 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.819 1.248 . . . . 0.0 112.676 175.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.76 25.01 0.64 Allowed Glycine 0 CA--C 1.532 1.148 0 CA-C-O 118.7 -1.055 . . . . 0.0 114.277 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.08 -50.67 67.44 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 119.474 1.637 . . . . 0.0 110.432 -170.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.24 -55.64 29.0 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-O 117.881 -1.511 . . . . 0.0 110.98 175.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -50.65 -37.98 54.61 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 CA-C-N 121.106 2.453 . . . . 0.0 114.77 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.9 tp -71.75 -38.88 70.33 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 120.014 1.279 . . . . 0.0 110.509 176.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.1 tp -60.44 -47.65 85.19 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.341 0.518 . . . . 0.0 110.216 175.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.67 -40.96 85.05 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.479 1.111 . . . . 0.0 110.975 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.0 tp10 -61.97 -49.68 75.11 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-N 118.717 0.69 . . . . 0.0 109.693 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -63.64 -45.3 90.87 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.729 0.412 . . . . 0.0 110.81 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 75.5 m -65.32 -38.35 89.89 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.566 0.621 . . . . 0.0 111.094 178.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.91 -39.84 95.1 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.248 0.931 . . . . 0.0 110.906 176.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.41 -33.87 75.0 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.261 0.624 . . . . 0.0 111.805 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.47 91.08 3.35 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 125.141 1.376 . . . . 0.0 108.767 -173.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -51.66 161.32 2.13 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 124.035 3.157 . . . . 0.0 114.852 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.409 ' HE2' ' CE1' ' A' ' 136' ' ' TYR . 37.9 mmtm -137.98 158.78 43.63 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.345 1.458 . . . . 0.0 108.969 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 41.44 -120.15 1.86 Allowed Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.362 1.458 . . . . 0.0 111.737 175.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -136.79 16.26 3.09 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.685 1.194 . . . . 0.0 110.787 174.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 2.0 m95 -75.0 120.29 20.34 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 121.324 -0.86 . . . . 0.0 109.018 -170.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.7 t -71.02 111.12 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 168.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.3 t -71.33 138.33 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -177.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 98.5 mt -135.91 142.73 38.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 104.03 -2.581 . . . . 0.0 104.03 173.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -126.37 107.04 9.92 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 175.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.3 -11.38 71.29 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 118.523 -1.154 . . . . 0.0 113.391 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.17 34.64 80.7 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-N 119.425 1.612 . . . . 0.0 113.713 170.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 63.23 14.04 7.43 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.007 1.723 . . . . 0.0 114.242 -174.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.79 56.88 12.11 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 125.385 1.474 . . . . 0.0 108.057 169.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -68.58 -15.41 41.37 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.396 2.064 . . . . 0.0 113.128 -168.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -51.45 -34.14 33.99 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.086 0.857 . . . . 0.0 112.074 170.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.17 -26.4 68.31 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.215 0.606 . . . . 0.0 112.289 177.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -103.0 -5.66 23.18 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.956 1.302 . . . . 0.0 111.403 -170.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 73.9 mt -55.47 -41.63 64.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 119.112 0.869 . . . . 0.0 109.604 174.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.6 t -60.3 -41.21 86.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 118.524 0.602 . . . . 0.0 109.797 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.76 -45.19 83.47 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.87 0.468 . . . . 0.0 110.38 -178.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 90.2 mt -56.43 -48.38 80.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -63.02 -34.52 77.73 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 118.206 -0.902 . . . . 0.0 112.005 -174.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -58.01 -32.2 67.71 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.482 1.037 . . . . 0.0 111.537 175.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 78.9 mt -84.75 -8.65 58.75 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.174 0.99 . . . . 0.0 112.703 -175.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 27.74 62.26 0.64 Allowed Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 126.892 2.077 . . . . 0.0 112.794 -168.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.33 149.62 63.89 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.246 1.964 . . . . 0.0 113.543 -173.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.49 -26.43 35.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.784 168.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -145.21 151.32 38.22 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.811 0.844 . . . . 0.0 109.841 177.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 25.1 tp -140.91 141.31 34.56 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 125.551 1.54 . . . . 0.0 108.132 172.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 34.3 tp -129.34 138.88 51.81 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 171.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.8 mt -124.66 141.37 44.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 -174.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.9 t -140.86 133.47 30.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 118.728 0.694 . . . . 0.0 109.898 -174.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -161.28 172.44 16.63 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.442 2.297 . . . . 0.0 107.122 174.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.27 158.28 36.16 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.157 -0.965 . . . . 0.0 108.622 167.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.5 m -153.23 129.22 10.3 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 174.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -77.03 80.59 3.56 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.705 0.764 . . . . 0.0 109.94 175.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 76.3 mtm -76.46 -6.76 53.13 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.313 1.445 . . . . 0.0 112.241 -174.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.58 31.28 60.89 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -172.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 77.3 mt -110.97 -170.8 1.7 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.745 1.218 . . . . 0.0 109.722 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -81.14 140.82 49.61 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 117.668 -1.158 . . . . 0.0 108.84 174.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -46.51 132.94 16.34 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.198 2.599 . . . . 0.0 113.614 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.58 1.33 90.1 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 118.506 -1.164 . . . . 0.0 113.412 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -65.65 153.79 40.65 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 119.902 1.851 . . . . 0.0 108.49 168.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 62.3 mt -132.74 140.95 46.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -170.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 82.3 mmt-85 -149.44 152.98 36.59 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.365 0.666 . . . . 0.0 109.981 170.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 35.8 mm -77.29 145.33 10.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 165.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.3 mt -129.57 161.97 38.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 176.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -131.14 144.78 54.95 Favored Pre-proline 0 C--O 1.234 0.288 0 C-N-CA 126.519 1.928 . . . . 0.0 107.181 -171.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -54.28 -27.97 50.43 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 123.18 2.586 . . . . 0.0 115.139 -174.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -68.96 -19.98 64.18 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.948 0.794 . . . . 0.0 112.197 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -117.01 -30.88 5.56 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.164 1.386 . . . . 0.0 111.771 -171.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 65.6 mt -50.15 -40.87 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.268 1.427 . . . . 0.0 109.78 169.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.25 -26.13 37.92 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.822 1.249 . . . . 0.0 113.458 -176.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -108.14 -39.42 5.5 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 123.337 0.655 . . . . 0.0 110.021 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 21.4 mmt -69.21 -26.32 64.76 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -174.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -72.13 -46.37 56.83 Favored 'General case' 0 C--O 1.228 -0.052 0 CA-C-N 119.109 0.868 . . . . 0.0 110.799 174.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 27.6 ptm . . . . . 0 CA--C 1.541 0.598 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -176.502 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.1 mt . . . . . 0 N--CA 1.47 0.534 0 N-CA-C 116.939 2.2 . . . . 0.0 116.939 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.47 -20.31 4.62 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 117.878 -1.058 . . . . 0.0 113.02 168.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -54.77 -35.74 64.12 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 119.967 1.258 . . . . 0.0 111.517 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.8 tt -75.38 -44.09 46.7 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.329 0.652 . . . . 0.0 109.592 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 94.3 mt -62.95 -44.11 99.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -64.67 -17.65 64.26 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -171.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -109.6 13.68 23.76 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.306 1.043 . . . . 0.0 112.085 178.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 72.8 mt -129.5 -34.48 1.8 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.178 1.391 . . . . 0.0 110.783 177.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -57.5 -22.17 42.39 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.265 1.426 . . . . 0.0 112.693 176.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -70.16 -14.84 62.82 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.656 1.182 . . . . 0.0 111.931 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -137.52 -32.31 0.77 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.144 0.883 . . . . 0.0 113.045 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 32.5 mt -70.46 138.26 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 174.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -64.24 -42.87 97.71 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.268 0.937 . . . . 0.0 112.385 -176.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -144.75 134.62 23.72 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.664 1.232 . . . . 0.0 108.336 175.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 47.8 t -125.95 127.8 71.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 177.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.9 mt -130.84 153.29 38.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 -168.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -133.17 145.56 50.75 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 175.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.1 tt -127.87 133.46 49.34 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 171.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -114.16 157.06 15.22 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 80.8 mt -134.47 126.88 49.31 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -65.04 116.52 30.71 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-O 117.583 -1.199 . . . . 0.0 110.372 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -79.17 173.5 13.29 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.247 2.631 . . . . 0.0 111.789 171.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -136.71 -28.7 0.97 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.373 2.269 . . . . 0.0 111.382 172.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -132.42 119.63 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 -173.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.3 t -143.67 131.78 18.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 153.54 152.82 6.16 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -67.12 150.89 48.54 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.974 0.893 . . . . 0.0 111.27 -174.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 13.0 t80 51.69 40.67 27.9 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.839 2.055 . . . . 0.0 112.107 -174.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.4 m-30 -115.79 142.54 29.18 Favored Pre-proline 0 C--O 1.237 0.434 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 170.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -74.27 160.44 42.22 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.636 2.224 . . . . 0.0 110.46 170.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.1 ttm -74.69 141.98 44.49 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 169.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 39.9 p -79.53 157.42 27.42 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.426 1.091 . . . . 0.0 110.653 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -52.55 -42.47 88.39 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-O 116.579 -1.677 . . . . 0.0 114.721 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -70.81 -28.55 20.08 Favored 'Trans proline' 0 C--N 1.351 0.707 0 CA-C-N 123.043 2.123 . . . . 0.0 111.883 -175.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.23 -36.53 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -56.68 -45.93 81.43 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.297 0.953 . . . . 0.0 110.091 170.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -63.34 -41.6 98.89 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 123.064 0.546 . . . . 0.0 111.117 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.69 -47.09 85.13 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.833 0.453 . . . . 0.0 111.043 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.0 t -60.81 -42.33 91.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 177.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -68.26 -28.27 67.06 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.874 0.761 . . . . 0.0 111.602 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 42.9 m -69.03 -46.29 68.3 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.214 -0.929 . . . . 0.0 109.492 173.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 90.1 t -61.65 -43.43 97.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 119.111 0.869 . . . . 0.0 109.597 176.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.409 ' CE1' ' HE2' ' A' ' 31' ' ' LYS . 20.4 t80 -52.96 -46.12 68.07 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.209 1.004 . . . . 0.0 111.227 175.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -66.11 -42.43 89.23 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.628 0.649 . . . . 0.0 111.003 175.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -58.4 -37.31 75.05 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.882 0.873 . . . . 0.0 111.76 -175.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 72.1 mt -57.21 -18.59 16.49 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.154 0.982 . . . . 0.0 113.137 -175.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 . . . . . 0 CA--C 1.542 0.635 0 CA-C-N 119.671 1.123 . . . . 0.0 112.431 177.161 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 . . . . . 0 N--CA 1.448 -0.537 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -78.24 151.86 32.87 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 172.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -98.19 119.74 37.38 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 55.1 tp . . . . . 0 C--O 1.233 0.207 0 C-N-CA 125.262 1.425 . . . . 0.0 110.301 -179.152 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.5 t0 . . . . . 0 C--O 1.233 0.184 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 51.2 t -139.42 151.8 22.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 119.003 0.82 . . . . 0.0 109.921 -167.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 33.7 tp -126.2 129.86 49.82 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 126.069 1.748 . . . . 0.0 106.402 176.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.9 tp -117.31 100.95 8.03 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 124.915 1.286 . . . . 0.0 107.886 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 89.4 m -76.04 141.23 42.15 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 169.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 50.9 t -139.96 142.93 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 143.18 174.39 15.43 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.252 0.93 . . . . 0.0 111.709 176.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -118.32 120.16 36.8 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.7 1.2 . . . . 0.0 108.869 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -59.67 -15.97 23.12 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.356 1.862 . . . . 0.0 115.228 -170.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 27.7 ptm -126.88 14.47 7.42 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.206 1.003 . . . . 0.0 111.167 -175.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.2 ttt -101.78 31.58 3.78 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.41 0.684 . . . . 0.0 110.048 -177.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.29 -142.49 21.3 Favored Glycine 0 C--N 1.337 0.584 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -60.26 -17.68 43.82 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.784 1.234 . . . . 0.0 112.352 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -57.09 -19.75 21.36 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.88 1.272 . . . . 0.0 112.557 176.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.13 21.17 0.85 Allowed Glycine 0 CA--C 1.534 1.238 0 O-C-N 120.761 -1.212 . . . . 0.0 114.278 176.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.25 -53.18 58.86 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.588 1.694 . . . . 0.0 110.943 -170.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.59 -53.94 41.86 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 117.791 -1.561 . . . . 0.0 111.02 175.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -48.97 -41.02 40.63 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 CA-C-N 120.78 2.29 . . . . 0.0 115.217 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.7 tp -71.51 -37.74 71.19 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 120.265 1.393 . . . . 0.0 110.372 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.9 tp -61.91 -46.98 87.02 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.047 0.385 . . . . 0.0 110.252 175.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.53 -40.6 87.69 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 124.021 0.929 . . . . 0.0 111.111 177.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -60.94 -48.81 80.1 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 118.833 0.742 . . . . 0.0 109.789 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -62.34 -46.13 90.07 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 122.959 0.504 . . . . 0.0 110.569 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 79.6 m -64.57 -38.36 90.74 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.271 0.487 . . . . 0.0 111.219 178.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.54 -38.64 91.72 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.886 0.766 . . . . 0.0 110.988 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.36 -38.28 78.02 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.203 0.601 . . . . 0.0 111.157 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.32 94.57 2.16 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 125.205 1.402 . . . . 0.0 108.497 -173.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -56.01 159.67 11.75 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 123.526 2.817 . . . . 0.0 113.328 178.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -135.74 167.51 21.01 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 126.053 1.741 . . . . 0.0 108.336 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 44.23 -127.32 6.54 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.509 1.052 . . . . 0.0 111.831 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -136.16 9.89 3.26 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.854 1.261 . . . . 0.0 111.699 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -71.33 125.12 26.13 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 123.986 0.914 . . . . 0.0 109.252 -172.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 51.1 t -69.9 123.79 24.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 166.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.4 t -77.45 135.38 26.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -178.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.6 mm -130.65 145.9 34.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 104.292 -2.484 . . . . 0.0 104.292 168.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -134.33 107.92 7.9 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 177.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.54 -1.9 89.06 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 118.966 -0.908 . . . . 0.0 112.49 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 54.22 -145.1 27.23 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -169.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.8 p -89.71 13.75 13.48 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 122.01 -0.7 . . . . 0.0 111.869 177.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.54 58.63 10.42 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 124.995 1.318 . . . . 0.0 110.498 -177.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -72.25 -22.09 22.57 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.873 2.382 . . . . 0.0 112.967 -171.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.72 -36.19 78.22 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.847 0.749 . . . . 0.0 111.856 -177.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -65.0 -11.89 44.06 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.867 0.867 . . . . 0.0 112.931 175.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -113.75 -0.25 14.3 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.305 1.042 . . . . 0.0 112.29 -172.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 62.5 mt -48.17 -41.19 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 125.124 1.37 . . . . 0.0 110.732 174.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.0 t -56.77 -44.02 80.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.313 0.645 . . . . 0.0 110.198 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.32 93.03 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.974 0.51 . . . . 0.0 110.966 -177.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 64.7 mt -64.27 -45.53 95.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.1 mtp180 -64.89 -31.29 72.45 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.512 -176.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -57.92 -33.06 68.38 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.667 1.121 . . . . 0.0 111.558 174.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 33.0 mt -76.22 -8.23 56.61 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 118.571 -0.728 . . . . 0.0 112.778 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.1 mtp180 31.8 62.12 1.23 Allowed Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 126.994 2.118 . . . . 0.0 112.359 -169.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -55.07 142.67 76.63 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.835 2.357 . . . . 0.0 112.305 -172.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.2 m -81.68 -31.84 32.04 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.682 0.793 . . . . 0.0 108.913 168.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -142.55 150.76 40.82 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.611 1.564 . . . . 0.0 107.721 174.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 56.4 tp -138.81 142.89 38.7 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.645 1.178 . . . . 0.0 108.088 173.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 35.0 tp -128.49 138.93 52.52 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 173.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.1 mt -125.31 142.07 43.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 -175.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.4 t -140.83 134.11 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 118.593 0.633 . . . . 0.0 110.08 -174.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -161.52 171.18 18.54 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.252 2.221 . . . . 0.0 107.739 171.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.4 156.84 39.01 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.133 -0.979 . . . . 0.0 108.621 168.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.3 m -155.86 127.74 7.45 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 176.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -71.48 123.76 23.12 Favored 'General case' 0 N--CA 1.461 0.097 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 171.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 75.4 mtm -123.24 1.73 9.12 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.032 1.733 . . . . 0.0 110.705 -175.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.83 25.21 68.97 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-N 118.747 0.703 . . . . 0.0 112.332 -173.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.0 mt -99.92 -172.25 2.2 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.332 1.453 . . . . 0.0 109.292 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -75.36 140.22 72.34 Favored Pre-proline 0 N--CA 1.469 0.49 0 CA-C-O 117.539 -1.219 . . . . 0.0 108.667 173.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -43.43 136.32 6.1 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 123.343 2.695 . . . . 0.0 113.081 172.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.31 3.48 76.91 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 118.779 -1.012 . . . . 0.0 113.75 178.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -64.74 148.57 50.88 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 119.754 1.777 . . . . 0.0 108.581 168.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 76.5 mt -125.89 136.09 61.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 -173.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 90.1 mmt-85 -148.18 152.64 37.59 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 118.512 0.596 . . . . 0.0 111.101 175.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 41.5 mm -81.58 144.74 9.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 166.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.8 mt -126.79 129.33 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -73.5 139.14 77.86 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 118.185 -0.912 . . . . 0.0 109.36 172.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -45.37 -36.26 12.81 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 124.46 3.44 . . . . 0.0 116.4 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -66.67 -26.78 67.2 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.445 0.566 . . . . 0.0 111.687 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -97.7 -28.57 13.84 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.515 1.126 . . . . 0.0 111.149 -178.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 45.9 mt -51.04 -43.38 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.613 1.165 . . . . 0.0 110.229 170.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -52.99 -31.49 41.17 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.593 1.157 . . . . 0.0 112.804 -177.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -97.58 -42.33 7.72 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.314 0.646 . . . . 0.0 109.843 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 22.5 mmt -67.3 -33.38 75.17 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -171.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -62.43 -43.37 98.97 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 118.454 0.57 . . . . 0.0 110.655 176.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 27.8 ptm . . . . . 0 CA--C 1.538 0.498 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -179.751 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.6 mt . . . . . 0 N--CA 1.464 0.258 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -52.84 -23.32 6.75 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.256 0.934 . . . . 0.0 112.045 167.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -60.64 -27.08 67.52 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.828 0.74 . . . . 0.0 112.583 175.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.5 tt -69.64 -43.78 71.95 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 119.023 0.829 . . . . 0.0 109.372 175.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 76.7 mt -61.95 -43.48 97.58 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.093 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -64.38 -16.46 62.33 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -105.54 16.98 24.6 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.33 1.452 . . . . 0.0 111.18 177.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.6 mt -136.06 -37.5 0.72 Allowed 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.703 1.201 . . . . 0.0 110.994 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -55.59 -22.32 21.63 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.569 1.148 . . . . 0.0 112.742 176.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -60.23 -24.71 65.08 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.504 1.522 . . . . 0.0 112.122 -177.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -134.05 7.42 3.7 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.681 0.792 . . . . 0.0 112.488 -171.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 76.5 mt -122.41 141.51 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.977 1.311 . . . . 0.0 108.291 -174.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.27 -39.64 81.88 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 123.864 0.745 . . . . 0.0 111.809 -176.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -147.38 132.86 18.65 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 118.307 1.054 . . . . 0.0 108.256 176.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 41.5 t -122.65 129.38 75.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 172.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 15.1 mt -129.24 148.68 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 -169.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -129.6 141.18 51.0 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 170.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.5 tt -123.53 127.98 49.11 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 175.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -109.48 155.63 16.0 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 83.4 mt -133.06 126.01 52.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.103 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -62.76 114.47 12.32 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-O 117.778 -1.106 . . . . 0.0 110.453 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -75.96 170.48 20.02 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.171 2.581 . . . . 0.0 111.111 170.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -129.75 -30.11 2.08 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.493 1.917 . . . . 0.0 111.025 169.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.1 pp -136.03 137.02 49.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 123.891 0.876 . . . . 0.0 109.025 176.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 75.7 t -146.36 139.64 20.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 153.9 151.51 5.78 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 108.776 -1.729 . . . . 0.0 108.776 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -64.27 149.11 48.73 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 118.086 0.943 . . . . 0.0 110.597 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.6 t80 58.43 46.08 15.7 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.292 1.837 . . . . 0.0 111.577 -175.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -132.81 147.27 64.8 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 123.853 0.861 . . . . 0.0 109.759 168.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -81.87 166.12 17.23 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.554 2.836 . . . . 0.0 110.827 176.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.1 ttm -70.0 134.64 48.52 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 169.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.04 159.66 31.46 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.557 1.143 . . . . 0.0 110.57 175.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.63 -46.39 99.59 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-O 117.233 -1.365 . . . . 0.0 113.538 -171.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -67.07 -26.8 42.74 Favored 'Trans proline' 0 C--N 1.35 0.615 0 CA-C-N 122.209 1.824 . . . . 0.0 112.593 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.24 -35.7 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -56.24 -46.79 79.45 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.138 0.881 . . . . 0.0 109.984 170.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -63.11 -38.09 89.8 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 122.722 0.409 . . . . 0.0 111.444 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.49 -47.78 77.67 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 122.033 -0.417 . . . . 0.0 111.056 175.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 71.4 t -61.21 -39.28 81.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 118.672 0.669 . . . . 0.0 109.719 178.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 32.6 tp10 -63.91 -39.09 93.36 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.13 0.877 . . . . 0.0 110.927 175.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 51.7 m -63.9 -48.07 78.08 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.763 -0.586 . . . . 0.0 109.854 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 79.2 t -60.3 -46.08 95.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -54.62 -48.78 71.82 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.05 0.94 . . . . 0.0 110.849 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -65.06 -38.16 89.91 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.456 0.571 . . . . 0.0 111.194 177.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -62.14 -29.25 70.21 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 118.367 -0.825 . . . . 0.0 111.552 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 83.9 mt -55.01 -21.28 11.54 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.3 0.954 . . . . 0.0 112.909 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 . . . . . 0 CA--C 1.539 0.55 0 CA-C-N 119.309 0.959 . . . . 0.0 112.595 -179.514 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 . . . . . 0 N--CA 1.448 -0.533 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.95 146.41 47.79 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -92.3 121.02 33.39 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 177.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 62.5 tp . . . . . 0 C--O 1.233 0.203 0 C-N-CA 125.791 1.637 . . . . 0.0 110.631 178.566 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 . . . . . 0 C--O 1.235 0.291 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.432 HG21 ' HG3' ' A' ' 55' ' ' PRO . 78.4 t -136.77 149.11 26.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -175.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 37.0 tp -127.93 112.06 14.26 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.415 1.486 . . . . 0.0 107.066 -175.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 51.9 tp -101.45 97.22 7.71 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 125.129 1.372 . . . . 0.0 107.883 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 87.3 m -73.11 143.03 47.51 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 169.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.0 t -141.71 144.82 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 176.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.79 174.34 17.87 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -124.76 119.31 28.55 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.128 1.371 . . . . 0.0 107.846 176.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 m -60.44 -14.2 17.87 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.185 1.794 . . . . 0.0 115.313 -169.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 27.9 ptm -125.22 13.14 8.29 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.153 0.981 . . . . 0.0 111.067 -176.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.3 ttt -100.7 29.68 4.38 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.567 0.747 . . . . 0.0 109.83 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.78 -142.26 20.75 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -61.86 -17.04 55.02 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.592 1.157 . . . . 0.0 112.221 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -54.87 -24.53 23.67 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.433 1.493 . . . . 0.0 113.236 176.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.21 24.49 0.71 Allowed Glycine 0 CA--C 1.533 1.191 0 CA-C-O 118.575 -1.125 . . . . 0.0 114.447 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.31 -51.45 65.98 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 119.468 1.634 . . . . 0.0 110.826 -169.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.17 -54.8 34.33 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-O 117.809 -1.55 . . . . 0.0 111.021 175.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -50.22 -37.68 49.73 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 CA-C-N 121.085 2.442 . . . . 0.0 114.841 178.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.7 tp -71.05 -39.79 72.04 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 120.117 1.326 . . . . 0.0 110.546 176.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.7 tp -60.9 -46.74 89.43 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.225 0.466 . . . . 0.0 110.479 175.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.48 -41.74 90.51 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 124.222 1.009 . . . . 0.0 110.913 176.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -61.06 -48.36 82.09 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 118.932 0.787 . . . . 0.0 110.046 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -61.2 -47.55 85.6 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 122.917 0.487 . . . . 0.0 110.513 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 80.9 m -64.5 -38.16 90.06 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.252 0.478 . . . . 0.0 111.183 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.7 -38.45 91.05 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.857 0.753 . . . . 0.0 111.077 177.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.78 -37.58 76.39 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.349 0.659 . . . . 0.0 111.218 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.31 98.56 1.97 Allowed Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 125.448 1.499 . . . . 0.0 107.856 -174.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -56.08 167.39 2.48 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 123.93 3.087 . . . . 0.0 114.664 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.5 ' HE2' ' CZ ' ' A' ' 136' ' ' TYR . 71.4 mmtt -135.93 160.14 39.51 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 126.055 1.742 . . . . 0.0 107.858 176.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 42.29 -121.19 2.6 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.861 1.22 . . . . 0.0 111.867 175.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -137.25 15.76 3.0 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.036 1.734 . . . . 0.0 111.142 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 13.0 m95 -72.26 131.27 42.49 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.565 0.746 . . . . 0.0 110.243 -171.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.0 t -75.73 118.03 21.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 104.273 -2.491 . . . . 0.0 104.273 165.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.0 t -72.81 134.82 29.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.7 mm -133.33 148.1 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 171.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -135.45 113.82 11.53 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 176.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.04 -13.27 83.21 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 118.613 -1.104 . . . . 0.0 112.81 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.56 34.05 79.69 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-N 119.62 1.71 . . . . 0.0 113.784 172.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 61.87 14.03 5.98 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.951 1.7 . . . . 0.0 114.261 -172.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -135.54 58.05 23.0 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 125.807 1.643 . . . . 0.0 107.657 169.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -71.26 -25.41 22.05 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.018 1.812 . . . . 0.0 111.873 -169.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.42 -30.69 71.77 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.668 0.787 . . . . 0.0 111.867 -179.068 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -63.02 -15.34 56.1 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.029 0.932 . . . . 0.0 112.419 172.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -117.32 1.07 12.37 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.369 1.068 . . . . 0.0 112.568 -169.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 78.7 mt -48.82 -37.29 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.869 1.268 . . . . 0.0 110.512 171.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.8 t -55.93 -41.26 66.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 123.683 0.793 . . . . 0.0 110.333 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.78 -41.96 82.41 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 118.479 0.582 . . . . 0.0 110.562 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.6 mt -61.06 -41.57 89.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 176.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -67.33 -19.99 65.53 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 117.693 -1.146 . . . . 0.0 112.505 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -72.25 -44.97 62.06 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 120.655 1.57 . . . . 0.0 108.894 169.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 56.5 mt -69.04 -26.4 64.96 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 118.489 -0.767 . . . . 0.0 112.703 -176.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 37.43 63.65 3.19 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 125.778 1.631 . . . . 0.0 111.443 -169.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.432 ' HG3' HG21 ' A' ' 4' ' ' VAL . 53.1 Cg_exo -51.45 144.55 31.57 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.214 2.609 . . . . 0.0 113.774 -170.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.4 m -67.08 -42.18 85.1 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 167.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 73.0 mtm180 -144.08 153.82 42.57 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 124.769 1.228 . . . . 0.0 108.105 174.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 56.9 tp -133.16 137.01 46.07 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 35.0 tp -124.01 133.71 53.61 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.715 -1.958 . . . . 0.0 105.715 174.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.2 mt -122.22 139.75 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 -175.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.4 t -140.24 133.36 34.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 118.203 0.456 . . . . 0.0 109.828 -172.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -162.32 172.9 14.92 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.24 2.216 . . . . 0.0 107.397 176.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.73 157.73 37.4 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.112 -0.993 . . . . 0.0 108.326 167.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.0 m -154.66 130.18 9.86 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 174.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -74.55 124.19 26.17 Favored 'General case' 0 N--CA 1.461 0.105 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 172.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 77.1 mtm -122.18 0.44 9.57 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.547 1.539 . . . . 0.0 110.814 -175.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.55 24.83 68.19 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-N 118.576 0.626 . . . . 0.0 112.364 -172.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 58.8 mt -100.67 -169.61 1.74 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.964 1.305 . . . . 0.0 108.568 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -82.2 147.01 56.06 Favored Pre-proline 0 N--CA 1.471 0.62 0 CA-C-O 118.466 -0.778 . . . . 0.0 109.747 174.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -46.81 136.1 17.02 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.379 2.719 . . . . 0.0 112.348 176.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.56 1.87 90.3 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 118.483 -1.176 . . . . 0.0 113.45 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -64.53 148.54 50.5 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 119.906 1.853 . . . . 0.0 108.356 168.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 69.3 mt -128.76 135.95 61.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 -172.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 -148.7 150.84 33.87 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 118.666 0.666 . . . . 0.0 111.926 177.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 51.4 mm -79.45 143.61 12.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 166.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.8 mt -128.63 125.61 63.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -74.87 140.54 74.34 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.266 172.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -45.66 -34.57 11.69 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 124.369 3.379 . . . . 0.0 116.628 177.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -68.58 -24.99 64.66 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.57 0.623 . . . . 0.0 111.807 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -98.69 -30.37 12.49 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.865 1.266 . . . . 0.0 111.076 -177.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 63.7 mt -49.91 -40.91 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.692 1.197 . . . . 0.0 109.189 169.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.0 -19.72 19.99 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.161 1.384 . . . . 0.0 114.454 -174.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -117.91 -36.24 3.69 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 118.699 0.682 . . . . 0.0 110.084 176.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 38.4 mmt -69.19 -25.46 64.34 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -176.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -70.21 -47.15 62.71 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 119.164 0.893 . . . . 0.0 111.238 173.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 20.1 ptp . . . . . 0 CA--C 1.532 0.271 0 CA-C-O 118.608 -0.711 . . . . 0.0 112.881 179.361 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 mt . . . . . 0 N--CA 1.468 0.452 0 N-CA-C 117.694 2.479 . . . . 0.0 117.694 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -54.42 -21.79 10.71 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.21 -0.931 . . . . 0.0 112.192 167.025 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -60.0 -31.77 70.24 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.445 1.02 . . . . 0.0 111.751 174.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.9 tt -73.91 -45.71 48.9 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.758 0.708 . . . . 0.0 109.114 174.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 85.4 mt -57.22 -42.81 80.7 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -62.41 -21.58 65.5 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -85.42 -2.33 57.99 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.829 0.852 . . . . 0.0 112.226 177.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.442 ' HB3' HD12 ' A' ' 105' ' ' ILE . 2.4 mm? -129.95 -33.93 1.74 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.316 1.047 . . . . 0.0 112.51 -178.19 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 13.4 pttm -62.92 -19.72 64.5 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.658 0.783 . . . . 0.0 112.983 -171.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -72.09 -12.17 61.08 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.389 1.075 . . . . 0.0 111.814 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -133.26 -34.05 1.09 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.226 0.921 . . . . 0.0 112.915 -177.019 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.442 HD12 ' HB3' ' A' ' 101' ' ' LEU . 23.8 mt -67.87 143.19 15.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 171.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.81 -39.9 93.6 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 123.954 0.788 . . . . 0.0 112.39 -177.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -150.49 138.72 20.3 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 118.379 1.089 . . . . 0.0 108.442 174.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 39.0 t -122.41 132.07 71.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 174.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.2 mt -130.92 147.35 33.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 -169.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -132.68 140.74 48.27 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 175.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.9 tt -125.5 133.85 52.24 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 174.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -116.71 156.83 15.4 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 177.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 87.1 mt -134.39 127.53 50.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 -177.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -63.9 114.34 13.25 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 117.38 -1.295 . . . . 0.0 110.151 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -76.09 170.56 19.83 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.152 2.568 . . . . 0.0 111.154 170.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -128.81 -32.04 2.14 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.031 1.732 . . . . 0.0 110.986 171.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -135.58 136.23 50.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 177.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.4 t -141.73 135.55 30.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 176.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 157.47 150.73 5.8 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -66.14 152.67 44.25 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.78 0.8 . . . . 0.0 111.08 -176.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 25.0 t80 55.05 39.88 31.74 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.536 1.934 . . . . 0.0 111.648 -175.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -125.06 147.96 58.67 Favored Pre-proline 0 C--O 1.237 0.427 0 C-N-CA 123.669 0.787 . . . . 0.0 109.815 169.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -82.4 164.47 16.78 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.38 2.72 . . . . 0.0 111.087 176.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 53.0 ttm -71.83 138.0 47.97 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 168.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 71.5 p -78.41 159.49 28.28 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.153 0.981 . . . . 0.0 110.494 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.3 tp60 -53.09 -44.42 97.08 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-O 116.533 -1.699 . . . . 0.0 114.23 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -68.58 -30.53 28.45 Favored 'Trans proline' 0 C--N 1.351 0.683 0 CA-C-N 122.914 2.076 . . . . 0.0 112.164 -176.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.81 -35.31 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 119.021 0.828 . . . . 0.0 108.841 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -56.56 -46.64 80.63 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.3 0.955 . . . . 0.0 110.056 170.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -63.97 -37.14 86.33 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.055 0.542 . . . . 0.0 111.434 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.38 -47.25 77.02 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.919 -0.488 . . . . 0.0 111.17 175.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 78.9 t -61.74 -39.66 84.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 118.564 0.62 . . . . 0.0 109.525 177.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -61.37 -42.31 98.5 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.911 0.778 . . . . 0.0 110.534 174.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 52.2 m -62.19 -45.74 92.02 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.747 -0.596 . . . . 0.0 110.237 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 80.3 t -61.9 -47.53 92.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 176.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.5 ' CZ ' ' HE2' ' A' ' 31' ' ' LYS . 38.7 t80 -55.42 -49.66 71.82 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.913 0.885 . . . . 0.0 110.923 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 48.7 mm-40 -68.78 -23.35 64.29 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.734 -0.604 . . . . 0.0 112.102 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.18 -29.24 64.93 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.66 1.118 . . . . 0.0 111.583 175.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 67.6 mt -58.58 -20.38 46.34 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -168.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 . . . . . 0 CA--C 1.54 0.562 0 CA-C-N 120.254 1.388 . . . . 0.0 113.297 177.118 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.02 151.37 47.77 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.774 0.829 . . . . 0.0 109.527 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -92.59 123.98 36.28 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 62.0 tp . . . . . 0 C--O 1.234 0.266 0 C-N-CA 125.381 1.472 . . . . 0.0 109.741 176.858 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.2 t0 . . . . . 0 C--O 1.233 0.223 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 70.8 t -124.0 148.61 28.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 121.409 0.623 . . . . 0.0 110.709 -167.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 33.7 tp -114.37 129.56 56.65 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.628 -1.989 . . . . 0.0 105.628 168.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.8 tp -120.63 100.82 7.35 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 92.7 m -75.33 143.03 43.11 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 171.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 51.9 t -141.01 142.04 30.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.285 1.434 . . . . 0.0 107.306 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 144.57 176.88 18.97 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.336 0.969 . . . . 0.0 111.873 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -126.55 122.54 35.42 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.8 1.24 . . . . 0.0 108.844 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 m -60.82 -15.33 29.0 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.572 1.949 . . . . 0.0 115.661 -169.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 25.8 ptm -127.4 11.01 6.82 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.074 0.95 . . . . 0.0 110.989 -176.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.6 ttt -88.68 14.32 10.33 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.225 1.01 . . . . 0.0 110.098 176.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.54 -140.96 15.34 Favored Glycine 0 C--N 1.337 0.637 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -60.44 -17.42 44.45 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.504 1.121 . . . . 0.0 112.224 176.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -55.81 -20.68 16.01 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.614 1.566 . . . . 0.0 113.207 174.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.44 21.5 0.7 Allowed Glycine 0 CA--C 1.534 1.253 0 O-C-N 120.823 -1.173 . . . . 0.0 114.286 177.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.4 -51.0 67.64 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 119.477 1.639 . . . . 0.0 110.788 -169.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.64 -54.91 33.74 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-O 117.76 -1.578 . . . . 0.0 111.073 175.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -49.75 -41.08 47.21 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 CA-C-N 120.826 2.313 . . . . 0.0 115.282 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.9 tp -71.34 -39.08 71.56 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 120.135 1.334 . . . . 0.0 110.267 178.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.8 tp -61.18 -46.15 91.69 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 122.055 -0.403 . . . . 0.0 110.314 175.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.14 -40.2 84.76 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 124.08 0.952 . . . . 0.0 111.167 177.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -61.41 -48.52 80.86 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 118.918 0.781 . . . . 0.0 109.866 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -61.87 -46.39 89.61 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.895 0.478 . . . . 0.0 110.506 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 80.1 m -64.59 -39.05 93.04 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.191 0.451 . . . . 0.0 111.209 178.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.47 -37.62 88.19 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.774 0.715 . . . . 0.0 111.052 177.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.88 -37.45 79.04 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.172 0.589 . . . . 0.0 111.058 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.0 96.24 1.72 Allowed Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 124.985 1.314 . . . . 0.0 108.553 -173.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -55.93 164.34 4.86 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.869 3.046 . . . . 0.0 113.969 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -134.02 166.1 23.51 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.383 1.473 . . . . 0.0 109.011 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 44.76 -113.25 0.82 Allowed Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.767 1.175 . . . . 0.0 111.418 175.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -144.57 8.94 1.35 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.795 1.238 . . . . 0.0 111.741 176.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 3.9 m95 -68.13 131.54 45.6 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.951 0.901 . . . . 0.0 110.201 -169.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 62.1 t -77.58 119.04 25.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 166.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.5 t -82.55 136.52 22.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -174.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 70.0 mt -133.74 145.29 33.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 169.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -129.58 107.91 9.82 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 175.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.98 -2.16 90.49 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-O 118.892 -0.949 . . . . 0.0 112.95 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 55.28 -144.93 31.88 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 108.441 -1.863 . . . . 0.0 108.441 -169.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.4 p -88.52 9.13 24.88 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.738 -0.86 . . . . 0.0 112.084 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -135.86 57.19 17.42 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 124.991 1.316 . . . . 0.0 110.493 -176.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -68.74 -14.37 39.02 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.735 2.29 . . . . 0.0 113.197 -171.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -55.48 -32.5 62.88 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.074 0.852 . . . . 0.0 112.001 173.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.99 -27.31 66.75 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.192 0.597 . . . . 0.0 112.119 176.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -99.38 -2.74 35.49 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.804 1.242 . . . . 0.0 111.458 -171.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 77.3 mt -54.56 -43.09 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 119.405 1.002 . . . . 0.0 109.641 175.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.3 t -61.6 -42.29 93.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 118.348 0.522 . . . . 0.0 109.737 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.68 -46.31 79.57 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 122.948 0.499 . . . . 0.0 110.666 -177.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 67.5 mt -55.16 -48.05 76.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 172.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -68.18 -23.28 64.83 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 117.865 -1.064 . . . . 0.0 112.778 -174.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -62.96 -37.56 87.57 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 120.519 1.509 . . . . 0.0 110.34 169.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 39.2 mt -77.19 -16.55 59.05 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.851 0.86 . . . . 0.0 111.917 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 26.89 64.6 0.56 Allowed Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 127.883 2.473 . . . . 0.0 113.538 -169.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -58.67 151.25 64.53 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.704 2.936 . . . . 0.0 113.912 -169.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.9 m -69.85 -36.1 75.25 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.085 0.954 . . . . 0.0 108.736 167.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -146.68 153.94 40.86 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.394 1.078 . . . . 0.0 110.402 -175.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 46.7 tp -142.77 136.85 29.28 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 125.301 1.44 . . . . 0.0 108.373 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 27.1 tp -125.32 135.33 52.36 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 172.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.5 mt -123.25 145.17 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 -172.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 44.0 t -141.06 135.53 32.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 118.74 0.7 . . . . 0.0 110.043 -175.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -163.99 172.26 14.13 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.598 2.359 . . . . 0.0 107.544 173.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.58 158.49 36.11 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.366 -0.834 . . . . 0.0 109.17 167.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.7 m -154.41 128.67 9.04 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -75.98 83.88 2.88 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 119.004 0.82 . . . . 0.0 109.925 174.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 74.6 mtm -77.44 -8.98 58.59 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.45 1.5 . . . . 0.0 112.212 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.04 29.26 67.1 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-N 118.914 0.779 . . . . 0.0 111.362 -171.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.3 mt -106.07 -172.36 2.07 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.965 1.306 . . . . 0.0 109.721 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -74.6 141.16 75.84 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-O 117.749 -1.12 . . . . 0.0 108.58 169.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -43.19 137.95 4.72 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 123.445 2.763 . . . . 0.0 113.395 172.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.29 1.02 79.94 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-O 118.625 -1.097 . . . . 0.0 113.82 176.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -68.2 149.34 49.64 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 119.875 1.838 . . . . 0.0 108.299 168.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 48.2 mt -128.82 135.07 63.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 125.607 1.563 . . . . 0.0 106.952 -172.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.2 mmt-85 -144.99 152.12 39.65 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.068 0.849 . . . . 0.0 109.653 175.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 42.6 mm -78.12 146.57 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 167.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.3 mt -128.49 118.18 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -71.88 139.85 83.15 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-O 117.926 -1.035 . . . . 0.0 109.172 174.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -47.56 -33.22 17.47 Favored 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 124.22 3.28 . . . . 0.0 116.654 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -67.95 -24.27 65.15 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.763 0.71 . . . . 0.0 111.641 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -100.64 -28.85 12.63 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.284 1.434 . . . . 0.0 111.307 -177.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.414 HG23 ' CD1' ' A' ' 85' ' ' PHE . 61.0 mt -49.34 -45.87 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.69 1.196 . . . . 0.0 109.044 169.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.68 -14.89 15.88 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.257 1.423 . . . . 0.0 113.969 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -126.2 4.89 7.08 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.226 1.01 . . . . 0.0 111.637 -177.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 20.9 mmt -121.64 -25.71 5.05 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -176.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.414 ' CD1' HG23 ' A' ' 81' ' ' ILE . 8.2 m-85 -73.79 -40.89 63.08 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.835 1.198 . . . . 0.0 111.449 -178.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.448 0 O-C-N 121.773 -0.58 . . . . 0.0 112.397 175.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 mt . . . . . 0 N--CA 1.475 0.817 0 N-CA-C 117.642 2.46 . . . . 0.0 117.642 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.06 -20.97 4.05 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.053 0.842 . . . . 0.0 112.641 168.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -58.39 -32.4 68.57 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.641 1.11 . . . . 0.0 112.083 174.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.4 tt -74.77 -43.5 54.51 Favored 'General case' 0 N--CA 1.462 0.125 0 O-C-N 121.623 -0.673 . . . . 0.0 109.669 176.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 74.5 mt -62.0 -40.28 86.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 123.946 0.898 . . . . 0.0 109.705 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.1 -27.89 65.99 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.505 0.722 . . . . 0.0 112.386 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -91.47 8.49 36.14 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.816 1.246 . . . . 0.0 111.943 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 88.4 mt -133.47 -29.81 1.34 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.223 1.009 . . . . 0.0 111.865 -176.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 45.0 mttm -56.16 -19.14 12.25 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.095 0.958 . . . . 0.0 112.779 170.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -59.02 -18.81 37.94 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.423 1.089 . . . . 0.0 112.205 175.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -138.23 -42.93 0.51 Allowed 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.868 0.867 . . . . 0.0 112.012 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 20.3 mt -68.62 133.4 31.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -173.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -75.97 -34.07 48.61 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.203 0.906 . . . . 0.0 112.432 -173.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -143.62 125.75 15.47 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.4 t -127.07 128.85 70.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 3.8 mt -131.55 150.11 33.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 -169.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -130.96 141.04 50.23 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 169.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.9 tt -120.62 128.74 53.3 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 174.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -111.94 156.23 15.7 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -178.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 62.6 mt -133.92 124.52 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 -176.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -65.47 117.84 44.7 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-O 117.389 -1.291 . . . . 0.0 110.4 -178.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -77.21 171.99 16.82 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.662 2.908 . . . . 0.0 111.485 170.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -128.11 -31.43 2.35 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.669 1.587 . . . . 0.0 111.073 170.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.1 pp -136.52 135.54 49.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.309 1.044 . . . . 0.0 108.751 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.3 t -143.77 145.92 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 176.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 173.28 -120.58 0.81 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -156.21 154.18 30.36 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.647 1.224 . . . . 0.0 108.33 175.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 3.0 t80 53.73 33.07 15.97 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.691 1.197 . . . . 0.0 110.861 -171.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 12.5 m-30 -118.96 140.38 28.57 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 124.816 1.246 . . . . 0.0 109.84 -173.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -82.72 165.22 15.81 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.433 2.755 . . . . 0.0 111.215 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.3 ttm -75.71 139.35 41.86 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 168.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 73.0 p -80.74 160.5 24.91 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.484 1.114 . . . . 0.0 110.475 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -53.1 -45.04 98.44 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-O 116.493 -1.718 . . . . 0.0 114.117 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -68.52 -30.56 28.83 Favored 'Trans proline' 0 C--N 1.35 0.653 0 CA-C-N 122.847 2.052 . . . . 0.0 112.215 -176.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -80.56 -35.47 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -56.3 -46.42 79.8 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.366 0.985 . . . . 0.0 109.946 170.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -64.05 -38.62 91.74 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 122.937 0.495 . . . . 0.0 111.254 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.53 -46.49 82.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 119.013 -0.518 . . . . 0.0 111.09 175.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 79.7 t -62.87 -38.92 83.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 119.147 0.885 . . . . 0.0 109.793 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -62.79 -42.29 99.64 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.396 0.998 . . . . 0.0 110.355 174.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 57.3 m -61.14 -49.75 75.97 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 71.1 t -60.66 -42.17 90.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 123.646 0.779 . . . . 0.0 109.893 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -57.1 -48.3 78.96 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.465 0.575 . . . . 0.0 110.575 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 63.9 mm-40 -64.53 -38.57 91.47 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.992 0.815 . . . . 0.0 110.895 175.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -63.92 -27.43 69.14 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 123.436 0.695 . . . . 0.0 112.414 -177.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 75.1 mt -59.11 -18.5 36.19 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.376 0.989 . . . . 0.0 112.16 175.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 . . . . . 0 CA--C 1.544 0.739 0 CA-C-N 119.149 0.886 . . . . 0.0 111.947 178.708 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 . . . . . 0 N--CA 1.452 -0.367 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -88.75 148.56 23.89 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 170.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.6 121.9 29.77 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 174.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 52.3 tp . . . . . 0 CA--C 1.532 0.281 0 C-N-CA 125.612 1.565 . . . . 0.0 109.793 178.49 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 C--O 1.235 0.315 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.412 HG21 ' HG3' ' A' ' 55' ' ' PRO . 69.6 t -136.33 148.38 27.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.274 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 39.3 tp -123.36 119.15 29.24 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.9 tp -109.95 96.91 6.54 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 99.4 m -71.29 142.39 50.48 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 169.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.3 t -140.82 143.12 29.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 177.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.02 174.54 17.36 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -122.71 121.05 35.43 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.365 1.466 . . . . 0.0 107.422 177.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 m -59.56 -14.78 14.52 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.934 1.693 . . . . 0.0 115.495 -169.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -128.86 14.12 6.35 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.839 0.856 . . . . 0.0 111.243 -176.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.2 ttt -97.73 30.6 2.9 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 118.682 0.674 . . . . 0.0 109.898 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.26 -142.39 20.45 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -178.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -61.2 -17.31 52.48 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.593 1.157 . . . . 0.0 112.111 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -56.63 -19.97 18.84 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.217 1.407 . . . . 0.0 112.871 174.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.36 20.26 0.77 Allowed Glycine 0 CA--C 1.534 1.258 0 O-C-N 120.691 -1.256 . . . . 0.0 114.311 177.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.8 -52.7 63.14 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 119.571 1.685 . . . . 0.0 110.862 -169.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.62 -54.81 34.55 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-O 117.88 -1.511 . . . . 0.0 111.214 175.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -49.67 -40.76 46.75 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 CA-C-N 120.818 2.309 . . . . 0.0 115.077 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 65.6 tp -70.65 -39.27 73.72 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-N 119.963 1.256 . . . . 0.0 110.311 178.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.0 tp -61.28 -46.87 88.54 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.065 0.393 . . . . 0.0 110.348 175.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.38 -42.23 86.58 Favored 'General case' 0 C--O 1.227 -0.125 0 C-N-CA 124.134 0.974 . . . . 0.0 110.829 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -60.72 -49.15 78.68 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.476 0.58 . . . . 0.0 110.0 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -61.75 -49.83 74.83 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 122.99 0.516 . . . . 0.0 110.723 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 75.7 m -64.02 -37.79 88.71 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.549 0.613 . . . . 0.0 111.399 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.46 -40.65 96.12 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.112 0.869 . . . . 0.0 111.073 176.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.64 -33.05 73.34 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.511 0.724 . . . . 0.0 111.704 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.44 96.08 2.66 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.544 1.537 . . . . 0.0 107.762 -173.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -53.31 159.5 5.87 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 123.439 2.759 . . . . 0.0 113.939 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -134.53 155.54 50.23 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.638 1.575 . . . . 0.0 108.085 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 40.71 -119.08 1.32 Allowed Glycine 0 CA--C 1.532 1.104 0 C-N-CA 125.128 1.346 . . . . 0.0 111.88 176.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -137.14 14.87 3.04 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.913 1.685 . . . . 0.0 111.309 177.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -72.52 128.17 34.77 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.337 0.655 . . . . 0.0 109.791 -173.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.2 t -72.86 120.45 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 166.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.0 t -76.22 133.72 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 24.4 mm -133.15 147.94 31.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 104.967 -2.235 . . . . 0.0 104.967 171.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -134.7 114.06 12.32 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 177.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.79 -16.28 76.19 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 118.654 -1.081 . . . . 0.0 113.003 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 57.95 39.0 91.14 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-N 119.264 1.532 . . . . 0.0 113.722 170.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . 0.252 75.3 p 60.71 14.29 4.95 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.502 2.321 . . . . 0.0 114.69 -173.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.2 56.29 6.22 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 125.632 1.573 . . . . 0.0 108.995 172.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -67.05 -28.75 41.11 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.395 2.063 . . . . 0.0 112.258 -169.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.59 -36.19 77.96 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.592 0.757 . . . . 0.0 111.892 -178.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -64.43 -13.59 52.2 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.702 0.801 . . . . 0.0 112.574 176.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -112.66 -0.36 15.12 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.314 1.046 . . . . 0.0 112.38 -172.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 87.5 mt -50.01 -36.92 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 124.577 1.151 . . . . 0.0 110.518 172.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 51.3 t -56.41 -40.82 69.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 123.646 0.778 . . . . 0.0 110.455 178.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.46 -41.85 83.99 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.498 0.59 . . . . 0.0 110.504 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 51.1 mt -61.91 -40.29 86.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -66.23 -20.25 66.06 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 117.785 -1.103 . . . . 0.0 112.528 176.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -72.45 -43.94 63.07 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 120.677 1.581 . . . . 0.0 109.097 169.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 49.0 mt -68.75 -27.91 66.33 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 118.671 -0.681 . . . . 0.0 112.568 -177.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 39.12 64.74 3.69 Favored Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 125.589 1.556 . . . . 0.0 111.306 -169.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.412 ' HG3' HG21 ' A' ' 4' ' ' VAL . 51.6 Cg_exo -49.69 141.04 28.23 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.269 2.646 . . . . 0.0 113.402 -172.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.1 m -66.99 -41.29 87.01 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 167.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.2 mtm-85 -146.72 149.97 34.47 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.115 1.766 . . . . 0.0 106.789 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 52.9 tp -134.59 137.76 43.99 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 33.6 tp -125.6 133.8 52.13 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 175.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.4 mt -121.96 142.38 38.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -174.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.5 t -141.01 133.56 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 118.764 0.711 . . . . 0.0 110.056 -174.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -161.42 171.24 18.55 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.39 2.276 . . . . 0.0 107.464 172.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.54 156.28 39.6 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.951 -1.093 . . . . 0.0 108.583 168.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.8 m -155.9 132.56 10.38 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -78.13 122.73 26.01 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 73.5 mtm -121.43 1.49 10.14 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.209 1.803 . . . . 0.0 110.699 -176.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.24 18.17 60.24 Favored Glycine 0 CA--C 1.537 1.412 0 CA-C-N 118.676 0.671 . . . . 0.0 112.579 -171.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.6 mt -87.47 -176.1 5.47 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.487 1.515 . . . . 0.0 109.744 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -76.08 140.26 69.76 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-O 117.871 -1.062 . . . . 0.0 108.818 171.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -45.86 134.93 14.0 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.417 2.744 . . . . 0.0 113.71 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.01 2.27 88.54 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.574 -1.126 . . . . 0.0 113.359 177.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -65.99 151.93 45.72 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 119.867 1.833 . . . . 0.0 108.025 168.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 81.0 mt -128.12 141.91 45.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -171.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 84.2 mmt-85 -151.04 154.19 36.55 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 123.326 0.651 . . . . 0.0 110.858 172.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 35.8 mm -81.6 144.68 9.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 165.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.7 mt -125.53 128.12 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 176.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -72.87 140.1 80.67 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-O 118.084 -0.96 . . . . 0.0 109.655 173.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -46.98 -32.55 13.05 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 124.356 3.37 . . . . 0.0 116.79 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -67.49 -26.48 66.38 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.778 0.717 . . . . 0.0 111.782 178.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -101.66 -25.08 13.99 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.991 1.316 . . . . 0.0 111.446 -176.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.443 HD11 ' HB3' ' A' ' 110' ' ' PHE . 45.0 mt -50.17 -41.21 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.54 1.136 . . . . 0.0 109.512 169.231 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.33 -30.67 52.11 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.53 1.132 . . . . 0.0 113.15 -177.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -100.38 -39.16 8.12 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.052 0.541 . . . . 0.0 110.06 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 26.1 mmt -73.47 -27.85 61.62 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 121.714 -0.616 . . . . 0.0 112.256 -173.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -68.59 -49.95 55.39 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 118.838 0.745 . . . . 0.0 110.306 171.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 27.6 ptm . . . . . 0 CA--C 1.535 0.384 0 CA-C-N 119.206 0.912 . . . . 0.0 111.911 -178.556 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.1 mt . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 117.363 2.357 . . . . 0.0 117.363 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -54.08 -19.42 4.89 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.437 1.017 . . . . 0.0 112.243 166.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -59.35 -28.46 66.87 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.608 1.095 . . . . 0.0 112.125 173.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.7 tt -70.78 -45.6 64.41 Favored 'General case' 0 N--CA 1.463 0.18 0 O-C-N 121.334 -0.854 . . . . 0.0 109.625 173.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 90.0 mt -61.5 -42.11 92.66 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.137 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -60.38 -24.85 65.43 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -85.89 0.11 53.94 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.921 0.888 . . . . 0.0 112.453 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 65.3 mt -135.89 -31.34 0.93 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.21 1.004 . . . . 0.0 112.401 -171.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -59.29 -21.84 60.29 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.895 1.278 . . . . 0.0 112.712 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -71.44 -13.06 61.71 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.513 1.125 . . . . 0.0 111.916 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -134.67 -32.98 0.97 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.219 0.918 . . . . 0.0 112.983 -176.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 53.7 mt -68.55 143.58 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 172.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -67.17 -41.66 92.05 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 123.96 0.791 . . . . 0.0 112.236 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -150.63 143.15 24.42 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 118.582 1.191 . . . . 0.0 108.999 173.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.0 t -127.66 129.44 70.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 177.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.6 mt -129.93 148.86 33.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 -169.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.443 ' HB3' HD11 ' A' ' 81' ' ' ILE . 77.3 t80 -132.86 142.38 48.91 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 171.256 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.4 tt -122.44 127.8 50.09 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.434 1.494 . . . . 0.0 107.124 174.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -109.16 156.09 15.78 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 77.8 mt -133.93 126.98 51.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -61.28 114.95 12.19 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-O 117.346 -1.311 . . . . 0.0 110.34 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -76.52 171.4 18.13 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.184 2.589 . . . . 0.0 111.174 170.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -129.59 -31.81 1.98 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.915 1.686 . . . . 0.0 111.041 171.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -135.84 135.85 50.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 124.282 1.033 . . . . 0.0 108.215 176.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.6 t -141.58 135.4 30.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 158.4 151.16 5.99 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 178.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -65.99 153.33 42.45 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.844 0.831 . . . . 0.0 111.344 -175.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 54.62 38.79 30.55 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.92 2.088 . . . . 0.0 112.141 -176.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -123.4 148.32 55.06 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 123.961 0.904 . . . . 0.0 109.996 172.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -81.74 163.83 18.48 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.19 2.594 . . . . 0.0 111.161 176.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 52.2 ttm -72.24 138.94 47.84 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 168.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 68.8 p -79.07 159.27 27.61 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.153 0.981 . . . . 0.0 110.529 178.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -52.9 -44.1 95.63 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-O 116.569 -1.681 . . . . 0.0 114.277 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -68.67 -31.26 26.49 Favored 'Trans proline' 0 C--N 1.351 0.667 0 CA-C-N 122.892 2.069 . . . . 0.0 112.215 -176.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.09 -35.28 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -56.3 -46.02 80.0 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.196 0.907 . . . . 0.0 110.172 170.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -64.15 -37.92 89.2 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 122.987 0.515 . . . . 0.0 111.41 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.58 -47.33 79.08 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 121.944 -0.473 . . . . 0.0 110.986 175.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 72.4 t -62.71 -39.37 84.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 118.552 0.615 . . . . 0.0 109.789 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -60.31 -43.26 96.51 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.022 0.828 . . . . 0.0 110.265 173.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 55.2 m -61.52 -47.5 85.33 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.959 -0.463 . . . . 0.0 109.971 178.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 87.8 t -61.44 -45.65 98.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 118.552 0.615 . . . . 0.0 109.648 178.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -54.4 -48.84 71.11 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.802 0.841 . . . . 0.0 110.71 177.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 48.2 mm-40 -65.58 -37.34 86.37 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.642 0.656 . . . . 0.0 111.41 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.1 -35.54 71.6 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.545 0.738 . . . . 0.0 111.843 -178.001 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 77.6 mt -59.07 -16.88 21.27 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -172.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 . . . . . 0 CA--C 1.54 0.576 0 CA-C-N 120.042 1.292 . . . . 0.0 112.54 177.164 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 . . . . . 0 N--CA 1.45 -0.455 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -76.7 148.08 37.02 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 174.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -91.3 120.54 32.27 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 176.261 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 44.9 tp . . . . . 0 C--O 1.233 0.219 0 C-N-CA 125.819 1.647 . . . . 0.0 109.883 177.334 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 . . . . . 0 C--O 1.234 0.259 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.6 t -138.02 148.19 25.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -175.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 31.7 tp -122.71 119.55 31.01 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.3 tp -109.02 97.68 7.27 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 125.405 1.482 . . . . 0.0 107.487 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 87.7 m -73.53 143.17 46.63 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 169.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.8 t -140.21 142.11 32.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 142.37 178.92 18.83 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 124.214 0.912 . . . . 0.0 111.861 177.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -127.95 123.59 35.23 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.768 1.227 . . . . 0.0 108.619 177.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 m -58.74 -16.05 14.93 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.631 1.972 . . . . 0.0 115.461 -169.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.0 ptp -128.7 15.98 6.42 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 119.197 0.908 . . . . 0.0 111.259 -178.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 11.3 tpt -92.19 25.48 2.89 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.621 0.768 . . . . 0.0 109.397 176.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.75 -142.64 20.21 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -176.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -61.0 -16.82 47.68 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.695 1.198 . . . . 0.0 112.221 178.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -55.58 -20.56 13.87 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.483 1.513 . . . . 0.0 112.906 173.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.14 17.91 0.94 Allowed Glycine 0 CA--C 1.534 1.257 0 O-C-N 120.789 -1.194 . . . . 0.0 114.437 177.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.19 -51.29 69.63 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 119.566 1.683 . . . . 0.0 110.838 -170.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.77 -55.96 27.52 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-O 117.794 -1.559 . . . . 0.0 111.136 175.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -49.77 -40.78 47.66 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 CA-C-N 120.784 2.292 . . . . 0.0 115.113 178.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 62.6 tp -70.61 -39.89 73.51 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 119.862 1.21 . . . . 0.0 109.986 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.2 tp -61.47 -46.37 90.33 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.443 0.297 . . . . 0.0 110.388 176.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.69 -42.6 88.93 Favored 'General case' 0 C--O 1.227 -0.127 0 C-N-CA 123.838 0.855 . . . . 0.0 110.883 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -60.93 -48.98 79.3 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 118.616 0.643 . . . . 0.0 109.871 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -63.62 -48.69 76.28 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 123.016 0.526 . . . . 0.0 110.907 -178.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 93.0 m -65.39 -34.56 78.6 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.732 0.696 . . . . 0.0 111.478 178.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.99 -40.64 95.26 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.689 1.132 . . . . 0.0 110.848 174.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.14 -33.05 72.83 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.434 0.693 . . . . 0.0 111.8 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.57 89.54 4.42 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.394 1.478 . . . . 0.0 108.548 -174.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -52.6 155.8 9.7 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.955 3.103 . . . . 0.0 113.606 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -133.37 156.65 47.27 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.635 1.174 . . . . 0.0 109.479 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 40.84 -111.95 0.3 Allowed Glycine 0 CA--C 1.527 0.844 0 C-N-CA 125.85 1.691 . . . . 0.0 112.612 172.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -138.04 9.91 2.8 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.145 1.378 . . . . 0.0 111.295 -173.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 1.5 m95 -85.07 123.07 30.18 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 121.286 -0.884 . . . . 0.0 110.753 -168.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.7 t -70.68 119.88 17.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 166.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.6 t -74.04 132.6 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.1 mm -133.98 148.0 30.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 172.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -135.61 111.66 9.6 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.23 -1.99 88.05 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-O 118.991 -0.894 . . . . 0.0 112.727 179.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 56.16 -147.52 30.63 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -169.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 p -90.08 10.95 22.31 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.841 0.856 . . . . 0.0 111.94 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.83 55.17 7.43 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.267 1.427 . . . . 0.0 109.77 -177.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -66.36 -20.35 55.06 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.825 2.35 . . . . 0.0 113.479 -169.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.3 pm0 -61.6 -30.39 70.65 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 119.05 0.841 . . . . 0.0 111.911 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.02 -25.85 67.89 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.373 0.669 . . . . 0.0 112.084 175.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -102.84 -2.51 27.79 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.106 0.962 . . . . 0.0 113.06 -168.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.9 mt -48.52 -40.4 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.518 1.127 . . . . 0.0 110.288 174.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.1 t -56.19 -40.26 64.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.926 0.89 . . . . 0.0 110.582 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.32 -42.26 83.94 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 118.318 0.508 . . . . 0.0 110.398 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 35.3 mt -64.97 -37.48 80.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.38 -21.05 66.05 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 117.855 -1.069 . . . . 0.0 112.397 175.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -70.91 -39.74 72.57 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 120.613 1.552 . . . . 0.0 109.745 170.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 59.5 mt -70.48 -26.55 63.67 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.499 0.72 . . . . 0.0 112.187 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 40.89 65.71 4.08 Favored Pre-proline 0 N--CA 1.472 0.668 0 C-N-CA 125.698 1.599 . . . . 0.0 110.932 -171.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -52.14 137.4 54.39 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 123.253 2.635 . . . . 0.0 112.79 -169.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.0 m -69.53 -38.67 77.61 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 167.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -144.45 157.7 44.11 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 124.889 1.276 . . . . 0.0 107.885 171.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 53.5 tp -136.74 136.16 38.72 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 32.5 tp -123.67 134.92 53.66 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 175.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.0 mt -123.29 141.82 42.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 -173.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 44.6 t -140.87 134.36 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 118.773 0.715 . . . . 0.0 110.642 -174.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -162.82 171.22 17.04 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.783 2.433 . . . . 0.0 107.481 172.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.75 157.69 37.59 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 120.989 -1.069 . . . . 0.0 108.54 167.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.0 m -156.2 127.79 7.23 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 175.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -70.74 124.21 23.74 Favored 'General case' 0 C--O 1.23 0.058 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 172.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 73.6 mtm -122.39 2.2 9.66 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.142 1.777 . . . . 0.0 110.562 -177.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.11 24.64 68.9 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-N 118.66 0.664 . . . . 0.0 112.195 -172.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.6 mt -98.04 -172.71 2.42 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.398 1.479 . . . . 0.0 109.24 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -79.6 140.4 55.37 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-O 117.746 -1.121 . . . . 0.0 108.931 173.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -45.64 134.0 13.26 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.343 2.695 . . . . 0.0 113.705 178.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.49 2.08 89.27 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-O 118.254 -1.303 . . . . 0.0 113.345 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -66.29 150.24 49.15 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 120.156 1.978 . . . . 0.0 107.728 167.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 34.4 mt -131.52 135.14 59.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -169.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.4 mmt-85 -146.6 153.3 40.17 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.504 0.593 . . . . 0.0 109.984 176.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 29.4 mm -83.0 143.36 12.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 167.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.6 mt -126.11 124.17 65.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -71.39 141.09 85.33 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.419 173.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -46.99 -32.5 13.01 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 124.133 3.222 . . . . 0.0 116.594 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -67.19 -25.54 66.18 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.803 0.728 . . . . 0.0 111.799 177.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -101.42 -26.21 13.67 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.915 1.286 . . . . 0.0 111.447 -177.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.429 HD11 ' HB3' ' A' ' 110' ' ' PHE . 51.6 mt -50.19 -41.36 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.478 1.111 . . . . 0.0 109.109 168.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.39 -22.1 18.44 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.425 1.49 . . . . 0.0 114.075 -177.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -115.2 -33.75 5.24 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 118.68 0.673 . . . . 0.0 110.387 177.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 23.3 mmt -72.28 -28.51 63.15 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -177.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.404 ' CD1' HG23 ' A' ' 81' ' ' ILE . 2.1 m-85 -66.39 -46.29 77.12 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 119.241 0.928 . . . . 0.0 110.92 176.402 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 CA--C 1.541 0.629 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 -178.818 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.468 0.447 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -55.46 -17.31 4.93 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 120.997 -1.065 . . . . 0.0 112.179 166.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -59.29 -32.15 69.77 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 120.155 1.343 . . . . 0.0 111.924 173.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.3 tt -67.59 -48.92 65.46 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 174.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 74.5 mt -61.27 -45.31 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -174.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.56 -21.08 66.56 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.014 -1.054 . . . . 0.0 113.38 -174.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -91.84 5.64 49.18 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.149 0.98 . . . . 0.0 111.852 177.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 40.5 tp -140.89 -32.88 0.55 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.593 0.757 . . . . 0.0 112.311 -169.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.0 pttm -61.68 -25.28 67.31 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 125.63 1.572 . . . . 0.0 112.62 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -62.6 -18.04 61.41 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.315 1.046 . . . . 0.0 112.275 -175.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -114.12 6.21 16.27 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.231 1.012 . . . . 0.0 112.155 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 79.9 mt -120.6 146.42 25.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.848 1.259 . . . . 0.0 108.522 -171.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -75.19 -36.25 46.22 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.774 0.702 . . . . 0.0 112.143 -177.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -152.12 141.05 21.11 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.107 0.954 . . . . 0.0 108.679 175.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.6 t -124.99 135.23 64.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 171.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.0 mp -129.49 149.72 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 -177.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.429 ' HB3' HD11 ' A' ' 81' ' ' ILE . 43.2 t80 -130.75 141.8 50.39 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 169.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.4 tt -120.28 130.54 54.52 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.313 1.445 . . . . 0.0 107.544 173.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -111.41 155.01 16.4 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 176.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 77.1 mt -133.24 127.37 54.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -60.93 114.63 10.98 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-O 117.351 -1.309 . . . . 0.0 110.179 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -76.2 171.5 17.99 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.158 2.572 . . . . 0.0 111.116 170.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -129.42 -31.56 2.04 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.053 1.741 . . . . 0.0 111.012 171.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -135.85 136.03 50.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.237 1.015 . . . . 0.0 108.309 176.275 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.8 t -141.45 134.84 30.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 175.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 159.47 153.94 7.06 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -69.52 153.46 43.47 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.882 0.849 . . . . 0.0 110.775 -173.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.4 t80 51.8 39.16 25.02 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.846 2.058 . . . . 0.0 112.296 -176.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 23.0 m-30 -121.97 147.63 49.34 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 124.067 0.947 . . . . 0.0 109.961 173.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -81.15 164.09 19.77 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.153 2.568 . . . . 0.0 111.15 177.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.3 ttm -72.59 139.41 47.44 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 168.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 68.6 p -79.08 159.36 27.55 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.191 0.996 . . . . 0.0 110.522 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.2 tp60 -52.87 -44.26 95.88 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-O 116.579 -1.677 . . . . 0.0 114.232 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -68.78 -30.55 27.08 Favored 'Trans proline' 0 C--N 1.35 0.647 0 CA-C-N 122.869 2.06 . . . . 0.0 112.295 -176.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.97 -35.26 15.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 119.072 0.851 . . . . 0.0 108.706 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -56.29 -46.91 79.56 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.136 0.88 . . . . 0.0 109.977 169.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -63.28 -38.27 90.5 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.037 0.535 . . . . 0.0 111.248 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.35 -47.14 80.44 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 121.967 -0.458 . . . . 0.0 111.133 176.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.5 t -61.4 -41.27 89.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 118.581 0.628 . . . . 0.0 109.655 177.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -62.36 -33.86 75.55 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.863 0.865 . . . . 0.0 111.074 175.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 44.3 m -69.52 -46.23 67.02 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.462 -0.774 . . . . 0.0 109.926 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 92.3 t -61.97 -44.35 98.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 119.203 0.911 . . . . 0.0 109.592 178.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -53.37 -43.82 68.09 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.32 1.048 . . . . 0.0 111.172 176.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -68.73 -45.02 72.61 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.527 0.603 . . . . 0.0 111.119 175.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -58.7 -36.66 74.58 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.133 0.573 . . . . 0.0 111.221 -174.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 56.9 mt -56.27 -19.06 12.47 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -175.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 . . . . . 0 CA--C 1.538 0.481 0 CA-C-N 120.09 1.314 . . . . 0.0 112.211 176.31 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 . . . . . 0 N--CA 1.447 -0.595 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.87 148.47 42.29 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.196 176.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -92.15 119.85 32.19 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 60.4 tp . . . . . 0 CA--C 1.53 0.199 0 C-N-CA 126.024 1.729 . . . . 0.0 110.104 178.749 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.1 t0 . . . . . 0 C--O 1.234 0.265 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.8 m -86.41 150.72 3.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 123.758 0.823 . . . . 0.0 110.04 -172.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 52.6 tp -115.32 124.51 51.47 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 171.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 67.2 tp -112.95 97.41 6.51 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 92.2 m -72.97 141.97 47.78 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 169.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.4 t -141.23 142.03 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 125.216 1.407 . . . . 0.0 107.734 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 148.91 178.04 23.61 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 123.971 0.796 . . . . 0.0 112.272 175.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -124.93 117.17 23.46 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 125.387 1.475 . . . . 0.0 107.908 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 m -56.13 -21.63 23.63 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 126.5 1.92 . . . . 0.0 115.339 -170.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 25.7 ptp -123.91 20.48 9.2 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.665 0.666 . . . . 0.0 110.794 -174.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.9 ttt -102.34 29.23 5.31 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.38 1.072 . . . . 0.0 110.29 179.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.33 -142.07 21.83 Favored Glycine 0 N--CA 1.441 -1.021 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -63.17 -15.44 56.89 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.37 1.068 . . . . 0.0 112.223 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -56.17 -21.49 23.24 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.15 1.38 . . . . 0.0 112.987 175.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.33 21.29 0.69 Allowed Glycine 0 CA--C 1.534 1.246 0 CA-C-O 118.491 -1.172 . . . . 0.0 114.475 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.1 -51.88 67.27 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 119.545 1.673 . . . . 0.0 110.758 -169.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.28 -55.32 30.81 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 117.502 -1.721 . . . . 0.0 111.423 177.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -50.47 -40.14 54.23 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 CA-C-N 120.921 2.36 . . . . 0.0 115.076 178.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.6 tp -71.07 -39.48 72.18 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 119.878 1.217 . . . . 0.0 110.039 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 51.1 tp -61.53 -48.85 79.13 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 176.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.26 -41.7 80.14 Favored 'General case' 0 C--O 1.227 -0.107 0 C-N-CA 124.054 0.942 . . . . 0.0 111.283 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -60.77 -49.1 78.86 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.661 0.664 . . . . 0.0 109.897 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -62.66 -47.74 82.37 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 122.983 0.513 . . . . 0.0 110.702 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 73.8 m -64.74 -37.95 89.33 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.574 0.624 . . . . 0.0 111.458 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.81 -40.91 97.77 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.991 0.814 . . . . 0.0 110.806 176.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.67 -32.53 72.42 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.483 0.713 . . . . 0.0 111.837 178.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.86 92.6 2.85 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 125.268 1.427 . . . . 0.0 108.461 -172.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -53.8 158.85 7.8 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.34 2.693 . . . . 0.0 113.567 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.424 ' HE2' ' CE1' ' A' ' 136' ' ' TYR . 74.7 mmtt -129.36 166.39 19.61 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.481 1.512 . . . . 0.0 108.474 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 41.17 -124.37 2.88 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.478 1.513 . . . . 0.0 112.139 175.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -138.47 35.98 2.26 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.185 1.394 . . . . 0.0 109.028 170.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -70.49 167.02 19.25 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.146 0.978 . . . . 0.0 111.441 -175.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 68.7 t -122.29 101.95 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 168.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.9 t -72.43 136.91 24.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -175.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 90.9 mt -135.33 142.31 40.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 172.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -127.01 105.29 8.5 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.55 -6.36 80.76 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 118.973 -0.904 . . . . 0.0 112.69 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 54.22 -140.7 35.42 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 -169.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.4 p -93.2 7.89 42.43 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.624 0.77 . . . . 0.0 112.469 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.72 64.22 42.52 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 124.875 1.27 . . . . 0.0 109.528 177.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -65.17 -15.63 51.15 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.668 2.245 . . . . 0.0 112.183 -177.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -46.92 -42.37 17.55 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.703 1.601 . . . . 0.0 111.161 168.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.96 -27.29 68.73 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.93 -5.43 41.4 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.854 1.261 . . . . 0.0 111.33 -169.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.8 mt -52.86 -44.9 49.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 118.919 0.781 . . . . 0.0 109.18 171.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.7 t -60.99 -42.29 92.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.22 -44.69 87.48 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 123.192 0.597 . . . . 0.0 110.854 -177.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 72.9 mt -55.39 -48.15 77.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.091 0.956 . . . . 0.0 108.504 173.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 49.7 mtp180 -67.83 -19.17 65.03 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 117.598 -1.192 . . . . 0.0 113.135 -176.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -58.97 -27.39 65.33 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 121.023 1.738 . . . . 0.0 110.977 171.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 58.6 mt -95.93 -9.52 31.05 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.582 1.153 . . . . 0.0 112.33 -172.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 48.7 mmm-85 32.85 58.48 1.47 Allowed Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 126.423 1.889 . . . . 0.0 111.764 -169.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -56.09 152.49 37.14 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.073 2.515 . . . . 0.0 114.867 -168.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.1 m -71.97 -39.06 69.6 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.089 0.955 . . . . 0.0 109.244 168.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -148.67 160.12 43.46 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.633 0.773 . . . . 0.0 111.126 -177.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 24.1 tp -141.91 139.52 32.57 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 125.304 1.442 . . . . 0.0 109.074 177.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 54.4 tp -124.17 135.98 53.86 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 168.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.9 mt -119.49 144.97 26.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -178.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 46.3 t -139.92 133.68 36.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 123.148 0.579 . . . . 0.0 109.649 -175.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -162.65 171.68 16.52 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 127.335 2.254 . . . . 0.0 107.245 173.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.07 155.31 40.58 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 167.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.1 m -153.86 135.56 14.44 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 177.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -81.09 84.45 6.51 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.945 0.793 . . . . 0.0 109.873 176.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -69.48 -8.88 50.79 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.698 0.799 . . . . 0.0 112.121 173.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.36 24.89 76.39 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 119.434 1.016 . . . . 0.0 111.634 -171.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 98.0 mt -100.01 -173.26 2.39 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.232 1.413 . . . . 0.0 110.477 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -69.66 139.76 89.01 Favored Pre-proline 0 N--CA 1.467 0.407 0 CA-C-O 117.606 -1.188 . . . . 0.0 108.72 169.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -43.04 138.92 3.88 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.544 2.829 . . . . 0.0 113.57 172.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.17 0.27 76.42 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 118.6 -1.111 . . . . 0.0 113.679 176.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -65.72 154.78 38.0 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 119.794 1.797 . . . . 0.0 108.815 168.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 77.4 mt -134.7 132.87 54.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 125.825 1.65 . . . . 0.0 106.699 -170.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.2 mmt-85 -143.39 148.11 35.69 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.291 0.95 . . . . 0.0 109.733 177.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 47.1 mm -77.92 144.68 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 169.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -135.5 165.63 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 124.777 1.231 . . . . 0.0 108.205 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -139.42 146.16 47.21 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 127.086 2.155 . . . . 0.0 107.619 -169.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -54.12 -27.97 48.88 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.399 2.733 . . . . 0.0 115.088 -174.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -67.29 -20.02 65.57 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.862 0.755 . . . . 0.0 112.123 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -119.85 -31.2 4.56 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.91 1.284 . . . . 0.0 111.84 -171.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 67.2 mt -50.74 -39.98 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.373 1.469 . . . . 0.0 109.938 169.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.45 -28.28 53.36 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.359 1.064 . . . . 0.0 113.129 -177.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -102.24 -43.83 5.6 Favored 'General case' 0 C--O 1.23 0.078 0 C-N-CA 123.202 0.601 . . . . 0.0 109.53 176.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 21.2 mmt -69.06 -28.76 66.83 Favored 'General case' 0 C--O 1.23 0.057 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -169.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -68.06 -48.36 65.82 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 119.038 0.835 . . . . 0.0 110.724 175.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 28.8 ptm . . . . . 0 CA--C 1.535 0.385 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 179.631 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.3 mt . . . . . 0 N--CA 1.471 0.579 0 N-CA-C 117.087 2.255 . . . . 0.0 117.087 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -52.78 -23.24 6.46 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.318 -0.864 . . . . 0.0 112.278 167.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -58.83 -34.4 71.49 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.396 0.998 . . . . 0.0 111.593 175.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.3 tt -75.83 -44.29 41.73 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 86.7 mt -60.96 -42.0 91.18 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.175 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -60.84 -26.01 67.04 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.853 0.751 . . . . 0.0 112.606 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -85.06 -3.57 58.84 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.753 0.821 . . . . 0.0 112.211 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 80.3 mt -130.01 -26.59 2.37 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.22 1.008 . . . . 0.0 111.946 -173.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -63.44 -23.11 67.26 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.221 -0.924 . . . . 0.0 112.286 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -80.09 -6.06 57.0 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.148 0.979 . . . . 0.0 111.789 175.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -132.51 -3.06 3.38 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.689 1.195 . . . . 0.0 113.038 -168.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.3 mt -134.85 143.41 37.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 126.549 1.94 . . . . 0.0 106.163 -175.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -70.37 -37.15 70.2 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-O 119.464 -0.631 . . . . 0.0 112.539 -172.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -146.53 130.88 17.59 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 -177.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 48.6 t -132.12 124.31 52.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 21.3 mt -130.19 156.68 42.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 -169.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -130.82 147.47 52.48 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 174.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.8 tt -126.37 126.5 43.99 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 170.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -107.69 156.16 15.98 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 82.5 mt -131.82 126.32 56.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 71.1 tp60 -64.64 116.03 25.44 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-O 117.201 -1.381 . . . . 0.0 110.438 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -76.51 170.59 19.64 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.268 2.645 . . . . 0.0 111.377 170.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -128.08 -31.9 2.32 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.978 1.711 . . . . 0.0 110.984 171.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.1 pp -137.14 139.77 43.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 124.369 1.068 . . . . 0.0 108.531 178.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 92.8 t -143.22 138.55 26.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 175.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 163.01 140.06 2.78 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 175.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -74.1 42.71 0.15 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.806 2.042 . . . . 0.0 113.759 -169.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -161.39 26.1 0.13 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.608 1.563 . . . . 0.0 110.731 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -135.04 153.24 78.33 Favored Pre-proline 0 CA--C 1.536 0.421 0 O-C-N 121.517 -0.74 . . . . 0.0 112.15 -174.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -83.75 166.1 13.52 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.601 2.867 . . . . 0.0 110.854 172.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.4 ttm -69.83 140.87 53.32 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 168.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 71.7 p -81.32 160.45 24.17 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.509 1.124 . . . . 0.0 110.682 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 6.9 tm0? -50.91 -48.81 83.32 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-O 117.004 -1.474 . . . . 0.0 113.351 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -67.53 -29.3 37.26 Favored 'Trans proline' 0 C--N 1.352 0.753 0 CA-C-N 122.575 1.955 . . . . 0.0 112.573 -175.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -81.63 -34.76 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 119.134 0.879 . . . . 0.0 108.865 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -56.65 -46.61 80.95 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 119.183 0.901 . . . . 0.0 109.782 169.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -62.36 -38.74 90.7 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 123.092 0.557 . . . . 0.0 111.525 177.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.41 -46.93 81.13 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 122.036 -0.415 . . . . 0.0 111.094 176.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 62.7 t -62.38 -40.32 87.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 118.81 0.732 . . . . 0.0 109.782 178.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -61.48 -40.06 93.17 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.625 0.648 . . . . 0.0 110.52 174.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 49.5 m -63.94 -46.92 82.6 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.785 -0.626 . . . . 0.0 109.962 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 85.4 t -58.83 -47.6 88.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 119.209 0.913 . . . . 0.0 109.133 177.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.424 ' CE1' ' HE2' ' A' ' 31' ' ' LYS . 24.4 t80 -53.83 -46.87 71.31 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.939 0.896 . . . . 0.0 111.2 177.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -72.36 -4.96 33.05 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 178.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.38 -11.4 10.57 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.17 1.388 . . . . 0.0 109.452 -175.176 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 59.5 mt -59.72 -25.45 64.83 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 119.348 -2.095 . . . . 0.0 111.449 170.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 . . . . . 0 CA--C 1.544 0.716 0 C-N-CA 124.668 1.187 . . . . 0.0 113.555 177.413 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 . . . . . 0 C--O 1.232 0.168 0 CA-C-O 121.815 0.816 . . . . 0.0 110.049 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.36 144.65 44.33 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -87.88 119.81 28.59 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 48.4 tp . . . . . 0 C--O 1.233 0.236 0 C-N-CA 125.322 1.449 . . . . 0.0 110.255 -179.579 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.8 t0 . . . . . 0 C--O 1.234 0.242 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 49.1 t -88.42 143.56 10.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-O 121.518 0.675 . . . . 0.0 109.357 -170.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.2 tp -113.22 108.67 17.59 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 169.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.1 tp -98.09 103.14 15.06 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 99.8 m -77.58 141.67 39.4 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 169.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 54.3 t -140.84 141.67 31.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 152.73 176.48 25.34 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-N 118.44 0.563 . . . . 0.0 112.9 174.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -120.15 115.65 24.08 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.73 1.612 . . . . 0.0 108.494 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -66.5 -10.39 44.18 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 -170.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 21.9 ptp -117.34 2.0 12.46 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.912 1.233 . . . . 0.0 111.267 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.3 ttt -95.75 39.85 1.13 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 122.087 0.946 . . . . 0.0 109.227 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 57.66 -121.83 27.13 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 124.327 0.965 . . . . 0.0 110.759 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -61.43 -19.67 62.22 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.096 0.959 . . . . 0.0 112.502 -174.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -65.61 -13.02 58.23 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.614 0.765 . . . . 0.0 112.274 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.19 17.4 1.4 Allowed Glycine 0 CA--C 1.531 1.039 0 O-C-N 120.743 -1.223 . . . . 0.0 113.097 176.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.26 -52.22 65.67 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.604 1.702 . . . . 0.0 110.821 -169.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.59 -55.6 29.02 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-O 117.745 -1.586 . . . . 0.0 111.024 175.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -49.73 -40.98 47.27 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 CA-C-N 120.878 2.339 . . . . 0.0 115.217 177.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.7 tp -71.98 -36.66 69.85 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 119.876 1.216 . . . . 0.0 110.408 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 49.4 tp -61.74 -49.94 74.41 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.332 0.515 . . . . 0.0 109.936 174.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.73 -39.49 77.43 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.923 0.889 . . . . 0.0 111.102 177.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.9 tp10 -62.05 -49.48 75.82 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 118.778 0.717 . . . . 0.0 109.87 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -62.24 -44.49 96.43 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.816 0.446 . . . . 0.0 110.614 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 84.9 m -63.64 -42.34 98.15 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.298 0.499 . . . . 0.0 110.997 178.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.18 -39.53 94.91 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.309 0.504 . . . . 0.0 111.046 178.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.37 -36.36 76.75 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.258 0.623 . . . . 0.0 111.486 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.01 91.61 2.43 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 124.8 1.24 . . . . 0.0 108.877 -171.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -55.65 163.26 5.51 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.633 2.889 . . . . 0.0 113.811 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -133.71 174.42 10.46 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 126.033 1.733 . . . . 0.0 108.87 176.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 40.1 -125.4 2.46 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.228 1.394 . . . . 0.0 112.336 177.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -141.25 38.4 1.73 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.319 1.447 . . . . 0.0 109.169 172.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -74.93 168.38 20.05 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.341 1.057 . . . . 0.0 111.904 -172.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 67.9 t -120.38 105.6 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 167.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.0 t -70.44 137.77 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -178.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.0 mm -134.59 148.21 29.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 169.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -130.66 109.81 10.92 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 175.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.22 -1.91 88.12 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 118.868 -0.962 . . . . 0.0 112.833 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 60.93 -146.5 47.54 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -170.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.8 p -94.44 -1.78 53.02 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.15 0.98 . . . . 0.0 112.917 -172.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.66 70.0 31.07 Favored Pre-proline 0 C--O 1.235 0.303 0 C-N-CA 125.138 1.375 . . . . 0.0 107.993 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -66.1 -12.42 35.37 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.777 2.318 . . . . 0.0 112.77 -169.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.8 tp10 -44.57 -41.15 6.3 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.592 1.557 . . . . 0.0 110.938 168.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -62.86 -23.71 67.45 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -177.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -113.86 -2.22 13.68 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -168.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 79.6 mt -50.59 -37.7 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.154 0.981 . . . . 0.0 110.311 172.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 53.1 t -55.92 -40.28 61.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 123.852 0.861 . . . . 0.0 110.395 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.81 -43.29 84.19 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.431 0.56 . . . . 0.0 110.406 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.3 mt -62.36 -39.5 84.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -65.91 -18.99 65.71 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 117.724 -1.131 . . . . 0.0 112.513 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -69.19 -42.95 75.14 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 120.702 1.592 . . . . 0.0 109.241 169.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.4 mt -72.6 -25.75 61.44 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.648 0.779 . . . . 0.0 112.447 -175.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 38.22 60.32 4.83 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.703 1.601 . . . . 0.0 111.929 -169.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.37 151.02 38.73 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.862 2.374 . . . . 0.0 113.501 -170.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.6 m -71.66 -37.28 70.81 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 168.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -147.4 155.86 42.34 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.201 1.0 . . . . 0.0 109.31 -176.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 37.1 tp -144.51 136.22 25.79 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.63 1.172 . . . . 0.0 108.633 -177.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 56.9 tp -122.14 137.85 54.67 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 169.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.2 mt -122.21 143.19 35.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 -177.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.9 t -140.97 134.07 31.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 118.294 0.497 . . . . 0.0 110.013 -174.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -161.92 173.15 14.9 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 127.11 2.164 . . . . 0.0 107.456 169.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.69 156.58 39.29 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.055 -1.028 . . . . 0.0 109.906 169.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.8 m -152.92 129.49 10.74 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -178.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -79.85 83.63 5.75 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 119.031 0.832 . . . . 0.0 109.561 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 74.9 mtm -77.26 -7.28 55.7 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.583 1.553 . . . . 0.0 112.018 -177.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.33 26.67 72.98 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 123.816 0.722 . . . . 0.0 111.672 -172.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.4 mt -104.88 -171.24 1.88 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.936 1.294 . . . . 0.0 110.004 -177.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -73.66 140.2 78.17 Favored Pre-proline 0 N--CA 1.468 0.467 0 CA-C-O 117.47 -1.252 . . . . 0.0 108.676 171.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -42.96 137.59 4.37 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.303 2.668 . . . . 0.0 113.378 172.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.66 2.74 76.87 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 118.692 -1.06 . . . . 0.0 113.7 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -66.11 148.1 52.34 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.743 1.771 . . . . 0.0 108.348 168.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.13 136.32 59.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -173.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 89.4 mmt-85 -145.9 151.16 37.41 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 118.8 0.727 . . . . 0.0 110.703 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 49.0 mm -75.9 144.09 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 167.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.409 HG22 ' H ' ' A' ' 77' ' ' ASP . 1.4 mt -133.64 165.79 30.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 124.55 1.14 . . . . 0.0 107.989 177.453 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.409 ' H ' HG22 ' A' ' 76' ' ' ILE . 5.9 t70 -135.63 145.89 55.12 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 127.116 2.166 . . . . 0.0 107.681 -170.234 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -54.46 -26.6 45.54 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.395 2.73 . . . . 0.0 115.147 -174.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -66.51 -21.37 66.17 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.012 0.824 . . . . 0.0 112.273 177.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -120.39 -28.52 4.99 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.708 1.203 . . . . 0.0 112.14 -171.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 72.0 mt -51.23 -39.78 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.845 1.258 . . . . 0.0 109.743 169.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.9 -28.6 51.91 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.53 1.132 . . . . 0.0 113.261 -177.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -100.9 -44.27 5.81 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 123.068 0.547 . . . . 0.0 109.657 175.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 21.3 mmt -67.26 -26.77 66.73 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -171.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.435 ' CE2' HD12 ' A' ' 94' ' ' LEU . 4.7 m-85 -76.85 -43.33 36.64 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.741 0.701 . . . . 0.0 111.502 174.367 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 22.0 ptt? . . . . . 0 CA--C 1.533 0.307 0 CA-C-N 119.102 0.864 . . . . 0.0 112.044 178.938 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.435 HD12 ' CE2' ' A' ' 85' ' ' PHE . 18.8 mt . . . . . 0 N--CA 1.468 0.452 0 N-CA-C 116.903 2.186 . . . . 0.0 116.903 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -52.42 -24.94 8.71 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.406 1.003 . . . . 0.0 112.578 168.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -59.18 -33.05 70.48 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 119.32 0.964 . . . . 0.0 111.803 176.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.6 tt -75.61 -41.77 53.49 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 -177.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 92.2 mt -61.4 -48.59 88.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -61.7 -29.44 70.1 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.392 0.542 . . . . 0.0 112.395 -177.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -82.28 -2.69 53.41 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.002 0.921 . . . . 0.0 113.246 178.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 64.4 mt -133.08 -25.71 1.77 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.676 1.125 . . . . 0.0 112.549 -174.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -59.02 -21.62 59.34 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.353 1.061 . . . . 0.0 112.862 177.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -72.8 -11.19 60.51 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.415 1.086 . . . . 0.0 112.051 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -133.09 -42.54 0.88 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.349 1.06 . . . . 0.0 111.733 -173.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 28.2 mt -73.65 140.42 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 175.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.05 -40.89 95.34 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.185 0.897 . . . . 0.0 112.141 -177.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -148.49 137.14 21.47 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 118.633 1.216 . . . . 0.0 108.429 177.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.8 t -131.9 123.06 50.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -178.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 18.2 mt -129.54 155.39 41.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 -171.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -127.99 147.13 50.49 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 175.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.6 tt -129.1 130.36 46.39 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 172.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -115.19 156.96 15.31 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 77.6 mt -133.49 127.53 53.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 125.215 1.406 . . . . 0.0 107.269 -176.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 69.1 tp60 -67.25 117.6 48.05 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-O 117.607 -1.187 . . . . 0.0 111.129 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.35 175.04 11.78 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 124.27 3.313 . . . . 0.0 111.887 170.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -134.12 -29.16 1.29 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.257 1.423 . . . . 0.0 112.78 175.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.2 pp -132.29 4.22 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 119.362 0.983 . . . . 0.0 113.408 -171.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 8.5 p -38.43 118.49 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 125.929 1.692 . . . . 0.0 113.713 -167.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 170.31 158.37 14.09 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -175.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -67.17 152.56 45.53 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.996 0.919 . . . . 0.0 111.647 -173.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 56.32 41.76 28.67 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.883 2.073 . . . . 0.0 112.046 177.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -127.33 152.59 76.46 Favored Pre-proline 0 C--O 1.236 0.356 0 C-N-CA 124.287 1.035 . . . . 0.0 109.176 172.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -77.76 157.57 31.58 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.031 2.487 . . . . 0.0 109.875 168.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 56.5 ttm -66.25 136.64 56.14 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 169.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 18.1 p -77.75 154.45 31.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.588 0.709 . . . . 0.0 111.318 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -49.33 -47.25 77.17 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-O 116.916 -1.516 . . . . 0.0 113.443 -177.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -66.98 -28.13 42.11 Favored 'Trans proline' 0 C--N 1.351 0.69 0 CA-C-N 122.46 1.914 . . . . 0.0 112.407 -177.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 mp -78.12 -37.81 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 119.29 0.95 . . . . 0.0 108.564 177.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -57.28 -47.42 81.51 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.44 1.018 . . . . 0.0 110.074 172.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.18 -41.81 97.46 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 123.347 0.659 . . . . 0.0 111.053 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.94 -47.82 81.58 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 118.997 -0.525 . . . . 0.0 111.15 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.2 t -59.22 -41.21 83.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 118.886 0.766 . . . . 0.0 109.467 178.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -69.49 -27.83 65.54 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.861 0.755 . . . . 0.0 111.776 177.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 40.1 m -72.2 -42.39 65.86 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 120.982 -1.074 . . . . 0.0 109.944 174.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 88.0 t -61.18 -44.38 98.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 174.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -54.31 -47.04 72.91 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.163 0.985 . . . . 0.0 110.875 175.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -62.73 -40.72 98.09 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 118.869 0.758 . . . . 0.0 111.461 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -60.32 -25.39 65.76 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 118.368 -0.825 . . . . 0.0 112.463 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 93.0 mt -57.18 -22.66 42.07 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.852 1.205 . . . . 0.0 112.421 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 . . . . . 0 CA--C 1.544 0.745 0 C-N-CA 123.731 0.812 . . . . 0.0 112.411 -178.91 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 . . . . . 0 C--O 1.233 0.224 0 CA-C-O 121.799 0.809 . . . . 0.0 110.685 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -90.55 153.4 20.38 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 170.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -91.79 123.12 34.94 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 177.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 58.3 tp . . . . . 0 CA--C 1.53 0.206 0 C-N-CA 124.986 1.314 . . . . 0.0 109.809 178.493 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.3 t70 . . . . . 0 C--O 1.232 0.166 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 88.4 t -135.47 146.2 30.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 121.425 0.631 . . . . 0.0 110.284 -168.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 17.1 tp -115.03 126.94 55.31 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 104.889 -2.263 . . . . 0.0 104.889 168.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.8 tp -116.29 99.36 7.15 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 87.9 m -72.68 142.76 48.25 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 169.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.4 t -143.79 144.75 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 147.17 172.17 17.11 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -121.96 114.37 20.88 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 123.818 0.847 . . . . 0.0 109.138 -176.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -59.87 -11.76 6.17 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.624 1.97 . . . . 0.0 115.197 -170.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 22.5 ptp -127.72 10.13 6.54 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 119.212 0.915 . . . . 0.0 111.303 -178.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.4 ttt -98.04 31.33 2.75 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.072 0.851 . . . . 0.0 109.665 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.22 -140.49 20.67 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -178.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -62.04 -16.92 55.38 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.681 1.192 . . . . 0.0 112.389 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -58.19 -16.55 14.07 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.89 1.276 . . . . 0.0 112.995 176.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.32 21.86 0.84 Allowed Glycine 0 CA--C 1.535 1.324 0 O-C-N 120.288 -1.507 . . . . 0.0 114.451 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.94 -50.55 70.37 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 119.522 1.661 . . . . 0.0 111.363 -169.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.26 -54.43 37.96 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 117.555 -1.692 . . . . 0.0 111.322 177.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -48.37 -41.72 35.3 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 CA-C-N 120.656 2.228 . . . . 0.0 115.1 175.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.3 tp -72.54 -37.59 68.23 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.848 1.204 . . . . 0.0 110.706 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.6 tp -61.74 -45.95 91.74 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.605 0.639 . . . . 0.0 109.998 174.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.89 -38.55 86.05 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.903 0.881 . . . . 0.0 111.09 179.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.4 tp10 -61.86 -49.08 77.69 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 118.7 0.682 . . . . 0.0 109.541 178.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -63.84 -44.85 91.95 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.781 0.432 . . . . 0.0 110.501 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 73.3 m -63.69 -39.47 94.39 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.487 0.585 . . . . 0.0 111.444 177.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.22 -37.51 87.73 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.89 0.768 . . . . 0.0 111.113 177.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.48 -36.65 76.74 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.089 0.556 . . . . 0.0 111.245 178.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.71 98.51 1.53 Allowed Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 125.023 1.329 . . . . 0.0 108.163 -173.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -55.14 169.18 1.02 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 124.316 3.344 . . . . 0.0 114.983 -178.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.54 ' HE2' ' CZ ' ' A' ' 136' ' ' TYR . 14.9 mmtm -140.52 158.9 43.31 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.758 1.623 . . . . 0.0 108.28 -177.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 42.79 -126.33 4.71 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.007 1.289 . . . . 0.0 111.95 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -136.53 12.1 3.21 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.036 1.334 . . . . 0.0 111.164 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -73.64 131.03 41.22 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.942 0.897 . . . . 0.0 108.806 -173.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 97.5 t -69.85 112.86 5.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 166.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.3 t -71.56 133.16 32.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 60.4 mt -132.84 145.13 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 104.258 -2.497 . . . . 0.0 104.258 169.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -128.42 98.48 5.06 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 177.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.43 -14.07 71.54 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-O 119.136 -0.814 . . . . 0.0 112.121 175.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 51.71 -135.66 33.66 Favored Glycine 0 C--N 1.34 0.795 0 CA-C-N 118.208 1.004 . . . . 0.0 110.591 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.6 t -88.4 7.21 33.69 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.109 0.964 . . . . 0.0 111.554 -175.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.47 60.56 5.61 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.666 1.186 . . . . 0.0 110.12 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -69.7 -18.2 37.41 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.723 2.282 . . . . 0.0 112.929 -169.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -56.66 -31.69 64.65 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.44 0.696 . . . . 0.0 112.267 177.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.47 -30.32 69.6 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.296 0.639 . . . . 0.0 111.982 176.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -94.16 -6.4 44.96 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.022 0.929 . . . . 0.0 111.496 -169.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.2 mt -53.19 -43.85 50.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 118.964 0.802 . . . . 0.0 109.2 173.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.0 t -61.14 -42.11 92.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 122.981 0.512 . . . . 0.0 110.012 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.0 -46.87 73.21 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 122.923 0.489 . . . . 0.0 110.689 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.6 mt -55.09 -45.72 77.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.258 1.023 . . . . 0.0 109.179 174.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -60.86 -30.96 70.44 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 117.846 -1.073 . . . . 0.0 112.357 -177.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -59.46 -30.73 68.73 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 120.083 1.31 . . . . 0.0 111.265 176.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 56.5 mt -87.07 -9.06 56.37 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.666 1.186 . . . . 0.0 112.374 -173.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 27.34 61.73 0.6 Allowed Pre-proline 0 N--CA 1.475 0.811 0 C-N-CA 127.084 2.154 . . . . 0.0 112.229 -168.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.22 142.99 66.05 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.75 2.3 . . . . 0.0 114.203 -169.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.2 m -74.39 -30.37 61.92 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 168.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -146.54 151.66 37.7 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.007 0.923 . . . . 0.0 110.023 177.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 46.0 tp -141.24 136.11 31.36 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.674 1.59 . . . . 0.0 107.83 174.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 20.8 tp -126.8 133.42 50.79 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 105.674 -1.972 . . . . 0.0 105.674 172.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.4 mt -119.36 144.7 27.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -172.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.6 t -140.46 134.76 34.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 118.557 0.617 . . . . 0.0 109.875 -174.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -161.4 175.94 11.66 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 127.347 2.259 . . . . 0.0 107.082 172.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.44 160.4 30.28 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 120.805 -1.184 . . . . 0.0 108.494 167.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.0 m -156.29 125.27 6.02 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -70.72 122.3 19.57 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 169.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 77.1 mtm -122.46 1.39 9.56 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.53 1.532 . . . . 0.0 110.896 -175.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.87 26.05 71.01 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 118.568 0.622 . . . . 0.0 112.071 -173.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 74.9 mt -103.68 -171.1 1.88 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.479 1.512 . . . . 0.0 109.026 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -81.29 138.67 48.5 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-O 117.649 -1.167 . . . . 0.0 109.34 176.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -45.32 132.72 12.13 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.417 2.745 . . . . 0.0 113.814 177.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.95 3.22 90.65 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 118.502 -1.166 . . . . 0.0 113.241 179.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -64.58 145.71 55.73 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 119.895 1.847 . . . . 0.0 107.664 167.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 41.7 mt -126.72 138.84 53.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 -173.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 -148.94 148.96 30.41 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 118.236 0.471 . . . . 0.0 111.764 -179.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 41.3 mm -76.11 144.63 11.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 165.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.4 mt -135.38 163.79 34.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 176.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -136.72 145.73 52.32 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 126.36 1.864 . . . . 0.0 107.688 -170.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -52.17 -28.1 32.28 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.448 2.766 . . . . 0.0 115.197 -174.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -66.53 -23.23 66.2 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.817 0.735 . . . . 0.0 112.567 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -117.41 -29.51 5.81 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.659 1.184 . . . . 0.0 111.701 -173.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 53.5 mt -50.14 -41.02 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.322 1.449 . . . . 0.0 110.12 169.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.8 -24.43 57.25 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -173.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -103.34 -44.15 5.23 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 172.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 33.8 mmt -65.04 -34.44 78.43 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -170.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -66.79 -22.12 66.03 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -178.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 CA--C 1.535 0.369 0 C-N-CA 123.773 0.829 . . . . 0.0 111.208 174.701 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.5 mt . . . . . 0 N--CA 1.468 0.467 0 N-CA-C 117.343 2.349 . . . . 0.0 117.343 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.12 -26.43 16.57 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 119.298 0.954 . . . . 0.0 111.614 167.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -60.36 -34.46 73.9 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.827 0.74 . . . . 0.0 111.604 176.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.5 tt -77.22 -43.35 33.93 Favored 'General case' 0 C--N 1.338 0.087 0 C-N-CA 123.334 0.654 . . . . 0.0 109.374 177.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 85.8 mt -59.78 -43.75 92.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -178.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -61.98 -23.94 66.72 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -84.71 0.68 49.59 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.723 0.809 . . . . 0.0 112.314 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 84.5 mt -133.58 -35.7 0.99 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.071 0.948 . . . . 0.0 111.626 -173.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -58.83 -22.77 59.42 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.307 1.043 . . . . 0.0 113.07 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -71.32 -13.37 61.85 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.061 0.944 . . . . 0.0 111.988 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -134.84 -30.35 1.09 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.175 0.898 . . . . 0.0 112.931 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 28.9 mt -69.19 138.92 21.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 174.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -63.95 -42.86 98.15 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 123.763 0.697 . . . . 0.0 112.442 -177.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -146.94 134.14 20.53 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.404 1.102 . . . . 0.0 108.367 177.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.8 t -126.09 133.59 68.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 176.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.9 mp -132.01 154.66 40.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 -176.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -128.69 146.52 50.86 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 170.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.0 tt -126.94 132.73 50.78 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 170.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -118.58 159.28 14.43 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 124.571 1.081 . . . . 0.0 110.853 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 82.1 mt -133.85 126.14 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 -177.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -62.48 115.42 16.42 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-O 117.463 -1.256 . . . . 0.0 110.199 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -75.45 171.13 18.83 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 123.394 2.73 . . . . 0.0 111.196 169.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -125.21 -30.91 3.12 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 125.867 1.667 . . . . 0.0 110.734 170.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -136.01 134.32 50.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 176.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.3 t -140.27 135.49 36.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 174.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 158.08 150.8 5.86 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -66.9 154.42 41.05 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.952 0.882 . . . . 0.0 111.522 -175.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 54.81 38.65 30.6 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.048 2.139 . . . . 0.0 112.273 -176.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -124.79 149.09 61.53 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 123.899 0.88 . . . . 0.0 110.281 172.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -83.13 165.16 14.98 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.437 2.758 . . . . 0.0 111.461 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.4 ttm -72.73 139.92 47.47 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 168.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 82.4 p -80.64 159.82 25.24 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.816 1.246 . . . . 0.0 110.549 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.3 tp60 -53.78 -44.79 98.61 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-O 116.675 -1.631 . . . . 0.0 114.298 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -68.29 -30.47 30.49 Favored 'Trans proline' 0 C--N 1.351 0.71 0 CA-C-N 122.86 2.057 . . . . 0.0 112.034 -176.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.6 mp -78.94 -35.79 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -56.82 -46.36 81.71 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.549 1.068 . . . . 0.0 110.044 171.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -63.21 -41.67 99.18 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 122.965 0.506 . . . . 0.0 111.07 178.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.98 -47.97 82.44 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 118.958 -0.544 . . . . 0.0 110.974 176.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 76.5 t -60.76 -40.01 83.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 118.98 0.809 . . . . 0.0 109.705 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -69.93 -30.62 68.06 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.583 1.083 . . . . 0.0 111.551 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 28.1 m -68.68 -46.87 67.94 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.36 -0.837 . . . . 0.0 109.443 173.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 53.9 t -58.73 -45.52 91.07 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.163 0 C-N-CA 123.875 0.87 . . . . 0.0 109.152 176.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.54 ' CZ ' ' HE2' ' A' ' 31' ' ' LYS . 33.5 t80 -52.37 -48.64 65.47 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.275 1.03 . . . . 0.0 110.861 177.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -64.39 -38.74 92.11 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.568 0.622 . . . . 0.0 110.838 176.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 9.2 tpp85 -65.46 -23.25 66.87 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 118.145 -0.931 . . . . 0.0 112.862 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -59.2 -17.27 26.23 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 120.431 1.469 . . . . 0.0 111.036 172.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 . . . . . 0 CA--C 1.541 0.624 0 CA-C-N 120.167 1.349 . . . . 0.0 112.706 176.938 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 . . . . . 0 C--O 1.235 0.314 0 CA-C-O 121.231 0.539 . . . . 0.0 109.835 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -87.69 155.46 19.92 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 169.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -88.53 125.72 34.91 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 174.051 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 67.7 tp . . . . . 0 C--O 1.234 0.246 0 C-N-CA 124.941 1.296 . . . . 0.0 109.785 176.753 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.0 t70 . . . . . 0 CA--C 1.522 -0.129 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 74.0 t -135.73 145.52 31.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 123.3 0.64 . . . . 0.0 109.986 -170.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 25.8 tp -114.14 124.89 53.2 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 169.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 56.7 tp -114.2 96.26 5.7 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 178.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 91.5 m -72.54 142.22 48.48 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.131 169.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.4 t -140.4 142.94 30.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 125.176 1.39 . . . . 0.0 107.517 178.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 144.76 172.26 15.14 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 124.657 1.122 . . . . 0.0 111.442 176.01 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -113.77 121.14 43.16 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 107.832 -1.174 . . . . 0.0 107.832 174.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -59.2 -13.63 8.09 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.401 1.88 . . . . 0.0 115.423 -169.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.0 ptt? -130.78 12.79 5.31 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.976 0.91 . . . . 0.0 111.172 -176.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.9 ttt -92.95 35.24 1.06 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.816 0.734 . . . . 0.0 109.311 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.28 -143.89 30.08 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -173.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -60.24 -18.01 45.79 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 126.016 1.726 . . . . 0.0 112.445 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -54.02 -26.96 29.06 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.649 1.18 . . . . 0.0 112.57 176.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.18 27.83 0.68 Allowed Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.643 -1.087 . . . . 0.0 114.165 178.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.45 -47.97 74.32 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 119.45 1.625 . . . . 0.0 110.253 -172.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.03 -55.82 28.78 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 117.692 -1.616 . . . . 0.0 111.071 174.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -48.21 -41.82 34.07 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 CA-C-N 121.01 2.405 . . . . 0.0 115.372 176.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.3 tp -70.78 -38.28 73.38 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.889 1.222 . . . . 0.0 110.495 178.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.4 tp -61.99 -46.6 88.51 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.936 -0.477 . . . . 0.0 110.291 175.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.35 -40.57 82.55 Favored 'General case' 0 C--O 1.227 -0.088 0 C-N-CA 124.025 0.93 . . . . 0.0 110.978 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -60.72 -48.82 80.1 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 118.594 0.634 . . . . 0.0 109.821 178.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -63.37 -48.8 76.4 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.171 0.589 . . . . 0.0 110.515 -178.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 70.7 m -64.32 -36.74 85.11 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.45 0.568 . . . . 0.0 111.449 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.74 -37.56 88.02 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.166 0.894 . . . . 0.0 111.151 176.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.75 -34.27 75.31 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.18 0.592 . . . . 0.0 111.406 178.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.72 98.89 1.87 Allowed Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 125.325 1.45 . . . . 0.0 108.156 -174.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -54.89 161.02 6.82 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 123.483 2.789 . . . . 0.0 113.854 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.427 ' HE2' ' CE1' ' A' ' 136' ' ' TYR . 72.8 mmtt -135.08 162.21 33.13 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.912 1.685 . . . . 0.0 108.137 178.473 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 43.53 -121.73 3.56 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.96 1.267 . . . . 0.0 111.614 176.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -134.07 10.7 3.89 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.672 1.189 . . . . 0.0 111.136 174.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -72.86 117.71 14.91 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 121.469 -0.77 . . . . 0.0 109.31 -169.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 89.4 t -67.98 118.31 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 167.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.1 t -73.9 134.13 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -177.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 56.1 mt -132.45 141.34 45.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 103.875 -2.639 . . . . 0.0 103.875 169.073 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -125.98 106.19 9.45 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 175.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.36 -1.89 82.63 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 118.997 -0.89 . . . . 0.0 112.919 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 56.52 -146.99 33.04 Favored Glycine 0 C--N 1.34 0.76 0 N-CA-C 108.17 -1.972 . . . . 0.0 108.17 -168.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.2 p -88.5 10.49 20.06 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.772 -0.84 . . . . 0.0 111.867 177.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.37 57.96 15.91 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 125.151 1.38 . . . . 0.0 110.393 -176.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -68.87 -14.29 38.52 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.834 2.356 . . . . 0.0 112.978 -171.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -56.7 -32.21 65.25 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.05 0.841 . . . . 0.0 112.03 175.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -61.64 -27.88 68.98 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.4 0.68 . . . . 0.0 112.258 175.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -98.25 -1.88 40.89 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.945 1.298 . . . . 0.0 111.575 -169.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.7 mt -53.86 -42.4 52.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 118.866 0.757 . . . . 0.0 109.783 175.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 43.2 t -61.08 -41.04 87.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 118.378 0.535 . . . . 0.0 110.065 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.33 -43.91 84.82 Favored 'General case' 0 N--CA 1.456 -0.159 0 O-C-N 121.842 -0.536 . . . . 0.0 110.757 -177.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 63.3 mt -58.84 -48.99 84.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 173.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -60.82 -35.88 77.66 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 118.163 -0.922 . . . . 0.0 111.947 -174.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -57.07 -29.73 63.7 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.521 1.055 . . . . 0.0 111.794 177.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 55.2 mt -87.15 -9.78 54.39 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.883 0.873 . . . . 0.0 112.457 -177.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 29.14 61.06 0.78 Allowed Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 126.768 2.027 . . . . 0.0 112.464 -168.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -56.33 145.99 75.16 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.86 2.374 . . . . 0.0 112.589 -171.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.8 m -73.13 -30.35 63.55 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.938 0.895 . . . . 0.0 108.937 168.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -145.36 151.88 38.99 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.28 1.032 . . . . 0.0 109.954 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 41.9 tp -143.17 134.0 25.35 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.329 1.452 . . . . 0.0 107.862 176.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 23.5 tp -126.65 135.27 50.97 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 172.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.0 mt -121.33 143.76 32.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 -171.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.5 t -142.14 135.64 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 119.117 0.871 . . . . 0.0 110.296 -175.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -164.89 170.93 14.73 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 127.372 2.269 . . . . 0.0 107.871 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.82 155.42 37.59 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 121.437 -0.789 . . . . 0.0 108.963 168.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.2 m -154.67 125.08 6.88 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -72.66 121.75 20.3 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 172.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 74.2 mtm -121.53 1.73 10.11 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.168 1.787 . . . . 0.0 110.709 -176.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.43 23.87 67.06 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 118.686 0.675 . . . . 0.0 112.317 -172.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.0 mt -96.2 -174.32 3.05 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.315 1.446 . . . . 0.0 109.43 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -73.7 140.43 78.22 Favored Pre-proline 0 N--CA 1.467 0.393 0 CA-C-O 117.645 -1.169 . . . . 0.0 108.286 170.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -44.29 137.52 7.73 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.216 2.611 . . . . 0.0 112.962 173.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.41 2.32 79.24 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 118.695 -1.058 . . . . 0.0 113.83 176.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -67.12 147.85 52.6 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.911 1.855 . . . . 0.0 108.23 168.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 70.4 mt -124.39 135.92 62.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -172.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.3 mmt-85 -145.26 147.76 32.74 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 118.853 0.751 . . . . 0.0 110.513 176.009 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 42.3 mm -78.05 142.81 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 167.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.7 mt -129.02 136.38 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 119.98 1.264 . . . . 0.0 108.729 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -80.66 141.29 51.83 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 124.536 1.134 . . . . 0.0 109.761 175.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -47.62 -34.35 20.37 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 124.162 3.241 . . . . 0.0 116.216 178.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -66.54 -26.27 67.05 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.528 0.604 . . . . 0.0 111.719 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -101.09 -29.05 12.36 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.541 1.137 . . . . 0.0 111.094 -176.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.405 HD11 ' HB3' ' A' ' 110' ' ' PHE . 24.9 mt -49.34 -41.08 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.317 1.447 . . . . 0.0 110.839 169.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.9 -24.4 15.97 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.138 1.375 . . . . 0.0 113.601 -177.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -113.61 -37.35 4.62 Favored 'General case' 0 C--O 1.228 -0.063 0 C-N-CA 123.304 0.642 . . . . 0.0 110.381 175.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 22.3 mmt -66.89 -31.86 72.74 Favored 'General case' 0 C--N 1.334 -0.096 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -173.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -63.77 -53.02 57.5 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 119.053 0.842 . . . . 0.0 109.869 174.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.3 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -176.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.3 mt . . . . . 0 N--CA 1.466 0.36 0 N-CA-C 118.822 2.897 . . . . 0.0 118.822 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.49 -25.92 39.72 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 120.006 1.276 . . . . 0.0 110.762 166.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -62.03 -29.64 70.42 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.618 0.767 . . . . 0.0 112.171 174.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.2 tt -74.68 -45.86 41.69 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.175 0.898 . . . . 0.0 108.858 174.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 98.5 mt -58.59 -42.14 83.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -178.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.11 -23.88 64.2 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -87.94 -1.77 58.19 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.993 0.917 . . . . 0.0 112.449 178.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -123.63 -34.93 2.98 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.102 0.961 . . . . 0.0 111.789 178.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -60.68 -21.78 63.21 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.859 0.864 . . . . 0.0 113.063 -173.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -72.34 -12.11 60.99 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.079 0.952 . . . . 0.0 112.012 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -136.31 -32.62 0.85 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.265 0.939 . . . . 0.0 113.082 -178.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 15.3 mt -69.6 138.83 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 172.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -65.91 -41.14 95.58 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.111 0.862 . . . . 0.0 112.397 -176.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -145.9 137.57 25.04 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 118.582 1.191 . . . . 0.0 109.113 175.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.5 t -130.22 129.4 65.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.9 mp -130.52 154.12 40.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -174.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.405 ' HB3' HD11 ' A' ' 81' ' ' ILE . 78.5 t80 -133.35 144.5 49.65 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 168.396 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.3 tt -126.32 123.31 37.74 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.641 1.576 . . . . 0.0 106.966 177.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -109.65 155.6 16.01 Favored Glycine 0 C--N 1.334 0.436 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 64.6 mt -133.97 124.19 46.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 -173.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.7 tp60 -61.64 115.94 17.9 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-O 117.547 -1.216 . . . . 0.0 110.619 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -79.12 172.47 14.77 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.308 2.672 . . . . 0.0 111.582 170.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -135.95 -29.2 1.03 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 127.263 2.225 . . . . 0.0 111.317 173.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -132.97 120.42 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 -173.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 64.5 t -143.56 132.62 20.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 153.54 152.39 6.03 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -67.73 150.15 49.04 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.882 0.849 . . . . 0.0 111.441 -173.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 14.2 t80 51.24 41.41 27.86 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.884 2.074 . . . . 0.0 112.101 -173.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.3 m-30 -115.19 142.9 29.29 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 169.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.03 159.44 44.54 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.596 2.197 . . . . 0.0 110.531 171.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.7 ttm -73.98 142.45 45.83 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 168.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 37.3 p -81.71 157.61 24.52 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.367 1.067 . . . . 0.0 110.701 178.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -52.1 -42.6 86.67 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-O 116.52 -1.705 . . . . 0.0 114.697 -178.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.37 -29.07 21.53 Favored 'Trans proline' 0 C--N 1.35 0.628 0 CA-C-N 123.087 2.138 . . . . 0.0 111.878 -176.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.63 -36.11 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -56.52 -46.15 80.74 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.166 0.893 . . . . 0.0 109.986 170.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -64.61 -37.83 88.9 Favored 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 123.302 0.641 . . . . 0.0 111.435 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.25 -47.24 80.39 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 121.933 -0.479 . . . . 0.0 110.706 175.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 61.0 t -62.6 -39.91 86.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 118.643 0.656 . . . . 0.0 109.842 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -60.7 -42.88 98.09 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.136 0.88 . . . . 0.0 110.283 173.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 54.2 m -61.35 -48.76 79.82 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 79.3 t -60.39 -45.97 95.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 118.762 0.71 . . . . 0.0 109.654 179.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.427 ' CE1' ' HE2' ' A' ' 31' ' ' LYS . 19.3 t80 -54.06 -49.7 68.4 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.92 0.888 . . . . 0.0 110.578 177.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -69.83 -26.8 64.4 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.525 -0.734 . . . . 0.0 112.114 178.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -73.48 -24.36 60.18 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.23 -0.919 . . . . 0.0 112.065 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 33.4 mt -61.1 -21.94 64.17 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.393 0.997 . . . . 0.0 113.454 -172.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 . . . . . 0 CA--C 1.54 0.573 0 CA-C-N 119.833 1.197 . . . . 0.0 112.794 176.693 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 . . . . . 0 N--CA 1.452 -0.363 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -89.42 147.08 24.23 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 172.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -93.22 119.91 32.92 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 44.1 tp . . . . . 0 CA--C 1.532 0.267 0 C-N-CA 124.913 1.285 . . . . 0.0 109.797 -179.786 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.5 t0 . . . . . 0 C--O 1.234 0.266 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 53.1 t -124.87 141.1 46.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.624 0.726 . . . . 0.0 109.541 -170.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 34.8 tp -107.42 128.1 54.18 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 168.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 56.5 tp -116.18 97.81 6.27 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 177.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 93.2 m -73.18 142.19 47.38 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 170.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.8 t -140.34 141.58 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 125.31 1.444 . . . . 0.0 107.274 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.74 174.94 18.39 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 123.988 0.804 . . . . 0.0 112.219 175.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -117.13 121.25 40.74 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.94 1.296 . . . . 0.0 108.25 176.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 m -59.39 -14.87 13.55 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.458 1.903 . . . . 0.0 115.524 -169.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -130.0 13.98 5.75 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.983 0.913 . . . . 0.0 111.282 -175.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.9 ttt -97.24 34.42 1.78 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.599 0.636 . . . . 0.0 109.756 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.86 -140.95 22.98 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -177.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -62.77 -15.77 55.04 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.474 1.11 . . . . 0.0 112.279 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -59.4 -16.51 23.56 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.035 1.334 . . . . 0.0 112.669 174.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.64 17.84 1.47 Allowed Glycine 0 CA--C 1.533 1.208 0 O-C-N 120.568 -1.332 . . . . 0.0 114.01 175.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.45 -51.16 68.61 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 119.682 1.741 . . . . 0.0 111.032 -169.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.84 -55.18 31.82 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-O 117.806 -1.552 . . . . 0.0 110.984 175.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -48.96 -40.94 40.63 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 CA-C-N 120.687 2.243 . . . . 0.0 115.298 176.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.9 tp -71.97 -37.84 69.85 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 120.254 1.388 . . . . 0.0 110.443 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.2 tp -62.18 -45.63 92.53 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.899 -0.501 . . . . 0.0 110.315 175.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.43 -40.55 87.13 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 123.894 0.878 . . . . 0.0 111.023 177.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.4 tp10 -60.85 -48.66 80.77 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.792 0.723 . . . . 0.0 109.661 178.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -62.28 -46.69 87.65 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.062 0.545 . . . . 0.0 110.639 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 81.1 m -64.98 -37.89 89.17 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.267 0.485 . . . . 0.0 111.237 179.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.66 -37.83 88.93 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.853 0.751 . . . . 0.0 111.107 176.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.13 -37.95 78.57 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.204 0.602 . . . . 0.0 111.092 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.63 95.81 2.03 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 125.166 1.386 . . . . 0.0 108.489 -173.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -55.78 164.32 4.67 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 123.813 3.009 . . . . 0.0 114.182 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.421 ' HE2' ' CZ ' ' A' ' 136' ' ' TYR . 21.0 mmtt -131.56 167.54 19.22 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.625 1.57 . . . . 0.0 109.058 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 40.08 -116.63 0.75 Allowed Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.048 1.309 . . . . 0.0 111.513 175.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -140.65 28.45 1.98 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.62 1.168 . . . . 0.0 109.843 169.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -73.58 125.66 28.5 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.372 -0.83 . . . . 0.0 109.514 -173.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.9 t -78.14 115.32 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 104.103 -2.555 . . . . 0.0 104.103 166.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.4 t -75.77 136.2 25.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -175.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.9 mm -131.38 145.35 35.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 103.972 -2.603 . . . . 0.0 103.972 169.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -132.85 103.79 6.26 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 178.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.5 -4.54 87.44 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-O 118.855 -0.969 . . . . 0.0 112.743 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 54.71 -143.72 31.75 Favored Glycine 0 C--N 1.34 0.754 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 -169.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.2 p -89.67 6.74 40.04 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.985 -0.714 . . . . 0.0 112.41 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.28 64.59 47.22 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 124.866 1.266 . . . . 0.0 109.749 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -64.51 -16.39 54.94 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.732 2.288 . . . . 0.0 112.505 -177.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -47.71 -42.28 24.72 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.51 1.524 . . . . 0.0 111.164 169.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.26 -24.99 66.67 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.015 0.526 . . . . 0.0 112.342 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.04 -3.8 31.27 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 125.071 1.348 . . . . 0.0 111.821 -169.394 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 84.0 mt -51.2 -41.09 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.866 0.866 . . . . 0.0 110.423 175.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 49.0 t -58.46 -42.04 83.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 118.844 0.747 . . . . 0.0 110.319 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.39 -32.99 73.45 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.212 0.605 . . . . 0.0 111.227 -175.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 58.5 mt -67.33 -50.57 61.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 170.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -66.65 -33.24 75.22 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 118.247 -0.882 . . . . 0.0 112.464 -169.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -62.91 -20.74 65.46 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.979 1.263 . . . . 0.0 112.03 178.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 62.5 mt -86.03 -10.18 55.47 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.391 1.076 . . . . 0.0 113.067 174.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 28.91 61.79 0.75 Allowed Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 127.231 2.212 . . . . 0.0 112.856 -167.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -58.05 150.38 65.21 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.383 2.722 . . . . 0.0 113.549 -169.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.3 m -71.13 -36.27 72.03 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.221 1.009 . . . . 0.0 109.359 168.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 21.3 mtm180 -144.52 162.2 37.17 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.346 1.059 . . . . 0.0 110.199 179.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.5 tp -146.19 134.8 22.16 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 125.256 1.422 . . . . 0.0 107.836 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 37.7 tp -125.78 131.1 52.55 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 173.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.0 mt -115.95 143.2 26.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -175.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.5 t -140.27 134.07 34.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 118.64 0.654 . . . . 0.0 109.91 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -161.7 173.46 14.64 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.275 2.23 . . . . 0.0 107.304 170.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.89 157.78 35.88 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 166.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.3 m -154.6 124.47 6.67 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 176.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -71.57 125.63 27.56 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 172.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 72.9 mtm -127.01 1.96 6.54 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.445 1.898 . . . . 0.0 110.427 -175.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.66 23.74 67.36 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-N 118.693 0.679 . . . . 0.0 112.553 -172.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.2 mt -96.41 -172.47 2.53 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.251 1.421 . . . . 0.0 109.41 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -76.02 139.33 69.18 Favored Pre-proline 0 N--CA 1.468 0.426 0 CA-C-O 117.669 -1.158 . . . . 0.0 108.338 171.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -43.38 137.5 5.41 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.411 2.741 . . . . 0.0 113.131 172.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.93 2.11 81.0 Favored Glycine 0 CA--C 1.534 1.234 0 CA-C-O 118.528 -1.151 . . . . 0.0 113.739 176.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -66.57 144.16 56.6 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 119.909 1.855 . . . . 0.0 107.786 168.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 51.8 mt -121.05 140.71 44.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 -174.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 90.3 mmt-85 -148.4 147.67 29.46 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 118.522 0.601 . . . . 0.0 112.131 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 50.6 mm -77.94 143.28 13.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 164.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.6 mt -128.57 123.84 60.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 176.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -75.16 139.89 72.83 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-O 117.739 -1.124 . . . . 0.0 109.433 175.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_exo -46.75 -36.39 19.33 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 124.235 3.29 . . . . 0.0 116.609 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -69.32 -25.83 64.42 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 118.532 0.605 . . . . 0.0 111.38 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -93.35 -34.46 13.48 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.87 1.268 . . . . 0.0 110.985 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 71.6 mt -48.78 -46.48 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.901 1.28 . . . . 0.0 108.956 169.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.46 -19.54 37.63 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.609 1.164 . . . . 0.0 114.002 -174.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -115.01 -25.34 8.18 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.469 0.708 . . . . 0.0 110.867 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 22.7 mmt -80.5 -36.68 32.98 Favored 'General case' 0 C--O 1.231 0.079 0 CA-C-N 118.238 0.472 . . . . 0.0 112.005 -178.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.64 -37.7 88.48 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 118.906 0.775 . . . . 0.0 112.584 -169.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.6 ppp? . . . . . 0 CA--C 1.538 0.482 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 178.965 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.2 mt . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 117.435 2.383 . . . . 0.0 117.435 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.73 -20.04 4.99 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.333 -0.854 . . . . 0.0 112.554 167.363 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -58.88 -31.3 68.45 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.517 1.053 . . . . 0.0 111.71 174.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.4 tt -72.95 -45.95 55.2 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 174.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 83.8 mt -58.84 -39.48 77.43 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 123.196 0.599 . . . . 0.0 109.881 -177.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -58.33 -24.72 60.58 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.677 0.671 . . . . 0.0 112.805 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -89.79 -6.71 55.68 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.231 1.012 . . . . 0.0 112.086 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -118.63 -28.15 5.72 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.252 1.021 . . . . 0.0 111.703 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -63.46 -24.18 67.72 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 119.379 0.991 . . . . 0.0 112.403 -175.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -79.27 -4.78 52.33 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.47 1.108 . . . . 0.0 111.843 176.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -134.33 -1.81 2.85 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.33 1.452 . . . . 0.0 112.688 -168.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 20.0 mt -137.29 145.41 29.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 126.094 1.758 . . . . 0.0 107.15 -173.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -71.46 -37.68 62.41 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-O 119.236 -0.758 . . . . 0.0 112.45 -174.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -146.75 135.37 22.09 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.56 1.18 . . . . 0.0 108.076 174.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.2 t -124.68 132.62 71.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 175.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 5.4 mt -133.49 152.29 34.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 -168.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -130.43 142.02 50.51 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 169.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.8 tt -124.31 129.05 50.05 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 174.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -112.88 156.46 15.59 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 77.6 mt -132.75 123.71 49.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -178.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -60.63 115.94 15.95 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-O 117.43 -1.271 . . . . 0.0 110.439 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -76.05 171.53 17.97 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.59 2.86 . . . . 0.0 111.416 170.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -127.96 -32.45 2.31 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.976 1.71 . . . . 0.0 110.932 171.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.69 137.03 47.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.296 1.038 . . . . 0.0 108.333 176.199 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 90.1 t -141.41 134.93 30.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 175.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 159.21 150.93 5.96 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -65.29 152.55 43.47 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.865 0.84 . . . . 0.0 111.308 -175.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 54.87 38.96 31.21 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.852 2.061 . . . . 0.0 112.09 -177.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -123.14 148.41 54.53 Favored Pre-proline 0 C--O 1.237 0.399 0 C-N-CA 123.987 0.915 . . . . 0.0 109.794 172.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.99 162.5 20.67 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.164 2.576 . . . . 0.0 111.13 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 52.5 ttm -71.43 138.91 49.45 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 168.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 67.4 p -79.85 159.51 26.43 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.285 1.034 . . . . 0.0 110.496 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 21.8 tp60 -53.03 -44.8 97.93 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 116.565 -1.683 . . . . 0.0 114.101 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -68.63 -30.53 28.09 Favored 'Trans proline' 0 C--N 1.351 0.695 0 CA-C-N 122.912 2.076 . . . . 0.0 112.144 -176.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.6 mp -80.05 -35.61 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 118.971 0.805 . . . . 0.0 108.889 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -56.26 -46.56 79.62 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.354 0.979 . . . . 0.0 109.941 170.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -63.92 -38.58 91.6 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.024 0.53 . . . . 0.0 111.319 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.9 -46.19 82.75 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 119.097 -0.478 . . . . 0.0 111.164 175.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 71.8 t -62.68 -39.5 84.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 118.994 0.816 . . . . 0.0 109.658 178.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -62.35 -42.46 99.41 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.191 0.905 . . . . 0.0 110.508 173.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 59.0 m -61.48 -49.4 76.93 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 72.7 t -60.09 -44.25 94.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 123.539 0.736 . . . . 0.0 109.642 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.421 ' CZ ' ' HE2' ' A' ' 31' ' ' LYS . 43.1 t80 -55.96 -48.59 75.53 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.184 0.594 . . . . 0.0 110.631 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 60.0 mm-40 -64.89 -39.09 93.0 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.038 0.836 . . . . 0.0 110.903 176.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -62.3 -29.42 70.42 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 118.732 -0.651 . . . . 0.0 112.263 -177.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 76.8 mt -57.52 -21.78 40.19 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.11 0.868 . . . . 0.0 112.389 177.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 . . . . . 0 CA--C 1.544 0.714 0 CA-C-N 119.105 0.866 . . . . 0.0 112.21 179.278 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 . . . . . 0 N--CA 1.452 -0.342 0 CA-C-O 121.761 0.791 . . . . 0.0 109.794 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.28 144.68 30.45 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 172.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -81.42 123.97 29.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 170.243 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 67.0 tp . . . . . 0 C--O 1.234 0.258 0 C-N-CA 124.004 0.922 . . . . 0.0 109.914 176.731 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 53.4 t0 . . . . . 0 C--O 1.235 0.315 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.41 HG23 HD13 ' A' ' 58' ' ' LEU . 1.4 m -108.76 146.48 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 123.977 0.911 . . . . 0.0 109.78 -169.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 54.7 tp -119.47 104.35 10.25 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 179.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.3 tp -93.71 97.61 10.56 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 98.5 m -72.89 140.83 47.79 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 169.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.5 t -141.0 141.84 30.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 125.063 1.345 . . . . 0.0 107.768 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.59 176.68 19.72 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.248 0.928 . . . . 0.0 111.862 176.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -118.84 121.55 40.28 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.737 1.215 . . . . 0.0 108.253 176.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -59.97 -14.67 17.06 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.65 1.98 . . . . 0.0 115.469 -169.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.8 ptt? -126.91 13.53 7.35 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.115 0.966 . . . . 0.0 111.065 -177.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 27.0 ttt -97.68 33.54 2.04 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.038 0.835 . . . . 0.0 110.25 -177.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.46 -139.71 21.96 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -178.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -63.26 -15.47 57.25 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.251 1.02 . . . . 0.0 111.977 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -59.79 -16.61 29.31 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.933 1.293 . . . . 0.0 112.651 174.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.1 17.63 1.32 Allowed Glycine 0 CA--C 1.534 1.221 0 O-C-N 120.562 -1.336 . . . . 0.0 114.015 175.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.83 -53.3 59.58 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 119.562 1.681 . . . . 0.0 111.096 -169.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.83 -55.04 32.03 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-O 117.812 -1.549 . . . . 0.0 111.152 176.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -49.44 -39.63 44.7 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 CA-C-N 120.787 2.294 . . . . 0.0 115.381 177.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.8 tp -71.18 -38.86 72.11 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 120.083 1.311 . . . . 0.0 110.394 177.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 52.5 tp -61.21 -47.58 85.46 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 122.002 -0.436 . . . . 0.0 110.277 175.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.71 -41.04 85.4 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.862 0.865 . . . . 0.0 111.082 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -60.94 -48.52 81.42 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 118.858 0.753 . . . . 0.0 109.963 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -61.47 -47.15 87.02 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 122.907 0.483 . . . . 0.0 110.668 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 75.7 m -63.88 -40.69 97.12 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.209 0.459 . . . . 0.0 110.938 179.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.8 -39.63 94.72 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.383 0.538 . . . . 0.0 111.094 178.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.18 -35.9 76.76 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.374 0.669 . . . . 0.0 111.457 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.23 95.71 2.11 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 125.086 1.354 . . . . 0.0 108.296 -172.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -55.45 165.53 3.19 Favored 'Trans proline' 0 CA--C 1.537 0.625 0 C-N-CA 123.674 2.916 . . . . 0.0 114.445 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.443 ' HE2' ' CZ ' ' A' ' 136' ' ' TYR . 68.5 mmtt -133.3 170.77 14.96 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 126.327 1.851 . . . . 0.0 108.215 176.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 38.16 -121.93 1.1 Allowed Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.366 1.46 . . . . 0.0 112.307 177.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -140.22 38.21 1.92 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.242 1.417 . . . . 0.0 108.763 169.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -71.59 160.93 31.82 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.912 0.885 . . . . 0.0 111.565 -172.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 98.8 t -115.12 99.26 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 167.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.8 t -68.17 138.3 22.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -178.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 87.7 mt -136.23 141.16 42.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 172.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -125.64 104.36 8.34 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 177.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.22 -4.02 83.02 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.939 -0.923 . . . . 0.0 112.835 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 54.61 -143.8 31.2 Favored Glycine 0 C--N 1.341 0.82 0 N-CA-C 108.427 -1.869 . . . . 0.0 108.427 -169.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.0 p -91.46 10.98 25.47 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 122.064 -0.668 . . . . 0.0 111.891 177.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.52 58.57 21.02 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 125.352 1.461 . . . . 0.0 110.131 -177.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -70.24 -15.44 35.29 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.61 2.207 . . . . 0.0 113.784 -169.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -55.89 -32.07 63.4 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.22 0.918 . . . . 0.0 111.877 174.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.17 -28.59 68.05 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.284 0.634 . . . . 0.0 112.036 177.242 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -96.45 -3.29 43.71 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.386 1.075 . . . . 0.0 111.607 -170.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 90.0 mt -54.72 -41.74 57.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 118.898 0.772 . . . . 0.0 109.386 173.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.0 t -61.79 -41.7 91.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 O-C-N 121.869 -0.519 . . . . 0.0 110.063 178.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.38 -44.88 86.18 Favored 'General case' 0 N--CA 1.457 -0.1 0 O-C-N 121.972 -0.455 . . . . 0.0 110.512 -178.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 80.8 mt -57.11 -47.89 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.787 0.835 . . . . 0.0 109.237 173.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -60.58 -34.65 74.5 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 118.131 -0.938 . . . . 0.0 112.048 -174.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -57.82 -31.24 66.41 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.481 1.037 . . . . 0.0 111.638 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 70.1 mt -86.26 -12.18 50.29 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.319 1.048 . . . . 0.0 112.339 -174.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 30.53 60.09 0.98 Allowed Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 126.512 1.925 . . . . 0.0 112.57 -168.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -56.78 154.79 30.05 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.923 2.416 . . . . 0.0 114.766 -170.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.7 m -74.83 -37.28 62.32 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.401 1.08 . . . . 0.0 109.874 169.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 36.2 mtm180 -144.03 159.66 42.21 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.355 1.062 . . . . 0.0 109.872 -177.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.41 HD13 HG23 ' A' ' 4' ' ' VAL . 30.8 tp -147.38 141.81 26.41 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.748 1.219 . . . . 0.0 108.472 176.125 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.5 123.59 26.89 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 177.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.4 mm -98.79 144.4 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 175.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.9 t -137.56 132.9 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 119.093 0.86 . . . . 0.0 110.0 175.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -160.91 173.5 15.21 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.35 2.26 . . . . 0.0 107.222 169.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.09 157.34 37.04 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.071 -1.018 . . . . 0.0 109.181 168.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.9 m -156.23 127.15 6.89 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 176.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -71.55 124.55 24.92 Favored 'General case' 0 C--O 1.231 0.096 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 172.028 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 76.2 mtm -122.15 0.8 9.66 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.805 1.642 . . . . 0.0 111.058 -176.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.03 34.22 88.25 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 119.162 0.892 . . . . 0.0 111.5 -171.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.5 mt -109.53 -176.66 3.07 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.405 1.482 . . . . 0.0 109.676 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -70.34 141.22 88.24 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-O 117.988 -1.006 . . . . 0.0 108.832 170.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -42.99 138.12 4.15 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.53 2.82 . . . . 0.0 113.453 172.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.41 3.14 70.23 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-O 118.733 -1.037 . . . . 0.0 113.451 175.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -66.25 148.6 51.6 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 120.101 1.951 . . . . 0.0 108.335 168.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 65.3 mt -124.44 134.5 66.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 -172.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.1 mmt-85 -143.16 151.08 40.26 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.934 0.788 . . . . 0.0 109.747 173.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 50.7 mm -79.11 145.53 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 169.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.1 mt -132.81 163.42 37.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 124.612 1.165 . . . . 0.0 107.89 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -133.07 144.93 54.83 Favored Pre-proline 0 C--O 1.236 0.345 0 C-N-CA 126.868 2.067 . . . . 0.0 107.617 -170.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -54.81 -27.04 50.81 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 123.24 2.626 . . . . 0.0 115.141 -173.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -66.76 -20.58 65.98 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.006 0.821 . . . . 0.0 112.249 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -119.25 -31.1 4.77 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.794 1.238 . . . . 0.0 111.875 -171.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 79.7 mt -50.77 -40.58 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.09 1.356 . . . . 0.0 109.869 170.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.02 -25.59 31.38 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.7 1.2 . . . . 0.0 113.446 -176.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -111.35 -35.66 5.78 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.362 0.665 . . . . 0.0 110.215 177.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 22.1 mmt -67.1 -29.71 69.53 Favored 'General case' 0 C--N 1.334 -0.1 0 O-C-N 121.757 -0.589 . . . . 0.0 112.412 -178.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -71.72 -42.67 67.05 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 119.095 0.861 . . . . 0.0 111.598 177.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 19.0 ptp . . . . . 0 CA--C 1.537 0.451 0 CA-C-N 119.134 0.879 . . . . 0.0 113.01 -179.666 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.471 0.585 0 N-CA-C 117.782 2.512 . . . . 0.0 117.782 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -52.8 -22.02 4.86 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.979 0.911 . . . . 0.0 112.957 168.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -56.86 -32.37 65.74 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 119.402 1.001 . . . . 0.0 111.664 176.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.5 tt -73.23 -44.32 59.75 Favored 'General case' 0 C--N 1.339 0.118 0 O-C-N 121.845 -0.535 . . . . 0.0 109.58 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 98.0 mt -60.31 -45.4 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -64.32 -21.25 66.55 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -175.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -88.17 1.58 54.08 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.245 1.018 . . . . 0.0 112.425 177.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 79.1 mt -135.52 -33.3 0.88 Allowed 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.042 0.937 . . . . 0.0 112.128 -171.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -59.85 -20.63 58.15 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.471 1.108 . . . . 0.0 112.676 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -68.2 -17.2 64.26 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.45 1.1 . . . . 0.0 111.813 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -136.51 -31.18 0.88 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.066 0.848 . . . . 0.0 113.12 -177.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 30.4 mt -69.65 140.89 17.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 172.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -62.58 -42.56 99.68 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 124.105 0.86 . . . . 0.0 112.218 -177.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -149.5 142.28 24.64 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.742 1.271 . . . . 0.0 109.221 175.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 43.5 t -134.06 121.36 38.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 21.5 mt -127.91 154.45 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 C-N-CA 125.094 1.358 . . . . 0.0 107.914 -171.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -125.04 145.14 50.05 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 174.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.7 tt -125.12 128.0 47.75 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 171.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -113.35 155.44 16.3 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 73.9 mt -131.98 126.92 57.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 -178.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.8 tp60 -61.36 114.87 12.07 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-O 117.282 -1.342 . . . . 0.0 110.062 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -76.31 170.28 20.3 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.917 2.412 . . . . 0.0 111.041 170.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -130.04 -32.06 1.86 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.924 1.69 . . . . 0.0 111.014 172.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -135.43 136.04 51.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 175.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 90.9 t -141.55 134.87 30.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 175.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 158.83 149.04 5.39 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -68.67 157.5 36.1 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 122.065 0.936 . . . . 0.0 111.353 -173.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 14.1 t80 48.88 41.38 18.47 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.769 2.028 . . . . 0.0 112.391 -172.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -123.73 148.39 56.2 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 124.067 0.947 . . . . 0.0 109.759 170.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -81.44 160.88 19.75 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.053 2.502 . . . . 0.0 111.157 177.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 52.0 ttm -70.05 138.22 51.92 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 168.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 68.7 p -78.06 158.98 28.98 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 123.967 0.907 . . . . 0.0 110.459 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -52.84 -44.46 96.24 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-O 116.629 -1.653 . . . . 0.0 114.211 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -68.22 -31.86 28.15 Favored 'Trans proline' 0 C--N 1.351 0.702 0 CA-C-N 122.906 2.074 . . . . 0.0 112.065 -176.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.92 -33.91 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 119.074 0.852 . . . . 0.0 108.872 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -56.89 -46.63 81.76 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.477 1.035 . . . . 0.0 110.059 169.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -63.65 -37.01 85.73 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 122.977 0.511 . . . . 0.0 111.228 178.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.56 -49.31 73.94 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 119.172 -0.442 . . . . 0.0 110.895 175.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 75.8 t -61.46 -38.37 79.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 118.743 0.701 . . . . 0.0 109.837 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -61.61 -43.24 99.22 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.09 0.859 . . . . 0.0 110.486 173.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 29.2 m -63.31 -43.46 97.78 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.602 -0.687 . . . . 0.0 110.331 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 78.2 t -62.01 -45.71 98.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 123.3 0.64 . . . . 0.0 109.406 176.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.443 ' CZ ' ' HE2' ' A' ' 31' ' ' LYS . 48.7 t80 -56.68 -48.06 78.47 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.788 0.835 . . . . 0.0 110.624 178.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -66.62 -26.85 67.28 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.589 -0.695 . . . . 0.0 112.17 178.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -68.0 -23.54 65.02 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 119.203 0.91 . . . . 0.0 112.694 176.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.44 -24.25 66.41 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -169.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 . . . . . 0 CA--C 1.541 0.601 0 CA-C-N 119.649 1.113 . . . . 0.0 112.966 178.103 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 . . . . . 0 C--O 1.237 0.413 0 CA-C-O 121.889 0.852 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -76.22 155.75 34.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.325 176.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -97.56 121.78 39.86 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.789 1.236 . . . . 0.0 107.756 -178.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 52.3 tp . . . . . 0 CA--C 1.533 0.322 0 C-N-CA 125.564 1.546 . . . . 0.0 110.044 179.672 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 mmt . . . . . 0 N--CA 1.484 1.26 0 CA-C-O 118.872 -0.585 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.4 m -140.91 147.96 39.69 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -177.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -142.02 124.85 16.04 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -177.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.9 m -112.63 152.66 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 124.487 1.115 . . . . 0.0 109.891 -169.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 23.8 tp -125.29 107.45 10.73 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 177.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 62.5 tp -96.71 95.68 8.09 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 81.8 m -69.66 142.44 53.41 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 168.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.6 t -140.63 143.29 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 146.12 175.94 19.56 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.561 -1.015 . . . . 0.0 110.561 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -125.61 120.9 32.05 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.29 1.436 . . . . 0.0 107.813 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -59.59 -15.18 16.86 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.111 1.764 . . . . 0.0 115.377 -169.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -127.43 13.59 7.08 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.942 0.897 . . . . 0.0 111.119 -176.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.8 ttt -98.34 29.03 3.76 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.28 0.632 . . . . 0.0 109.771 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.23 -146.9 21.3 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 -177.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -58.34 -18.69 29.35 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 126.019 1.727 . . . . 0.0 112.171 175.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -51.97 -25.42 8.25 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.991 1.316 . . . . 0.0 112.645 173.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.13 24.01 0.56 Allowed Glycine 0 CA--C 1.534 1.278 0 CA-C-O 118.602 -1.11 . . . . 0.0 114.554 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.95 -52.25 63.75 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 119.559 1.68 . . . . 0.0 110.611 -171.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.41 -54.66 35.95 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 117.803 -1.554 . . . . 0.0 111.165 176.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -50.15 -40.16 51.26 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 CA-C-N 120.911 2.356 . . . . 0.0 114.99 177.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 62.9 tp -70.6 -39.88 73.54 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 119.89 1.223 . . . . 0.0 110.201 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.0 tp -61.29 -46.77 88.95 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 117.932 0.333 . . . . 0.0 110.346 175.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.67 -42.2 87.92 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.412 1.085 . . . . 0.0 110.939 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -60.81 -49.06 78.99 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 118.499 0.59 . . . . 0.0 109.778 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -62.87 -48.01 80.88 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.104 0.561 . . . . 0.0 110.749 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 89.2 m -63.75 -39.61 94.7 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.641 0.655 . . . . 0.0 111.437 177.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.45 -40.04 96.08 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.144 0.884 . . . . 0.0 110.871 177.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.35 -33.52 74.44 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.372 0.669 . . . . 0.0 111.773 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.79 92.08 2.45 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 124.861 1.264 . . . . 0.0 108.94 -171.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -51.73 161.91 1.93 Allowed 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 124.064 3.176 . . . . 0.0 114.795 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -140.25 157.21 45.94 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 126.256 1.822 . . . . 0.0 106.978 176.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 34.48 30.25 0.01 OUTLIER Glycine 0 CA--C 1.536 1.347 0 C-N-CA 128.332 2.872 . . . . 0.0 118.213 168.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 43.07 35.41 0.78 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.128 1.771 . . . . 0.0 112.837 -169.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -70.69 128.63 36.74 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 120.828 -1.17 . . . . 0.0 108.103 175.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.4 t -78.04 87.66 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 105.231 -2.137 . . . . 0.0 105.231 168.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.9 p -64.48 138.92 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 96.0 mt -137.95 144.94 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 103.454 -2.795 . . . . 0.0 103.454 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -126.85 109.02 11.54 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -66.08 -16.79 64.85 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 124.899 1.237 . . . . 0.0 113.394 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 57.0 39.85 90.24 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 119.303 1.551 . . . . 0.0 113.643 170.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . 0.258 78.3 p 62.73 12.36 5.58 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.698 2.399 . . . . 0.0 114.689 -175.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.86 59.7 13.97 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 125.447 1.499 . . . . 0.0 108.423 170.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -66.88 -19.31 52.64 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.832 2.355 . . . . 0.0 113.279 -168.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -58.02 -30.49 66.16 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.707 0.685 . . . . 0.0 112.334 177.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.43 -30.61 68.61 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.183 0.593 . . . . 0.0 111.931 175.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -94.32 -4.88 47.86 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.087 0.955 . . . . 0.0 111.501 -170.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.5 mt -54.22 -42.66 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 118.977 0.808 . . . . 0.0 109.167 173.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.7 t -62.44 -42.08 94.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 118.273 0.488 . . . . 0.0 109.99 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.24 -44.89 86.73 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.925 -0.485 . . . . 0.0 110.613 -177.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 78.2 mt -57.91 -48.04 84.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.823 0.849 . . . . 0.0 108.997 173.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -60.15 -35.3 75.0 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 118.097 -0.954 . . . . 0.0 111.994 -175.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -57.4 -31.9 66.29 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.544 1.065 . . . . 0.0 111.513 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 73.2 mt -86.12 -11.86 51.53 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.986 0.914 . . . . 0.0 112.544 -175.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 30.36 60.59 0.96 Allowed Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 126.43 1.892 . . . . 0.0 112.465 -168.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -56.52 151.65 44.83 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.977 2.451 . . . . 0.0 114.328 -169.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.1 m -69.11 -39.69 78.79 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.78 1.232 . . . . 0.0 109.642 169.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 58.2 mtm180 -144.69 166.11 26.13 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.061 0.944 . . . . 0.0 110.136 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.6 tp -145.01 141.66 29.12 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 125.312 1.445 . . . . 0.0 108.071 175.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 39.2 tp -128.15 135.43 49.75 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 173.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.4 mt -123.34 141.81 42.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 -176.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.3 t -140.51 132.83 31.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 118.566 0.621 . . . . 0.0 109.766 -173.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -162.78 173.8 13.31 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.075 2.15 . . . . 0.0 107.443 176.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.24 158.31 36.1 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 167.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 m -154.65 128.22 8.59 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 175.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -72.4 123.42 23.02 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 172.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 73.6 mtm -124.57 1.1 8.25 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.828 1.651 . . . . 0.0 110.957 -175.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.3 24.68 67.65 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-N 118.618 0.644 . . . . 0.0 112.368 -172.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.4 mt -95.85 -173.19 2.78 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.229 1.412 . . . . 0.0 109.417 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -74.84 141.23 75.1 Favored Pre-proline 0 N--CA 1.468 0.44 0 CA-C-O 117.551 -1.214 . . . . 0.0 108.338 170.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -43.44 136.74 5.94 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.202 2.602 . . . . 0.0 113.223 173.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.7 1.55 72.37 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-O 118.646 -1.085 . . . . 0.0 113.375 176.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -64.62 149.25 49.27 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 120.182 1.991 . . . . 0.0 108.307 168.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 91.5 mt -121.51 142.01 39.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 -172.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 83.9 mmt-85 -148.35 149.77 32.39 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 118.387 0.539 . . . . 0.0 111.362 169.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 49.0 mm -77.75 144.0 12.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 166.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.43 165.09 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -137.5 145.64 50.11 Favored Pre-proline 0 C--O 1.235 0.332 0 C-N-CA 126.747 2.019 . . . . 0.0 107.453 -170.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -53.64 -27.1 40.36 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.313 2.675 . . . . 0.0 115.398 -174.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -66.37 -21.69 66.24 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.032 0.833 . . . . 0.0 112.324 177.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -119.31 -29.73 5.1 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.912 1.285 . . . . 0.0 111.921 -171.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.1 mt -51.16 -38.81 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.325 1.45 . . . . 0.0 109.777 169.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.7 -29.01 61.96 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.272 1.029 . . . . 0.0 113.078 -177.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -99.32 -45.23 5.93 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 176.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 22.0 mmt -69.07 -29.31 67.41 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -168.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -70.99 -41.51 70.86 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-N 119.414 1.006 . . . . 0.0 111.393 175.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -81.15 10.0 6.0 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.791 0.723 . . . . 0.0 112.228 175.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 50.5 tpp -61.71 -25.31 67.34 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.516 1.053 . . . . 0.0 109.648 167.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 74.2 p -61.28 -8.19 3.57 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.71 2.004 . . . . 0.0 112.729 169.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.6 m 65.87 9.2 5.89 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.157 2.183 . . . . 0.0 112.095 -172.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 51.5 p-80 -155.31 -26.61 0.11 Allowed 'General case' 0 C--N 1.349 0.583 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -65.0 146.16 55.39 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 120.784 1.629 . . . . 0.0 109.885 -174.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 40.7 tpp -57.45 138.31 81.37 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 173.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -74.19 81.72 1.94 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.977 3.118 . . . . 0.0 109.197 178.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.9 mt -49.63 -9.56 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 117.528 2.418 . . . . 0.0 117.528 -168.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.44 -23.39 9.85 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.354 0.979 . . . . 0.0 112.504 168.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -57.77 -39.67 77.99 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 119.271 0.941 . . . . 0.0 110.844 176.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.4 tt -70.15 -43.93 69.9 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 123.41 0.684 . . . . 0.0 109.622 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 95.4 mt -57.74 -41.66 80.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -63.98 -18.26 64.11 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 56.2 mm-40 -83.12 -5.43 59.11 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.941 0.792 . . . . 0.0 112.095 175.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 90.0 mt -132.89 -35.19 1.09 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.933 0.893 . . . . 0.0 112.274 -168.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 12.0 pttm -62.16 -19.76 63.41 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.413 1.085 . . . . 0.0 112.805 -176.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -72.56 -12.99 61.29 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.28 1.032 . . . . 0.0 111.805 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -136.23 -32.72 0.85 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.249 0.931 . . . . 0.0 113.014 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 22.9 mt -68.16 139.64 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 170.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.61 -37.5 92.57 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.097 0.856 . . . . 0.0 112.561 -176.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -149.45 136.66 19.87 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 118.429 1.114 . . . . 0.0 108.505 175.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 56.9 t -123.45 129.78 74.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 175.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.2 mt -129.78 152.0 36.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 -168.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -134.33 146.45 49.98 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 176.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.9 tt -127.19 130.98 50.73 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 170.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -113.23 157.51 14.9 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 175.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 68.0 mt -134.53 128.37 51.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -61.85 115.52 15.98 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-O 117.635 -1.174 . . . . 0.0 110.014 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -78.89 172.42 15.03 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.562 2.175 . . . . 0.0 111.249 170.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -136.54 -31.16 0.88 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 127.533 2.333 . . . . 0.0 110.978 173.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -127.25 122.41 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 -176.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 94.0 t -144.94 132.98 16.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 152.79 150.35 5.38 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -65.7 150.3 48.71 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.137 0.968 . . . . 0.0 110.838 -177.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 18.2 t80 56.29 47.2 19.68 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.595 1.958 . . . . 0.0 111.955 -174.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -130.6 141.65 42.71 Favored Pre-proline 0 C--O 1.236 0.362 0 C-N-CA 123.935 0.894 . . . . 0.0 109.199 168.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -75.84 164.52 31.68 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.909 2.406 . . . . 0.0 110.358 170.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 49.5 ttm -72.63 140.98 48.31 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 168.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 38.3 p -78.53 157.53 28.8 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.414 1.086 . . . . 0.0 110.497 176.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.1 tm0? -49.77 -46.63 80.26 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-O 117.089 -1.434 . . . . 0.0 114.034 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -68.59 -29.27 30.43 Favored 'Trans proline' 0 C--N 1.351 0.695 0 CA-C-N 122.62 1.971 . . . . 0.0 112.163 -174.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 mp -79.63 -35.14 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -56.62 -46.68 80.81 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.39 0.996 . . . . 0.0 109.956 170.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -62.19 -38.28 88.53 Favored 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 123.108 0.563 . . . . 0.0 111.402 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.83 -48.55 76.34 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 122.045 -0.409 . . . . 0.0 111.045 176.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 79.8 t -61.27 -40.58 86.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -60.87 -42.78 98.58 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.919 0.781 . . . . 0.0 110.364 174.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 46.6 m -62.35 -45.13 94.58 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.351 0.523 . . . . 0.0 110.129 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 84.7 t -62.47 -48.16 89.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 118.644 0.657 . . . . 0.0 109.3 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -53.95 -45.77 71.4 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.127 0.971 . . . . 0.0 111.197 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 68.3 mm-40 -68.4 -34.43 76.01 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.399 0.545 . . . . 0.0 111.777 177.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.18 -33.38 75.63 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.755 0.707 . . . . 0.0 111.346 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 38.0 mt -55.18 -24.19 25.55 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -168.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -83.72 -5.74 59.26 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 120.515 1.507 . . . . 0.0 113.605 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -143.77 18.46 2.19 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.12 1.343 . . . . 0.0 112.166 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 4.3 t-105 -62.46 -37.66 86.77 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.892 1.677 . . . . 0.0 112.067 -174.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 67.78 -48.67 0.52 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 128.554 2.741 . . . . 0.0 114.895 174.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -160.84 -41.78 0.02 OUTLIER Glycine 0 CA--C 1.523 0.577 0 CA-C-O 118.815 -0.992 . . . . 0.0 112.025 -178.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -143.59 7.95 1.52 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 118.72 1.26 . . . . 0.0 113.368 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 61.41 15.2 44.83 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-O 119.038 -0.868 . . . . 0.0 114.498 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 65.09 7.85 33.06 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-N 118.8 1.3 . . . . 0.0 113.604 -175.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -69.23 141.6 54.41 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 119.367 1.584 . . . . 0.0 109.123 177.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -64.44 154.43 35.75 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.087 0.955 . . . . 0.0 109.509 177.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -105.45 122.8 46.75 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 -175.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 60.4 tp -56.94 118.59 5.11 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.301 1.44 . . . . 0.0 109.822 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.57 38.96 0.87 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.757 0.423 . . . . 0.0 111.173 -175.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 6.8 t 57.88 17.4 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 125.289 1.436 . . . . 0.0 110.839 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 47.18 40.77 10.67 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 128.193 2.597 . . . . 0.0 113.082 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -142.58 169.11 18.19 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.381 1.472 . . . . 0.0 109.394 175.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 . . . . . 0 C--O 1.25 1.113 0 C-N-CA 125.697 1.599 . . . . 0.0 106.931 179.514 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.8 mtt . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.3 m -146.04 154.19 41.58 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -131.81 144.84 51.21 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 176.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.8 t -141.15 145.71 24.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 118.982 0.81 . . . . 0.0 109.708 -167.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 36.5 tp -118.14 126.21 51.77 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 174.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.4 tp -113.43 101.62 9.55 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 176.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 95.3 m -76.73 142.52 40.43 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 169.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.2 t -139.92 142.56 31.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 125.112 1.365 . . . . 0.0 107.46 177.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 144.21 177.42 19.08 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.418 1.008 . . . . 0.0 112.046 176.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -125.45 122.39 36.53 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.302 1.441 . . . . 0.0 108.256 176.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 m -59.72 -17.01 31.37 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.306 1.842 . . . . 0.0 115.417 -169.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 27.4 ptm -126.13 15.81 7.86 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.091 0.956 . . . . 0.0 111.034 -175.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 11.8 tpt -94.93 25.99 3.85 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.657 1.183 . . . . 0.0 108.955 175.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.82 -142.56 23.59 Favored Glycine 0 C--N 1.338 0.642 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -61.72 -16.89 53.08 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.706 1.202 . . . . 0.0 112.552 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -53.1 -26.66 17.15 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.346 1.458 . . . . 0.0 112.819 175.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.62 25.47 0.62 Allowed Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.548 -1.14 . . . . 0.0 114.369 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.1 -48.08 80.1 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 119.461 1.631 . . . . 0.0 110.079 -171.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.28 -58.09 16.26 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-O 117.627 -1.652 . . . . 0.0 111.19 174.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -48.75 -41.07 38.94 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 CA-C-N 121.035 2.417 . . . . 0.0 115.735 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.3 tp -70.83 -39.4 73.02 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 120.209 1.368 . . . . 0.0 110.332 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.2 tp -61.56 -46.07 91.48 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.563 0.345 . . . . 0.0 110.342 176.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.09 -41.87 89.1 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.279 1.032 . . . . 0.0 111.033 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -60.86 -49.49 77.25 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 118.706 0.685 . . . . 0.0 109.784 178.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -62.66 -46.2 89.29 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.963 0.505 . . . . 0.0 110.849 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 79.1 m -68.04 -34.53 76.64 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.336 0.516 . . . . 0.0 111.265 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.36 -40.08 93.13 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.416 1.007 . . . . 0.0 110.736 174.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.43 -33.0 73.43 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.329 0.652 . . . . 0.0 111.723 178.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -151.3 89.27 4.24 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 125.315 1.446 . . . . 0.0 108.809 -174.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -53.29 151.09 23.68 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 123.634 2.889 . . . . 0.0 112.795 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.528 ' HE2' ' CE1' ' A' ' 136' ' ' TYR . 32.5 mmtt -127.28 163.96 22.78 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.723 1.209 . . . . 0.0 109.637 -178.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 40.16 -115.58 0.63 Allowed Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.253 1.406 . . . . 0.0 111.865 175.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -134.03 9.71 3.84 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.841 1.257 . . . . 0.0 111.107 174.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 2.8 m95 -71.26 121.58 18.69 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 121.316 -0.865 . . . . 0.0 110.149 -169.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.7 t -72.23 119.65 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 104.362 -2.458 . . . . 0.0 104.362 166.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 36.5 t -76.29 135.13 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 -178.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 62.8 mt -132.48 144.34 37.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 169.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -129.73 110.21 11.58 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.038 -1.468 . . . . 0.0 107.038 174.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.7 -2.1 90.41 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 119.08 -0.844 . . . . 0.0 112.463 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 56.51 -145.89 34.85 Favored Glycine 0 C--N 1.34 0.762 0 N-CA-C 108.357 -1.897 . . . . 0.0 108.357 -169.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.1 p -88.67 10.61 20.07 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.944 -0.739 . . . . 0.0 111.8 176.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.3 57.9 15.89 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 125.07 1.348 . . . . 0.0 110.664 -175.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -70.08 -21.84 31.45 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.899 2.399 . . . . 0.0 113.158 -172.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.51 -35.92 79.08 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.109 0.868 . . . . 0.0 112.174 -176.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -65.99 -10.3 38.18 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.744 0.818 . . . . 0.0 112.919 175.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -116.03 0.17 12.94 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.259 1.024 . . . . 0.0 112.427 -171.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 81.8 mt -48.17 -41.37 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 125.224 1.41 . . . . 0.0 110.683 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.6 t -56.36 -42.52 74.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.427 0.691 . . . . 0.0 110.248 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.07 -40.67 87.06 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 122.955 0.502 . . . . 0.0 110.874 -176.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 55.5 mt -57.86 -49.11 82.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 173.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -64.01 -35.21 79.95 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 118.082 -0.961 . . . . 0.0 111.994 -173.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -57.48 -28.8 63.71 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.432 1.015 . . . . 0.0 112.064 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 34.5 mt -76.41 -3.57 37.77 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.467 0.707 . . . . 0.0 112.639 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 41.47 53.8 7.45 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 126.307 1.843 . . . . 0.0 111.565 -171.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -57.91 135.01 66.2 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.203 1.936 . . . . 0.0 112.343 -169.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.7 m -78.32 -31.97 49.0 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.037 0.935 . . . . 0.0 108.577 168.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 20.7 ttp-105 -142.2 155.29 45.27 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.405 1.082 . . . . 0.0 109.79 173.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.4 tp -136.13 141.47 44.15 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 126.09 1.756 . . . . 0.0 107.66 169.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 24.0 tp -130.63 134.44 46.97 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 172.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.5 mt -121.29 145.17 28.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -171.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 38.3 t -141.37 135.65 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 118.938 0.79 . . . . 0.0 110.421 -175.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -163.22 169.79 18.71 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.583 2.353 . . . . 0.0 107.871 177.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.3 155.98 39.6 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.318 -0.864 . . . . 0.0 109.194 168.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.8 m -154.15 123.63 6.58 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -72.15 121.98 20.21 Favored 'General case' 0 N--CA 1.46 0.068 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 171.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 74.8 mtm -122.89 1.01 9.28 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.59 1.556 . . . . 0.0 110.736 -174.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.53 23.5 64.93 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-N 118.639 0.654 . . . . 0.0 112.341 -172.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.0 mt -96.6 -173.85 2.86 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.275 1.43 . . . . 0.0 109.052 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -73.82 140.55 77.91 Favored Pre-proline 0 N--CA 1.467 0.389 0 CA-C-O 117.744 -1.122 . . . . 0.0 108.429 172.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -43.58 137.29 6.05 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.364 2.709 . . . . 0.0 113.195 173.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.36 4.57 74.55 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 118.772 -1.015 . . . . 0.0 113.845 177.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -68.01 150.94 47.83 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 119.714 1.757 . . . . 0.0 108.13 168.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 74.1 mt -128.02 138.02 55.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 -171.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 90.1 mmt-85 -145.58 147.09 31.7 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 118.836 0.744 . . . . 0.0 112.081 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 51.0 mm -75.77 143.0 13.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 166.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mt -134.81 161.48 40.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 174.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -125.69 144.0 46.82 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 126.493 1.917 . . . . 0.0 108.312 -174.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -42.76 -37.82 6.12 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 124.726 3.618 . . . . 0.0 116.685 -178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -64.84 -22.17 66.94 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.367 0.667 . . . . 0.0 112.34 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -113.33 -32.05 6.38 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.123 1.369 . . . . 0.0 111.1 -174.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.4 HD11 ' HB3' ' A' ' 110' ' ' PHE . 34.5 mt -49.08 -40.44 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.776 1.63 . . . . 0.0 110.359 169.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.31 -21.93 16.82 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.097 1.359 . . . . 0.0 113.733 -176.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -115.97 -36.46 4.13 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 118.574 0.625 . . . . 0.0 110.336 174.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 86.2 mmm -72.15 -26.64 62.17 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 118.479 -0.772 . . . . 0.0 113.032 -171.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -64.53 -51.84 60.85 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 119.933 1.242 . . . . 0.0 109.801 170.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -75.86 6.82 4.55 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 51.6 tpp -61.88 -25.36 67.51 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.585 1.084 . . . . 0.0 109.748 167.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 70.0 p -63.05 -6.89 4.46 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.92 1.688 . . . . 0.0 112.685 168.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.4 m 68.73 4.12 4.24 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 127.43 2.292 . . . . 0.0 112.371 -171.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 49.2 p-80 -155.7 -25.56 0.11 Allowed 'General case' 0 C--N 1.35 0.616 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -63.51 139.99 58.83 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 120.776 1.626 . . . . 0.0 108.447 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -64.38 146.73 97.8 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-O 118.566 -0.73 . . . . 0.0 109.501 -174.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -72.68 63.72 3.85 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 125.166 3.91 . . . . 0.0 110.449 175.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 mt -53.11 -3.14 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 129.577 3.151 . . . . 0.0 117.108 -168.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -52.56 -28.23 20.01 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.546 -0.721 . . . . 0.0 111.207 167.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -59.55 -39.18 83.17 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.118 0.567 . . . . 0.0 111.12 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.6 tt -70.12 -43.68 70.5 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 123.67 0.788 . . . . 0.0 109.471 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 94.0 mt -59.78 -39.05 78.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -63.9 -19.28 64.97 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -82.37 -9.33 59.5 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.537 -0.727 . . . . 0.0 112.009 175.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 68.9 mt -126.83 -30.69 2.73 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.318 1.047 . . . . 0.0 112.09 -168.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 12.5 pttm -63.59 -24.88 67.98 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.317 -0.864 . . . . 0.0 111.942 178.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -78.33 -5.54 52.48 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.772 1.229 . . . . 0.0 111.804 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -132.54 -3.66 3.35 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.867 1.267 . . . . 0.0 112.896 -168.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 65.7 mt -135.89 143.64 35.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 126.111 1.764 . . . . 0.0 106.878 -173.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.68 -37.48 76.78 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-O 119.396 -0.669 . . . . 0.0 112.823 -171.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -144.89 124.63 13.33 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 37.2 t -127.92 130.36 69.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 3.3 mt -136.24 154.17 32.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 -169.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.4 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.2 t80 -131.55 146.04 52.02 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 168.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.0 tt -126.67 122.11 34.02 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.759 1.624 . . . . 0.0 106.934 176.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -107.61 156.33 15.92 Favored Glycine 0 C--N 1.333 0.377 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -178.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 56.1 mt -133.79 125.85 49.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -175.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.5 tp60 -64.09 115.24 17.78 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-O 117.624 -1.179 . . . . 0.0 110.377 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -76.06 170.39 20.19 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.302 2.668 . . . . 0.0 111.352 170.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -131.03 -30.08 1.81 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.62 1.968 . . . . 0.0 111.056 170.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.1 pp -135.24 136.4 51.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 119.105 0.866 . . . . 0.0 108.708 173.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 65.1 t -142.02 136.91 30.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 176.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 156.03 152.85 6.37 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -67.04 154.0 42.27 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.611 0.72 . . . . 0.0 110.199 -176.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.8 t80 58.21 33.93 23.63 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.196 1.798 . . . . 0.0 111.682 -177.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -123.58 145.84 48.28 Favored Pre-proline 0 C--O 1.237 0.407 0 O-C-N 121.562 -0.711 . . . . 0.0 110.199 174.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -80.3 164.74 21.57 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.198 2.599 . . . . 0.0 110.657 174.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.9 ttm -68.45 134.53 50.29 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 168.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.94 159.6 31.62 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.329 1.052 . . . . 0.0 110.471 176.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.51 -46.62 99.59 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-O 117.196 -1.383 . . . . 0.0 113.316 -171.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -66.89 -26.12 44.57 Favored 'Trans proline' 0 C--N 1.35 0.613 0 CA-C-N 122.288 1.853 . . . . 0.0 112.717 -178.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 mp -80.66 -34.86 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 119.313 0.961 . . . . 0.0 108.666 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -56.99 -46.38 82.3 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 118.988 0.813 . . . . 0.0 109.745 169.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -63.09 -37.95 89.26 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 122.787 0.435 . . . . 0.0 111.356 178.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.55 -47.38 81.82 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 121.88 -0.513 . . . . 0.0 110.9 175.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.16 -39.17 82.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 118.702 0.683 . . . . 0.0 109.871 177.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -63.21 -33.77 76.21 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.193 0.906 . . . . 0.0 111.126 174.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 39.2 m -70.31 -43.17 70.88 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.678 0.791 . . . . 0.0 110.1 175.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 91.2 t -63.45 -45.93 96.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 119.363 0.983 . . . . 0.0 109.26 176.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.528 ' CE1' ' HE2' ' A' ' 31' ' ' LYS . 22.3 t80 -52.36 -50.97 61.32 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.155 0.982 . . . . 0.0 110.884 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -71.28 -34.74 70.94 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.873 0.761 . . . . 0.0 111.818 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.21 -32.51 74.11 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 118.926 0.784 . . . . 0.0 111.43 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 55.2 mt -57.52 -18.65 20.12 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.54 1.064 . . . . 0.0 112.708 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -83.69 -12.64 55.6 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 119.403 1.001 . . . . 0.0 112.368 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -145.71 7.13 1.47 Allowed Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.151 0.881 . . . . 0.0 114.39 -173.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -55.51 146.72 19.45 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.447 1.499 . . . . 0.0 109.405 172.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -150.8 100.28 2.8 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 171.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 79.41 -41.51 2.29 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.691 1.615 . . . . 0.0 114.165 169.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -146.2 -16.91 0.45 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.323 1.449 . . . . 0.0 112.111 -169.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 64.7 17.08 62.16 Favored Glycine 0 CA--C 1.531 1.084 0 O-C-N 121.429 -0.795 . . . . 0.0 113.464 175.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.61 5.03 55.06 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 118.614 -1.103 . . . . 0.0 113.275 -176.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -74.14 159.51 32.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 119.578 1.689 . . . . 0.0 109.601 176.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -84.24 146.91 27.54 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 172.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -78.89 131.77 36.53 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 169.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 56.7 tp -54.39 144.92 19.37 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.8 1.24 . . . . 0.0 110.887 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 71.86 -47.93 0.67 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 130.423 3.489 . . . . 0.0 112.734 170.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 60.5 t -81.38 55.13 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 127.651 2.38 . . . . 0.0 104.849 168.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -58.28 154.83 12.64 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.325 1.85 . . . . 0.0 111.437 -169.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -133.73 28.78 3.89 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.732 1.213 . . . . 0.0 110.188 -171.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 . . . . . 0 C--O 1.25 1.115 0 C-N-CA 124.646 1.178 . . . . 0.0 109.33 174.38 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.6 ttp . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 119.078 -0.487 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 22.8 m -145.53 149.3 34.35 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -173.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -144.6 128.09 16.99 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 -176.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.9 m -118.06 153.47 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 124.051 0.94 . . . . 0.0 110.561 -169.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 41.4 tp -124.09 101.54 7.27 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 56.5 tp -89.84 98.94 12.06 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.071 0.949 . . . . 0.0 108.938 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 95.9 m -75.01 141.09 43.98 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 169.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.5 t -141.38 143.31 27.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 125.328 1.451 . . . . 0.0 107.782 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 148.91 171.5 17.73 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.094 0.854 . . . . 0.0 112.231 175.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -109.0 117.1 33.33 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.919 1.288 . . . . 0.0 107.951 175.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -59.57 -13.83 10.88 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.109 1.764 . . . . 0.0 115.741 -169.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -129.57 13.55 5.96 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 119.436 1.016 . . . . 0.0 111.878 -174.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.2 ttt -100.64 40.12 1.3 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.49 0.662 . . . . 0.0 110.158 -176.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.51 -136.39 18.37 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -50.9 -30.26 14.21 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.901 1.281 . . . . 0.0 113.328 174.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -60.25 -17.91 45.21 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -167.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.34 25.58 0.71 Allowed Glycine 0 CA--C 1.533 1.187 0 CA-C-O 118.14 -1.366 . . . . 0.0 113.791 175.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.51 -49.14 77.92 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 119.944 1.872 . . . . 0.0 110.382 -170.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.19 -56.44 23.76 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-O 117.612 -1.66 . . . . 0.0 111.203 173.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -47.09 -42.47 26.13 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 CA-C-N 120.991 2.396 . . . . 0.0 115.659 177.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 62.6 tp -71.49 -37.43 71.27 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 120.173 1.351 . . . . 0.0 110.713 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.4 tp -61.34 -47.39 86.13 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.324 0.511 . . . . 0.0 110.283 174.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.96 -40.28 88.5 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 123.859 0.864 . . . . 0.0 110.903 177.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.6 tp10 -62.03 -49.29 76.58 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 118.659 0.663 . . . . 0.0 109.726 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -63.21 -45.9 89.53 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 119.166 -0.445 . . . . 0.0 110.477 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 78.4 m -63.5 -40.34 96.82 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.581 0.628 . . . . 0.0 111.228 177.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.91 -39.31 93.88 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.844 0.747 . . . . 0.0 111.146 177.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.37 -36.9 77.28 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.343 0.657 . . . . 0.0 111.467 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.89 95.58 2.19 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.113 1.365 . . . . 0.0 108.063 -172.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -53.04 170.19 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 124.907 3.738 . . . . 0.0 115.729 -176.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.562 ' HE2' ' CZ ' ' A' ' 136' ' ' TYR . 19.4 mmtm -138.85 157.04 46.79 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.342 1.457 . . . . 0.0 108.94 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 38.33 -115.1 0.38 Allowed Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.241 1.4 . . . . 0.0 111.625 177.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -140.71 22.29 2.31 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.473 1.109 . . . . 0.0 110.425 170.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 10.0 m95 -69.87 128.63 37.06 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 121.32 -0.862 . . . . 0.0 109.302 -173.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 86.4 t -76.88 106.72 7.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 168.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.7 t -64.02 136.67 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.0 mm -131.02 148.06 33.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 169.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -135.6 100.26 4.43 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.59 -8.33 80.88 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-O 118.88 -0.956 . . . . 0.0 112.419 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 51.48 -140.19 25.12 Favored Glycine 0 C--N 1.341 0.807 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -169.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.9 p -91.53 14.76 13.99 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.032 0.933 . . . . 0.0 111.799 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.48 57.06 6.8 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 125.291 1.437 . . . . 0.0 110.142 -176.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -68.46 -18.66 43.6 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.822 2.348 . . . . 0.0 113.648 -169.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -61.47 -32.14 72.13 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.338 0.972 . . . . 0.0 111.473 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.43 -31.31 71.25 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.189 0.595 . . . . 0.0 111.579 175.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.54 -9.56 49.44 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 123.645 0.778 . . . . 0.0 111.326 -169.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 95.6 mt -53.1 -42.17 44.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 170.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.6 t -58.1 -40.26 76.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.565 0.746 . . . . 0.0 110.241 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.81 -45.45 71.18 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.232 0.469 . . . . 0.0 110.249 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.3 mt -62.72 -37.5 79.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -64.07 -19.04 64.94 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 117.871 -1.061 . . . . 0.0 112.578 176.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -70.91 -46.79 61.9 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 120.483 1.492 . . . . 0.0 108.964 169.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.4 mt -69.9 -21.1 63.34 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.47 1.108 . . . . 0.0 112.657 -173.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.3 mtt85 41.92 54.63 8.76 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.04 1.736 . . . . 0.0 112.202 -177.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -57.87 153.86 41.57 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.768 2.312 . . . . 0.0 114.793 -169.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.8 m -72.35 -38.82 68.48 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.085 1.354 . . . . 0.0 109.536 168.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 53.3 mtm180 -143.99 164.57 30.24 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.036 0.934 . . . . 0.0 110.577 178.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.0 tp -146.01 141.69 27.91 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.345 1.458 . . . . 0.0 108.235 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 41.7 tp -128.49 135.35 49.32 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 172.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.5 mt -122.04 144.16 32.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -175.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.5 t -140.18 132.82 33.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 118.413 0.551 . . . . 0.0 109.663 -175.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -158.78 175.19 13.92 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.556 2.342 . . . . 0.0 106.742 169.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.68 162.74 28.46 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 121.028 -1.045 . . . . 0.0 110.628 169.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.7 m -157.24 128.22 6.7 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 176.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -73.42 116.63 14.21 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 170.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 77.1 mtm -114.64 1.55 14.25 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.767 1.627 . . . . 0.0 110.461 -176.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.48 13.6 45.32 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 123.948 0.785 . . . . 0.0 113.011 -172.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 72.3 mt -85.92 -176.31 5.94 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.904 1.681 . . . . 0.0 109.928 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -72.54 139.1 80.79 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 117.928 -1.034 . . . . 0.0 109.388 172.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -43.99 134.34 8.24 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.812 3.008 . . . . 0.0 114.224 177.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.87 4.73 86.03 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 118.858 -0.968 . . . . 0.0 113.547 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -66.75 152.67 45.05 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 119.722 1.761 . . . . 0.0 108.435 168.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 85.6 mt -127.78 139.92 50.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 -171.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 90.9 mmt-85 -148.64 151.81 35.62 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.624 0.647 . . . . 0.0 111.147 173.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 43.8 mm -78.41 146.13 8.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 167.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.6 mt -135.17 165.19 31.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 177.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -138.67 146.41 50.4 Favored Pre-proline 0 C--O 1.235 0.32 0 C-N-CA 126.925 2.09 . . . . 0.0 107.009 -170.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -53.08 -28.43 40.86 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.38 2.72 . . . . 0.0 114.982 -175.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -66.69 -21.38 66.09 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 118.943 0.792 . . . . 0.0 112.359 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -117.96 -30.18 5.43 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.873 1.269 . . . . 0.0 111.894 -172.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 69.5 mt -50.5 -40.89 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 124.658 1.183 . . . . 0.0 109.89 170.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.81 -27.36 50.88 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.857 0.863 . . . . 0.0 113.254 -176.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -99.23 -43.22 6.7 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 174.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 95.0 mmm -72.1 -25.52 61.78 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.631 -0.668 . . . . 0.0 112.708 -169.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -80.0 1.01 29.22 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 172.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 23.3 ptt? -121.06 -3.12 9.59 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.407 0.683 . . . . 0.0 111.846 167.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 15.8 tpt -61.93 -29.27 70.11 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.213 0.915 . . . . 0.0 109.804 168.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.4 p -54.37 -28.55 43.92 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 127.988 2.515 . . . . 0.0 113.023 169.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.8 m 118.72 -52.38 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.446 1 C-N-CA 133.537 4.735 . . . . 0.0 104.091 -168.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -168.87 154.59 6.41 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.713 2.005 . . . . 0.0 107.449 168.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -140.45 -77.86 0.3 Allowed 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 168.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 36.3 mtt -164.44 133.82 2.92 Favored Pre-proline 0 C--N 1.329 -0.302 0 C-N-CA 129.376 3.071 . . . . 0.0 102.78 168.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -73.97 61.0 4.69 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.521 2.814 . . . . 0.0 110.631 177.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.6 mt -47.69 -12.46 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 129.608 3.163 . . . . 0.0 116.66 -168.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -52.48 -26.77 13.81 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.202 0.91 . . . . 0.0 112.199 168.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -63.53 -33.82 76.44 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.713 1.142 . . . . 0.0 111.671 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.6 tt -69.59 -46.39 66.42 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.0 mt -60.5 -49.49 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -67.18 -14.14 62.63 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -171.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -106.04 7.96 32.11 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.675 1.19 . . . . 0.0 111.668 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 26.6 tp -138.5 -27.86 0.85 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.785 0.834 . . . . 0.0 111.167 -173.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -59.35 -19.77 49.34 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.849 1.26 . . . . 0.0 111.494 168.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -64.39 -16.77 62.93 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.288 1.435 . . . . 0.0 111.361 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -125.75 -40.41 2.06 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.477 1.111 . . . . 0.0 111.426 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 36.5 mt -71.82 139.04 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.76 -38.89 93.42 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.361 0.981 . . . . 0.0 112.747 -177.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -147.22 135.95 22.06 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 118.662 1.231 . . . . 0.0 108.395 176.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.8 t -126.11 127.57 71.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.2 mt -130.24 155.31 41.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -168.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -136.13 147.8 47.92 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.4 tt -129.68 135.48 48.56 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.043 1.337 . . . . 0.0 108.167 171.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -118.13 158.91 14.48 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 125.112 1.339 . . . . 0.0 111.117 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 92.3 mt -136.31 129.73 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 C-N-CA 125.444 1.498 . . . . 0.0 107.593 -175.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -66.74 119.47 63.69 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 117.513 -1.232 . . . . 0.0 111.245 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.11 170.15 17.68 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 124.755 3.636 . . . . 0.0 113.449 173.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -137.82 -36.73 0.61 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.453 1.101 . . . . 0.0 112.028 168.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.1 pp -136.67 138.06 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 170.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 89.8 t -139.98 136.46 38.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 175.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 160.5 151.81 6.34 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -65.37 151.35 46.5 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.7 0.762 . . . . 0.0 111.079 -174.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 54.86 38.29 30.07 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.733 2.013 . . . . 0.0 112.061 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -121.6 149.54 53.05 Favored Pre-proline 0 C--O 1.237 0.439 0 C-N-CA 124.026 0.93 . . . . 0.0 109.451 173.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -78.0 158.37 30.72 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.831 2.354 . . . . 0.0 110.68 177.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 59.5 ttm -64.88 132.57 49.76 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 168.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.0 151.17 47.41 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 123.913 0.885 . . . . 0.0 111.209 177.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -57.59 -47.13 99.5 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 117.198 -1.382 . . . . 0.0 112.925 -174.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -67.92 -25.48 38.7 Favored 'Trans proline' 0 C--N 1.35 0.657 0 CA-C-N 122.105 1.787 . . . . 0.0 112.166 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 mp -76.96 -38.67 28.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -57.01 -46.88 81.98 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.977 0.808 . . . . 0.0 109.863 171.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -61.91 -39.22 91.25 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 122.639 0.376 . . . . 0.0 111.144 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.51 -49.9 71.7 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.755 0.422 . . . . 0.0 110.929 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 76.4 t -59.2 -40.78 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 118.634 0.652 . . . . 0.0 109.618 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -68.73 -28.93 67.26 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.921 0.782 . . . . 0.0 111.742 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 46.7 m -69.27 -46.79 66.39 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.558 -0.713 . . . . 0.0 109.527 173.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 96.3 t -59.39 -46.32 92.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 118.965 0.802 . . . . 0.0 108.968 176.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.562 ' CZ ' ' HE2' ' A' ' 31' ' ' LYS . 37.6 t80 -52.33 -57.93 8.25 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.317 1.047 . . . . 0.0 110.637 178.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -69.27 -29.95 67.95 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.025 0.83 . . . . 0.0 111.852 -176.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -61.43 -33.7 74.16 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 118.777 0.717 . . . . 0.0 110.881 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 52.7 mt -57.99 -17.2 15.79 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -177.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -79.46 -14.88 58.61 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 120.248 1.386 . . . . 0.0 112.793 177.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -135.23 -5.14 2.42 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.609 1.099 . . . . 0.0 113.328 -178.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -54.16 135.26 44.03 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 126.135 1.774 . . . . 0.0 109.048 174.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -143.96 151.41 39.73 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 167.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.01 -107.75 0.93 Allowed Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 -172.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -108.27 11.18 27.48 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.861 1.264 . . . . 0.0 112.463 -177.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 73.42 6.19 69.57 Favored Glycine 0 CA--C 1.528 0.887 0 O-C-N 121.379 -0.826 . . . . 0.0 113.395 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 73.17 5.71 66.91 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-N 119.024 1.412 . . . . 0.0 113.303 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -67.0 151.83 46.92 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 119.209 1.504 . . . . 0.0 108.83 170.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.62 155.77 40.14 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 123.811 0.844 . . . . 0.0 109.256 173.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -102.65 123.95 47.29 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.985 1.314 . . . . 0.0 108.196 -177.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 58.9 tp -56.05 129.31 39.35 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 126.226 1.81 . . . . 0.0 110.727 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -143.54 56.18 1.35 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.047 0.939 . . . . 0.0 110.139 178.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 6.9 t 53.78 51.69 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 125.201 1.401 . . . . 0.0 110.013 176.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -75.67 177.0 7.16 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.73 1.212 . . . . 0.0 110.913 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -145.32 153.25 41.05 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.048 1.739 . . . . 0.0 106.909 169.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 . . . . . 0 C--O 1.25 1.127 0 C-N-CA 124.781 1.232 . . . . 0.0 109.713 169.95 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.4 tpp . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 91.4 m -130.99 126.19 35.32 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 171.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -119.53 101.58 8.04 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 -175.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.1 m -89.88 141.36 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 29.3 tp -109.37 126.48 53.46 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 105.18 -2.155 . . . . 0.0 105.18 171.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 48.9 tp -114.61 97.38 6.25 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 177.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 93.2 m -71.78 140.12 49.31 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.84 169.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.1 t -140.26 141.84 32.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 148.0 -175.52 27.27 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 118.43 0.559 . . . . 0.0 112.153 177.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -136.79 117.78 14.28 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.057 1.343 . . . . 0.0 107.983 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.7 m -58.74 -11.55 3.29 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.477 2.311 . . . . 0.0 115.798 -170.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 23.4 ptp -131.97 12.35 4.74 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.805 1.184 . . . . 0.0 111.425 -177.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 27.7 mmm -89.45 24.54 2.22 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.64 0.776 . . . . 0.0 110.261 173.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.58 -139.15 16.3 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -63.42 -14.98 56.14 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.407 1.083 . . . . 0.0 112.108 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -61.39 -5.84 1.93 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.629 1.571 . . . . 0.0 113.324 174.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.64 16.89 28.48 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 120.537 -1.352 . . . . 0.0 113.412 174.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.37 -50.33 74.04 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.4 1.6 . . . . 0.0 111.578 -169.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.54 -55.22 31.19 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 117.718 -1.601 . . . . 0.0 111.144 176.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -48.73 -40.08 38.66 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 CA-C-N 120.849 2.325 . . . . 0.0 115.24 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.6 tp -71.19 -38.93 72.09 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 119.975 1.261 . . . . 0.0 110.464 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.3 tp -60.9 -46.36 90.95 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.066 0.394 . . . . 0.0 110.187 175.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.41 -39.92 81.02 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 123.85 0.86 . . . . 0.0 110.956 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -62.67 -49.36 75.42 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 118.815 0.734 . . . . 0.0 109.829 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -62.84 -44.51 95.95 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.558 0.343 . . . . 0.0 110.515 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 79.5 m -65.0 -39.64 93.76 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 118.21 0.459 . . . . 0.0 111.157 177.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.52 -37.54 87.9 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.039 0.836 . . . . 0.0 111.199 177.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.07 -38.8 79.23 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.226 0.61 . . . . 0.0 111.116 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.5 90.2 2.9 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.765 1.226 . . . . 0.0 109.191 -173.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -55.24 160.19 8.92 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 124.07 3.18 . . . . 0.0 114.0 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 32.1 mmtt -117.39 168.12 10.64 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.871 1.268 . . . . 0.0 109.768 174.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 37.52 -112.3 0.17 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 126.193 1.854 . . . . 0.0 111.564 176.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -139.13 36.27 2.11 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.852 1.261 . . . . 0.0 108.886 169.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -67.47 144.94 55.45 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 121.591 -0.693 . . . . 0.0 110.653 -175.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.1 t -103.16 103.5 15.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 168.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.8 t -71.36 136.97 24.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -176.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 54.9 mt -136.96 142.19 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 104.55 -2.389 . . . . 0.0 104.55 172.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -131.01 110.07 10.97 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -88.83 0.65 82.67 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 118.811 -0.994 . . . . 0.0 112.879 -178.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 56.9 -144.29 38.87 Favored Glycine 0 C--N 1.34 0.766 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -171.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.1 p -94.19 1.63 56.02 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.693 0.797 . . . . 0.0 112.629 -175.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.02 64.16 40.13 Favored Pre-proline 0 C--O 1.238 0.454 0 C-N-CA 124.798 1.239 . . . . 0.0 109.458 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -65.06 -14.35 44.78 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.194 2.596 . . . . 0.0 112.875 -173.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.7 tp10 -43.1 -41.74 3.73 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.087 1.755 . . . . 0.0 111.536 168.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -69.64 -17.41 63.51 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.048 0.939 . . . . 0.0 112.655 -175.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -117.79 0.8 12.06 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.797 0.839 . . . . 0.0 113.251 -168.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 73.5 mt -48.96 -38.9 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 125.147 1.379 . . . . 0.0 110.62 172.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.9 t -55.35 -42.02 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 123.955 0.902 . . . . 0.0 110.453 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.0 -40.77 91.41 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.954 0.501 . . . . 0.0 110.799 -176.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.5 mt -60.8 -49.31 85.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.975 0.91 . . . . 0.0 108.608 173.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -61.21 -36.02 78.77 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 118.386 -0.816 . . . . 0.0 111.857 -173.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -55.79 -30.19 60.94 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.871 0.76 . . . . 0.0 111.994 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 68.6 mt -87.67 -9.48 54.05 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.085 0.954 . . . . 0.0 112.377 -174.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 30.75 59.87 1.01 Allowed Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 126.588 1.955 . . . . 0.0 112.504 -168.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -57.45 155.59 30.03 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.02 2.48 . . . . 0.0 114.242 -169.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.3 m -72.77 -42.01 64.45 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.889 0.476 . . . . 0.0 109.802 170.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 50.3 mtm180 -142.7 160.62 39.95 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.439 0.696 . . . . 0.0 109.91 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 26.3 tp -141.17 138.86 33.69 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 124.645 1.178 . . . . 0.0 108.583 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 62.3 tp -127.62 114.54 17.5 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 176.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 mm -86.39 148.6 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 172.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.9 t -140.7 133.5 31.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 118.459 0.572 . . . . 0.0 109.634 171.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -161.95 173.84 13.91 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.266 2.226 . . . . 0.0 107.351 169.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.18 157.54 37.98 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.052 -1.03 . . . . 0.0 109.734 169.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.7 m -151.55 126.44 9.7 Favored 'General case' 0 CA--C 1.527 0.09 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -77.42 80.51 3.91 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.994 0.902 . . . . 0.0 110.261 175.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 74.0 mtm -75.4 -6.55 50.61 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.012 1.725 . . . . 0.0 112.345 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.0 21.02 76.74 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 123.87 0.747 . . . . 0.0 111.943 -172.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.5 mt -93.49 -172.65 2.97 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.132 1.373 . . . . 0.0 109.706 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -74.2 140.45 76.55 Favored Pre-proline 0 N--CA 1.468 0.437 0 CA-C-O 117.695 -1.145 . . . . 0.0 108.434 169.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -43.01 137.99 4.25 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.423 2.749 . . . . 0.0 113.445 172.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.05 1.59 74.39 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 118.587 -1.118 . . . . 0.0 113.689 176.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -67.12 147.22 53.41 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.926 1.863 . . . . 0.0 107.891 168.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 55.2 mt -124.97 139.81 49.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 -173.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 91.3 mmt-85 -147.26 152.46 38.35 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 118.765 0.712 . . . . 0.0 111.734 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 48.5 mm -80.51 142.53 13.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 166.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.2 mt -134.99 164.3 34.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 124.871 1.268 . . . . 0.0 107.844 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -135.05 145.78 55.77 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 126.884 2.074 . . . . 0.0 107.974 -169.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -55.32 -25.04 45.48 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.292 2.662 . . . . 0.0 115.229 -173.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -66.33 -21.16 66.25 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.157 0.89 . . . . 0.0 112.271 176.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -122.16 -29.8 4.14 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.655 1.182 . . . . 0.0 112.149 -170.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.0 mt -50.8 -40.36 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.15 1.38 . . . . 0.0 109.675 169.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.91 -29.18 59.66 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.409 1.084 . . . . 0.0 112.989 -176.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -99.45 -43.91 6.37 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 20.8 mmt -68.06 -31.4 71.01 Favored 'General case' 0 CA--C 1.523 -0.087 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -169.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -70.33 -45.65 65.76 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 118.766 0.712 . . . . 0.0 111.491 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -83.33 8.48 13.45 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 15.3 tpt -60.49 -26.53 66.89 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.174 0.897 . . . . 0.0 109.589 167.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 55.4 p -59.76 -15.86 23.37 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.963 1.705 . . . . 0.0 112.916 169.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.0 m 56.6 31.95 20.07 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.956 1.703 . . . . 0.0 109.845 -168.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -153.37 -60.05 0.14 Allowed 'General case' 0 C--N 1.345 0.37 0 O-C-N 121.411 -0.806 . . . . 0.0 112.724 -170.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -71.63 147.0 47.97 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 122.796 0.438 . . . . 0.0 109.884 -169.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 77.6 mtm -67.35 145.96 98.65 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 122.963 0.505 . . . . 0.0 109.981 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.8 81.44 1.89 Allowed 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 123.99 3.127 . . . . 0.0 110.139 177.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.2 mt -50.95 -8.47 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 127.257 2.223 . . . . 0.0 116.779 -169.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -52.48 -25.06 9.15 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.487 1.039 . . . . 0.0 112.128 167.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -59.11 -32.55 69.94 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.072 0.851 . . . . 0.0 111.529 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.8 tt -79.51 -44.6 20.91 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 85.0 mt -57.55 -42.39 81.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -59.63 -24.94 64.26 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -89.06 -4.0 58.5 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.151 0.98 . . . . 0.0 112.506 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -123.0 -30.87 3.71 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.449 1.022 . . . . 0.0 111.832 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -60.17 -20.66 59.59 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.103 0.961 . . . . 0.0 113.048 -176.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -69.62 -16.15 63.33 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.362 1.065 . . . . 0.0 112.094 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -140.2 -32.39 0.61 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.372 0.987 . . . . 0.0 113.621 -176.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 12.4 mt -69.53 138.78 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 170.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.62 -37.59 92.62 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.344 0.973 . . . . 0.0 112.483 -175.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -148.69 137.76 21.63 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 118.497 1.149 . . . . 0.0 108.462 175.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 45.2 t -129.63 124.45 59.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 25.8 mt -129.93 154.93 41.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -169.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -125.66 143.48 51.01 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 174.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.6 tt -122.23 124.08 42.95 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 169.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -110.71 156.73 15.39 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 57.7 mt -134.44 124.9 46.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 -176.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -64.89 118.14 45.81 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-O 117.448 -1.263 . . . . 0.0 110.447 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -76.18 171.68 17.66 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.703 2.935 . . . . 0.0 111.569 170.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -128.0 -31.96 2.34 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 125.765 1.626 . . . . 0.0 110.98 171.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -135.86 136.55 49.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.344 1.058 . . . . 0.0 108.161 175.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.9 t -140.79 132.2 29.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 174.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 162.83 154.76 7.75 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -70.11 153.18 43.48 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.898 0.856 . . . . 0.0 110.929 -171.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.9 t80 50.96 39.18 22.24 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.915 2.086 . . . . 0.0 112.222 -176.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.5 m-30 -120.29 148.04 46.42 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 123.793 0.837 . . . . 0.0 109.947 174.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -81.27 164.39 19.39 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.23 2.62 . . . . 0.0 111.162 177.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 52.0 ttm -72.74 140.54 47.85 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 168.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 71.4 p -81.25 159.81 24.42 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.374 1.07 . . . . 0.0 110.656 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.2 tm0? -51.04 -48.65 84.39 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-O 116.978 -1.487 . . . . 0.0 113.329 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -67.78 -30.01 34.55 Favored 'Trans proline' 0 C--N 1.352 0.731 0 CA-C-N 122.546 1.945 . . . . 0.0 112.368 -174.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.77 -35.88 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 119.092 0.86 . . . . 0.0 108.931 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -56.97 -47.13 81.49 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.46 1.027 . . . . 0.0 109.926 171.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -61.52 -42.49 98.9 Favored 'General case' 0 C--O 1.231 0.087 0 C-N-CA 122.995 0.518 . . . . 0.0 111.082 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.96 -48.47 80.23 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 119.04 -0.505 . . . . 0.0 110.952 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 55.5 t -60.01 -41.66 87.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 118.705 0.684 . . . . 0.0 109.617 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -69.58 -29.93 67.58 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.044 0.838 . . . . 0.0 111.568 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 38.0 m -69.58 -45.48 68.55 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.325 -0.86 . . . . 0.0 109.776 174.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 78.7 t -59.23 -47.15 91.29 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 175.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -52.08 -48.11 64.86 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.008 0.923 . . . . 0.0 110.811 177.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -64.0 -44.0 93.98 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 118.564 0.62 . . . . 0.0 110.991 177.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.6 tpp85 -64.11 -26.54 68.59 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 118.736 -0.65 . . . . 0.0 112.234 -175.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 61.0 mt -57.2 -23.68 49.39 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.412 1.006 . . . . 0.0 112.317 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -67.69 -19.03 65.12 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.325 0.966 . . . . 0.0 112.558 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -136.97 6.41 3.73 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.725 1.155 . . . . 0.0 113.361 -174.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 21.0 t90 -62.36 141.53 58.26 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 118.485 1.142 . . . . 0.0 108.822 172.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -151.3 70.34 0.97 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 80.69 -45.28 3.09 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.448 1.023 . . . . 0.0 110.945 -172.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -148.84 96.08 2.51 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 169.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -60.61 7.97 0.08 OUTLIER Glycine 0 CA--C 1.532 1.114 0 C-N-CA 125.865 1.698 . . . . 0.0 116.541 171.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 110.81 42.39 1.12 Allowed Glycine 0 CA--C 1.522 0.51 0 CA-C-N 120.034 1.917 . . . . 0.0 112.877 168.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -112.19 154.6 25.29 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 118.332 1.066 . . . . 0.0 110.121 169.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.81 151.13 39.09 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -91.98 120.47 32.67 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 59.0 tp -59.47 125.33 23.2 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.486 1.115 . . . . 0.0 109.794 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -139.82 -47.59 0.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.719 0.808 . . . . 0.0 111.133 173.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -164.09 -55.52 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 125.254 1.422 . . . . 0.0 109.022 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 47.91 31.83 2.52 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.822 2.049 . . . . 0.0 112.898 -170.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -139.48 27.74 2.27 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.395 1.878 . . . . 0.0 108.937 175.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 . . . . . 0 C--O 1.247 0.956 0 C-N-CA 126.913 2.085 . . . . 0.0 106.9 -176.806 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 tpt . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.4 m -137.47 135.54 36.92 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 172.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -129.94 118.53 21.8 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 105.056 -2.202 . . . . 0.0 105.056 -174.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.4 t -121.84 147.45 25.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.431 0.634 . . . . 0.0 109.995 -165.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 28.6 tp -116.27 127.95 55.16 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 56.8 tp -117.45 94.49 4.57 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 94.5 m -71.14 143.51 50.54 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.459 -0.791 . . . . 0.0 108.918 170.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.9 t -141.38 141.46 30.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 125.23 1.412 . . . . 0.0 107.655 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 143.38 176.34 17.33 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 124.494 1.045 . . . . 0.0 111.949 176.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -120.83 121.49 38.25 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 125.017 1.327 . . . . 0.0 108.124 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 m -59.07 -16.86 21.19 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.438 1.895 . . . . 0.0 115.342 -169.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -126.38 14.27 7.69 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.958 0.903 . . . . 0.0 111.03 -175.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.6 ttt -97.84 32.77 2.26 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.274 0.63 . . . . 0.0 109.586 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.2 -146.3 27.66 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -174.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -60.31 -17.39 42.45 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 126.028 1.731 . . . . 0.0 112.377 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -51.72 -28.03 13.75 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.022 1.329 . . . . 0.0 112.681 175.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.28 26.61 0.56 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.845 1.212 . . . . 0.0 114.456 178.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.77 -50.19 73.38 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 119.291 1.545 . . . . 0.0 110.297 -173.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.95 -56.69 23.33 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-O 117.75 -1.584 . . . . 0.0 111.111 175.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -48.78 -41.04 39.2 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 CA-C-N 120.972 2.386 . . . . 0.0 115.214 178.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.0 tp -71.24 -37.91 71.98 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-N 119.962 1.255 . . . . 0.0 110.605 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.6 tp -60.97 -48.35 82.23 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.308 0.504 . . . . 0.0 109.934 175.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.19 -40.01 88.56 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.773 0.829 . . . . 0.0 111.046 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.6 tp10 -61.06 -49.54 76.96 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 118.492 0.587 . . . . 0.0 109.535 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -63.51 -44.83 93.15 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 119.192 -0.433 . . . . 0.0 110.742 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 75.4 m -63.71 -42.25 97.99 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.716 0.689 . . . . 0.0 111.039 178.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.83 -41.15 99.21 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.417 0.553 . . . . 0.0 110.788 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.92 -32.86 72.78 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.379 0.672 . . . . 0.0 111.99 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.7 88.53 3.29 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 124.707 1.203 . . . . 0.0 109.014 -171.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -51.39 160.92 2.07 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 123.967 3.111 . . . . 0.0 114.329 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -135.75 164.26 28.31 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.473 1.509 . . . . 0.0 108.964 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 41.8 -120.18 2.03 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.491 1.52 . . . . 0.0 111.374 175.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -140.91 34.99 1.76 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.844 1.257 . . . . 0.0 109.443 170.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -69.3 162.21 27.68 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.636 0.774 . . . . 0.0 111.99 -174.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.2 t -116.61 119.13 61.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 103.728 -2.693 . . . . 0.0 103.728 165.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.4 t -88.1 136.79 22.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -172.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 73.0 mt -133.08 143.99 37.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 104.705 -2.332 . . . . 0.0 104.705 169.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -128.03 106.96 9.43 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 172.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.14 -2.98 80.63 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-O 118.929 -0.928 . . . . 0.0 112.807 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 56.83 -147.29 33.7 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 -168.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.6 p -86.61 10.38 15.71 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.732 -0.863 . . . . 0.0 111.876 177.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.76 59.76 17.19 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 125.138 1.375 . . . . 0.0 110.519 -175.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -67.75 -15.4 44.22 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.824 2.35 . . . . 0.0 113.355 -172.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -57.25 -30.75 64.91 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.824 0.738 . . . . 0.0 112.126 173.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.0 -28.46 70.11 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.185 0.594 . . . . 0.0 111.97 175.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.18 -4.12 36.19 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.954 1.301 . . . . 0.0 111.894 -169.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.8 mt -48.57 -43.73 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 124.265 1.026 . . . . 0.0 109.79 170.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 52.5 t -59.5 -38.73 76.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 118.591 0.632 . . . . 0.0 110.644 -177.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.69 -44.53 81.48 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 121.918 -0.489 . . . . 0.0 110.21 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 77.6 mt -60.02 -39.62 80.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 123.489 0.716 . . . . 0.0 109.507 176.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -65.8 -20.33 66.21 Favored 'General case' 0 N--CA 1.462 0.145 0 O-C-N 121.024 -1.048 . . . . 0.0 112.311 178.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -75.55 -48.18 23.56 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 120.122 1.328 . . . . 0.0 109.087 169.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.8 mt -66.04 -26.94 67.75 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.402 0.681 . . . . 0.0 112.368 -175.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 42.77 59.61 10.76 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 125.87 1.668 . . . . 0.0 110.863 -175.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -53.92 146.35 47.23 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.691 2.26 . . . . 0.0 113.413 -169.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.3 m -74.75 -35.1 62.6 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 167.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -147.98 152.5 37.58 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.78 1.232 . . . . 0.0 109.086 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 51.3 tp -140.9 141.37 34.57 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.433 1.093 . . . . 0.0 108.862 -177.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 58.8 tp -125.54 136.92 53.83 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 170.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.5 mt -121.17 143.67 32.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.5 t -140.58 135.41 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 118.586 0.63 . . . . 0.0 110.018 -173.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -162.9 170.37 18.27 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.727 2.411 . . . . 0.0 107.454 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.48 154.94 39.71 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 168.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.9 m -153.23 124.13 7.37 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -69.64 120.99 16.25 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 169.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 76.7 mtm -119.04 1.29 11.41 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.636 1.575 . . . . 0.0 110.704 -177.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.94 34.2 89.24 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 118.929 0.786 . . . . 0.0 111.577 -172.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.3 mt -111.54 -172.14 1.98 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.774 1.63 . . . . 0.0 109.446 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -75.28 140.18 72.62 Favored Pre-proline 0 N--CA 1.468 0.453 0 CA-C-O 117.456 -1.259 . . . . 0.0 108.681 173.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -43.64 136.55 6.55 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.198 2.599 . . . . 0.0 112.896 172.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.65 1.79 83.95 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-O 118.584 -1.12 . . . . 0.0 113.758 177.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -65.75 147.24 53.71 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 120.02 1.91 . . . . 0.0 108.68 168.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 66.9 mt -126.82 133.12 69.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 C-N-CA 125.403 1.481 . . . . 0.0 107.077 -172.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.3 mmt-85 -143.42 151.81 40.81 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.864 0.756 . . . . 0.0 109.691 174.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 48.7 mm -80.83 145.72 8.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 168.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 11.1 mt -131.81 123.39 51.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -175.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -76.81 140.69 67.51 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-O 117.87 -1.062 . . . . 0.0 109.716 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_exo -46.81 -35.24 17.4 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 124.264 3.309 . . . . 0.0 116.677 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -68.59 -23.96 64.53 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.648 0.658 . . . . 0.0 111.687 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -98.81 -31.46 11.86 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.279 1.431 . . . . 0.0 111.116 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 68.0 mt -50.11 -40.82 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.796 1.238 . . . . 0.0 109.569 169.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.93 -19.97 7.9 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.887 1.675 . . . . 0.0 114.327 -175.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -124.33 -37.0 2.58 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 118.72 0.691 . . . . 0.0 110.553 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 21.3 mmt -66.85 -29.43 69.34 Favored 'General case' 0 N--CA 1.46 0.063 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -175.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -69.35 -45.4 69.52 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 119.155 0.889 . . . . 0.0 110.487 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 21.7 ptp -78.31 8.02 5.61 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 118.923 -0.56 . . . . 0.0 112.468 176.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 50.0 tpp -61.24 -27.51 68.5 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.945 1.248 . . . . 0.0 109.743 168.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 68.4 p -62.16 -12.69 21.16 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.914 1.686 . . . . 0.0 113.008 169.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.8 m 57.48 30.6 18.93 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.919 1.687 . . . . 0.0 109.963 -168.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -152.64 -57.63 0.14 Allowed 'General case' 0 C--N 1.345 0.391 0 O-C-N 121.344 -0.847 . . . . 0.0 113.12 -172.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -67.46 146.35 54.08 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 122.838 0.455 . . . . 0.0 109.899 -169.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 94.8 mmm -67.13 148.95 98.73 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 123.228 0.611 . . . . 0.0 109.565 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -71.9 72.66 2.58 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 124.273 3.315 . . . . 0.0 109.433 171.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.7 mt -48.94 -11.47 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 128.532 2.733 . . . . 0.0 116.854 -168.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.04 -22.59 6.11 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.188 0.995 . . . . 0.0 112.608 168.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -59.51 -33.77 71.77 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.336 0.971 . . . . 0.0 111.755 175.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.9 tt -73.41 -44.49 58.26 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 74.4 mt -60.55 -42.29 90.93 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.107 0 C-N-CA 123.258 0.623 . . . . 0.0 109.63 -177.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -60.5 -24.37 65.25 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -176.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -85.03 -11.42 55.41 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.754 0.822 . . . . 0.0 112.063 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.4 mp -121.14 -31.28 4.16 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.32 1.448 . . . . 0.0 111.855 -168.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -60.57 -21.1 62.22 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.68 1.192 . . . . 0.0 112.611 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -71.78 -11.31 60.75 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.593 1.157 . . . . 0.0 111.694 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -134.35 -38.55 0.84 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.092 0.957 . . . . 0.0 112.138 -176.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 53.3 mt -72.17 139.96 18.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 174.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.08 -41.64 94.96 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.052 0.834 . . . . 0.0 111.972 -178.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -149.41 137.63 20.67 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 118.564 1.182 . . . . 0.0 108.612 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 41.4 t -131.13 123.98 54.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 19.9 mt -127.09 154.79 37.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 -171.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -129.74 141.84 50.81 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 173.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.1 tt -121.76 128.42 51.73 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 173.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -114.67 156.29 15.75 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 72.5 mt -131.98 128.09 59.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -177.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.1 tp60 -62.55 115.48 16.91 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 117.579 -1.201 . . . . 0.0 110.157 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -78.76 172.91 14.35 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.143 2.562 . . . . 0.0 111.552 171.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -137.29 -30.7 0.84 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 127.811 2.444 . . . . 0.0 111.045 173.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -129.74 124.14 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 -176.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.7 t -145.27 132.91 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 151.63 150.56 5.37 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -63.8 149.95 45.76 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 118.155 0.978 . . . . 0.0 110.901 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 57.95 43.62 21.03 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.601 1.96 . . . . 0.0 111.951 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -127.72 140.65 38.7 Favored Pre-proline 0 C--O 1.236 0.345 0 C-N-CA 124.116 0.967 . . . . 0.0 108.78 168.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -73.97 161.66 40.74 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.462 2.108 . . . . 0.0 110.041 170.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 52.1 ttm -70.27 139.49 52.17 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 168.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 33.1 p -76.32 156.49 33.31 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.134 0.974 . . . . 0.0 110.504 176.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.1 tm0? -49.32 -46.79 77.5 Favored Pre-proline 0 CA--C 1.544 0.733 0 CA-C-O 117.009 -1.472 . . . . 0.0 113.912 -178.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.46 -28.0 32.87 Favored 'Trans proline' 0 C--N 1.35 0.645 0 CA-C-N 122.616 1.97 . . . . 0.0 112.257 -175.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 mp -80.41 -35.55 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 119.358 0.981 . . . . 0.0 108.64 177.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -56.91 -47.23 81.03 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.405 1.002 . . . . 0.0 109.913 170.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -61.3 -41.81 97.6 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 123.303 0.641 . . . . 0.0 111.013 178.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.98 -48.99 77.89 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 119.121 -0.466 . . . . 0.0 110.929 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 56.0 t -59.48 -41.04 83.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 118.712 0.687 . . . . 0.0 109.728 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -68.94 -30.48 68.95 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.028 0.831 . . . . 0.0 111.483 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 32.9 m -69.41 -40.97 76.98 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.062 -1.024 . . . . 0.0 109.981 174.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 77.4 t -61.25 -50.08 81.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -56.28 -35.66 67.72 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.517 1.127 . . . . 0.0 112.156 177.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -67.9 -43.52 79.08 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.524 1.056 . . . . 0.0 110.685 171.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -58.91 -31.39 68.59 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 118.568 -0.729 . . . . 0.0 112.441 176.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.7 mp -56.52 -22.96 36.5 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.449 1.022 . . . . 0.0 111.973 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 -71.84 -16.3 62.15 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 119.449 1.022 . . . . 0.0 112.795 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -149.71 -0.36 0.41 Allowed Glycine 0 CA--C 1.533 1.213 0 N-CA-C 115.512 0.965 . . . . 0.0 115.512 -171.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 25.8 t90 -58.72 140.37 54.86 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.239 1.519 . . . . 0.0 109.022 170.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -138.49 10.63 2.72 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.44 1.096 . . . . 0.0 111.577 173.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 165.62 -47.93 0.28 Allowed Glycine 0 C--N 1.338 0.679 0 O-C-N 121.403 -0.811 . . . . 0.0 111.234 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -123.12 -24.36 4.73 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 54.86 26.27 40.09 Favored Glycine 0 CA--C 1.536 1.359 0 CA-C-N 119.267 0.94 . . . . 0.0 112.755 -172.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.38 -8.84 51.9 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 118.159 -1.356 . . . . 0.0 114.104 -176.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -69.23 145.46 53.15 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 120.362 2.081 . . . . 0.0 110.26 175.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.9 153.41 38.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.574 176.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -93.42 121.88 35.27 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 50.1 tp -56.47 124.45 18.22 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.663 1.585 . . . . 0.0 109.837 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.56 62.2 1.49 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.458 1.103 . . . . 0.0 109.006 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.6 t 52.86 42.01 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 125.463 1.505 . . . . 0.0 110.115 -176.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -73.01 157.67 36.92 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.001 0.92 . . . . 0.0 108.804 172.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -154.67 158.12 39.15 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.264 1.426 . . . . 0.0 107.685 169.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 . . . . . 0 C--O 1.248 1.005 0 C-N-CA 124.519 1.128 . . . . 0.0 108.062 175.843 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.482 1.135 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.8 m -134.97 138.05 43.65 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 173.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -137.85 101.01 4.33 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -168.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 56.3 t -93.93 146.69 6.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.556 0.693 . . . . 0.0 109.655 -169.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 58.5 tp -115.76 114.75 25.21 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 170.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 55.3 tp -103.59 102.29 12.16 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.456 1.102 . . . . 0.0 108.03 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 90.6 m -76.63 142.3 40.7 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 170.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.5 t -141.0 142.63 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 143.49 178.77 19.57 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -132.53 121.0 22.63 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 124.613 1.165 . . . . 0.0 108.443 177.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 m -58.58 -5.33 0.53 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.957 2.503 . . . . 0.0 116.391 -169.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -133.03 10.36 4.19 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.294 0.952 . . . . 0.0 111.446 -176.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 63.8 mtp -95.71 27.97 3.24 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.599 0.76 . . . . 0.0 110.581 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.6 -139.34 19.39 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 -177.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -62.9 -15.81 56.59 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.321 1.048 . . . . 0.0 112.148 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -58.29 -18.6 28.11 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.922 1.289 . . . . 0.0 112.755 174.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.54 19.67 0.86 Allowed Glycine 0 CA--C 1.535 1.3 0 O-C-N 120.626 -1.296 . . . . 0.0 114.237 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.85 -53.3 57.72 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 119.865 1.832 . . . . 0.0 111.157 -169.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.92 -53.93 41.7 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-O 117.953 -1.471 . . . . 0.0 111.21 176.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -50.57 -38.97 55.92 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 CA-C-N 120.907 2.353 . . . . 0.0 115.188 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.1 tp -70.3 -38.7 75.05 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 120.029 1.286 . . . . 0.0 110.243 177.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 51.1 tp -61.89 -48.89 78.43 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.001 0.364 . . . . 0.0 110.219 175.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.66 -41.05 80.73 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 124.302 1.041 . . . . 0.0 111.115 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -61.7 -48.74 79.4 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.771 0.714 . . . . 0.0 109.995 178.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -61.13 -46.24 91.38 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 122.817 0.447 . . . . 0.0 110.518 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 85.6 m -64.0 -40.38 96.23 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.278 0.49 . . . . 0.0 111.117 178.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.44 -38.9 92.92 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.334 0.516 . . . . 0.0 110.947 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.64 -37.65 76.86 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.3 0.64 . . . . 0.0 111.244 178.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.72 98.81 1.69 Allowed Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 125.122 1.369 . . . . 0.0 108.549 -172.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.52 167.36 25.64 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.305 2.004 . . . . 0.0 111.679 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -128.62 177.41 7.05 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.927 1.691 . . . . 0.0 108.654 177.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 41.16 -124.65 2.95 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.054 1.311 . . . . 0.0 112.317 175.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -141.44 37.91 1.69 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.25 1.42 . . . . 0.0 109.337 172.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -72.63 167.83 19.93 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.374 1.07 . . . . 0.0 111.85 -174.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.0 t -123.57 110.31 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 167.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.6 t -75.21 139.32 19.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -175.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 22.9 mm -134.59 147.95 29.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 169.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -130.72 112.2 12.87 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 176.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.52 -11.49 80.18 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 118.79 -1.005 . . . . 0.0 112.982 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.65 35.51 81.44 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 119.017 1.408 . . . . 0.0 113.667 170.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 66.92 10.26 7.49 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.772 1.629 . . . . 0.0 113.5 -177.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.79 53.68 4.84 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 125.341 1.457 . . . . 0.0 108.794 173.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -64.02 -24.63 66.79 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.488 2.125 . . . . 0.0 112.7 -169.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -63.49 -33.53 75.77 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.974 0.806 . . . . 0.0 111.741 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.52 -22.57 67.0 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.569 0.748 . . . . 0.0 111.552 174.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -105.59 -2.2 23.77 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.444 1.098 . . . . 0.0 112.653 -169.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.8 mt -47.24 -42.73 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.989 1.315 . . . . 0.0 110.372 173.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.3 t -56.42 -42.32 74.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.068 0.547 . . . . 0.0 110.167 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.12 -35.55 76.54 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.072 0.549 . . . . 0.0 111.525 -177.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 68.6 mt -63.83 -46.88 93.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 173.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 37.0 mtp180 -69.37 -22.43 63.73 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 117.888 -1.053 . . . . 0.0 112.624 -174.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -56.33 -32.45 64.67 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 120.535 1.516 . . . . 0.0 110.847 170.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 55.1 mt -86.64 -10.85 52.94 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.11 0.964 . . . . 0.0 112.773 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 28.68 61.85 0.72 Allowed Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 126.825 2.05 . . . . 0.0 112.54 -167.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.53 149.15 40.33 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.294 2.663 . . . . 0.0 113.873 -169.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.0 m -71.81 -37.59 70.36 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 168.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -147.97 156.61 42.86 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.059 0.944 . . . . 0.0 109.537 -176.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 41.7 tp -143.75 139.09 29.25 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 124.805 1.242 . . . . 0.0 108.653 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 57.1 tp -124.1 137.17 54.6 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 169.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.7 mt -120.58 143.21 33.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.4 t -140.58 134.03 33.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 118.442 0.565 . . . . 0.0 109.83 -175.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -161.87 172.57 15.86 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.241 2.217 . . . . 0.0 107.39 170.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.49 157.51 36.98 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 121.288 -0.883 . . . . 0.0 108.753 167.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.2 m -152.8 129.38 10.75 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -77.52 82.78 3.94 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 118.921 0.782 . . . . 0.0 109.731 176.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 77.5 mtm -76.82 -6.45 52.38 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.281 1.433 . . . . 0.0 111.806 -177.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.36 25.61 72.43 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.091 0.853 . . . . 0.0 111.752 -174.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 47.5 mt -107.84 -168.56 1.39 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.512 1.125 . . . . 0.0 109.873 -176.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -79.31 138.47 55.82 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-O 117.738 -1.125 . . . . 0.0 109.263 175.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -45.51 134.93 12.68 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.474 2.782 . . . . 0.0 113.864 177.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.13 1.82 90.17 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-O 118.597 -1.113 . . . . 0.0 113.238 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -64.1 145.79 55.32 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 119.767 1.784 . . . . 0.0 107.804 167.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 59.0 mt -126.74 137.33 58.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 -175.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.2 mmt-85 -147.59 150.19 33.98 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 118.792 0.724 . . . . 0.0 111.445 175.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 50.2 mm -72.97 149.38 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 164.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.6 mt -133.41 133.62 57.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -80.91 142.75 52.52 Favored Pre-proline 0 N--CA 1.471 0.614 0 CA-C-O 117.508 -1.234 . . . . 0.0 109.37 174.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -46.59 -37.48 20.35 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 123.997 3.131 . . . . 0.0 116.435 177.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -69.57 -22.32 63.54 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.552 0.614 . . . . 0.0 111.603 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -97.13 -34.1 11.26 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.956 1.303 . . . . 0.0 110.75 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.407 HD11 ' CB ' ' A' ' 110' ' ' PHE . 83.7 mt -50.81 -42.15 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 125.513 1.525 . . . . 0.0 109.111 169.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.55 -23.61 51.49 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.611 1.164 . . . . 0.0 113.571 -175.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -107.39 -40.76 5.27 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 123.184 0.593 . . . . 0.0 109.613 176.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 22.4 mmt -71.71 -29.49 64.62 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -169.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -71.09 -43.03 68.54 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 119.458 1.026 . . . . 0.0 110.981 175.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 28.9 ptm -81.21 10.74 4.98 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 176.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 51.3 tpp -61.78 -24.77 67.06 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.417 1.008 . . . . 0.0 109.862 168.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 45.0 p -62.16 -15.65 47.46 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.347 1.859 . . . . 0.0 112.81 169.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.6 m 60.57 22.03 11.81 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.139 1.776 . . . . 0.0 110.344 -168.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -142.15 -53.61 0.43 Allowed 'General case' 0 C--N 1.343 0.324 0 O-C-N 121.208 -0.932 . . . . 0.0 112.161 -169.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -69.61 147.88 50.11 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 118.272 0.487 . . . . 0.0 110.719 -168.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 12.7 tpt -61.76 140.92 95.34 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 171.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.96 81.34 1.95 Allowed 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 124.044 3.163 . . . . 0.0 109.686 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.8 mt -47.2 -11.12 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 128.326 2.65 . . . . 0.0 118.116 -168.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.06 -23.6 8.07 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.333 0.969 . . . . 0.0 112.821 168.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -59.19 -33.07 70.51 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.351 0.978 . . . . 0.0 111.883 175.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.6 tt -74.58 -43.23 56.63 Favored 'General case' 0 C--N 1.338 0.071 0 O-C-N 121.719 -0.613 . . . . 0.0 109.399 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 87.7 mt -61.73 -40.14 85.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.544 0.738 . . . . 0.0 109.728 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -57.39 -30.61 65.05 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.262 0.625 . . . . 0.0 112.264 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -84.74 -1.62 56.51 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.427 1.091 . . . . 0.0 112.27 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 70.7 mt -126.53 -26.13 3.33 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.457 1.103 . . . . 0.0 112.061 -175.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -58.69 -29.45 66.64 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.805 1.184 . . . . 0.0 111.82 170.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -66.97 -11.93 58.16 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.992 0.917 . . . . 0.0 113.132 173.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -129.84 -11.42 4.33 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.382 1.073 . . . . 0.0 113.701 -168.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 46.7 mt -132.33 143.41 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 125.488 1.515 . . . . 0.0 107.995 -169.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -68.52 -40.77 86.14 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-O 119.211 -0.772 . . . . 0.0 112.261 -175.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -147.46 138.75 23.77 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 118.686 1.243 . . . . 0.0 108.52 177.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 51.3 t -134.25 121.62 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 -176.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 18.2 mt -127.41 154.66 38.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 -170.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.407 ' CB ' HD11 ' A' ' 81' ' ' ILE . 4.8 t80 -130.32 144.19 51.23 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 174.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.3 tt -124.96 128.21 48.25 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 173.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -111.14 156.48 15.52 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 74.4 mt -133.44 126.39 52.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -66.12 117.27 41.21 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 117.368 -1.301 . . . . 0.0 110.296 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -76.84 172.06 16.88 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.515 2.81 . . . . 0.0 111.499 170.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -128.44 -32.27 2.21 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.882 1.673 . . . . 0.0 111.103 171.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -135.55 135.21 51.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 176.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.3 t -141.22 134.85 31.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 175.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 157.81 155.1 7.38 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 177.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -64.96 153.62 40.01 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.941 0.877 . . . . 0.0 111.339 -174.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 52.88 39.64 29.42 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.036 2.134 . . . . 0.0 112.127 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -123.41 148.76 56.32 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 123.828 0.851 . . . . 0.0 109.943 173.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -82.15 163.02 17.76 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.262 2.641 . . . . 0.0 111.184 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 53.1 ttm -71.47 139.41 49.6 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 168.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 72.5 p -79.65 159.27 26.79 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.356 1.063 . . . . 0.0 110.538 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.3 tp60 -53.06 -44.54 97.31 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 116.565 -1.683 . . . . 0.0 114.197 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -68.42 -30.46 29.65 Favored 'Trans proline' 0 C--N 1.352 0.717 0 CA-C-N 122.888 2.067 . . . . 0.0 112.176 -176.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.8 -35.45 16.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 119.026 0.83 . . . . 0.0 108.788 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -56.5 -46.85 80.29 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.318 0.963 . . . . 0.0 110.074 170.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -63.94 -37.98 89.41 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 123.039 0.536 . . . . 0.0 111.203 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.69 -47.28 78.97 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 119.108 -0.472 . . . . 0.0 111.045 175.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 76.5 t -61.5 -38.56 80.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 118.915 0.779 . . . . 0.0 109.688 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -63.65 -39.2 93.74 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 119.361 0.982 . . . . 0.0 110.926 174.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 41.2 m -64.76 -45.01 88.21 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.55 -0.719 . . . . 0.0 110.092 177.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 73.8 t -62.26 -44.48 99.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.32 0.648 . . . . 0.0 109.574 176.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -55.41 -47.44 75.9 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.032 0.933 . . . . 0.0 110.521 177.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -63.77 -38.98 93.14 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 121.827 -0.546 . . . . 0.0 111.248 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -61.12 -25.57 67.07 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 118.27 -0.872 . . . . 0.0 112.534 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 94.5 mt -57.7 -23.36 51.3 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.99 1.268 . . . . 0.0 112.195 178.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -84.4 0.56 48.98 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 118.973 0.806 . . . . 0.0 112.428 -178.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -151.15 -14.51 0.08 OUTLIER Glycine 0 CA--C 1.533 1.171 0 N-CA-C 115.331 0.892 . . . . 0.0 115.331 -174.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 24.8 t90 -57.85 142.25 46.49 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.969 1.384 . . . . 0.0 109.261 172.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -140.8 15.7 2.31 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.704 1.202 . . . . 0.0 110.184 177.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 149.89 -33.89 1.04 Allowed Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.876 1.227 . . . . 0.0 111.648 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -135.51 -28.14 1.14 Allowed 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -172.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 61.07 13.35 34.22 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-N 118.931 0.787 . . . . 0.0 115.038 175.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 83.96 2.18 89.61 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-O 118.411 -1.216 . . . . 0.0 112.984 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -72.36 160.68 31.95 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 119.92 1.86 . . . . 0.0 110.159 174.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.29 153.69 21.79 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 169.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -91.29 134.61 34.44 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 173.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 56.8 tp -62.36 127.23 30.36 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 175.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -150.66 79.34 1.33 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . 0.285 27.0 m 43.89 39.08 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 127.589 2.356 . . . . 0.0 114.158 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -70.27 166.21 20.62 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.12 0.968 . . . . 0.0 110.323 172.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -144.27 155.57 43.9 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.327 1.851 . . . . 0.0 106.533 171.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 . . . . . 0 C--O 1.247 0.974 0 C-N-CA 123.528 0.731 . . . . 0.0 109.578 169.763 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.7 tpp . . . . . 0 N--CA 1.483 1.19 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 51.0 m -101.7 100.89 11.31 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 170.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -84.54 147.03 27.25 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 170.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 79.8 t -137.35 146.91 27.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 36.1 tp -121.55 128.32 51.89 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 56.0 tp -118.83 95.98 5.06 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 89.1 m -70.39 142.96 52.03 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 169.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.8 t -140.64 142.08 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.314 1.446 . . . . 0.0 107.327 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 143.53 172.61 14.5 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 123.976 0.798 . . . . 0.0 112.059 175.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -110.2 118.56 36.67 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.537 1.135 . . . . 0.0 108.16 177.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -60.53 -13.88 16.55 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.235 1.814 . . . . 0.0 115.14 -170.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 26.0 ptm -127.94 18.13 6.68 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.584 1.153 . . . . 0.0 111.246 -173.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.2 ttt -110.72 37.95 2.63 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.101 0.864 . . . . 0.0 110.055 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.83 -141.37 26.24 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -61.35 -16.77 49.47 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.498 1.519 . . . . 0.0 112.198 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -60.51 -16.06 33.33 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.17 0.988 . . . . 0.0 112.127 174.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.64 17.16 2.77 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-O 118.35 -1.25 . . . . 0.0 113.649 174.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.09 -50.43 71.96 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 119.891 1.846 . . . . 0.0 111.123 -170.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.84 -54.96 32.59 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-O 117.789 -1.562 . . . . 0.0 110.825 175.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -48.51 -40.1 37.01 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 CA-C-N 120.758 2.279 . . . . 0.0 115.206 175.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.6 tp -71.4 -37.94 71.5 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.931 1.242 . . . . 0.0 110.466 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.8 tp -61.22 -46.89 88.58 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.235 0.47 . . . . 0.0 110.033 174.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.09 -40.74 86.2 Favored 'General case' 0 C--O 1.226 -0.159 0 C-N-CA 123.71 0.804 . . . . 0.0 111.036 178.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.8 tp10 -61.71 -49.52 76.12 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.601 0.637 . . . . 0.0 109.549 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -63.74 -45.6 89.12 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.87 0.468 . . . . 0.0 110.71 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 74.0 m -65.05 -37.84 88.87 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.703 0.683 . . . . 0.0 111.172 178.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.37 -40.38 95.73 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.263 0.938 . . . . 0.0 110.876 176.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.36 -34.05 75.38 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.277 0.631 . . . . 0.0 111.705 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.12 90.52 3.51 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 125.164 1.386 . . . . 0.0 108.792 -173.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -51.64 162.01 1.8 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 124.127 3.218 . . . . 0.0 114.486 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.417 ' HE2' ' CE1' ' A' ' 136' ' ' TYR . 36.7 mmtm -134.81 156.43 48.89 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 124.538 1.135 . . . . 0.0 110.052 -178.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 38.57 -111.45 0.17 Allowed Glycine 0 CA--C 1.527 0.817 0 C-N-CA 126.394 1.949 . . . . 0.0 113.096 170.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -137.74 9.68 2.86 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.392 1.477 . . . . 0.0 111.018 -171.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -81.77 126.41 31.8 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 121.33 -0.856 . . . . 0.0 111.205 -168.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.9 t -75.27 117.77 20.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 165.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.1 t -80.13 134.51 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -177.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 84.7 mt -133.54 146.19 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 170.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -127.57 110.47 12.74 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 173.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.5 -1.38 90.2 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 119.105 -0.83 . . . . 0.0 112.864 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 56.34 -147.57 31.24 Favored Glycine 0 C--N 1.339 0.737 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 -169.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.9 p -88.66 6.78 36.8 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.522 0.729 . . . . 0.0 112.155 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.37 58.2 20.24 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.179 1.392 . . . . 0.0 109.856 -177.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -68.68 -16.15 41.85 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.844 2.363 . . . . 0.0 113.237 -169.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -57.37 -31.07 65.41 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.479 0.711 . . . . 0.0 111.882 175.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.24 -28.26 69.04 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.256 0.622 . . . . 0.0 112.157 175.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.4 -2.48 45.46 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.967 1.307 . . . . 0.0 111.936 -169.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 87.9 mt -51.71 -43.72 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 123.923 0.889 . . . . 0.0 109.915 176.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.5 t -58.26 -41.05 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.265 0.626 . . . . 0.0 110.192 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.0 -44.96 75.36 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.241 0.473 . . . . 0.0 110.674 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.2 mt -59.11 -42.26 86.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -59.88 -31.17 69.54 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 118.061 -0.971 . . . . 0.0 111.847 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -59.97 -31.76 70.19 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.985 1.266 . . . . 0.0 111.133 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.6 mt -81.99 -13.0 58.04 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.176 0.99 . . . . 0.0 112.095 -175.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 72.8 mtp180 33.15 61.79 1.56 Allowed Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 126.552 1.941 . . . . 0.0 111.721 -169.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -53.88 143.2 61.14 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.008 2.472 . . . . 0.0 113.074 -169.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.4 m -72.81 -38.8 67.07 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 167.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 71.4 mtm180 -144.45 156.87 44.4 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 124.455 1.102 . . . . 0.0 108.969 176.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 45.6 tp -137.72 140.24 40.61 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.4 tp -126.24 136.38 52.73 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 174.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.0 mt -125.07 142.06 43.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 -174.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.1 t -141.56 133.77 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 118.806 0.73 . . . . 0.0 110.846 -174.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -161.36 172.21 16.96 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.565 2.346 . . . . 0.0 107.647 169.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.45 156.81 38.26 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.011 -1.056 . . . . 0.0 108.895 168.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.0 m -156.15 129.18 8.0 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 177.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -71.84 124.64 25.26 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 173.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 74.2 mtm -123.6 1.51 8.88 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.16 1.784 . . . . 0.0 110.766 -177.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.64 24.45 66.2 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-N 118.683 0.674 . . . . 0.0 112.423 -172.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.9 mt -95.74 -173.69 2.93 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.223 1.409 . . . . 0.0 109.333 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -73.38 140.4 79.27 Favored Pre-proline 0 N--CA 1.466 0.355 0 CA-C-O 117.72 -1.133 . . . . 0.0 108.18 170.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -44.23 136.59 8.07 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.258 2.639 . . . . 0.0 112.748 173.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.27 1.97 82.36 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-O 118.501 -1.166 . . . . 0.0 113.796 177.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -67.89 152.21 45.92 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 120.135 1.968 . . . . 0.0 108.257 168.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 51.5 mt -131.5 134.67 60.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -169.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.6 mmt-85 -147.01 148.85 32.11 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 118.721 0.691 . . . . 0.0 109.772 175.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 44.3 mm -73.79 152.85 7.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 166.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.9 mt -135.18 134.74 52.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 176.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -79.02 143.4 61.38 Favored Pre-proline 0 N--CA 1.472 0.661 0 CA-C-O 117.4 -1.286 . . . . 0.0 109.256 173.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo -45.47 -38.22 15.73 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 124.029 3.152 . . . . 0.0 116.439 176.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -68.04 -26.34 65.82 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.363 0.529 . . . . 0.0 111.523 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -94.35 -29.91 14.78 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.786 1.235 . . . . 0.0 111.232 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.487 HD11 ' HB3' ' A' ' 110' ' ' PHE . 59.9 mt -51.71 -45.59 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.15 1.38 . . . . 0.0 109.339 170.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -52.96 -31.35 40.0 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.292 1.037 . . . . 0.0 112.898 -177.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -96.8 -37.63 10.19 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.328 0.651 . . . . 0.0 110.328 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 24.8 mmt -80.64 -27.08 37.32 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 119.09 -0.481 . . . . 0.0 112.249 -170.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -64.8 -45.9 84.31 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 119.187 0.903 . . . . 0.0 110.286 175.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 20.2 ptt? -71.4 -7.63 48.51 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 45.0 tpp -59.18 -26.81 65.11 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.888 0.875 . . . . 0.0 112.106 -175.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 22.6 p -59.51 -55.53 33.36 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.163 0.985 . . . . 0.0 110.286 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -165.98 -46.51 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.776 1.63 . . . . 0.0 110.334 174.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -157.41 -44.39 0.07 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.728 0.811 . . . . 0.0 110.452 -179.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 47.8 -138.87 0.71 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.9 1.28 . . . . 0.0 110.567 176.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 71.0 mtm -139.66 144.15 38.07 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 169.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.21 55.48 5.08 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 124.233 3.289 . . . . 0.0 111.046 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.1 mt -48.68 -9.84 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 129.182 2.993 . . . . 0.0 117.836 -167.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.95 -20.34 6.01 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.31 0.959 . . . . 0.0 112.055 167.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -59.91 -27.18 66.52 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.557 1.071 . . . . 0.0 112.582 173.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.7 tt -63.35 -49.42 73.98 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 119.141 0.882 . . . . 0.0 108.909 172.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 84.1 mt -64.82 -43.21 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -63.54 -19.65 64.97 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -175.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -102.55 8.77 39.78 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.176 1.39 . . . . 0.0 111.781 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.6 tp -140.31 -25.77 0.78 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.826 0.851 . . . . 0.0 112.163 -170.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 50.5 pttt -56.01 -24.66 40.4 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.51 1.524 . . . . 0.0 112.271 172.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -62.4 -17.07 58.31 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.996 1.318 . . . . 0.0 112.635 -172.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -130.15 9.12 5.21 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.646 0.778 . . . . 0.0 112.584 -175.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 56.3 mt -122.96 143.14 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.894 1.278 . . . . 0.0 108.409 -175.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -73.43 -37.01 54.14 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.868 0.747 . . . . 0.0 112.027 -177.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -149.43 136.56 19.83 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 118.226 1.013 . . . . 0.0 108.508 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 43.8 t -122.24 128.92 75.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 171.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.8 mt -126.64 149.26 31.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 -169.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.487 ' HB3' HD11 ' A' ' 81' ' ' ILE . 60.0 t80 -131.31 144.46 51.28 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 169.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.1 tt -124.56 127.79 47.94 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.45 1.5 . . . . 0.0 107.045 174.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -109.77 155.82 15.9 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 78.4 mt -133.78 127.69 52.82 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 -178.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 69.1 tp60 -61.77 114.79 12.28 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-O 117.467 -1.254 . . . . 0.0 110.517 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -77.34 171.46 17.66 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.402 2.735 . . . . 0.0 111.188 170.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -138.24 -26.93 0.9 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 127.088 2.155 . . . . 0.0 111.536 173.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -136.77 120.12 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 -173.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.5 t -143.22 129.4 16.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 156.76 151.75 6.07 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -63.21 145.28 55.84 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.421 0.629 . . . . 0.0 110.765 -174.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 64.83 0.08 1.1 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 128.199 2.6 . . . . 0.0 113.834 -175.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 19.3 m-30 -77.28 142.51 67.88 Favored Pre-proline 0 C--O 1.237 0.418 0 CA-C-N 120.309 1.413 . . . . 0.0 109.133 174.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -73.61 158.29 47.58 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.48 2.12 . . . . 0.0 109.914 169.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 47.3 ttm -73.88 142.78 46.0 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 168.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 29.9 p -81.12 155.09 26.42 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.082 0.953 . . . . 0.0 110.798 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -53.69 -40.43 80.64 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-O 116.529 -1.7 . . . . 0.0 114.729 -178.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -63.68 -39.68 33.57 Favored 'Trans proline' 0 C--N 1.35 0.647 0 CA-C-N 122.819 2.043 . . . . 0.0 111.291 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.6 mp -73.21 -37.53 52.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -57.19 -47.06 82.21 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.35 0.977 . . . . 0.0 110.305 172.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -63.99 -39.25 93.7 Favored 'General case' 0 C--N 1.334 -0.095 0 C-N-CA 122.959 0.504 . . . . 0.0 110.903 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.59 -46.68 84.72 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 122.994 0.517 . . . . 0.0 111.095 176.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 52.7 t -59.94 -41.31 85.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -67.69 -27.88 67.21 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 118.843 0.747 . . . . 0.0 111.858 177.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 36.7 m -71.13 -41.86 69.95 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.366 -0.833 . . . . 0.0 109.952 174.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 98.2 t -62.73 -48.7 86.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 119.2 0.909 . . . . 0.0 108.761 173.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.417 ' CE1' ' HE2' ' A' ' 31' ' ' LYS . 18.0 t80 -50.91 -50.17 57.99 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.655 1.182 . . . . 0.0 111.301 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -73.18 -31.71 64.38 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.915 0.779 . . . . 0.0 111.988 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -61.3 -38.01 85.27 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.077 0.853 . . . . 0.0 110.642 176.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 75.7 mt -55.7 -20.48 14.47 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -174.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -72.57 -29.07 63.22 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.649 1.113 . . . . 0.0 112.352 177.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -131.13 1.87 5.44 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.544 1.069 . . . . 0.0 113.561 -171.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -52.21 136.9 29.44 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 126.297 1.839 . . . . 0.0 109.561 173.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -146.19 149.95 34.93 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 167.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 50.47 -118.21 5.9 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.157 0.884 . . . . 0.0 111.666 -177.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -76.47 -0.49 23.15 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.574 1.149 . . . . 0.0 113.134 -176.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 74.37 16.56 79.85 Favored Glycine 0 CA--C 1.527 0.811 0 O-C-N 121.347 -0.846 . . . . 0.0 113.066 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.66 -15.94 2.02 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-N 118.368 1.084 . . . . 0.0 113.471 -176.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -66.54 147.37 53.37 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.987 1.315 . . . . 0.0 109.412 174.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.88 155.65 37.26 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.784 0.834 . . . . 0.0 109.0 170.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -92.18 140.8 29.26 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 173.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 52.0 tp -64.44 117.25 7.03 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.969 1.308 . . . . 0.0 107.806 173.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -152.61 50.45 0.75 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.9 t 50.79 37.4 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 126.052 1.741 . . . . 0.0 111.241 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 51.03 34.18 10.34 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.116 1.767 . . . . 0.0 113.356 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -134.38 34.95 3.23 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.659 1.584 . . . . 0.0 109.846 174.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 . . . . . 0 C--O 1.252 1.212 0 C-N-CA 125.378 1.471 . . . . 0.0 109.87 169.895 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ttt . . . . . 0 N--CA 1.482 1.164 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 44.4 m -129.19 136.94 50.81 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 169.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -139.54 101.02 4.12 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -168.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 55.4 t -92.74 145.96 6.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -169.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 50.4 tp -119.76 98.19 5.99 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 172.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.9 tp -90.07 106.12 18.27 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -75.49 150.41 38.22 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 172.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.9 t -142.27 140.05 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 143.66 172.6 14.59 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.017 0.818 . . . . 0.0 112.135 176.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -116.67 120.25 38.05 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.92 1.288 . . . . 0.0 108.257 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 m -59.43 -13.72 9.69 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.644 1.977 . . . . 0.0 115.529 -169.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.1 ptt? -129.83 12.36 5.74 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 119.239 0.927 . . . . 0.0 111.485 -176.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.6 ttt -96.99 34.27 1.76 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.718 0.69 . . . . 0.0 110.002 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.37 -140.81 22.4 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -178.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -62.73 -15.98 55.47 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 124.387 1.075 . . . . 0.0 112.293 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -59.1 -17.81 29.79 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.961 1.304 . . . . 0.0 112.729 175.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.08 19.02 1.07 Allowed Glycine 0 CA--C 1.534 1.248 0 O-C-N 120.693 -1.254 . . . . 0.0 114.033 176.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.14 -49.98 73.69 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.572 1.686 . . . . 0.0 110.819 -170.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.68 -55.78 28.57 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.076 -1.402 . . . . 0.0 111.191 175.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -48.58 -42.75 35.17 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 CA-C-N 120.275 2.037 . . . . 0.0 115.487 176.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.6 tp -70.68 -37.15 73.6 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 120.217 1.371 . . . . 0.0 110.448 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 51.1 tp -61.41 -49.56 76.38 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.159 0.436 . . . . 0.0 110.108 175.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.79 -36.87 82.35 Favored 'General case' 0 C--O 1.227 -0.12 0 CA-C-O 118.594 -0.717 . . . . 0.0 111.774 178.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -60.59 -48.59 81.12 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 119.058 0.845 . . . . 0.0 109.682 176.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -62.01 -44.59 96.39 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 122.938 0.495 . . . . 0.0 110.605 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 75.0 m -62.62 -43.85 97.78 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 118.495 0.589 . . . . 0.0 111.023 177.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.44 -40.3 96.14 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.085 0.554 . . . . 0.0 110.787 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.21 -31.88 70.76 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.387 0.675 . . . . 0.0 111.951 177.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.73 93.09 2.17 Favored Pre-proline 0 CA--C 1.537 0.481 0 C-N-CA 124.93 1.292 . . . . 0.0 108.742 -171.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -55.64 158.13 14.0 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.819 2.346 . . . . 0.0 112.486 177.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -131.67 173.47 11.1 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.467 1.507 . . . . 0.0 108.892 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 37.93 -119.48 0.76 Allowed Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.216 1.389 . . . . 0.0 111.929 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -142.91 40.89 1.53 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.092 1.357 . . . . 0.0 108.592 169.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -76.54 165.06 25.31 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.705 0.764 . . . . 0.0 111.573 -170.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.3 t -120.41 84.41 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 104.478 -2.416 . . . . 0.0 104.478 167.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.2 p -64.97 143.57 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 O-C-N 121.596 -0.69 . . . . 0.0 109.386 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.2 mt -132.12 128.15 58.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -83.92 78.78 9.67 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.05 0.94 . . . . 0.0 109.312 172.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -66.35 -29.69 75.31 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.604 -0.599 . . . . 0.0 111.604 176.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 55.65 -140.03 41.44 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 175.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.9 p -88.18 1.54 54.19 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.726 0.81 . . . . 0.0 112.949 -171.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -145.18 61.46 7.97 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 124.583 1.153 . . . . 0.0 110.183 178.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -66.22 -15.37 48.06 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 122.679 2.253 . . . . 0.0 112.646 -175.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -47.88 -40.37 21.45 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.751 1.621 . . . . 0.0 111.011 169.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -64.65 -31.2 72.32 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 122.097 -0.377 . . . . 0.0 111.959 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -89.28 -9.17 51.61 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.2 1.0 . . . . 0.0 111.329 -169.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.7 mt -52.86 -40.07 34.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 123.811 0.845 . . . . 0.0 109.211 169.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.1 t -60.21 -40.84 84.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.041 0.537 . . . . 0.0 110.145 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.53 -47.49 63.56 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.836 0.454 . . . . 0.0 110.102 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 95.4 mt -53.55 -41.58 46.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.222 1.009 . . . . 0.0 110.079 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -66.34 -18.99 65.68 Favored 'General case' 0 CA--C 1.53 0.173 0 O-C-N 121.05 -1.031 . . . . 0.0 112.725 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -72.64 -40.7 66.21 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 120.228 1.376 . . . . 0.0 109.379 169.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 60.2 mt -73.72 -29.05 62.02 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.434 1.094 . . . . 0.0 111.934 -174.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 39.6 60.18 6.29 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 125.941 1.696 . . . . 0.0 111.877 -169.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.02 153.56 31.52 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.757 2.305 . . . . 0.0 114.043 -170.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.5 m -70.9 -37.81 72.98 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 168.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -148.59 155.5 41.18 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.038 0.935 . . . . 0.0 109.454 -174.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.6 tp -144.67 136.56 25.87 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.651 1.181 . . . . 0.0 108.347 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 58.5 tp -122.4 140.02 53.17 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 169.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.3 mt -124.06 143.17 38.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 41.4 t -141.07 135.33 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 118.571 0.623 . . . . 0.0 109.778 -173.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -163.96 171.8 14.79 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.52 2.328 . . . . 0.0 107.495 173.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.03 157.66 37.84 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.575 -0.703 . . . . 0.0 109.16 168.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.6 m -152.32 127.89 10.07 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -78.07 80.1 4.51 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 119.099 0.863 . . . . 0.0 110.222 176.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 73.7 mtm -75.47 -6.45 50.22 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.033 1.733 . . . . 0.0 112.379 -177.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.62 23.25 78.27 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-N 118.621 0.646 . . . . 0.0 111.822 -172.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.9 mt -100.33 -171.66 2.07 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.889 1.276 . . . . 0.0 109.948 -178.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -74.89 139.99 73.85 Favored Pre-proline 0 N--CA 1.468 0.451 0 CA-C-O 117.431 -1.271 . . . . 0.0 108.612 170.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -43.07 137.44 4.66 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.316 2.677 . . . . 0.0 113.31 172.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.45 0.58 79.32 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 118.641 -1.089 . . . . 0.0 113.646 176.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -65.05 146.57 54.83 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 119.82 1.81 . . . . 0.0 108.243 168.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.6 mt -125.94 138.44 54.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -175.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 91.0 mmt-85 -147.69 152.49 37.9 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 118.69 0.677 . . . . 0.0 111.442 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 37.3 mm -78.78 145.33 9.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 105.828 -1.915 . . . . 0.0 105.828 165.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.5 mt -129.61 124.14 58.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -76.8 140.68 67.56 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 117.859 -1.067 . . . . 0.0 109.586 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -47.42 -34.28 18.94 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 124.086 3.191 . . . . 0.0 116.581 179.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -67.74 -22.91 65.2 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.596 0.634 . . . . 0.0 111.806 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -101.54 -30.9 11.13 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.177 1.391 . . . . 0.0 111.35 -178.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 68.8 mt -50.41 -38.59 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.707 1.203 . . . . 0.0 109.547 169.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.22 -20.19 6.48 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.917 1.687 . . . . 0.0 114.285 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -124.76 -38.76 2.34 Favored 'General case' 0 C--N 1.334 -0.067 0 CA-C-N 118.811 0.732 . . . . 0.0 110.638 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 10.9 mmt -68.12 -24.48 65.02 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -172.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -74.78 -45.35 44.25 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 119.358 0.981 . . . . 0.0 111.066 173.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -78.56 6.23 9.13 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.732 -0.605 . . . . 0.0 112.583 177.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 50.4 tpp -58.7 -26.39 63.84 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.197 0.908 . . . . 0.0 110.115 168.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 42.4 p -59.22 -14.89 12.36 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.23 1.812 . . . . 0.0 113.059 169.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.7 m 61.4 23.25 13.53 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 126.325 1.85 . . . . 0.0 110.734 -168.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 59.8 m80 -147.43 -53.84 0.22 Allowed 'General case' 0 C--N 1.344 0.355 0 O-C-N 121.409 -0.807 . . . . 0.0 112.929 -171.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -68.23 150.0 48.83 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 118.155 0.434 . . . . 0.0 110.412 -169.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 90.8 mmm -63.12 150.53 88.51 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 171.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -73.06 82.32 1.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.708 2.939 . . . . 0.0 108.639 170.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 mt -50.05 -10.43 0.05 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 117.235 2.309 . . . . 0.0 117.235 -168.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.1 -21.13 4.37 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.093 0.957 . . . . 0.0 112.783 168.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -59.57 -29.49 67.97 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.453 1.024 . . . . 0.0 112.04 174.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.7 tt -76.62 -43.57 37.76 Favored 'General case' 0 C--N 1.338 0.103 0 O-C-N 121.399 -0.813 . . . . 0.0 109.667 175.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 77.7 mt -60.47 -43.93 95.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 C-N-CA 123.409 0.684 . . . . 0.0 109.299 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -60.79 -25.43 66.54 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -177.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -82.68 -3.09 55.82 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.879 0.872 . . . . 0.0 112.47 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.0 mt -134.89 -28.4 1.21 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.099 0.959 . . . . 0.0 112.626 -171.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -60.63 -22.04 63.38 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.149 0.98 . . . . 0.0 112.668 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -72.03 -10.25 59.52 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.623 1.169 . . . . 0.0 111.834 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -133.08 -42.57 0.88 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.433 1.093 . . . . 0.0 111.949 -173.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 29.0 mt -72.26 141.4 16.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -64.69 -41.86 97.5 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.119 0.866 . . . . 0.0 112.037 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -149.47 138.37 21.14 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.635 1.218 . . . . 0.0 108.906 176.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 54.0 t -131.28 124.98 56.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 16.9 mt -129.79 154.45 40.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -171.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -129.82 140.63 50.98 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 173.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.0 tt -120.09 129.72 54.32 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 174.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -112.58 156.55 15.52 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 68.8 mt -134.07 124.78 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 -177.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -65.28 118.1 46.69 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-O 117.423 -1.275 . . . . 0.0 110.363 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -77.15 172.05 16.77 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.656 2.904 . . . . 0.0 111.572 171.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -128.84 -31.96 2.14 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.785 1.634 . . . . 0.0 110.974 172.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.15 136.38 49.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.415 1.086 . . . . 0.0 108.269 175.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.1 t -141.1 134.36 31.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 175.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 159.7 151.55 6.2 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -64.71 157.98 25.91 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 117.642 0.721 . . . . 0.0 111.608 -175.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . 0.253 44.1 p90 44.37 41.4 4.49 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.333 2.253 . . . . 0.0 113.072 -174.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -121.51 148.41 50.12 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 123.95 0.9 . . . . 0.0 109.919 172.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -81.06 163.06 20.38 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.238 2.625 . . . . 0.0 111.259 177.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 54.2 ttm -72.22 139.66 48.28 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 168.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 68.3 p -80.6 159.88 25.28 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.365 1.066 . . . . 0.0 110.603 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.1 tm0? -51.23 -48.6 85.18 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-O 117.011 -1.471 . . . . 0.0 113.303 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -67.7 -29.64 35.65 Favored 'Trans proline' 0 C--N 1.352 0.727 0 CA-C-N 122.55 1.946 . . . . 0.0 112.423 -174.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -80.35 -35.32 15.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 119.046 0.839 . . . . 0.0 108.937 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -56.67 -46.78 80.93 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.418 1.008 . . . . 0.0 109.89 170.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -62.98 -38.57 91.66 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 122.961 0.504 . . . . 0.0 111.517 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.84 -46.74 80.62 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 119.193 -0.432 . . . . 0.0 111.017 176.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 73.8 t -62.25 -39.41 83.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 118.883 0.765 . . . . 0.0 109.81 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 34.6 tp10 -61.69 -40.98 96.92 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.031 0.832 . . . . 0.0 110.56 174.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 50.2 m -63.84 -45.87 87.59 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.06 0.544 . . . . 0.0 110.063 177.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 76.6 t -62.56 -44.17 99.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 118.831 0.741 . . . . 0.0 109.605 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -55.05 -46.95 75.4 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.317 1.047 . . . . 0.0 110.611 176.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -63.72 -39.7 94.94 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.659 0.663 . . . . 0.0 110.989 175.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.13 -26.06 67.43 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.421 0.688 . . . . 0.0 112.647 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 91.3 mt -57.11 -22.81 42.53 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.184 0.902 . . . . 0.0 112.231 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -81.43 -3.07 51.81 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.277 1.031 . . . . 0.0 112.166 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -152.01 -14.71 0.07 OUTLIER Glycine 0 CA--C 1.535 1.307 0 N-CA-C 115.962 1.145 . . . . 0.0 115.962 -172.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 15.7 t90 -59.71 141.66 54.7 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.573 1.686 . . . . 0.0 109.031 170.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -138.84 15.09 2.68 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.614 1.165 . . . . 0.0 111.407 173.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 156.53 -37.8 0.58 Allowed Glycine 0 CA--C 1.525 0.699 0 O-C-N 121.361 -0.837 . . . . 0.0 111.618 176.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -130.77 -26.76 2.18 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.781 0.659 . . . . 0.0 112.781 -174.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 57.45 17.08 24.36 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-N 118.675 0.671 . . . . 0.0 114.5 178.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.36 2.96 81.43 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-N 118.814 1.307 . . . . 0.0 113.531 -177.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -71.89 158.85 35.3 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 120.101 1.95 . . . . 0.0 110.153 175.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -80.81 149.71 29.47 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 171.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -88.98 123.07 32.97 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 173.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 62.9 tp -53.9 118.09 3.71 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.158 1.383 . . . . 0.0 109.925 177.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -151.66 102.85 2.9 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.642 0.777 . . . . 0.0 109.558 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . 0.263 33.9 m 40.64 46.56 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 127.27 2.228 . . . . 0.0 114.261 171.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -79.45 62.11 3.68 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.891 1.276 . . . . 0.0 109.924 -177.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 57.51 32.06 21.23 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.544 1.938 . . . . 0.0 112.271 -177.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 . . . . . 0 C--O 1.248 0.976 0 C-N-CA 126.676 1.99 . . . . 0.0 105.783 171.546 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.1 mtp . . . . . 0 N--CA 1.484 1.261 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.0 m -146.73 164.95 31.11 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.94 1.296 . . . . 0.0 107.82 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -144.44 133.34 22.56 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.8 m -132.92 154.73 40.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 124.002 0.921 . . . . 0.0 110.541 -169.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 30.6 tp -125.66 117.21 23.03 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 174.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 64.8 tp -104.74 97.52 7.39 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 96.9 m -73.15 143.73 47.16 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 169.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.0 t -142.16 144.47 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 175.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 147.64 174.48 19.6 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 124.653 1.121 . . . . 0.0 110.335 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -121.83 120.22 33.92 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 174.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 m -58.93 -12.95 5.13 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.446 1.898 . . . . 0.0 115.545 -169.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -129.61 12.82 5.91 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 119.321 0.964 . . . . 0.0 111.226 -177.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.8 ttt -94.32 32.17 1.59 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.868 0.758 . . . . 0.0 109.589 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.05 -145.12 26.75 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 -175.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -59.34 -18.06 34.88 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 125.952 1.701 . . . . 0.0 112.308 178.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -53.89 -25.58 20.77 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.819 1.248 . . . . 0.0 112.676 175.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.76 25.01 0.64 Allowed Glycine 0 CA--C 1.532 1.148 0 CA-C-O 118.7 -1.055 . . . . 0.0 114.277 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.08 -50.67 67.44 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 119.474 1.637 . . . . 0.0 110.432 -170.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.24 -55.64 29.0 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-O 117.881 -1.511 . . . . 0.0 110.98 175.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -50.65 -37.98 54.61 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 CA-C-N 121.106 2.453 . . . . 0.0 114.77 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.9 tp -71.75 -38.88 70.33 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 120.014 1.279 . . . . 0.0 110.509 176.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.1 tp -60.44 -47.65 85.19 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.341 0.518 . . . . 0.0 110.216 175.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.67 -40.96 85.05 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.479 1.111 . . . . 0.0 110.975 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.0 tp10 -61.97 -49.68 75.11 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-N 118.717 0.69 . . . . 0.0 109.693 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -63.64 -45.3 90.87 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.729 0.412 . . . . 0.0 110.81 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 75.5 m -65.32 -38.35 89.89 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.566 0.621 . . . . 0.0 111.094 178.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.91 -39.84 95.1 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.248 0.931 . . . . 0.0 110.906 176.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.41 -33.87 75.0 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.261 0.624 . . . . 0.0 111.805 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.47 91.08 3.35 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 125.141 1.376 . . . . 0.0 108.767 -173.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -51.66 161.32 2.13 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 124.035 3.157 . . . . 0.0 114.852 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.409 ' HE2' ' CE1' ' A' ' 136' ' ' TYR . 37.9 mmtm -137.98 158.78 43.63 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.345 1.458 . . . . 0.0 108.969 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 41.44 -120.15 1.86 Allowed Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.362 1.458 . . . . 0.0 111.737 175.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -136.79 16.26 3.09 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.685 1.194 . . . . 0.0 110.787 174.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 2.0 m95 -75.0 120.29 20.34 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 121.324 -0.86 . . . . 0.0 109.018 -170.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.7 t -71.02 111.12 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 168.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.3 t -71.33 138.33 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -177.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 98.5 mt -135.91 142.73 38.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 104.03 -2.581 . . . . 0.0 104.03 173.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -126.37 107.04 9.92 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 175.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.3 -11.38 71.29 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 118.523 -1.154 . . . . 0.0 113.391 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.17 34.64 80.7 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-N 119.425 1.612 . . . . 0.0 113.713 170.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 63.23 14.04 7.43 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.007 1.723 . . . . 0.0 114.242 -174.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.79 56.88 12.11 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 125.385 1.474 . . . . 0.0 108.057 169.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -68.58 -15.41 41.37 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.396 2.064 . . . . 0.0 113.128 -168.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -51.45 -34.14 33.99 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.086 0.857 . . . . 0.0 112.074 170.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.17 -26.4 68.31 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.215 0.606 . . . . 0.0 112.289 177.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -103.0 -5.66 23.18 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.956 1.302 . . . . 0.0 111.403 -170.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 73.9 mt -55.47 -41.63 64.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 119.112 0.869 . . . . 0.0 109.604 174.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.6 t -60.3 -41.21 86.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 118.524 0.602 . . . . 0.0 109.797 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.76 -45.19 83.47 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.87 0.468 . . . . 0.0 110.38 -178.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 90.2 mt -56.43 -48.38 80.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -63.02 -34.52 77.73 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 118.206 -0.902 . . . . 0.0 112.005 -174.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -58.01 -32.2 67.71 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.482 1.037 . . . . 0.0 111.537 175.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 78.9 mt -84.75 -8.65 58.75 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.174 0.99 . . . . 0.0 112.703 -175.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 27.74 62.26 0.64 Allowed Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 126.892 2.077 . . . . 0.0 112.794 -168.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.33 149.62 63.89 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.246 1.964 . . . . 0.0 113.543 -173.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.49 -26.43 35.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.784 168.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -145.21 151.32 38.22 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.811 0.844 . . . . 0.0 109.841 177.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 25.1 tp -140.91 141.31 34.56 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 125.551 1.54 . . . . 0.0 108.132 172.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 34.3 tp -129.34 138.88 51.81 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 171.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.8 mt -124.66 141.37 44.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 -174.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.9 t -140.86 133.47 30.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 118.728 0.694 . . . . 0.0 109.898 -174.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -161.28 172.44 16.63 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.442 2.297 . . . . 0.0 107.122 174.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.27 158.28 36.16 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.157 -0.965 . . . . 0.0 108.622 167.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.5 m -153.23 129.22 10.3 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 174.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -77.03 80.59 3.56 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.705 0.764 . . . . 0.0 109.94 175.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 76.3 mtm -76.46 -6.76 53.13 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.313 1.445 . . . . 0.0 112.241 -174.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.58 31.28 60.89 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -172.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 77.3 mt -110.97 -170.8 1.7 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.745 1.218 . . . . 0.0 109.722 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -81.14 140.82 49.61 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 117.668 -1.158 . . . . 0.0 108.84 174.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -46.51 132.94 16.34 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.198 2.599 . . . . 0.0 113.614 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.58 1.33 90.1 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 118.506 -1.164 . . . . 0.0 113.412 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -65.65 153.79 40.65 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 119.902 1.851 . . . . 0.0 108.49 168.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 62.3 mt -132.74 140.95 46.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -170.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 82.3 mmt-85 -149.44 152.98 36.59 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.365 0.666 . . . . 0.0 109.981 170.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 35.8 mm -77.29 145.33 10.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 165.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.3 mt -129.57 161.97 38.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 176.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -131.14 144.78 54.95 Favored Pre-proline 0 C--O 1.234 0.288 0 C-N-CA 126.519 1.928 . . . . 0.0 107.181 -171.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -54.28 -27.97 50.43 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 123.18 2.586 . . . . 0.0 115.139 -174.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -68.96 -19.98 64.18 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.948 0.794 . . . . 0.0 112.197 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -117.01 -30.88 5.56 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.164 1.386 . . . . 0.0 111.771 -171.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 65.6 mt -50.15 -40.87 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.268 1.427 . . . . 0.0 109.78 169.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.25 -26.13 37.92 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.822 1.249 . . . . 0.0 113.458 -176.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -108.14 -39.42 5.5 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 123.337 0.655 . . . . 0.0 110.021 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 21.4 mmt -69.21 -26.32 64.76 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -174.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -72.13 -46.37 56.83 Favored 'General case' 0 C--O 1.228 -0.052 0 CA-C-N 119.109 0.868 . . . . 0.0 110.799 174.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 27.6 ptm -74.94 9.23 2.01 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -176.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 76.7 mmm -53.88 -28.41 36.15 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.635 1.174 . . . . 0.0 111.977 171.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 30.9 p -76.56 32.69 0.13 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.361 1.864 . . . . 0.0 112.064 -178.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.4 m 68.87 -41.5 0.47 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 128.644 2.778 . . . . 0.0 112.081 -169.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -152.01 152.52 32.55 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.925 1.69 . . . . 0.0 107.084 169.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -163.44 175.37 10.85 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.828 1.251 . . . . 0.0 107.933 174.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 65.9 mtt -70.37 127.01 92.48 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 168.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -76.91 71.6 6.12 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 123.312 2.675 . . . . 0.0 108.603 173.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.1 mt -49.3 -14.86 0.1 Allowed 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 116.939 2.2 . . . . 0.0 116.939 -167.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.47 -20.31 4.62 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 117.878 -1.058 . . . . 0.0 113.02 168.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -54.77 -35.74 64.12 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 119.967 1.258 . . . . 0.0 111.517 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.8 tt -75.38 -44.09 46.7 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.329 0.652 . . . . 0.0 109.592 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 94.3 mt -62.95 -44.11 99.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -64.67 -17.65 64.26 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -171.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -109.6 13.68 23.76 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.306 1.043 . . . . 0.0 112.085 178.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 72.8 mt -129.5 -34.48 1.8 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.178 1.391 . . . . 0.0 110.783 177.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -57.5 -22.17 42.39 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.265 1.426 . . . . 0.0 112.693 176.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -70.16 -14.84 62.82 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.656 1.182 . . . . 0.0 111.931 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -137.52 -32.31 0.77 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.144 0.883 . . . . 0.0 113.045 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 32.5 mt -70.46 138.26 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 174.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -64.24 -42.87 97.71 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.268 0.937 . . . . 0.0 112.385 -176.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -144.75 134.62 23.72 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.664 1.232 . . . . 0.0 108.336 175.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 47.8 t -125.95 127.8 71.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 177.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.9 mt -130.84 153.29 38.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 -168.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -133.17 145.56 50.75 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 175.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.1 tt -127.87 133.46 49.34 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 171.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -114.16 157.06 15.22 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 80.8 mt -134.47 126.88 49.31 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -65.04 116.52 30.71 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-O 117.583 -1.199 . . . . 0.0 110.372 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -79.17 173.5 13.29 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.247 2.631 . . . . 0.0 111.789 171.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -136.71 -28.7 0.97 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.373 2.269 . . . . 0.0 111.382 172.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -132.42 119.63 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 -173.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.3 t -143.67 131.78 18.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 153.54 152.82 6.16 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -67.12 150.89 48.54 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.974 0.893 . . . . 0.0 111.27 -174.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 13.0 t80 51.69 40.67 27.9 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.839 2.055 . . . . 0.0 112.107 -174.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.4 m-30 -115.79 142.54 29.18 Favored Pre-proline 0 C--O 1.237 0.434 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 170.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -74.27 160.44 42.22 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.636 2.224 . . . . 0.0 110.46 170.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.1 ttm -74.69 141.98 44.49 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 169.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 39.9 p -79.53 157.42 27.42 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.426 1.091 . . . . 0.0 110.653 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -52.55 -42.47 88.39 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-O 116.579 -1.677 . . . . 0.0 114.721 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -70.81 -28.55 20.08 Favored 'Trans proline' 0 C--N 1.351 0.707 0 CA-C-N 123.043 2.123 . . . . 0.0 111.883 -175.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.23 -36.53 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -56.68 -45.93 81.43 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.297 0.953 . . . . 0.0 110.091 170.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -63.34 -41.6 98.89 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 123.064 0.546 . . . . 0.0 111.117 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.69 -47.09 85.13 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.833 0.453 . . . . 0.0 111.043 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.0 t -60.81 -42.33 91.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 177.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -68.26 -28.27 67.06 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.874 0.761 . . . . 0.0 111.602 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 42.9 m -69.03 -46.29 68.3 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.214 -0.929 . . . . 0.0 109.492 173.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 90.1 t -61.65 -43.43 97.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 119.111 0.869 . . . . 0.0 109.597 176.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.409 ' CE1' ' HE2' ' A' ' 31' ' ' LYS . 20.4 t80 -52.96 -46.12 68.07 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.209 1.004 . . . . 0.0 111.227 175.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -66.11 -42.43 89.23 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.628 0.649 . . . . 0.0 111.003 175.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -58.4 -37.31 75.05 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.882 0.873 . . . . 0.0 111.76 -175.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 72.1 mt -57.21 -18.59 16.49 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.154 0.982 . . . . 0.0 113.137 -175.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -77.29 -24.12 50.99 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.671 1.123 . . . . 0.0 112.431 177.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -139.14 3.0 2.7 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-N 118.93 0.786 . . . . 0.0 114.45 -169.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -54.43 133.74 45.71 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.699 1.6 . . . . 0.0 109.208 173.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -139.14 149.4 44.45 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 169.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 51.38 -121.67 12.86 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 123.995 0.807 . . . . 0.0 111.749 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -76.29 5.53 6.88 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.768 1.227 . . . . 0.0 112.957 -178.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 68.96 15.16 69.03 Favored Glycine 0 CA--C 1.528 0.856 0 O-C-N 121.068 -1.02 . . . . 0.0 112.529 -176.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 69.06 -9.47 2.07 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-N 118.642 1.221 . . . . 0.0 113.844 -174.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -68.81 156.44 38.37 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.103 1.451 . . . . 0.0 109.27 173.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -78.24 151.86 32.87 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 172.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -98.19 119.74 37.38 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 55.1 tp -57.05 130.42 46.04 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.262 1.425 . . . . 0.0 110.301 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.91 -50.4 0.65 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.073 0.949 . . . . 0.0 111.86 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 8.5 p -157.53 -0.97 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 123.74 0.816 . . . . 0.0 112.47 -169.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -63.95 155.05 32.13 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.337 -0.852 . . . . 0.0 111.617 -170.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -148.21 141.89 25.57 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 169.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 . . . . . 0 C--O 1.249 1.066 0 C-N-CA 124.791 1.236 . . . . 0.0 107.733 -175.966 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 N--CA 1.483 1.194 0 CA-C-O 118.616 -0.707 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.5 m -145.8 159.83 42.63 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.374 0.988 . . . . 0.0 108.413 -176.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -134.91 137.68 43.4 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 174.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 51.2 t -139.42 151.8 22.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 119.003 0.82 . . . . 0.0 109.921 -167.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 33.7 tp -126.2 129.86 49.82 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 126.069 1.748 . . . . 0.0 106.402 176.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.9 tp -117.31 100.95 8.03 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 124.915 1.286 . . . . 0.0 107.886 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 89.4 m -76.04 141.23 42.15 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 169.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 50.9 t -139.96 142.93 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 143.18 174.39 15.43 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.252 0.93 . . . . 0.0 111.709 176.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -118.32 120.16 36.8 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.7 1.2 . . . . 0.0 108.869 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -59.67 -15.97 23.12 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.356 1.862 . . . . 0.0 115.228 -170.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 27.7 ptm -126.88 14.47 7.42 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.206 1.003 . . . . 0.0 111.167 -175.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.2 ttt -101.78 31.58 3.78 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.41 0.684 . . . . 0.0 110.048 -177.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.29 -142.49 21.3 Favored Glycine 0 C--N 1.337 0.584 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -60.26 -17.68 43.82 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.784 1.234 . . . . 0.0 112.352 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -57.09 -19.75 21.36 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.88 1.272 . . . . 0.0 112.557 176.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.13 21.17 0.85 Allowed Glycine 0 CA--C 1.534 1.238 0 O-C-N 120.761 -1.212 . . . . 0.0 114.278 176.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.25 -53.18 58.86 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.588 1.694 . . . . 0.0 110.943 -170.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.59 -53.94 41.86 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 117.791 -1.561 . . . . 0.0 111.02 175.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -48.97 -41.02 40.63 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 CA-C-N 120.78 2.29 . . . . 0.0 115.217 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.7 tp -71.51 -37.74 71.19 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 120.265 1.393 . . . . 0.0 110.372 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.9 tp -61.91 -46.98 87.02 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.047 0.385 . . . . 0.0 110.252 175.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.53 -40.6 87.69 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 124.021 0.929 . . . . 0.0 111.111 177.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -60.94 -48.81 80.1 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 118.833 0.742 . . . . 0.0 109.789 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -62.34 -46.13 90.07 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 122.959 0.504 . . . . 0.0 110.569 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 79.6 m -64.57 -38.36 90.74 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.271 0.487 . . . . 0.0 111.219 178.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.54 -38.64 91.72 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.886 0.766 . . . . 0.0 110.988 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.36 -38.28 78.02 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.203 0.601 . . . . 0.0 111.157 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.32 94.57 2.16 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 125.205 1.402 . . . . 0.0 108.497 -173.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -56.01 159.67 11.75 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 123.526 2.817 . . . . 0.0 113.328 178.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -135.74 167.51 21.01 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 126.053 1.741 . . . . 0.0 108.336 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 44.23 -127.32 6.54 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.509 1.052 . . . . 0.0 111.831 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -136.16 9.89 3.26 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.854 1.261 . . . . 0.0 111.699 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -71.33 125.12 26.13 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 123.986 0.914 . . . . 0.0 109.252 -172.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 51.1 t -69.9 123.79 24.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 166.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.4 t -77.45 135.38 26.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -178.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.6 mm -130.65 145.9 34.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 104.292 -2.484 . . . . 0.0 104.292 168.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -134.33 107.92 7.9 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 177.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.54 -1.9 89.06 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 118.966 -0.908 . . . . 0.0 112.49 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 54.22 -145.1 27.23 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -169.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.8 p -89.71 13.75 13.48 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 122.01 -0.7 . . . . 0.0 111.869 177.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.54 58.63 10.42 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 124.995 1.318 . . . . 0.0 110.498 -177.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -72.25 -22.09 22.57 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.873 2.382 . . . . 0.0 112.967 -171.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.72 -36.19 78.22 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.847 0.749 . . . . 0.0 111.856 -177.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -65.0 -11.89 44.06 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.867 0.867 . . . . 0.0 112.931 175.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -113.75 -0.25 14.3 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.305 1.042 . . . . 0.0 112.29 -172.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 62.5 mt -48.17 -41.19 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 125.124 1.37 . . . . 0.0 110.732 174.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.0 t -56.77 -44.02 80.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.313 0.645 . . . . 0.0 110.198 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.32 93.03 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.974 0.51 . . . . 0.0 110.966 -177.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 64.7 mt -64.27 -45.53 95.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.1 mtp180 -64.89 -31.29 72.45 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.512 -176.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -57.92 -33.06 68.38 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.667 1.121 . . . . 0.0 111.558 174.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 33.0 mt -76.22 -8.23 56.61 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 118.571 -0.728 . . . . 0.0 112.778 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.1 mtp180 31.8 62.12 1.23 Allowed Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 126.994 2.118 . . . . 0.0 112.359 -169.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -55.07 142.67 76.63 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.835 2.357 . . . . 0.0 112.305 -172.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.2 m -81.68 -31.84 32.04 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.682 0.793 . . . . 0.0 108.913 168.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -142.55 150.76 40.82 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.611 1.564 . . . . 0.0 107.721 174.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 56.4 tp -138.81 142.89 38.7 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.645 1.178 . . . . 0.0 108.088 173.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 35.0 tp -128.49 138.93 52.52 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 173.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.1 mt -125.31 142.07 43.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 -175.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.4 t -140.83 134.11 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 118.593 0.633 . . . . 0.0 110.08 -174.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -161.52 171.18 18.54 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.252 2.221 . . . . 0.0 107.739 171.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.4 156.84 39.01 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.133 -0.979 . . . . 0.0 108.621 168.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.3 m -155.86 127.74 7.45 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 176.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -71.48 123.76 23.12 Favored 'General case' 0 N--CA 1.461 0.097 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 171.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 75.4 mtm -123.24 1.73 9.12 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.032 1.733 . . . . 0.0 110.705 -175.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.83 25.21 68.97 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-N 118.747 0.703 . . . . 0.0 112.332 -173.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.0 mt -99.92 -172.25 2.2 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.332 1.453 . . . . 0.0 109.292 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -75.36 140.22 72.34 Favored Pre-proline 0 N--CA 1.469 0.49 0 CA-C-O 117.539 -1.219 . . . . 0.0 108.667 173.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -43.43 136.32 6.1 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 123.343 2.695 . . . . 0.0 113.081 172.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.31 3.48 76.91 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 118.779 -1.012 . . . . 0.0 113.75 178.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -64.74 148.57 50.88 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 119.754 1.777 . . . . 0.0 108.581 168.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 76.5 mt -125.89 136.09 61.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 -173.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 90.1 mmt-85 -148.18 152.64 37.59 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 118.512 0.596 . . . . 0.0 111.101 175.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 41.5 mm -81.58 144.74 9.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 166.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.8 mt -126.79 129.33 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -73.5 139.14 77.86 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 118.185 -0.912 . . . . 0.0 109.36 172.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -45.37 -36.26 12.81 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 124.46 3.44 . . . . 0.0 116.4 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -66.67 -26.78 67.2 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.445 0.566 . . . . 0.0 111.687 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -97.7 -28.57 13.84 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.515 1.126 . . . . 0.0 111.149 -178.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 45.9 mt -51.04 -43.38 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.613 1.165 . . . . 0.0 110.229 170.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -52.99 -31.49 41.17 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.593 1.157 . . . . 0.0 112.804 -177.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -97.58 -42.33 7.72 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.314 0.646 . . . . 0.0 109.843 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 22.5 mmt -67.3 -33.38 75.17 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -171.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -62.43 -43.37 98.97 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 118.454 0.57 . . . . 0.0 110.655 176.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 27.8 ptm -80.43 15.61 1.58 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 26.2 mmt -74.0 -29.0 61.73 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.896 -1.127 . . . . 0.0 109.675 168.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 67.1 p -74.34 -45.87 44.4 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 122.937 0.495 . . . . 0.0 110.846 -173.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.5 p -164.82 -172.03 2.48 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 128.808 2.843 . . . . 0.0 105.194 -167.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -73.2 51.8 0.33 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.359 1.064 . . . . 0.0 109.448 167.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -65.34 161.05 20.43 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 126.985 2.114 . . . . 0.0 110.45 -171.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.2 mmt -63.3 136.27 96.62 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-O 118.402 -0.809 . . . . 0.0 109.075 172.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.87 61.48 6.33 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 123.946 3.097 . . . . 0.0 109.188 169.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.6 mt -52.63 -7.08 0.06 Allowed 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 128.016 2.526 . . . . 0.0 117.061 -167.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -52.84 -23.32 6.75 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.256 0.934 . . . . 0.0 112.045 167.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -60.64 -27.08 67.52 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.828 0.74 . . . . 0.0 112.583 175.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.5 tt -69.64 -43.78 71.95 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 119.023 0.829 . . . . 0.0 109.372 175.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 76.7 mt -61.95 -43.48 97.58 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.093 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -64.38 -16.46 62.33 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -105.54 16.98 24.6 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.33 1.452 . . . . 0.0 111.18 177.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.6 mt -136.06 -37.5 0.72 Allowed 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.703 1.201 . . . . 0.0 110.994 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -55.59 -22.32 21.63 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.569 1.148 . . . . 0.0 112.742 176.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -60.23 -24.71 65.08 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.504 1.522 . . . . 0.0 112.122 -177.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -134.05 7.42 3.7 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.681 0.792 . . . . 0.0 112.488 -171.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 76.5 mt -122.41 141.51 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.977 1.311 . . . . 0.0 108.291 -174.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.27 -39.64 81.88 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 123.864 0.745 . . . . 0.0 111.809 -176.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -147.38 132.86 18.65 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 118.307 1.054 . . . . 0.0 108.256 176.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 41.5 t -122.65 129.38 75.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 172.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 15.1 mt -129.24 148.68 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 -169.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -129.6 141.18 51.0 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 170.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.5 tt -123.53 127.98 49.11 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 175.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -109.48 155.63 16.0 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 83.4 mt -133.06 126.01 52.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.103 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -62.76 114.47 12.32 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-O 117.778 -1.106 . . . . 0.0 110.453 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -75.96 170.48 20.02 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.171 2.581 . . . . 0.0 111.111 170.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -129.75 -30.11 2.08 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.493 1.917 . . . . 0.0 111.025 169.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.1 pp -136.03 137.02 49.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 123.891 0.876 . . . . 0.0 109.025 176.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 75.7 t -146.36 139.64 20.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 153.9 151.51 5.78 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 108.776 -1.729 . . . . 0.0 108.776 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -64.27 149.11 48.73 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 118.086 0.943 . . . . 0.0 110.597 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.6 t80 58.43 46.08 15.7 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.292 1.837 . . . . 0.0 111.577 -175.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -132.81 147.27 64.8 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 123.853 0.861 . . . . 0.0 109.759 168.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -81.87 166.12 17.23 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.554 2.836 . . . . 0.0 110.827 176.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.1 ttm -70.0 134.64 48.52 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 169.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.04 159.66 31.46 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.557 1.143 . . . . 0.0 110.57 175.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.63 -46.39 99.59 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-O 117.233 -1.365 . . . . 0.0 113.538 -171.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -67.07 -26.8 42.74 Favored 'Trans proline' 0 C--N 1.35 0.615 0 CA-C-N 122.209 1.824 . . . . 0.0 112.593 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.24 -35.7 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -56.24 -46.79 79.45 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.138 0.881 . . . . 0.0 109.984 170.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -63.11 -38.09 89.8 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 122.722 0.409 . . . . 0.0 111.444 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.49 -47.78 77.67 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 122.033 -0.417 . . . . 0.0 111.056 175.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 71.4 t -61.21 -39.28 81.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 118.672 0.669 . . . . 0.0 109.719 178.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 32.6 tp10 -63.91 -39.09 93.36 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.13 0.877 . . . . 0.0 110.927 175.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 51.7 m -63.9 -48.07 78.08 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.763 -0.586 . . . . 0.0 109.854 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 79.2 t -60.3 -46.08 95.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -54.62 -48.78 71.82 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.05 0.94 . . . . 0.0 110.849 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -65.06 -38.16 89.91 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.456 0.571 . . . . 0.0 111.194 177.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -62.14 -29.25 70.21 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 118.367 -0.825 . . . . 0.0 111.552 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 83.9 mt -55.01 -21.28 11.54 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.3 0.954 . . . . 0.0 112.909 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -80.06 -21.94 42.84 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.309 0.959 . . . . 0.0 112.595 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -143.61 5.53 1.81 Allowed Glycine 0 CA--C 1.532 1.104 0 CA-C-N 118.859 0.754 . . . . 0.0 114.726 -169.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.8 t-105 -52.81 138.46 29.33 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.809 1.643 . . . . 0.0 109.266 171.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -141.52 145.34 35.05 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 170.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 58.09 -106.4 0.81 Allowed Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -174.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -110.2 14.28 22.86 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.28 1.432 . . . . 0.0 112.097 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 79.19 2.65 87.63 Favored Glycine 0 CA--C 1.526 0.748 0 O-C-N 121.535 -0.728 . . . . 0.0 112.65 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.32 6.13 64.6 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 118.965 1.382 . . . . 0.0 112.67 -176.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -67.22 148.8 51.3 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 118.829 1.315 . . . . 0.0 108.48 171.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.95 146.41 47.79 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -92.3 121.02 33.39 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 177.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 62.5 tp -55.12 130.52 42.27 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.791 1.637 . . . . 0.0 110.631 178.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -145.34 53.9 1.19 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.314 1.046 . . . . 0.0 109.522 176.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 57.1 t 71.75 -44.4 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 128.567 2.747 . . . . 0.0 113.026 176.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 53.47 30.92 11.28 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.693 1.997 . . . . 0.0 113.362 174.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -153.22 170.69 19.95 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.168 1.787 . . . . 0.0 108.217 169.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 . . . . . 0 C--O 1.246 0.917 0 C-N-CA 125.541 1.537 . . . . 0.0 106.889 178.376 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.3 mmt . . . . . 0 N--CA 1.484 1.254 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.6 m -135.09 93.17 2.96 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -174.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -78.5 143.58 36.47 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 169.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.432 HG21 ' HG3' ' A' ' 55' ' ' PRO . 78.4 t -136.77 149.11 26.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -175.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 37.0 tp -127.93 112.06 14.26 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.415 1.486 . . . . 0.0 107.066 -175.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 51.9 tp -101.45 97.22 7.71 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 125.129 1.372 . . . . 0.0 107.883 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 87.3 m -73.11 143.03 47.51 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 169.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.0 t -141.71 144.82 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 176.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.79 174.34 17.87 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -124.76 119.31 28.55 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.128 1.371 . . . . 0.0 107.846 176.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 m -60.44 -14.2 17.87 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.185 1.794 . . . . 0.0 115.313 -169.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 27.9 ptm -125.22 13.14 8.29 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.153 0.981 . . . . 0.0 111.067 -176.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.3 ttt -100.7 29.68 4.38 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.567 0.747 . . . . 0.0 109.83 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.78 -142.26 20.75 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -61.86 -17.04 55.02 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.592 1.157 . . . . 0.0 112.221 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -54.87 -24.53 23.67 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.433 1.493 . . . . 0.0 113.236 176.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.21 24.49 0.71 Allowed Glycine 0 CA--C 1.533 1.191 0 CA-C-O 118.575 -1.125 . . . . 0.0 114.447 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.31 -51.45 65.98 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 119.468 1.634 . . . . 0.0 110.826 -169.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.17 -54.8 34.33 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-O 117.809 -1.55 . . . . 0.0 111.021 175.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -50.22 -37.68 49.73 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 CA-C-N 121.085 2.442 . . . . 0.0 114.841 178.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.7 tp -71.05 -39.79 72.04 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 120.117 1.326 . . . . 0.0 110.546 176.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.7 tp -60.9 -46.74 89.43 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.225 0.466 . . . . 0.0 110.479 175.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.48 -41.74 90.51 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 124.222 1.009 . . . . 0.0 110.913 176.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -61.06 -48.36 82.09 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 118.932 0.787 . . . . 0.0 110.046 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -61.2 -47.55 85.6 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 122.917 0.487 . . . . 0.0 110.513 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 80.9 m -64.5 -38.16 90.06 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.252 0.478 . . . . 0.0 111.183 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.7 -38.45 91.05 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.857 0.753 . . . . 0.0 111.077 177.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.78 -37.58 76.39 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.349 0.659 . . . . 0.0 111.218 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.31 98.56 1.97 Allowed Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 125.448 1.499 . . . . 0.0 107.856 -174.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -56.08 167.39 2.48 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 123.93 3.087 . . . . 0.0 114.664 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.5 ' HE2' ' CZ ' ' A' ' 136' ' ' TYR . 71.4 mmtt -135.93 160.14 39.51 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 126.055 1.742 . . . . 0.0 107.858 176.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 42.29 -121.19 2.6 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.861 1.22 . . . . 0.0 111.867 175.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -137.25 15.76 3.0 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.036 1.734 . . . . 0.0 111.142 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 13.0 m95 -72.26 131.27 42.49 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.565 0.746 . . . . 0.0 110.243 -171.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.0 t -75.73 118.03 21.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 104.273 -2.491 . . . . 0.0 104.273 165.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.0 t -72.81 134.82 29.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.7 mm -133.33 148.1 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 171.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -135.45 113.82 11.53 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 176.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.04 -13.27 83.21 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 118.613 -1.104 . . . . 0.0 112.81 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.56 34.05 79.69 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-N 119.62 1.71 . . . . 0.0 113.784 172.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 61.87 14.03 5.98 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.951 1.7 . . . . 0.0 114.261 -172.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -135.54 58.05 23.0 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 125.807 1.643 . . . . 0.0 107.657 169.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -71.26 -25.41 22.05 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.018 1.812 . . . . 0.0 111.873 -169.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.42 -30.69 71.77 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.668 0.787 . . . . 0.0 111.867 -179.068 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -63.02 -15.34 56.1 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.029 0.932 . . . . 0.0 112.419 172.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -117.32 1.07 12.37 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.369 1.068 . . . . 0.0 112.568 -169.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 78.7 mt -48.82 -37.29 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.869 1.268 . . . . 0.0 110.512 171.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.8 t -55.93 -41.26 66.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 123.683 0.793 . . . . 0.0 110.333 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.78 -41.96 82.41 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 118.479 0.582 . . . . 0.0 110.562 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.6 mt -61.06 -41.57 89.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 176.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -67.33 -19.99 65.53 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 117.693 -1.146 . . . . 0.0 112.505 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -72.25 -44.97 62.06 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 120.655 1.57 . . . . 0.0 108.894 169.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 56.5 mt -69.04 -26.4 64.96 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 118.489 -0.767 . . . . 0.0 112.703 -176.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 37.43 63.65 3.19 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 125.778 1.631 . . . . 0.0 111.443 -169.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.432 ' HG3' HG21 ' A' ' 4' ' ' VAL . 53.1 Cg_exo -51.45 144.55 31.57 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.214 2.609 . . . . 0.0 113.774 -170.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.4 m -67.08 -42.18 85.1 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 167.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 73.0 mtm180 -144.08 153.82 42.57 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 124.769 1.228 . . . . 0.0 108.105 174.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 56.9 tp -133.16 137.01 46.07 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 35.0 tp -124.01 133.71 53.61 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.715 -1.958 . . . . 0.0 105.715 174.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.2 mt -122.22 139.75 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 -175.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.4 t -140.24 133.36 34.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 118.203 0.456 . . . . 0.0 109.828 -172.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -162.32 172.9 14.92 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.24 2.216 . . . . 0.0 107.397 176.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.73 157.73 37.4 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.112 -0.993 . . . . 0.0 108.326 167.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.0 m -154.66 130.18 9.86 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 174.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -74.55 124.19 26.17 Favored 'General case' 0 N--CA 1.461 0.105 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 172.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 77.1 mtm -122.18 0.44 9.57 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.547 1.539 . . . . 0.0 110.814 -175.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.55 24.83 68.19 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-N 118.576 0.626 . . . . 0.0 112.364 -172.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 58.8 mt -100.67 -169.61 1.74 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.964 1.305 . . . . 0.0 108.568 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -82.2 147.01 56.06 Favored Pre-proline 0 N--CA 1.471 0.62 0 CA-C-O 118.466 -0.778 . . . . 0.0 109.747 174.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -46.81 136.1 17.02 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.379 2.719 . . . . 0.0 112.348 176.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.56 1.87 90.3 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 118.483 -1.176 . . . . 0.0 113.45 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -64.53 148.54 50.5 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 119.906 1.853 . . . . 0.0 108.356 168.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 69.3 mt -128.76 135.95 61.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 -172.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 -148.7 150.84 33.87 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 118.666 0.666 . . . . 0.0 111.926 177.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 51.4 mm -79.45 143.61 12.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 166.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.8 mt -128.63 125.61 63.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -74.87 140.54 74.34 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.266 172.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -45.66 -34.57 11.69 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 124.369 3.379 . . . . 0.0 116.628 177.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -68.58 -24.99 64.66 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.57 0.623 . . . . 0.0 111.807 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -98.69 -30.37 12.49 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.865 1.266 . . . . 0.0 111.076 -177.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 63.7 mt -49.91 -40.91 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.692 1.197 . . . . 0.0 109.189 169.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.0 -19.72 19.99 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.161 1.384 . . . . 0.0 114.454 -174.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -117.91 -36.24 3.69 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 118.699 0.682 . . . . 0.0 110.084 176.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 38.4 mmt -69.19 -25.46 64.34 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -176.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -70.21 -47.15 62.71 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 119.164 0.893 . . . . 0.0 111.238 173.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 20.1 ptp -70.48 -13.4 62.1 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 118.608 -0.711 . . . . 0.0 112.881 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 27.9 ttt -58.49 -24.24 59.96 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.051 0.841 . . . . 0.0 111.663 175.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 44.0 p -61.85 -82.29 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.414 1.086 . . . . 0.0 110.082 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.3 p -155.7 54.31 0.6 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.556 2.343 . . . . 0.0 107.544 178.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 56.59 39.18 29.95 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.554 1.142 . . . . 0.0 112.52 -176.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -60.02 150.68 28.47 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 167.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -58.67 140.88 85.13 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 123.654 0.781 . . . . 0.0 109.735 -176.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -72.55 79.01 1.92 Allowed 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 125.101 3.868 . . . . 0.0 108.881 178.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 mt -50.87 -7.29 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 117.694 2.479 . . . . 0.0 117.694 -167.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -54.42 -21.79 10.71 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.21 -0.931 . . . . 0.0 112.192 167.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -60.0 -31.77 70.24 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.445 1.02 . . . . 0.0 111.751 174.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.9 tt -73.91 -45.71 48.9 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.758 0.708 . . . . 0.0 109.114 174.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 85.4 mt -57.22 -42.81 80.7 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -62.41 -21.58 65.5 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -85.42 -2.33 57.99 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.829 0.852 . . . . 0.0 112.226 177.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.442 ' HB3' HD12 ' A' ' 105' ' ' ILE . 2.4 mm? -129.95 -33.93 1.74 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.316 1.047 . . . . 0.0 112.51 -178.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 13.4 pttm -62.92 -19.72 64.5 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.658 0.783 . . . . 0.0 112.983 -171.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -72.09 -12.17 61.08 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.389 1.075 . . . . 0.0 111.814 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -133.26 -34.05 1.09 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.226 0.921 . . . . 0.0 112.915 -177.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.442 HD12 ' HB3' ' A' ' 101' ' ' LEU . 23.8 mt -67.87 143.19 15.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 171.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.81 -39.9 93.6 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 123.954 0.788 . . . . 0.0 112.39 -177.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -150.49 138.72 20.3 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 118.379 1.089 . . . . 0.0 108.442 174.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 39.0 t -122.41 132.07 71.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 174.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.2 mt -130.92 147.35 33.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 -169.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -132.68 140.74 48.27 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 175.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.9 tt -125.5 133.85 52.24 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 174.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -116.71 156.83 15.4 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 177.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 87.1 mt -134.39 127.53 50.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 -177.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -63.9 114.34 13.25 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 117.38 -1.295 . . . . 0.0 110.151 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -76.09 170.56 19.83 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.152 2.568 . . . . 0.0 111.154 170.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -128.81 -32.04 2.14 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.031 1.732 . . . . 0.0 110.986 171.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -135.58 136.23 50.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 177.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.4 t -141.73 135.55 30.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 176.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 157.47 150.73 5.8 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -66.14 152.67 44.25 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.78 0.8 . . . . 0.0 111.08 -176.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 25.0 t80 55.05 39.88 31.74 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.536 1.934 . . . . 0.0 111.648 -175.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -125.06 147.96 58.67 Favored Pre-proline 0 C--O 1.237 0.427 0 C-N-CA 123.669 0.787 . . . . 0.0 109.815 169.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -82.4 164.47 16.78 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.38 2.72 . . . . 0.0 111.087 176.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 53.0 ttm -71.83 138.0 47.97 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 168.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 71.5 p -78.41 159.49 28.28 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.153 0.981 . . . . 0.0 110.494 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.3 tp60 -53.09 -44.42 97.08 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-O 116.533 -1.699 . . . . 0.0 114.23 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -68.58 -30.53 28.45 Favored 'Trans proline' 0 C--N 1.351 0.683 0 CA-C-N 122.914 2.076 . . . . 0.0 112.164 -176.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.81 -35.31 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 119.021 0.828 . . . . 0.0 108.841 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -56.56 -46.64 80.63 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.3 0.955 . . . . 0.0 110.056 170.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -63.97 -37.14 86.33 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.055 0.542 . . . . 0.0 111.434 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.38 -47.25 77.02 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.919 -0.488 . . . . 0.0 111.17 175.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 78.9 t -61.74 -39.66 84.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 118.564 0.62 . . . . 0.0 109.525 177.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -61.37 -42.31 98.5 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.911 0.778 . . . . 0.0 110.534 174.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 52.2 m -62.19 -45.74 92.02 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.747 -0.596 . . . . 0.0 110.237 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 80.3 t -61.9 -47.53 92.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 176.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.5 ' CZ ' ' HE2' ' A' ' 31' ' ' LYS . 38.7 t80 -55.42 -49.66 71.82 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.913 0.885 . . . . 0.0 110.923 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 48.7 mm-40 -68.78 -23.35 64.29 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.734 -0.604 . . . . 0.0 112.102 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.18 -29.24 64.93 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.66 1.118 . . . . 0.0 111.583 175.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 67.6 mt -58.58 -20.38 46.34 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -168.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -83.81 -12.66 55.31 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 120.254 1.388 . . . . 0.0 113.297 177.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -131.56 -3.13 4.27 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.822 1.201 . . . . 0.0 113.092 -175.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 -56.62 111.94 1.14 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.428 1.891 . . . . 0.0 108.753 173.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -83.15 -36.0 25.11 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 122.66 0.384 . . . . 0.0 110.98 -177.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -165.79 -38.56 0.02 OUTLIER Glycine 0 CA--C 1.526 0.731 0 CA-C-O 118.804 -0.998 . . . . 0.0 112.377 -175.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -136.97 13.41 3.1 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.709 1.255 . . . . 0.0 113.015 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 61.43 12.74 33.94 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 119.188 -0.785 . . . . 0.0 114.437 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 65.61 8.45 39.7 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-N 118.793 1.297 . . . . 0.0 113.277 -173.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -72.03 143.3 49.19 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 119.335 1.567 . . . . 0.0 108.932 177.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.02 151.37 47.77 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.774 0.829 . . . . 0.0 109.527 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -92.59 123.98 36.28 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 62.0 tp -54.73 127.62 29.11 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.381 1.472 . . . . 0.0 109.741 176.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -141.83 34.36 1.59 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.545 1.138 . . . . 0.0 109.686 175.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.3 t 52.06 52.16 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 126.338 1.855 . . . . 0.0 110.391 175.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -56.06 150.0 14.6 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.568 0.747 . . . . 0.0 110.843 176.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -137.12 30.1 2.74 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.299 1.44 . . . . 0.0 109.128 175.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 . . . . . 0 C--O 1.251 1.182 0 C-N-CA 126.754 2.022 . . . . 0.0 108.154 -177.225 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.5 mmm . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 118.937 -0.554 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.9 m -143.09 151.87 41.22 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 -173.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -144.97 128.65 17.18 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 -171.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 70.8 t -124.0 148.61 28.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 121.409 0.623 . . . . 0.0 110.709 -167.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 33.7 tp -114.37 129.56 56.65 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.628 -1.989 . . . . 0.0 105.628 168.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.8 tp -120.63 100.82 7.35 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 92.7 m -75.33 143.03 43.11 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 171.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 51.9 t -141.01 142.04 30.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.285 1.434 . . . . 0.0 107.306 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 144.57 176.88 18.97 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.336 0.969 . . . . 0.0 111.873 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -126.55 122.54 35.42 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.8 1.24 . . . . 0.0 108.844 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 m -60.82 -15.33 29.0 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.572 1.949 . . . . 0.0 115.661 -169.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 25.8 ptm -127.4 11.01 6.82 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.074 0.95 . . . . 0.0 110.989 -176.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.6 ttt -88.68 14.32 10.33 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.225 1.01 . . . . 0.0 110.098 176.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.54 -140.96 15.34 Favored Glycine 0 C--N 1.337 0.637 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -60.44 -17.42 44.45 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.504 1.121 . . . . 0.0 112.224 176.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -55.81 -20.68 16.01 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.614 1.566 . . . . 0.0 113.207 174.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.44 21.5 0.7 Allowed Glycine 0 CA--C 1.534 1.253 0 O-C-N 120.823 -1.173 . . . . 0.0 114.286 177.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.4 -51.0 67.64 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 119.477 1.639 . . . . 0.0 110.788 -169.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.64 -54.91 33.74 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-O 117.76 -1.578 . . . . 0.0 111.073 175.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -49.75 -41.08 47.21 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 CA-C-N 120.826 2.313 . . . . 0.0 115.282 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.9 tp -71.34 -39.08 71.56 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 120.135 1.334 . . . . 0.0 110.267 178.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.8 tp -61.18 -46.15 91.69 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 122.055 -0.403 . . . . 0.0 110.314 175.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.14 -40.2 84.76 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 124.08 0.952 . . . . 0.0 111.167 177.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -61.41 -48.52 80.86 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 118.918 0.781 . . . . 0.0 109.866 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -61.87 -46.39 89.61 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.895 0.478 . . . . 0.0 110.506 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 80.1 m -64.59 -39.05 93.04 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.191 0.451 . . . . 0.0 111.209 178.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.47 -37.62 88.19 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.774 0.715 . . . . 0.0 111.052 177.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.88 -37.45 79.04 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.172 0.589 . . . . 0.0 111.058 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.0 96.24 1.72 Allowed Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 124.985 1.314 . . . . 0.0 108.553 -173.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -55.93 164.34 4.86 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.869 3.046 . . . . 0.0 113.969 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -134.02 166.1 23.51 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.383 1.473 . . . . 0.0 109.011 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 44.76 -113.25 0.82 Allowed Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.767 1.175 . . . . 0.0 111.418 175.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -144.57 8.94 1.35 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.795 1.238 . . . . 0.0 111.741 176.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 3.9 m95 -68.13 131.54 45.6 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.951 0.901 . . . . 0.0 110.201 -169.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 62.1 t -77.58 119.04 25.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 166.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.5 t -82.55 136.52 22.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -174.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 70.0 mt -133.74 145.29 33.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 169.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -129.58 107.91 9.82 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 175.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.98 -2.16 90.49 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-O 118.892 -0.949 . . . . 0.0 112.95 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 55.28 -144.93 31.88 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 108.441 -1.863 . . . . 0.0 108.441 -169.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.4 p -88.52 9.13 24.88 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.738 -0.86 . . . . 0.0 112.084 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -135.86 57.19 17.42 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 124.991 1.316 . . . . 0.0 110.493 -176.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -68.74 -14.37 39.02 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.735 2.29 . . . . 0.0 113.197 -171.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -55.48 -32.5 62.88 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.074 0.852 . . . . 0.0 112.001 173.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.99 -27.31 66.75 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.192 0.597 . . . . 0.0 112.119 176.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -99.38 -2.74 35.49 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.804 1.242 . . . . 0.0 111.458 -171.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 77.3 mt -54.56 -43.09 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 119.405 1.002 . . . . 0.0 109.641 175.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.3 t -61.6 -42.29 93.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 118.348 0.522 . . . . 0.0 109.737 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.68 -46.31 79.57 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 122.948 0.499 . . . . 0.0 110.666 -177.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 67.5 mt -55.16 -48.05 76.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 172.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -68.18 -23.28 64.83 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 117.865 -1.064 . . . . 0.0 112.778 -174.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -62.96 -37.56 87.57 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 120.519 1.509 . . . . 0.0 110.34 169.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 39.2 mt -77.19 -16.55 59.05 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.851 0.86 . . . . 0.0 111.917 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 26.89 64.6 0.56 Allowed Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 127.883 2.473 . . . . 0.0 113.538 -169.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -58.67 151.25 64.53 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.704 2.936 . . . . 0.0 113.912 -169.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.9 m -69.85 -36.1 75.25 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.085 0.954 . . . . 0.0 108.736 167.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -146.68 153.94 40.86 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.394 1.078 . . . . 0.0 110.402 -175.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 46.7 tp -142.77 136.85 29.28 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 125.301 1.44 . . . . 0.0 108.373 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 27.1 tp -125.32 135.33 52.36 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 172.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.5 mt -123.25 145.17 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 -172.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 44.0 t -141.06 135.53 32.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 118.74 0.7 . . . . 0.0 110.043 -175.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -163.99 172.26 14.13 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.598 2.359 . . . . 0.0 107.544 173.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.58 158.49 36.11 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.366 -0.834 . . . . 0.0 109.17 167.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.7 m -154.41 128.67 9.04 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -75.98 83.88 2.88 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 119.004 0.82 . . . . 0.0 109.925 174.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 74.6 mtm -77.44 -8.98 58.59 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.45 1.5 . . . . 0.0 112.212 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.04 29.26 67.1 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-N 118.914 0.779 . . . . 0.0 111.362 -171.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.3 mt -106.07 -172.36 2.07 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.965 1.306 . . . . 0.0 109.721 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -74.6 141.16 75.84 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-O 117.749 -1.12 . . . . 0.0 108.58 169.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -43.19 137.95 4.72 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 123.445 2.763 . . . . 0.0 113.395 172.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.29 1.02 79.94 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-O 118.625 -1.097 . . . . 0.0 113.82 176.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -68.2 149.34 49.64 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 119.875 1.838 . . . . 0.0 108.299 168.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 48.2 mt -128.82 135.07 63.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 125.607 1.563 . . . . 0.0 106.952 -172.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.2 mmt-85 -144.99 152.12 39.65 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.068 0.849 . . . . 0.0 109.653 175.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 42.6 mm -78.12 146.57 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 167.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.3 mt -128.49 118.18 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -71.88 139.85 83.15 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-O 117.926 -1.035 . . . . 0.0 109.172 174.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -47.56 -33.22 17.47 Favored 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 124.22 3.28 . . . . 0.0 116.654 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -67.95 -24.27 65.15 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.763 0.71 . . . . 0.0 111.641 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -100.64 -28.85 12.63 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.284 1.434 . . . . 0.0 111.307 -177.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.414 HG23 ' CD1' ' A' ' 85' ' ' PHE . 61.0 mt -49.34 -45.87 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.69 1.196 . . . . 0.0 109.044 169.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.68 -14.89 15.88 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.257 1.423 . . . . 0.0 113.969 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -126.2 4.89 7.08 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.226 1.01 . . . . 0.0 111.637 -177.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 20.9 mmt -121.64 -25.71 5.05 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -176.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.414 ' CD1' HG23 ' A' ' 81' ' ' ILE . 8.2 m-85 -73.79 -40.89 63.08 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.835 1.198 . . . . 0.0 111.449 -178.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.05 6.15 10.13 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.773 -0.58 . . . . 0.0 112.397 175.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 54.0 tpp -59.53 -26.13 65.08 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.573 1.079 . . . . 0.0 110.096 169.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 48.7 p -59.06 -14.05 8.65 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.207 1.803 . . . . 0.0 113.062 169.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.8 m 61.37 22.85 13.18 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.383 1.873 . . . . 0.0 110.751 -168.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 63.5 m80 -146.84 -55.08 0.25 Allowed 'General case' 0 C--N 1.346 0.42 0 O-C-N 121.349 -0.844 . . . . 0.0 112.804 -172.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -69.77 146.05 51.74 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 118.241 0.473 . . . . 0.0 110.399 -169.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 25.1 mmt -68.49 154.33 94.55 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 173.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.8 80.72 2.31 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 124.336 3.357 . . . . 0.0 109.876 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 mt -47.23 -11.72 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 127.994 2.518 . . . . 0.0 117.642 -168.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.06 -20.97 4.05 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.053 0.842 . . . . 0.0 112.641 168.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -58.39 -32.4 68.57 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.641 1.11 . . . . 0.0 112.083 174.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.4 tt -74.77 -43.5 54.51 Favored 'General case' 0 N--CA 1.462 0.125 0 O-C-N 121.623 -0.673 . . . . 0.0 109.669 176.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 74.5 mt -62.0 -40.28 86.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 123.946 0.898 . . . . 0.0 109.705 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.1 -27.89 65.99 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.505 0.722 . . . . 0.0 112.386 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -91.47 8.49 36.14 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.816 1.246 . . . . 0.0 111.943 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 88.4 mt -133.47 -29.81 1.34 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.223 1.009 . . . . 0.0 111.865 -176.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 45.0 mttm -56.16 -19.14 12.25 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.095 0.958 . . . . 0.0 112.779 170.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -59.02 -18.81 37.94 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.423 1.089 . . . . 0.0 112.205 175.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -138.23 -42.93 0.51 Allowed 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.868 0.867 . . . . 0.0 112.012 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 20.3 mt -68.62 133.4 31.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -173.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -75.97 -34.07 48.61 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.203 0.906 . . . . 0.0 112.432 -173.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -143.62 125.75 15.47 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.4 t -127.07 128.85 70.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 3.8 mt -131.55 150.11 33.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 -169.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -130.96 141.04 50.23 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 169.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.9 tt -120.62 128.74 53.3 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 174.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -111.94 156.23 15.7 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -178.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 62.6 mt -133.92 124.52 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 -176.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -65.47 117.84 44.7 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-O 117.389 -1.291 . . . . 0.0 110.4 -178.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -77.21 171.99 16.82 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.662 2.908 . . . . 0.0 111.485 170.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -128.11 -31.43 2.35 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.669 1.587 . . . . 0.0 111.073 170.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.1 pp -136.52 135.54 49.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.309 1.044 . . . . 0.0 108.751 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.3 t -143.77 145.92 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 176.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 173.28 -120.58 0.81 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -156.21 154.18 30.36 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.647 1.224 . . . . 0.0 108.33 175.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 3.0 t80 53.73 33.07 15.97 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.691 1.197 . . . . 0.0 110.861 -171.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 12.5 m-30 -118.96 140.38 28.57 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 124.816 1.246 . . . . 0.0 109.84 -173.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -82.72 165.22 15.81 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.433 2.755 . . . . 0.0 111.215 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.3 ttm -75.71 139.35 41.86 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 168.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 73.0 p -80.74 160.5 24.91 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.484 1.114 . . . . 0.0 110.475 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -53.1 -45.04 98.44 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-O 116.493 -1.718 . . . . 0.0 114.117 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -68.52 -30.56 28.83 Favored 'Trans proline' 0 C--N 1.35 0.653 0 CA-C-N 122.847 2.052 . . . . 0.0 112.215 -176.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -80.56 -35.47 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -56.3 -46.42 79.8 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.366 0.985 . . . . 0.0 109.946 170.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -64.05 -38.62 91.74 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 122.937 0.495 . . . . 0.0 111.254 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.53 -46.49 82.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 119.013 -0.518 . . . . 0.0 111.09 175.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 79.7 t -62.87 -38.92 83.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 119.147 0.885 . . . . 0.0 109.793 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -62.79 -42.29 99.64 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.396 0.998 . . . . 0.0 110.355 174.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 57.3 m -61.14 -49.75 75.97 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 71.1 t -60.66 -42.17 90.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 123.646 0.779 . . . . 0.0 109.893 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -57.1 -48.3 78.96 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.465 0.575 . . . . 0.0 110.575 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 63.9 mm-40 -64.53 -38.57 91.47 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.992 0.815 . . . . 0.0 110.895 175.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -63.92 -27.43 69.14 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 123.436 0.695 . . . . 0.0 112.414 -177.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 75.1 mt -59.11 -18.5 36.19 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.376 0.989 . . . . 0.0 112.16 175.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -91.44 2.11 56.65 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.149 0.886 . . . . 0.0 111.947 178.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -149.69 -3.74 0.26 Allowed Glycine 0 CA--C 1.535 1.323 0 CA-C-O 119.017 -0.879 . . . . 0.0 115.272 -173.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -53.94 144.13 19.74 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.169 1.387 . . . . 0.0 108.803 169.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.09 -27.51 1.61 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.282 1.433 . . . . 0.0 112.604 -169.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 178.4 -26.81 0.06 OUTLIER Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.15 1.357 . . . . 0.0 112.303 -176.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -145.52 4.78 1.04 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.792 1.296 . . . . 0.0 112.282 178.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 63.32 13.68 50.67 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.497 1.522 . . . . 0.0 112.495 -171.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 61.56 6.79 9.1 Favored Glycine 0 CA--C 1.538 1.508 0 CA-C-N 118.543 1.172 . . . . 0.0 112.914 -168.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -72.29 167.31 20.68 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.997 1.399 . . . . 0.0 109.076 172.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -88.75 148.56 23.89 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 170.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.6 121.9 29.77 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 174.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 52.3 tp -53.77 124.38 15.08 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.612 1.565 . . . . 0.0 109.793 178.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -139.3 57.28 1.65 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.638 1.175 . . . . 0.0 109.295 -175.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.5 t 53.2 40.18 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 125.429 1.492 . . . . 0.0 110.048 -175.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -72.76 152.38 41.64 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.22 1.008 . . . . 0.0 108.395 172.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -141.2 150.7 43.04 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 169.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 . . . . . 0 C--O 1.247 0.965 0 C-N-CA 124.545 1.138 . . . . 0.0 108.161 179.039 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.485 1.309 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 24.6 m -102.71 86.32 2.73 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -177.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -75.78 145.58 40.64 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 168.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.412 HG21 ' HG3' ' A' ' 55' ' ' PRO . 69.6 t -136.33 148.38 27.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 39.3 tp -123.36 119.15 29.24 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.9 tp -109.95 96.91 6.54 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 99.4 m -71.29 142.39 50.48 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 169.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.3 t -140.82 143.12 29.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 177.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.02 174.54 17.36 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -122.71 121.05 35.43 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.365 1.466 . . . . 0.0 107.422 177.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 m -59.56 -14.78 14.52 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.934 1.693 . . . . 0.0 115.495 -169.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -128.86 14.12 6.35 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.839 0.856 . . . . 0.0 111.243 -176.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.2 ttt -97.73 30.6 2.9 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 118.682 0.674 . . . . 0.0 109.898 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.26 -142.39 20.45 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -178.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -61.2 -17.31 52.48 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.593 1.157 . . . . 0.0 112.111 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -56.63 -19.97 18.84 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.217 1.407 . . . . 0.0 112.871 174.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.36 20.26 0.77 Allowed Glycine 0 CA--C 1.534 1.258 0 O-C-N 120.691 -1.256 . . . . 0.0 114.311 177.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.8 -52.7 63.14 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 119.571 1.685 . . . . 0.0 110.862 -169.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.62 -54.81 34.55 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-O 117.88 -1.511 . . . . 0.0 111.214 175.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -49.67 -40.76 46.75 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 CA-C-N 120.818 2.309 . . . . 0.0 115.077 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 65.6 tp -70.65 -39.27 73.72 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-N 119.963 1.256 . . . . 0.0 110.311 178.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.0 tp -61.28 -46.87 88.54 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.065 0.393 . . . . 0.0 110.348 175.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.38 -42.23 86.58 Favored 'General case' 0 C--O 1.227 -0.125 0 C-N-CA 124.134 0.974 . . . . 0.0 110.829 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -60.72 -49.15 78.68 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.476 0.58 . . . . 0.0 110.0 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -61.75 -49.83 74.83 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 122.99 0.516 . . . . 0.0 110.723 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 75.7 m -64.02 -37.79 88.71 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.549 0.613 . . . . 0.0 111.399 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.46 -40.65 96.12 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.112 0.869 . . . . 0.0 111.073 176.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.64 -33.05 73.34 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.511 0.724 . . . . 0.0 111.704 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.44 96.08 2.66 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.544 1.537 . . . . 0.0 107.762 -173.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -53.31 159.5 5.87 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 123.439 2.759 . . . . 0.0 113.939 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -134.53 155.54 50.23 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.638 1.575 . . . . 0.0 108.085 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 40.71 -119.08 1.32 Allowed Glycine 0 CA--C 1.532 1.104 0 C-N-CA 125.128 1.346 . . . . 0.0 111.88 176.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -137.14 14.87 3.04 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.913 1.685 . . . . 0.0 111.309 177.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -72.52 128.17 34.77 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.337 0.655 . . . . 0.0 109.791 -173.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.2 t -72.86 120.45 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 166.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.0 t -76.22 133.72 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 24.4 mm -133.15 147.94 31.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 104.967 -2.235 . . . . 0.0 104.967 171.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -134.7 114.06 12.32 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 177.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.79 -16.28 76.19 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 118.654 -1.081 . . . . 0.0 113.003 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 57.95 39.0 91.14 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-N 119.264 1.532 . . . . 0.0 113.722 170.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . 0.252 75.3 p 60.71 14.29 4.95 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.502 2.321 . . . . 0.0 114.69 -173.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.2 56.29 6.22 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 125.632 1.573 . . . . 0.0 108.995 172.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -67.05 -28.75 41.11 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.395 2.063 . . . . 0.0 112.258 -169.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.59 -36.19 77.96 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.592 0.757 . . . . 0.0 111.892 -178.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -64.43 -13.59 52.2 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.702 0.801 . . . . 0.0 112.574 176.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -112.66 -0.36 15.12 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.314 1.046 . . . . 0.0 112.38 -172.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 87.5 mt -50.01 -36.92 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 124.577 1.151 . . . . 0.0 110.518 172.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 51.3 t -56.41 -40.82 69.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 123.646 0.778 . . . . 0.0 110.455 178.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.46 -41.85 83.99 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.498 0.59 . . . . 0.0 110.504 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 51.1 mt -61.91 -40.29 86.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -66.23 -20.25 66.06 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 117.785 -1.103 . . . . 0.0 112.528 176.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -72.45 -43.94 63.07 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 120.677 1.581 . . . . 0.0 109.097 169.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 49.0 mt -68.75 -27.91 66.33 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 118.671 -0.681 . . . . 0.0 112.568 -177.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 39.12 64.74 3.69 Favored Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 125.589 1.556 . . . . 0.0 111.306 -169.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.412 ' HG3' HG21 ' A' ' 4' ' ' VAL . 51.6 Cg_exo -49.69 141.04 28.23 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.269 2.646 . . . . 0.0 113.402 -172.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.1 m -66.99 -41.29 87.01 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 167.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.2 mtm-85 -146.72 149.97 34.47 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.115 1.766 . . . . 0.0 106.789 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 52.9 tp -134.59 137.76 43.99 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 33.6 tp -125.6 133.8 52.13 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 175.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.4 mt -121.96 142.38 38.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -174.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.5 t -141.01 133.56 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 118.764 0.711 . . . . 0.0 110.056 -174.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -161.42 171.24 18.55 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.39 2.276 . . . . 0.0 107.464 172.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.54 156.28 39.6 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.951 -1.093 . . . . 0.0 108.583 168.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.8 m -155.9 132.56 10.38 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -78.13 122.73 26.01 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 73.5 mtm -121.43 1.49 10.14 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.209 1.803 . . . . 0.0 110.699 -176.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.24 18.17 60.24 Favored Glycine 0 CA--C 1.537 1.412 0 CA-C-N 118.676 0.671 . . . . 0.0 112.579 -171.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.6 mt -87.47 -176.1 5.47 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.487 1.515 . . . . 0.0 109.744 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -76.08 140.26 69.76 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-O 117.871 -1.062 . . . . 0.0 108.818 171.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -45.86 134.93 14.0 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.417 2.744 . . . . 0.0 113.71 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.01 2.27 88.54 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.574 -1.126 . . . . 0.0 113.359 177.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -65.99 151.93 45.72 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 119.867 1.833 . . . . 0.0 108.025 168.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 81.0 mt -128.12 141.91 45.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -171.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 84.2 mmt-85 -151.04 154.19 36.55 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 123.326 0.651 . . . . 0.0 110.858 172.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 35.8 mm -81.6 144.68 9.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 165.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.7 mt -125.53 128.12 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 176.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -72.87 140.1 80.67 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-O 118.084 -0.96 . . . . 0.0 109.655 173.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -46.98 -32.55 13.05 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 124.356 3.37 . . . . 0.0 116.79 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -67.49 -26.48 66.38 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.778 0.717 . . . . 0.0 111.782 178.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -101.66 -25.08 13.99 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.991 1.316 . . . . 0.0 111.446 -176.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.443 HD11 ' HB3' ' A' ' 110' ' ' PHE . 45.0 mt -50.17 -41.21 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.54 1.136 . . . . 0.0 109.512 169.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.33 -30.67 52.11 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.53 1.132 . . . . 0.0 113.15 -177.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -100.38 -39.16 8.12 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.052 0.541 . . . . 0.0 110.06 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 26.1 mmt -73.47 -27.85 61.62 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 121.714 -0.616 . . . . 0.0 112.256 -173.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -68.59 -49.95 55.39 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 118.838 0.745 . . . . 0.0 110.306 171.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 27.6 ptm -63.21 -20.78 65.74 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.206 0.912 . . . . 0.0 111.911 -178.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 10.7 tpt -58.4 -25.28 61.93 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.935 0.894 . . . . 0.0 112.249 173.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 82.4 p -68.99 -7.08 32.07 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 119.378 0.99 . . . . 0.0 113.136 176.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.4 m 118.68 81.33 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 130.929 3.692 . . . . 0.0 108.188 169.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 24.5 m80 56.29 26.58 10.68 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.914 1.686 . . . . 0.0 113.388 176.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -63.17 157.42 22.5 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.222 1.009 . . . . 0.0 109.543 172.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 63.4 mtt -67.43 146.22 98.65 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -76.61 73.46 5.2 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 124.285 3.323 . . . . 0.0 109.827 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.1 mt -51.85 -6.83 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 117.363 2.357 . . . . 0.0 117.363 -168.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -54.08 -19.42 4.89 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.437 1.017 . . . . 0.0 112.243 166.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -59.35 -28.46 66.87 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.608 1.095 . . . . 0.0 112.125 173.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.7 tt -70.78 -45.6 64.41 Favored 'General case' 0 N--CA 1.463 0.18 0 O-C-N 121.334 -0.854 . . . . 0.0 109.625 173.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 90.0 mt -61.5 -42.11 92.66 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.137 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -60.38 -24.85 65.43 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -85.89 0.11 53.94 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.921 0.888 . . . . 0.0 112.453 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 65.3 mt -135.89 -31.34 0.93 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.21 1.004 . . . . 0.0 112.401 -171.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -59.29 -21.84 60.29 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.895 1.278 . . . . 0.0 112.712 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -71.44 -13.06 61.71 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.513 1.125 . . . . 0.0 111.916 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -134.67 -32.98 0.97 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.219 0.918 . . . . 0.0 112.983 -176.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 53.7 mt -68.55 143.58 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 172.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -67.17 -41.66 92.05 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 123.96 0.791 . . . . 0.0 112.236 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -150.63 143.15 24.42 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 118.582 1.191 . . . . 0.0 108.999 173.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.0 t -127.66 129.44 70.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 177.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.6 mt -129.93 148.86 33.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 -169.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.443 ' HB3' HD11 ' A' ' 81' ' ' ILE . 77.3 t80 -132.86 142.38 48.91 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 171.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.4 tt -122.44 127.8 50.09 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.434 1.494 . . . . 0.0 107.124 174.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -109.16 156.09 15.78 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 77.8 mt -133.93 126.98 51.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -61.28 114.95 12.19 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-O 117.346 -1.311 . . . . 0.0 110.34 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -76.52 171.4 18.13 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.184 2.589 . . . . 0.0 111.174 170.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -129.59 -31.81 1.98 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.915 1.686 . . . . 0.0 111.041 171.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -135.84 135.85 50.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 124.282 1.033 . . . . 0.0 108.215 176.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.6 t -141.58 135.4 30.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 158.4 151.16 5.99 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 178.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -65.99 153.33 42.45 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.844 0.831 . . . . 0.0 111.344 -175.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 54.62 38.79 30.55 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.92 2.088 . . . . 0.0 112.141 -176.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -123.4 148.32 55.06 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 123.961 0.904 . . . . 0.0 109.996 172.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -81.74 163.83 18.48 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.19 2.594 . . . . 0.0 111.161 176.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 52.2 ttm -72.24 138.94 47.84 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 168.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 68.8 p -79.07 159.27 27.61 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.153 0.981 . . . . 0.0 110.529 178.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -52.9 -44.1 95.63 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-O 116.569 -1.681 . . . . 0.0 114.277 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -68.67 -31.26 26.49 Favored 'Trans proline' 0 C--N 1.351 0.667 0 CA-C-N 122.892 2.069 . . . . 0.0 112.215 -176.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.09 -35.28 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -56.3 -46.02 80.0 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.196 0.907 . . . . 0.0 110.172 170.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -64.15 -37.92 89.2 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 122.987 0.515 . . . . 0.0 111.41 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.58 -47.33 79.08 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 121.944 -0.473 . . . . 0.0 110.986 175.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 72.4 t -62.71 -39.37 84.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 118.552 0.615 . . . . 0.0 109.789 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -60.31 -43.26 96.51 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.022 0.828 . . . . 0.0 110.265 173.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 55.2 m -61.52 -47.5 85.33 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.959 -0.463 . . . . 0.0 109.971 178.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 87.8 t -61.44 -45.65 98.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 118.552 0.615 . . . . 0.0 109.648 178.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -54.4 -48.84 71.11 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.802 0.841 . . . . 0.0 110.71 177.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 48.2 mm-40 -65.58 -37.34 86.37 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.642 0.656 . . . . 0.0 111.41 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.1 -35.54 71.6 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.545 0.738 . . . . 0.0 111.843 -178.001 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 77.6 mt -59.07 -16.88 21.27 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -172.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -77.52 -20.34 54.39 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 120.042 1.292 . . . . 0.0 112.54 177.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -145.76 5.81 1.35 Allowed Glycine 0 CA--C 1.532 1.145 0 CA-C-O 119.393 -0.67 . . . . 0.0 114.713 -169.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -52.06 138.19 25.81 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.647 1.579 . . . . 0.0 108.907 170.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -143.61 145.78 32.76 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 170.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 53.59 -121.27 16.94 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 123.971 0.796 . . . . 0.0 111.581 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -75.33 5.09 6.07 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.71 1.204 . . . . 0.0 112.916 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 70.8 13.76 72.28 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 124.213 0.911 . . . . 0.0 112.398 -174.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.54 -4.5 3.88 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-N 118.413 1.107 . . . . 0.0 113.526 -172.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -71.82 152.22 42.84 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 119.094 1.447 . . . . 0.0 109.023 174.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -76.7 148.08 37.02 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 174.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -91.3 120.54 32.27 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 176.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 44.9 tp -55.89 124.31 17.2 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.819 1.647 . . . . 0.0 109.883 177.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.98 -42.51 0.16 Allowed 'General case' 0 C--O 1.233 0.189 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -177.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 16.4 t -151.27 -47.9 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 118.711 0.687 . . . . 0.0 110.172 -169.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 57.83 28.79 16.51 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.487 1.915 . . . . 0.0 113.128 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -143.35 162.67 35.12 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.377 1.871 . . . . 0.0 107.357 174.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 . . . . . 0 C--O 1.25 1.111 0 C-N-CA 125.897 1.679 . . . . 0.0 107.035 179.86 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ttt . . . . . 0 N--CA 1.483 1.209 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.8 m -104.04 93.77 5.03 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 -177.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -77.38 151.99 34.6 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 169.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.6 t -138.02 148.19 25.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -175.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 31.7 tp -122.71 119.55 31.01 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.3 tp -109.02 97.68 7.27 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 125.405 1.482 . . . . 0.0 107.487 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 87.7 m -73.53 143.17 46.63 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 169.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.8 t -140.21 142.11 32.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 142.37 178.92 18.83 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 124.214 0.912 . . . . 0.0 111.861 177.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -127.95 123.59 35.23 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.768 1.227 . . . . 0.0 108.619 177.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 m -58.74 -16.05 14.93 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.631 1.972 . . . . 0.0 115.461 -169.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.0 ptp -128.7 15.98 6.42 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 119.197 0.908 . . . . 0.0 111.259 -178.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 11.3 tpt -92.19 25.48 2.89 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.621 0.768 . . . . 0.0 109.397 176.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.75 -142.64 20.21 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -176.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -61.0 -16.82 47.68 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.695 1.198 . . . . 0.0 112.221 178.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -55.58 -20.56 13.87 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.483 1.513 . . . . 0.0 112.906 173.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.14 17.91 0.94 Allowed Glycine 0 CA--C 1.534 1.257 0 O-C-N 120.789 -1.194 . . . . 0.0 114.437 177.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.19 -51.29 69.63 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 119.566 1.683 . . . . 0.0 110.838 -170.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.77 -55.96 27.52 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-O 117.794 -1.559 . . . . 0.0 111.136 175.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -49.77 -40.78 47.66 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 CA-C-N 120.784 2.292 . . . . 0.0 115.113 178.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 62.6 tp -70.61 -39.89 73.51 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 119.862 1.21 . . . . 0.0 109.986 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.2 tp -61.47 -46.37 90.33 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.443 0.297 . . . . 0.0 110.388 176.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.69 -42.6 88.93 Favored 'General case' 0 C--O 1.227 -0.127 0 C-N-CA 123.838 0.855 . . . . 0.0 110.883 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -60.93 -48.98 79.3 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 118.616 0.643 . . . . 0.0 109.871 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -63.62 -48.69 76.28 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 123.016 0.526 . . . . 0.0 110.907 -178.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 93.0 m -65.39 -34.56 78.6 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.732 0.696 . . . . 0.0 111.478 178.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.99 -40.64 95.26 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.689 1.132 . . . . 0.0 110.848 174.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.14 -33.05 72.83 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.434 0.693 . . . . 0.0 111.8 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.57 89.54 4.42 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.394 1.478 . . . . 0.0 108.548 -174.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -52.6 155.8 9.7 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.955 3.103 . . . . 0.0 113.606 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -133.37 156.65 47.27 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.635 1.174 . . . . 0.0 109.479 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 40.84 -111.95 0.3 Allowed Glycine 0 CA--C 1.527 0.844 0 C-N-CA 125.85 1.691 . . . . 0.0 112.612 172.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -138.04 9.91 2.8 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.145 1.378 . . . . 0.0 111.295 -173.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 1.5 m95 -85.07 123.07 30.18 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 121.286 -0.884 . . . . 0.0 110.753 -168.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.7 t -70.68 119.88 17.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 166.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.6 t -74.04 132.6 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.1 mm -133.98 148.0 30.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 172.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -135.61 111.66 9.6 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.23 -1.99 88.05 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-O 118.991 -0.894 . . . . 0.0 112.727 179.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 56.16 -147.52 30.63 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -169.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 p -90.08 10.95 22.31 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.841 0.856 . . . . 0.0 111.94 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.83 55.17 7.43 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.267 1.427 . . . . 0.0 109.77 -177.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -66.36 -20.35 55.06 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.825 2.35 . . . . 0.0 113.479 -169.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.3 pm0 -61.6 -30.39 70.65 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 119.05 0.841 . . . . 0.0 111.911 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.02 -25.85 67.89 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.373 0.669 . . . . 0.0 112.084 175.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -102.84 -2.51 27.79 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.106 0.962 . . . . 0.0 113.06 -168.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.9 mt -48.52 -40.4 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.518 1.127 . . . . 0.0 110.288 174.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.1 t -56.19 -40.26 64.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.926 0.89 . . . . 0.0 110.582 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.32 -42.26 83.94 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 118.318 0.508 . . . . 0.0 110.398 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 35.3 mt -64.97 -37.48 80.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.38 -21.05 66.05 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 117.855 -1.069 . . . . 0.0 112.397 175.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -70.91 -39.74 72.57 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 120.613 1.552 . . . . 0.0 109.745 170.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 59.5 mt -70.48 -26.55 63.67 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.499 0.72 . . . . 0.0 112.187 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 40.89 65.71 4.08 Favored Pre-proline 0 N--CA 1.472 0.668 0 C-N-CA 125.698 1.599 . . . . 0.0 110.932 -171.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -52.14 137.4 54.39 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 123.253 2.635 . . . . 0.0 112.79 -169.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.0 m -69.53 -38.67 77.61 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 167.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -144.45 157.7 44.11 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 124.889 1.276 . . . . 0.0 107.885 171.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 53.5 tp -136.74 136.16 38.72 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 32.5 tp -123.67 134.92 53.66 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 175.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.0 mt -123.29 141.82 42.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 -173.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 44.6 t -140.87 134.36 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 118.773 0.715 . . . . 0.0 110.642 -174.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -162.82 171.22 17.04 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.783 2.433 . . . . 0.0 107.481 172.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.75 157.69 37.59 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 120.989 -1.069 . . . . 0.0 108.54 167.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.0 m -156.2 127.79 7.23 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 175.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -70.74 124.21 23.74 Favored 'General case' 0 C--O 1.23 0.058 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 172.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 73.6 mtm -122.39 2.2 9.66 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.142 1.777 . . . . 0.0 110.562 -177.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.11 24.64 68.9 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-N 118.66 0.664 . . . . 0.0 112.195 -172.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.6 mt -98.04 -172.71 2.42 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.398 1.479 . . . . 0.0 109.24 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -79.6 140.4 55.37 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-O 117.746 -1.121 . . . . 0.0 108.931 173.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -45.64 134.0 13.26 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.343 2.695 . . . . 0.0 113.705 178.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.49 2.08 89.27 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-O 118.254 -1.303 . . . . 0.0 113.345 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -66.29 150.24 49.15 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 120.156 1.978 . . . . 0.0 107.728 167.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 34.4 mt -131.52 135.14 59.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -169.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.4 mmt-85 -146.6 153.3 40.17 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.504 0.593 . . . . 0.0 109.984 176.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 29.4 mm -83.0 143.36 12.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 167.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.6 mt -126.11 124.17 65.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -71.39 141.09 85.33 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.419 173.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -46.99 -32.5 13.01 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 124.133 3.222 . . . . 0.0 116.594 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -67.19 -25.54 66.18 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.803 0.728 . . . . 0.0 111.799 177.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -101.42 -26.21 13.67 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.915 1.286 . . . . 0.0 111.447 -177.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.429 HD11 ' HB3' ' A' ' 110' ' ' PHE . 51.6 mt -50.19 -41.36 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.478 1.111 . . . . 0.0 109.109 168.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.39 -22.1 18.44 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.425 1.49 . . . . 0.0 114.075 -177.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -115.2 -33.75 5.24 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 118.68 0.673 . . . . 0.0 110.387 177.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 23.3 mmt -72.28 -28.51 63.15 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -177.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.404 ' CD1' HG23 ' A' ' 81' ' ' ILE . 2.1 m-85 -66.39 -46.29 77.12 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 119.241 0.928 . . . . 0.0 110.92 176.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -69.55 1.34 4.16 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 -178.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 87.2 mmm -62.7 -40.06 95.94 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 166.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 63.4 p -72.2 134.69 45.8 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 169.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.6 m -49.47 114.61 1.08 Allowed 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.813 1.645 . . . . 0.0 111.428 -166.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 30.1 m170 55.78 20.77 4.24 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.422 1.489 . . . . 0.0 113.905 173.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -67.51 148.0 52.07 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.369 -0.832 . . . . 0.0 109.471 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 26.4 mmt -72.19 151.36 92.37 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -74.9 74.56 3.91 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 124.321 3.347 . . . . 0.0 109.433 175.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.83 -6.78 0.06 Allowed 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 -167.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -55.46 -17.31 4.93 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 120.997 -1.065 . . . . 0.0 112.179 166.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -59.29 -32.15 69.77 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 120.155 1.343 . . . . 0.0 111.924 173.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.3 tt -67.59 -48.92 65.46 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 174.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 74.5 mt -61.27 -45.31 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -174.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.56 -21.08 66.56 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.014 -1.054 . . . . 0.0 113.38 -174.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -91.84 5.64 49.18 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.149 0.98 . . . . 0.0 111.852 177.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 40.5 tp -140.89 -32.88 0.55 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.593 0.757 . . . . 0.0 112.311 -169.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.0 pttm -61.68 -25.28 67.31 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 125.63 1.572 . . . . 0.0 112.62 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -62.6 -18.04 61.41 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.315 1.046 . . . . 0.0 112.275 -175.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -114.12 6.21 16.27 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.231 1.012 . . . . 0.0 112.155 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 79.9 mt -120.6 146.42 25.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.848 1.259 . . . . 0.0 108.522 -171.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -75.19 -36.25 46.22 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.774 0.702 . . . . 0.0 112.143 -177.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -152.12 141.05 21.11 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.107 0.954 . . . . 0.0 108.679 175.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.6 t -124.99 135.23 64.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 171.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.0 mp -129.49 149.72 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 -177.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.429 ' HB3' HD11 ' A' ' 81' ' ' ILE . 43.2 t80 -130.75 141.8 50.39 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 169.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.4 tt -120.28 130.54 54.52 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.313 1.445 . . . . 0.0 107.544 173.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -111.41 155.01 16.4 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 176.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 77.1 mt -133.24 127.37 54.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -60.93 114.63 10.98 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-O 117.351 -1.309 . . . . 0.0 110.179 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -76.2 171.5 17.99 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.158 2.572 . . . . 0.0 111.116 170.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -129.42 -31.56 2.04 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.053 1.741 . . . . 0.0 111.012 171.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -135.85 136.03 50.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.237 1.015 . . . . 0.0 108.309 176.275 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.8 t -141.45 134.84 30.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 175.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 159.47 153.94 7.06 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -69.52 153.46 43.47 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.882 0.849 . . . . 0.0 110.775 -173.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.4 t80 51.8 39.16 25.02 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.846 2.058 . . . . 0.0 112.296 -176.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 23.0 m-30 -121.97 147.63 49.34 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 124.067 0.947 . . . . 0.0 109.961 173.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -81.15 164.09 19.77 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.153 2.568 . . . . 0.0 111.15 177.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.3 ttm -72.59 139.41 47.44 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 168.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 68.6 p -79.08 159.36 27.55 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.191 0.996 . . . . 0.0 110.522 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.2 tp60 -52.87 -44.26 95.88 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-O 116.579 -1.677 . . . . 0.0 114.232 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -68.78 -30.55 27.08 Favored 'Trans proline' 0 C--N 1.35 0.647 0 CA-C-N 122.869 2.06 . . . . 0.0 112.295 -176.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.97 -35.26 15.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 119.072 0.851 . . . . 0.0 108.706 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -56.29 -46.91 79.56 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.136 0.88 . . . . 0.0 109.977 169.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -63.28 -38.27 90.5 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.037 0.535 . . . . 0.0 111.248 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.35 -47.14 80.44 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 121.967 -0.458 . . . . 0.0 111.133 176.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.5 t -61.4 -41.27 89.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 118.581 0.628 . . . . 0.0 109.655 177.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -62.36 -33.86 75.55 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.863 0.865 . . . . 0.0 111.074 175.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 44.3 m -69.52 -46.23 67.02 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.462 -0.774 . . . . 0.0 109.926 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 92.3 t -61.97 -44.35 98.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 119.203 0.911 . . . . 0.0 109.592 178.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -53.37 -43.82 68.09 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.32 1.048 . . . . 0.0 111.172 176.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -68.73 -45.02 72.61 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.527 0.603 . . . . 0.0 111.119 175.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -58.7 -36.66 74.58 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.133 0.573 . . . . 0.0 111.221 -174.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 56.9 mt -56.27 -19.06 12.47 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -175.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -72.92 -25.65 61.12 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 120.09 1.314 . . . . 0.0 112.211 176.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -132.21 1.8 4.99 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.416 1.008 . . . . 0.0 113.72 -173.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -54.42 113.0 1.11 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.342 1.857 . . . . 0.0 109.09 175.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -80.09 -43.45 21.73 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.621 0.368 . . . . 0.0 110.721 -177.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -168.77 -39.2 0.02 OUTLIER Glycine 0 CA--C 1.529 0.91 0 CA-C-O 118.822 -0.988 . . . . 0.0 112.671 -178.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -113.38 3.73 16.01 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 118.406 1.103 . . . . 0.0 112.209 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 61.3 15.8 46.54 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.187 0.899 . . . . 0.0 113.832 -176.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 63.99 2.22 6.3 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-N 118.625 1.212 . . . . 0.0 113.574 -171.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -75.17 148.55 39.49 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 119.202 1.501 . . . . 0.0 108.818 177.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.87 148.47 42.29 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.196 176.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -92.15 119.85 32.19 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 60.4 tp -56.66 124.31 17.9 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.024 1.729 . . . . 0.0 110.104 178.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -145.78 44.34 1.27 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.103 0.961 . . . . 0.0 110.653 -174.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 4.5 t 52.72 49.11 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 125.295 1.438 . . . . 0.0 109.792 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -65.14 163.14 15.59 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.933 0.893 . . . . 0.0 111.108 176.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -143.15 163.49 32.75 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.804 1.642 . . . . 0.0 107.892 177.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 . . . . . 0 C--O 1.248 0.989 0 C-N-CA 125.659 1.583 . . . . 0.0 106.891 177.395 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.6 mmt . . . . . 0 N--CA 1.484 1.23 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 15.2 m -145.6 139.11 26.43 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -176.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -136.54 97.07 3.47 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 -172.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.8 m -86.41 150.72 3.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 123.758 0.823 . . . . 0.0 110.04 -172.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 52.6 tp -115.32 124.51 51.47 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 171.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 67.2 tp -112.95 97.41 6.51 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 92.2 m -72.97 141.97 47.78 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 169.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.4 t -141.23 142.03 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 125.216 1.407 . . . . 0.0 107.734 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 148.91 178.04 23.61 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 123.971 0.796 . . . . 0.0 112.272 175.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -124.93 117.17 23.46 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 125.387 1.475 . . . . 0.0 107.908 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 m -56.13 -21.63 23.63 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 126.5 1.92 . . . . 0.0 115.339 -170.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 25.7 ptp -123.91 20.48 9.2 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.665 0.666 . . . . 0.0 110.794 -174.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.9 ttt -102.34 29.23 5.31 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.38 1.072 . . . . 0.0 110.29 179.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.33 -142.07 21.83 Favored Glycine 0 N--CA 1.441 -1.021 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -63.17 -15.44 56.89 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.37 1.068 . . . . 0.0 112.223 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -56.17 -21.49 23.24 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.15 1.38 . . . . 0.0 112.987 175.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.33 21.29 0.69 Allowed Glycine 0 CA--C 1.534 1.246 0 CA-C-O 118.491 -1.172 . . . . 0.0 114.475 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.1 -51.88 67.27 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 119.545 1.673 . . . . 0.0 110.758 -169.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.28 -55.32 30.81 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 117.502 -1.721 . . . . 0.0 111.423 177.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -50.47 -40.14 54.23 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 CA-C-N 120.921 2.36 . . . . 0.0 115.076 178.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.6 tp -71.07 -39.48 72.18 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 119.878 1.217 . . . . 0.0 110.039 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 51.1 tp -61.53 -48.85 79.13 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 176.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.26 -41.7 80.14 Favored 'General case' 0 C--O 1.227 -0.107 0 C-N-CA 124.054 0.942 . . . . 0.0 111.283 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -60.77 -49.1 78.86 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.661 0.664 . . . . 0.0 109.897 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -62.66 -47.74 82.37 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 122.983 0.513 . . . . 0.0 110.702 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 73.8 m -64.74 -37.95 89.33 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.574 0.624 . . . . 0.0 111.458 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.81 -40.91 97.77 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.991 0.814 . . . . 0.0 110.806 176.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.67 -32.53 72.42 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.483 0.713 . . . . 0.0 111.837 178.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.86 92.6 2.85 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 125.268 1.427 . . . . 0.0 108.461 -172.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -53.8 158.85 7.8 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.34 2.693 . . . . 0.0 113.567 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.424 ' HE2' ' CE1' ' A' ' 136' ' ' TYR . 74.7 mmtt -129.36 166.39 19.61 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.481 1.512 . . . . 0.0 108.474 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 41.17 -124.37 2.88 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.478 1.513 . . . . 0.0 112.139 175.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -138.47 35.98 2.26 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.185 1.394 . . . . 0.0 109.028 170.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -70.49 167.02 19.25 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.146 0.978 . . . . 0.0 111.441 -175.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 68.7 t -122.29 101.95 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 168.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.9 t -72.43 136.91 24.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -175.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 90.9 mt -135.33 142.31 40.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 172.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -127.01 105.29 8.5 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.55 -6.36 80.76 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 118.973 -0.904 . . . . 0.0 112.69 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 54.22 -140.7 35.42 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 -169.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.4 p -93.2 7.89 42.43 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.624 0.77 . . . . 0.0 112.469 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.72 64.22 42.52 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 124.875 1.27 . . . . 0.0 109.528 177.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -65.17 -15.63 51.15 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.668 2.245 . . . . 0.0 112.183 -177.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -46.92 -42.37 17.55 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.703 1.601 . . . . 0.0 111.161 168.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.96 -27.29 68.73 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.93 -5.43 41.4 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.854 1.261 . . . . 0.0 111.33 -169.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.8 mt -52.86 -44.9 49.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 118.919 0.781 . . . . 0.0 109.18 171.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.7 t -60.99 -42.29 92.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.22 -44.69 87.48 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 123.192 0.597 . . . . 0.0 110.854 -177.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 72.9 mt -55.39 -48.15 77.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.091 0.956 . . . . 0.0 108.504 173.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 49.7 mtp180 -67.83 -19.17 65.03 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 117.598 -1.192 . . . . 0.0 113.135 -176.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -58.97 -27.39 65.33 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 121.023 1.738 . . . . 0.0 110.977 171.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 58.6 mt -95.93 -9.52 31.05 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.582 1.153 . . . . 0.0 112.33 -172.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 48.7 mmm-85 32.85 58.48 1.47 Allowed Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 126.423 1.889 . . . . 0.0 111.764 -169.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -56.09 152.49 37.14 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.073 2.515 . . . . 0.0 114.867 -168.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.1 m -71.97 -39.06 69.6 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.089 0.955 . . . . 0.0 109.244 168.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -148.67 160.12 43.46 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.633 0.773 . . . . 0.0 111.126 -177.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 24.1 tp -141.91 139.52 32.57 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 125.304 1.442 . . . . 0.0 109.074 177.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 54.4 tp -124.17 135.98 53.86 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 168.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.9 mt -119.49 144.97 26.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -178.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 46.3 t -139.92 133.68 36.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 123.148 0.579 . . . . 0.0 109.649 -175.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -162.65 171.68 16.52 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 127.335 2.254 . . . . 0.0 107.245 173.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.07 155.31 40.58 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 167.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.1 m -153.86 135.56 14.44 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 177.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -81.09 84.45 6.51 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.945 0.793 . . . . 0.0 109.873 176.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -69.48 -8.88 50.79 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.698 0.799 . . . . 0.0 112.121 173.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.36 24.89 76.39 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 119.434 1.016 . . . . 0.0 111.634 -171.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 98.0 mt -100.01 -173.26 2.39 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.232 1.413 . . . . 0.0 110.477 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -69.66 139.76 89.01 Favored Pre-proline 0 N--CA 1.467 0.407 0 CA-C-O 117.606 -1.188 . . . . 0.0 108.72 169.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -43.04 138.92 3.88 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.544 2.829 . . . . 0.0 113.57 172.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.17 0.27 76.42 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 118.6 -1.111 . . . . 0.0 113.679 176.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -65.72 154.78 38.0 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 119.794 1.797 . . . . 0.0 108.815 168.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 77.4 mt -134.7 132.87 54.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 125.825 1.65 . . . . 0.0 106.699 -170.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.2 mmt-85 -143.39 148.11 35.69 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.291 0.95 . . . . 0.0 109.733 177.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 47.1 mm -77.92 144.68 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 169.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -135.5 165.63 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 124.777 1.231 . . . . 0.0 108.205 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -139.42 146.16 47.21 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 127.086 2.155 . . . . 0.0 107.619 -169.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -54.12 -27.97 48.88 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.399 2.733 . . . . 0.0 115.088 -174.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -67.29 -20.02 65.57 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.862 0.755 . . . . 0.0 112.123 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -119.85 -31.2 4.56 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.91 1.284 . . . . 0.0 111.84 -171.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 67.2 mt -50.74 -39.98 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.373 1.469 . . . . 0.0 109.938 169.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.45 -28.28 53.36 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.359 1.064 . . . . 0.0 113.129 -177.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -102.24 -43.83 5.6 Favored 'General case' 0 C--O 1.23 0.078 0 C-N-CA 123.202 0.601 . . . . 0.0 109.53 176.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 21.2 mmt -69.06 -28.76 66.83 Favored 'General case' 0 C--O 1.23 0.057 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -169.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -68.06 -48.36 65.82 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 119.038 0.835 . . . . 0.0 110.724 175.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 28.8 ptm -80.64 9.86 5.59 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 15.1 tpt -60.8 -27.37 67.98 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.432 1.015 . . . . 0.0 109.488 167.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 45.4 p -59.81 -15.56 21.59 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.096 1.758 . . . . 0.0 112.9 169.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.9 m 56.78 31.34 19.31 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.941 1.696 . . . . 0.0 109.961 -168.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -153.52 -54.58 0.11 Allowed 'General case' 0 C--N 1.345 0.404 0 O-C-N 121.393 -0.817 . . . . 0.0 112.988 -171.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -70.5 150.92 45.66 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 118.113 0.415 . . . . 0.0 110.321 -169.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 26.3 mmt -68.34 145.47 97.39 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 123.31 0.644 . . . . 0.0 109.632 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -73.83 76.58 2.87 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 124.463 3.442 . . . . 0.0 109.057 176.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.3 mt -52.03 -7.56 0.06 Allowed 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 117.087 2.255 . . . . 0.0 117.087 -167.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -52.78 -23.24 6.46 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.318 -0.864 . . . . 0.0 112.278 167.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -58.83 -34.4 71.49 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.396 0.998 . . . . 0.0 111.593 175.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.3 tt -75.83 -44.29 41.73 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 86.7 mt -60.96 -42.0 91.18 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.175 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -60.84 -26.01 67.04 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.853 0.751 . . . . 0.0 112.606 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -85.06 -3.57 58.84 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.753 0.821 . . . . 0.0 112.211 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 80.3 mt -130.01 -26.59 2.37 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.22 1.008 . . . . 0.0 111.946 -173.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -63.44 -23.11 67.26 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.221 -0.924 . . . . 0.0 112.286 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -80.09 -6.06 57.0 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.148 0.979 . . . . 0.0 111.789 175.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -132.51 -3.06 3.38 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.689 1.195 . . . . 0.0 113.038 -168.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.3 mt -134.85 143.41 37.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 126.549 1.94 . . . . 0.0 106.163 -175.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -70.37 -37.15 70.2 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-O 119.464 -0.631 . . . . 0.0 112.539 -172.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -146.53 130.88 17.59 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 -177.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 48.6 t -132.12 124.31 52.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 21.3 mt -130.19 156.68 42.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 -169.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -130.82 147.47 52.48 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 174.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.8 tt -126.37 126.5 43.99 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 170.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -107.69 156.16 15.98 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 82.5 mt -131.82 126.32 56.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 71.1 tp60 -64.64 116.03 25.44 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-O 117.201 -1.381 . . . . 0.0 110.438 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -76.51 170.59 19.64 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.268 2.645 . . . . 0.0 111.377 170.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -128.08 -31.9 2.32 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.978 1.711 . . . . 0.0 110.984 171.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.1 pp -137.14 139.77 43.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 124.369 1.068 . . . . 0.0 108.531 178.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 92.8 t -143.22 138.55 26.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 175.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 163.01 140.06 2.78 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 175.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -74.1 42.71 0.15 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.806 2.042 . . . . 0.0 113.759 -169.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -161.39 26.1 0.13 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.608 1.563 . . . . 0.0 110.731 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -135.04 153.24 78.33 Favored Pre-proline 0 CA--C 1.536 0.421 0 O-C-N 121.517 -0.74 . . . . 0.0 112.15 -174.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -83.75 166.1 13.52 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.601 2.867 . . . . 0.0 110.854 172.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.4 ttm -69.83 140.87 53.32 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 168.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 71.7 p -81.32 160.45 24.17 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.509 1.124 . . . . 0.0 110.682 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 6.9 tm0? -50.91 -48.81 83.32 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-O 117.004 -1.474 . . . . 0.0 113.351 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -67.53 -29.3 37.26 Favored 'Trans proline' 0 C--N 1.352 0.753 0 CA-C-N 122.575 1.955 . . . . 0.0 112.573 -175.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -81.63 -34.76 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 119.134 0.879 . . . . 0.0 108.865 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -56.65 -46.61 80.95 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 119.183 0.901 . . . . 0.0 109.782 169.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -62.36 -38.74 90.7 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 123.092 0.557 . . . . 0.0 111.525 177.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.41 -46.93 81.13 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 122.036 -0.415 . . . . 0.0 111.094 176.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 62.7 t -62.38 -40.32 87.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 118.81 0.732 . . . . 0.0 109.782 178.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -61.48 -40.06 93.17 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.625 0.648 . . . . 0.0 110.52 174.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 49.5 m -63.94 -46.92 82.6 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.785 -0.626 . . . . 0.0 109.962 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 85.4 t -58.83 -47.6 88.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 119.209 0.913 . . . . 0.0 109.133 177.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.424 ' CE1' ' HE2' ' A' ' 31' ' ' LYS . 24.4 t80 -53.83 -46.87 71.31 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.939 0.896 . . . . 0.0 111.2 177.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -72.36 -4.96 33.05 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 178.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.38 -11.4 10.57 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.17 1.388 . . . . 0.0 109.452 -175.176 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 59.5 mt -59.72 -25.45 64.83 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 119.348 -2.095 . . . . 0.0 111.449 170.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -81.33 -1.05 43.83 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.668 1.187 . . . . 0.0 113.555 177.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -137.4 -19.29 0.6 Allowed Glycine 0 CA--C 1.532 1.138 0 CA-C-N 119.182 0.901 . . . . 0.0 114.476 -172.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 17.1 t90 -60.26 149.62 32.74 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 118.422 1.111 . . . . 0.0 110.527 172.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.48 -2.36 2.47 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.391 1.876 . . . . 0.0 111.646 -175.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 150.93 -25.28 1.02 Allowed Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.725 1.631 . . . . 0.0 111.616 -173.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -142.79 -29.75 0.55 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.563 1.182 . . . . 0.0 112.652 -177.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 56.74 29.0 57.74 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.025 1.298 . . . . 0.0 113.751 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 78.76 4.87 88.39 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-O 118.204 -1.331 . . . . 0.0 114.265 173.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -87.74 150.87 23.33 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 119.874 1.837 . . . . 0.0 110.049 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.36 144.65 44.33 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -87.88 119.81 28.59 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 48.4 tp -57.96 137.91 56.35 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.322 1.449 . . . . 0.0 110.255 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -137.19 -63.9 0.58 Allowed 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.253 0.621 . . . . 0.0 111.431 173.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 8.1 p -156.26 9.0 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 C-N-CA 124.243 1.017 . . . . 0.0 111.121 -173.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -68.43 146.13 53.47 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.188 -0.945 . . . . 0.0 109.472 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -143.5 163.84 32.01 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.617 1.567 . . . . 0.0 108.109 177.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 . . . . . 0 C--O 1.252 1.204 0 C-N-CA 125.166 1.386 . . . . 0.0 109.874 173.491 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 44.4 m -128.2 135.98 50.46 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 170.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -137.81 96.68 3.27 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 -168.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 49.1 t -88.42 143.56 10.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-O 121.518 0.675 . . . . 0.0 109.357 -170.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.2 tp -113.22 108.67 17.59 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 169.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.1 tp -98.09 103.14 15.06 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 99.8 m -77.58 141.67 39.4 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 169.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 54.3 t -140.84 141.67 31.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 152.73 176.48 25.34 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-N 118.44 0.563 . . . . 0.0 112.9 174.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -120.15 115.65 24.08 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.73 1.612 . . . . 0.0 108.494 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -66.5 -10.39 44.18 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 -170.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 21.9 ptp -117.34 2.0 12.46 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.912 1.233 . . . . 0.0 111.267 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.3 ttt -95.75 39.85 1.13 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 122.087 0.946 . . . . 0.0 109.227 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 57.66 -121.83 27.13 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 124.327 0.965 . . . . 0.0 110.759 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -61.43 -19.67 62.22 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.096 0.959 . . . . 0.0 112.502 -174.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -65.61 -13.02 58.23 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.614 0.765 . . . . 0.0 112.274 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.19 17.4 1.4 Allowed Glycine 0 CA--C 1.531 1.039 0 O-C-N 120.743 -1.223 . . . . 0.0 113.097 176.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.26 -52.22 65.67 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.604 1.702 . . . . 0.0 110.821 -169.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.59 -55.6 29.02 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-O 117.745 -1.586 . . . . 0.0 111.024 175.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -49.73 -40.98 47.27 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 CA-C-N 120.878 2.339 . . . . 0.0 115.217 177.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.7 tp -71.98 -36.66 69.85 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 119.876 1.216 . . . . 0.0 110.408 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 49.4 tp -61.74 -49.94 74.41 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.332 0.515 . . . . 0.0 109.936 174.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.73 -39.49 77.43 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.923 0.889 . . . . 0.0 111.102 177.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.9 tp10 -62.05 -49.48 75.82 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 118.778 0.717 . . . . 0.0 109.87 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -62.24 -44.49 96.43 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.816 0.446 . . . . 0.0 110.614 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 84.9 m -63.64 -42.34 98.15 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.298 0.499 . . . . 0.0 110.997 178.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.18 -39.53 94.91 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.309 0.504 . . . . 0.0 111.046 178.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.37 -36.36 76.75 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.258 0.623 . . . . 0.0 111.486 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.01 91.61 2.43 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 124.8 1.24 . . . . 0.0 108.877 -171.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -55.65 163.26 5.51 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.633 2.889 . . . . 0.0 113.811 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -133.71 174.42 10.46 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 126.033 1.733 . . . . 0.0 108.87 176.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 40.1 -125.4 2.46 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.228 1.394 . . . . 0.0 112.336 177.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -141.25 38.4 1.73 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.319 1.447 . . . . 0.0 109.169 172.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -74.93 168.38 20.05 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.341 1.057 . . . . 0.0 111.904 -172.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 67.9 t -120.38 105.6 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 167.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.0 t -70.44 137.77 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -178.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.0 mm -134.59 148.21 29.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 169.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -130.66 109.81 10.92 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 175.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.22 -1.91 88.12 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 118.868 -0.962 . . . . 0.0 112.833 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 60.93 -146.5 47.54 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -170.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.8 p -94.44 -1.78 53.02 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.15 0.98 . . . . 0.0 112.917 -172.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.66 70.0 31.07 Favored Pre-proline 0 C--O 1.235 0.303 0 C-N-CA 125.138 1.375 . . . . 0.0 107.993 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -66.1 -12.42 35.37 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.777 2.318 . . . . 0.0 112.77 -169.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.8 tp10 -44.57 -41.15 6.3 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.592 1.557 . . . . 0.0 110.938 168.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -62.86 -23.71 67.45 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -177.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -113.86 -2.22 13.68 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -168.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 79.6 mt -50.59 -37.7 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.154 0.981 . . . . 0.0 110.311 172.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 53.1 t -55.92 -40.28 61.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 123.852 0.861 . . . . 0.0 110.395 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.81 -43.29 84.19 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.431 0.56 . . . . 0.0 110.406 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.3 mt -62.36 -39.5 84.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -65.91 -18.99 65.71 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 117.724 -1.131 . . . . 0.0 112.513 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -69.19 -42.95 75.14 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 120.702 1.592 . . . . 0.0 109.241 169.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.4 mt -72.6 -25.75 61.44 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.648 0.779 . . . . 0.0 112.447 -175.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 38.22 60.32 4.83 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.703 1.601 . . . . 0.0 111.929 -169.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.37 151.02 38.73 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.862 2.374 . . . . 0.0 113.501 -170.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.6 m -71.66 -37.28 70.81 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 168.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -147.4 155.86 42.34 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.201 1.0 . . . . 0.0 109.31 -176.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 37.1 tp -144.51 136.22 25.79 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.63 1.172 . . . . 0.0 108.633 -177.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 56.9 tp -122.14 137.85 54.67 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 169.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.2 mt -122.21 143.19 35.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 -177.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.9 t -140.97 134.07 31.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 118.294 0.497 . . . . 0.0 110.013 -174.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -161.92 173.15 14.9 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 127.11 2.164 . . . . 0.0 107.456 169.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.69 156.58 39.29 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.055 -1.028 . . . . 0.0 109.906 169.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.8 m -152.92 129.49 10.74 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -178.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -79.85 83.63 5.75 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 119.031 0.832 . . . . 0.0 109.561 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 74.9 mtm -77.26 -7.28 55.7 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.583 1.553 . . . . 0.0 112.018 -177.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.33 26.67 72.98 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 123.816 0.722 . . . . 0.0 111.672 -172.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.4 mt -104.88 -171.24 1.88 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.936 1.294 . . . . 0.0 110.004 -177.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -73.66 140.2 78.17 Favored Pre-proline 0 N--CA 1.468 0.467 0 CA-C-O 117.47 -1.252 . . . . 0.0 108.676 171.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -42.96 137.59 4.37 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.303 2.668 . . . . 0.0 113.378 172.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.66 2.74 76.87 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 118.692 -1.06 . . . . 0.0 113.7 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -66.11 148.1 52.34 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.743 1.771 . . . . 0.0 108.348 168.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.13 136.32 59.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -173.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 89.4 mmt-85 -145.9 151.16 37.41 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 118.8 0.727 . . . . 0.0 110.703 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 49.0 mm -75.9 144.09 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 167.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.409 HG22 ' H ' ' A' ' 77' ' ' ASP . 1.4 mt -133.64 165.79 30.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 124.55 1.14 . . . . 0.0 107.989 177.453 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.409 ' H ' HG22 ' A' ' 76' ' ' ILE . 5.9 t70 -135.63 145.89 55.12 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 127.116 2.166 . . . . 0.0 107.681 -170.234 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -54.46 -26.6 45.54 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.395 2.73 . . . . 0.0 115.147 -174.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -66.51 -21.37 66.17 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.012 0.824 . . . . 0.0 112.273 177.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -120.39 -28.52 4.99 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.708 1.203 . . . . 0.0 112.14 -171.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 72.0 mt -51.23 -39.78 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.845 1.258 . . . . 0.0 109.743 169.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.9 -28.6 51.91 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.53 1.132 . . . . 0.0 113.261 -177.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -100.9 -44.27 5.81 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 123.068 0.547 . . . . 0.0 109.657 175.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 21.3 mmt -67.26 -26.77 66.73 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -171.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.435 ' CE2' HD12 ' A' ' 94' ' ' LEU . 4.7 m-85 -76.85 -43.33 36.64 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.741 0.701 . . . . 0.0 111.502 174.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 22.0 ptt? -71.15 -17.79 62.53 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.102 0.864 . . . . 0.0 112.044 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 14.4 tpt -55.35 -27.22 45.78 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.347 1.059 . . . . 0.0 112.229 173.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 75.9 p -59.67 -31.15 69.29 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.63 0.772 . . . . 0.0 112.501 176.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.3 m 139.07 -41.89 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.605 1 C-N-CA 133.43 4.692 . . . . 0.0 105.849 -168.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -166.66 -46.25 0.02 OUTLIER 'General case' 0 C--N 1.347 0.481 0 C-N-CA 123.414 0.686 . . . . 0.0 112.144 174.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 42.77 -105.72 0.07 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.681 1.592 . . . . 0.0 108.332 -165.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 17.3 mmt -149.34 141.79 15.38 Favored Pre-proline 0 N--CA 1.452 -0.364 0 N-CA-C 104.036 -2.579 . . . . 0.0 104.036 168.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -74.83 59.05 4.95 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.786 2.991 . . . . 0.0 110.613 175.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.435 HD12 ' CE2' ' A' ' 85' ' ' PHE . 18.8 mt -47.86 -14.36 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 129.148 2.979 . . . . 0.0 116.903 -168.17 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -52.42 -24.94 8.71 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.406 1.003 . . . . 0.0 112.578 168.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -59.18 -33.05 70.48 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 119.32 0.964 . . . . 0.0 111.803 176.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.6 tt -75.61 -41.77 53.49 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 -177.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 92.2 mt -61.4 -48.59 88.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -61.7 -29.44 70.1 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.392 0.542 . . . . 0.0 112.395 -177.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -82.28 -2.69 53.41 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.002 0.921 . . . . 0.0 113.246 178.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 64.4 mt -133.08 -25.71 1.77 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.676 1.125 . . . . 0.0 112.549 -174.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -59.02 -21.62 59.34 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.353 1.061 . . . . 0.0 112.862 177.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -72.8 -11.19 60.51 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.415 1.086 . . . . 0.0 112.051 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -133.09 -42.54 0.88 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.349 1.06 . . . . 0.0 111.733 -173.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 28.2 mt -73.65 140.42 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 175.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.05 -40.89 95.34 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.185 0.897 . . . . 0.0 112.141 -177.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -148.49 137.14 21.47 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 118.633 1.216 . . . . 0.0 108.429 177.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.8 t -131.9 123.06 50.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -178.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 18.2 mt -129.54 155.39 41.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 -171.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -127.99 147.13 50.49 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 175.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.6 tt -129.1 130.36 46.39 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 172.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -115.19 156.96 15.31 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 77.6 mt -133.49 127.53 53.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 125.215 1.406 . . . . 0.0 107.269 -176.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 69.1 tp60 -67.25 117.6 48.05 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-O 117.607 -1.187 . . . . 0.0 111.129 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.35 175.04 11.78 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 124.27 3.313 . . . . 0.0 111.887 170.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -134.12 -29.16 1.29 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.257 1.423 . . . . 0.0 112.78 175.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.2 pp -132.29 4.22 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 119.362 0.983 . . . . 0.0 113.408 -171.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 8.5 p -38.43 118.49 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 125.929 1.692 . . . . 0.0 113.713 -167.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 170.31 158.37 14.09 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -175.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -67.17 152.56 45.53 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.996 0.919 . . . . 0.0 111.647 -173.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 56.32 41.76 28.67 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.883 2.073 . . . . 0.0 112.046 177.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -127.33 152.59 76.46 Favored Pre-proline 0 C--O 1.236 0.356 0 C-N-CA 124.287 1.035 . . . . 0.0 109.176 172.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -77.76 157.57 31.58 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.031 2.487 . . . . 0.0 109.875 168.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 56.5 ttm -66.25 136.64 56.14 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 169.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 18.1 p -77.75 154.45 31.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.588 0.709 . . . . 0.0 111.318 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -49.33 -47.25 77.17 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-O 116.916 -1.516 . . . . 0.0 113.443 -177.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -66.98 -28.13 42.11 Favored 'Trans proline' 0 C--N 1.351 0.69 0 CA-C-N 122.46 1.914 . . . . 0.0 112.407 -177.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 mp -78.12 -37.81 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 119.29 0.95 . . . . 0.0 108.564 177.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -57.28 -47.42 81.51 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.44 1.018 . . . . 0.0 110.074 172.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.18 -41.81 97.46 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 123.347 0.659 . . . . 0.0 111.053 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.94 -47.82 81.58 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 118.997 -0.525 . . . . 0.0 111.15 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.2 t -59.22 -41.21 83.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 118.886 0.766 . . . . 0.0 109.467 178.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -69.49 -27.83 65.54 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.861 0.755 . . . . 0.0 111.776 177.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 40.1 m -72.2 -42.39 65.86 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 120.982 -1.074 . . . . 0.0 109.944 174.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 88.0 t -61.18 -44.38 98.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 174.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -54.31 -47.04 72.91 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.163 0.985 . . . . 0.0 110.875 175.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -62.73 -40.72 98.09 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 118.869 0.758 . . . . 0.0 111.461 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -60.32 -25.39 65.76 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 118.368 -0.825 . . . . 0.0 112.463 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 93.0 mt -57.18 -22.66 42.07 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.852 1.205 . . . . 0.0 112.421 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -79.13 -9.45 59.56 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.731 0.812 . . . . 0.0 112.411 -178.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -150.99 -10.85 0.1 OUTLIER Glycine 0 CA--C 1.535 1.291 0 N-CA-C 115.884 1.114 . . . . 0.0 115.884 -171.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 17.7 t90 -58.17 139.53 54.69 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 119.175 1.487 . . . . 0.0 108.772 170.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -137.65 14.07 2.94 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.007 1.323 . . . . 0.0 111.058 172.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 158.05 -34.58 0.52 Allowed Glycine 0 CA--C 1.527 0.801 0 C-N-CA 123.866 0.746 . . . . 0.0 111.762 177.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -133.64 -26.32 1.61 Allowed 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -171.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 58.73 13.7 19.18 Favored Glycine 0 CA--C 1.537 1.423 0 N-CA-C 115.389 0.916 . . . . 0.0 115.389 176.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 85.14 1.27 88.58 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-N 118.793 1.296 . . . . 0.0 113.239 -178.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -74.57 165.87 24.49 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 119.721 1.76 . . . . 0.0 110.685 176.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -90.55 153.4 20.38 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 170.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -91.79 123.12 34.94 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 177.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 58.3 tp -59.02 116.75 4.02 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.986 1.314 . . . . 0.0 109.809 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -149.56 55.62 0.97 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.088 0.955 . . . . 0.0 109.379 -174.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . 0.272 35.1 m 42.62 47.84 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 127.017 2.127 . . . . 0.0 113.292 178.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -61.61 149.9 37.87 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.623 1.169 . . . . 0.0 110.916 176.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -142.09 31.34 1.58 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.461 1.504 . . . . 0.0 109.352 -178.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 . . . . . 0 C--O 1.25 1.079 0 C-N-CA 126.261 1.824 . . . . 0.0 108.486 -177.637 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 N--CA 1.482 1.15 0 N-CA-C 110.705 -0.109 . . . . 0.0 110.705 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.42 158.34 44.04 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -146.68 138.13 24.37 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -176.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 88.4 t -135.47 146.2 30.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 121.425 0.631 . . . . 0.0 110.284 -168.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 17.1 tp -115.03 126.94 55.31 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 104.889 -2.263 . . . . 0.0 104.889 168.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.8 tp -116.29 99.36 7.15 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 87.9 m -72.68 142.76 48.25 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 169.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.4 t -143.79 144.75 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 147.17 172.17 17.11 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -121.96 114.37 20.88 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 123.818 0.847 . . . . 0.0 109.138 -176.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -59.87 -11.76 6.17 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.624 1.97 . . . . 0.0 115.197 -170.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 22.5 ptp -127.72 10.13 6.54 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 119.212 0.915 . . . . 0.0 111.303 -178.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.4 ttt -98.04 31.33 2.75 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.072 0.851 . . . . 0.0 109.665 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.22 -140.49 20.67 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -178.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -62.04 -16.92 55.38 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.681 1.192 . . . . 0.0 112.389 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -58.19 -16.55 14.07 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.89 1.276 . . . . 0.0 112.995 176.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.32 21.86 0.84 Allowed Glycine 0 CA--C 1.535 1.324 0 O-C-N 120.288 -1.507 . . . . 0.0 114.451 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.94 -50.55 70.37 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 119.522 1.661 . . . . 0.0 111.363 -169.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.26 -54.43 37.96 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 117.555 -1.692 . . . . 0.0 111.322 177.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -48.37 -41.72 35.3 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 CA-C-N 120.656 2.228 . . . . 0.0 115.1 175.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.3 tp -72.54 -37.59 68.23 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.848 1.204 . . . . 0.0 110.706 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.6 tp -61.74 -45.95 91.74 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.605 0.639 . . . . 0.0 109.998 174.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.89 -38.55 86.05 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.903 0.881 . . . . 0.0 111.09 179.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.4 tp10 -61.86 -49.08 77.69 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 118.7 0.682 . . . . 0.0 109.541 178.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -63.84 -44.85 91.95 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.781 0.432 . . . . 0.0 110.501 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 73.3 m -63.69 -39.47 94.39 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.487 0.585 . . . . 0.0 111.444 177.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.22 -37.51 87.73 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.89 0.768 . . . . 0.0 111.113 177.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.48 -36.65 76.74 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.089 0.556 . . . . 0.0 111.245 178.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.71 98.51 1.53 Allowed Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 125.023 1.329 . . . . 0.0 108.163 -173.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -55.14 169.18 1.02 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 124.316 3.344 . . . . 0.0 114.983 -178.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.54 ' HE2' ' CZ ' ' A' ' 136' ' ' TYR . 14.9 mmtm -140.52 158.9 43.31 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.758 1.623 . . . . 0.0 108.28 -177.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 42.79 -126.33 4.71 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.007 1.289 . . . . 0.0 111.95 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -136.53 12.1 3.21 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.036 1.334 . . . . 0.0 111.164 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -73.64 131.03 41.22 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.942 0.897 . . . . 0.0 108.806 -173.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 97.5 t -69.85 112.86 5.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 166.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.3 t -71.56 133.16 32.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 60.4 mt -132.84 145.13 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 104.258 -2.497 . . . . 0.0 104.258 169.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -128.42 98.48 5.06 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 177.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.43 -14.07 71.54 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-O 119.136 -0.814 . . . . 0.0 112.121 175.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 51.71 -135.66 33.66 Favored Glycine 0 C--N 1.34 0.795 0 CA-C-N 118.208 1.004 . . . . 0.0 110.591 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.6 t -88.4 7.21 33.69 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.109 0.964 . . . . 0.0 111.554 -175.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.47 60.56 5.61 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.666 1.186 . . . . 0.0 110.12 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -69.7 -18.2 37.41 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.723 2.282 . . . . 0.0 112.929 -169.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -56.66 -31.69 64.65 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.44 0.696 . . . . 0.0 112.267 177.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.47 -30.32 69.6 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.296 0.639 . . . . 0.0 111.982 176.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -94.16 -6.4 44.96 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.022 0.929 . . . . 0.0 111.496 -169.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.2 mt -53.19 -43.85 50.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 118.964 0.802 . . . . 0.0 109.2 173.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.0 t -61.14 -42.11 92.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 122.981 0.512 . . . . 0.0 110.012 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.0 -46.87 73.21 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 122.923 0.489 . . . . 0.0 110.689 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.6 mt -55.09 -45.72 77.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.258 1.023 . . . . 0.0 109.179 174.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -60.86 -30.96 70.44 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 117.846 -1.073 . . . . 0.0 112.357 -177.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -59.46 -30.73 68.73 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 120.083 1.31 . . . . 0.0 111.265 176.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 56.5 mt -87.07 -9.06 56.37 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.666 1.186 . . . . 0.0 112.374 -173.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 27.34 61.73 0.6 Allowed Pre-proline 0 N--CA 1.475 0.811 0 C-N-CA 127.084 2.154 . . . . 0.0 112.229 -168.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.22 142.99 66.05 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.75 2.3 . . . . 0.0 114.203 -169.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.2 m -74.39 -30.37 61.92 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 168.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -146.54 151.66 37.7 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.007 0.923 . . . . 0.0 110.023 177.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 46.0 tp -141.24 136.11 31.36 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.674 1.59 . . . . 0.0 107.83 174.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 20.8 tp -126.8 133.42 50.79 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 105.674 -1.972 . . . . 0.0 105.674 172.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.4 mt -119.36 144.7 27.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -172.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.6 t -140.46 134.76 34.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 118.557 0.617 . . . . 0.0 109.875 -174.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -161.4 175.94 11.66 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 127.347 2.259 . . . . 0.0 107.082 172.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.44 160.4 30.28 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 120.805 -1.184 . . . . 0.0 108.494 167.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.0 m -156.29 125.27 6.02 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -70.72 122.3 19.57 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 169.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 77.1 mtm -122.46 1.39 9.56 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.53 1.532 . . . . 0.0 110.896 -175.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.87 26.05 71.01 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 118.568 0.622 . . . . 0.0 112.071 -173.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 74.9 mt -103.68 -171.1 1.88 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.479 1.512 . . . . 0.0 109.026 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -81.29 138.67 48.5 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-O 117.649 -1.167 . . . . 0.0 109.34 176.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -45.32 132.72 12.13 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.417 2.745 . . . . 0.0 113.814 177.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.95 3.22 90.65 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 118.502 -1.166 . . . . 0.0 113.241 179.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -64.58 145.71 55.73 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 119.895 1.847 . . . . 0.0 107.664 167.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 41.7 mt -126.72 138.84 53.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 -173.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 -148.94 148.96 30.41 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 118.236 0.471 . . . . 0.0 111.764 -179.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 41.3 mm -76.11 144.63 11.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 165.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.4 mt -135.38 163.79 34.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 176.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -136.72 145.73 52.32 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 126.36 1.864 . . . . 0.0 107.688 -170.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -52.17 -28.1 32.28 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.448 2.766 . . . . 0.0 115.197 -174.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -66.53 -23.23 66.2 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.817 0.735 . . . . 0.0 112.567 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -117.41 -29.51 5.81 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.659 1.184 . . . . 0.0 111.701 -173.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 53.5 mt -50.14 -41.02 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.322 1.449 . . . . 0.0 110.12 169.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.8 -24.43 57.25 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -173.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -103.34 -44.15 5.23 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 172.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 33.8 mmt -65.04 -34.44 78.43 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -170.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -66.79 -22.12 66.03 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -178.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -121.29 30.68 6.68 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.773 0.829 . . . . 0.0 111.208 174.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 15.1 tpt -61.38 -31.94 71.85 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 167.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.1 t -102.06 161.2 13.86 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.111 1.764 . . . . 0.0 107.547 169.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.6 p -76.02 37.44 0.15 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.631 1.972 . . . . 0.0 112.523 -176.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -145.62 177.86 8.57 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.862 1.265 . . . . 0.0 110.714 -167.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 52.75 -157.0 0.16 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.991 1.716 . . . . 0.0 110.765 -178.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 66.4 mtt -140.23 153.3 68.82 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 125.445 1.498 . . . . 0.0 107.672 176.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -70.94 72.86 1.98 Allowed 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 124.581 3.521 . . . . 0.0 110.822 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.5 mt -50.63 -6.36 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 129.228 3.011 . . . . 0.0 117.343 -168.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.12 -26.43 16.57 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 119.298 0.954 . . . . 0.0 111.614 167.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -60.36 -34.46 73.9 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.827 0.74 . . . . 0.0 111.604 176.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.5 tt -77.22 -43.35 33.93 Favored 'General case' 0 C--N 1.338 0.087 0 C-N-CA 123.334 0.654 . . . . 0.0 109.374 177.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 85.8 mt -59.78 -43.75 92.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -178.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -61.98 -23.94 66.72 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -84.71 0.68 49.59 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.723 0.809 . . . . 0.0 112.314 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 84.5 mt -133.58 -35.7 0.99 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.071 0.948 . . . . 0.0 111.626 -173.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -58.83 -22.77 59.42 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.307 1.043 . . . . 0.0 113.07 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -71.32 -13.37 61.85 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.061 0.944 . . . . 0.0 111.988 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -134.84 -30.35 1.09 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.175 0.898 . . . . 0.0 112.931 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 28.9 mt -69.19 138.92 21.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 174.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -63.95 -42.86 98.15 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 123.763 0.697 . . . . 0.0 112.442 -177.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -146.94 134.14 20.53 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.404 1.102 . . . . 0.0 108.367 177.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.8 t -126.09 133.59 68.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 176.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.9 mp -132.01 154.66 40.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 -176.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -128.69 146.52 50.86 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 170.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.0 tt -126.94 132.73 50.78 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 170.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -118.58 159.28 14.43 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 124.571 1.081 . . . . 0.0 110.853 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 82.1 mt -133.85 126.14 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 -177.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -62.48 115.42 16.42 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-O 117.463 -1.256 . . . . 0.0 110.199 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -75.45 171.13 18.83 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 123.394 2.73 . . . . 0.0 111.196 169.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -125.21 -30.91 3.12 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 125.867 1.667 . . . . 0.0 110.734 170.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -136.01 134.32 50.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 176.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.3 t -140.27 135.49 36.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 174.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 158.08 150.8 5.86 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -66.9 154.42 41.05 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.952 0.882 . . . . 0.0 111.522 -175.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 54.81 38.65 30.6 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.048 2.139 . . . . 0.0 112.273 -176.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -124.79 149.09 61.53 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 123.899 0.88 . . . . 0.0 110.281 172.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -83.13 165.16 14.98 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.437 2.758 . . . . 0.0 111.461 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.4 ttm -72.73 139.92 47.47 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 168.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 82.4 p -80.64 159.82 25.24 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.816 1.246 . . . . 0.0 110.549 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.3 tp60 -53.78 -44.79 98.61 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-O 116.675 -1.631 . . . . 0.0 114.298 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -68.29 -30.47 30.49 Favored 'Trans proline' 0 C--N 1.351 0.71 0 CA-C-N 122.86 2.057 . . . . 0.0 112.034 -176.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.6 mp -78.94 -35.79 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -56.82 -46.36 81.71 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.549 1.068 . . . . 0.0 110.044 171.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -63.21 -41.67 99.18 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 122.965 0.506 . . . . 0.0 111.07 178.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.98 -47.97 82.44 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 118.958 -0.544 . . . . 0.0 110.974 176.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 76.5 t -60.76 -40.01 83.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 118.98 0.809 . . . . 0.0 109.705 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -69.93 -30.62 68.06 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.583 1.083 . . . . 0.0 111.551 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 28.1 m -68.68 -46.87 67.94 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.36 -0.837 . . . . 0.0 109.443 173.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 53.9 t -58.73 -45.52 91.07 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.163 0 C-N-CA 123.875 0.87 . . . . 0.0 109.152 176.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.54 ' CZ ' ' HE2' ' A' ' 31' ' ' LYS . 33.5 t80 -52.37 -48.64 65.47 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.275 1.03 . . . . 0.0 110.861 177.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -64.39 -38.74 92.11 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.568 0.622 . . . . 0.0 110.838 176.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 9.2 tpp85 -65.46 -23.25 66.87 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 118.145 -0.931 . . . . 0.0 112.862 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -59.2 -17.27 26.23 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 120.431 1.469 . . . . 0.0 111.036 172.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -91.97 -2.07 56.94 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 120.167 1.349 . . . . 0.0 112.706 176.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -152.43 13.44 0.7 Allowed Glycine 0 CA--C 1.531 1.06 0 CA-C-N 119.083 0.856 . . . . 0.0 114.922 -169.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 6.7 t90 -58.07 140.93 51.55 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.567 1.183 . . . . 0.0 108.347 169.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -138.35 10.48 2.75 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -168.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 140.97 -34.28 1.95 Allowed Glycine 0 CA--C 1.524 0.637 0 C-N-CA 124.186 0.898 . . . . 0.0 112.211 175.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -136.86 20.62 3.05 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.644 1.178 . . . . 0.0 109.983 177.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 59.47 7.04 5.19 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.802 1.668 . . . . 0.0 115.17 -175.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.76 -0.2 29.46 Favored Glycine 0 CA--C 1.538 1.496 0 CA-C-N 119.364 1.582 . . . . 0.0 112.025 -168.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -80.72 169.78 17.16 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.891 1.276 . . . . 0.0 109.835 172.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -87.69 155.46 19.92 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 169.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -88.53 125.72 34.91 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 174.051 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 67.7 tp -54.87 127.37 28.31 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.941 1.296 . . . . 0.0 109.785 176.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -142.16 36.47 1.54 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.934 0.894 . . . . 0.0 109.598 171.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.8 t 53.03 52.79 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 126.198 1.799 . . . . 0.0 110.296 174.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -54.25 149.39 9.89 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.486 0.714 . . . . 0.0 110.489 174.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -154.17 169.18 24.2 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.402 1.481 . . . . 0.0 108.543 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 . . . . . 0 C--O 1.247 0.921 0 C-N-CA 125.953 1.701 . . . . 0.0 106.972 178.854 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ptm . . . . . 0 N--CA 1.484 1.243 0 CA-C-O 120.629 0.252 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.5 m -136.37 152.33 50.52 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 173.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -150.37 141.63 23.22 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -169.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 74.0 t -135.73 145.52 31.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 123.3 0.64 . . . . 0.0 109.986 -170.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 25.8 tp -114.14 124.89 53.2 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 169.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 56.7 tp -114.2 96.26 5.7 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 178.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 91.5 m -72.54 142.22 48.48 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.131 169.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.4 t -140.4 142.94 30.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 125.176 1.39 . . . . 0.0 107.517 178.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 144.76 172.26 15.14 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 124.657 1.122 . . . . 0.0 111.442 176.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -113.77 121.14 43.16 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 107.832 -1.174 . . . . 0.0 107.832 174.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -59.2 -13.63 8.09 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.401 1.88 . . . . 0.0 115.423 -169.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.0 ptt? -130.78 12.79 5.31 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.976 0.91 . . . . 0.0 111.172 -176.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.9 ttt -92.95 35.24 1.06 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.816 0.734 . . . . 0.0 109.311 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.28 -143.89 30.08 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -173.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -60.24 -18.01 45.79 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 126.016 1.726 . . . . 0.0 112.445 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -54.02 -26.96 29.06 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.649 1.18 . . . . 0.0 112.57 176.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.18 27.83 0.68 Allowed Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.643 -1.087 . . . . 0.0 114.165 178.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.45 -47.97 74.32 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 119.45 1.625 . . . . 0.0 110.253 -172.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.03 -55.82 28.78 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 117.692 -1.616 . . . . 0.0 111.071 174.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -48.21 -41.82 34.07 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 CA-C-N 121.01 2.405 . . . . 0.0 115.372 176.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.3 tp -70.78 -38.28 73.38 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.889 1.222 . . . . 0.0 110.495 178.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.4 tp -61.99 -46.6 88.51 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.936 -0.477 . . . . 0.0 110.291 175.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.35 -40.57 82.55 Favored 'General case' 0 C--O 1.227 -0.088 0 C-N-CA 124.025 0.93 . . . . 0.0 110.978 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -60.72 -48.82 80.1 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 118.594 0.634 . . . . 0.0 109.821 178.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -63.37 -48.8 76.4 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.171 0.589 . . . . 0.0 110.515 -178.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 70.7 m -64.32 -36.74 85.11 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.45 0.568 . . . . 0.0 111.449 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.74 -37.56 88.02 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.166 0.894 . . . . 0.0 111.151 176.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.75 -34.27 75.31 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.18 0.592 . . . . 0.0 111.406 178.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.72 98.89 1.87 Allowed Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 125.325 1.45 . . . . 0.0 108.156 -174.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -54.89 161.02 6.82 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 123.483 2.789 . . . . 0.0 113.854 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.427 ' HE2' ' CE1' ' A' ' 136' ' ' TYR . 72.8 mmtt -135.08 162.21 33.13 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.912 1.685 . . . . 0.0 108.137 178.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 43.53 -121.73 3.56 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.96 1.267 . . . . 0.0 111.614 176.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -134.07 10.7 3.89 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.672 1.189 . . . . 0.0 111.136 174.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -72.86 117.71 14.91 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 121.469 -0.77 . . . . 0.0 109.31 -169.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 89.4 t -67.98 118.31 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 167.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.1 t -73.9 134.13 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -177.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 56.1 mt -132.45 141.34 45.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 103.875 -2.639 . . . . 0.0 103.875 169.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -125.98 106.19 9.45 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 175.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.36 -1.89 82.63 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 118.997 -0.89 . . . . 0.0 112.919 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 56.52 -146.99 33.04 Favored Glycine 0 C--N 1.34 0.76 0 N-CA-C 108.17 -1.972 . . . . 0.0 108.17 -168.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.2 p -88.5 10.49 20.06 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.772 -0.84 . . . . 0.0 111.867 177.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.37 57.96 15.91 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 125.151 1.38 . . . . 0.0 110.393 -176.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -68.87 -14.29 38.52 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.834 2.356 . . . . 0.0 112.978 -171.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -56.7 -32.21 65.25 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.05 0.841 . . . . 0.0 112.03 175.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -61.64 -27.88 68.98 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.4 0.68 . . . . 0.0 112.258 175.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -98.25 -1.88 40.89 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.945 1.298 . . . . 0.0 111.575 -169.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.7 mt -53.86 -42.4 52.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 118.866 0.757 . . . . 0.0 109.783 175.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 43.2 t -61.08 -41.04 87.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 118.378 0.535 . . . . 0.0 110.065 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.33 -43.91 84.82 Favored 'General case' 0 N--CA 1.456 -0.159 0 O-C-N 121.842 -0.536 . . . . 0.0 110.757 -177.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 63.3 mt -58.84 -48.99 84.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 173.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -60.82 -35.88 77.66 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 118.163 -0.922 . . . . 0.0 111.947 -174.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -57.07 -29.73 63.7 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.521 1.055 . . . . 0.0 111.794 177.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 55.2 mt -87.15 -9.78 54.39 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.883 0.873 . . . . 0.0 112.457 -177.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 29.14 61.06 0.78 Allowed Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 126.768 2.027 . . . . 0.0 112.464 -168.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -56.33 145.99 75.16 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.86 2.374 . . . . 0.0 112.589 -171.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.8 m -73.13 -30.35 63.55 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.938 0.895 . . . . 0.0 108.937 168.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -145.36 151.88 38.99 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.28 1.032 . . . . 0.0 109.954 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 41.9 tp -143.17 134.0 25.35 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.329 1.452 . . . . 0.0 107.862 176.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 23.5 tp -126.65 135.27 50.97 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 172.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.0 mt -121.33 143.76 32.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 -171.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.5 t -142.14 135.64 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 119.117 0.871 . . . . 0.0 110.296 -175.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -164.89 170.93 14.73 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 127.372 2.269 . . . . 0.0 107.871 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.82 155.42 37.59 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 121.437 -0.789 . . . . 0.0 108.963 168.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.2 m -154.67 125.08 6.88 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -72.66 121.75 20.3 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 172.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 74.2 mtm -121.53 1.73 10.11 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.168 1.787 . . . . 0.0 110.709 -176.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.43 23.87 67.06 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 118.686 0.675 . . . . 0.0 112.317 -172.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.0 mt -96.2 -174.32 3.05 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.315 1.446 . . . . 0.0 109.43 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -73.7 140.43 78.22 Favored Pre-proline 0 N--CA 1.467 0.393 0 CA-C-O 117.645 -1.169 . . . . 0.0 108.286 170.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -44.29 137.52 7.73 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.216 2.611 . . . . 0.0 112.962 173.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.41 2.32 79.24 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 118.695 -1.058 . . . . 0.0 113.83 176.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -67.12 147.85 52.6 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.911 1.855 . . . . 0.0 108.23 168.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 70.4 mt -124.39 135.92 62.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -172.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.3 mmt-85 -145.26 147.76 32.74 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 118.853 0.751 . . . . 0.0 110.513 176.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 42.3 mm -78.05 142.81 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 167.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.7 mt -129.02 136.38 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 119.98 1.264 . . . . 0.0 108.729 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -80.66 141.29 51.83 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 124.536 1.134 . . . . 0.0 109.761 175.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -47.62 -34.35 20.37 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 124.162 3.241 . . . . 0.0 116.216 178.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -66.54 -26.27 67.05 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.528 0.604 . . . . 0.0 111.719 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -101.09 -29.05 12.36 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.541 1.137 . . . . 0.0 111.094 -176.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.405 HD11 ' HB3' ' A' ' 110' ' ' PHE . 24.9 mt -49.34 -41.08 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.317 1.447 . . . . 0.0 110.839 169.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.9 -24.4 15.97 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.138 1.375 . . . . 0.0 113.601 -177.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -113.61 -37.35 4.62 Favored 'General case' 0 C--O 1.228 -0.063 0 C-N-CA 123.304 0.642 . . . . 0.0 110.381 175.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 22.3 mmt -66.89 -31.86 72.74 Favored 'General case' 0 C--N 1.334 -0.096 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -173.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -63.77 -53.02 57.5 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 119.053 0.842 . . . . 0.0 109.869 174.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.55 4.82 17.17 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -176.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 14.3 tpt -60.31 -26.64 66.68 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.323 -0.861 . . . . 0.0 110.021 168.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 65.6 p -62.5 -13.39 30.02 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.511 1.524 . . . . 0.0 113.042 169.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.6 m 61.22 21.85 12.26 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.462 1.905 . . . . 0.0 110.54 -168.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -142.88 -58.05 0.43 Allowed 'General case' 0 C--N 1.344 0.369 0 O-C-N 121.046 -1.034 . . . . 0.0 112.101 -170.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -68.43 149.37 49.4 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 123.168 0.587 . . . . 0.0 110.002 -169.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 64.3 mtt -77.5 149.93 78.94 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-O 118.404 -0.808 . . . . 0.0 109.522 -175.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -73.88 56.23 3.53 Favored 'Trans proline' 0 CA--C 1.538 0.684 1 C-N-CA 125.683 4.256 . . . . 0.0 112.667 -177.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.3 mt -49.66 -1.06 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 130.36 3.464 . . . . 0.0 118.822 -168.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.49 -25.92 39.72 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 120.006 1.276 . . . . 0.0 110.762 166.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -62.03 -29.64 70.42 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.618 0.767 . . . . 0.0 112.171 174.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.2 tt -74.68 -45.86 41.69 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.175 0.898 . . . . 0.0 108.858 174.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 98.5 mt -58.59 -42.14 83.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -178.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.11 -23.88 64.2 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -87.94 -1.77 58.19 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.993 0.917 . . . . 0.0 112.449 178.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -123.63 -34.93 2.98 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.102 0.961 . . . . 0.0 111.789 178.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -60.68 -21.78 63.21 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.859 0.864 . . . . 0.0 113.063 -173.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -72.34 -12.11 60.99 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.079 0.952 . . . . 0.0 112.012 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -136.31 -32.62 0.85 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.265 0.939 . . . . 0.0 113.082 -178.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 15.3 mt -69.6 138.83 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 172.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -65.91 -41.14 95.58 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.111 0.862 . . . . 0.0 112.397 -176.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -145.9 137.57 25.04 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 118.582 1.191 . . . . 0.0 109.113 175.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.5 t -130.22 129.4 65.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.9 mp -130.52 154.12 40.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -174.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.405 ' HB3' HD11 ' A' ' 81' ' ' ILE . 78.5 t80 -133.35 144.5 49.65 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 168.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.3 tt -126.32 123.31 37.74 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.641 1.576 . . . . 0.0 106.966 177.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -109.65 155.6 16.01 Favored Glycine 0 C--N 1.334 0.436 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 64.6 mt -133.97 124.19 46.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 -173.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.7 tp60 -61.64 115.94 17.9 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-O 117.547 -1.216 . . . . 0.0 110.619 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -79.12 172.47 14.77 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.308 2.672 . . . . 0.0 111.582 170.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -135.95 -29.2 1.03 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 127.263 2.225 . . . . 0.0 111.317 173.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -132.97 120.42 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 -173.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 64.5 t -143.56 132.62 20.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 153.54 152.39 6.03 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -67.73 150.15 49.04 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.882 0.849 . . . . 0.0 111.441 -173.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 14.2 t80 51.24 41.41 27.86 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.884 2.074 . . . . 0.0 112.101 -173.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.3 m-30 -115.19 142.9 29.29 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 169.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.03 159.44 44.54 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.596 2.197 . . . . 0.0 110.531 171.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.7 ttm -73.98 142.45 45.83 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 168.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 37.3 p -81.71 157.61 24.52 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.367 1.067 . . . . 0.0 110.701 178.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -52.1 -42.6 86.67 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-O 116.52 -1.705 . . . . 0.0 114.697 -178.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.37 -29.07 21.53 Favored 'Trans proline' 0 C--N 1.35 0.628 0 CA-C-N 123.087 2.138 . . . . 0.0 111.878 -176.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.63 -36.11 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -56.52 -46.15 80.74 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.166 0.893 . . . . 0.0 109.986 170.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -64.61 -37.83 88.9 Favored 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 123.302 0.641 . . . . 0.0 111.435 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.25 -47.24 80.39 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 121.933 -0.479 . . . . 0.0 110.706 175.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 61.0 t -62.6 -39.91 86.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 118.643 0.656 . . . . 0.0 109.842 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -60.7 -42.88 98.09 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.136 0.88 . . . . 0.0 110.283 173.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 54.2 m -61.35 -48.76 79.82 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 79.3 t -60.39 -45.97 95.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 118.762 0.71 . . . . 0.0 109.654 179.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.427 ' CE1' ' HE2' ' A' ' 31' ' ' LYS . 19.3 t80 -54.06 -49.7 68.4 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.92 0.888 . . . . 0.0 110.578 177.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -69.83 -26.8 64.4 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.525 -0.734 . . . . 0.0 112.114 178.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -73.48 -24.36 60.18 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.23 -0.919 . . . . 0.0 112.065 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 33.4 mt -61.1 -21.94 64.17 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.393 0.997 . . . . 0.0 113.454 -172.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -88.69 -1.94 58.34 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.833 1.197 . . . . 0.0 112.794 176.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -137.58 5.83 3.5 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.479 1.037 . . . . 0.0 113.754 -172.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -59.4 139.49 57.01 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.405 1.082 . . . . 0.0 108.259 169.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -143.88 23.11 1.74 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.572 0.749 . . . . 0.0 111.315 -170.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 146.08 -34.65 1.41 Allowed Glycine 0 C--N 1.339 0.704 0 O-C-N 121.427 -0.796 . . . . 0.0 112.64 171.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -153.33 16.4 0.54 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.221 1.008 . . . . 0.0 111.327 173.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 69.23 3.1 36.3 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.652 1.12 . . . . 0.0 114.246 -177.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.81 10.25 60.82 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-N 119.422 1.611 . . . . 0.0 112.09 -170.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -69.63 167.7 16.38 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 118.371 1.085 . . . . 0.0 109.133 170.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -89.42 147.08 24.23 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 172.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -93.22 119.91 32.92 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 44.1 tp -60.82 126.56 27.86 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.913 1.285 . . . . 0.0 109.797 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.31 56.38 1.61 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.35 1.06 . . . . 0.0 109.207 -179.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 6.5 t 50.79 51.96 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 125.434 1.493 . . . . 0.0 109.007 -173.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 -64.77 136.51 56.99 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.234 1.014 . . . . 0.0 109.77 -176.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -146.19 163.56 35.03 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.179 1.792 . . . . 0.0 107.416 175.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 . . . . . 0 C--O 1.25 1.108 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 176.34 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 119.062 -0.494 . . . . 0.0 110.82 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.2 m -143.51 152.14 41.11 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 -172.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -140.1 139.2 35.79 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 53.1 t -124.87 141.1 46.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.624 0.726 . . . . 0.0 109.541 -170.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 34.8 tp -107.42 128.1 54.18 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 168.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 56.5 tp -116.18 97.81 6.27 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 177.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 93.2 m -73.18 142.19 47.38 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 170.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.8 t -140.34 141.58 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 125.31 1.444 . . . . 0.0 107.274 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.74 174.94 18.39 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 123.988 0.804 . . . . 0.0 112.219 175.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -117.13 121.25 40.74 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.94 1.296 . . . . 0.0 108.25 176.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 m -59.39 -14.87 13.55 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.458 1.903 . . . . 0.0 115.524 -169.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -130.0 13.98 5.75 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.983 0.913 . . . . 0.0 111.282 -175.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.9 ttt -97.24 34.42 1.78 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.599 0.636 . . . . 0.0 109.756 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.86 -140.95 22.98 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -177.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -62.77 -15.77 55.04 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.474 1.11 . . . . 0.0 112.279 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -59.4 -16.51 23.56 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.035 1.334 . . . . 0.0 112.669 174.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.64 17.84 1.47 Allowed Glycine 0 CA--C 1.533 1.208 0 O-C-N 120.568 -1.332 . . . . 0.0 114.01 175.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.45 -51.16 68.61 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 119.682 1.741 . . . . 0.0 111.032 -169.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.84 -55.18 31.82 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-O 117.806 -1.552 . . . . 0.0 110.984 175.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -48.96 -40.94 40.63 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 CA-C-N 120.687 2.243 . . . . 0.0 115.298 176.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.9 tp -71.97 -37.84 69.85 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 120.254 1.388 . . . . 0.0 110.443 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.2 tp -62.18 -45.63 92.53 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.899 -0.501 . . . . 0.0 110.315 175.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.43 -40.55 87.13 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 123.894 0.878 . . . . 0.0 111.023 177.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.4 tp10 -60.85 -48.66 80.77 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.792 0.723 . . . . 0.0 109.661 178.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -62.28 -46.69 87.65 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.062 0.545 . . . . 0.0 110.639 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 81.1 m -64.98 -37.89 89.17 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.267 0.485 . . . . 0.0 111.237 179.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.66 -37.83 88.93 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.853 0.751 . . . . 0.0 111.107 176.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.13 -37.95 78.57 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.204 0.602 . . . . 0.0 111.092 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.63 95.81 2.03 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 125.166 1.386 . . . . 0.0 108.489 -173.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -55.78 164.32 4.67 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 123.813 3.009 . . . . 0.0 114.182 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.421 ' HE2' ' CZ ' ' A' ' 136' ' ' TYR . 21.0 mmtt -131.56 167.54 19.22 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.625 1.57 . . . . 0.0 109.058 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 40.08 -116.63 0.75 Allowed Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.048 1.309 . . . . 0.0 111.513 175.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -140.65 28.45 1.98 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.62 1.168 . . . . 0.0 109.843 169.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -73.58 125.66 28.5 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.372 -0.83 . . . . 0.0 109.514 -173.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.9 t -78.14 115.32 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 104.103 -2.555 . . . . 0.0 104.103 166.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.4 t -75.77 136.2 25.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -175.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.9 mm -131.38 145.35 35.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 103.972 -2.603 . . . . 0.0 103.972 169.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -132.85 103.79 6.26 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 178.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.5 -4.54 87.44 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-O 118.855 -0.969 . . . . 0.0 112.743 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 54.71 -143.72 31.75 Favored Glycine 0 C--N 1.34 0.754 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 -169.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.2 p -89.67 6.74 40.04 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.985 -0.714 . . . . 0.0 112.41 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.28 64.59 47.22 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 124.866 1.266 . . . . 0.0 109.749 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -64.51 -16.39 54.94 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.732 2.288 . . . . 0.0 112.505 -177.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -47.71 -42.28 24.72 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.51 1.524 . . . . 0.0 111.164 169.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.26 -24.99 66.67 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.015 0.526 . . . . 0.0 112.342 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.04 -3.8 31.27 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 125.071 1.348 . . . . 0.0 111.821 -169.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 84.0 mt -51.2 -41.09 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.866 0.866 . . . . 0.0 110.423 175.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 49.0 t -58.46 -42.04 83.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 118.844 0.747 . . . . 0.0 110.319 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.39 -32.99 73.45 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.212 0.605 . . . . 0.0 111.227 -175.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 58.5 mt -67.33 -50.57 61.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 170.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -66.65 -33.24 75.22 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 118.247 -0.882 . . . . 0.0 112.464 -169.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -62.91 -20.74 65.46 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.979 1.263 . . . . 0.0 112.03 178.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 62.5 mt -86.03 -10.18 55.47 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.391 1.076 . . . . 0.0 113.067 174.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 28.91 61.79 0.75 Allowed Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 127.231 2.212 . . . . 0.0 112.856 -167.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -58.05 150.38 65.21 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.383 2.722 . . . . 0.0 113.549 -169.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.3 m -71.13 -36.27 72.03 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.221 1.009 . . . . 0.0 109.359 168.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 21.3 mtm180 -144.52 162.2 37.17 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.346 1.059 . . . . 0.0 110.199 179.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.5 tp -146.19 134.8 22.16 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 125.256 1.422 . . . . 0.0 107.836 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 37.7 tp -125.78 131.1 52.55 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 173.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.0 mt -115.95 143.2 26.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -175.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.5 t -140.27 134.07 34.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 118.64 0.654 . . . . 0.0 109.91 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -161.7 173.46 14.64 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.275 2.23 . . . . 0.0 107.304 170.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.89 157.78 35.88 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 166.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.3 m -154.6 124.47 6.67 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 176.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -71.57 125.63 27.56 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 172.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 72.9 mtm -127.01 1.96 6.54 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.445 1.898 . . . . 0.0 110.427 -175.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.66 23.74 67.36 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-N 118.693 0.679 . . . . 0.0 112.553 -172.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.2 mt -96.41 -172.47 2.53 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.251 1.421 . . . . 0.0 109.41 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -76.02 139.33 69.18 Favored Pre-proline 0 N--CA 1.468 0.426 0 CA-C-O 117.669 -1.158 . . . . 0.0 108.338 171.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -43.38 137.5 5.41 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.411 2.741 . . . . 0.0 113.131 172.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.93 2.11 81.0 Favored Glycine 0 CA--C 1.534 1.234 0 CA-C-O 118.528 -1.151 . . . . 0.0 113.739 176.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -66.57 144.16 56.6 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 119.909 1.855 . . . . 0.0 107.786 168.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 51.8 mt -121.05 140.71 44.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 -174.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 90.3 mmt-85 -148.4 147.67 29.46 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 118.522 0.601 . . . . 0.0 112.131 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 50.6 mm -77.94 143.28 13.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 164.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.6 mt -128.57 123.84 60.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 176.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -75.16 139.89 72.83 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-O 117.739 -1.124 . . . . 0.0 109.433 175.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_exo -46.75 -36.39 19.33 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 124.235 3.29 . . . . 0.0 116.609 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -69.32 -25.83 64.42 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 118.532 0.605 . . . . 0.0 111.38 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -93.35 -34.46 13.48 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.87 1.268 . . . . 0.0 110.985 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 71.6 mt -48.78 -46.48 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.901 1.28 . . . . 0.0 108.956 169.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.46 -19.54 37.63 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.609 1.164 . . . . 0.0 114.002 -174.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -115.01 -25.34 8.18 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.469 0.708 . . . . 0.0 110.867 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 22.7 mmt -80.5 -36.68 32.98 Favored 'General case' 0 C--O 1.231 0.079 0 CA-C-N 118.238 0.472 . . . . 0.0 112.005 -178.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.64 -37.7 88.48 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 118.906 0.775 . . . . 0.0 112.584 -169.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -63.27 -10.43 15.95 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 178.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.6 ttt -62.14 -23.0 66.31 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.501 1.046 . . . . 0.0 111.064 172.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 55.9 p -76.86 47.51 0.52 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.348 1.059 . . . . 0.0 111.107 169.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.5 m 61.62 65.67 0.92 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.971 1.708 . . . . 0.0 111.931 174.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 21.0 t-80 58.84 32.59 22.38 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.673 1.589 . . . . 0.0 111.986 175.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -60.84 159.85 10.52 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 123.784 0.834 . . . . 0.0 110.004 169.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 26.4 mmt -64.18 145.59 98.01 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 123.149 0.579 . . . . 0.0 109.969 178.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -75.25 78.33 2.99 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 124.708 3.605 . . . . 0.0 108.213 174.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.2 mt -48.89 -11.2 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 117.435 2.383 . . . . 0.0 117.435 -167.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.73 -20.04 4.99 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.333 -0.854 . . . . 0.0 112.554 167.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -58.88 -31.3 68.45 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.517 1.053 . . . . 0.0 111.71 174.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.4 tt -72.95 -45.95 55.2 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 174.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 83.8 mt -58.84 -39.48 77.43 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 123.196 0.599 . . . . 0.0 109.881 -177.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -58.33 -24.72 60.58 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.677 0.671 . . . . 0.0 112.805 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -89.79 -6.71 55.68 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.231 1.012 . . . . 0.0 112.086 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -118.63 -28.15 5.72 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.252 1.021 . . . . 0.0 111.703 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -63.46 -24.18 67.72 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 119.379 0.991 . . . . 0.0 112.403 -175.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -79.27 -4.78 52.33 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.47 1.108 . . . . 0.0 111.843 176.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -134.33 -1.81 2.85 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.33 1.452 . . . . 0.0 112.688 -168.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 20.0 mt -137.29 145.41 29.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 126.094 1.758 . . . . 0.0 107.15 -173.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -71.46 -37.68 62.41 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-O 119.236 -0.758 . . . . 0.0 112.45 -174.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -146.75 135.37 22.09 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.56 1.18 . . . . 0.0 108.076 174.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.2 t -124.68 132.62 71.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 175.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 5.4 mt -133.49 152.29 34.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 -168.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -130.43 142.02 50.51 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 169.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.8 tt -124.31 129.05 50.05 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 174.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -112.88 156.46 15.59 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 77.6 mt -132.75 123.71 49.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -178.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -60.63 115.94 15.95 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-O 117.43 -1.271 . . . . 0.0 110.439 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -76.05 171.53 17.97 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.59 2.86 . . . . 0.0 111.416 170.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -127.96 -32.45 2.31 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.976 1.71 . . . . 0.0 110.932 171.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.69 137.03 47.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.296 1.038 . . . . 0.0 108.333 176.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 90.1 t -141.41 134.93 30.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 175.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 159.21 150.93 5.96 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -65.29 152.55 43.47 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.865 0.84 . . . . 0.0 111.308 -175.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 54.87 38.96 31.21 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.852 2.061 . . . . 0.0 112.09 -177.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -123.14 148.41 54.53 Favored Pre-proline 0 C--O 1.237 0.399 0 C-N-CA 123.987 0.915 . . . . 0.0 109.794 172.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.99 162.5 20.67 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.164 2.576 . . . . 0.0 111.13 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 52.5 ttm -71.43 138.91 49.45 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 168.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 67.4 p -79.85 159.51 26.43 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.285 1.034 . . . . 0.0 110.496 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 21.8 tp60 -53.03 -44.8 97.93 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 116.565 -1.683 . . . . 0.0 114.101 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -68.63 -30.53 28.09 Favored 'Trans proline' 0 C--N 1.351 0.695 0 CA-C-N 122.912 2.076 . . . . 0.0 112.144 -176.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.6 mp -80.05 -35.61 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 118.971 0.805 . . . . 0.0 108.889 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -56.26 -46.56 79.62 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.354 0.979 . . . . 0.0 109.941 170.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -63.92 -38.58 91.6 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.024 0.53 . . . . 0.0 111.319 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.9 -46.19 82.75 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 119.097 -0.478 . . . . 0.0 111.164 175.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 71.8 t -62.68 -39.5 84.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 118.994 0.816 . . . . 0.0 109.658 178.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -62.35 -42.46 99.41 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.191 0.905 . . . . 0.0 110.508 173.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 59.0 m -61.48 -49.4 76.93 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 72.7 t -60.09 -44.25 94.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 123.539 0.736 . . . . 0.0 109.642 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.421 ' CZ ' ' HE2' ' A' ' 31' ' ' LYS . 43.1 t80 -55.96 -48.59 75.53 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.184 0.594 . . . . 0.0 110.631 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 60.0 mm-40 -64.89 -39.09 93.0 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.038 0.836 . . . . 0.0 110.903 176.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -62.3 -29.42 70.42 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 118.732 -0.651 . . . . 0.0 112.263 -177.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 76.8 mt -57.52 -21.78 40.19 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.11 0.868 . . . . 0.0 112.389 177.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -81.49 -13.6 57.96 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.105 0.866 . . . . 0.0 112.21 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -134.79 -9.88 1.67 Allowed Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.215 0.912 . . . . 0.0 114.342 -171.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 17.5 t90 -55.18 141.83 33.53 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.177 1.391 . . . . 0.0 109.253 171.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -145.08 12.28 1.39 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.085 0.954 . . . . 0.0 112.705 -178.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 159.96 -36.16 0.46 Allowed Glycine 0 CA--C 1.529 0.919 0 O-C-N 121.653 -0.654 . . . . 0.0 112.264 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -148.5 -17.03 0.33 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.318 1.047 . . . . 0.0 112.495 -175.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 67.89 7.93 51.21 Favored Glycine 0 CA--C 1.531 1.043 0 O-C-N 121.257 -0.902 . . . . 0.0 113.661 177.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 76.61 5.5 83.15 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 118.319 -1.267 . . . . 0.0 112.728 -174.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -71.06 157.64 37.86 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 119.98 1.89 . . . . 0.0 109.794 175.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.28 144.68 30.45 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 172.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -81.42 123.97 29.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 170.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 67.0 tp -53.53 121.08 7.01 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.004 0.922 . . . . 0.0 109.914 176.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -150.38 29.38 0.71 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.911 1.285 . . . . 0.0 109.346 173.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . 0.332 24.6 m 42.94 28.92 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 128.512 2.725 . . . . 0.0 114.31 -169.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 36.96 56.08 1.22 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 129.821 3.248 . . . . 0.0 113.561 168.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -133.92 24.35 3.93 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.804 1.242 . . . . 0.0 111.098 174.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 . . . . . 0 C--O 1.247 0.96 0 C-N-CA 126.744 2.017 . . . . 0.0 106.82 178.127 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.8 ttm . . . . . 0 N--CA 1.482 1.15 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 27.6 m -133.19 139.8 47.22 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 169.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -142.44 117.44 9.99 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -171.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.41 HG23 HD13 ' A' ' 58' ' ' LEU . 1.4 m -108.76 146.48 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 123.977 0.911 . . . . 0.0 109.78 -169.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 54.7 tp -119.47 104.35 10.25 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 179.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.3 tp -93.71 97.61 10.56 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 98.5 m -72.89 140.83 47.79 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 169.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.5 t -141.0 141.84 30.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 125.063 1.345 . . . . 0.0 107.768 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.59 176.68 19.72 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.248 0.928 . . . . 0.0 111.862 176.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -118.84 121.55 40.28 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.737 1.215 . . . . 0.0 108.253 176.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -59.97 -14.67 17.06 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.65 1.98 . . . . 0.0 115.469 -169.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.8 ptt? -126.91 13.53 7.35 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.115 0.966 . . . . 0.0 111.065 -177.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 27.0 ttt -97.68 33.54 2.04 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.038 0.835 . . . . 0.0 110.25 -177.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.46 -139.71 21.96 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -178.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -63.26 -15.47 57.25 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.251 1.02 . . . . 0.0 111.977 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -59.79 -16.61 29.31 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.933 1.293 . . . . 0.0 112.651 174.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.1 17.63 1.32 Allowed Glycine 0 CA--C 1.534 1.221 0 O-C-N 120.562 -1.336 . . . . 0.0 114.015 175.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.83 -53.3 59.58 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 119.562 1.681 . . . . 0.0 111.096 -169.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.83 -55.04 32.03 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-O 117.812 -1.549 . . . . 0.0 111.152 176.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -49.44 -39.63 44.7 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 CA-C-N 120.787 2.294 . . . . 0.0 115.381 177.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.8 tp -71.18 -38.86 72.11 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 120.083 1.311 . . . . 0.0 110.394 177.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 52.5 tp -61.21 -47.58 85.46 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 122.002 -0.436 . . . . 0.0 110.277 175.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.71 -41.04 85.4 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.862 0.865 . . . . 0.0 111.082 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -60.94 -48.52 81.42 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 118.858 0.753 . . . . 0.0 109.963 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -61.47 -47.15 87.02 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 122.907 0.483 . . . . 0.0 110.668 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 75.7 m -63.88 -40.69 97.12 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.209 0.459 . . . . 0.0 110.938 179.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.8 -39.63 94.72 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.383 0.538 . . . . 0.0 111.094 178.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.18 -35.9 76.76 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.374 0.669 . . . . 0.0 111.457 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.23 95.71 2.11 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 125.086 1.354 . . . . 0.0 108.296 -172.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -55.45 165.53 3.19 Favored 'Trans proline' 0 CA--C 1.537 0.625 0 C-N-CA 123.674 2.916 . . . . 0.0 114.445 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.443 ' HE2' ' CZ ' ' A' ' 136' ' ' TYR . 68.5 mmtt -133.3 170.77 14.96 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 126.327 1.851 . . . . 0.0 108.215 176.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 38.16 -121.93 1.1 Allowed Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.366 1.46 . . . . 0.0 112.307 177.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -140.22 38.21 1.92 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.242 1.417 . . . . 0.0 108.763 169.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -71.59 160.93 31.82 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.912 0.885 . . . . 0.0 111.565 -172.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 98.8 t -115.12 99.26 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 167.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.8 t -68.17 138.3 22.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -178.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 87.7 mt -136.23 141.16 42.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 172.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -125.64 104.36 8.34 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 177.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.22 -4.02 83.02 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.939 -0.923 . . . . 0.0 112.835 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 54.61 -143.8 31.2 Favored Glycine 0 C--N 1.341 0.82 0 N-CA-C 108.427 -1.869 . . . . 0.0 108.427 -169.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.0 p -91.46 10.98 25.47 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 122.064 -0.668 . . . . 0.0 111.891 177.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.52 58.57 21.02 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 125.352 1.461 . . . . 0.0 110.131 -177.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -70.24 -15.44 35.29 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.61 2.207 . . . . 0.0 113.784 -169.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -55.89 -32.07 63.4 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.22 0.918 . . . . 0.0 111.877 174.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.17 -28.59 68.05 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.284 0.634 . . . . 0.0 112.036 177.242 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -96.45 -3.29 43.71 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.386 1.075 . . . . 0.0 111.607 -170.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 90.0 mt -54.72 -41.74 57.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 118.898 0.772 . . . . 0.0 109.386 173.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.0 t -61.79 -41.7 91.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 O-C-N 121.869 -0.519 . . . . 0.0 110.063 178.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.38 -44.88 86.18 Favored 'General case' 0 N--CA 1.457 -0.1 0 O-C-N 121.972 -0.455 . . . . 0.0 110.512 -178.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 80.8 mt -57.11 -47.89 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.787 0.835 . . . . 0.0 109.237 173.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -60.58 -34.65 74.5 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 118.131 -0.938 . . . . 0.0 112.048 -174.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -57.82 -31.24 66.41 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.481 1.037 . . . . 0.0 111.638 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 70.1 mt -86.26 -12.18 50.29 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.319 1.048 . . . . 0.0 112.339 -174.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 30.53 60.09 0.98 Allowed Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 126.512 1.925 . . . . 0.0 112.57 -168.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -56.78 154.79 30.05 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.923 2.416 . . . . 0.0 114.766 -170.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.7 m -74.83 -37.28 62.32 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.401 1.08 . . . . 0.0 109.874 169.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 36.2 mtm180 -144.03 159.66 42.21 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.355 1.062 . . . . 0.0 109.872 -177.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.41 HD13 HG23 ' A' ' 4' ' ' VAL . 30.8 tp -147.38 141.81 26.41 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.748 1.219 . . . . 0.0 108.472 176.125 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.5 123.59 26.89 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 177.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.4 mm -98.79 144.4 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 175.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.9 t -137.56 132.9 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 119.093 0.86 . . . . 0.0 110.0 175.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -160.91 173.5 15.21 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.35 2.26 . . . . 0.0 107.222 169.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.09 157.34 37.04 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.071 -1.018 . . . . 0.0 109.181 168.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.9 m -156.23 127.15 6.89 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 176.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -71.55 124.55 24.92 Favored 'General case' 0 C--O 1.231 0.096 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 172.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 76.2 mtm -122.15 0.8 9.66 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.805 1.642 . . . . 0.0 111.058 -176.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.03 34.22 88.25 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 119.162 0.892 . . . . 0.0 111.5 -171.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.5 mt -109.53 -176.66 3.07 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.405 1.482 . . . . 0.0 109.676 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -70.34 141.22 88.24 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-O 117.988 -1.006 . . . . 0.0 108.832 170.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -42.99 138.12 4.15 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.53 2.82 . . . . 0.0 113.453 172.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.41 3.14 70.23 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-O 118.733 -1.037 . . . . 0.0 113.451 175.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -66.25 148.6 51.6 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 120.101 1.951 . . . . 0.0 108.335 168.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 65.3 mt -124.44 134.5 66.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 -172.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.1 mmt-85 -143.16 151.08 40.26 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.934 0.788 . . . . 0.0 109.747 173.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 50.7 mm -79.11 145.53 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 169.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.1 mt -132.81 163.42 37.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 124.612 1.165 . . . . 0.0 107.89 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -133.07 144.93 54.83 Favored Pre-proline 0 C--O 1.236 0.345 0 C-N-CA 126.868 2.067 . . . . 0.0 107.617 -170.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -54.81 -27.04 50.81 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 123.24 2.626 . . . . 0.0 115.141 -173.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -66.76 -20.58 65.98 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.006 0.821 . . . . 0.0 112.249 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -119.25 -31.1 4.77 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.794 1.238 . . . . 0.0 111.875 -171.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 79.7 mt -50.77 -40.58 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.09 1.356 . . . . 0.0 109.869 170.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.02 -25.59 31.38 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.7 1.2 . . . . 0.0 113.446 -176.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -111.35 -35.66 5.78 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.362 0.665 . . . . 0.0 110.215 177.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 22.1 mmt -67.1 -29.71 69.53 Favored 'General case' 0 C--N 1.334 -0.1 0 O-C-N 121.757 -0.589 . . . . 0.0 112.412 -178.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -71.72 -42.67 67.05 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 119.095 0.861 . . . . 0.0 111.598 177.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 19.0 ptp -66.47 -9.01 29.98 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.134 0.879 . . . . 0.0 113.01 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 24.0 mmt -58.04 -28.98 64.99 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.318 0.963 . . . . 0.0 110.987 168.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 74.5 p -79.92 51.16 1.29 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.675 1.19 . . . . 0.0 110.64 177.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.0 m 58.58 67.91 0.88 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.662 1.985 . . . . 0.0 111.958 178.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 57.3 34.64 25.03 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.556 1.542 . . . . 0.0 111.936 174.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -61.17 159.47 11.94 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.794 0.838 . . . . 0.0 110.653 174.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 17.1 ptt? -61.14 138.93 94.46 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 124.366 1.066 . . . . 0.0 110.587 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -79.57 72.86 6.3 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 124.691 3.594 . . . . 0.0 109.827 -175.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -46.33 -13.24 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 128.124 2.57 . . . . 0.0 117.782 -168.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -52.8 -22.02 4.86 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.979 0.911 . . . . 0.0 112.957 168.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -56.86 -32.37 65.74 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 119.402 1.001 . . . . 0.0 111.664 176.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.5 tt -73.23 -44.32 59.75 Favored 'General case' 0 C--N 1.339 0.118 0 O-C-N 121.845 -0.535 . . . . 0.0 109.58 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 98.0 mt -60.31 -45.4 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -64.32 -21.25 66.55 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -175.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -88.17 1.58 54.08 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.245 1.018 . . . . 0.0 112.425 177.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 79.1 mt -135.52 -33.3 0.88 Allowed 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.042 0.937 . . . . 0.0 112.128 -171.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -59.85 -20.63 58.15 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.471 1.108 . . . . 0.0 112.676 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -68.2 -17.2 64.26 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.45 1.1 . . . . 0.0 111.813 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -136.51 -31.18 0.88 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.066 0.848 . . . . 0.0 113.12 -177.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 30.4 mt -69.65 140.89 17.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 172.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -62.58 -42.56 99.68 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 124.105 0.86 . . . . 0.0 112.218 -177.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -149.5 142.28 24.64 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.742 1.271 . . . . 0.0 109.221 175.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 43.5 t -134.06 121.36 38.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 21.5 mt -127.91 154.45 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 C-N-CA 125.094 1.358 . . . . 0.0 107.914 -171.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -125.04 145.14 50.05 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 174.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.7 tt -125.12 128.0 47.75 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 171.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -113.35 155.44 16.3 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 73.9 mt -131.98 126.92 57.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 -178.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.8 tp60 -61.36 114.87 12.07 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-O 117.282 -1.342 . . . . 0.0 110.062 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -76.31 170.28 20.3 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.917 2.412 . . . . 0.0 111.041 170.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -130.04 -32.06 1.86 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.924 1.69 . . . . 0.0 111.014 172.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -135.43 136.04 51.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 175.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 90.9 t -141.55 134.87 30.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 175.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 158.83 149.04 5.39 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -68.67 157.5 36.1 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 122.065 0.936 . . . . 0.0 111.353 -173.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 14.1 t80 48.88 41.38 18.47 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.769 2.028 . . . . 0.0 112.391 -172.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -123.73 148.39 56.2 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 124.067 0.947 . . . . 0.0 109.759 170.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -81.44 160.88 19.75 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.053 2.502 . . . . 0.0 111.157 177.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 52.0 ttm -70.05 138.22 51.92 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 168.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 68.7 p -78.06 158.98 28.98 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 123.967 0.907 . . . . 0.0 110.459 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -52.84 -44.46 96.24 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-O 116.629 -1.653 . . . . 0.0 114.211 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -68.22 -31.86 28.15 Favored 'Trans proline' 0 C--N 1.351 0.702 0 CA-C-N 122.906 2.074 . . . . 0.0 112.065 -176.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.92 -33.91 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 119.074 0.852 . . . . 0.0 108.872 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -56.89 -46.63 81.76 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.477 1.035 . . . . 0.0 110.059 169.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -63.65 -37.01 85.73 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 122.977 0.511 . . . . 0.0 111.228 178.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.56 -49.31 73.94 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 119.172 -0.442 . . . . 0.0 110.895 175.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 75.8 t -61.46 -38.37 79.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 118.743 0.701 . . . . 0.0 109.837 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -61.61 -43.24 99.22 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.09 0.859 . . . . 0.0 110.486 173.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 29.2 m -63.31 -43.46 97.78 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.602 -0.687 . . . . 0.0 110.331 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 78.2 t -62.01 -45.71 98.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 123.3 0.64 . . . . 0.0 109.406 176.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.443 ' CZ ' ' HE2' ' A' ' 31' ' ' LYS . 48.7 t80 -56.68 -48.06 78.47 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.788 0.835 . . . . 0.0 110.624 178.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -66.62 -26.85 67.28 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.589 -0.695 . . . . 0.0 112.17 178.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -68.0 -23.54 65.02 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 119.203 0.91 . . . . 0.0 112.694 176.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.44 -24.25 66.41 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -169.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -82.87 -2.74 55.59 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.649 1.113 . . . . 0.0 112.966 178.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -136.39 -18.36 0.72 Allowed Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.378 0.99 . . . . 0.0 114.143 -172.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 51.1 t90 -57.11 140.87 48.02 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 118.707 1.254 . . . . 0.0 109.78 172.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -146.02 17.18 1.4 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.513 1.125 . . . . 0.0 110.543 170.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 162.43 -48.2 0.34 Allowed Glycine 0 C--N 1.34 0.802 0 O-C-N 121.193 -0.942 . . . . 0.0 111.104 178.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -125.02 -23.36 4.25 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 55.68 26.43 46.4 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 119.507 1.048 . . . . 0.0 112.636 -172.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 78.82 -8.24 44.79 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.292 -1.282 . . . . 0.0 113.994 -176.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -69.73 147.44 50.51 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 120.192 1.996 . . . . 0.0 110.312 176.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -76.22 155.75 34.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.325 176.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -97.56 121.78 39.86 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.789 1.236 . . . . 0.0 107.756 -178.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 52.3 tp -58.28 123.76 17.17 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.564 1.546 . . . . 0.0 110.044 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -141.62 62.89 1.44 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.422 1.089 . . . . 0.0 108.998 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.6 t 52.64 43.72 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 125.554 1.542 . . . . 0.0 110.066 -176.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -71.09 155.4 40.83 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.917 0.887 . . . . 0.0 108.846 172.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -144.79 158.97 43.59 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.806 1.642 . . . . 0.0 106.821 170.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 . . . . . 0 C--O 1.248 0.977 0 C-N-CA 124.376 1.071 . . . . 0.0 108.61 -177.295 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 44.0 t0 . . . . . 0 C--O 1.235 0.311 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.9 m -112.63 152.66 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 124.487 1.115 . . . . 0.0 109.891 -169.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 23.8 tp -125.29 107.45 10.73 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 177.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 62.5 tp -96.71 95.68 8.09 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 81.8 m -69.66 142.44 53.41 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 168.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.6 t -140.63 143.29 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 146.12 175.94 19.56 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.561 -1.015 . . . . 0.0 110.561 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -125.61 120.9 32.05 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.29 1.436 . . . . 0.0 107.813 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -59.59 -15.18 16.86 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.111 1.764 . . . . 0.0 115.377 -169.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -127.43 13.59 7.08 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.942 0.897 . . . . 0.0 111.119 -176.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.8 ttt -98.34 29.03 3.76 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.28 0.632 . . . . 0.0 109.771 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.23 -146.9 21.3 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 -177.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -58.34 -18.69 29.35 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 126.019 1.727 . . . . 0.0 112.171 175.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -51.97 -25.42 8.25 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.991 1.316 . . . . 0.0 112.645 173.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.13 24.01 0.56 Allowed Glycine 0 CA--C 1.534 1.278 0 CA-C-O 118.602 -1.11 . . . . 0.0 114.554 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.95 -52.25 63.75 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 119.559 1.68 . . . . 0.0 110.611 -171.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.41 -54.66 35.95 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 117.803 -1.554 . . . . 0.0 111.165 176.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -50.15 -40.16 51.26 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 CA-C-N 120.911 2.356 . . . . 0.0 114.99 177.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 62.9 tp -70.6 -39.88 73.54 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 119.89 1.223 . . . . 0.0 110.201 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.0 tp -61.29 -46.77 88.95 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 117.932 0.333 . . . . 0.0 110.346 175.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.67 -42.2 87.92 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.412 1.085 . . . . 0.0 110.939 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -60.81 -49.06 78.99 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 118.499 0.59 . . . . 0.0 109.778 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -62.87 -48.01 80.88 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.104 0.561 . . . . 0.0 110.749 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 89.2 m -63.75 -39.61 94.7 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.641 0.655 . . . . 0.0 111.437 177.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.45 -40.04 96.08 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.144 0.884 . . . . 0.0 110.871 177.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.35 -33.52 74.44 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.372 0.669 . . . . 0.0 111.773 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.79 92.08 2.45 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 124.861 1.264 . . . . 0.0 108.94 -171.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -51.73 161.91 1.93 Allowed 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 124.064 3.176 . . . . 0.0 114.795 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -140.25 157.21 45.94 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 126.256 1.822 . . . . 0.0 106.978 176.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 34.48 30.25 0.01 OUTLIER Glycine 0 CA--C 1.536 1.347 0 C-N-CA 128.332 2.872 . . . . 0.0 118.213 168.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 43.07 35.41 0.78 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.128 1.771 . . . . 0.0 112.837 -169.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -70.69 128.63 36.74 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 120.828 -1.17 . . . . 0.0 108.103 175.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.4 t -78.04 87.66 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 105.231 -2.137 . . . . 0.0 105.231 168.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.9 p -64.48 138.92 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 96.0 mt -137.95 144.94 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 103.454 -2.795 . . . . 0.0 103.454 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -126.85 109.02 11.54 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -66.08 -16.79 64.85 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 124.899 1.237 . . . . 0.0 113.394 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 57.0 39.85 90.24 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 119.303 1.551 . . . . 0.0 113.643 170.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . 0.258 78.3 p 62.73 12.36 5.58 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.698 2.399 . . . . 0.0 114.689 -175.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.86 59.7 13.97 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 125.447 1.499 . . . . 0.0 108.423 170.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -66.88 -19.31 52.64 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.832 2.355 . . . . 0.0 113.279 -168.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -58.02 -30.49 66.16 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.707 0.685 . . . . 0.0 112.334 177.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.43 -30.61 68.61 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.183 0.593 . . . . 0.0 111.931 175.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -94.32 -4.88 47.86 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.087 0.955 . . . . 0.0 111.501 -170.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.5 mt -54.22 -42.66 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 118.977 0.808 . . . . 0.0 109.167 173.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.7 t -62.44 -42.08 94.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 118.273 0.488 . . . . 0.0 109.99 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.24 -44.89 86.73 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.925 -0.485 . . . . 0.0 110.613 -177.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 78.2 mt -57.91 -48.04 84.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.823 0.849 . . . . 0.0 108.997 173.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -60.15 -35.3 75.0 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 118.097 -0.954 . . . . 0.0 111.994 -175.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -57.4 -31.9 66.29 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.544 1.065 . . . . 0.0 111.513 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 73.2 mt -86.12 -11.86 51.53 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.986 0.914 . . . . 0.0 112.544 -175.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 30.36 60.59 0.96 Allowed Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 126.43 1.892 . . . . 0.0 112.465 -168.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -56.52 151.65 44.83 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.977 2.451 . . . . 0.0 114.328 -169.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.1 m -69.11 -39.69 78.79 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.78 1.232 . . . . 0.0 109.642 169.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 58.2 mtm180 -144.69 166.11 26.13 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.061 0.944 . . . . 0.0 110.136 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.6 tp -145.01 141.66 29.12 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 125.312 1.445 . . . . 0.0 108.071 175.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 39.2 tp -128.15 135.43 49.75 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 173.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.4 mt -123.34 141.81 42.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 -176.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.3 t -140.51 132.83 31.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 118.566 0.621 . . . . 0.0 109.766 -173.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -162.78 173.8 13.31 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.075 2.15 . . . . 0.0 107.443 176.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.24 158.31 36.1 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 167.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 m -154.65 128.22 8.59 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 175.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -72.4 123.42 23.02 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 172.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 73.6 mtm -124.57 1.1 8.25 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.828 1.651 . . . . 0.0 110.957 -175.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.3 24.68 67.65 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-N 118.618 0.644 . . . . 0.0 112.368 -172.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.4 mt -95.85 -173.19 2.78 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.229 1.412 . . . . 0.0 109.417 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -74.84 141.23 75.1 Favored Pre-proline 0 N--CA 1.468 0.44 0 CA-C-O 117.551 -1.214 . . . . 0.0 108.338 170.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -43.44 136.74 5.94 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.202 2.602 . . . . 0.0 113.223 173.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.7 1.55 72.37 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-O 118.646 -1.085 . . . . 0.0 113.375 176.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -64.62 149.25 49.27 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 120.182 1.991 . . . . 0.0 108.307 168.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 91.5 mt -121.51 142.01 39.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 -172.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 83.9 mmt-85 -148.35 149.77 32.39 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 118.387 0.539 . . . . 0.0 111.362 169.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 49.0 mm -77.75 144.0 12.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 166.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.43 165.09 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -137.5 145.64 50.11 Favored Pre-proline 0 C--O 1.235 0.332 0 C-N-CA 126.747 2.019 . . . . 0.0 107.453 -170.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -53.64 -27.1 40.36 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.313 2.675 . . . . 0.0 115.398 -174.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -66.37 -21.69 66.24 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.032 0.833 . . . . 0.0 112.324 177.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -119.31 -29.73 5.1 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.912 1.285 . . . . 0.0 111.921 -171.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.1 mt -51.16 -38.81 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.325 1.45 . . . . 0.0 109.777 169.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.7 -29.01 61.96 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.272 1.029 . . . . 0.0 113.078 -177.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -99.32 -45.23 5.93 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 176.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 22.0 mmt -69.07 -29.31 67.41 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -168.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -70.99 -41.51 70.86 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-N 119.414 1.006 . . . . 0.0 111.393 175.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 CA--C 1.538 0.496 0 CA-C-N 118.791 0.723 . . . . 0.0 112.228 175.242 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.9 mt . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 117.528 2.418 . . . . 0.0 117.528 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.44 -23.39 9.85 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.354 0.979 . . . . 0.0 112.504 168.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -57.77 -39.67 77.99 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 119.271 0.941 . . . . 0.0 110.844 176.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.4 tt -70.15 -43.93 69.9 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 123.41 0.684 . . . . 0.0 109.622 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 95.4 mt -57.74 -41.66 80.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -63.98 -18.26 64.11 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 56.2 mm-40 -83.12 -5.43 59.11 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.941 0.792 . . . . 0.0 112.095 175.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 90.0 mt -132.89 -35.19 1.09 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.933 0.893 . . . . 0.0 112.274 -168.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 12.0 pttm -62.16 -19.76 63.41 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.413 1.085 . . . . 0.0 112.805 -176.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -72.56 -12.99 61.29 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.28 1.032 . . . . 0.0 111.805 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -136.23 -32.72 0.85 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.249 0.931 . . . . 0.0 113.014 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 22.9 mt -68.16 139.64 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 170.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.61 -37.5 92.57 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.097 0.856 . . . . 0.0 112.561 -176.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -149.45 136.66 19.87 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 118.429 1.114 . . . . 0.0 108.505 175.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 56.9 t -123.45 129.78 74.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 175.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.2 mt -129.78 152.0 36.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 -168.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -134.33 146.45 49.98 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 176.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.9 tt -127.19 130.98 50.73 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 170.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -113.23 157.51 14.9 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 175.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 68.0 mt -134.53 128.37 51.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -61.85 115.52 15.98 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-O 117.635 -1.174 . . . . 0.0 110.014 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -78.89 172.42 15.03 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.562 2.175 . . . . 0.0 111.249 170.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -136.54 -31.16 0.88 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 127.533 2.333 . . . . 0.0 110.978 173.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -127.25 122.41 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 -176.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 94.0 t -144.94 132.98 16.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 152.79 150.35 5.38 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -65.7 150.3 48.71 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.137 0.968 . . . . 0.0 110.838 -177.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 18.2 t80 56.29 47.2 19.68 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.595 1.958 . . . . 0.0 111.955 -174.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -130.6 141.65 42.71 Favored Pre-proline 0 C--O 1.236 0.362 0 C-N-CA 123.935 0.894 . . . . 0.0 109.199 168.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -75.84 164.52 31.68 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.909 2.406 . . . . 0.0 110.358 170.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 49.5 ttm -72.63 140.98 48.31 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 168.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 38.3 p -78.53 157.53 28.8 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.414 1.086 . . . . 0.0 110.497 176.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.1 tm0? -49.77 -46.63 80.26 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-O 117.089 -1.434 . . . . 0.0 114.034 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -68.59 -29.27 30.43 Favored 'Trans proline' 0 C--N 1.351 0.695 0 CA-C-N 122.62 1.971 . . . . 0.0 112.163 -174.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 mp -79.63 -35.14 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -56.62 -46.68 80.81 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.39 0.996 . . . . 0.0 109.956 170.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -62.19 -38.28 88.53 Favored 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 123.108 0.563 . . . . 0.0 111.402 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.83 -48.55 76.34 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 122.045 -0.409 . . . . 0.0 111.045 176.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 79.8 t -61.27 -40.58 86.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -60.87 -42.78 98.58 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.919 0.781 . . . . 0.0 110.364 174.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 46.6 m -62.35 -45.13 94.58 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.351 0.523 . . . . 0.0 110.129 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 84.7 t -62.47 -48.16 89.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 118.644 0.657 . . . . 0.0 109.3 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -53.95 -45.77 71.4 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.127 0.971 . . . . 0.0 111.197 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 68.3 mm-40 -68.4 -34.43 76.01 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.399 0.545 . . . . 0.0 111.777 177.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.18 -33.38 75.63 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.755 0.707 . . . . 0.0 111.346 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 38.0 mt -55.18 -24.19 25.55 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -168.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 CA--C 1.542 0.646 0 CA-C-N 120.515 1.507 . . . . 0.0 113.605 178.478 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 . . . . . 0 N--CA 1.45 -0.44 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -64.44 154.43 35.75 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.087 0.955 . . . . 0.0 109.509 177.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -105.45 122.8 46.75 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 -175.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 60.4 tp . . . . . 0 C--O 1.234 0.269 0 C-N-CA 125.301 1.44 . . . . 0.0 109.822 179.167 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.5 t0 . . . . . 0 C--O 1.234 0.28 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.8 t -141.15 145.71 24.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 118.982 0.81 . . . . 0.0 109.708 -167.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 36.5 tp -118.14 126.21 51.77 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 174.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.4 tp -113.43 101.62 9.55 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 176.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 95.3 m -76.73 142.52 40.43 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 169.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.2 t -139.92 142.56 31.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 125.112 1.365 . . . . 0.0 107.46 177.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 144.21 177.42 19.08 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.418 1.008 . . . . 0.0 112.046 176.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -125.45 122.39 36.53 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.302 1.441 . . . . 0.0 108.256 176.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 m -59.72 -17.01 31.37 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.306 1.842 . . . . 0.0 115.417 -169.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 27.4 ptm -126.13 15.81 7.86 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.091 0.956 . . . . 0.0 111.034 -175.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 11.8 tpt -94.93 25.99 3.85 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.657 1.183 . . . . 0.0 108.955 175.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.82 -142.56 23.59 Favored Glycine 0 C--N 1.338 0.642 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -61.72 -16.89 53.08 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.706 1.202 . . . . 0.0 112.552 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -53.1 -26.66 17.15 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.346 1.458 . . . . 0.0 112.819 175.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.62 25.47 0.62 Allowed Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.548 -1.14 . . . . 0.0 114.369 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.1 -48.08 80.1 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 119.461 1.631 . . . . 0.0 110.079 -171.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.28 -58.09 16.26 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-O 117.627 -1.652 . . . . 0.0 111.19 174.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -48.75 -41.07 38.94 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 CA-C-N 121.035 2.417 . . . . 0.0 115.735 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.3 tp -70.83 -39.4 73.02 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 120.209 1.368 . . . . 0.0 110.332 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.2 tp -61.56 -46.07 91.48 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.563 0.345 . . . . 0.0 110.342 176.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.09 -41.87 89.1 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.279 1.032 . . . . 0.0 111.033 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -60.86 -49.49 77.25 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 118.706 0.685 . . . . 0.0 109.784 178.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -62.66 -46.2 89.29 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.963 0.505 . . . . 0.0 110.849 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 79.1 m -68.04 -34.53 76.64 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.336 0.516 . . . . 0.0 111.265 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.36 -40.08 93.13 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.416 1.007 . . . . 0.0 110.736 174.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.43 -33.0 73.43 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.329 0.652 . . . . 0.0 111.723 178.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -151.3 89.27 4.24 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 125.315 1.446 . . . . 0.0 108.809 -174.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -53.29 151.09 23.68 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 123.634 2.889 . . . . 0.0 112.795 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.528 ' HE2' ' CE1' ' A' ' 136' ' ' TYR . 32.5 mmtt -127.28 163.96 22.78 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.723 1.209 . . . . 0.0 109.637 -178.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 40.16 -115.58 0.63 Allowed Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.253 1.406 . . . . 0.0 111.865 175.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -134.03 9.71 3.84 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.841 1.257 . . . . 0.0 111.107 174.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 2.8 m95 -71.26 121.58 18.69 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 121.316 -0.865 . . . . 0.0 110.149 -169.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.7 t -72.23 119.65 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 104.362 -2.458 . . . . 0.0 104.362 166.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 36.5 t -76.29 135.13 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 -178.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 62.8 mt -132.48 144.34 37.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 169.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -129.73 110.21 11.58 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.038 -1.468 . . . . 0.0 107.038 174.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.7 -2.1 90.41 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 119.08 -0.844 . . . . 0.0 112.463 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 56.51 -145.89 34.85 Favored Glycine 0 C--N 1.34 0.762 0 N-CA-C 108.357 -1.897 . . . . 0.0 108.357 -169.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.1 p -88.67 10.61 20.07 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.944 -0.739 . . . . 0.0 111.8 176.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.3 57.9 15.89 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 125.07 1.348 . . . . 0.0 110.664 -175.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -70.08 -21.84 31.45 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.899 2.399 . . . . 0.0 113.158 -172.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.51 -35.92 79.08 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.109 0.868 . . . . 0.0 112.174 -176.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -65.99 -10.3 38.18 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.744 0.818 . . . . 0.0 112.919 175.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -116.03 0.17 12.94 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.259 1.024 . . . . 0.0 112.427 -171.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 81.8 mt -48.17 -41.37 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 125.224 1.41 . . . . 0.0 110.683 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.6 t -56.36 -42.52 74.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.427 0.691 . . . . 0.0 110.248 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.07 -40.67 87.06 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 122.955 0.502 . . . . 0.0 110.874 -176.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 55.5 mt -57.86 -49.11 82.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 173.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -64.01 -35.21 79.95 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 118.082 -0.961 . . . . 0.0 111.994 -173.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -57.48 -28.8 63.71 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.432 1.015 . . . . 0.0 112.064 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 34.5 mt -76.41 -3.57 37.77 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.467 0.707 . . . . 0.0 112.639 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 41.47 53.8 7.45 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 126.307 1.843 . . . . 0.0 111.565 -171.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -57.91 135.01 66.2 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.203 1.936 . . . . 0.0 112.343 -169.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.7 m -78.32 -31.97 49.0 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.037 0.935 . . . . 0.0 108.577 168.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 20.7 ttp-105 -142.2 155.29 45.27 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.405 1.082 . . . . 0.0 109.79 173.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.4 tp -136.13 141.47 44.15 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 126.09 1.756 . . . . 0.0 107.66 169.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 24.0 tp -130.63 134.44 46.97 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 172.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.5 mt -121.29 145.17 28.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -171.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 38.3 t -141.37 135.65 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 118.938 0.79 . . . . 0.0 110.421 -175.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -163.22 169.79 18.71 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.583 2.353 . . . . 0.0 107.871 177.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.3 155.98 39.6 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.318 -0.864 . . . . 0.0 109.194 168.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.8 m -154.15 123.63 6.58 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -72.15 121.98 20.21 Favored 'General case' 0 N--CA 1.46 0.068 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 171.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 74.8 mtm -122.89 1.01 9.28 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.59 1.556 . . . . 0.0 110.736 -174.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.53 23.5 64.93 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-N 118.639 0.654 . . . . 0.0 112.341 -172.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.0 mt -96.6 -173.85 2.86 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.275 1.43 . . . . 0.0 109.052 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -73.82 140.55 77.91 Favored Pre-proline 0 N--CA 1.467 0.389 0 CA-C-O 117.744 -1.122 . . . . 0.0 108.429 172.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -43.58 137.29 6.05 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.364 2.709 . . . . 0.0 113.195 173.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.36 4.57 74.55 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 118.772 -1.015 . . . . 0.0 113.845 177.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -68.01 150.94 47.83 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 119.714 1.757 . . . . 0.0 108.13 168.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 74.1 mt -128.02 138.02 55.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 -171.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 90.1 mmt-85 -145.58 147.09 31.7 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 118.836 0.744 . . . . 0.0 112.081 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 51.0 mm -75.77 143.0 13.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 166.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mt -134.81 161.48 40.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 174.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -125.69 144.0 46.82 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 126.493 1.917 . . . . 0.0 108.312 -174.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -42.76 -37.82 6.12 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 124.726 3.618 . . . . 0.0 116.685 -178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -64.84 -22.17 66.94 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.367 0.667 . . . . 0.0 112.34 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -113.33 -32.05 6.38 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.123 1.369 . . . . 0.0 111.1 -174.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.4 HD11 ' HB3' ' A' ' 110' ' ' PHE . 34.5 mt -49.08 -40.44 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.776 1.63 . . . . 0.0 110.359 169.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.31 -21.93 16.82 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.097 1.359 . . . . 0.0 113.733 -176.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -115.97 -36.46 4.13 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 118.574 0.625 . . . . 0.0 110.336 174.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 86.2 mmm -72.15 -26.64 62.17 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 118.479 -0.772 . . . . 0.0 113.032 -171.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -64.53 -51.84 60.85 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 119.933 1.242 . . . . 0.0 109.801 170.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 CA--C 1.537 0.459 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -179.155 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 mt . . . . . 0 CA--C 1.533 0.302 0 N-CA-C 117.108 2.262 . . . . 0.0 117.108 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -52.56 -28.23 20.01 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.546 -0.721 . . . . 0.0 111.207 167.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -59.55 -39.18 83.17 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.118 0.567 . . . . 0.0 111.12 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.6 tt -70.12 -43.68 70.5 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 123.67 0.788 . . . . 0.0 109.471 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 94.0 mt -59.78 -39.05 78.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -63.9 -19.28 64.97 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -82.37 -9.33 59.5 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.537 -0.727 . . . . 0.0 112.009 175.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 68.9 mt -126.83 -30.69 2.73 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.318 1.047 . . . . 0.0 112.09 -168.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 12.5 pttm -63.59 -24.88 67.98 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.317 -0.864 . . . . 0.0 111.942 178.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -78.33 -5.54 52.48 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.772 1.229 . . . . 0.0 111.804 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -132.54 -3.66 3.35 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.867 1.267 . . . . 0.0 112.896 -168.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 65.7 mt -135.89 143.64 35.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 126.111 1.764 . . . . 0.0 106.878 -173.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.68 -37.48 76.78 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-O 119.396 -0.669 . . . . 0.0 112.823 -171.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -144.89 124.63 13.33 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 37.2 t -127.92 130.36 69.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 3.3 mt -136.24 154.17 32.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 -169.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.4 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.2 t80 -131.55 146.04 52.02 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 168.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.0 tt -126.67 122.11 34.02 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.759 1.624 . . . . 0.0 106.934 176.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -107.61 156.33 15.92 Favored Glycine 0 C--N 1.333 0.377 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -178.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 56.1 mt -133.79 125.85 49.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -175.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.5 tp60 -64.09 115.24 17.78 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-O 117.624 -1.179 . . . . 0.0 110.377 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -76.06 170.39 20.19 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.302 2.668 . . . . 0.0 111.352 170.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -131.03 -30.08 1.81 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.62 1.968 . . . . 0.0 111.056 170.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.1 pp -135.24 136.4 51.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 119.105 0.866 . . . . 0.0 108.708 173.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 65.1 t -142.02 136.91 30.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 176.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 156.03 152.85 6.37 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -67.04 154.0 42.27 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.611 0.72 . . . . 0.0 110.199 -176.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.8 t80 58.21 33.93 23.63 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.196 1.798 . . . . 0.0 111.682 -177.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -123.58 145.84 48.28 Favored Pre-proline 0 C--O 1.237 0.407 0 O-C-N 121.562 -0.711 . . . . 0.0 110.199 174.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -80.3 164.74 21.57 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.198 2.599 . . . . 0.0 110.657 174.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.9 ttm -68.45 134.53 50.29 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 168.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.94 159.6 31.62 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.329 1.052 . . . . 0.0 110.471 176.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.51 -46.62 99.59 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-O 117.196 -1.383 . . . . 0.0 113.316 -171.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -66.89 -26.12 44.57 Favored 'Trans proline' 0 C--N 1.35 0.613 0 CA-C-N 122.288 1.853 . . . . 0.0 112.717 -178.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 mp -80.66 -34.86 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 119.313 0.961 . . . . 0.0 108.666 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -56.99 -46.38 82.3 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 118.988 0.813 . . . . 0.0 109.745 169.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -63.09 -37.95 89.26 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 122.787 0.435 . . . . 0.0 111.356 178.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.55 -47.38 81.82 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 121.88 -0.513 . . . . 0.0 110.9 175.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.16 -39.17 82.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 118.702 0.683 . . . . 0.0 109.871 177.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -63.21 -33.77 76.21 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.193 0.906 . . . . 0.0 111.126 174.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 39.2 m -70.31 -43.17 70.88 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.678 0.791 . . . . 0.0 110.1 175.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 91.2 t -63.45 -45.93 96.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 119.363 0.983 . . . . 0.0 109.26 176.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.528 ' CE1' ' HE2' ' A' ' 31' ' ' LYS . 22.3 t80 -52.36 -50.97 61.32 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.155 0.982 . . . . 0.0 110.884 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -71.28 -34.74 70.94 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.873 0.761 . . . . 0.0 111.818 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.21 -32.51 74.11 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 118.926 0.784 . . . . 0.0 111.43 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 55.2 mt -57.52 -18.65 20.12 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.54 1.064 . . . . 0.0 112.708 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 . . . . . 0 CA--C 1.544 0.73 0 CA-C-N 119.403 1.001 . . . . 0.0 112.368 178.581 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 . . . . . 0 N--CA 1.452 -0.372 0 CA-C-O 121.769 0.795 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -84.24 146.91 27.54 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 172.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -78.89 131.77 36.53 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 169.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 56.7 tp . . . . . 0 N--CA 1.456 -0.166 0 C-N-CA 124.8 1.24 . . . . 0.0 110.887 179.344 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.4 t0 . . . . . 0 C--O 1.234 0.288 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.9 m -118.06 153.47 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 124.051 0.94 . . . . 0.0 110.561 -169.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 41.4 tp -124.09 101.54 7.27 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 56.5 tp -89.84 98.94 12.06 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.071 0.949 . . . . 0.0 108.938 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 95.9 m -75.01 141.09 43.98 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 169.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.5 t -141.38 143.31 27.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 125.328 1.451 . . . . 0.0 107.782 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 148.91 171.5 17.73 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.094 0.854 . . . . 0.0 112.231 175.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -109.0 117.1 33.33 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.919 1.288 . . . . 0.0 107.951 175.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -59.57 -13.83 10.88 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.109 1.764 . . . . 0.0 115.741 -169.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -129.57 13.55 5.96 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 119.436 1.016 . . . . 0.0 111.878 -174.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.2 ttt -100.64 40.12 1.3 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.49 0.662 . . . . 0.0 110.158 -176.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.51 -136.39 18.37 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -50.9 -30.26 14.21 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.901 1.281 . . . . 0.0 113.328 174.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -60.25 -17.91 45.21 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -167.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.34 25.58 0.71 Allowed Glycine 0 CA--C 1.533 1.187 0 CA-C-O 118.14 -1.366 . . . . 0.0 113.791 175.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.51 -49.14 77.92 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 119.944 1.872 . . . . 0.0 110.382 -170.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.19 -56.44 23.76 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-O 117.612 -1.66 . . . . 0.0 111.203 173.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -47.09 -42.47 26.13 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 CA-C-N 120.991 2.396 . . . . 0.0 115.659 177.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 62.6 tp -71.49 -37.43 71.27 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 120.173 1.351 . . . . 0.0 110.713 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.4 tp -61.34 -47.39 86.13 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.324 0.511 . . . . 0.0 110.283 174.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.96 -40.28 88.5 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 123.859 0.864 . . . . 0.0 110.903 177.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.6 tp10 -62.03 -49.29 76.58 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 118.659 0.663 . . . . 0.0 109.726 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -63.21 -45.9 89.53 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 119.166 -0.445 . . . . 0.0 110.477 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 78.4 m -63.5 -40.34 96.82 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.581 0.628 . . . . 0.0 111.228 177.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.91 -39.31 93.88 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.844 0.747 . . . . 0.0 111.146 177.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.37 -36.9 77.28 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.343 0.657 . . . . 0.0 111.467 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.89 95.58 2.19 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.113 1.365 . . . . 0.0 108.063 -172.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -53.04 170.19 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 124.907 3.738 . . . . 0.0 115.729 -176.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.562 ' HE2' ' CZ ' ' A' ' 136' ' ' TYR . 19.4 mmtm -138.85 157.04 46.79 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.342 1.457 . . . . 0.0 108.94 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 38.33 -115.1 0.38 Allowed Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.241 1.4 . . . . 0.0 111.625 177.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -140.71 22.29 2.31 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.473 1.109 . . . . 0.0 110.425 170.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 10.0 m95 -69.87 128.63 37.06 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 121.32 -0.862 . . . . 0.0 109.302 -173.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 86.4 t -76.88 106.72 7.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 168.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.7 t -64.02 136.67 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.0 mm -131.02 148.06 33.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 169.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -135.6 100.26 4.43 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.59 -8.33 80.88 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-O 118.88 -0.956 . . . . 0.0 112.419 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 51.48 -140.19 25.12 Favored Glycine 0 C--N 1.341 0.807 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -169.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.9 p -91.53 14.76 13.99 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.032 0.933 . . . . 0.0 111.799 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.48 57.06 6.8 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 125.291 1.437 . . . . 0.0 110.142 -176.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -68.46 -18.66 43.6 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.822 2.348 . . . . 0.0 113.648 -169.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -61.47 -32.14 72.13 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.338 0.972 . . . . 0.0 111.473 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.43 -31.31 71.25 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.189 0.595 . . . . 0.0 111.579 175.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.54 -9.56 49.44 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 123.645 0.778 . . . . 0.0 111.326 -169.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 95.6 mt -53.1 -42.17 44.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 170.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.6 t -58.1 -40.26 76.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.565 0.746 . . . . 0.0 110.241 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.81 -45.45 71.18 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.232 0.469 . . . . 0.0 110.249 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.3 mt -62.72 -37.5 79.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -64.07 -19.04 64.94 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 117.871 -1.061 . . . . 0.0 112.578 176.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -70.91 -46.79 61.9 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 120.483 1.492 . . . . 0.0 108.964 169.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.4 mt -69.9 -21.1 63.34 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.47 1.108 . . . . 0.0 112.657 -173.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.3 mtt85 41.92 54.63 8.76 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.04 1.736 . . . . 0.0 112.202 -177.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -57.87 153.86 41.57 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.768 2.312 . . . . 0.0 114.793 -169.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.8 m -72.35 -38.82 68.48 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.085 1.354 . . . . 0.0 109.536 168.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 53.3 mtm180 -143.99 164.57 30.24 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.036 0.934 . . . . 0.0 110.577 178.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.0 tp -146.01 141.69 27.91 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.345 1.458 . . . . 0.0 108.235 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 41.7 tp -128.49 135.35 49.32 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 172.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.5 mt -122.04 144.16 32.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -175.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.5 t -140.18 132.82 33.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 118.413 0.551 . . . . 0.0 109.663 -175.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -158.78 175.19 13.92 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.556 2.342 . . . . 0.0 106.742 169.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.68 162.74 28.46 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 121.028 -1.045 . . . . 0.0 110.628 169.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.7 m -157.24 128.22 6.7 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 176.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -73.42 116.63 14.21 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 170.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 77.1 mtm -114.64 1.55 14.25 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.767 1.627 . . . . 0.0 110.461 -176.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.48 13.6 45.32 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 123.948 0.785 . . . . 0.0 113.011 -172.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 72.3 mt -85.92 -176.31 5.94 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.904 1.681 . . . . 0.0 109.928 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -72.54 139.1 80.79 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 117.928 -1.034 . . . . 0.0 109.388 172.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -43.99 134.34 8.24 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.812 3.008 . . . . 0.0 114.224 177.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.87 4.73 86.03 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 118.858 -0.968 . . . . 0.0 113.547 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -66.75 152.67 45.05 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 119.722 1.761 . . . . 0.0 108.435 168.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 85.6 mt -127.78 139.92 50.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 -171.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 90.9 mmt-85 -148.64 151.81 35.62 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.624 0.647 . . . . 0.0 111.147 173.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 43.8 mm -78.41 146.13 8.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 167.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.6 mt -135.17 165.19 31.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 177.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -138.67 146.41 50.4 Favored Pre-proline 0 C--O 1.235 0.32 0 C-N-CA 126.925 2.09 . . . . 0.0 107.009 -170.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -53.08 -28.43 40.86 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.38 2.72 . . . . 0.0 114.982 -175.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -66.69 -21.38 66.09 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 118.943 0.792 . . . . 0.0 112.359 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -117.96 -30.18 5.43 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.873 1.269 . . . . 0.0 111.894 -172.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 69.5 mt -50.5 -40.89 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 124.658 1.183 . . . . 0.0 109.89 170.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.81 -27.36 50.88 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.857 0.863 . . . . 0.0 113.254 -176.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -99.23 -43.22 6.7 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 174.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 95.0 mmm -72.1 -25.52 61.78 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.631 -0.668 . . . . 0.0 112.708 -169.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -80.0 1.01 29.22 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 172.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 23.3 ptt? . . . . . 0 CA--C 1.537 0.454 0 C-N-CA 123.407 0.683 . . . . 0.0 111.846 167.612 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.6 mt . . . . . 0 N--CA 1.47 0.532 0 N-CA-C 116.66 2.096 . . . . 0.0 116.66 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -52.48 -26.77 13.81 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.202 0.91 . . . . 0.0 112.199 168.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -63.53 -33.82 76.44 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.713 1.142 . . . . 0.0 111.671 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.6 tt -69.59 -46.39 66.42 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.0 mt -60.5 -49.49 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -67.18 -14.14 62.63 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -171.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -106.04 7.96 32.11 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.675 1.19 . . . . 0.0 111.668 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 26.6 tp -138.5 -27.86 0.85 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.785 0.834 . . . . 0.0 111.167 -173.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -59.35 -19.77 49.34 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.849 1.26 . . . . 0.0 111.494 168.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -64.39 -16.77 62.93 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.288 1.435 . . . . 0.0 111.361 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -125.75 -40.41 2.06 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.477 1.111 . . . . 0.0 111.426 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 36.5 mt -71.82 139.04 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.76 -38.89 93.42 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.361 0.981 . . . . 0.0 112.747 -177.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -147.22 135.95 22.06 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 118.662 1.231 . . . . 0.0 108.395 176.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.8 t -126.11 127.57 71.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.2 mt -130.24 155.31 41.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -168.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -136.13 147.8 47.92 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.4 tt -129.68 135.48 48.56 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.043 1.337 . . . . 0.0 108.167 171.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -118.13 158.91 14.48 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 125.112 1.339 . . . . 0.0 111.117 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 92.3 mt -136.31 129.73 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 C-N-CA 125.444 1.498 . . . . 0.0 107.593 -175.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -66.74 119.47 63.69 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 117.513 -1.232 . . . . 0.0 111.245 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.11 170.15 17.68 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 124.755 3.636 . . . . 0.0 113.449 173.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -137.82 -36.73 0.61 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.453 1.101 . . . . 0.0 112.028 168.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.1 pp -136.67 138.06 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 170.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 89.8 t -139.98 136.46 38.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 175.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 160.5 151.81 6.34 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -65.37 151.35 46.5 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.7 0.762 . . . . 0.0 111.079 -174.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 54.86 38.29 30.07 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.733 2.013 . . . . 0.0 112.061 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -121.6 149.54 53.05 Favored Pre-proline 0 C--O 1.237 0.439 0 C-N-CA 124.026 0.93 . . . . 0.0 109.451 173.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -78.0 158.37 30.72 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.831 2.354 . . . . 0.0 110.68 177.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 59.5 ttm -64.88 132.57 49.76 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 168.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.0 151.17 47.41 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 123.913 0.885 . . . . 0.0 111.209 177.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -57.59 -47.13 99.5 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 117.198 -1.382 . . . . 0.0 112.925 -174.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -67.92 -25.48 38.7 Favored 'Trans proline' 0 C--N 1.35 0.657 0 CA-C-N 122.105 1.787 . . . . 0.0 112.166 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 mp -76.96 -38.67 28.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -57.01 -46.88 81.98 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.977 0.808 . . . . 0.0 109.863 171.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -61.91 -39.22 91.25 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 122.639 0.376 . . . . 0.0 111.144 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.51 -49.9 71.7 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.755 0.422 . . . . 0.0 110.929 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 76.4 t -59.2 -40.78 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 118.634 0.652 . . . . 0.0 109.618 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -68.73 -28.93 67.26 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.921 0.782 . . . . 0.0 111.742 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 46.7 m -69.27 -46.79 66.39 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.558 -0.713 . . . . 0.0 109.527 173.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 96.3 t -59.39 -46.32 92.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 118.965 0.802 . . . . 0.0 108.968 176.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.562 ' CZ ' ' HE2' ' A' ' 31' ' ' LYS . 37.6 t80 -52.33 -57.93 8.25 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.317 1.047 . . . . 0.0 110.637 178.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -69.27 -29.95 67.95 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.025 0.83 . . . . 0.0 111.852 -176.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -61.43 -33.7 74.16 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 118.777 0.717 . . . . 0.0 110.881 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 52.7 mt -57.99 -17.2 15.79 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -177.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 . . . . . 0 CA--C 1.539 0.543 0 CA-C-N 120.248 1.386 . . . . 0.0 112.793 177.372 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 . . . . . 0 N--CA 1.451 -0.42 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.62 155.77 40.14 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 123.811 0.844 . . . . 0.0 109.256 173.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -102.65 123.95 47.29 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.985 1.314 . . . . 0.0 108.196 -177.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 58.9 tp . . . . . 0 C--O 1.233 0.202 0 C-N-CA 126.226 1.81 . . . . 0.0 110.727 179.807 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 . . . . . 0 C--O 1.233 0.22 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.1 m -89.88 141.36 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 29.3 tp -109.37 126.48 53.46 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 105.18 -2.155 . . . . 0.0 105.18 171.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 48.9 tp -114.61 97.38 6.25 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 177.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 93.2 m -71.78 140.12 49.31 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.84 169.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.1 t -140.26 141.84 32.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 148.0 -175.52 27.27 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 118.43 0.559 . . . . 0.0 112.153 177.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -136.79 117.78 14.28 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.057 1.343 . . . . 0.0 107.983 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.7 m -58.74 -11.55 3.29 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.477 2.311 . . . . 0.0 115.798 -170.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 23.4 ptp -131.97 12.35 4.74 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.805 1.184 . . . . 0.0 111.425 -177.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 27.7 mmm -89.45 24.54 2.22 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.64 0.776 . . . . 0.0 110.261 173.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.58 -139.15 16.3 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -63.42 -14.98 56.14 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.407 1.083 . . . . 0.0 112.108 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -61.39 -5.84 1.93 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.629 1.571 . . . . 0.0 113.324 174.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.64 16.89 28.48 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 120.537 -1.352 . . . . 0.0 113.412 174.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.37 -50.33 74.04 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.4 1.6 . . . . 0.0 111.578 -169.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.54 -55.22 31.19 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 117.718 -1.601 . . . . 0.0 111.144 176.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -48.73 -40.08 38.66 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 CA-C-N 120.849 2.325 . . . . 0.0 115.24 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.6 tp -71.19 -38.93 72.09 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 119.975 1.261 . . . . 0.0 110.464 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.3 tp -60.9 -46.36 90.95 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.066 0.394 . . . . 0.0 110.187 175.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.41 -39.92 81.02 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 123.85 0.86 . . . . 0.0 110.956 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -62.67 -49.36 75.42 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 118.815 0.734 . . . . 0.0 109.829 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -62.84 -44.51 95.95 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.558 0.343 . . . . 0.0 110.515 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 79.5 m -65.0 -39.64 93.76 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 118.21 0.459 . . . . 0.0 111.157 177.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.52 -37.54 87.9 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.039 0.836 . . . . 0.0 111.199 177.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.07 -38.8 79.23 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.226 0.61 . . . . 0.0 111.116 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.5 90.2 2.9 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.765 1.226 . . . . 0.0 109.191 -173.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -55.24 160.19 8.92 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 124.07 3.18 . . . . 0.0 114.0 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 32.1 mmtt -117.39 168.12 10.64 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.871 1.268 . . . . 0.0 109.768 174.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 37.52 -112.3 0.17 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 126.193 1.854 . . . . 0.0 111.564 176.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -139.13 36.27 2.11 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.852 1.261 . . . . 0.0 108.886 169.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -67.47 144.94 55.45 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 121.591 -0.693 . . . . 0.0 110.653 -175.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.1 t -103.16 103.5 15.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 168.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.8 t -71.36 136.97 24.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -176.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 54.9 mt -136.96 142.19 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 104.55 -2.389 . . . . 0.0 104.55 172.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -131.01 110.07 10.97 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -88.83 0.65 82.67 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 118.811 -0.994 . . . . 0.0 112.879 -178.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 56.9 -144.29 38.87 Favored Glycine 0 C--N 1.34 0.766 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -171.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.1 p -94.19 1.63 56.02 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.693 0.797 . . . . 0.0 112.629 -175.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.02 64.16 40.13 Favored Pre-proline 0 C--O 1.238 0.454 0 C-N-CA 124.798 1.239 . . . . 0.0 109.458 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -65.06 -14.35 44.78 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.194 2.596 . . . . 0.0 112.875 -173.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.7 tp10 -43.1 -41.74 3.73 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.087 1.755 . . . . 0.0 111.536 168.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -69.64 -17.41 63.51 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.048 0.939 . . . . 0.0 112.655 -175.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -117.79 0.8 12.06 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.797 0.839 . . . . 0.0 113.251 -168.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 73.5 mt -48.96 -38.9 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 125.147 1.379 . . . . 0.0 110.62 172.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.9 t -55.35 -42.02 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 123.955 0.902 . . . . 0.0 110.453 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.0 -40.77 91.41 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.954 0.501 . . . . 0.0 110.799 -176.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.5 mt -60.8 -49.31 85.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.975 0.91 . . . . 0.0 108.608 173.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -61.21 -36.02 78.77 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 118.386 -0.816 . . . . 0.0 111.857 -173.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -55.79 -30.19 60.94 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.871 0.76 . . . . 0.0 111.994 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 68.6 mt -87.67 -9.48 54.05 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.085 0.954 . . . . 0.0 112.377 -174.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 30.75 59.87 1.01 Allowed Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 126.588 1.955 . . . . 0.0 112.504 -168.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -57.45 155.59 30.03 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.02 2.48 . . . . 0.0 114.242 -169.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.3 m -72.77 -42.01 64.45 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.889 0.476 . . . . 0.0 109.802 170.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 50.3 mtm180 -142.7 160.62 39.95 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.439 0.696 . . . . 0.0 109.91 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 26.3 tp -141.17 138.86 33.69 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 124.645 1.178 . . . . 0.0 108.583 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 62.3 tp -127.62 114.54 17.5 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 176.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 mm -86.39 148.6 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 172.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.9 t -140.7 133.5 31.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 118.459 0.572 . . . . 0.0 109.634 171.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -161.95 173.84 13.91 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.266 2.226 . . . . 0.0 107.351 169.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.18 157.54 37.98 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.052 -1.03 . . . . 0.0 109.734 169.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.7 m -151.55 126.44 9.7 Favored 'General case' 0 CA--C 1.527 0.09 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -77.42 80.51 3.91 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.994 0.902 . . . . 0.0 110.261 175.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 74.0 mtm -75.4 -6.55 50.61 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.012 1.725 . . . . 0.0 112.345 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.0 21.02 76.74 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 123.87 0.747 . . . . 0.0 111.943 -172.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.5 mt -93.49 -172.65 2.97 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.132 1.373 . . . . 0.0 109.706 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -74.2 140.45 76.55 Favored Pre-proline 0 N--CA 1.468 0.437 0 CA-C-O 117.695 -1.145 . . . . 0.0 108.434 169.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -43.01 137.99 4.25 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.423 2.749 . . . . 0.0 113.445 172.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.05 1.59 74.39 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 118.587 -1.118 . . . . 0.0 113.689 176.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -67.12 147.22 53.41 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.926 1.863 . . . . 0.0 107.891 168.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 55.2 mt -124.97 139.81 49.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 -173.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 91.3 mmt-85 -147.26 152.46 38.35 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 118.765 0.712 . . . . 0.0 111.734 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 48.5 mm -80.51 142.53 13.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 166.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.2 mt -134.99 164.3 34.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 124.871 1.268 . . . . 0.0 107.844 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -135.05 145.78 55.77 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 126.884 2.074 . . . . 0.0 107.974 -169.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -55.32 -25.04 45.48 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.292 2.662 . . . . 0.0 115.229 -173.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -66.33 -21.16 66.25 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.157 0.89 . . . . 0.0 112.271 176.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -122.16 -29.8 4.14 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.655 1.182 . . . . 0.0 112.149 -170.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.0 mt -50.8 -40.36 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.15 1.38 . . . . 0.0 109.675 169.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.91 -29.18 59.66 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.409 1.084 . . . . 0.0 112.989 -176.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -99.45 -43.91 6.37 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 20.8 mmt -68.06 -31.4 71.01 Favored 'General case' 0 CA--C 1.523 -0.087 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -169.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -70.33 -45.65 65.76 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 118.766 0.712 . . . . 0.0 111.491 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 CA--C 1.533 0.304 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.541 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.2 mt . . . . . 0 N--CA 1.476 0.834 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -52.48 -25.06 9.15 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.487 1.039 . . . . 0.0 112.128 167.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -59.11 -32.55 69.94 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.072 0.851 . . . . 0.0 111.529 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.8 tt -79.51 -44.6 20.91 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 85.0 mt -57.55 -42.39 81.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -59.63 -24.94 64.26 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -89.06 -4.0 58.5 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.151 0.98 . . . . 0.0 112.506 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -123.0 -30.87 3.71 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.449 1.022 . . . . 0.0 111.832 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -60.17 -20.66 59.59 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.103 0.961 . . . . 0.0 113.048 -176.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -69.62 -16.15 63.33 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.362 1.065 . . . . 0.0 112.094 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -140.2 -32.39 0.61 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.372 0.987 . . . . 0.0 113.621 -176.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 12.4 mt -69.53 138.78 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 170.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.62 -37.59 92.62 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.344 0.973 . . . . 0.0 112.483 -175.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -148.69 137.76 21.63 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 118.497 1.149 . . . . 0.0 108.462 175.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 45.2 t -129.63 124.45 59.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 25.8 mt -129.93 154.93 41.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -169.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -125.66 143.48 51.01 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 174.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.6 tt -122.23 124.08 42.95 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 169.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -110.71 156.73 15.39 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 57.7 mt -134.44 124.9 46.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 -176.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -64.89 118.14 45.81 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-O 117.448 -1.263 . . . . 0.0 110.447 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -76.18 171.68 17.66 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.703 2.935 . . . . 0.0 111.569 170.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -128.0 -31.96 2.34 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 125.765 1.626 . . . . 0.0 110.98 171.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -135.86 136.55 49.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.344 1.058 . . . . 0.0 108.161 175.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.9 t -140.79 132.2 29.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 174.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 162.83 154.76 7.75 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -70.11 153.18 43.48 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.898 0.856 . . . . 0.0 110.929 -171.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.9 t80 50.96 39.18 22.24 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.915 2.086 . . . . 0.0 112.222 -176.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.5 m-30 -120.29 148.04 46.42 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 123.793 0.837 . . . . 0.0 109.947 174.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -81.27 164.39 19.39 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.23 2.62 . . . . 0.0 111.162 177.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 52.0 ttm -72.74 140.54 47.85 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 168.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 71.4 p -81.25 159.81 24.42 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.374 1.07 . . . . 0.0 110.656 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.2 tm0? -51.04 -48.65 84.39 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-O 116.978 -1.487 . . . . 0.0 113.329 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -67.78 -30.01 34.55 Favored 'Trans proline' 0 C--N 1.352 0.731 0 CA-C-N 122.546 1.945 . . . . 0.0 112.368 -174.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.77 -35.88 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 119.092 0.86 . . . . 0.0 108.931 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -56.97 -47.13 81.49 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.46 1.027 . . . . 0.0 109.926 171.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -61.52 -42.49 98.9 Favored 'General case' 0 C--O 1.231 0.087 0 C-N-CA 122.995 0.518 . . . . 0.0 111.082 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.96 -48.47 80.23 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 119.04 -0.505 . . . . 0.0 110.952 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 55.5 t -60.01 -41.66 87.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 118.705 0.684 . . . . 0.0 109.617 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -69.58 -29.93 67.58 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.044 0.838 . . . . 0.0 111.568 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 38.0 m -69.58 -45.48 68.55 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.325 -0.86 . . . . 0.0 109.776 174.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 78.7 t -59.23 -47.15 91.29 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 175.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -52.08 -48.11 64.86 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.008 0.923 . . . . 0.0 110.811 177.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -64.0 -44.0 93.98 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 118.564 0.62 . . . . 0.0 110.991 177.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.6 tpp85 -64.11 -26.54 68.59 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 118.736 -0.65 . . . . 0.0 112.234 -175.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 61.0 mt -57.2 -23.68 49.39 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.412 1.006 . . . . 0.0 112.317 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 . . . . . 0 CA--C 1.538 0.487 0 CA-C-N 119.325 0.966 . . . . 0.0 112.558 178.121 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 . . . . . 0 C--O 1.236 0.343 0 CA-C-O 121.338 0.59 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.81 151.13 39.09 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -91.98 120.47 32.67 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 59.0 tp . . . . . 0 C--O 1.233 0.236 0 C-N-CA 124.486 1.115 . . . . 0.0 109.794 178.482 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 29.8 t0 . . . . . 0 C--O 1.235 0.315 0 N-CA-C 105.056 -2.202 . . . . 0.0 105.056 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.4 t -121.84 147.45 25.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.431 0.634 . . . . 0.0 109.995 -165.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 28.6 tp -116.27 127.95 55.16 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 56.8 tp -117.45 94.49 4.57 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 94.5 m -71.14 143.51 50.54 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.459 -0.791 . . . . 0.0 108.918 170.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.9 t -141.38 141.46 30.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 125.23 1.412 . . . . 0.0 107.655 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 143.38 176.34 17.33 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 124.494 1.045 . . . . 0.0 111.949 176.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -120.83 121.49 38.25 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 125.017 1.327 . . . . 0.0 108.124 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 m -59.07 -16.86 21.19 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.438 1.895 . . . . 0.0 115.342 -169.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -126.38 14.27 7.69 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.958 0.903 . . . . 0.0 111.03 -175.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.6 ttt -97.84 32.77 2.26 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.274 0.63 . . . . 0.0 109.586 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.2 -146.3 27.66 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -174.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -60.31 -17.39 42.45 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 126.028 1.731 . . . . 0.0 112.377 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -51.72 -28.03 13.75 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.022 1.329 . . . . 0.0 112.681 175.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.28 26.61 0.56 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.845 1.212 . . . . 0.0 114.456 178.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.77 -50.19 73.38 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 119.291 1.545 . . . . 0.0 110.297 -173.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.95 -56.69 23.33 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-O 117.75 -1.584 . . . . 0.0 111.111 175.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -48.78 -41.04 39.2 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 CA-C-N 120.972 2.386 . . . . 0.0 115.214 178.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.0 tp -71.24 -37.91 71.98 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-N 119.962 1.255 . . . . 0.0 110.605 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.6 tp -60.97 -48.35 82.23 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.308 0.504 . . . . 0.0 109.934 175.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.19 -40.01 88.56 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.773 0.829 . . . . 0.0 111.046 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.6 tp10 -61.06 -49.54 76.96 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 118.492 0.587 . . . . 0.0 109.535 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -63.51 -44.83 93.15 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 119.192 -0.433 . . . . 0.0 110.742 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 75.4 m -63.71 -42.25 97.99 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.716 0.689 . . . . 0.0 111.039 178.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.83 -41.15 99.21 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.417 0.553 . . . . 0.0 110.788 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.92 -32.86 72.78 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.379 0.672 . . . . 0.0 111.99 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.7 88.53 3.29 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 124.707 1.203 . . . . 0.0 109.014 -171.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -51.39 160.92 2.07 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 123.967 3.111 . . . . 0.0 114.329 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -135.75 164.26 28.31 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.473 1.509 . . . . 0.0 108.964 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 41.8 -120.18 2.03 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.491 1.52 . . . . 0.0 111.374 175.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -140.91 34.99 1.76 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.844 1.257 . . . . 0.0 109.443 170.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -69.3 162.21 27.68 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.636 0.774 . . . . 0.0 111.99 -174.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.2 t -116.61 119.13 61.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 103.728 -2.693 . . . . 0.0 103.728 165.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.4 t -88.1 136.79 22.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -172.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 73.0 mt -133.08 143.99 37.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 104.705 -2.332 . . . . 0.0 104.705 169.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -128.03 106.96 9.43 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 172.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.14 -2.98 80.63 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-O 118.929 -0.928 . . . . 0.0 112.807 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 56.83 -147.29 33.7 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 -168.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.6 p -86.61 10.38 15.71 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.732 -0.863 . . . . 0.0 111.876 177.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.76 59.76 17.19 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 125.138 1.375 . . . . 0.0 110.519 -175.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -67.75 -15.4 44.22 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.824 2.35 . . . . 0.0 113.355 -172.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -57.25 -30.75 64.91 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.824 0.738 . . . . 0.0 112.126 173.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.0 -28.46 70.11 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.185 0.594 . . . . 0.0 111.97 175.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.18 -4.12 36.19 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.954 1.301 . . . . 0.0 111.894 -169.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.8 mt -48.57 -43.73 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 124.265 1.026 . . . . 0.0 109.79 170.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 52.5 t -59.5 -38.73 76.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 118.591 0.632 . . . . 0.0 110.644 -177.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.69 -44.53 81.48 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 121.918 -0.489 . . . . 0.0 110.21 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 77.6 mt -60.02 -39.62 80.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 123.489 0.716 . . . . 0.0 109.507 176.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -65.8 -20.33 66.21 Favored 'General case' 0 N--CA 1.462 0.145 0 O-C-N 121.024 -1.048 . . . . 0.0 112.311 178.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -75.55 -48.18 23.56 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 120.122 1.328 . . . . 0.0 109.087 169.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.8 mt -66.04 -26.94 67.75 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.402 0.681 . . . . 0.0 112.368 -175.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 42.77 59.61 10.76 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 125.87 1.668 . . . . 0.0 110.863 -175.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -53.92 146.35 47.23 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.691 2.26 . . . . 0.0 113.413 -169.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.3 m -74.75 -35.1 62.6 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 167.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -147.98 152.5 37.58 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.78 1.232 . . . . 0.0 109.086 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 51.3 tp -140.9 141.37 34.57 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.433 1.093 . . . . 0.0 108.862 -177.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 58.8 tp -125.54 136.92 53.83 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 170.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.5 mt -121.17 143.67 32.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.5 t -140.58 135.41 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 118.586 0.63 . . . . 0.0 110.018 -173.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -162.9 170.37 18.27 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.727 2.411 . . . . 0.0 107.454 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.48 154.94 39.71 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 168.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.9 m -153.23 124.13 7.37 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -69.64 120.99 16.25 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 169.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 76.7 mtm -119.04 1.29 11.41 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.636 1.575 . . . . 0.0 110.704 -177.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.94 34.2 89.24 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 118.929 0.786 . . . . 0.0 111.577 -172.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.3 mt -111.54 -172.14 1.98 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.774 1.63 . . . . 0.0 109.446 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -75.28 140.18 72.62 Favored Pre-proline 0 N--CA 1.468 0.453 0 CA-C-O 117.456 -1.259 . . . . 0.0 108.681 173.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -43.64 136.55 6.55 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.198 2.599 . . . . 0.0 112.896 172.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.65 1.79 83.95 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-O 118.584 -1.12 . . . . 0.0 113.758 177.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -65.75 147.24 53.71 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 120.02 1.91 . . . . 0.0 108.68 168.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 66.9 mt -126.82 133.12 69.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 C-N-CA 125.403 1.481 . . . . 0.0 107.077 -172.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.3 mmt-85 -143.42 151.81 40.81 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.864 0.756 . . . . 0.0 109.691 174.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 48.7 mm -80.83 145.72 8.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 168.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 11.1 mt -131.81 123.39 51.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -175.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -76.81 140.69 67.51 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-O 117.87 -1.062 . . . . 0.0 109.716 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_exo -46.81 -35.24 17.4 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 124.264 3.309 . . . . 0.0 116.677 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -68.59 -23.96 64.53 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.648 0.658 . . . . 0.0 111.687 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -98.81 -31.46 11.86 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.279 1.431 . . . . 0.0 111.116 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 68.0 mt -50.11 -40.82 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.796 1.238 . . . . 0.0 109.569 169.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.93 -19.97 7.9 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.887 1.675 . . . . 0.0 114.327 -175.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -124.33 -37.0 2.58 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 118.72 0.691 . . . . 0.0 110.553 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 21.3 mmt -66.85 -29.43 69.34 Favored 'General case' 0 N--CA 1.46 0.063 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -175.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -69.35 -45.4 69.52 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 119.155 0.889 . . . . 0.0 110.487 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 21.7 ptp . . . . . 0 CA--C 1.537 0.469 0 CA-C-O 118.923 -0.56 . . . . 0.0 112.468 176.564 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.7 mt . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 116.854 2.168 . . . . 0.0 116.854 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.04 -22.59 6.11 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.188 0.995 . . . . 0.0 112.608 168.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -59.51 -33.77 71.77 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.336 0.971 . . . . 0.0 111.755 175.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.9 tt -73.41 -44.49 58.26 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 74.4 mt -60.55 -42.29 90.93 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.107 0 C-N-CA 123.258 0.623 . . . . 0.0 109.63 -177.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -60.5 -24.37 65.25 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -176.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -85.03 -11.42 55.41 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.754 0.822 . . . . 0.0 112.063 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.4 mp -121.14 -31.28 4.16 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.32 1.448 . . . . 0.0 111.855 -168.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -60.57 -21.1 62.22 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.68 1.192 . . . . 0.0 112.611 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -71.78 -11.31 60.75 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.593 1.157 . . . . 0.0 111.694 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -134.35 -38.55 0.84 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.092 0.957 . . . . 0.0 112.138 -176.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 53.3 mt -72.17 139.96 18.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 174.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.08 -41.64 94.96 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.052 0.834 . . . . 0.0 111.972 -178.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -149.41 137.63 20.67 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 118.564 1.182 . . . . 0.0 108.612 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 41.4 t -131.13 123.98 54.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 19.9 mt -127.09 154.79 37.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 -171.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -129.74 141.84 50.81 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 173.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.1 tt -121.76 128.42 51.73 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 173.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -114.67 156.29 15.75 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 72.5 mt -131.98 128.09 59.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -177.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.1 tp60 -62.55 115.48 16.91 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 117.579 -1.201 . . . . 0.0 110.157 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -78.76 172.91 14.35 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.143 2.562 . . . . 0.0 111.552 171.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -137.29 -30.7 0.84 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 127.811 2.444 . . . . 0.0 111.045 173.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -129.74 124.14 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 -176.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.7 t -145.27 132.91 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 151.63 150.56 5.37 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -63.8 149.95 45.76 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 118.155 0.978 . . . . 0.0 110.901 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 57.95 43.62 21.03 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.601 1.96 . . . . 0.0 111.951 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -127.72 140.65 38.7 Favored Pre-proline 0 C--O 1.236 0.345 0 C-N-CA 124.116 0.967 . . . . 0.0 108.78 168.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -73.97 161.66 40.74 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.462 2.108 . . . . 0.0 110.041 170.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 52.1 ttm -70.27 139.49 52.17 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 168.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 33.1 p -76.32 156.49 33.31 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.134 0.974 . . . . 0.0 110.504 176.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.1 tm0? -49.32 -46.79 77.5 Favored Pre-proline 0 CA--C 1.544 0.733 0 CA-C-O 117.009 -1.472 . . . . 0.0 113.912 -178.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.46 -28.0 32.87 Favored 'Trans proline' 0 C--N 1.35 0.645 0 CA-C-N 122.616 1.97 . . . . 0.0 112.257 -175.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 mp -80.41 -35.55 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 119.358 0.981 . . . . 0.0 108.64 177.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -56.91 -47.23 81.03 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.405 1.002 . . . . 0.0 109.913 170.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -61.3 -41.81 97.6 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 123.303 0.641 . . . . 0.0 111.013 178.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.98 -48.99 77.89 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 119.121 -0.466 . . . . 0.0 110.929 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 56.0 t -59.48 -41.04 83.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 118.712 0.687 . . . . 0.0 109.728 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -68.94 -30.48 68.95 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.028 0.831 . . . . 0.0 111.483 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 32.9 m -69.41 -40.97 76.98 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.062 -1.024 . . . . 0.0 109.981 174.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 77.4 t -61.25 -50.08 81.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -56.28 -35.66 67.72 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.517 1.127 . . . . 0.0 112.156 177.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -67.9 -43.52 79.08 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.524 1.056 . . . . 0.0 110.685 171.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -58.91 -31.39 68.59 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 118.568 -0.729 . . . . 0.0 112.441 176.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.7 mp -56.52 -22.96 36.5 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.449 1.022 . . . . 0.0 111.973 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 . . . . . 0 CA--C 1.542 0.669 0 CA-C-N 119.449 1.022 . . . . 0.0 112.795 178.835 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 . . . . . 0 C--O 1.236 0.387 0 CA-C-O 121.73 0.776 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.9 153.41 38.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.574 176.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -93.42 121.88 35.27 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 50.1 tp . . . . . 0 CA--C 1.532 0.282 0 C-N-CA 125.663 1.585 . . . . 0.0 109.837 178.68 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.6 t0 . . . . . 0 C--O 1.233 0.206 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 56.3 t -93.93 146.69 6.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.556 0.693 . . . . 0.0 109.655 -169.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 58.5 tp -115.76 114.75 25.21 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 170.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 55.3 tp -103.59 102.29 12.16 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.456 1.102 . . . . 0.0 108.03 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 90.6 m -76.63 142.3 40.7 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 170.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.5 t -141.0 142.63 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 143.49 178.77 19.57 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -132.53 121.0 22.63 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 124.613 1.165 . . . . 0.0 108.443 177.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 m -58.58 -5.33 0.53 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.957 2.503 . . . . 0.0 116.391 -169.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -133.03 10.36 4.19 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.294 0.952 . . . . 0.0 111.446 -176.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 63.8 mtp -95.71 27.97 3.24 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.599 0.76 . . . . 0.0 110.581 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.6 -139.34 19.39 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 -177.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -62.9 -15.81 56.59 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.321 1.048 . . . . 0.0 112.148 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -58.29 -18.6 28.11 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.922 1.289 . . . . 0.0 112.755 174.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.54 19.67 0.86 Allowed Glycine 0 CA--C 1.535 1.3 0 O-C-N 120.626 -1.296 . . . . 0.0 114.237 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.85 -53.3 57.72 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 119.865 1.832 . . . . 0.0 111.157 -169.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.92 -53.93 41.7 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-O 117.953 -1.471 . . . . 0.0 111.21 176.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -50.57 -38.97 55.92 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 CA-C-N 120.907 2.353 . . . . 0.0 115.188 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.1 tp -70.3 -38.7 75.05 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 120.029 1.286 . . . . 0.0 110.243 177.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 51.1 tp -61.89 -48.89 78.43 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.001 0.364 . . . . 0.0 110.219 175.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.66 -41.05 80.73 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 124.302 1.041 . . . . 0.0 111.115 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -61.7 -48.74 79.4 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.771 0.714 . . . . 0.0 109.995 178.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -61.13 -46.24 91.38 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 122.817 0.447 . . . . 0.0 110.518 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 85.6 m -64.0 -40.38 96.23 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.278 0.49 . . . . 0.0 111.117 178.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.44 -38.9 92.92 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.334 0.516 . . . . 0.0 110.947 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.64 -37.65 76.86 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.3 0.64 . . . . 0.0 111.244 178.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.72 98.81 1.69 Allowed Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 125.122 1.369 . . . . 0.0 108.549 -172.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.52 167.36 25.64 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.305 2.004 . . . . 0.0 111.679 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -128.62 177.41 7.05 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.927 1.691 . . . . 0.0 108.654 177.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 41.16 -124.65 2.95 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.054 1.311 . . . . 0.0 112.317 175.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -141.44 37.91 1.69 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.25 1.42 . . . . 0.0 109.337 172.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -72.63 167.83 19.93 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.374 1.07 . . . . 0.0 111.85 -174.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.0 t -123.57 110.31 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 167.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.6 t -75.21 139.32 19.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -175.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 22.9 mm -134.59 147.95 29.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 169.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -130.72 112.2 12.87 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 176.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.52 -11.49 80.18 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 118.79 -1.005 . . . . 0.0 112.982 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.65 35.51 81.44 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 119.017 1.408 . . . . 0.0 113.667 170.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 66.92 10.26 7.49 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.772 1.629 . . . . 0.0 113.5 -177.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.79 53.68 4.84 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 125.341 1.457 . . . . 0.0 108.794 173.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -64.02 -24.63 66.79 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.488 2.125 . . . . 0.0 112.7 -169.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -63.49 -33.53 75.77 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.974 0.806 . . . . 0.0 111.741 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.52 -22.57 67.0 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.569 0.748 . . . . 0.0 111.552 174.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -105.59 -2.2 23.77 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.444 1.098 . . . . 0.0 112.653 -169.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.8 mt -47.24 -42.73 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.989 1.315 . . . . 0.0 110.372 173.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.3 t -56.42 -42.32 74.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.068 0.547 . . . . 0.0 110.167 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.12 -35.55 76.54 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.072 0.549 . . . . 0.0 111.525 -177.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 68.6 mt -63.83 -46.88 93.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 173.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 37.0 mtp180 -69.37 -22.43 63.73 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 117.888 -1.053 . . . . 0.0 112.624 -174.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -56.33 -32.45 64.67 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 120.535 1.516 . . . . 0.0 110.847 170.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 55.1 mt -86.64 -10.85 52.94 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.11 0.964 . . . . 0.0 112.773 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 28.68 61.85 0.72 Allowed Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 126.825 2.05 . . . . 0.0 112.54 -167.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.53 149.15 40.33 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.294 2.663 . . . . 0.0 113.873 -169.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.0 m -71.81 -37.59 70.36 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 168.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -147.97 156.61 42.86 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.059 0.944 . . . . 0.0 109.537 -176.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 41.7 tp -143.75 139.09 29.25 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 124.805 1.242 . . . . 0.0 108.653 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 57.1 tp -124.1 137.17 54.6 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 169.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.7 mt -120.58 143.21 33.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.4 t -140.58 134.03 33.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 118.442 0.565 . . . . 0.0 109.83 -175.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -161.87 172.57 15.86 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.241 2.217 . . . . 0.0 107.39 170.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.49 157.51 36.98 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 121.288 -0.883 . . . . 0.0 108.753 167.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.2 m -152.8 129.38 10.75 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -77.52 82.78 3.94 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 118.921 0.782 . . . . 0.0 109.731 176.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 77.5 mtm -76.82 -6.45 52.38 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.281 1.433 . . . . 0.0 111.806 -177.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.36 25.61 72.43 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.091 0.853 . . . . 0.0 111.752 -174.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 47.5 mt -107.84 -168.56 1.39 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.512 1.125 . . . . 0.0 109.873 -176.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -79.31 138.47 55.82 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-O 117.738 -1.125 . . . . 0.0 109.263 175.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -45.51 134.93 12.68 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.474 2.782 . . . . 0.0 113.864 177.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.13 1.82 90.17 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-O 118.597 -1.113 . . . . 0.0 113.238 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -64.1 145.79 55.32 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 119.767 1.784 . . . . 0.0 107.804 167.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 59.0 mt -126.74 137.33 58.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 -175.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.2 mmt-85 -147.59 150.19 33.98 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 118.792 0.724 . . . . 0.0 111.445 175.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 50.2 mm -72.97 149.38 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 164.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.6 mt -133.41 133.62 57.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -80.91 142.75 52.52 Favored Pre-proline 0 N--CA 1.471 0.614 0 CA-C-O 117.508 -1.234 . . . . 0.0 109.37 174.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -46.59 -37.48 20.35 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 123.997 3.131 . . . . 0.0 116.435 177.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -69.57 -22.32 63.54 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.552 0.614 . . . . 0.0 111.603 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -97.13 -34.1 11.26 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.956 1.303 . . . . 0.0 110.75 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.407 HD11 ' CB ' ' A' ' 110' ' ' PHE . 83.7 mt -50.81 -42.15 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 125.513 1.525 . . . . 0.0 109.111 169.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.55 -23.61 51.49 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.611 1.164 . . . . 0.0 113.571 -175.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -107.39 -40.76 5.27 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 123.184 0.593 . . . . 0.0 109.613 176.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 22.4 mmt -71.71 -29.49 64.62 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -169.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -71.09 -43.03 68.54 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 119.458 1.026 . . . . 0.0 110.981 175.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 28.9 ptm . . . . . 0 CA--C 1.537 0.454 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 176.376 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.8 mt . . . . . 0 N--CA 1.474 0.755 0 N-CA-C 118.116 2.636 . . . . 0.0 118.116 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.06 -23.6 8.07 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.333 0.969 . . . . 0.0 112.821 168.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -59.19 -33.07 70.51 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.351 0.978 . . . . 0.0 111.883 175.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.6 tt -74.58 -43.23 56.63 Favored 'General case' 0 C--N 1.338 0.071 0 O-C-N 121.719 -0.613 . . . . 0.0 109.399 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 87.7 mt -61.73 -40.14 85.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.544 0.738 . . . . 0.0 109.728 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -57.39 -30.61 65.05 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.262 0.625 . . . . 0.0 112.264 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -84.74 -1.62 56.51 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.427 1.091 . . . . 0.0 112.27 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 70.7 mt -126.53 -26.13 3.33 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.457 1.103 . . . . 0.0 112.061 -175.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -58.69 -29.45 66.64 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.805 1.184 . . . . 0.0 111.82 170.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -66.97 -11.93 58.16 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.992 0.917 . . . . 0.0 113.132 173.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -129.84 -11.42 4.33 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.382 1.073 . . . . 0.0 113.701 -168.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 46.7 mt -132.33 143.41 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 125.488 1.515 . . . . 0.0 107.995 -169.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -68.52 -40.77 86.14 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-O 119.211 -0.772 . . . . 0.0 112.261 -175.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -147.46 138.75 23.77 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 118.686 1.243 . . . . 0.0 108.52 177.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 51.3 t -134.25 121.62 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 -176.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 18.2 mt -127.41 154.66 38.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 -170.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.407 ' CB ' HD11 ' A' ' 81' ' ' ILE . 4.8 t80 -130.32 144.19 51.23 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 174.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.3 tt -124.96 128.21 48.25 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 173.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -111.14 156.48 15.52 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 74.4 mt -133.44 126.39 52.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -66.12 117.27 41.21 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 117.368 -1.301 . . . . 0.0 110.296 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -76.84 172.06 16.88 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.515 2.81 . . . . 0.0 111.499 170.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -128.44 -32.27 2.21 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.882 1.673 . . . . 0.0 111.103 171.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -135.55 135.21 51.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 176.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.3 t -141.22 134.85 31.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 175.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 157.81 155.1 7.38 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 177.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -64.96 153.62 40.01 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.941 0.877 . . . . 0.0 111.339 -174.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 52.88 39.64 29.42 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.036 2.134 . . . . 0.0 112.127 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -123.41 148.76 56.32 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 123.828 0.851 . . . . 0.0 109.943 173.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -82.15 163.02 17.76 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.262 2.641 . . . . 0.0 111.184 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 53.1 ttm -71.47 139.41 49.6 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 168.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 72.5 p -79.65 159.27 26.79 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.356 1.063 . . . . 0.0 110.538 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.3 tp60 -53.06 -44.54 97.31 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 116.565 -1.683 . . . . 0.0 114.197 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -68.42 -30.46 29.65 Favored 'Trans proline' 0 C--N 1.352 0.717 0 CA-C-N 122.888 2.067 . . . . 0.0 112.176 -176.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.8 -35.45 16.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 119.026 0.83 . . . . 0.0 108.788 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -56.5 -46.85 80.29 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.318 0.963 . . . . 0.0 110.074 170.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -63.94 -37.98 89.41 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 123.039 0.536 . . . . 0.0 111.203 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.69 -47.28 78.97 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 119.108 -0.472 . . . . 0.0 111.045 175.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 76.5 t -61.5 -38.56 80.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 118.915 0.779 . . . . 0.0 109.688 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -63.65 -39.2 93.74 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 119.361 0.982 . . . . 0.0 110.926 174.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 41.2 m -64.76 -45.01 88.21 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.55 -0.719 . . . . 0.0 110.092 177.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 73.8 t -62.26 -44.48 99.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.32 0.648 . . . . 0.0 109.574 176.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -55.41 -47.44 75.9 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.032 0.933 . . . . 0.0 110.521 177.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -63.77 -38.98 93.14 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 121.827 -0.546 . . . . 0.0 111.248 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -61.12 -25.57 67.07 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 118.27 -0.872 . . . . 0.0 112.534 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 94.5 mt -57.7 -23.36 51.3 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.99 1.268 . . . . 0.0 112.195 178.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 . . . . . 0 CA--C 1.546 0.803 0 CA-C-N 118.973 0.806 . . . . 0.0 112.428 -178.511 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 . . . . . 0 N--CA 1.454 -0.253 0 CA-C-O 121.902 0.858 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.29 153.69 21.79 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 169.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -91.29 134.61 34.44 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 173.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 56.8 tp . . . . . 0 N--CA 1.45 -0.442 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 175.971 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 . . . . . 0 C--O 1.234 0.288 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 79.8 t -137.35 146.91 27.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 36.1 tp -121.55 128.32 51.89 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 56.0 tp -118.83 95.98 5.06 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 89.1 m -70.39 142.96 52.03 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 169.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.8 t -140.64 142.08 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.314 1.446 . . . . 0.0 107.327 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 143.53 172.61 14.5 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 123.976 0.798 . . . . 0.0 112.059 175.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -110.2 118.56 36.67 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.537 1.135 . . . . 0.0 108.16 177.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -60.53 -13.88 16.55 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.235 1.814 . . . . 0.0 115.14 -170.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 26.0 ptm -127.94 18.13 6.68 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.584 1.153 . . . . 0.0 111.246 -173.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.2 ttt -110.72 37.95 2.63 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.101 0.864 . . . . 0.0 110.055 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.83 -141.37 26.24 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -61.35 -16.77 49.47 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.498 1.519 . . . . 0.0 112.198 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -60.51 -16.06 33.33 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.17 0.988 . . . . 0.0 112.127 174.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.64 17.16 2.77 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-O 118.35 -1.25 . . . . 0.0 113.649 174.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.09 -50.43 71.96 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 119.891 1.846 . . . . 0.0 111.123 -170.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.84 -54.96 32.59 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-O 117.789 -1.562 . . . . 0.0 110.825 175.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -48.51 -40.1 37.01 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 CA-C-N 120.758 2.279 . . . . 0.0 115.206 175.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.6 tp -71.4 -37.94 71.5 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.931 1.242 . . . . 0.0 110.466 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.8 tp -61.22 -46.89 88.58 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.235 0.47 . . . . 0.0 110.033 174.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.09 -40.74 86.2 Favored 'General case' 0 C--O 1.226 -0.159 0 C-N-CA 123.71 0.804 . . . . 0.0 111.036 178.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.8 tp10 -61.71 -49.52 76.12 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.601 0.637 . . . . 0.0 109.549 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -63.74 -45.6 89.12 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.87 0.468 . . . . 0.0 110.71 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 74.0 m -65.05 -37.84 88.87 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.703 0.683 . . . . 0.0 111.172 178.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.37 -40.38 95.73 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.263 0.938 . . . . 0.0 110.876 176.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.36 -34.05 75.38 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.277 0.631 . . . . 0.0 111.705 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.12 90.52 3.51 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 125.164 1.386 . . . . 0.0 108.792 -173.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -51.64 162.01 1.8 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 124.127 3.218 . . . . 0.0 114.486 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.417 ' HE2' ' CE1' ' A' ' 136' ' ' TYR . 36.7 mmtm -134.81 156.43 48.89 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 124.538 1.135 . . . . 0.0 110.052 -178.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 38.57 -111.45 0.17 Allowed Glycine 0 CA--C 1.527 0.817 0 C-N-CA 126.394 1.949 . . . . 0.0 113.096 170.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -137.74 9.68 2.86 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.392 1.477 . . . . 0.0 111.018 -171.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -81.77 126.41 31.8 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 121.33 -0.856 . . . . 0.0 111.205 -168.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.9 t -75.27 117.77 20.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 165.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.1 t -80.13 134.51 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -177.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 84.7 mt -133.54 146.19 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 170.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -127.57 110.47 12.74 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 173.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.5 -1.38 90.2 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 119.105 -0.83 . . . . 0.0 112.864 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 56.34 -147.57 31.24 Favored Glycine 0 C--N 1.339 0.737 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 -169.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.9 p -88.66 6.78 36.8 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.522 0.729 . . . . 0.0 112.155 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.37 58.2 20.24 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.179 1.392 . . . . 0.0 109.856 -177.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -68.68 -16.15 41.85 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.844 2.363 . . . . 0.0 113.237 -169.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -57.37 -31.07 65.41 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.479 0.711 . . . . 0.0 111.882 175.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.24 -28.26 69.04 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.256 0.622 . . . . 0.0 112.157 175.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.4 -2.48 45.46 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.967 1.307 . . . . 0.0 111.936 -169.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 87.9 mt -51.71 -43.72 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 123.923 0.889 . . . . 0.0 109.915 176.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.5 t -58.26 -41.05 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.265 0.626 . . . . 0.0 110.192 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.0 -44.96 75.36 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.241 0.473 . . . . 0.0 110.674 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.2 mt -59.11 -42.26 86.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -59.88 -31.17 69.54 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 118.061 -0.971 . . . . 0.0 111.847 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -59.97 -31.76 70.19 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.985 1.266 . . . . 0.0 111.133 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.6 mt -81.99 -13.0 58.04 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.176 0.99 . . . . 0.0 112.095 -175.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 72.8 mtp180 33.15 61.79 1.56 Allowed Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 126.552 1.941 . . . . 0.0 111.721 -169.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -53.88 143.2 61.14 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.008 2.472 . . . . 0.0 113.074 -169.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.4 m -72.81 -38.8 67.07 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 167.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 71.4 mtm180 -144.45 156.87 44.4 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 124.455 1.102 . . . . 0.0 108.969 176.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 45.6 tp -137.72 140.24 40.61 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.4 tp -126.24 136.38 52.73 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 174.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.0 mt -125.07 142.06 43.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 -174.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.1 t -141.56 133.77 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 118.806 0.73 . . . . 0.0 110.846 -174.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -161.36 172.21 16.96 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.565 2.346 . . . . 0.0 107.647 169.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.45 156.81 38.26 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.011 -1.056 . . . . 0.0 108.895 168.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.0 m -156.15 129.18 8.0 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 177.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -71.84 124.64 25.26 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 173.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 74.2 mtm -123.6 1.51 8.88 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.16 1.784 . . . . 0.0 110.766 -177.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.64 24.45 66.2 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-N 118.683 0.674 . . . . 0.0 112.423 -172.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.9 mt -95.74 -173.69 2.93 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.223 1.409 . . . . 0.0 109.333 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -73.38 140.4 79.27 Favored Pre-proline 0 N--CA 1.466 0.355 0 CA-C-O 117.72 -1.133 . . . . 0.0 108.18 170.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -44.23 136.59 8.07 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.258 2.639 . . . . 0.0 112.748 173.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.27 1.97 82.36 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-O 118.501 -1.166 . . . . 0.0 113.796 177.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -67.89 152.21 45.92 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 120.135 1.968 . . . . 0.0 108.257 168.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 51.5 mt -131.5 134.67 60.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -169.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.6 mmt-85 -147.01 148.85 32.11 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 118.721 0.691 . . . . 0.0 109.772 175.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 44.3 mm -73.79 152.85 7.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 166.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.9 mt -135.18 134.74 52.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 176.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -79.02 143.4 61.38 Favored Pre-proline 0 N--CA 1.472 0.661 0 CA-C-O 117.4 -1.286 . . . . 0.0 109.256 173.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo -45.47 -38.22 15.73 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 124.029 3.152 . . . . 0.0 116.439 176.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -68.04 -26.34 65.82 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.363 0.529 . . . . 0.0 111.523 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -94.35 -29.91 14.78 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.786 1.235 . . . . 0.0 111.232 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.487 HD11 ' HB3' ' A' ' 110' ' ' PHE . 59.9 mt -51.71 -45.59 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.15 1.38 . . . . 0.0 109.339 170.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -52.96 -31.35 40.0 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.292 1.037 . . . . 0.0 112.898 -177.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -96.8 -37.63 10.19 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.328 0.651 . . . . 0.0 110.328 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 24.8 mmt -80.64 -27.08 37.32 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 119.09 -0.481 . . . . 0.0 112.249 -170.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -64.8 -45.9 84.31 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 119.187 0.903 . . . . 0.0 110.286 175.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 20.2 ptt? . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -179.535 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.1 mt . . . . . 0 N--CA 1.466 0.331 0 N-CA-C 117.836 2.532 . . . . 0.0 117.836 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.95 -20.34 6.01 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.31 0.959 . . . . 0.0 112.055 167.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -59.91 -27.18 66.52 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.557 1.071 . . . . 0.0 112.582 173.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.7 tt -63.35 -49.42 73.98 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 119.141 0.882 . . . . 0.0 108.909 172.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 84.1 mt -64.82 -43.21 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -63.54 -19.65 64.97 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -175.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -102.55 8.77 39.78 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.176 1.39 . . . . 0.0 111.781 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.6 tp -140.31 -25.77 0.78 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.826 0.851 . . . . 0.0 112.163 -170.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 50.5 pttt -56.01 -24.66 40.4 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.51 1.524 . . . . 0.0 112.271 172.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -62.4 -17.07 58.31 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.996 1.318 . . . . 0.0 112.635 -172.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -130.15 9.12 5.21 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.646 0.778 . . . . 0.0 112.584 -175.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 56.3 mt -122.96 143.14 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.894 1.278 . . . . 0.0 108.409 -175.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -73.43 -37.01 54.14 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.868 0.747 . . . . 0.0 112.027 -177.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -149.43 136.56 19.83 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 118.226 1.013 . . . . 0.0 108.508 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 43.8 t -122.24 128.92 75.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 171.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.8 mt -126.64 149.26 31.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 -169.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.487 ' HB3' HD11 ' A' ' 81' ' ' ILE . 60.0 t80 -131.31 144.46 51.28 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 169.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.1 tt -124.56 127.79 47.94 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.45 1.5 . . . . 0.0 107.045 174.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -109.77 155.82 15.9 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 78.4 mt -133.78 127.69 52.82 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 -178.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 69.1 tp60 -61.77 114.79 12.28 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-O 117.467 -1.254 . . . . 0.0 110.517 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -77.34 171.46 17.66 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.402 2.735 . . . . 0.0 111.188 170.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -138.24 -26.93 0.9 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 127.088 2.155 . . . . 0.0 111.536 173.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -136.77 120.12 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 -173.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.5 t -143.22 129.4 16.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 156.76 151.75 6.07 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -63.21 145.28 55.84 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.421 0.629 . . . . 0.0 110.765 -174.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 64.83 0.08 1.1 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 128.199 2.6 . . . . 0.0 113.834 -175.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 19.3 m-30 -77.28 142.51 67.88 Favored Pre-proline 0 C--O 1.237 0.418 0 CA-C-N 120.309 1.413 . . . . 0.0 109.133 174.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -73.61 158.29 47.58 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.48 2.12 . . . . 0.0 109.914 169.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 47.3 ttm -73.88 142.78 46.0 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 168.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 29.9 p -81.12 155.09 26.42 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.082 0.953 . . . . 0.0 110.798 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -53.69 -40.43 80.64 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-O 116.529 -1.7 . . . . 0.0 114.729 -178.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -63.68 -39.68 33.57 Favored 'Trans proline' 0 C--N 1.35 0.647 0 CA-C-N 122.819 2.043 . . . . 0.0 111.291 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.6 mp -73.21 -37.53 52.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -57.19 -47.06 82.21 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.35 0.977 . . . . 0.0 110.305 172.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -63.99 -39.25 93.7 Favored 'General case' 0 C--N 1.334 -0.095 0 C-N-CA 122.959 0.504 . . . . 0.0 110.903 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.59 -46.68 84.72 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 122.994 0.517 . . . . 0.0 111.095 176.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 52.7 t -59.94 -41.31 85.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -67.69 -27.88 67.21 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 118.843 0.747 . . . . 0.0 111.858 177.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 36.7 m -71.13 -41.86 69.95 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.366 -0.833 . . . . 0.0 109.952 174.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 98.2 t -62.73 -48.7 86.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 119.2 0.909 . . . . 0.0 108.761 173.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.417 ' CE1' ' HE2' ' A' ' 31' ' ' LYS . 18.0 t80 -50.91 -50.17 57.99 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.655 1.182 . . . . 0.0 111.301 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -73.18 -31.71 64.38 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.915 0.779 . . . . 0.0 111.988 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -61.3 -38.01 85.27 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.077 0.853 . . . . 0.0 110.642 176.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 75.7 mt -55.7 -20.48 14.47 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -174.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 . . . . . 0 CA--C 1.54 0.581 0 CA-C-N 119.649 1.113 . . . . 0.0 112.352 177.17 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 . . . . . 0 N--CA 1.446 -0.654 0 CA-C-O 121.484 0.659 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.88 155.65 37.26 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.784 0.834 . . . . 0.0 109.0 170.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -92.18 140.8 29.26 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 173.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 52.0 tp . . . . . 0 N--CA 1.449 -0.5 0 C-N-CA 124.969 1.308 . . . . 0.0 107.806 173.86 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.6 t0 . . . . . 0 C--O 1.231 0.129 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 55.4 t -92.74 145.96 6.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -169.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 50.4 tp -119.76 98.19 5.99 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 172.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.9 tp -90.07 106.12 18.27 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -75.49 150.41 38.22 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 172.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.9 t -142.27 140.05 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 143.66 172.6 14.59 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.017 0.818 . . . . 0.0 112.135 176.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -116.67 120.25 38.05 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.92 1.288 . . . . 0.0 108.257 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 m -59.43 -13.72 9.69 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.644 1.977 . . . . 0.0 115.529 -169.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.1 ptt? -129.83 12.36 5.74 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 119.239 0.927 . . . . 0.0 111.485 -176.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.6 ttt -96.99 34.27 1.76 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.718 0.69 . . . . 0.0 110.002 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.37 -140.81 22.4 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -178.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -62.73 -15.98 55.47 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 124.387 1.075 . . . . 0.0 112.293 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -59.1 -17.81 29.79 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.961 1.304 . . . . 0.0 112.729 175.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.08 19.02 1.07 Allowed Glycine 0 CA--C 1.534 1.248 0 O-C-N 120.693 -1.254 . . . . 0.0 114.033 176.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.14 -49.98 73.69 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.572 1.686 . . . . 0.0 110.819 -170.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.68 -55.78 28.57 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.076 -1.402 . . . . 0.0 111.191 175.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -48.58 -42.75 35.17 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 CA-C-N 120.275 2.037 . . . . 0.0 115.487 176.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.6 tp -70.68 -37.15 73.6 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 120.217 1.371 . . . . 0.0 110.448 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 51.1 tp -61.41 -49.56 76.38 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.159 0.436 . . . . 0.0 110.108 175.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.79 -36.87 82.35 Favored 'General case' 0 C--O 1.227 -0.12 0 CA-C-O 118.594 -0.717 . . . . 0.0 111.774 178.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -60.59 -48.59 81.12 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 119.058 0.845 . . . . 0.0 109.682 176.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -62.01 -44.59 96.39 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 122.938 0.495 . . . . 0.0 110.605 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 75.0 m -62.62 -43.85 97.78 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 118.495 0.589 . . . . 0.0 111.023 177.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.44 -40.3 96.14 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.085 0.554 . . . . 0.0 110.787 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.21 -31.88 70.76 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.387 0.675 . . . . 0.0 111.951 177.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.73 93.09 2.17 Favored Pre-proline 0 CA--C 1.537 0.481 0 C-N-CA 124.93 1.292 . . . . 0.0 108.742 -171.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -55.64 158.13 14.0 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.819 2.346 . . . . 0.0 112.486 177.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -131.67 173.47 11.1 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.467 1.507 . . . . 0.0 108.892 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 37.93 -119.48 0.76 Allowed Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.216 1.389 . . . . 0.0 111.929 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -142.91 40.89 1.53 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.092 1.357 . . . . 0.0 108.592 169.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -76.54 165.06 25.31 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.705 0.764 . . . . 0.0 111.573 -170.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.3 t -120.41 84.41 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 104.478 -2.416 . . . . 0.0 104.478 167.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.2 p -64.97 143.57 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 O-C-N 121.596 -0.69 . . . . 0.0 109.386 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.2 mt -132.12 128.15 58.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -83.92 78.78 9.67 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.05 0.94 . . . . 0.0 109.312 172.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -66.35 -29.69 75.31 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.604 -0.599 . . . . 0.0 111.604 176.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 55.65 -140.03 41.44 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 175.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.9 p -88.18 1.54 54.19 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.726 0.81 . . . . 0.0 112.949 -171.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -145.18 61.46 7.97 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 124.583 1.153 . . . . 0.0 110.183 178.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -66.22 -15.37 48.06 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 122.679 2.253 . . . . 0.0 112.646 -175.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -47.88 -40.37 21.45 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.751 1.621 . . . . 0.0 111.011 169.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -64.65 -31.2 72.32 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 122.097 -0.377 . . . . 0.0 111.959 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -89.28 -9.17 51.61 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.2 1.0 . . . . 0.0 111.329 -169.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.7 mt -52.86 -40.07 34.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 123.811 0.845 . . . . 0.0 109.211 169.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.1 t -60.21 -40.84 84.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.041 0.537 . . . . 0.0 110.145 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.53 -47.49 63.56 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.836 0.454 . . . . 0.0 110.102 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 95.4 mt -53.55 -41.58 46.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.222 1.009 . . . . 0.0 110.079 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -66.34 -18.99 65.68 Favored 'General case' 0 CA--C 1.53 0.173 0 O-C-N 121.05 -1.031 . . . . 0.0 112.725 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -72.64 -40.7 66.21 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 120.228 1.376 . . . . 0.0 109.379 169.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 60.2 mt -73.72 -29.05 62.02 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.434 1.094 . . . . 0.0 111.934 -174.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 39.6 60.18 6.29 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 125.941 1.696 . . . . 0.0 111.877 -169.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.02 153.56 31.52 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.757 2.305 . . . . 0.0 114.043 -170.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.5 m -70.9 -37.81 72.98 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 168.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -148.59 155.5 41.18 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.038 0.935 . . . . 0.0 109.454 -174.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.6 tp -144.67 136.56 25.87 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.651 1.181 . . . . 0.0 108.347 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 58.5 tp -122.4 140.02 53.17 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 169.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.3 mt -124.06 143.17 38.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 41.4 t -141.07 135.33 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 118.571 0.623 . . . . 0.0 109.778 -173.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -163.96 171.8 14.79 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.52 2.328 . . . . 0.0 107.495 173.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.03 157.66 37.84 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.575 -0.703 . . . . 0.0 109.16 168.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.6 m -152.32 127.89 10.07 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -78.07 80.1 4.51 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 119.099 0.863 . . . . 0.0 110.222 176.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 73.7 mtm -75.47 -6.45 50.22 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.033 1.733 . . . . 0.0 112.379 -177.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.62 23.25 78.27 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-N 118.621 0.646 . . . . 0.0 111.822 -172.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.9 mt -100.33 -171.66 2.07 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.889 1.276 . . . . 0.0 109.948 -178.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -74.89 139.99 73.85 Favored Pre-proline 0 N--CA 1.468 0.451 0 CA-C-O 117.431 -1.271 . . . . 0.0 108.612 170.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -43.07 137.44 4.66 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.316 2.677 . . . . 0.0 113.31 172.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.45 0.58 79.32 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 118.641 -1.089 . . . . 0.0 113.646 176.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -65.05 146.57 54.83 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 119.82 1.81 . . . . 0.0 108.243 168.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.6 mt -125.94 138.44 54.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -175.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 91.0 mmt-85 -147.69 152.49 37.9 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 118.69 0.677 . . . . 0.0 111.442 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 37.3 mm -78.78 145.33 9.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 105.828 -1.915 . . . . 0.0 105.828 165.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.5 mt -129.61 124.14 58.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -76.8 140.68 67.56 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 117.859 -1.067 . . . . 0.0 109.586 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -47.42 -34.28 18.94 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 124.086 3.191 . . . . 0.0 116.581 179.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -67.74 -22.91 65.2 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.596 0.634 . . . . 0.0 111.806 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -101.54 -30.9 11.13 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.177 1.391 . . . . 0.0 111.35 -178.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 68.8 mt -50.41 -38.59 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.707 1.203 . . . . 0.0 109.547 169.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.22 -20.19 6.48 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.917 1.687 . . . . 0.0 114.285 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -124.76 -38.76 2.34 Favored 'General case' 0 C--N 1.334 -0.067 0 CA-C-N 118.811 0.732 . . . . 0.0 110.638 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 10.9 mmt -68.12 -24.48 65.02 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -172.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -74.78 -45.35 44.25 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 119.358 0.981 . . . . 0.0 111.066 173.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 25.7 ptt? . . . . . 0 CA--C 1.535 0.389 0 O-C-N 121.732 -0.605 . . . . 0.0 112.583 177.004 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 mt . . . . . 0 N--CA 1.474 0.765 0 N-CA-C 117.235 2.309 . . . . 0.0 117.235 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.1 -21.13 4.37 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.093 0.957 . . . . 0.0 112.783 168.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -59.57 -29.49 67.97 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.453 1.024 . . . . 0.0 112.04 174.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.7 tt -76.62 -43.57 37.76 Favored 'General case' 0 C--N 1.338 0.103 0 O-C-N 121.399 -0.813 . . . . 0.0 109.667 175.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 77.7 mt -60.47 -43.93 95.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 C-N-CA 123.409 0.684 . . . . 0.0 109.299 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -60.79 -25.43 66.54 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -177.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -82.68 -3.09 55.82 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.879 0.872 . . . . 0.0 112.47 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.0 mt -134.89 -28.4 1.21 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.099 0.959 . . . . 0.0 112.626 -171.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -60.63 -22.04 63.38 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.149 0.98 . . . . 0.0 112.668 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -72.03 -10.25 59.52 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.623 1.169 . . . . 0.0 111.834 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -133.08 -42.57 0.88 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.433 1.093 . . . . 0.0 111.949 -173.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 29.0 mt -72.26 141.4 16.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -64.69 -41.86 97.5 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.119 0.866 . . . . 0.0 112.037 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -149.47 138.37 21.14 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.635 1.218 . . . . 0.0 108.906 176.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 54.0 t -131.28 124.98 56.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 16.9 mt -129.79 154.45 40.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -171.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -129.82 140.63 50.98 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 173.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.0 tt -120.09 129.72 54.32 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 174.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -112.58 156.55 15.52 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 68.8 mt -134.07 124.78 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 -177.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -65.28 118.1 46.69 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-O 117.423 -1.275 . . . . 0.0 110.363 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -77.15 172.05 16.77 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.656 2.904 . . . . 0.0 111.572 171.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -128.84 -31.96 2.14 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.785 1.634 . . . . 0.0 110.974 172.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.15 136.38 49.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.415 1.086 . . . . 0.0 108.269 175.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.1 t -141.1 134.36 31.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 175.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 159.7 151.55 6.2 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -64.71 157.98 25.91 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 117.642 0.721 . . . . 0.0 111.608 -175.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . 0.253 44.1 p90 44.37 41.4 4.49 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.333 2.253 . . . . 0.0 113.072 -174.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -121.51 148.41 50.12 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 123.95 0.9 . . . . 0.0 109.919 172.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -81.06 163.06 20.38 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.238 2.625 . . . . 0.0 111.259 177.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 54.2 ttm -72.22 139.66 48.28 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 168.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 68.3 p -80.6 159.88 25.28 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.365 1.066 . . . . 0.0 110.603 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.1 tm0? -51.23 -48.6 85.18 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-O 117.011 -1.471 . . . . 0.0 113.303 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -67.7 -29.64 35.65 Favored 'Trans proline' 0 C--N 1.352 0.727 0 CA-C-N 122.55 1.946 . . . . 0.0 112.423 -174.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -80.35 -35.32 15.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 119.046 0.839 . . . . 0.0 108.937 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -56.67 -46.78 80.93 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.418 1.008 . . . . 0.0 109.89 170.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -62.98 -38.57 91.66 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 122.961 0.504 . . . . 0.0 111.517 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.84 -46.74 80.62 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 119.193 -0.432 . . . . 0.0 111.017 176.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 73.8 t -62.25 -39.41 83.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 118.883 0.765 . . . . 0.0 109.81 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 34.6 tp10 -61.69 -40.98 96.92 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.031 0.832 . . . . 0.0 110.56 174.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 50.2 m -63.84 -45.87 87.59 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.06 0.544 . . . . 0.0 110.063 177.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 76.6 t -62.56 -44.17 99.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 118.831 0.741 . . . . 0.0 109.605 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -55.05 -46.95 75.4 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.317 1.047 . . . . 0.0 110.611 176.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -63.72 -39.7 94.94 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.659 0.663 . . . . 0.0 110.989 175.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.13 -26.06 67.43 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.421 0.688 . . . . 0.0 112.647 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 91.3 mt -57.11 -22.81 42.53 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.184 0.902 . . . . 0.0 112.231 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 . . . . . 0 CA--C 1.546 0.795 0 C-N-CA 124.277 1.031 . . . . 0.0 112.166 -178.911 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 . . . . . 0 C--O 1.233 0.218 0 CA-C-O 121.948 0.88 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -80.81 149.71 29.47 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 171.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -88.98 123.07 32.97 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 173.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 62.9 tp . . . . . 0 C--O 1.233 0.205 0 C-N-CA 125.158 1.383 . . . . 0.0 109.925 177.693 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.3 t70 . . . . . 0 C--O 1.232 0.178 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.8 m -132.92 154.73 40.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 124.002 0.921 . . . . 0.0 110.541 -169.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 30.6 tp -125.66 117.21 23.03 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 174.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 64.8 tp -104.74 97.52 7.39 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 96.9 m -73.15 143.73 47.16 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 169.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.0 t -142.16 144.47 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 175.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 147.64 174.48 19.6 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 124.653 1.121 . . . . 0.0 110.335 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -121.83 120.22 33.92 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 174.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 m -58.93 -12.95 5.13 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.446 1.898 . . . . 0.0 115.545 -169.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -129.61 12.82 5.91 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 119.321 0.964 . . . . 0.0 111.226 -177.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.8 ttt -94.32 32.17 1.59 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.868 0.758 . . . . 0.0 109.589 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.05 -145.12 26.75 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 -175.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -59.34 -18.06 34.88 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 125.952 1.701 . . . . 0.0 112.308 178.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -53.89 -25.58 20.77 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.819 1.248 . . . . 0.0 112.676 175.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.76 25.01 0.64 Allowed Glycine 0 CA--C 1.532 1.148 0 CA-C-O 118.7 -1.055 . . . . 0.0 114.277 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.08 -50.67 67.44 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 119.474 1.637 . . . . 0.0 110.432 -170.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.24 -55.64 29.0 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-O 117.881 -1.511 . . . . 0.0 110.98 175.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -50.65 -37.98 54.61 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 CA-C-N 121.106 2.453 . . . . 0.0 114.77 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.9 tp -71.75 -38.88 70.33 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 120.014 1.279 . . . . 0.0 110.509 176.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.1 tp -60.44 -47.65 85.19 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.341 0.518 . . . . 0.0 110.216 175.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.67 -40.96 85.05 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.479 1.111 . . . . 0.0 110.975 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.0 tp10 -61.97 -49.68 75.11 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-N 118.717 0.69 . . . . 0.0 109.693 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -63.64 -45.3 90.87 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.729 0.412 . . . . 0.0 110.81 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 75.5 m -65.32 -38.35 89.89 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.566 0.621 . . . . 0.0 111.094 178.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.91 -39.84 95.1 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.248 0.931 . . . . 0.0 110.906 176.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.41 -33.87 75.0 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.261 0.624 . . . . 0.0 111.805 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.47 91.08 3.35 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 125.141 1.376 . . . . 0.0 108.767 -173.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -51.66 161.32 2.13 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 124.035 3.157 . . . . 0.0 114.852 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.409 ' HE2' ' CE1' ' A' ' 136' ' ' TYR . 37.9 mmtm -137.98 158.78 43.63 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.345 1.458 . . . . 0.0 108.969 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 41.44 -120.15 1.86 Allowed Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.362 1.458 . . . . 0.0 111.737 175.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -136.79 16.26 3.09 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.685 1.194 . . . . 0.0 110.787 174.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 2.0 m95 -75.0 120.29 20.34 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 121.324 -0.86 . . . . 0.0 109.018 -170.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.7 t -71.02 111.12 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 168.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.3 t -71.33 138.33 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -177.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 98.5 mt -135.91 142.73 38.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 104.03 -2.581 . . . . 0.0 104.03 173.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -126.37 107.04 9.92 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 175.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.3 -11.38 71.29 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 118.523 -1.154 . . . . 0.0 113.391 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.17 34.64 80.7 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-N 119.425 1.612 . . . . 0.0 113.713 170.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 63.23 14.04 7.43 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.007 1.723 . . . . 0.0 114.242 -174.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.79 56.88 12.11 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 125.385 1.474 . . . . 0.0 108.057 169.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -68.58 -15.41 41.37 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.396 2.064 . . . . 0.0 113.128 -168.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -51.45 -34.14 33.99 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.086 0.857 . . . . 0.0 112.074 170.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.17 -26.4 68.31 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.215 0.606 . . . . 0.0 112.289 177.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -103.0 -5.66 23.18 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.956 1.302 . . . . 0.0 111.403 -170.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 73.9 mt -55.47 -41.63 64.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 119.112 0.869 . . . . 0.0 109.604 174.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.6 t -60.3 -41.21 86.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 118.524 0.602 . . . . 0.0 109.797 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.76 -45.19 83.47 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.87 0.468 . . . . 0.0 110.38 -178.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 90.2 mt -56.43 -48.38 80.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -63.02 -34.52 77.73 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 118.206 -0.902 . . . . 0.0 112.005 -174.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -58.01 -32.2 67.71 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.482 1.037 . . . . 0.0 111.537 175.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 78.9 mt -84.75 -8.65 58.75 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.174 0.99 . . . . 0.0 112.703 -175.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 27.74 62.26 0.64 Allowed Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 126.892 2.077 . . . . 0.0 112.794 -168.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.33 149.62 63.89 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.246 1.964 . . . . 0.0 113.543 -173.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.49 -26.43 35.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.784 168.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -145.21 151.32 38.22 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.811 0.844 . . . . 0.0 109.841 177.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 25.1 tp -140.91 141.31 34.56 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 125.551 1.54 . . . . 0.0 108.132 172.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 34.3 tp -129.34 138.88 51.81 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 171.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.8 mt -124.66 141.37 44.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 -174.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.9 t -140.86 133.47 30.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 118.728 0.694 . . . . 0.0 109.898 -174.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -161.28 172.44 16.63 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.442 2.297 . . . . 0.0 107.122 174.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.27 158.28 36.16 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.157 -0.965 . . . . 0.0 108.622 167.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.5 m -153.23 129.22 10.3 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 174.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -77.03 80.59 3.56 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.705 0.764 . . . . 0.0 109.94 175.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 76.3 mtm -76.46 -6.76 53.13 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.313 1.445 . . . . 0.0 112.241 -174.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.58 31.28 60.89 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -172.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 77.3 mt -110.97 -170.8 1.7 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.745 1.218 . . . . 0.0 109.722 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -81.14 140.82 49.61 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 117.668 -1.158 . . . . 0.0 108.84 174.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -46.51 132.94 16.34 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.198 2.599 . . . . 0.0 113.614 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.58 1.33 90.1 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 118.506 -1.164 . . . . 0.0 113.412 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -65.65 153.79 40.65 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 119.902 1.851 . . . . 0.0 108.49 168.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 62.3 mt -132.74 140.95 46.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -170.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 82.3 mmt-85 -149.44 152.98 36.59 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.365 0.666 . . . . 0.0 109.981 170.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 35.8 mm -77.29 145.33 10.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 165.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.3 mt -129.57 161.97 38.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 176.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -131.14 144.78 54.95 Favored Pre-proline 0 C--O 1.234 0.288 0 C-N-CA 126.519 1.928 . . . . 0.0 107.181 -171.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -54.28 -27.97 50.43 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 123.18 2.586 . . . . 0.0 115.139 -174.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -68.96 -19.98 64.18 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.948 0.794 . . . . 0.0 112.197 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -117.01 -30.88 5.56 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.164 1.386 . . . . 0.0 111.771 -171.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 65.6 mt -50.15 -40.87 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.268 1.427 . . . . 0.0 109.78 169.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.25 -26.13 37.92 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.822 1.249 . . . . 0.0 113.458 -176.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -108.14 -39.42 5.5 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 123.337 0.655 . . . . 0.0 110.021 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 21.4 mmt -69.21 -26.32 64.76 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -174.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -72.13 -46.37 56.83 Favored 'General case' 0 C--O 1.228 -0.052 0 CA-C-N 119.109 0.868 . . . . 0.0 110.799 174.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 27.6 ptm . . . . . 0 CA--C 1.541 0.598 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -176.502 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.1 mt . . . . . 0 N--CA 1.47 0.534 0 N-CA-C 116.939 2.2 . . . . 0.0 116.939 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.47 -20.31 4.62 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 117.878 -1.058 . . . . 0.0 113.02 168.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -54.77 -35.74 64.12 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 119.967 1.258 . . . . 0.0 111.517 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.8 tt -75.38 -44.09 46.7 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.329 0.652 . . . . 0.0 109.592 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 94.3 mt -62.95 -44.11 99.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -64.67 -17.65 64.26 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -171.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -109.6 13.68 23.76 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.306 1.043 . . . . 0.0 112.085 178.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 72.8 mt -129.5 -34.48 1.8 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.178 1.391 . . . . 0.0 110.783 177.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -57.5 -22.17 42.39 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.265 1.426 . . . . 0.0 112.693 176.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -70.16 -14.84 62.82 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.656 1.182 . . . . 0.0 111.931 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -137.52 -32.31 0.77 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.144 0.883 . . . . 0.0 113.045 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 32.5 mt -70.46 138.26 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 174.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -64.24 -42.87 97.71 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.268 0.937 . . . . 0.0 112.385 -176.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -144.75 134.62 23.72 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.664 1.232 . . . . 0.0 108.336 175.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 47.8 t -125.95 127.8 71.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 177.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.9 mt -130.84 153.29 38.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 -168.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -133.17 145.56 50.75 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 175.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.1 tt -127.87 133.46 49.34 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 171.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -114.16 157.06 15.22 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 80.8 mt -134.47 126.88 49.31 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -65.04 116.52 30.71 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-O 117.583 -1.199 . . . . 0.0 110.372 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -79.17 173.5 13.29 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.247 2.631 . . . . 0.0 111.789 171.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -136.71 -28.7 0.97 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.373 2.269 . . . . 0.0 111.382 172.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -132.42 119.63 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 -173.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.3 t -143.67 131.78 18.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 153.54 152.82 6.16 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -67.12 150.89 48.54 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.974 0.893 . . . . 0.0 111.27 -174.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 13.0 t80 51.69 40.67 27.9 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.839 2.055 . . . . 0.0 112.107 -174.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.4 m-30 -115.79 142.54 29.18 Favored Pre-proline 0 C--O 1.237 0.434 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 170.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -74.27 160.44 42.22 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.636 2.224 . . . . 0.0 110.46 170.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.1 ttm -74.69 141.98 44.49 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 169.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 39.9 p -79.53 157.42 27.42 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.426 1.091 . . . . 0.0 110.653 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -52.55 -42.47 88.39 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-O 116.579 -1.677 . . . . 0.0 114.721 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -70.81 -28.55 20.08 Favored 'Trans proline' 0 C--N 1.351 0.707 0 CA-C-N 123.043 2.123 . . . . 0.0 111.883 -175.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.23 -36.53 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -56.68 -45.93 81.43 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.297 0.953 . . . . 0.0 110.091 170.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -63.34 -41.6 98.89 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 123.064 0.546 . . . . 0.0 111.117 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.69 -47.09 85.13 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.833 0.453 . . . . 0.0 111.043 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.0 t -60.81 -42.33 91.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 177.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -68.26 -28.27 67.06 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.874 0.761 . . . . 0.0 111.602 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 42.9 m -69.03 -46.29 68.3 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.214 -0.929 . . . . 0.0 109.492 173.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 90.1 t -61.65 -43.43 97.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 119.111 0.869 . . . . 0.0 109.597 176.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.409 ' CE1' ' HE2' ' A' ' 31' ' ' LYS . 20.4 t80 -52.96 -46.12 68.07 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.209 1.004 . . . . 0.0 111.227 175.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -66.11 -42.43 89.23 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.628 0.649 . . . . 0.0 111.003 175.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -58.4 -37.31 75.05 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.882 0.873 . . . . 0.0 111.76 -175.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 72.1 mt -57.21 -18.59 16.49 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.154 0.982 . . . . 0.0 113.137 -175.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 . . . . . 0 CA--C 1.542 0.635 0 CA-C-N 119.671 1.123 . . . . 0.0 112.431 177.161 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 . . . . . 0 N--CA 1.448 -0.537 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -78.24 151.86 32.87 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 172.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -98.19 119.74 37.38 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 55.1 tp . . . . . 0 C--O 1.233 0.207 0 C-N-CA 125.262 1.425 . . . . 0.0 110.301 -179.152 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.5 t0 . . . . . 0 C--O 1.233 0.184 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 51.2 t -139.42 151.8 22.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 119.003 0.82 . . . . 0.0 109.921 -167.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 33.7 tp -126.2 129.86 49.82 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 126.069 1.748 . . . . 0.0 106.402 176.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.9 tp -117.31 100.95 8.03 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 124.915 1.286 . . . . 0.0 107.886 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 89.4 m -76.04 141.23 42.15 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 169.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 50.9 t -139.96 142.93 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 143.18 174.39 15.43 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.252 0.93 . . . . 0.0 111.709 176.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -118.32 120.16 36.8 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.7 1.2 . . . . 0.0 108.869 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -59.67 -15.97 23.12 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.356 1.862 . . . . 0.0 115.228 -170.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 27.7 ptm -126.88 14.47 7.42 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.206 1.003 . . . . 0.0 111.167 -175.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.2 ttt -101.78 31.58 3.78 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.41 0.684 . . . . 0.0 110.048 -177.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.29 -142.49 21.3 Favored Glycine 0 C--N 1.337 0.584 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -60.26 -17.68 43.82 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.784 1.234 . . . . 0.0 112.352 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -57.09 -19.75 21.36 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.88 1.272 . . . . 0.0 112.557 176.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.13 21.17 0.85 Allowed Glycine 0 CA--C 1.534 1.238 0 O-C-N 120.761 -1.212 . . . . 0.0 114.278 176.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.25 -53.18 58.86 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.588 1.694 . . . . 0.0 110.943 -170.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.59 -53.94 41.86 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 117.791 -1.561 . . . . 0.0 111.02 175.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -48.97 -41.02 40.63 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 CA-C-N 120.78 2.29 . . . . 0.0 115.217 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.7 tp -71.51 -37.74 71.19 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 120.265 1.393 . . . . 0.0 110.372 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.9 tp -61.91 -46.98 87.02 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.047 0.385 . . . . 0.0 110.252 175.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.53 -40.6 87.69 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 124.021 0.929 . . . . 0.0 111.111 177.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -60.94 -48.81 80.1 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 118.833 0.742 . . . . 0.0 109.789 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -62.34 -46.13 90.07 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 122.959 0.504 . . . . 0.0 110.569 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 79.6 m -64.57 -38.36 90.74 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.271 0.487 . . . . 0.0 111.219 178.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.54 -38.64 91.72 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.886 0.766 . . . . 0.0 110.988 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.36 -38.28 78.02 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.203 0.601 . . . . 0.0 111.157 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.32 94.57 2.16 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 125.205 1.402 . . . . 0.0 108.497 -173.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -56.01 159.67 11.75 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 123.526 2.817 . . . . 0.0 113.328 178.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -135.74 167.51 21.01 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 126.053 1.741 . . . . 0.0 108.336 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 44.23 -127.32 6.54 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.509 1.052 . . . . 0.0 111.831 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -136.16 9.89 3.26 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.854 1.261 . . . . 0.0 111.699 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -71.33 125.12 26.13 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 123.986 0.914 . . . . 0.0 109.252 -172.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 51.1 t -69.9 123.79 24.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 166.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.4 t -77.45 135.38 26.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -178.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.6 mm -130.65 145.9 34.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 104.292 -2.484 . . . . 0.0 104.292 168.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -134.33 107.92 7.9 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 177.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.54 -1.9 89.06 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 118.966 -0.908 . . . . 0.0 112.49 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 54.22 -145.1 27.23 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -169.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.8 p -89.71 13.75 13.48 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 122.01 -0.7 . . . . 0.0 111.869 177.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.54 58.63 10.42 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 124.995 1.318 . . . . 0.0 110.498 -177.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -72.25 -22.09 22.57 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.873 2.382 . . . . 0.0 112.967 -171.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.72 -36.19 78.22 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.847 0.749 . . . . 0.0 111.856 -177.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -65.0 -11.89 44.06 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.867 0.867 . . . . 0.0 112.931 175.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -113.75 -0.25 14.3 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.305 1.042 . . . . 0.0 112.29 -172.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 62.5 mt -48.17 -41.19 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 125.124 1.37 . . . . 0.0 110.732 174.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.0 t -56.77 -44.02 80.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.313 0.645 . . . . 0.0 110.198 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.32 93.03 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.974 0.51 . . . . 0.0 110.966 -177.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 64.7 mt -64.27 -45.53 95.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.1 mtp180 -64.89 -31.29 72.45 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.512 -176.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -57.92 -33.06 68.38 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.667 1.121 . . . . 0.0 111.558 174.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 33.0 mt -76.22 -8.23 56.61 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 118.571 -0.728 . . . . 0.0 112.778 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.1 mtp180 31.8 62.12 1.23 Allowed Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 126.994 2.118 . . . . 0.0 112.359 -169.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -55.07 142.67 76.63 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.835 2.357 . . . . 0.0 112.305 -172.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.2 m -81.68 -31.84 32.04 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.682 0.793 . . . . 0.0 108.913 168.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -142.55 150.76 40.82 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.611 1.564 . . . . 0.0 107.721 174.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 56.4 tp -138.81 142.89 38.7 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.645 1.178 . . . . 0.0 108.088 173.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 35.0 tp -128.49 138.93 52.52 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 173.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.1 mt -125.31 142.07 43.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 -175.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.4 t -140.83 134.11 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 118.593 0.633 . . . . 0.0 110.08 -174.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -161.52 171.18 18.54 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.252 2.221 . . . . 0.0 107.739 171.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.4 156.84 39.01 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.133 -0.979 . . . . 0.0 108.621 168.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.3 m -155.86 127.74 7.45 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 176.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -71.48 123.76 23.12 Favored 'General case' 0 N--CA 1.461 0.097 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 171.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 75.4 mtm -123.24 1.73 9.12 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.032 1.733 . . . . 0.0 110.705 -175.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.83 25.21 68.97 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-N 118.747 0.703 . . . . 0.0 112.332 -173.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.0 mt -99.92 -172.25 2.2 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.332 1.453 . . . . 0.0 109.292 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -75.36 140.22 72.34 Favored Pre-proline 0 N--CA 1.469 0.49 0 CA-C-O 117.539 -1.219 . . . . 0.0 108.667 173.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -43.43 136.32 6.1 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 123.343 2.695 . . . . 0.0 113.081 172.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.31 3.48 76.91 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 118.779 -1.012 . . . . 0.0 113.75 178.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -64.74 148.57 50.88 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 119.754 1.777 . . . . 0.0 108.581 168.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 76.5 mt -125.89 136.09 61.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 -173.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 90.1 mmt-85 -148.18 152.64 37.59 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 118.512 0.596 . . . . 0.0 111.101 175.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 41.5 mm -81.58 144.74 9.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 166.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.8 mt -126.79 129.33 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -73.5 139.14 77.86 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 118.185 -0.912 . . . . 0.0 109.36 172.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -45.37 -36.26 12.81 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 124.46 3.44 . . . . 0.0 116.4 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -66.67 -26.78 67.2 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.445 0.566 . . . . 0.0 111.687 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -97.7 -28.57 13.84 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.515 1.126 . . . . 0.0 111.149 -178.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 45.9 mt -51.04 -43.38 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.613 1.165 . . . . 0.0 110.229 170.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -52.99 -31.49 41.17 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.593 1.157 . . . . 0.0 112.804 -177.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -97.58 -42.33 7.72 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.314 0.646 . . . . 0.0 109.843 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 22.5 mmt -67.3 -33.38 75.17 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -171.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -62.43 -43.37 98.97 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 118.454 0.57 . . . . 0.0 110.655 176.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 27.8 ptm . . . . . 0 CA--C 1.538 0.498 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -179.751 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.6 mt . . . . . 0 N--CA 1.464 0.258 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -52.84 -23.32 6.75 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.256 0.934 . . . . 0.0 112.045 167.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -60.64 -27.08 67.52 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.828 0.74 . . . . 0.0 112.583 175.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.5 tt -69.64 -43.78 71.95 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 119.023 0.829 . . . . 0.0 109.372 175.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 76.7 mt -61.95 -43.48 97.58 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.093 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -64.38 -16.46 62.33 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -105.54 16.98 24.6 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.33 1.452 . . . . 0.0 111.18 177.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.6 mt -136.06 -37.5 0.72 Allowed 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.703 1.201 . . . . 0.0 110.994 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -55.59 -22.32 21.63 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.569 1.148 . . . . 0.0 112.742 176.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -60.23 -24.71 65.08 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.504 1.522 . . . . 0.0 112.122 -177.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -134.05 7.42 3.7 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.681 0.792 . . . . 0.0 112.488 -171.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 76.5 mt -122.41 141.51 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.977 1.311 . . . . 0.0 108.291 -174.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.27 -39.64 81.88 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 123.864 0.745 . . . . 0.0 111.809 -176.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -147.38 132.86 18.65 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 118.307 1.054 . . . . 0.0 108.256 176.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 41.5 t -122.65 129.38 75.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 172.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 15.1 mt -129.24 148.68 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 -169.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -129.6 141.18 51.0 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 170.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.5 tt -123.53 127.98 49.11 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 175.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -109.48 155.63 16.0 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 83.4 mt -133.06 126.01 52.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.103 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -62.76 114.47 12.32 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-O 117.778 -1.106 . . . . 0.0 110.453 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -75.96 170.48 20.02 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.171 2.581 . . . . 0.0 111.111 170.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -129.75 -30.11 2.08 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.493 1.917 . . . . 0.0 111.025 169.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.1 pp -136.03 137.02 49.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 123.891 0.876 . . . . 0.0 109.025 176.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 75.7 t -146.36 139.64 20.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 153.9 151.51 5.78 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 108.776 -1.729 . . . . 0.0 108.776 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -64.27 149.11 48.73 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 118.086 0.943 . . . . 0.0 110.597 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.6 t80 58.43 46.08 15.7 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.292 1.837 . . . . 0.0 111.577 -175.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -132.81 147.27 64.8 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 123.853 0.861 . . . . 0.0 109.759 168.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -81.87 166.12 17.23 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.554 2.836 . . . . 0.0 110.827 176.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.1 ttm -70.0 134.64 48.52 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 169.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.04 159.66 31.46 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.557 1.143 . . . . 0.0 110.57 175.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.63 -46.39 99.59 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-O 117.233 -1.365 . . . . 0.0 113.538 -171.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -67.07 -26.8 42.74 Favored 'Trans proline' 0 C--N 1.35 0.615 0 CA-C-N 122.209 1.824 . . . . 0.0 112.593 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.24 -35.7 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -56.24 -46.79 79.45 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.138 0.881 . . . . 0.0 109.984 170.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -63.11 -38.09 89.8 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 122.722 0.409 . . . . 0.0 111.444 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.49 -47.78 77.67 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 122.033 -0.417 . . . . 0.0 111.056 175.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 71.4 t -61.21 -39.28 81.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 118.672 0.669 . . . . 0.0 109.719 178.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 32.6 tp10 -63.91 -39.09 93.36 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.13 0.877 . . . . 0.0 110.927 175.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 51.7 m -63.9 -48.07 78.08 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.763 -0.586 . . . . 0.0 109.854 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 79.2 t -60.3 -46.08 95.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -54.62 -48.78 71.82 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.05 0.94 . . . . 0.0 110.849 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -65.06 -38.16 89.91 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.456 0.571 . . . . 0.0 111.194 177.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -62.14 -29.25 70.21 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 118.367 -0.825 . . . . 0.0 111.552 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 83.9 mt -55.01 -21.28 11.54 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.3 0.954 . . . . 0.0 112.909 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 . . . . . 0 CA--C 1.539 0.55 0 CA-C-N 119.309 0.959 . . . . 0.0 112.595 -179.514 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 . . . . . 0 N--CA 1.448 -0.533 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.95 146.41 47.79 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -92.3 121.02 33.39 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 177.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 62.5 tp . . . . . 0 C--O 1.233 0.203 0 C-N-CA 125.791 1.637 . . . . 0.0 110.631 178.566 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 . . . . . 0 C--O 1.235 0.291 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.432 HG21 ' HG3' ' A' ' 55' ' ' PRO . 78.4 t -136.77 149.11 26.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -175.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 37.0 tp -127.93 112.06 14.26 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.415 1.486 . . . . 0.0 107.066 -175.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 51.9 tp -101.45 97.22 7.71 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 125.129 1.372 . . . . 0.0 107.883 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 87.3 m -73.11 143.03 47.51 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 169.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.0 t -141.71 144.82 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 176.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.79 174.34 17.87 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -124.76 119.31 28.55 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.128 1.371 . . . . 0.0 107.846 176.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 m -60.44 -14.2 17.87 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.185 1.794 . . . . 0.0 115.313 -169.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 27.9 ptm -125.22 13.14 8.29 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.153 0.981 . . . . 0.0 111.067 -176.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.3 ttt -100.7 29.68 4.38 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.567 0.747 . . . . 0.0 109.83 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.78 -142.26 20.75 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -61.86 -17.04 55.02 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.592 1.157 . . . . 0.0 112.221 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -54.87 -24.53 23.67 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.433 1.493 . . . . 0.0 113.236 176.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.21 24.49 0.71 Allowed Glycine 0 CA--C 1.533 1.191 0 CA-C-O 118.575 -1.125 . . . . 0.0 114.447 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.31 -51.45 65.98 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 119.468 1.634 . . . . 0.0 110.826 -169.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.17 -54.8 34.33 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-O 117.809 -1.55 . . . . 0.0 111.021 175.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -50.22 -37.68 49.73 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 CA-C-N 121.085 2.442 . . . . 0.0 114.841 178.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.7 tp -71.05 -39.79 72.04 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 120.117 1.326 . . . . 0.0 110.546 176.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.7 tp -60.9 -46.74 89.43 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.225 0.466 . . . . 0.0 110.479 175.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.48 -41.74 90.51 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 124.222 1.009 . . . . 0.0 110.913 176.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -61.06 -48.36 82.09 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 118.932 0.787 . . . . 0.0 110.046 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -61.2 -47.55 85.6 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 122.917 0.487 . . . . 0.0 110.513 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 80.9 m -64.5 -38.16 90.06 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.252 0.478 . . . . 0.0 111.183 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.7 -38.45 91.05 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.857 0.753 . . . . 0.0 111.077 177.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.78 -37.58 76.39 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.349 0.659 . . . . 0.0 111.218 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.31 98.56 1.97 Allowed Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 125.448 1.499 . . . . 0.0 107.856 -174.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -56.08 167.39 2.48 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 123.93 3.087 . . . . 0.0 114.664 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.5 ' HE2' ' CZ ' ' A' ' 136' ' ' TYR . 71.4 mmtt -135.93 160.14 39.51 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 126.055 1.742 . . . . 0.0 107.858 176.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 42.29 -121.19 2.6 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.861 1.22 . . . . 0.0 111.867 175.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -137.25 15.76 3.0 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.036 1.734 . . . . 0.0 111.142 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 13.0 m95 -72.26 131.27 42.49 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.565 0.746 . . . . 0.0 110.243 -171.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.0 t -75.73 118.03 21.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 104.273 -2.491 . . . . 0.0 104.273 165.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.0 t -72.81 134.82 29.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.7 mm -133.33 148.1 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 171.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -135.45 113.82 11.53 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 176.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.04 -13.27 83.21 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 118.613 -1.104 . . . . 0.0 112.81 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.56 34.05 79.69 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-N 119.62 1.71 . . . . 0.0 113.784 172.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 61.87 14.03 5.98 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.951 1.7 . . . . 0.0 114.261 -172.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -135.54 58.05 23.0 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 125.807 1.643 . . . . 0.0 107.657 169.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -71.26 -25.41 22.05 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.018 1.812 . . . . 0.0 111.873 -169.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.42 -30.69 71.77 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.668 0.787 . . . . 0.0 111.867 -179.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -63.02 -15.34 56.1 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.029 0.932 . . . . 0.0 112.419 172.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -117.32 1.07 12.37 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.369 1.068 . . . . 0.0 112.568 -169.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 78.7 mt -48.82 -37.29 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.869 1.268 . . . . 0.0 110.512 171.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.8 t -55.93 -41.26 66.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 123.683 0.793 . . . . 0.0 110.333 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.78 -41.96 82.41 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 118.479 0.582 . . . . 0.0 110.562 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.6 mt -61.06 -41.57 89.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 176.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -67.33 -19.99 65.53 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 117.693 -1.146 . . . . 0.0 112.505 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -72.25 -44.97 62.06 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 120.655 1.57 . . . . 0.0 108.894 169.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 56.5 mt -69.04 -26.4 64.96 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 118.489 -0.767 . . . . 0.0 112.703 -176.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 37.43 63.65 3.19 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 125.778 1.631 . . . . 0.0 111.443 -169.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.432 ' HG3' HG21 ' A' ' 4' ' ' VAL . 53.1 Cg_exo -51.45 144.55 31.57 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.214 2.609 . . . . 0.0 113.774 -170.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.4 m -67.08 -42.18 85.1 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 167.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 73.0 mtm180 -144.08 153.82 42.57 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 124.769 1.228 . . . . 0.0 108.105 174.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 56.9 tp -133.16 137.01 46.07 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 35.0 tp -124.01 133.71 53.61 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.715 -1.958 . . . . 0.0 105.715 174.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.2 mt -122.22 139.75 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 -175.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.4 t -140.24 133.36 34.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 118.203 0.456 . . . . 0.0 109.828 -172.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -162.32 172.9 14.92 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.24 2.216 . . . . 0.0 107.397 176.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.73 157.73 37.4 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.112 -0.993 . . . . 0.0 108.326 167.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.0 m -154.66 130.18 9.86 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 174.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -74.55 124.19 26.17 Favored 'General case' 0 N--CA 1.461 0.105 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 172.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 77.1 mtm -122.18 0.44 9.57 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.547 1.539 . . . . 0.0 110.814 -175.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.55 24.83 68.19 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-N 118.576 0.626 . . . . 0.0 112.364 -172.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 58.8 mt -100.67 -169.61 1.74 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.964 1.305 . . . . 0.0 108.568 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -82.2 147.01 56.06 Favored Pre-proline 0 N--CA 1.471 0.62 0 CA-C-O 118.466 -0.778 . . . . 0.0 109.747 174.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -46.81 136.1 17.02 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.379 2.719 . . . . 0.0 112.348 176.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.56 1.87 90.3 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 118.483 -1.176 . . . . 0.0 113.45 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -64.53 148.54 50.5 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 119.906 1.853 . . . . 0.0 108.356 168.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 69.3 mt -128.76 135.95 61.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 -172.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 -148.7 150.84 33.87 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 118.666 0.666 . . . . 0.0 111.926 177.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 51.4 mm -79.45 143.61 12.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 166.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.8 mt -128.63 125.61 63.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -74.87 140.54 74.34 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.266 172.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -45.66 -34.57 11.69 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 124.369 3.379 . . . . 0.0 116.628 177.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -68.58 -24.99 64.66 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.57 0.623 . . . . 0.0 111.807 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -98.69 -30.37 12.49 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.865 1.266 . . . . 0.0 111.076 -177.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 63.7 mt -49.91 -40.91 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.692 1.197 . . . . 0.0 109.189 169.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.0 -19.72 19.99 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.161 1.384 . . . . 0.0 114.454 -174.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -117.91 -36.24 3.69 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 118.699 0.682 . . . . 0.0 110.084 176.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 38.4 mmt -69.19 -25.46 64.34 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -176.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -70.21 -47.15 62.71 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 119.164 0.893 . . . . 0.0 111.238 173.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 20.1 ptp . . . . . 0 CA--C 1.532 0.271 0 CA-C-O 118.608 -0.711 . . . . 0.0 112.881 179.361 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 mt . . . . . 0 N--CA 1.468 0.452 0 N-CA-C 117.694 2.479 . . . . 0.0 117.694 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -54.42 -21.79 10.71 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.21 -0.931 . . . . 0.0 112.192 167.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -60.0 -31.77 70.24 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.445 1.02 . . . . 0.0 111.751 174.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.9 tt -73.91 -45.71 48.9 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.758 0.708 . . . . 0.0 109.114 174.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 85.4 mt -57.22 -42.81 80.7 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -62.41 -21.58 65.5 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -85.42 -2.33 57.99 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.829 0.852 . . . . 0.0 112.226 177.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.442 ' HB3' HD12 ' A' ' 105' ' ' ILE . 2.4 mm? -129.95 -33.93 1.74 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.316 1.047 . . . . 0.0 112.51 -178.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 13.4 pttm -62.92 -19.72 64.5 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.658 0.783 . . . . 0.0 112.983 -171.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -72.09 -12.17 61.08 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.389 1.075 . . . . 0.0 111.814 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -133.26 -34.05 1.09 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.226 0.921 . . . . 0.0 112.915 -177.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.442 HD12 ' HB3' ' A' ' 101' ' ' LEU . 23.8 mt -67.87 143.19 15.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 171.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.81 -39.9 93.6 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 123.954 0.788 . . . . 0.0 112.39 -177.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -150.49 138.72 20.3 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 118.379 1.089 . . . . 0.0 108.442 174.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 39.0 t -122.41 132.07 71.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 174.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.2 mt -130.92 147.35 33.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 -169.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -132.68 140.74 48.27 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 175.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.9 tt -125.5 133.85 52.24 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 174.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -116.71 156.83 15.4 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 177.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 87.1 mt -134.39 127.53 50.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 -177.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -63.9 114.34 13.25 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 117.38 -1.295 . . . . 0.0 110.151 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -76.09 170.56 19.83 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.152 2.568 . . . . 0.0 111.154 170.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -128.81 -32.04 2.14 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.031 1.732 . . . . 0.0 110.986 171.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -135.58 136.23 50.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 177.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.4 t -141.73 135.55 30.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 176.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 157.47 150.73 5.8 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -66.14 152.67 44.25 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.78 0.8 . . . . 0.0 111.08 -176.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 25.0 t80 55.05 39.88 31.74 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.536 1.934 . . . . 0.0 111.648 -175.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -125.06 147.96 58.67 Favored Pre-proline 0 C--O 1.237 0.427 0 C-N-CA 123.669 0.787 . . . . 0.0 109.815 169.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -82.4 164.47 16.78 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.38 2.72 . . . . 0.0 111.087 176.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 53.0 ttm -71.83 138.0 47.97 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 168.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 71.5 p -78.41 159.49 28.28 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.153 0.981 . . . . 0.0 110.494 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.3 tp60 -53.09 -44.42 97.08 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-O 116.533 -1.699 . . . . 0.0 114.23 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -68.58 -30.53 28.45 Favored 'Trans proline' 0 C--N 1.351 0.683 0 CA-C-N 122.914 2.076 . . . . 0.0 112.164 -176.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.81 -35.31 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 119.021 0.828 . . . . 0.0 108.841 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -56.56 -46.64 80.63 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.3 0.955 . . . . 0.0 110.056 170.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -63.97 -37.14 86.33 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.055 0.542 . . . . 0.0 111.434 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.38 -47.25 77.02 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.919 -0.488 . . . . 0.0 111.17 175.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 78.9 t -61.74 -39.66 84.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 118.564 0.62 . . . . 0.0 109.525 177.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -61.37 -42.31 98.5 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.911 0.778 . . . . 0.0 110.534 174.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 52.2 m -62.19 -45.74 92.02 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.747 -0.596 . . . . 0.0 110.237 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 80.3 t -61.9 -47.53 92.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 176.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.5 ' CZ ' ' HE2' ' A' ' 31' ' ' LYS . 38.7 t80 -55.42 -49.66 71.82 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.913 0.885 . . . . 0.0 110.923 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 48.7 mm-40 -68.78 -23.35 64.29 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.734 -0.604 . . . . 0.0 112.102 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.18 -29.24 64.93 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.66 1.118 . . . . 0.0 111.583 175.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 67.6 mt -58.58 -20.38 46.34 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -168.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 . . . . . 0 CA--C 1.54 0.562 0 CA-C-N 120.254 1.388 . . . . 0.0 113.297 177.118 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.02 151.37 47.77 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.774 0.829 . . . . 0.0 109.527 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -92.59 123.98 36.28 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 62.0 tp . . . . . 0 C--O 1.234 0.266 0 C-N-CA 125.381 1.472 . . . . 0.0 109.741 176.858 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.2 t0 . . . . . 0 C--O 1.233 0.223 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 70.8 t -124.0 148.61 28.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 121.409 0.623 . . . . 0.0 110.709 -167.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 33.7 tp -114.37 129.56 56.65 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.628 -1.989 . . . . 0.0 105.628 168.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.8 tp -120.63 100.82 7.35 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 92.7 m -75.33 143.03 43.11 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 171.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 51.9 t -141.01 142.04 30.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.285 1.434 . . . . 0.0 107.306 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 144.57 176.88 18.97 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.336 0.969 . . . . 0.0 111.873 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -126.55 122.54 35.42 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.8 1.24 . . . . 0.0 108.844 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 m -60.82 -15.33 29.0 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.572 1.949 . . . . 0.0 115.661 -169.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 25.8 ptm -127.4 11.01 6.82 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.074 0.95 . . . . 0.0 110.989 -176.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.6 ttt -88.68 14.32 10.33 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.225 1.01 . . . . 0.0 110.098 176.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.54 -140.96 15.34 Favored Glycine 0 C--N 1.337 0.637 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -60.44 -17.42 44.45 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.504 1.121 . . . . 0.0 112.224 176.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -55.81 -20.68 16.01 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.614 1.566 . . . . 0.0 113.207 174.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.44 21.5 0.7 Allowed Glycine 0 CA--C 1.534 1.253 0 O-C-N 120.823 -1.173 . . . . 0.0 114.286 177.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.4 -51.0 67.64 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 119.477 1.639 . . . . 0.0 110.788 -169.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.64 -54.91 33.74 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-O 117.76 -1.578 . . . . 0.0 111.073 175.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -49.75 -41.08 47.21 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 CA-C-N 120.826 2.313 . . . . 0.0 115.282 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.9 tp -71.34 -39.08 71.56 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 120.135 1.334 . . . . 0.0 110.267 178.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.8 tp -61.18 -46.15 91.69 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 122.055 -0.403 . . . . 0.0 110.314 175.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.14 -40.2 84.76 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 124.08 0.952 . . . . 0.0 111.167 177.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -61.41 -48.52 80.86 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 118.918 0.781 . . . . 0.0 109.866 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -61.87 -46.39 89.61 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.895 0.478 . . . . 0.0 110.506 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 80.1 m -64.59 -39.05 93.04 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.191 0.451 . . . . 0.0 111.209 178.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.47 -37.62 88.19 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.774 0.715 . . . . 0.0 111.052 177.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.88 -37.45 79.04 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.172 0.589 . . . . 0.0 111.058 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.0 96.24 1.72 Allowed Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 124.985 1.314 . . . . 0.0 108.553 -173.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -55.93 164.34 4.86 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.869 3.046 . . . . 0.0 113.969 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -134.02 166.1 23.51 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.383 1.473 . . . . 0.0 109.011 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 44.76 -113.25 0.82 Allowed Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.767 1.175 . . . . 0.0 111.418 175.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -144.57 8.94 1.35 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.795 1.238 . . . . 0.0 111.741 176.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 3.9 m95 -68.13 131.54 45.6 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.951 0.901 . . . . 0.0 110.201 -169.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 62.1 t -77.58 119.04 25.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 166.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.5 t -82.55 136.52 22.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -174.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 70.0 mt -133.74 145.29 33.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 169.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -129.58 107.91 9.82 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 175.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.98 -2.16 90.49 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-O 118.892 -0.949 . . . . 0.0 112.95 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 55.28 -144.93 31.88 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 108.441 -1.863 . . . . 0.0 108.441 -169.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.4 p -88.52 9.13 24.88 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.738 -0.86 . . . . 0.0 112.084 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -135.86 57.19 17.42 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 124.991 1.316 . . . . 0.0 110.493 -176.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -68.74 -14.37 39.02 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.735 2.29 . . . . 0.0 113.197 -171.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -55.48 -32.5 62.88 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.074 0.852 . . . . 0.0 112.001 173.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.99 -27.31 66.75 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.192 0.597 . . . . 0.0 112.119 176.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -99.38 -2.74 35.49 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.804 1.242 . . . . 0.0 111.458 -171.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 77.3 mt -54.56 -43.09 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 119.405 1.002 . . . . 0.0 109.641 175.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.3 t -61.6 -42.29 93.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 118.348 0.522 . . . . 0.0 109.737 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.68 -46.31 79.57 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 122.948 0.499 . . . . 0.0 110.666 -177.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 67.5 mt -55.16 -48.05 76.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 172.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -68.18 -23.28 64.83 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 117.865 -1.064 . . . . 0.0 112.778 -174.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -62.96 -37.56 87.57 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 120.519 1.509 . . . . 0.0 110.34 169.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 39.2 mt -77.19 -16.55 59.05 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.851 0.86 . . . . 0.0 111.917 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 26.89 64.6 0.56 Allowed Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 127.883 2.473 . . . . 0.0 113.538 -169.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -58.67 151.25 64.53 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.704 2.936 . . . . 0.0 113.912 -169.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.9 m -69.85 -36.1 75.25 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.085 0.954 . . . . 0.0 108.736 167.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -146.68 153.94 40.86 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.394 1.078 . . . . 0.0 110.402 -175.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 46.7 tp -142.77 136.85 29.28 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 125.301 1.44 . . . . 0.0 108.373 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 27.1 tp -125.32 135.33 52.36 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 172.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.5 mt -123.25 145.17 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 -172.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 44.0 t -141.06 135.53 32.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 118.74 0.7 . . . . 0.0 110.043 -175.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -163.99 172.26 14.13 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.598 2.359 . . . . 0.0 107.544 173.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.58 158.49 36.11 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.366 -0.834 . . . . 0.0 109.17 167.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.7 m -154.41 128.67 9.04 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -75.98 83.88 2.88 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 119.004 0.82 . . . . 0.0 109.925 174.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 74.6 mtm -77.44 -8.98 58.59 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.45 1.5 . . . . 0.0 112.212 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.04 29.26 67.1 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-N 118.914 0.779 . . . . 0.0 111.362 -171.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.3 mt -106.07 -172.36 2.07 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.965 1.306 . . . . 0.0 109.721 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -74.6 141.16 75.84 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-O 117.749 -1.12 . . . . 0.0 108.58 169.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -43.19 137.95 4.72 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 123.445 2.763 . . . . 0.0 113.395 172.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.29 1.02 79.94 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-O 118.625 -1.097 . . . . 0.0 113.82 176.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -68.2 149.34 49.64 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 119.875 1.838 . . . . 0.0 108.299 168.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 48.2 mt -128.82 135.07 63.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 125.607 1.563 . . . . 0.0 106.952 -172.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.2 mmt-85 -144.99 152.12 39.65 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.068 0.849 . . . . 0.0 109.653 175.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 42.6 mm -78.12 146.57 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 167.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.3 mt -128.49 118.18 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -71.88 139.85 83.15 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-O 117.926 -1.035 . . . . 0.0 109.172 174.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -47.56 -33.22 17.47 Favored 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 124.22 3.28 . . . . 0.0 116.654 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -67.95 -24.27 65.15 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.763 0.71 . . . . 0.0 111.641 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -100.64 -28.85 12.63 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.284 1.434 . . . . 0.0 111.307 -177.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.414 HG23 ' CD1' ' A' ' 85' ' ' PHE . 61.0 mt -49.34 -45.87 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.69 1.196 . . . . 0.0 109.044 169.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.68 -14.89 15.88 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.257 1.423 . . . . 0.0 113.969 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -126.2 4.89 7.08 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.226 1.01 . . . . 0.0 111.637 -177.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 20.9 mmt -121.64 -25.71 5.05 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -176.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.414 ' CD1' HG23 ' A' ' 81' ' ' ILE . 8.2 m-85 -73.79 -40.89 63.08 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.835 1.198 . . . . 0.0 111.449 -178.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.448 0 O-C-N 121.773 -0.58 . . . . 0.0 112.397 175.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 mt . . . . . 0 N--CA 1.475 0.817 0 N-CA-C 117.642 2.46 . . . . 0.0 117.642 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.06 -20.97 4.05 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.053 0.842 . . . . 0.0 112.641 168.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -58.39 -32.4 68.57 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.641 1.11 . . . . 0.0 112.083 174.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.4 tt -74.77 -43.5 54.51 Favored 'General case' 0 N--CA 1.462 0.125 0 O-C-N 121.623 -0.673 . . . . 0.0 109.669 176.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 74.5 mt -62.0 -40.28 86.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 123.946 0.898 . . . . 0.0 109.705 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.1 -27.89 65.99 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.505 0.722 . . . . 0.0 112.386 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -91.47 8.49 36.14 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.816 1.246 . . . . 0.0 111.943 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 88.4 mt -133.47 -29.81 1.34 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.223 1.009 . . . . 0.0 111.865 -176.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 45.0 mttm -56.16 -19.14 12.25 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.095 0.958 . . . . 0.0 112.779 170.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -59.02 -18.81 37.94 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.423 1.089 . . . . 0.0 112.205 175.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -138.23 -42.93 0.51 Allowed 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.868 0.867 . . . . 0.0 112.012 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 20.3 mt -68.62 133.4 31.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -173.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -75.97 -34.07 48.61 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.203 0.906 . . . . 0.0 112.432 -173.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -143.62 125.75 15.47 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.4 t -127.07 128.85 70.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 3.8 mt -131.55 150.11 33.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 -169.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -130.96 141.04 50.23 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 169.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.9 tt -120.62 128.74 53.3 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 174.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -111.94 156.23 15.7 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -178.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 62.6 mt -133.92 124.52 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 -176.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -65.47 117.84 44.7 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-O 117.389 -1.291 . . . . 0.0 110.4 -178.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -77.21 171.99 16.82 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.662 2.908 . . . . 0.0 111.485 170.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -128.11 -31.43 2.35 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.669 1.587 . . . . 0.0 111.073 170.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.1 pp -136.52 135.54 49.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.309 1.044 . . . . 0.0 108.751 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.3 t -143.77 145.92 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 176.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 173.28 -120.58 0.81 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -156.21 154.18 30.36 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.647 1.224 . . . . 0.0 108.33 175.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 3.0 t80 53.73 33.07 15.97 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.691 1.197 . . . . 0.0 110.861 -171.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 12.5 m-30 -118.96 140.38 28.57 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 124.816 1.246 . . . . 0.0 109.84 -173.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -82.72 165.22 15.81 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.433 2.755 . . . . 0.0 111.215 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.3 ttm -75.71 139.35 41.86 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 168.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 73.0 p -80.74 160.5 24.91 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.484 1.114 . . . . 0.0 110.475 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -53.1 -45.04 98.44 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-O 116.493 -1.718 . . . . 0.0 114.117 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -68.52 -30.56 28.83 Favored 'Trans proline' 0 C--N 1.35 0.653 0 CA-C-N 122.847 2.052 . . . . 0.0 112.215 -176.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -80.56 -35.47 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -56.3 -46.42 79.8 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.366 0.985 . . . . 0.0 109.946 170.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -64.05 -38.62 91.74 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 122.937 0.495 . . . . 0.0 111.254 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.53 -46.49 82.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 119.013 -0.518 . . . . 0.0 111.09 175.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 79.7 t -62.87 -38.92 83.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 119.147 0.885 . . . . 0.0 109.793 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -62.79 -42.29 99.64 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.396 0.998 . . . . 0.0 110.355 174.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 57.3 m -61.14 -49.75 75.97 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 71.1 t -60.66 -42.17 90.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 123.646 0.779 . . . . 0.0 109.893 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -57.1 -48.3 78.96 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.465 0.575 . . . . 0.0 110.575 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 63.9 mm-40 -64.53 -38.57 91.47 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.992 0.815 . . . . 0.0 110.895 175.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -63.92 -27.43 69.14 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 123.436 0.695 . . . . 0.0 112.414 -177.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 75.1 mt -59.11 -18.5 36.19 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.376 0.989 . . . . 0.0 112.16 175.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 . . . . . 0 CA--C 1.544 0.739 0 CA-C-N 119.149 0.886 . . . . 0.0 111.947 178.708 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 . . . . . 0 N--CA 1.452 -0.367 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -88.75 148.56 23.89 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 170.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.6 121.9 29.77 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 174.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 52.3 tp . . . . . 0 CA--C 1.532 0.281 0 C-N-CA 125.612 1.565 . . . . 0.0 109.793 178.49 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 C--O 1.235 0.315 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.412 HG21 ' HG3' ' A' ' 55' ' ' PRO . 69.6 t -136.33 148.38 27.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 39.3 tp -123.36 119.15 29.24 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.9 tp -109.95 96.91 6.54 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 99.4 m -71.29 142.39 50.48 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 169.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.3 t -140.82 143.12 29.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 177.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.02 174.54 17.36 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -122.71 121.05 35.43 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.365 1.466 . . . . 0.0 107.422 177.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 m -59.56 -14.78 14.52 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.934 1.693 . . . . 0.0 115.495 -169.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -128.86 14.12 6.35 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.839 0.856 . . . . 0.0 111.243 -176.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.2 ttt -97.73 30.6 2.9 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 118.682 0.674 . . . . 0.0 109.898 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.26 -142.39 20.45 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -178.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -61.2 -17.31 52.48 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.593 1.157 . . . . 0.0 112.111 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -56.63 -19.97 18.84 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.217 1.407 . . . . 0.0 112.871 174.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.36 20.26 0.77 Allowed Glycine 0 CA--C 1.534 1.258 0 O-C-N 120.691 -1.256 . . . . 0.0 114.311 177.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.8 -52.7 63.14 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 119.571 1.685 . . . . 0.0 110.862 -169.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.62 -54.81 34.55 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-O 117.88 -1.511 . . . . 0.0 111.214 175.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -49.67 -40.76 46.75 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 CA-C-N 120.818 2.309 . . . . 0.0 115.077 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 65.6 tp -70.65 -39.27 73.72 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-N 119.963 1.256 . . . . 0.0 110.311 178.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.0 tp -61.28 -46.87 88.54 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.065 0.393 . . . . 0.0 110.348 175.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.38 -42.23 86.58 Favored 'General case' 0 C--O 1.227 -0.125 0 C-N-CA 124.134 0.974 . . . . 0.0 110.829 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -60.72 -49.15 78.68 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.476 0.58 . . . . 0.0 110.0 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -61.75 -49.83 74.83 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 122.99 0.516 . . . . 0.0 110.723 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 75.7 m -64.02 -37.79 88.71 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.549 0.613 . . . . 0.0 111.399 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.46 -40.65 96.12 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.112 0.869 . . . . 0.0 111.073 176.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.64 -33.05 73.34 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.511 0.724 . . . . 0.0 111.704 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.44 96.08 2.66 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.544 1.537 . . . . 0.0 107.762 -173.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -53.31 159.5 5.87 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 123.439 2.759 . . . . 0.0 113.939 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -134.53 155.54 50.23 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.638 1.575 . . . . 0.0 108.085 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 40.71 -119.08 1.32 Allowed Glycine 0 CA--C 1.532 1.104 0 C-N-CA 125.128 1.346 . . . . 0.0 111.88 176.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -137.14 14.87 3.04 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.913 1.685 . . . . 0.0 111.309 177.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -72.52 128.17 34.77 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.337 0.655 . . . . 0.0 109.791 -173.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.2 t -72.86 120.45 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 166.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.0 t -76.22 133.72 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 24.4 mm -133.15 147.94 31.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 104.967 -2.235 . . . . 0.0 104.967 171.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -134.7 114.06 12.32 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 177.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.79 -16.28 76.19 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 118.654 -1.081 . . . . 0.0 113.003 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 57.95 39.0 91.14 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-N 119.264 1.532 . . . . 0.0 113.722 170.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . 0.252 75.3 p 60.71 14.29 4.95 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.502 2.321 . . . . 0.0 114.69 -173.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.2 56.29 6.22 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 125.632 1.573 . . . . 0.0 108.995 172.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -67.05 -28.75 41.11 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.395 2.063 . . . . 0.0 112.258 -169.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.59 -36.19 77.96 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.592 0.757 . . . . 0.0 111.892 -178.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -64.43 -13.59 52.2 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.702 0.801 . . . . 0.0 112.574 176.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -112.66 -0.36 15.12 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.314 1.046 . . . . 0.0 112.38 -172.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 87.5 mt -50.01 -36.92 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 124.577 1.151 . . . . 0.0 110.518 172.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 51.3 t -56.41 -40.82 69.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 123.646 0.778 . . . . 0.0 110.455 178.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.46 -41.85 83.99 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.498 0.59 . . . . 0.0 110.504 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 51.1 mt -61.91 -40.29 86.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -66.23 -20.25 66.06 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 117.785 -1.103 . . . . 0.0 112.528 176.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -72.45 -43.94 63.07 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 120.677 1.581 . . . . 0.0 109.097 169.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 49.0 mt -68.75 -27.91 66.33 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 118.671 -0.681 . . . . 0.0 112.568 -177.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 39.12 64.74 3.69 Favored Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 125.589 1.556 . . . . 0.0 111.306 -169.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.412 ' HG3' HG21 ' A' ' 4' ' ' VAL . 51.6 Cg_exo -49.69 141.04 28.23 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.269 2.646 . . . . 0.0 113.402 -172.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.1 m -66.99 -41.29 87.01 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 167.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.2 mtm-85 -146.72 149.97 34.47 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.115 1.766 . . . . 0.0 106.789 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 52.9 tp -134.59 137.76 43.99 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 33.6 tp -125.6 133.8 52.13 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 175.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.4 mt -121.96 142.38 38.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -174.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.5 t -141.01 133.56 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 118.764 0.711 . . . . 0.0 110.056 -174.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -161.42 171.24 18.55 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.39 2.276 . . . . 0.0 107.464 172.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.54 156.28 39.6 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.951 -1.093 . . . . 0.0 108.583 168.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.8 m -155.9 132.56 10.38 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -78.13 122.73 26.01 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 73.5 mtm -121.43 1.49 10.14 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.209 1.803 . . . . 0.0 110.699 -176.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.24 18.17 60.24 Favored Glycine 0 CA--C 1.537 1.412 0 CA-C-N 118.676 0.671 . . . . 0.0 112.579 -171.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.6 mt -87.47 -176.1 5.47 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.487 1.515 . . . . 0.0 109.744 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -76.08 140.26 69.76 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-O 117.871 -1.062 . . . . 0.0 108.818 171.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -45.86 134.93 14.0 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.417 2.744 . . . . 0.0 113.71 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.01 2.27 88.54 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.574 -1.126 . . . . 0.0 113.359 177.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -65.99 151.93 45.72 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 119.867 1.833 . . . . 0.0 108.025 168.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 81.0 mt -128.12 141.91 45.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -171.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 84.2 mmt-85 -151.04 154.19 36.55 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 123.326 0.651 . . . . 0.0 110.858 172.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 35.8 mm -81.6 144.68 9.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 165.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.7 mt -125.53 128.12 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 176.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -72.87 140.1 80.67 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-O 118.084 -0.96 . . . . 0.0 109.655 173.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -46.98 -32.55 13.05 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 124.356 3.37 . . . . 0.0 116.79 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -67.49 -26.48 66.38 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.778 0.717 . . . . 0.0 111.782 178.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -101.66 -25.08 13.99 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.991 1.316 . . . . 0.0 111.446 -176.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.443 HD11 ' HB3' ' A' ' 110' ' ' PHE . 45.0 mt -50.17 -41.21 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.54 1.136 . . . . 0.0 109.512 169.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.33 -30.67 52.11 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.53 1.132 . . . . 0.0 113.15 -177.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -100.38 -39.16 8.12 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.052 0.541 . . . . 0.0 110.06 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 26.1 mmt -73.47 -27.85 61.62 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 121.714 -0.616 . . . . 0.0 112.256 -173.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -68.59 -49.95 55.39 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 118.838 0.745 . . . . 0.0 110.306 171.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 27.6 ptm . . . . . 0 CA--C 1.535 0.384 0 CA-C-N 119.206 0.912 . . . . 0.0 111.911 -178.556 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.1 mt . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 117.363 2.357 . . . . 0.0 117.363 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -54.08 -19.42 4.89 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.437 1.017 . . . . 0.0 112.243 166.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -59.35 -28.46 66.87 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.608 1.095 . . . . 0.0 112.125 173.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.7 tt -70.78 -45.6 64.41 Favored 'General case' 0 N--CA 1.463 0.18 0 O-C-N 121.334 -0.854 . . . . 0.0 109.625 173.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 90.0 mt -61.5 -42.11 92.66 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.137 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -60.38 -24.85 65.43 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -85.89 0.11 53.94 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.921 0.888 . . . . 0.0 112.453 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 65.3 mt -135.89 -31.34 0.93 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.21 1.004 . . . . 0.0 112.401 -171.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -59.29 -21.84 60.29 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.895 1.278 . . . . 0.0 112.712 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -71.44 -13.06 61.71 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.513 1.125 . . . . 0.0 111.916 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -134.67 -32.98 0.97 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.219 0.918 . . . . 0.0 112.983 -176.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 53.7 mt -68.55 143.58 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 172.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -67.17 -41.66 92.05 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 123.96 0.791 . . . . 0.0 112.236 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -150.63 143.15 24.42 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 118.582 1.191 . . . . 0.0 108.999 173.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.0 t -127.66 129.44 70.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 177.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.6 mt -129.93 148.86 33.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 -169.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.443 ' HB3' HD11 ' A' ' 81' ' ' ILE . 77.3 t80 -132.86 142.38 48.91 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 171.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.4 tt -122.44 127.8 50.09 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.434 1.494 . . . . 0.0 107.124 174.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -109.16 156.09 15.78 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 77.8 mt -133.93 126.98 51.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -61.28 114.95 12.19 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-O 117.346 -1.311 . . . . 0.0 110.34 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -76.52 171.4 18.13 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.184 2.589 . . . . 0.0 111.174 170.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -129.59 -31.81 1.98 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.915 1.686 . . . . 0.0 111.041 171.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -135.84 135.85 50.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 124.282 1.033 . . . . 0.0 108.215 176.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.6 t -141.58 135.4 30.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 158.4 151.16 5.99 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 178.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -65.99 153.33 42.45 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.844 0.831 . . . . 0.0 111.344 -175.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 54.62 38.79 30.55 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.92 2.088 . . . . 0.0 112.141 -176.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -123.4 148.32 55.06 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 123.961 0.904 . . . . 0.0 109.996 172.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -81.74 163.83 18.48 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.19 2.594 . . . . 0.0 111.161 176.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 52.2 ttm -72.24 138.94 47.84 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 168.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 68.8 p -79.07 159.27 27.61 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.153 0.981 . . . . 0.0 110.529 178.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -52.9 -44.1 95.63 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-O 116.569 -1.681 . . . . 0.0 114.277 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -68.67 -31.26 26.49 Favored 'Trans proline' 0 C--N 1.351 0.667 0 CA-C-N 122.892 2.069 . . . . 0.0 112.215 -176.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.09 -35.28 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -56.3 -46.02 80.0 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.196 0.907 . . . . 0.0 110.172 170.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -64.15 -37.92 89.2 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 122.987 0.515 . . . . 0.0 111.41 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.58 -47.33 79.08 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 121.944 -0.473 . . . . 0.0 110.986 175.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 72.4 t -62.71 -39.37 84.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 118.552 0.615 . . . . 0.0 109.789 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -60.31 -43.26 96.51 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.022 0.828 . . . . 0.0 110.265 173.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 55.2 m -61.52 -47.5 85.33 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.959 -0.463 . . . . 0.0 109.971 178.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 87.8 t -61.44 -45.65 98.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 118.552 0.615 . . . . 0.0 109.648 178.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -54.4 -48.84 71.11 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.802 0.841 . . . . 0.0 110.71 177.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 48.2 mm-40 -65.58 -37.34 86.37 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.642 0.656 . . . . 0.0 111.41 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.1 -35.54 71.6 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.545 0.738 . . . . 0.0 111.843 -178.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 77.6 mt -59.07 -16.88 21.27 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -172.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 . . . . . 0 CA--C 1.54 0.576 0 CA-C-N 120.042 1.292 . . . . 0.0 112.54 177.164 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 . . . . . 0 N--CA 1.45 -0.455 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -76.7 148.08 37.02 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 174.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -91.3 120.54 32.27 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 176.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 44.9 tp . . . . . 0 C--O 1.233 0.219 0 C-N-CA 125.819 1.647 . . . . 0.0 109.883 177.334 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 . . . . . 0 C--O 1.234 0.259 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.6 t -138.02 148.19 25.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -175.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 31.7 tp -122.71 119.55 31.01 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.3 tp -109.02 97.68 7.27 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 125.405 1.482 . . . . 0.0 107.487 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 87.7 m -73.53 143.17 46.63 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 169.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.8 t -140.21 142.11 32.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 142.37 178.92 18.83 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 124.214 0.912 . . . . 0.0 111.861 177.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -127.95 123.59 35.23 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.768 1.227 . . . . 0.0 108.619 177.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 m -58.74 -16.05 14.93 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.631 1.972 . . . . 0.0 115.461 -169.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.0 ptp -128.7 15.98 6.42 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 119.197 0.908 . . . . 0.0 111.259 -178.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 11.3 tpt -92.19 25.48 2.89 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.621 0.768 . . . . 0.0 109.397 176.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.75 -142.64 20.21 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -176.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -61.0 -16.82 47.68 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.695 1.198 . . . . 0.0 112.221 178.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -55.58 -20.56 13.87 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.483 1.513 . . . . 0.0 112.906 173.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.14 17.91 0.94 Allowed Glycine 0 CA--C 1.534 1.257 0 O-C-N 120.789 -1.194 . . . . 0.0 114.437 177.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.19 -51.29 69.63 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 119.566 1.683 . . . . 0.0 110.838 -170.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.77 -55.96 27.52 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-O 117.794 -1.559 . . . . 0.0 111.136 175.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -49.77 -40.78 47.66 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 CA-C-N 120.784 2.292 . . . . 0.0 115.113 178.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 62.6 tp -70.61 -39.89 73.51 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 119.862 1.21 . . . . 0.0 109.986 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.2 tp -61.47 -46.37 90.33 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.443 0.297 . . . . 0.0 110.388 176.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.69 -42.6 88.93 Favored 'General case' 0 C--O 1.227 -0.127 0 C-N-CA 123.838 0.855 . . . . 0.0 110.883 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -60.93 -48.98 79.3 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 118.616 0.643 . . . . 0.0 109.871 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -63.62 -48.69 76.28 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 123.016 0.526 . . . . 0.0 110.907 -178.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 93.0 m -65.39 -34.56 78.6 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.732 0.696 . . . . 0.0 111.478 178.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.99 -40.64 95.26 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.689 1.132 . . . . 0.0 110.848 174.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.14 -33.05 72.83 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.434 0.693 . . . . 0.0 111.8 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.57 89.54 4.42 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.394 1.478 . . . . 0.0 108.548 -174.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -52.6 155.8 9.7 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.955 3.103 . . . . 0.0 113.606 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -133.37 156.65 47.27 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.635 1.174 . . . . 0.0 109.479 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 40.84 -111.95 0.3 Allowed Glycine 0 CA--C 1.527 0.844 0 C-N-CA 125.85 1.691 . . . . 0.0 112.612 172.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -138.04 9.91 2.8 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.145 1.378 . . . . 0.0 111.295 -173.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 1.5 m95 -85.07 123.07 30.18 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 121.286 -0.884 . . . . 0.0 110.753 -168.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.7 t -70.68 119.88 17.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 166.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.6 t -74.04 132.6 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.1 mm -133.98 148.0 30.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 172.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -135.61 111.66 9.6 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.23 -1.99 88.05 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-O 118.991 -0.894 . . . . 0.0 112.727 179.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 56.16 -147.52 30.63 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -169.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 p -90.08 10.95 22.31 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.841 0.856 . . . . 0.0 111.94 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.83 55.17 7.43 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.267 1.427 . . . . 0.0 109.77 -177.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -66.36 -20.35 55.06 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.825 2.35 . . . . 0.0 113.479 -169.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.3 pm0 -61.6 -30.39 70.65 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 119.05 0.841 . . . . 0.0 111.911 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.02 -25.85 67.89 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.373 0.669 . . . . 0.0 112.084 175.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -102.84 -2.51 27.79 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.106 0.962 . . . . 0.0 113.06 -168.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.9 mt -48.52 -40.4 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.518 1.127 . . . . 0.0 110.288 174.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.1 t -56.19 -40.26 64.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.926 0.89 . . . . 0.0 110.582 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.32 -42.26 83.94 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 118.318 0.508 . . . . 0.0 110.398 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 35.3 mt -64.97 -37.48 80.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.38 -21.05 66.05 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 117.855 -1.069 . . . . 0.0 112.397 175.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -70.91 -39.74 72.57 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 120.613 1.552 . . . . 0.0 109.745 170.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 59.5 mt -70.48 -26.55 63.67 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.499 0.72 . . . . 0.0 112.187 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 40.89 65.71 4.08 Favored Pre-proline 0 N--CA 1.472 0.668 0 C-N-CA 125.698 1.599 . . . . 0.0 110.932 -171.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -52.14 137.4 54.39 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 123.253 2.635 . . . . 0.0 112.79 -169.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.0 m -69.53 -38.67 77.61 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 167.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -144.45 157.7 44.11 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 124.889 1.276 . . . . 0.0 107.885 171.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 53.5 tp -136.74 136.16 38.72 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 32.5 tp -123.67 134.92 53.66 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 175.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.0 mt -123.29 141.82 42.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 -173.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 44.6 t -140.87 134.36 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 118.773 0.715 . . . . 0.0 110.642 -174.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -162.82 171.22 17.04 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.783 2.433 . . . . 0.0 107.481 172.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.75 157.69 37.59 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 120.989 -1.069 . . . . 0.0 108.54 167.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.0 m -156.2 127.79 7.23 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 175.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -70.74 124.21 23.74 Favored 'General case' 0 C--O 1.23 0.058 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 172.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 73.6 mtm -122.39 2.2 9.66 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.142 1.777 . . . . 0.0 110.562 -177.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.11 24.64 68.9 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-N 118.66 0.664 . . . . 0.0 112.195 -172.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.6 mt -98.04 -172.71 2.42 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.398 1.479 . . . . 0.0 109.24 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -79.6 140.4 55.37 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-O 117.746 -1.121 . . . . 0.0 108.931 173.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -45.64 134.0 13.26 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.343 2.695 . . . . 0.0 113.705 178.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.49 2.08 89.27 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-O 118.254 -1.303 . . . . 0.0 113.345 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -66.29 150.24 49.15 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 120.156 1.978 . . . . 0.0 107.728 167.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 34.4 mt -131.52 135.14 59.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -169.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.4 mmt-85 -146.6 153.3 40.17 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.504 0.593 . . . . 0.0 109.984 176.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 29.4 mm -83.0 143.36 12.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 167.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.6 mt -126.11 124.17 65.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -71.39 141.09 85.33 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.419 173.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -46.99 -32.5 13.01 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 124.133 3.222 . . . . 0.0 116.594 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -67.19 -25.54 66.18 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.803 0.728 . . . . 0.0 111.799 177.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -101.42 -26.21 13.67 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.915 1.286 . . . . 0.0 111.447 -177.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.429 HD11 ' HB3' ' A' ' 110' ' ' PHE . 51.6 mt -50.19 -41.36 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.478 1.111 . . . . 0.0 109.109 168.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.39 -22.1 18.44 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.425 1.49 . . . . 0.0 114.075 -177.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -115.2 -33.75 5.24 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 118.68 0.673 . . . . 0.0 110.387 177.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 23.3 mmt -72.28 -28.51 63.15 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -177.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.404 ' CD1' HG23 ' A' ' 81' ' ' ILE . 2.1 m-85 -66.39 -46.29 77.12 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 119.241 0.928 . . . . 0.0 110.92 176.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 CA--C 1.541 0.629 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 -178.818 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.468 0.447 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -55.46 -17.31 4.93 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 120.997 -1.065 . . . . 0.0 112.179 166.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -59.29 -32.15 69.77 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 120.155 1.343 . . . . 0.0 111.924 173.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.3 tt -67.59 -48.92 65.46 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 174.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 74.5 mt -61.27 -45.31 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -174.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.56 -21.08 66.56 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.014 -1.054 . . . . 0.0 113.38 -174.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -91.84 5.64 49.18 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.149 0.98 . . . . 0.0 111.852 177.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 40.5 tp -140.89 -32.88 0.55 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.593 0.757 . . . . 0.0 112.311 -169.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.0 pttm -61.68 -25.28 67.31 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 125.63 1.572 . . . . 0.0 112.62 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -62.6 -18.04 61.41 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.315 1.046 . . . . 0.0 112.275 -175.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -114.12 6.21 16.27 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.231 1.012 . . . . 0.0 112.155 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 79.9 mt -120.6 146.42 25.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.848 1.259 . . . . 0.0 108.522 -171.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -75.19 -36.25 46.22 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.774 0.702 . . . . 0.0 112.143 -177.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -152.12 141.05 21.11 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.107 0.954 . . . . 0.0 108.679 175.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.6 t -124.99 135.23 64.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 171.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.0 mp -129.49 149.72 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 -177.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.429 ' HB3' HD11 ' A' ' 81' ' ' ILE . 43.2 t80 -130.75 141.8 50.39 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 169.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.4 tt -120.28 130.54 54.52 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.313 1.445 . . . . 0.0 107.544 173.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -111.41 155.01 16.4 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 176.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 77.1 mt -133.24 127.37 54.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -60.93 114.63 10.98 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-O 117.351 -1.309 . . . . 0.0 110.179 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -76.2 171.5 17.99 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.158 2.572 . . . . 0.0 111.116 170.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -129.42 -31.56 2.04 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.053 1.741 . . . . 0.0 111.012 171.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -135.85 136.03 50.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.237 1.015 . . . . 0.0 108.309 176.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.8 t -141.45 134.84 30.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 175.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 159.47 153.94 7.06 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -69.52 153.46 43.47 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.882 0.849 . . . . 0.0 110.775 -173.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.4 t80 51.8 39.16 25.02 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.846 2.058 . . . . 0.0 112.296 -176.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 23.0 m-30 -121.97 147.63 49.34 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 124.067 0.947 . . . . 0.0 109.961 173.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -81.15 164.09 19.77 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.153 2.568 . . . . 0.0 111.15 177.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.3 ttm -72.59 139.41 47.44 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 168.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 68.6 p -79.08 159.36 27.55 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.191 0.996 . . . . 0.0 110.522 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.2 tp60 -52.87 -44.26 95.88 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-O 116.579 -1.677 . . . . 0.0 114.232 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -68.78 -30.55 27.08 Favored 'Trans proline' 0 C--N 1.35 0.647 0 CA-C-N 122.869 2.06 . . . . 0.0 112.295 -176.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.97 -35.26 15.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 119.072 0.851 . . . . 0.0 108.706 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -56.29 -46.91 79.56 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.136 0.88 . . . . 0.0 109.977 169.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -63.28 -38.27 90.5 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.037 0.535 . . . . 0.0 111.248 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.35 -47.14 80.44 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 121.967 -0.458 . . . . 0.0 111.133 176.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.5 t -61.4 -41.27 89.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 118.581 0.628 . . . . 0.0 109.655 177.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -62.36 -33.86 75.55 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.863 0.865 . . . . 0.0 111.074 175.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 44.3 m -69.52 -46.23 67.02 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.462 -0.774 . . . . 0.0 109.926 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 92.3 t -61.97 -44.35 98.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 119.203 0.911 . . . . 0.0 109.592 178.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -53.37 -43.82 68.09 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.32 1.048 . . . . 0.0 111.172 176.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -68.73 -45.02 72.61 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.527 0.603 . . . . 0.0 111.119 175.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -58.7 -36.66 74.58 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.133 0.573 . . . . 0.0 111.221 -174.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 56.9 mt -56.27 -19.06 12.47 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -175.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 . . . . . 0 CA--C 1.538 0.481 0 CA-C-N 120.09 1.314 . . . . 0.0 112.211 176.31 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 . . . . . 0 N--CA 1.447 -0.595 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.87 148.47 42.29 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.196 176.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -92.15 119.85 32.19 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 60.4 tp . . . . . 0 CA--C 1.53 0.199 0 C-N-CA 126.024 1.729 . . . . 0.0 110.104 178.749 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.1 t0 . . . . . 0 C--O 1.234 0.265 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.8 m -86.41 150.72 3.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 123.758 0.823 . . . . 0.0 110.04 -172.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 52.6 tp -115.32 124.51 51.47 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 171.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 67.2 tp -112.95 97.41 6.51 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 92.2 m -72.97 141.97 47.78 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 169.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.4 t -141.23 142.03 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 125.216 1.407 . . . . 0.0 107.734 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 148.91 178.04 23.61 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 123.971 0.796 . . . . 0.0 112.272 175.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -124.93 117.17 23.46 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 125.387 1.475 . . . . 0.0 107.908 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 m -56.13 -21.63 23.63 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 126.5 1.92 . . . . 0.0 115.339 -170.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 25.7 ptp -123.91 20.48 9.2 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.665 0.666 . . . . 0.0 110.794 -174.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.9 ttt -102.34 29.23 5.31 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.38 1.072 . . . . 0.0 110.29 179.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.33 -142.07 21.83 Favored Glycine 0 N--CA 1.441 -1.021 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -63.17 -15.44 56.89 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.37 1.068 . . . . 0.0 112.223 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -56.17 -21.49 23.24 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.15 1.38 . . . . 0.0 112.987 175.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.33 21.29 0.69 Allowed Glycine 0 CA--C 1.534 1.246 0 CA-C-O 118.491 -1.172 . . . . 0.0 114.475 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.1 -51.88 67.27 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 119.545 1.673 . . . . 0.0 110.758 -169.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.28 -55.32 30.81 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 117.502 -1.721 . . . . 0.0 111.423 177.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -50.47 -40.14 54.23 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 CA-C-N 120.921 2.36 . . . . 0.0 115.076 178.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.6 tp -71.07 -39.48 72.18 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 119.878 1.217 . . . . 0.0 110.039 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 51.1 tp -61.53 -48.85 79.13 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 176.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.26 -41.7 80.14 Favored 'General case' 0 C--O 1.227 -0.107 0 C-N-CA 124.054 0.942 . . . . 0.0 111.283 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -60.77 -49.1 78.86 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.661 0.664 . . . . 0.0 109.897 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -62.66 -47.74 82.37 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 122.983 0.513 . . . . 0.0 110.702 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 73.8 m -64.74 -37.95 89.33 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.574 0.624 . . . . 0.0 111.458 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.81 -40.91 97.77 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.991 0.814 . . . . 0.0 110.806 176.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.67 -32.53 72.42 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.483 0.713 . . . . 0.0 111.837 178.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.86 92.6 2.85 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 125.268 1.427 . . . . 0.0 108.461 -172.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -53.8 158.85 7.8 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.34 2.693 . . . . 0.0 113.567 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.424 ' HE2' ' CE1' ' A' ' 136' ' ' TYR . 74.7 mmtt -129.36 166.39 19.61 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.481 1.512 . . . . 0.0 108.474 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 41.17 -124.37 2.88 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.478 1.513 . . . . 0.0 112.139 175.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -138.47 35.98 2.26 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.185 1.394 . . . . 0.0 109.028 170.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -70.49 167.02 19.25 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.146 0.978 . . . . 0.0 111.441 -175.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 68.7 t -122.29 101.95 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 168.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.9 t -72.43 136.91 24.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -175.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 90.9 mt -135.33 142.31 40.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 172.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -127.01 105.29 8.5 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.55 -6.36 80.76 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 118.973 -0.904 . . . . 0.0 112.69 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 54.22 -140.7 35.42 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 -169.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.4 p -93.2 7.89 42.43 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.624 0.77 . . . . 0.0 112.469 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.72 64.22 42.52 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 124.875 1.27 . . . . 0.0 109.528 177.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -65.17 -15.63 51.15 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.668 2.245 . . . . 0.0 112.183 -177.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -46.92 -42.37 17.55 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.703 1.601 . . . . 0.0 111.161 168.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.96 -27.29 68.73 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.93 -5.43 41.4 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.854 1.261 . . . . 0.0 111.33 -169.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.8 mt -52.86 -44.9 49.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 118.919 0.781 . . . . 0.0 109.18 171.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.7 t -60.99 -42.29 92.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.22 -44.69 87.48 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 123.192 0.597 . . . . 0.0 110.854 -177.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 72.9 mt -55.39 -48.15 77.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.091 0.956 . . . . 0.0 108.504 173.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 49.7 mtp180 -67.83 -19.17 65.03 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 117.598 -1.192 . . . . 0.0 113.135 -176.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -58.97 -27.39 65.33 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 121.023 1.738 . . . . 0.0 110.977 171.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 58.6 mt -95.93 -9.52 31.05 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.582 1.153 . . . . 0.0 112.33 -172.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 48.7 mmm-85 32.85 58.48 1.47 Allowed Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 126.423 1.889 . . . . 0.0 111.764 -169.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -56.09 152.49 37.14 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.073 2.515 . . . . 0.0 114.867 -168.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.1 m -71.97 -39.06 69.6 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.089 0.955 . . . . 0.0 109.244 168.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -148.67 160.12 43.46 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.633 0.773 . . . . 0.0 111.126 -177.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 24.1 tp -141.91 139.52 32.57 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 125.304 1.442 . . . . 0.0 109.074 177.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 54.4 tp -124.17 135.98 53.86 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 168.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.9 mt -119.49 144.97 26.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -178.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 46.3 t -139.92 133.68 36.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 123.148 0.579 . . . . 0.0 109.649 -175.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -162.65 171.68 16.52 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 127.335 2.254 . . . . 0.0 107.245 173.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.07 155.31 40.58 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 167.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.1 m -153.86 135.56 14.44 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 177.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -81.09 84.45 6.51 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.945 0.793 . . . . 0.0 109.873 176.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -69.48 -8.88 50.79 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.698 0.799 . . . . 0.0 112.121 173.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.36 24.89 76.39 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 119.434 1.016 . . . . 0.0 111.634 -171.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 98.0 mt -100.01 -173.26 2.39 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.232 1.413 . . . . 0.0 110.477 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -69.66 139.76 89.01 Favored Pre-proline 0 N--CA 1.467 0.407 0 CA-C-O 117.606 -1.188 . . . . 0.0 108.72 169.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -43.04 138.92 3.88 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.544 2.829 . . . . 0.0 113.57 172.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.17 0.27 76.42 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 118.6 -1.111 . . . . 0.0 113.679 176.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -65.72 154.78 38.0 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 119.794 1.797 . . . . 0.0 108.815 168.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 77.4 mt -134.7 132.87 54.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 125.825 1.65 . . . . 0.0 106.699 -170.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.2 mmt-85 -143.39 148.11 35.69 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.291 0.95 . . . . 0.0 109.733 177.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 47.1 mm -77.92 144.68 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 169.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -135.5 165.63 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 124.777 1.231 . . . . 0.0 108.205 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -139.42 146.16 47.21 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 127.086 2.155 . . . . 0.0 107.619 -169.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -54.12 -27.97 48.88 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.399 2.733 . . . . 0.0 115.088 -174.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -67.29 -20.02 65.57 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.862 0.755 . . . . 0.0 112.123 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -119.85 -31.2 4.56 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.91 1.284 . . . . 0.0 111.84 -171.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 67.2 mt -50.74 -39.98 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.373 1.469 . . . . 0.0 109.938 169.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.45 -28.28 53.36 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.359 1.064 . . . . 0.0 113.129 -177.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -102.24 -43.83 5.6 Favored 'General case' 0 C--O 1.23 0.078 0 C-N-CA 123.202 0.601 . . . . 0.0 109.53 176.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 21.2 mmt -69.06 -28.76 66.83 Favored 'General case' 0 C--O 1.23 0.057 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -169.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -68.06 -48.36 65.82 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 119.038 0.835 . . . . 0.0 110.724 175.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 28.8 ptm . . . . . 0 CA--C 1.535 0.385 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 179.631 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.3 mt . . . . . 0 N--CA 1.471 0.579 0 N-CA-C 117.087 2.255 . . . . 0.0 117.087 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -52.78 -23.24 6.46 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.318 -0.864 . . . . 0.0 112.278 167.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -58.83 -34.4 71.49 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.396 0.998 . . . . 0.0 111.593 175.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.3 tt -75.83 -44.29 41.73 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 86.7 mt -60.96 -42.0 91.18 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.175 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -60.84 -26.01 67.04 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.853 0.751 . . . . 0.0 112.606 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -85.06 -3.57 58.84 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.753 0.821 . . . . 0.0 112.211 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 80.3 mt -130.01 -26.59 2.37 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.22 1.008 . . . . 0.0 111.946 -173.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -63.44 -23.11 67.26 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.221 -0.924 . . . . 0.0 112.286 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -80.09 -6.06 57.0 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.148 0.979 . . . . 0.0 111.789 175.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -132.51 -3.06 3.38 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.689 1.195 . . . . 0.0 113.038 -168.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.3 mt -134.85 143.41 37.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 126.549 1.94 . . . . 0.0 106.163 -175.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -70.37 -37.15 70.2 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-O 119.464 -0.631 . . . . 0.0 112.539 -172.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -146.53 130.88 17.59 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 -177.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 48.6 t -132.12 124.31 52.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 21.3 mt -130.19 156.68 42.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 -169.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -130.82 147.47 52.48 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 174.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.8 tt -126.37 126.5 43.99 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 170.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -107.69 156.16 15.98 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 82.5 mt -131.82 126.32 56.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 71.1 tp60 -64.64 116.03 25.44 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-O 117.201 -1.381 . . . . 0.0 110.438 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -76.51 170.59 19.64 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.268 2.645 . . . . 0.0 111.377 170.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -128.08 -31.9 2.32 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.978 1.711 . . . . 0.0 110.984 171.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.1 pp -137.14 139.77 43.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 124.369 1.068 . . . . 0.0 108.531 178.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 92.8 t -143.22 138.55 26.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 175.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 163.01 140.06 2.78 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 175.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -74.1 42.71 0.15 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.806 2.042 . . . . 0.0 113.759 -169.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -161.39 26.1 0.13 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.608 1.563 . . . . 0.0 110.731 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -135.04 153.24 78.33 Favored Pre-proline 0 CA--C 1.536 0.421 0 O-C-N 121.517 -0.74 . . . . 0.0 112.15 -174.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -83.75 166.1 13.52 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.601 2.867 . . . . 0.0 110.854 172.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.4 ttm -69.83 140.87 53.32 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 168.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 71.7 p -81.32 160.45 24.17 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.509 1.124 . . . . 0.0 110.682 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 6.9 tm0? -50.91 -48.81 83.32 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-O 117.004 -1.474 . . . . 0.0 113.351 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -67.53 -29.3 37.26 Favored 'Trans proline' 0 C--N 1.352 0.753 0 CA-C-N 122.575 1.955 . . . . 0.0 112.573 -175.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -81.63 -34.76 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 119.134 0.879 . . . . 0.0 108.865 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -56.65 -46.61 80.95 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 119.183 0.901 . . . . 0.0 109.782 169.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -62.36 -38.74 90.7 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 123.092 0.557 . . . . 0.0 111.525 177.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.41 -46.93 81.13 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 122.036 -0.415 . . . . 0.0 111.094 176.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 62.7 t -62.38 -40.32 87.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 118.81 0.732 . . . . 0.0 109.782 178.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -61.48 -40.06 93.17 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.625 0.648 . . . . 0.0 110.52 174.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 49.5 m -63.94 -46.92 82.6 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.785 -0.626 . . . . 0.0 109.962 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 85.4 t -58.83 -47.6 88.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 119.209 0.913 . . . . 0.0 109.133 177.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.424 ' CE1' ' HE2' ' A' ' 31' ' ' LYS . 24.4 t80 -53.83 -46.87 71.31 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.939 0.896 . . . . 0.0 111.2 177.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -72.36 -4.96 33.05 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 178.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.38 -11.4 10.57 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.17 1.388 . . . . 0.0 109.452 -175.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 59.5 mt -59.72 -25.45 64.83 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 119.348 -2.095 . . . . 0.0 111.449 170.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 . . . . . 0 CA--C 1.544 0.716 0 C-N-CA 124.668 1.187 . . . . 0.0 113.555 177.413 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 . . . . . 0 C--O 1.232 0.168 0 CA-C-O 121.815 0.816 . . . . 0.0 110.049 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.36 144.65 44.33 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -87.88 119.81 28.59 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 48.4 tp . . . . . 0 C--O 1.233 0.236 0 C-N-CA 125.322 1.449 . . . . 0.0 110.255 -179.579 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.8 t0 . . . . . 0 C--O 1.234 0.242 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 49.1 t -88.42 143.56 10.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-O 121.518 0.675 . . . . 0.0 109.357 -170.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.2 tp -113.22 108.67 17.59 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 169.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.1 tp -98.09 103.14 15.06 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 99.8 m -77.58 141.67 39.4 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 169.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 54.3 t -140.84 141.67 31.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 152.73 176.48 25.34 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-N 118.44 0.563 . . . . 0.0 112.9 174.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -120.15 115.65 24.08 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.73 1.612 . . . . 0.0 108.494 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -66.5 -10.39 44.18 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 -170.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 21.9 ptp -117.34 2.0 12.46 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.912 1.233 . . . . 0.0 111.267 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.3 ttt -95.75 39.85 1.13 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 122.087 0.946 . . . . 0.0 109.227 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 57.66 -121.83 27.13 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 124.327 0.965 . . . . 0.0 110.759 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -61.43 -19.67 62.22 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.096 0.959 . . . . 0.0 112.502 -174.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -65.61 -13.02 58.23 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.614 0.765 . . . . 0.0 112.274 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.19 17.4 1.4 Allowed Glycine 0 CA--C 1.531 1.039 0 O-C-N 120.743 -1.223 . . . . 0.0 113.097 176.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.26 -52.22 65.67 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.604 1.702 . . . . 0.0 110.821 -169.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.59 -55.6 29.02 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-O 117.745 -1.586 . . . . 0.0 111.024 175.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -49.73 -40.98 47.27 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 CA-C-N 120.878 2.339 . . . . 0.0 115.217 177.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.7 tp -71.98 -36.66 69.85 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 119.876 1.216 . . . . 0.0 110.408 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 49.4 tp -61.74 -49.94 74.41 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.332 0.515 . . . . 0.0 109.936 174.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.73 -39.49 77.43 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.923 0.889 . . . . 0.0 111.102 177.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.9 tp10 -62.05 -49.48 75.82 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 118.778 0.717 . . . . 0.0 109.87 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -62.24 -44.49 96.43 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.816 0.446 . . . . 0.0 110.614 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 84.9 m -63.64 -42.34 98.15 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.298 0.499 . . . . 0.0 110.997 178.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.18 -39.53 94.91 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.309 0.504 . . . . 0.0 111.046 178.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.37 -36.36 76.75 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.258 0.623 . . . . 0.0 111.486 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.01 91.61 2.43 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 124.8 1.24 . . . . 0.0 108.877 -171.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -55.65 163.26 5.51 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.633 2.889 . . . . 0.0 113.811 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -133.71 174.42 10.46 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 126.033 1.733 . . . . 0.0 108.87 176.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 40.1 -125.4 2.46 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.228 1.394 . . . . 0.0 112.336 177.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -141.25 38.4 1.73 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.319 1.447 . . . . 0.0 109.169 172.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -74.93 168.38 20.05 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.341 1.057 . . . . 0.0 111.904 -172.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 67.9 t -120.38 105.6 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 167.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.0 t -70.44 137.77 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -178.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.0 mm -134.59 148.21 29.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 169.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -130.66 109.81 10.92 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 175.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.22 -1.91 88.12 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 118.868 -0.962 . . . . 0.0 112.833 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 60.93 -146.5 47.54 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -170.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.8 p -94.44 -1.78 53.02 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.15 0.98 . . . . 0.0 112.917 -172.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.66 70.0 31.07 Favored Pre-proline 0 C--O 1.235 0.303 0 C-N-CA 125.138 1.375 . . . . 0.0 107.993 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -66.1 -12.42 35.37 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.777 2.318 . . . . 0.0 112.77 -169.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.8 tp10 -44.57 -41.15 6.3 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.592 1.557 . . . . 0.0 110.938 168.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -62.86 -23.71 67.45 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -177.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -113.86 -2.22 13.68 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -168.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 79.6 mt -50.59 -37.7 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.154 0.981 . . . . 0.0 110.311 172.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 53.1 t -55.92 -40.28 61.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 123.852 0.861 . . . . 0.0 110.395 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.81 -43.29 84.19 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.431 0.56 . . . . 0.0 110.406 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.3 mt -62.36 -39.5 84.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -65.91 -18.99 65.71 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 117.724 -1.131 . . . . 0.0 112.513 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -69.19 -42.95 75.14 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 120.702 1.592 . . . . 0.0 109.241 169.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.4 mt -72.6 -25.75 61.44 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.648 0.779 . . . . 0.0 112.447 -175.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 38.22 60.32 4.83 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.703 1.601 . . . . 0.0 111.929 -169.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.37 151.02 38.73 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.862 2.374 . . . . 0.0 113.501 -170.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.6 m -71.66 -37.28 70.81 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 168.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -147.4 155.86 42.34 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.201 1.0 . . . . 0.0 109.31 -176.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 37.1 tp -144.51 136.22 25.79 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.63 1.172 . . . . 0.0 108.633 -177.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 56.9 tp -122.14 137.85 54.67 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 169.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.2 mt -122.21 143.19 35.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 -177.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.9 t -140.97 134.07 31.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 118.294 0.497 . . . . 0.0 110.013 -174.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -161.92 173.15 14.9 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 127.11 2.164 . . . . 0.0 107.456 169.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.69 156.58 39.29 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.055 -1.028 . . . . 0.0 109.906 169.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.8 m -152.92 129.49 10.74 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -178.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -79.85 83.63 5.75 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 119.031 0.832 . . . . 0.0 109.561 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 74.9 mtm -77.26 -7.28 55.7 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.583 1.553 . . . . 0.0 112.018 -177.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.33 26.67 72.98 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 123.816 0.722 . . . . 0.0 111.672 -172.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.4 mt -104.88 -171.24 1.88 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.936 1.294 . . . . 0.0 110.004 -177.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -73.66 140.2 78.17 Favored Pre-proline 0 N--CA 1.468 0.467 0 CA-C-O 117.47 -1.252 . . . . 0.0 108.676 171.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -42.96 137.59 4.37 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.303 2.668 . . . . 0.0 113.378 172.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.66 2.74 76.87 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 118.692 -1.06 . . . . 0.0 113.7 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -66.11 148.1 52.34 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.743 1.771 . . . . 0.0 108.348 168.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.13 136.32 59.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -173.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 89.4 mmt-85 -145.9 151.16 37.41 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 118.8 0.727 . . . . 0.0 110.703 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 49.0 mm -75.9 144.09 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 167.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.409 HG22 ' H ' ' A' ' 77' ' ' ASP . 1.4 mt -133.64 165.79 30.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 124.55 1.14 . . . . 0.0 107.989 177.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.409 ' H ' HG22 ' A' ' 76' ' ' ILE . 5.9 t70 -135.63 145.89 55.12 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 127.116 2.166 . . . . 0.0 107.681 -170.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -54.46 -26.6 45.54 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.395 2.73 . . . . 0.0 115.147 -174.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -66.51 -21.37 66.17 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.012 0.824 . . . . 0.0 112.273 177.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -120.39 -28.52 4.99 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.708 1.203 . . . . 0.0 112.14 -171.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 72.0 mt -51.23 -39.78 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.845 1.258 . . . . 0.0 109.743 169.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.9 -28.6 51.91 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.53 1.132 . . . . 0.0 113.261 -177.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -100.9 -44.27 5.81 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 123.068 0.547 . . . . 0.0 109.657 175.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 21.3 mmt -67.26 -26.77 66.73 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -171.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.435 ' CE2' HD12 ' A' ' 94' ' ' LEU . 4.7 m-85 -76.85 -43.33 36.64 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.741 0.701 . . . . 0.0 111.502 174.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 22.0 ptt? . . . . . 0 CA--C 1.533 0.307 0 CA-C-N 119.102 0.864 . . . . 0.0 112.044 178.938 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.435 HD12 ' CE2' ' A' ' 85' ' ' PHE . 18.8 mt . . . . . 0 N--CA 1.468 0.452 0 N-CA-C 116.903 2.186 . . . . 0.0 116.903 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -52.42 -24.94 8.71 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.406 1.003 . . . . 0.0 112.578 168.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -59.18 -33.05 70.48 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 119.32 0.964 . . . . 0.0 111.803 176.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.6 tt -75.61 -41.77 53.49 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 -177.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 92.2 mt -61.4 -48.59 88.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -61.7 -29.44 70.1 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.392 0.542 . . . . 0.0 112.395 -177.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -82.28 -2.69 53.41 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.002 0.921 . . . . 0.0 113.246 178.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 64.4 mt -133.08 -25.71 1.77 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.676 1.125 . . . . 0.0 112.549 -174.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -59.02 -21.62 59.34 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.353 1.061 . . . . 0.0 112.862 177.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -72.8 -11.19 60.51 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.415 1.086 . . . . 0.0 112.051 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -133.09 -42.54 0.88 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.349 1.06 . . . . 0.0 111.733 -173.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 28.2 mt -73.65 140.42 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 175.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.05 -40.89 95.34 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.185 0.897 . . . . 0.0 112.141 -177.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -148.49 137.14 21.47 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 118.633 1.216 . . . . 0.0 108.429 177.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.8 t -131.9 123.06 50.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -178.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 18.2 mt -129.54 155.39 41.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 -171.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -127.99 147.13 50.49 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 175.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.6 tt -129.1 130.36 46.39 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 172.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -115.19 156.96 15.31 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 77.6 mt -133.49 127.53 53.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 125.215 1.406 . . . . 0.0 107.269 -176.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 69.1 tp60 -67.25 117.6 48.05 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-O 117.607 -1.187 . . . . 0.0 111.129 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.35 175.04 11.78 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 124.27 3.313 . . . . 0.0 111.887 170.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -134.12 -29.16 1.29 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.257 1.423 . . . . 0.0 112.78 175.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.2 pp -132.29 4.22 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 119.362 0.983 . . . . 0.0 113.408 -171.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 8.5 p -38.43 118.49 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 125.929 1.692 . . . . 0.0 113.713 -167.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 170.31 158.37 14.09 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -175.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -67.17 152.56 45.53 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.996 0.919 . . . . 0.0 111.647 -173.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 56.32 41.76 28.67 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.883 2.073 . . . . 0.0 112.046 177.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -127.33 152.59 76.46 Favored Pre-proline 0 C--O 1.236 0.356 0 C-N-CA 124.287 1.035 . . . . 0.0 109.176 172.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -77.76 157.57 31.58 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.031 2.487 . . . . 0.0 109.875 168.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 56.5 ttm -66.25 136.64 56.14 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 169.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 18.1 p -77.75 154.45 31.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.588 0.709 . . . . 0.0 111.318 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -49.33 -47.25 77.17 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-O 116.916 -1.516 . . . . 0.0 113.443 -177.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -66.98 -28.13 42.11 Favored 'Trans proline' 0 C--N 1.351 0.69 0 CA-C-N 122.46 1.914 . . . . 0.0 112.407 -177.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 mp -78.12 -37.81 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 119.29 0.95 . . . . 0.0 108.564 177.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -57.28 -47.42 81.51 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.44 1.018 . . . . 0.0 110.074 172.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.18 -41.81 97.46 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 123.347 0.659 . . . . 0.0 111.053 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.94 -47.82 81.58 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 118.997 -0.525 . . . . 0.0 111.15 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.2 t -59.22 -41.21 83.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 118.886 0.766 . . . . 0.0 109.467 178.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -69.49 -27.83 65.54 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.861 0.755 . . . . 0.0 111.776 177.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 40.1 m -72.2 -42.39 65.86 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 120.982 -1.074 . . . . 0.0 109.944 174.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 88.0 t -61.18 -44.38 98.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 174.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -54.31 -47.04 72.91 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.163 0.985 . . . . 0.0 110.875 175.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -62.73 -40.72 98.09 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 118.869 0.758 . . . . 0.0 111.461 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -60.32 -25.39 65.76 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 118.368 -0.825 . . . . 0.0 112.463 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 93.0 mt -57.18 -22.66 42.07 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.852 1.205 . . . . 0.0 112.421 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 . . . . . 0 CA--C 1.544 0.745 0 C-N-CA 123.731 0.812 . . . . 0.0 112.411 -178.91 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 . . . . . 0 C--O 1.233 0.224 0 CA-C-O 121.799 0.809 . . . . 0.0 110.685 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -90.55 153.4 20.38 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 170.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -91.79 123.12 34.94 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 177.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 58.3 tp . . . . . 0 CA--C 1.53 0.206 0 C-N-CA 124.986 1.314 . . . . 0.0 109.809 178.493 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.3 t70 . . . . . 0 C--O 1.232 0.166 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 88.4 t -135.47 146.2 30.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 121.425 0.631 . . . . 0.0 110.284 -168.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 17.1 tp -115.03 126.94 55.31 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 104.889 -2.263 . . . . 0.0 104.889 168.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.8 tp -116.29 99.36 7.15 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 87.9 m -72.68 142.76 48.25 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 169.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.4 t -143.79 144.75 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 147.17 172.17 17.11 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -121.96 114.37 20.88 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 123.818 0.847 . . . . 0.0 109.138 -176.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -59.87 -11.76 6.17 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.624 1.97 . . . . 0.0 115.197 -170.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 22.5 ptp -127.72 10.13 6.54 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 119.212 0.915 . . . . 0.0 111.303 -178.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.4 ttt -98.04 31.33 2.75 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.072 0.851 . . . . 0.0 109.665 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.22 -140.49 20.67 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -178.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -62.04 -16.92 55.38 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.681 1.192 . . . . 0.0 112.389 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -58.19 -16.55 14.07 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.89 1.276 . . . . 0.0 112.995 176.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.32 21.86 0.84 Allowed Glycine 0 CA--C 1.535 1.324 0 O-C-N 120.288 -1.507 . . . . 0.0 114.451 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.94 -50.55 70.37 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 119.522 1.661 . . . . 0.0 111.363 -169.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.26 -54.43 37.96 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 117.555 -1.692 . . . . 0.0 111.322 177.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -48.37 -41.72 35.3 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 CA-C-N 120.656 2.228 . . . . 0.0 115.1 175.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.3 tp -72.54 -37.59 68.23 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.848 1.204 . . . . 0.0 110.706 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.6 tp -61.74 -45.95 91.74 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.605 0.639 . . . . 0.0 109.998 174.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.89 -38.55 86.05 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.903 0.881 . . . . 0.0 111.09 179.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.4 tp10 -61.86 -49.08 77.69 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 118.7 0.682 . . . . 0.0 109.541 178.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -63.84 -44.85 91.95 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.781 0.432 . . . . 0.0 110.501 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 73.3 m -63.69 -39.47 94.39 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.487 0.585 . . . . 0.0 111.444 177.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.22 -37.51 87.73 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.89 0.768 . . . . 0.0 111.113 177.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.48 -36.65 76.74 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.089 0.556 . . . . 0.0 111.245 178.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.71 98.51 1.53 Allowed Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 125.023 1.329 . . . . 0.0 108.163 -173.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -55.14 169.18 1.02 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 124.316 3.344 . . . . 0.0 114.983 -178.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.54 ' HE2' ' CZ ' ' A' ' 136' ' ' TYR . 14.9 mmtm -140.52 158.9 43.31 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.758 1.623 . . . . 0.0 108.28 -177.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 42.79 -126.33 4.71 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.007 1.289 . . . . 0.0 111.95 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -136.53 12.1 3.21 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.036 1.334 . . . . 0.0 111.164 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -73.64 131.03 41.22 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.942 0.897 . . . . 0.0 108.806 -173.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 97.5 t -69.85 112.86 5.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 166.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.3 t -71.56 133.16 32.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 60.4 mt -132.84 145.13 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 104.258 -2.497 . . . . 0.0 104.258 169.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -128.42 98.48 5.06 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 177.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.43 -14.07 71.54 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-O 119.136 -0.814 . . . . 0.0 112.121 175.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 51.71 -135.66 33.66 Favored Glycine 0 C--N 1.34 0.795 0 CA-C-N 118.208 1.004 . . . . 0.0 110.591 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.6 t -88.4 7.21 33.69 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.109 0.964 . . . . 0.0 111.554 -175.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.47 60.56 5.61 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.666 1.186 . . . . 0.0 110.12 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -69.7 -18.2 37.41 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.723 2.282 . . . . 0.0 112.929 -169.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -56.66 -31.69 64.65 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.44 0.696 . . . . 0.0 112.267 177.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.47 -30.32 69.6 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.296 0.639 . . . . 0.0 111.982 176.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -94.16 -6.4 44.96 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.022 0.929 . . . . 0.0 111.496 -169.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.2 mt -53.19 -43.85 50.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 118.964 0.802 . . . . 0.0 109.2 173.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.0 t -61.14 -42.11 92.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 122.981 0.512 . . . . 0.0 110.012 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.0 -46.87 73.21 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 122.923 0.489 . . . . 0.0 110.689 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.6 mt -55.09 -45.72 77.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.258 1.023 . . . . 0.0 109.179 174.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -60.86 -30.96 70.44 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 117.846 -1.073 . . . . 0.0 112.357 -177.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -59.46 -30.73 68.73 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 120.083 1.31 . . . . 0.0 111.265 176.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 56.5 mt -87.07 -9.06 56.37 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.666 1.186 . . . . 0.0 112.374 -173.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 27.34 61.73 0.6 Allowed Pre-proline 0 N--CA 1.475 0.811 0 C-N-CA 127.084 2.154 . . . . 0.0 112.229 -168.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.22 142.99 66.05 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.75 2.3 . . . . 0.0 114.203 -169.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.2 m -74.39 -30.37 61.92 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 168.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -146.54 151.66 37.7 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.007 0.923 . . . . 0.0 110.023 177.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 46.0 tp -141.24 136.11 31.36 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.674 1.59 . . . . 0.0 107.83 174.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 20.8 tp -126.8 133.42 50.79 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 105.674 -1.972 . . . . 0.0 105.674 172.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.4 mt -119.36 144.7 27.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -172.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.6 t -140.46 134.76 34.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 118.557 0.617 . . . . 0.0 109.875 -174.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -161.4 175.94 11.66 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 127.347 2.259 . . . . 0.0 107.082 172.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.44 160.4 30.28 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 120.805 -1.184 . . . . 0.0 108.494 167.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.0 m -156.29 125.27 6.02 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -70.72 122.3 19.57 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 169.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 77.1 mtm -122.46 1.39 9.56 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.53 1.532 . . . . 0.0 110.896 -175.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.87 26.05 71.01 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 118.568 0.622 . . . . 0.0 112.071 -173.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 74.9 mt -103.68 -171.1 1.88 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.479 1.512 . . . . 0.0 109.026 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -81.29 138.67 48.5 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-O 117.649 -1.167 . . . . 0.0 109.34 176.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -45.32 132.72 12.13 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.417 2.745 . . . . 0.0 113.814 177.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.95 3.22 90.65 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 118.502 -1.166 . . . . 0.0 113.241 179.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -64.58 145.71 55.73 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 119.895 1.847 . . . . 0.0 107.664 167.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 41.7 mt -126.72 138.84 53.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 -173.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 -148.94 148.96 30.41 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 118.236 0.471 . . . . 0.0 111.764 -179.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 41.3 mm -76.11 144.63 11.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 165.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.4 mt -135.38 163.79 34.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 176.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -136.72 145.73 52.32 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 126.36 1.864 . . . . 0.0 107.688 -170.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -52.17 -28.1 32.28 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.448 2.766 . . . . 0.0 115.197 -174.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -66.53 -23.23 66.2 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.817 0.735 . . . . 0.0 112.567 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -117.41 -29.51 5.81 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.659 1.184 . . . . 0.0 111.701 -173.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 53.5 mt -50.14 -41.02 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.322 1.449 . . . . 0.0 110.12 169.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.8 -24.43 57.25 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -173.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -103.34 -44.15 5.23 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 172.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 33.8 mmt -65.04 -34.44 78.43 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -170.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -66.79 -22.12 66.03 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -178.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 CA--C 1.535 0.369 0 C-N-CA 123.773 0.829 . . . . 0.0 111.208 174.701 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.5 mt . . . . . 0 N--CA 1.468 0.467 0 N-CA-C 117.343 2.349 . . . . 0.0 117.343 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.12 -26.43 16.57 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 119.298 0.954 . . . . 0.0 111.614 167.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -60.36 -34.46 73.9 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.827 0.74 . . . . 0.0 111.604 176.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.5 tt -77.22 -43.35 33.93 Favored 'General case' 0 C--N 1.338 0.087 0 C-N-CA 123.334 0.654 . . . . 0.0 109.374 177.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 85.8 mt -59.78 -43.75 92.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -178.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -61.98 -23.94 66.72 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -84.71 0.68 49.59 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.723 0.809 . . . . 0.0 112.314 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 84.5 mt -133.58 -35.7 0.99 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.071 0.948 . . . . 0.0 111.626 -173.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -58.83 -22.77 59.42 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.307 1.043 . . . . 0.0 113.07 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -71.32 -13.37 61.85 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.061 0.944 . . . . 0.0 111.988 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -134.84 -30.35 1.09 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.175 0.898 . . . . 0.0 112.931 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 28.9 mt -69.19 138.92 21.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 174.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -63.95 -42.86 98.15 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 123.763 0.697 . . . . 0.0 112.442 -177.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -146.94 134.14 20.53 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.404 1.102 . . . . 0.0 108.367 177.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.8 t -126.09 133.59 68.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 176.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.9 mp -132.01 154.66 40.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 -176.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -128.69 146.52 50.86 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 170.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.0 tt -126.94 132.73 50.78 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 170.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -118.58 159.28 14.43 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 124.571 1.081 . . . . 0.0 110.853 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 82.1 mt -133.85 126.14 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 -177.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -62.48 115.42 16.42 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-O 117.463 -1.256 . . . . 0.0 110.199 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -75.45 171.13 18.83 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 123.394 2.73 . . . . 0.0 111.196 169.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -125.21 -30.91 3.12 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 125.867 1.667 . . . . 0.0 110.734 170.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -136.01 134.32 50.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 176.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.3 t -140.27 135.49 36.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 174.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 158.08 150.8 5.86 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -66.9 154.42 41.05 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.952 0.882 . . . . 0.0 111.522 -175.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 54.81 38.65 30.6 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.048 2.139 . . . . 0.0 112.273 -176.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -124.79 149.09 61.53 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 123.899 0.88 . . . . 0.0 110.281 172.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -83.13 165.16 14.98 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.437 2.758 . . . . 0.0 111.461 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.4 ttm -72.73 139.92 47.47 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 168.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 82.4 p -80.64 159.82 25.24 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.816 1.246 . . . . 0.0 110.549 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.3 tp60 -53.78 -44.79 98.61 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-O 116.675 -1.631 . . . . 0.0 114.298 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -68.29 -30.47 30.49 Favored 'Trans proline' 0 C--N 1.351 0.71 0 CA-C-N 122.86 2.057 . . . . 0.0 112.034 -176.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.6 mp -78.94 -35.79 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -56.82 -46.36 81.71 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.549 1.068 . . . . 0.0 110.044 171.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -63.21 -41.67 99.18 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 122.965 0.506 . . . . 0.0 111.07 178.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.98 -47.97 82.44 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 118.958 -0.544 . . . . 0.0 110.974 176.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 76.5 t -60.76 -40.01 83.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 118.98 0.809 . . . . 0.0 109.705 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -69.93 -30.62 68.06 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.583 1.083 . . . . 0.0 111.551 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 28.1 m -68.68 -46.87 67.94 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.36 -0.837 . . . . 0.0 109.443 173.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 53.9 t -58.73 -45.52 91.07 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.163 0 C-N-CA 123.875 0.87 . . . . 0.0 109.152 176.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.54 ' CZ ' ' HE2' ' A' ' 31' ' ' LYS . 33.5 t80 -52.37 -48.64 65.47 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.275 1.03 . . . . 0.0 110.861 177.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -64.39 -38.74 92.11 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.568 0.622 . . . . 0.0 110.838 176.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 9.2 tpp85 -65.46 -23.25 66.87 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 118.145 -0.931 . . . . 0.0 112.862 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -59.2 -17.27 26.23 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 120.431 1.469 . . . . 0.0 111.036 172.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 . . . . . 0 CA--C 1.541 0.624 0 CA-C-N 120.167 1.349 . . . . 0.0 112.706 176.938 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 . . . . . 0 C--O 1.235 0.314 0 CA-C-O 121.231 0.539 . . . . 0.0 109.835 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -87.69 155.46 19.92 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 169.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -88.53 125.72 34.91 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 174.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 67.7 tp . . . . . 0 C--O 1.234 0.246 0 C-N-CA 124.941 1.296 . . . . 0.0 109.785 176.753 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.0 t70 . . . . . 0 CA--C 1.522 -0.129 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 74.0 t -135.73 145.52 31.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 123.3 0.64 . . . . 0.0 109.986 -170.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 25.8 tp -114.14 124.89 53.2 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 169.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 56.7 tp -114.2 96.26 5.7 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 178.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 91.5 m -72.54 142.22 48.48 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.131 169.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.4 t -140.4 142.94 30.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 125.176 1.39 . . . . 0.0 107.517 178.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 144.76 172.26 15.14 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 124.657 1.122 . . . . 0.0 111.442 176.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -113.77 121.14 43.16 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 107.832 -1.174 . . . . 0.0 107.832 174.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -59.2 -13.63 8.09 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.401 1.88 . . . . 0.0 115.423 -169.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.0 ptt? -130.78 12.79 5.31 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.976 0.91 . . . . 0.0 111.172 -176.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.9 ttt -92.95 35.24 1.06 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.816 0.734 . . . . 0.0 109.311 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.28 -143.89 30.08 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -173.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -60.24 -18.01 45.79 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 126.016 1.726 . . . . 0.0 112.445 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -54.02 -26.96 29.06 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.649 1.18 . . . . 0.0 112.57 176.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.18 27.83 0.68 Allowed Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.643 -1.087 . . . . 0.0 114.165 178.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.45 -47.97 74.32 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 119.45 1.625 . . . . 0.0 110.253 -172.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.03 -55.82 28.78 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 117.692 -1.616 . . . . 0.0 111.071 174.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -48.21 -41.82 34.07 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 CA-C-N 121.01 2.405 . . . . 0.0 115.372 176.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.3 tp -70.78 -38.28 73.38 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.889 1.222 . . . . 0.0 110.495 178.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.4 tp -61.99 -46.6 88.51 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.936 -0.477 . . . . 0.0 110.291 175.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.35 -40.57 82.55 Favored 'General case' 0 C--O 1.227 -0.088 0 C-N-CA 124.025 0.93 . . . . 0.0 110.978 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -60.72 -48.82 80.1 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 118.594 0.634 . . . . 0.0 109.821 178.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -63.37 -48.8 76.4 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.171 0.589 . . . . 0.0 110.515 -178.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 70.7 m -64.32 -36.74 85.11 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.45 0.568 . . . . 0.0 111.449 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.74 -37.56 88.02 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.166 0.894 . . . . 0.0 111.151 176.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.75 -34.27 75.31 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.18 0.592 . . . . 0.0 111.406 178.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.72 98.89 1.87 Allowed Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 125.325 1.45 . . . . 0.0 108.156 -174.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -54.89 161.02 6.82 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 123.483 2.789 . . . . 0.0 113.854 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.427 ' HE2' ' CE1' ' A' ' 136' ' ' TYR . 72.8 mmtt -135.08 162.21 33.13 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.912 1.685 . . . . 0.0 108.137 178.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 43.53 -121.73 3.56 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.96 1.267 . . . . 0.0 111.614 176.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -134.07 10.7 3.89 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.672 1.189 . . . . 0.0 111.136 174.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -72.86 117.71 14.91 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 121.469 -0.77 . . . . 0.0 109.31 -169.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 89.4 t -67.98 118.31 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 167.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.1 t -73.9 134.13 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -177.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 56.1 mt -132.45 141.34 45.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 103.875 -2.639 . . . . 0.0 103.875 169.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -125.98 106.19 9.45 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 175.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.36 -1.89 82.63 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 118.997 -0.89 . . . . 0.0 112.919 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 56.52 -146.99 33.04 Favored Glycine 0 C--N 1.34 0.76 0 N-CA-C 108.17 -1.972 . . . . 0.0 108.17 -168.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.2 p -88.5 10.49 20.06 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.772 -0.84 . . . . 0.0 111.867 177.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.37 57.96 15.91 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 125.151 1.38 . . . . 0.0 110.393 -176.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -68.87 -14.29 38.52 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.834 2.356 . . . . 0.0 112.978 -171.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -56.7 -32.21 65.25 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.05 0.841 . . . . 0.0 112.03 175.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -61.64 -27.88 68.98 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.4 0.68 . . . . 0.0 112.258 175.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -98.25 -1.88 40.89 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.945 1.298 . . . . 0.0 111.575 -169.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.7 mt -53.86 -42.4 52.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 118.866 0.757 . . . . 0.0 109.783 175.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 43.2 t -61.08 -41.04 87.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 118.378 0.535 . . . . 0.0 110.065 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.33 -43.91 84.82 Favored 'General case' 0 N--CA 1.456 -0.159 0 O-C-N 121.842 -0.536 . . . . 0.0 110.757 -177.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 63.3 mt -58.84 -48.99 84.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 173.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -60.82 -35.88 77.66 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 118.163 -0.922 . . . . 0.0 111.947 -174.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -57.07 -29.73 63.7 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.521 1.055 . . . . 0.0 111.794 177.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 55.2 mt -87.15 -9.78 54.39 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.883 0.873 . . . . 0.0 112.457 -177.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 29.14 61.06 0.78 Allowed Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 126.768 2.027 . . . . 0.0 112.464 -168.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -56.33 145.99 75.16 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.86 2.374 . . . . 0.0 112.589 -171.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.8 m -73.13 -30.35 63.55 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.938 0.895 . . . . 0.0 108.937 168.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -145.36 151.88 38.99 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.28 1.032 . . . . 0.0 109.954 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 41.9 tp -143.17 134.0 25.35 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.329 1.452 . . . . 0.0 107.862 176.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 23.5 tp -126.65 135.27 50.97 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 172.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.0 mt -121.33 143.76 32.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 -171.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.5 t -142.14 135.64 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 119.117 0.871 . . . . 0.0 110.296 -175.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -164.89 170.93 14.73 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 127.372 2.269 . . . . 0.0 107.871 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.82 155.42 37.59 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 121.437 -0.789 . . . . 0.0 108.963 168.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.2 m -154.67 125.08 6.88 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -72.66 121.75 20.3 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 172.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 74.2 mtm -121.53 1.73 10.11 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.168 1.787 . . . . 0.0 110.709 -176.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.43 23.87 67.06 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 118.686 0.675 . . . . 0.0 112.317 -172.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.0 mt -96.2 -174.32 3.05 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.315 1.446 . . . . 0.0 109.43 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -73.7 140.43 78.22 Favored Pre-proline 0 N--CA 1.467 0.393 0 CA-C-O 117.645 -1.169 . . . . 0.0 108.286 170.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -44.29 137.52 7.73 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.216 2.611 . . . . 0.0 112.962 173.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.41 2.32 79.24 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 118.695 -1.058 . . . . 0.0 113.83 176.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -67.12 147.85 52.6 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.911 1.855 . . . . 0.0 108.23 168.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 70.4 mt -124.39 135.92 62.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -172.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.3 mmt-85 -145.26 147.76 32.74 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 118.853 0.751 . . . . 0.0 110.513 176.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 42.3 mm -78.05 142.81 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 167.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.7 mt -129.02 136.38 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 119.98 1.264 . . . . 0.0 108.729 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -80.66 141.29 51.83 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 124.536 1.134 . . . . 0.0 109.761 175.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -47.62 -34.35 20.37 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 124.162 3.241 . . . . 0.0 116.216 178.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -66.54 -26.27 67.05 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.528 0.604 . . . . 0.0 111.719 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -101.09 -29.05 12.36 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.541 1.137 . . . . 0.0 111.094 -176.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.405 HD11 ' HB3' ' A' ' 110' ' ' PHE . 24.9 mt -49.34 -41.08 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.317 1.447 . . . . 0.0 110.839 169.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.9 -24.4 15.97 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.138 1.375 . . . . 0.0 113.601 -177.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -113.61 -37.35 4.62 Favored 'General case' 0 C--O 1.228 -0.063 0 C-N-CA 123.304 0.642 . . . . 0.0 110.381 175.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 22.3 mmt -66.89 -31.86 72.74 Favored 'General case' 0 C--N 1.334 -0.096 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -173.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -63.77 -53.02 57.5 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 119.053 0.842 . . . . 0.0 109.869 174.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.3 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -176.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.3 mt . . . . . 0 N--CA 1.466 0.36 0 N-CA-C 118.822 2.897 . . . . 0.0 118.822 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.49 -25.92 39.72 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 120.006 1.276 . . . . 0.0 110.762 166.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -62.03 -29.64 70.42 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.618 0.767 . . . . 0.0 112.171 174.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.2 tt -74.68 -45.86 41.69 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.175 0.898 . . . . 0.0 108.858 174.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 98.5 mt -58.59 -42.14 83.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -178.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.11 -23.88 64.2 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -87.94 -1.77 58.19 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.993 0.917 . . . . 0.0 112.449 178.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -123.63 -34.93 2.98 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.102 0.961 . . . . 0.0 111.789 178.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -60.68 -21.78 63.21 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.859 0.864 . . . . 0.0 113.063 -173.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -72.34 -12.11 60.99 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.079 0.952 . . . . 0.0 112.012 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -136.31 -32.62 0.85 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.265 0.939 . . . . 0.0 113.082 -178.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 15.3 mt -69.6 138.83 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 172.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -65.91 -41.14 95.58 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.111 0.862 . . . . 0.0 112.397 -176.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -145.9 137.57 25.04 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 118.582 1.191 . . . . 0.0 109.113 175.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.5 t -130.22 129.4 65.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.9 mp -130.52 154.12 40.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -174.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.405 ' HB3' HD11 ' A' ' 81' ' ' ILE . 78.5 t80 -133.35 144.5 49.65 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 168.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.3 tt -126.32 123.31 37.74 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.641 1.576 . . . . 0.0 106.966 177.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -109.65 155.6 16.01 Favored Glycine 0 C--N 1.334 0.436 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 64.6 mt -133.97 124.19 46.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 -173.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.7 tp60 -61.64 115.94 17.9 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-O 117.547 -1.216 . . . . 0.0 110.619 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -79.12 172.47 14.77 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.308 2.672 . . . . 0.0 111.582 170.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -135.95 -29.2 1.03 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 127.263 2.225 . . . . 0.0 111.317 173.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -132.97 120.42 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 -173.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 64.5 t -143.56 132.62 20.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 153.54 152.39 6.03 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -67.73 150.15 49.04 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.882 0.849 . . . . 0.0 111.441 -173.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 14.2 t80 51.24 41.41 27.86 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.884 2.074 . . . . 0.0 112.101 -173.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.3 m-30 -115.19 142.9 29.29 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 169.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.03 159.44 44.54 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.596 2.197 . . . . 0.0 110.531 171.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.7 ttm -73.98 142.45 45.83 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 168.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 37.3 p -81.71 157.61 24.52 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.367 1.067 . . . . 0.0 110.701 178.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -52.1 -42.6 86.67 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-O 116.52 -1.705 . . . . 0.0 114.697 -178.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.37 -29.07 21.53 Favored 'Trans proline' 0 C--N 1.35 0.628 0 CA-C-N 123.087 2.138 . . . . 0.0 111.878 -176.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.63 -36.11 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -56.52 -46.15 80.74 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.166 0.893 . . . . 0.0 109.986 170.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -64.61 -37.83 88.9 Favored 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 123.302 0.641 . . . . 0.0 111.435 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.25 -47.24 80.39 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 121.933 -0.479 . . . . 0.0 110.706 175.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 61.0 t -62.6 -39.91 86.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 118.643 0.656 . . . . 0.0 109.842 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -60.7 -42.88 98.09 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.136 0.88 . . . . 0.0 110.283 173.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 54.2 m -61.35 -48.76 79.82 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 79.3 t -60.39 -45.97 95.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 118.762 0.71 . . . . 0.0 109.654 179.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.427 ' CE1' ' HE2' ' A' ' 31' ' ' LYS . 19.3 t80 -54.06 -49.7 68.4 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.92 0.888 . . . . 0.0 110.578 177.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -69.83 -26.8 64.4 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.525 -0.734 . . . . 0.0 112.114 178.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -73.48 -24.36 60.18 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.23 -0.919 . . . . 0.0 112.065 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 33.4 mt -61.1 -21.94 64.17 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.393 0.997 . . . . 0.0 113.454 -172.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 . . . . . 0 CA--C 1.54 0.573 0 CA-C-N 119.833 1.197 . . . . 0.0 112.794 176.693 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 . . . . . 0 N--CA 1.452 -0.363 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -89.42 147.08 24.23 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 172.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -93.22 119.91 32.92 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 44.1 tp . . . . . 0 CA--C 1.532 0.267 0 C-N-CA 124.913 1.285 . . . . 0.0 109.797 -179.786 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.5 t0 . . . . . 0 C--O 1.234 0.266 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 53.1 t -124.87 141.1 46.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.624 0.726 . . . . 0.0 109.541 -170.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 34.8 tp -107.42 128.1 54.18 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 168.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 56.5 tp -116.18 97.81 6.27 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 177.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 93.2 m -73.18 142.19 47.38 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 170.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.8 t -140.34 141.58 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 125.31 1.444 . . . . 0.0 107.274 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.74 174.94 18.39 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 123.988 0.804 . . . . 0.0 112.219 175.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -117.13 121.25 40.74 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.94 1.296 . . . . 0.0 108.25 176.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 m -59.39 -14.87 13.55 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.458 1.903 . . . . 0.0 115.524 -169.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -130.0 13.98 5.75 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.983 0.913 . . . . 0.0 111.282 -175.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.9 ttt -97.24 34.42 1.78 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.599 0.636 . . . . 0.0 109.756 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.86 -140.95 22.98 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -177.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -62.77 -15.77 55.04 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.474 1.11 . . . . 0.0 112.279 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -59.4 -16.51 23.56 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.035 1.334 . . . . 0.0 112.669 174.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.64 17.84 1.47 Allowed Glycine 0 CA--C 1.533 1.208 0 O-C-N 120.568 -1.332 . . . . 0.0 114.01 175.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.45 -51.16 68.61 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 119.682 1.741 . . . . 0.0 111.032 -169.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.84 -55.18 31.82 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-O 117.806 -1.552 . . . . 0.0 110.984 175.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -48.96 -40.94 40.63 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 CA-C-N 120.687 2.243 . . . . 0.0 115.298 176.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.9 tp -71.97 -37.84 69.85 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 120.254 1.388 . . . . 0.0 110.443 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.2 tp -62.18 -45.63 92.53 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.899 -0.501 . . . . 0.0 110.315 175.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.43 -40.55 87.13 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 123.894 0.878 . . . . 0.0 111.023 177.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.4 tp10 -60.85 -48.66 80.77 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.792 0.723 . . . . 0.0 109.661 178.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -62.28 -46.69 87.65 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.062 0.545 . . . . 0.0 110.639 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 81.1 m -64.98 -37.89 89.17 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.267 0.485 . . . . 0.0 111.237 179.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.66 -37.83 88.93 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.853 0.751 . . . . 0.0 111.107 176.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.13 -37.95 78.57 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.204 0.602 . . . . 0.0 111.092 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.63 95.81 2.03 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 125.166 1.386 . . . . 0.0 108.489 -173.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -55.78 164.32 4.67 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 123.813 3.009 . . . . 0.0 114.182 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.421 ' HE2' ' CZ ' ' A' ' 136' ' ' TYR . 21.0 mmtt -131.56 167.54 19.22 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.625 1.57 . . . . 0.0 109.058 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 40.08 -116.63 0.75 Allowed Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.048 1.309 . . . . 0.0 111.513 175.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -140.65 28.45 1.98 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.62 1.168 . . . . 0.0 109.843 169.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -73.58 125.66 28.5 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.372 -0.83 . . . . 0.0 109.514 -173.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.9 t -78.14 115.32 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 104.103 -2.555 . . . . 0.0 104.103 166.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.4 t -75.77 136.2 25.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -175.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.9 mm -131.38 145.35 35.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 103.972 -2.603 . . . . 0.0 103.972 169.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -132.85 103.79 6.26 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 178.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.5 -4.54 87.44 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-O 118.855 -0.969 . . . . 0.0 112.743 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 54.71 -143.72 31.75 Favored Glycine 0 C--N 1.34 0.754 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 -169.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.2 p -89.67 6.74 40.04 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.985 -0.714 . . . . 0.0 112.41 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.28 64.59 47.22 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 124.866 1.266 . . . . 0.0 109.749 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -64.51 -16.39 54.94 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.732 2.288 . . . . 0.0 112.505 -177.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -47.71 -42.28 24.72 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.51 1.524 . . . . 0.0 111.164 169.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.26 -24.99 66.67 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.015 0.526 . . . . 0.0 112.342 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.04 -3.8 31.27 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 125.071 1.348 . . . . 0.0 111.821 -169.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 84.0 mt -51.2 -41.09 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.866 0.866 . . . . 0.0 110.423 175.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 49.0 t -58.46 -42.04 83.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 118.844 0.747 . . . . 0.0 110.319 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.39 -32.99 73.45 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.212 0.605 . . . . 0.0 111.227 -175.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 58.5 mt -67.33 -50.57 61.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 170.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -66.65 -33.24 75.22 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 118.247 -0.882 . . . . 0.0 112.464 -169.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -62.91 -20.74 65.46 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.979 1.263 . . . . 0.0 112.03 178.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 62.5 mt -86.03 -10.18 55.47 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.391 1.076 . . . . 0.0 113.067 174.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 28.91 61.79 0.75 Allowed Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 127.231 2.212 . . . . 0.0 112.856 -167.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -58.05 150.38 65.21 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.383 2.722 . . . . 0.0 113.549 -169.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.3 m -71.13 -36.27 72.03 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.221 1.009 . . . . 0.0 109.359 168.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 21.3 mtm180 -144.52 162.2 37.17 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.346 1.059 . . . . 0.0 110.199 179.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.5 tp -146.19 134.8 22.16 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 125.256 1.422 . . . . 0.0 107.836 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 37.7 tp -125.78 131.1 52.55 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 173.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.0 mt -115.95 143.2 26.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -175.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.5 t -140.27 134.07 34.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 118.64 0.654 . . . . 0.0 109.91 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -161.7 173.46 14.64 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.275 2.23 . . . . 0.0 107.304 170.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.89 157.78 35.88 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 166.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.3 m -154.6 124.47 6.67 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 176.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -71.57 125.63 27.56 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 172.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 72.9 mtm -127.01 1.96 6.54 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.445 1.898 . . . . 0.0 110.427 -175.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.66 23.74 67.36 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-N 118.693 0.679 . . . . 0.0 112.553 -172.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.2 mt -96.41 -172.47 2.53 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.251 1.421 . . . . 0.0 109.41 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -76.02 139.33 69.18 Favored Pre-proline 0 N--CA 1.468 0.426 0 CA-C-O 117.669 -1.158 . . . . 0.0 108.338 171.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -43.38 137.5 5.41 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.411 2.741 . . . . 0.0 113.131 172.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.93 2.11 81.0 Favored Glycine 0 CA--C 1.534 1.234 0 CA-C-O 118.528 -1.151 . . . . 0.0 113.739 176.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -66.57 144.16 56.6 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 119.909 1.855 . . . . 0.0 107.786 168.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 51.8 mt -121.05 140.71 44.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 -174.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 90.3 mmt-85 -148.4 147.67 29.46 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 118.522 0.601 . . . . 0.0 112.131 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 50.6 mm -77.94 143.28 13.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 164.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.6 mt -128.57 123.84 60.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 176.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -75.16 139.89 72.83 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-O 117.739 -1.124 . . . . 0.0 109.433 175.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_exo -46.75 -36.39 19.33 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 124.235 3.29 . . . . 0.0 116.609 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -69.32 -25.83 64.42 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 118.532 0.605 . . . . 0.0 111.38 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -93.35 -34.46 13.48 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.87 1.268 . . . . 0.0 110.985 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 71.6 mt -48.78 -46.48 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.901 1.28 . . . . 0.0 108.956 169.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.46 -19.54 37.63 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.609 1.164 . . . . 0.0 114.002 -174.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -115.01 -25.34 8.18 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.469 0.708 . . . . 0.0 110.867 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 22.7 mmt -80.5 -36.68 32.98 Favored 'General case' 0 C--O 1.231 0.079 0 CA-C-N 118.238 0.472 . . . . 0.0 112.005 -178.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.64 -37.7 88.48 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 118.906 0.775 . . . . 0.0 112.584 -169.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.6 ppp? . . . . . 0 CA--C 1.538 0.482 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 178.965 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.2 mt . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 117.435 2.383 . . . . 0.0 117.435 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.73 -20.04 4.99 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.333 -0.854 . . . . 0.0 112.554 167.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -58.88 -31.3 68.45 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.517 1.053 . . . . 0.0 111.71 174.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.4 tt -72.95 -45.95 55.2 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 174.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 83.8 mt -58.84 -39.48 77.43 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 123.196 0.599 . . . . 0.0 109.881 -177.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -58.33 -24.72 60.58 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.677 0.671 . . . . 0.0 112.805 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -89.79 -6.71 55.68 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.231 1.012 . . . . 0.0 112.086 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -118.63 -28.15 5.72 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.252 1.021 . . . . 0.0 111.703 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -63.46 -24.18 67.72 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 119.379 0.991 . . . . 0.0 112.403 -175.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -79.27 -4.78 52.33 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.47 1.108 . . . . 0.0 111.843 176.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -134.33 -1.81 2.85 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.33 1.452 . . . . 0.0 112.688 -168.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 20.0 mt -137.29 145.41 29.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 126.094 1.758 . . . . 0.0 107.15 -173.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -71.46 -37.68 62.41 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-O 119.236 -0.758 . . . . 0.0 112.45 -174.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -146.75 135.37 22.09 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.56 1.18 . . . . 0.0 108.076 174.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.2 t -124.68 132.62 71.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 175.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 5.4 mt -133.49 152.29 34.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 -168.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -130.43 142.02 50.51 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 169.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.8 tt -124.31 129.05 50.05 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 174.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -112.88 156.46 15.59 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 77.6 mt -132.75 123.71 49.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -178.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -60.63 115.94 15.95 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-O 117.43 -1.271 . . . . 0.0 110.439 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -76.05 171.53 17.97 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.59 2.86 . . . . 0.0 111.416 170.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -127.96 -32.45 2.31 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.976 1.71 . . . . 0.0 110.932 171.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.69 137.03 47.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.296 1.038 . . . . 0.0 108.333 176.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 90.1 t -141.41 134.93 30.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 175.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 159.21 150.93 5.96 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -65.29 152.55 43.47 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.865 0.84 . . . . 0.0 111.308 -175.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 54.87 38.96 31.21 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.852 2.061 . . . . 0.0 112.09 -177.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -123.14 148.41 54.53 Favored Pre-proline 0 C--O 1.237 0.399 0 C-N-CA 123.987 0.915 . . . . 0.0 109.794 172.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.99 162.5 20.67 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.164 2.576 . . . . 0.0 111.13 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 52.5 ttm -71.43 138.91 49.45 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 168.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 67.4 p -79.85 159.51 26.43 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.285 1.034 . . . . 0.0 110.496 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 21.8 tp60 -53.03 -44.8 97.93 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 116.565 -1.683 . . . . 0.0 114.101 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -68.63 -30.53 28.09 Favored 'Trans proline' 0 C--N 1.351 0.695 0 CA-C-N 122.912 2.076 . . . . 0.0 112.144 -176.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.6 mp -80.05 -35.61 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 118.971 0.805 . . . . 0.0 108.889 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -56.26 -46.56 79.62 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.354 0.979 . . . . 0.0 109.941 170.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -63.92 -38.58 91.6 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.024 0.53 . . . . 0.0 111.319 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.9 -46.19 82.75 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 119.097 -0.478 . . . . 0.0 111.164 175.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 71.8 t -62.68 -39.5 84.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 118.994 0.816 . . . . 0.0 109.658 178.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -62.35 -42.46 99.41 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.191 0.905 . . . . 0.0 110.508 173.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 59.0 m -61.48 -49.4 76.93 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 72.7 t -60.09 -44.25 94.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 123.539 0.736 . . . . 0.0 109.642 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.421 ' CZ ' ' HE2' ' A' ' 31' ' ' LYS . 43.1 t80 -55.96 -48.59 75.53 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.184 0.594 . . . . 0.0 110.631 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 60.0 mm-40 -64.89 -39.09 93.0 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.038 0.836 . . . . 0.0 110.903 176.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -62.3 -29.42 70.42 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 118.732 -0.651 . . . . 0.0 112.263 -177.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 76.8 mt -57.52 -21.78 40.19 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.11 0.868 . . . . 0.0 112.389 177.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 . . . . . 0 CA--C 1.544 0.714 0 CA-C-N 119.105 0.866 . . . . 0.0 112.21 179.278 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 . . . . . 0 N--CA 1.452 -0.342 0 CA-C-O 121.761 0.791 . . . . 0.0 109.794 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.28 144.68 30.45 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 172.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -81.42 123.97 29.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 170.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 67.0 tp . . . . . 0 C--O 1.234 0.258 0 C-N-CA 124.004 0.922 . . . . 0.0 109.914 176.731 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 53.4 t0 . . . . . 0 C--O 1.235 0.315 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.41 HG23 HD13 ' A' ' 58' ' ' LEU . 1.4 m -108.76 146.48 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 123.977 0.911 . . . . 0.0 109.78 -169.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 54.7 tp -119.47 104.35 10.25 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 179.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.3 tp -93.71 97.61 10.56 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 98.5 m -72.89 140.83 47.79 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 169.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.5 t -141.0 141.84 30.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 125.063 1.345 . . . . 0.0 107.768 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.59 176.68 19.72 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.248 0.928 . . . . 0.0 111.862 176.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -118.84 121.55 40.28 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.737 1.215 . . . . 0.0 108.253 176.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -59.97 -14.67 17.06 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.65 1.98 . . . . 0.0 115.469 -169.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.8 ptt? -126.91 13.53 7.35 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.115 0.966 . . . . 0.0 111.065 -177.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 27.0 ttt -97.68 33.54 2.04 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.038 0.835 . . . . 0.0 110.25 -177.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.46 -139.71 21.96 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -178.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -63.26 -15.47 57.25 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.251 1.02 . . . . 0.0 111.977 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -59.79 -16.61 29.31 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.933 1.293 . . . . 0.0 112.651 174.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.1 17.63 1.32 Allowed Glycine 0 CA--C 1.534 1.221 0 O-C-N 120.562 -1.336 . . . . 0.0 114.015 175.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.83 -53.3 59.58 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 119.562 1.681 . . . . 0.0 111.096 -169.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.83 -55.04 32.03 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-O 117.812 -1.549 . . . . 0.0 111.152 176.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -49.44 -39.63 44.7 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 CA-C-N 120.787 2.294 . . . . 0.0 115.381 177.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.8 tp -71.18 -38.86 72.11 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 120.083 1.311 . . . . 0.0 110.394 177.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 52.5 tp -61.21 -47.58 85.46 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 122.002 -0.436 . . . . 0.0 110.277 175.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.71 -41.04 85.4 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.862 0.865 . . . . 0.0 111.082 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -60.94 -48.52 81.42 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 118.858 0.753 . . . . 0.0 109.963 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -61.47 -47.15 87.02 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 122.907 0.483 . . . . 0.0 110.668 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 75.7 m -63.88 -40.69 97.12 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.209 0.459 . . . . 0.0 110.938 179.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.8 -39.63 94.72 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.383 0.538 . . . . 0.0 111.094 178.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.18 -35.9 76.76 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.374 0.669 . . . . 0.0 111.457 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.23 95.71 2.11 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 125.086 1.354 . . . . 0.0 108.296 -172.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -55.45 165.53 3.19 Favored 'Trans proline' 0 CA--C 1.537 0.625 0 C-N-CA 123.674 2.916 . . . . 0.0 114.445 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.443 ' HE2' ' CZ ' ' A' ' 136' ' ' TYR . 68.5 mmtt -133.3 170.77 14.96 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 126.327 1.851 . . . . 0.0 108.215 176.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 38.16 -121.93 1.1 Allowed Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.366 1.46 . . . . 0.0 112.307 177.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -140.22 38.21 1.92 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.242 1.417 . . . . 0.0 108.763 169.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -71.59 160.93 31.82 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.912 0.885 . . . . 0.0 111.565 -172.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 98.8 t -115.12 99.26 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 167.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.8 t -68.17 138.3 22.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -178.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 87.7 mt -136.23 141.16 42.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 172.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -125.64 104.36 8.34 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 177.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.22 -4.02 83.02 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.939 -0.923 . . . . 0.0 112.835 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 54.61 -143.8 31.2 Favored Glycine 0 C--N 1.341 0.82 0 N-CA-C 108.427 -1.869 . . . . 0.0 108.427 -169.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.0 p -91.46 10.98 25.47 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 122.064 -0.668 . . . . 0.0 111.891 177.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.52 58.57 21.02 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 125.352 1.461 . . . . 0.0 110.131 -177.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -70.24 -15.44 35.29 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.61 2.207 . . . . 0.0 113.784 -169.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -55.89 -32.07 63.4 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.22 0.918 . . . . 0.0 111.877 174.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.17 -28.59 68.05 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.284 0.634 . . . . 0.0 112.036 177.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -96.45 -3.29 43.71 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.386 1.075 . . . . 0.0 111.607 -170.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 90.0 mt -54.72 -41.74 57.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 118.898 0.772 . . . . 0.0 109.386 173.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.0 t -61.79 -41.7 91.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 O-C-N 121.869 -0.519 . . . . 0.0 110.063 178.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.38 -44.88 86.18 Favored 'General case' 0 N--CA 1.457 -0.1 0 O-C-N 121.972 -0.455 . . . . 0.0 110.512 -178.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 80.8 mt -57.11 -47.89 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.787 0.835 . . . . 0.0 109.237 173.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -60.58 -34.65 74.5 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 118.131 -0.938 . . . . 0.0 112.048 -174.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -57.82 -31.24 66.41 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.481 1.037 . . . . 0.0 111.638 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 70.1 mt -86.26 -12.18 50.29 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.319 1.048 . . . . 0.0 112.339 -174.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 30.53 60.09 0.98 Allowed Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 126.512 1.925 . . . . 0.0 112.57 -168.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -56.78 154.79 30.05 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.923 2.416 . . . . 0.0 114.766 -170.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.7 m -74.83 -37.28 62.32 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.401 1.08 . . . . 0.0 109.874 169.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 36.2 mtm180 -144.03 159.66 42.21 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.355 1.062 . . . . 0.0 109.872 -177.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.41 HD13 HG23 ' A' ' 4' ' ' VAL . 30.8 tp -147.38 141.81 26.41 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.748 1.219 . . . . 0.0 108.472 176.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.5 123.59 26.89 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 177.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.4 mm -98.79 144.4 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 175.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.9 t -137.56 132.9 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 119.093 0.86 . . . . 0.0 110.0 175.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -160.91 173.5 15.21 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.35 2.26 . . . . 0.0 107.222 169.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.09 157.34 37.04 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.071 -1.018 . . . . 0.0 109.181 168.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.9 m -156.23 127.15 6.89 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 176.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -71.55 124.55 24.92 Favored 'General case' 0 C--O 1.231 0.096 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 172.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 76.2 mtm -122.15 0.8 9.66 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.805 1.642 . . . . 0.0 111.058 -176.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.03 34.22 88.25 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 119.162 0.892 . . . . 0.0 111.5 -171.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.5 mt -109.53 -176.66 3.07 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.405 1.482 . . . . 0.0 109.676 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -70.34 141.22 88.24 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-O 117.988 -1.006 . . . . 0.0 108.832 170.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -42.99 138.12 4.15 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.53 2.82 . . . . 0.0 113.453 172.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.41 3.14 70.23 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-O 118.733 -1.037 . . . . 0.0 113.451 175.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -66.25 148.6 51.6 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 120.101 1.951 . . . . 0.0 108.335 168.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 65.3 mt -124.44 134.5 66.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 -172.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.1 mmt-85 -143.16 151.08 40.26 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.934 0.788 . . . . 0.0 109.747 173.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 50.7 mm -79.11 145.53 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 169.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.1 mt -132.81 163.42 37.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 124.612 1.165 . . . . 0.0 107.89 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -133.07 144.93 54.83 Favored Pre-proline 0 C--O 1.236 0.345 0 C-N-CA 126.868 2.067 . . . . 0.0 107.617 -170.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -54.81 -27.04 50.81 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 123.24 2.626 . . . . 0.0 115.141 -173.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -66.76 -20.58 65.98 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.006 0.821 . . . . 0.0 112.249 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -119.25 -31.1 4.77 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.794 1.238 . . . . 0.0 111.875 -171.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 79.7 mt -50.77 -40.58 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.09 1.356 . . . . 0.0 109.869 170.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.02 -25.59 31.38 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.7 1.2 . . . . 0.0 113.446 -176.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -111.35 -35.66 5.78 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.362 0.665 . . . . 0.0 110.215 177.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 22.1 mmt -67.1 -29.71 69.53 Favored 'General case' 0 C--N 1.334 -0.1 0 O-C-N 121.757 -0.589 . . . . 0.0 112.412 -178.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -71.72 -42.67 67.05 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 119.095 0.861 . . . . 0.0 111.598 177.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 19.0 ptp . . . . . 0 CA--C 1.537 0.451 0 CA-C-N 119.134 0.879 . . . . 0.0 113.01 -179.666 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.471 0.585 0 N-CA-C 117.782 2.512 . . . . 0.0 117.782 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -52.8 -22.02 4.86 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.979 0.911 . . . . 0.0 112.957 168.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -56.86 -32.37 65.74 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 119.402 1.001 . . . . 0.0 111.664 176.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.5 tt -73.23 -44.32 59.75 Favored 'General case' 0 C--N 1.339 0.118 0 O-C-N 121.845 -0.535 . . . . 0.0 109.58 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 98.0 mt -60.31 -45.4 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -64.32 -21.25 66.55 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -175.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -88.17 1.58 54.08 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.245 1.018 . . . . 0.0 112.425 177.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 79.1 mt -135.52 -33.3 0.88 Allowed 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.042 0.937 . . . . 0.0 112.128 -171.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -59.85 -20.63 58.15 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.471 1.108 . . . . 0.0 112.676 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -68.2 -17.2 64.26 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.45 1.1 . . . . 0.0 111.813 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -136.51 -31.18 0.88 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.066 0.848 . . . . 0.0 113.12 -177.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 30.4 mt -69.65 140.89 17.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 172.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -62.58 -42.56 99.68 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 124.105 0.86 . . . . 0.0 112.218 -177.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -149.5 142.28 24.64 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.742 1.271 . . . . 0.0 109.221 175.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 43.5 t -134.06 121.36 38.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 21.5 mt -127.91 154.45 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 C-N-CA 125.094 1.358 . . . . 0.0 107.914 -171.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -125.04 145.14 50.05 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 174.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.7 tt -125.12 128.0 47.75 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 171.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -113.35 155.44 16.3 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 73.9 mt -131.98 126.92 57.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 -178.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.8 tp60 -61.36 114.87 12.07 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-O 117.282 -1.342 . . . . 0.0 110.062 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -76.31 170.28 20.3 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.917 2.412 . . . . 0.0 111.041 170.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -130.04 -32.06 1.86 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.924 1.69 . . . . 0.0 111.014 172.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -135.43 136.04 51.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 175.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 90.9 t -141.55 134.87 30.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 175.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 158.83 149.04 5.39 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -68.67 157.5 36.1 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 122.065 0.936 . . . . 0.0 111.353 -173.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 14.1 t80 48.88 41.38 18.47 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.769 2.028 . . . . 0.0 112.391 -172.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -123.73 148.39 56.2 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 124.067 0.947 . . . . 0.0 109.759 170.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -81.44 160.88 19.75 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.053 2.502 . . . . 0.0 111.157 177.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 52.0 ttm -70.05 138.22 51.92 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 168.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 68.7 p -78.06 158.98 28.98 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 123.967 0.907 . . . . 0.0 110.459 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -52.84 -44.46 96.24 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-O 116.629 -1.653 . . . . 0.0 114.211 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -68.22 -31.86 28.15 Favored 'Trans proline' 0 C--N 1.351 0.702 0 CA-C-N 122.906 2.074 . . . . 0.0 112.065 -176.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.92 -33.91 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 119.074 0.852 . . . . 0.0 108.872 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -56.89 -46.63 81.76 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.477 1.035 . . . . 0.0 110.059 169.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -63.65 -37.01 85.73 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 122.977 0.511 . . . . 0.0 111.228 178.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.56 -49.31 73.94 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 119.172 -0.442 . . . . 0.0 110.895 175.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 75.8 t -61.46 -38.37 79.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 118.743 0.701 . . . . 0.0 109.837 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -61.61 -43.24 99.22 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.09 0.859 . . . . 0.0 110.486 173.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 29.2 m -63.31 -43.46 97.78 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.602 -0.687 . . . . 0.0 110.331 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 78.2 t -62.01 -45.71 98.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 123.3 0.64 . . . . 0.0 109.406 176.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.443 ' CZ ' ' HE2' ' A' ' 31' ' ' LYS . 48.7 t80 -56.68 -48.06 78.47 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.788 0.835 . . . . 0.0 110.624 178.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -66.62 -26.85 67.28 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.589 -0.695 . . . . 0.0 112.17 178.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -68.0 -23.54 65.02 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 119.203 0.91 . . . . 0.0 112.694 176.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.44 -24.25 66.41 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -169.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 . . . . . 0 CA--C 1.541 0.601 0 CA-C-N 119.649 1.113 . . . . 0.0 112.966 178.103 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 . . . . . 0 C--O 1.237 0.413 0 CA-C-O 121.889 0.852 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -76.22 155.75 34.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.325 176.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -97.56 121.78 39.86 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.789 1.236 . . . . 0.0 107.756 -178.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 52.3 tp . . . . . 0 CA--C 1.533 0.322 0 C-N-CA 125.564 1.546 . . . . 0.0 110.044 179.672 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 mmt . . . . . 0 N--CA 1.484 1.26 0 CA-C-O 118.872 -0.585 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.4 m -140.91 147.96 39.69 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -177.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -142.02 124.85 16.04 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -177.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.9 m -112.63 152.66 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 124.487 1.115 . . . . 0.0 109.891 -169.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 23.8 tp -125.29 107.45 10.73 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 177.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 62.5 tp -96.71 95.68 8.09 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 81.8 m -69.66 142.44 53.41 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 168.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.6 t -140.63 143.29 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 146.12 175.94 19.56 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.561 -1.015 . . . . 0.0 110.561 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -125.61 120.9 32.05 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.29 1.436 . . . . 0.0 107.813 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -59.59 -15.18 16.86 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.111 1.764 . . . . 0.0 115.377 -169.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -127.43 13.59 7.08 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.942 0.897 . . . . 0.0 111.119 -176.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.8 ttt -98.34 29.03 3.76 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.28 0.632 . . . . 0.0 109.771 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.23 -146.9 21.3 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 -177.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -58.34 -18.69 29.35 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 126.019 1.727 . . . . 0.0 112.171 175.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -51.97 -25.42 8.25 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.991 1.316 . . . . 0.0 112.645 173.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.13 24.01 0.56 Allowed Glycine 0 CA--C 1.534 1.278 0 CA-C-O 118.602 -1.11 . . . . 0.0 114.554 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.95 -52.25 63.75 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 119.559 1.68 . . . . 0.0 110.611 -171.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.41 -54.66 35.95 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 117.803 -1.554 . . . . 0.0 111.165 176.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -50.15 -40.16 51.26 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 CA-C-N 120.911 2.356 . . . . 0.0 114.99 177.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 62.9 tp -70.6 -39.88 73.54 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 119.89 1.223 . . . . 0.0 110.201 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.0 tp -61.29 -46.77 88.95 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 117.932 0.333 . . . . 0.0 110.346 175.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.67 -42.2 87.92 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.412 1.085 . . . . 0.0 110.939 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -60.81 -49.06 78.99 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 118.499 0.59 . . . . 0.0 109.778 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -62.87 -48.01 80.88 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.104 0.561 . . . . 0.0 110.749 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 89.2 m -63.75 -39.61 94.7 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.641 0.655 . . . . 0.0 111.437 177.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.45 -40.04 96.08 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.144 0.884 . . . . 0.0 110.871 177.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.35 -33.52 74.44 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.372 0.669 . . . . 0.0 111.773 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.79 92.08 2.45 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 124.861 1.264 . . . . 0.0 108.94 -171.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -51.73 161.91 1.93 Allowed 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 124.064 3.176 . . . . 0.0 114.795 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -140.25 157.21 45.94 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 126.256 1.822 . . . . 0.0 106.978 176.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 34.48 30.25 0.01 OUTLIER Glycine 0 CA--C 1.536 1.347 0 C-N-CA 128.332 2.872 . . . . 0.0 118.213 168.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 43.07 35.41 0.78 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.128 1.771 . . . . 0.0 112.837 -169.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -70.69 128.63 36.74 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 120.828 -1.17 . . . . 0.0 108.103 175.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.4 t -78.04 87.66 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 105.231 -2.137 . . . . 0.0 105.231 168.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.9 p -64.48 138.92 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 96.0 mt -137.95 144.94 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 103.454 -2.795 . . . . 0.0 103.454 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -126.85 109.02 11.54 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -66.08 -16.79 64.85 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 124.899 1.237 . . . . 0.0 113.394 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 57.0 39.85 90.24 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 119.303 1.551 . . . . 0.0 113.643 170.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . 0.258 78.3 p 62.73 12.36 5.58 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.698 2.399 . . . . 0.0 114.689 -175.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.86 59.7 13.97 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 125.447 1.499 . . . . 0.0 108.423 170.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -66.88 -19.31 52.64 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.832 2.355 . . . . 0.0 113.279 -168.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -58.02 -30.49 66.16 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.707 0.685 . . . . 0.0 112.334 177.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.43 -30.61 68.61 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.183 0.593 . . . . 0.0 111.931 175.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -94.32 -4.88 47.86 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.087 0.955 . . . . 0.0 111.501 -170.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.5 mt -54.22 -42.66 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 118.977 0.808 . . . . 0.0 109.167 173.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.7 t -62.44 -42.08 94.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 118.273 0.488 . . . . 0.0 109.99 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.24 -44.89 86.73 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.925 -0.485 . . . . 0.0 110.613 -177.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 78.2 mt -57.91 -48.04 84.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.823 0.849 . . . . 0.0 108.997 173.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -60.15 -35.3 75.0 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 118.097 -0.954 . . . . 0.0 111.994 -175.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -57.4 -31.9 66.29 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.544 1.065 . . . . 0.0 111.513 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 73.2 mt -86.12 -11.86 51.53 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.986 0.914 . . . . 0.0 112.544 -175.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 30.36 60.59 0.96 Allowed Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 126.43 1.892 . . . . 0.0 112.465 -168.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -56.52 151.65 44.83 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.977 2.451 . . . . 0.0 114.328 -169.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.1 m -69.11 -39.69 78.79 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.78 1.232 . . . . 0.0 109.642 169.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 58.2 mtm180 -144.69 166.11 26.13 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.061 0.944 . . . . 0.0 110.136 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.6 tp -145.01 141.66 29.12 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 125.312 1.445 . . . . 0.0 108.071 175.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 39.2 tp -128.15 135.43 49.75 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 173.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.4 mt -123.34 141.81 42.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 -176.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.3 t -140.51 132.83 31.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 118.566 0.621 . . . . 0.0 109.766 -173.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -162.78 173.8 13.31 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.075 2.15 . . . . 0.0 107.443 176.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.24 158.31 36.1 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 167.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 m -154.65 128.22 8.59 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 175.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -72.4 123.42 23.02 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 172.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 73.6 mtm -124.57 1.1 8.25 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.828 1.651 . . . . 0.0 110.957 -175.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.3 24.68 67.65 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-N 118.618 0.644 . . . . 0.0 112.368 -172.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.4 mt -95.85 -173.19 2.78 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.229 1.412 . . . . 0.0 109.417 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -74.84 141.23 75.1 Favored Pre-proline 0 N--CA 1.468 0.44 0 CA-C-O 117.551 -1.214 . . . . 0.0 108.338 170.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -43.44 136.74 5.94 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.202 2.602 . . . . 0.0 113.223 173.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.7 1.55 72.37 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-O 118.646 -1.085 . . . . 0.0 113.375 176.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -64.62 149.25 49.27 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 120.182 1.991 . . . . 0.0 108.307 168.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 91.5 mt -121.51 142.01 39.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 -172.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 83.9 mmt-85 -148.35 149.77 32.39 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 118.387 0.539 . . . . 0.0 111.362 169.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 49.0 mm -77.75 144.0 12.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 166.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.43 165.09 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -137.5 145.64 50.11 Favored Pre-proline 0 C--O 1.235 0.332 0 C-N-CA 126.747 2.019 . . . . 0.0 107.453 -170.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -53.64 -27.1 40.36 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.313 2.675 . . . . 0.0 115.398 -174.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -66.37 -21.69 66.24 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.032 0.833 . . . . 0.0 112.324 177.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -119.31 -29.73 5.1 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.912 1.285 . . . . 0.0 111.921 -171.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.1 mt -51.16 -38.81 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.325 1.45 . . . . 0.0 109.777 169.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.7 -29.01 61.96 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.272 1.029 . . . . 0.0 113.078 -177.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -99.32 -45.23 5.93 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 176.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 22.0 mmt -69.07 -29.31 67.41 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -168.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -70.99 -41.51 70.86 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-N 119.414 1.006 . . . . 0.0 111.393 175.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -81.15 10.0 6.0 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.791 0.723 . . . . 0.0 112.228 175.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 50.5 tpp -61.71 -25.31 67.34 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.516 1.053 . . . . 0.0 109.648 167.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 74.2 p -61.28 -8.19 3.57 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.71 2.004 . . . . 0.0 112.729 169.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.6 m 65.87 9.2 5.89 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.157 2.183 . . . . 0.0 112.095 -172.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 51.5 p-80 -155.31 -26.61 0.11 Allowed 'General case' 0 C--N 1.349 0.583 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -65.0 146.16 55.39 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 120.784 1.629 . . . . 0.0 109.885 -174.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 40.7 tpp -57.45 138.31 81.37 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 173.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -74.19 81.72 1.94 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.977 3.118 . . . . 0.0 109.197 178.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.9 mt -49.63 -9.56 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 117.528 2.418 . . . . 0.0 117.528 -168.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.44 -23.39 9.85 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.354 0.979 . . . . 0.0 112.504 168.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -57.77 -39.67 77.99 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 119.271 0.941 . . . . 0.0 110.844 176.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.4 tt -70.15 -43.93 69.9 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 123.41 0.684 . . . . 0.0 109.622 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 95.4 mt -57.74 -41.66 80.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -63.98 -18.26 64.11 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 56.2 mm-40 -83.12 -5.43 59.11 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.941 0.792 . . . . 0.0 112.095 175.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 90.0 mt -132.89 -35.19 1.09 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.933 0.893 . . . . 0.0 112.274 -168.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 12.0 pttm -62.16 -19.76 63.41 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.413 1.085 . . . . 0.0 112.805 -176.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -72.56 -12.99 61.29 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.28 1.032 . . . . 0.0 111.805 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -136.23 -32.72 0.85 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.249 0.931 . . . . 0.0 113.014 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 22.9 mt -68.16 139.64 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 170.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.61 -37.5 92.57 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.097 0.856 . . . . 0.0 112.561 -176.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -149.45 136.66 19.87 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 118.429 1.114 . . . . 0.0 108.505 175.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 56.9 t -123.45 129.78 74.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 175.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.2 mt -129.78 152.0 36.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 -168.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -134.33 146.45 49.98 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 176.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.9 tt -127.19 130.98 50.73 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 170.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -113.23 157.51 14.9 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 175.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 68.0 mt -134.53 128.37 51.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -61.85 115.52 15.98 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-O 117.635 -1.174 . . . . 0.0 110.014 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -78.89 172.42 15.03 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.562 2.175 . . . . 0.0 111.249 170.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -136.54 -31.16 0.88 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 127.533 2.333 . . . . 0.0 110.978 173.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -127.25 122.41 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 -176.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 94.0 t -144.94 132.98 16.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 152.79 150.35 5.38 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -65.7 150.3 48.71 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.137 0.968 . . . . 0.0 110.838 -177.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 18.2 t80 56.29 47.2 19.68 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.595 1.958 . . . . 0.0 111.955 -174.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -130.6 141.65 42.71 Favored Pre-proline 0 C--O 1.236 0.362 0 C-N-CA 123.935 0.894 . . . . 0.0 109.199 168.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -75.84 164.52 31.68 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.909 2.406 . . . . 0.0 110.358 170.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 49.5 ttm -72.63 140.98 48.31 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 168.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 38.3 p -78.53 157.53 28.8 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.414 1.086 . . . . 0.0 110.497 176.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.1 tm0? -49.77 -46.63 80.26 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-O 117.089 -1.434 . . . . 0.0 114.034 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -68.59 -29.27 30.43 Favored 'Trans proline' 0 C--N 1.351 0.695 0 CA-C-N 122.62 1.971 . . . . 0.0 112.163 -174.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 mp -79.63 -35.14 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -56.62 -46.68 80.81 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.39 0.996 . . . . 0.0 109.956 170.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -62.19 -38.28 88.53 Favored 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 123.108 0.563 . . . . 0.0 111.402 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.83 -48.55 76.34 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 122.045 -0.409 . . . . 0.0 111.045 176.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 79.8 t -61.27 -40.58 86.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -60.87 -42.78 98.58 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.919 0.781 . . . . 0.0 110.364 174.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 46.6 m -62.35 -45.13 94.58 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.351 0.523 . . . . 0.0 110.129 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 84.7 t -62.47 -48.16 89.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 118.644 0.657 . . . . 0.0 109.3 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -53.95 -45.77 71.4 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.127 0.971 . . . . 0.0 111.197 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 68.3 mm-40 -68.4 -34.43 76.01 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.399 0.545 . . . . 0.0 111.777 177.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.18 -33.38 75.63 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.755 0.707 . . . . 0.0 111.346 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 38.0 mt -55.18 -24.19 25.55 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -168.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -83.72 -5.74 59.26 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 120.515 1.507 . . . . 0.0 113.605 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -143.77 18.46 2.19 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.12 1.343 . . . . 0.0 112.166 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 4.3 t-105 -62.46 -37.66 86.77 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.892 1.677 . . . . 0.0 112.067 -174.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 67.78 -48.67 0.52 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 128.554 2.741 . . . . 0.0 114.895 174.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -160.84 -41.78 0.02 OUTLIER Glycine 0 CA--C 1.523 0.577 0 CA-C-O 118.815 -0.992 . . . . 0.0 112.025 -178.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -143.59 7.95 1.52 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 118.72 1.26 . . . . 0.0 113.368 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 61.41 15.2 44.83 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-O 119.038 -0.868 . . . . 0.0 114.498 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 65.09 7.85 33.06 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-N 118.8 1.3 . . . . 0.0 113.604 -175.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -69.23 141.6 54.41 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 119.367 1.584 . . . . 0.0 109.123 177.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -64.44 154.43 35.75 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.087 0.955 . . . . 0.0 109.509 177.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -105.45 122.8 46.75 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 -175.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 60.4 tp -56.94 118.59 5.11 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.301 1.44 . . . . 0.0 109.822 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.57 38.96 0.87 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.757 0.423 . . . . 0.0 111.173 -175.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 6.8 t 57.88 17.4 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 125.289 1.436 . . . . 0.0 110.839 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 47.18 40.77 10.67 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 128.193 2.597 . . . . 0.0 113.082 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -142.58 169.11 18.19 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.381 1.472 . . . . 0.0 109.394 175.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 . . . . . 0 C--O 1.25 1.113 0 C-N-CA 125.697 1.599 . . . . 0.0 106.931 179.514 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.8 mtt . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.3 m -146.04 154.19 41.58 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -131.81 144.84 51.21 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 176.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.8 t -141.15 145.71 24.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 118.982 0.81 . . . . 0.0 109.708 -167.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 36.5 tp -118.14 126.21 51.77 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 174.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.4 tp -113.43 101.62 9.55 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 176.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 95.3 m -76.73 142.52 40.43 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 169.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.2 t -139.92 142.56 31.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 125.112 1.365 . . . . 0.0 107.46 177.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 144.21 177.42 19.08 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.418 1.008 . . . . 0.0 112.046 176.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -125.45 122.39 36.53 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.302 1.441 . . . . 0.0 108.256 176.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 m -59.72 -17.01 31.37 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.306 1.842 . . . . 0.0 115.417 -169.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 27.4 ptm -126.13 15.81 7.86 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.091 0.956 . . . . 0.0 111.034 -175.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 11.8 tpt -94.93 25.99 3.85 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.657 1.183 . . . . 0.0 108.955 175.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.82 -142.56 23.59 Favored Glycine 0 C--N 1.338 0.642 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -61.72 -16.89 53.08 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.706 1.202 . . . . 0.0 112.552 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -53.1 -26.66 17.15 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.346 1.458 . . . . 0.0 112.819 175.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.62 25.47 0.62 Allowed Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.548 -1.14 . . . . 0.0 114.369 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.1 -48.08 80.1 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 119.461 1.631 . . . . 0.0 110.079 -171.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.28 -58.09 16.26 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-O 117.627 -1.652 . . . . 0.0 111.19 174.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -48.75 -41.07 38.94 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 CA-C-N 121.035 2.417 . . . . 0.0 115.735 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.3 tp -70.83 -39.4 73.02 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 120.209 1.368 . . . . 0.0 110.332 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.2 tp -61.56 -46.07 91.48 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.563 0.345 . . . . 0.0 110.342 176.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.09 -41.87 89.1 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.279 1.032 . . . . 0.0 111.033 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -60.86 -49.49 77.25 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 118.706 0.685 . . . . 0.0 109.784 178.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -62.66 -46.2 89.29 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.963 0.505 . . . . 0.0 110.849 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 79.1 m -68.04 -34.53 76.64 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.336 0.516 . . . . 0.0 111.265 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.36 -40.08 93.13 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.416 1.007 . . . . 0.0 110.736 174.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.43 -33.0 73.43 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.329 0.652 . . . . 0.0 111.723 178.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -151.3 89.27 4.24 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 125.315 1.446 . . . . 0.0 108.809 -174.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -53.29 151.09 23.68 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 123.634 2.889 . . . . 0.0 112.795 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.528 ' HE2' ' CE1' ' A' ' 136' ' ' TYR . 32.5 mmtt -127.28 163.96 22.78 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.723 1.209 . . . . 0.0 109.637 -178.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 40.16 -115.58 0.63 Allowed Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.253 1.406 . . . . 0.0 111.865 175.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -134.03 9.71 3.84 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.841 1.257 . . . . 0.0 111.107 174.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 2.8 m95 -71.26 121.58 18.69 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 121.316 -0.865 . . . . 0.0 110.149 -169.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.7 t -72.23 119.65 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 104.362 -2.458 . . . . 0.0 104.362 166.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 36.5 t -76.29 135.13 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 -178.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 62.8 mt -132.48 144.34 37.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 169.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -129.73 110.21 11.58 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.038 -1.468 . . . . 0.0 107.038 174.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.7 -2.1 90.41 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 119.08 -0.844 . . . . 0.0 112.463 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 56.51 -145.89 34.85 Favored Glycine 0 C--N 1.34 0.762 0 N-CA-C 108.357 -1.897 . . . . 0.0 108.357 -169.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.1 p -88.67 10.61 20.07 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.944 -0.739 . . . . 0.0 111.8 176.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.3 57.9 15.89 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 125.07 1.348 . . . . 0.0 110.664 -175.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -70.08 -21.84 31.45 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.899 2.399 . . . . 0.0 113.158 -172.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.51 -35.92 79.08 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.109 0.868 . . . . 0.0 112.174 -176.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -65.99 -10.3 38.18 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.744 0.818 . . . . 0.0 112.919 175.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -116.03 0.17 12.94 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.259 1.024 . . . . 0.0 112.427 -171.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 81.8 mt -48.17 -41.37 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 125.224 1.41 . . . . 0.0 110.683 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.6 t -56.36 -42.52 74.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.427 0.691 . . . . 0.0 110.248 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.07 -40.67 87.06 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 122.955 0.502 . . . . 0.0 110.874 -176.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 55.5 mt -57.86 -49.11 82.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 173.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -64.01 -35.21 79.95 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 118.082 -0.961 . . . . 0.0 111.994 -173.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -57.48 -28.8 63.71 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.432 1.015 . . . . 0.0 112.064 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 34.5 mt -76.41 -3.57 37.77 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.467 0.707 . . . . 0.0 112.639 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 41.47 53.8 7.45 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 126.307 1.843 . . . . 0.0 111.565 -171.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -57.91 135.01 66.2 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.203 1.936 . . . . 0.0 112.343 -169.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.7 m -78.32 -31.97 49.0 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.037 0.935 . . . . 0.0 108.577 168.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 20.7 ttp-105 -142.2 155.29 45.27 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.405 1.082 . . . . 0.0 109.79 173.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.4 tp -136.13 141.47 44.15 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 126.09 1.756 . . . . 0.0 107.66 169.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 24.0 tp -130.63 134.44 46.97 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 172.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.5 mt -121.29 145.17 28.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -171.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 38.3 t -141.37 135.65 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 118.938 0.79 . . . . 0.0 110.421 -175.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -163.22 169.79 18.71 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.583 2.353 . . . . 0.0 107.871 177.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.3 155.98 39.6 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.318 -0.864 . . . . 0.0 109.194 168.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.8 m -154.15 123.63 6.58 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -72.15 121.98 20.21 Favored 'General case' 0 N--CA 1.46 0.068 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 171.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 74.8 mtm -122.89 1.01 9.28 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.59 1.556 . . . . 0.0 110.736 -174.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.53 23.5 64.93 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-N 118.639 0.654 . . . . 0.0 112.341 -172.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.0 mt -96.6 -173.85 2.86 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.275 1.43 . . . . 0.0 109.052 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -73.82 140.55 77.91 Favored Pre-proline 0 N--CA 1.467 0.389 0 CA-C-O 117.744 -1.122 . . . . 0.0 108.429 172.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -43.58 137.29 6.05 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.364 2.709 . . . . 0.0 113.195 173.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.36 4.57 74.55 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 118.772 -1.015 . . . . 0.0 113.845 177.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -68.01 150.94 47.83 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 119.714 1.757 . . . . 0.0 108.13 168.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 74.1 mt -128.02 138.02 55.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 -171.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 90.1 mmt-85 -145.58 147.09 31.7 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 118.836 0.744 . . . . 0.0 112.081 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 51.0 mm -75.77 143.0 13.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 166.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 mt -134.81 161.48 40.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 174.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -125.69 144.0 46.82 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 126.493 1.917 . . . . 0.0 108.312 -174.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -42.76 -37.82 6.12 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 124.726 3.618 . . . . 0.0 116.685 -178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -64.84 -22.17 66.94 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.367 0.667 . . . . 0.0 112.34 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -113.33 -32.05 6.38 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.123 1.369 . . . . 0.0 111.1 -174.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.4 HD11 ' HB3' ' A' ' 110' ' ' PHE . 34.5 mt -49.08 -40.44 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.776 1.63 . . . . 0.0 110.359 169.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.31 -21.93 16.82 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.097 1.359 . . . . 0.0 113.733 -176.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -115.97 -36.46 4.13 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 118.574 0.625 . . . . 0.0 110.336 174.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 86.2 mmm -72.15 -26.64 62.17 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 118.479 -0.772 . . . . 0.0 113.032 -171.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -64.53 -51.84 60.85 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 119.933 1.242 . . . . 0.0 109.801 170.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -75.86 6.82 4.55 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 51.6 tpp -61.88 -25.36 67.51 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.585 1.084 . . . . 0.0 109.748 167.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 70.0 p -63.05 -6.89 4.46 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.92 1.688 . . . . 0.0 112.685 168.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.4 m 68.73 4.12 4.24 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 127.43 2.292 . . . . 0.0 112.371 -171.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 49.2 p-80 -155.7 -25.56 0.11 Allowed 'General case' 0 C--N 1.35 0.616 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -63.51 139.99 58.83 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 120.776 1.626 . . . . 0.0 108.447 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -64.38 146.73 97.8 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-O 118.566 -0.73 . . . . 0.0 109.501 -174.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -72.68 63.72 3.85 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 125.166 3.91 . . . . 0.0 110.449 175.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 mt -53.11 -3.14 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 129.577 3.151 . . . . 0.0 117.108 -168.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -52.56 -28.23 20.01 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.546 -0.721 . . . . 0.0 111.207 167.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -59.55 -39.18 83.17 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.118 0.567 . . . . 0.0 111.12 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.6 tt -70.12 -43.68 70.5 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 123.67 0.788 . . . . 0.0 109.471 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 94.0 mt -59.78 -39.05 78.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -63.9 -19.28 64.97 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -82.37 -9.33 59.5 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.537 -0.727 . . . . 0.0 112.009 175.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 68.9 mt -126.83 -30.69 2.73 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.318 1.047 . . . . 0.0 112.09 -168.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 12.5 pttm -63.59 -24.88 67.98 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.317 -0.864 . . . . 0.0 111.942 178.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -78.33 -5.54 52.48 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.772 1.229 . . . . 0.0 111.804 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -132.54 -3.66 3.35 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.867 1.267 . . . . 0.0 112.896 -168.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 65.7 mt -135.89 143.64 35.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 126.111 1.764 . . . . 0.0 106.878 -173.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.68 -37.48 76.78 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-O 119.396 -0.669 . . . . 0.0 112.823 -171.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -144.89 124.63 13.33 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 37.2 t -127.92 130.36 69.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 3.3 mt -136.24 154.17 32.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 -169.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.4 ' HB3' HD11 ' A' ' 81' ' ' ILE . 86.2 t80 -131.55 146.04 52.02 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 168.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.0 tt -126.67 122.11 34.02 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.759 1.624 . . . . 0.0 106.934 176.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -107.61 156.33 15.92 Favored Glycine 0 C--N 1.333 0.377 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -178.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 56.1 mt -133.79 125.85 49.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -175.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.5 tp60 -64.09 115.24 17.78 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-O 117.624 -1.179 . . . . 0.0 110.377 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -76.06 170.39 20.19 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.302 2.668 . . . . 0.0 111.352 170.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -131.03 -30.08 1.81 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.62 1.968 . . . . 0.0 111.056 170.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.1 pp -135.24 136.4 51.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 119.105 0.866 . . . . 0.0 108.708 173.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 65.1 t -142.02 136.91 30.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 176.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 156.03 152.85 6.37 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -67.04 154.0 42.27 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.611 0.72 . . . . 0.0 110.199 -176.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.8 t80 58.21 33.93 23.63 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.196 1.798 . . . . 0.0 111.682 -177.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -123.58 145.84 48.28 Favored Pre-proline 0 C--O 1.237 0.407 0 O-C-N 121.562 -0.711 . . . . 0.0 110.199 174.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -80.3 164.74 21.57 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.198 2.599 . . . . 0.0 110.657 174.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.9 ttm -68.45 134.53 50.29 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 168.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.94 159.6 31.62 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.329 1.052 . . . . 0.0 110.471 176.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.51 -46.62 99.59 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-O 117.196 -1.383 . . . . 0.0 113.316 -171.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -66.89 -26.12 44.57 Favored 'Trans proline' 0 C--N 1.35 0.613 0 CA-C-N 122.288 1.853 . . . . 0.0 112.717 -178.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 mp -80.66 -34.86 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 119.313 0.961 . . . . 0.0 108.666 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -56.99 -46.38 82.3 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 118.988 0.813 . . . . 0.0 109.745 169.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -63.09 -37.95 89.26 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 122.787 0.435 . . . . 0.0 111.356 178.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.55 -47.38 81.82 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 121.88 -0.513 . . . . 0.0 110.9 175.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.16 -39.17 82.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 118.702 0.683 . . . . 0.0 109.871 177.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -63.21 -33.77 76.21 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.193 0.906 . . . . 0.0 111.126 174.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 39.2 m -70.31 -43.17 70.88 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.678 0.791 . . . . 0.0 110.1 175.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 91.2 t -63.45 -45.93 96.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 119.363 0.983 . . . . 0.0 109.26 176.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.528 ' CE1' ' HE2' ' A' ' 31' ' ' LYS . 22.3 t80 -52.36 -50.97 61.32 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.155 0.982 . . . . 0.0 110.884 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -71.28 -34.74 70.94 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.873 0.761 . . . . 0.0 111.818 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.21 -32.51 74.11 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 118.926 0.784 . . . . 0.0 111.43 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 55.2 mt -57.52 -18.65 20.12 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.54 1.064 . . . . 0.0 112.708 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -83.69 -12.64 55.6 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 119.403 1.001 . . . . 0.0 112.368 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -145.71 7.13 1.47 Allowed Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.151 0.881 . . . . 0.0 114.39 -173.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -55.51 146.72 19.45 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.447 1.499 . . . . 0.0 109.405 172.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -150.8 100.28 2.8 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 171.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 79.41 -41.51 2.29 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.691 1.615 . . . . 0.0 114.165 169.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -146.2 -16.91 0.45 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.323 1.449 . . . . 0.0 112.111 -169.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 64.7 17.08 62.16 Favored Glycine 0 CA--C 1.531 1.084 0 O-C-N 121.429 -0.795 . . . . 0.0 113.464 175.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.61 5.03 55.06 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 118.614 -1.103 . . . . 0.0 113.275 -176.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -74.14 159.51 32.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 119.578 1.689 . . . . 0.0 109.601 176.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -84.24 146.91 27.54 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 172.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -78.89 131.77 36.53 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 169.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 56.7 tp -54.39 144.92 19.37 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.8 1.24 . . . . 0.0 110.887 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 71.86 -47.93 0.67 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 130.423 3.489 . . . . 0.0 112.734 170.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 60.5 t -81.38 55.13 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 127.651 2.38 . . . . 0.0 104.849 168.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -58.28 154.83 12.64 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.325 1.85 . . . . 0.0 111.437 -169.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -133.73 28.78 3.89 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.732 1.213 . . . . 0.0 110.188 -171.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 . . . . . 0 C--O 1.25 1.115 0 C-N-CA 124.646 1.178 . . . . 0.0 109.33 174.38 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.6 ttp . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 119.078 -0.487 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 22.8 m -145.53 149.3 34.35 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -173.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -144.6 128.09 16.99 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 -176.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.9 m -118.06 153.47 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 124.051 0.94 . . . . 0.0 110.561 -169.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 41.4 tp -124.09 101.54 7.27 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 56.5 tp -89.84 98.94 12.06 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.071 0.949 . . . . 0.0 108.938 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 95.9 m -75.01 141.09 43.98 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 169.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.5 t -141.38 143.31 27.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 125.328 1.451 . . . . 0.0 107.782 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 148.91 171.5 17.73 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.094 0.854 . . . . 0.0 112.231 175.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -109.0 117.1 33.33 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.919 1.288 . . . . 0.0 107.951 175.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -59.57 -13.83 10.88 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.109 1.764 . . . . 0.0 115.741 -169.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -129.57 13.55 5.96 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 119.436 1.016 . . . . 0.0 111.878 -174.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.2 ttt -100.64 40.12 1.3 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.49 0.662 . . . . 0.0 110.158 -176.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.51 -136.39 18.37 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -50.9 -30.26 14.21 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.901 1.281 . . . . 0.0 113.328 174.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -60.25 -17.91 45.21 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -167.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.34 25.58 0.71 Allowed Glycine 0 CA--C 1.533 1.187 0 CA-C-O 118.14 -1.366 . . . . 0.0 113.791 175.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.51 -49.14 77.92 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 119.944 1.872 . . . . 0.0 110.382 -170.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.19 -56.44 23.76 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-O 117.612 -1.66 . . . . 0.0 111.203 173.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -47.09 -42.47 26.13 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 CA-C-N 120.991 2.396 . . . . 0.0 115.659 177.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 62.6 tp -71.49 -37.43 71.27 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 120.173 1.351 . . . . 0.0 110.713 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.4 tp -61.34 -47.39 86.13 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.324 0.511 . . . . 0.0 110.283 174.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.96 -40.28 88.5 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 123.859 0.864 . . . . 0.0 110.903 177.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.6 tp10 -62.03 -49.29 76.58 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 118.659 0.663 . . . . 0.0 109.726 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -63.21 -45.9 89.53 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 119.166 -0.445 . . . . 0.0 110.477 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 78.4 m -63.5 -40.34 96.82 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.581 0.628 . . . . 0.0 111.228 177.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.91 -39.31 93.88 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.844 0.747 . . . . 0.0 111.146 177.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.37 -36.9 77.28 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.343 0.657 . . . . 0.0 111.467 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.89 95.58 2.19 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.113 1.365 . . . . 0.0 108.063 -172.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -53.04 170.19 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 124.907 3.738 . . . . 0.0 115.729 -176.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.562 ' HE2' ' CZ ' ' A' ' 136' ' ' TYR . 19.4 mmtm -138.85 157.04 46.79 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.342 1.457 . . . . 0.0 108.94 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 38.33 -115.1 0.38 Allowed Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.241 1.4 . . . . 0.0 111.625 177.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -140.71 22.29 2.31 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.473 1.109 . . . . 0.0 110.425 170.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 10.0 m95 -69.87 128.63 37.06 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 121.32 -0.862 . . . . 0.0 109.302 -173.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 86.4 t -76.88 106.72 7.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 168.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.7 t -64.02 136.67 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.0 mm -131.02 148.06 33.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 169.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -135.6 100.26 4.43 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.59 -8.33 80.88 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-O 118.88 -0.956 . . . . 0.0 112.419 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 51.48 -140.19 25.12 Favored Glycine 0 C--N 1.341 0.807 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -169.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.9 p -91.53 14.76 13.99 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.032 0.933 . . . . 0.0 111.799 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.48 57.06 6.8 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 125.291 1.437 . . . . 0.0 110.142 -176.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -68.46 -18.66 43.6 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.822 2.348 . . . . 0.0 113.648 -169.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -61.47 -32.14 72.13 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.338 0.972 . . . . 0.0 111.473 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.43 -31.31 71.25 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.189 0.595 . . . . 0.0 111.579 175.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.54 -9.56 49.44 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 123.645 0.778 . . . . 0.0 111.326 -169.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 95.6 mt -53.1 -42.17 44.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 170.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.6 t -58.1 -40.26 76.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.565 0.746 . . . . 0.0 110.241 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.81 -45.45 71.18 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.232 0.469 . . . . 0.0 110.249 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.3 mt -62.72 -37.5 79.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -64.07 -19.04 64.94 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 117.871 -1.061 . . . . 0.0 112.578 176.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -70.91 -46.79 61.9 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 120.483 1.492 . . . . 0.0 108.964 169.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.4 mt -69.9 -21.1 63.34 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.47 1.108 . . . . 0.0 112.657 -173.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.3 mtt85 41.92 54.63 8.76 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.04 1.736 . . . . 0.0 112.202 -177.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -57.87 153.86 41.57 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.768 2.312 . . . . 0.0 114.793 -169.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.8 m -72.35 -38.82 68.48 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.085 1.354 . . . . 0.0 109.536 168.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 53.3 mtm180 -143.99 164.57 30.24 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.036 0.934 . . . . 0.0 110.577 178.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.0 tp -146.01 141.69 27.91 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.345 1.458 . . . . 0.0 108.235 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 41.7 tp -128.49 135.35 49.32 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 172.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.5 mt -122.04 144.16 32.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -175.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.5 t -140.18 132.82 33.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 118.413 0.551 . . . . 0.0 109.663 -175.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -158.78 175.19 13.92 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.556 2.342 . . . . 0.0 106.742 169.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.68 162.74 28.46 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 121.028 -1.045 . . . . 0.0 110.628 169.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.7 m -157.24 128.22 6.7 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 176.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -73.42 116.63 14.21 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 170.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 77.1 mtm -114.64 1.55 14.25 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.767 1.627 . . . . 0.0 110.461 -176.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.48 13.6 45.32 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 123.948 0.785 . . . . 0.0 113.011 -172.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 72.3 mt -85.92 -176.31 5.94 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.904 1.681 . . . . 0.0 109.928 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -72.54 139.1 80.79 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 117.928 -1.034 . . . . 0.0 109.388 172.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -43.99 134.34 8.24 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.812 3.008 . . . . 0.0 114.224 177.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.87 4.73 86.03 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 118.858 -0.968 . . . . 0.0 113.547 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -66.75 152.67 45.05 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 119.722 1.761 . . . . 0.0 108.435 168.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 85.6 mt -127.78 139.92 50.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 -171.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 90.9 mmt-85 -148.64 151.81 35.62 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.624 0.647 . . . . 0.0 111.147 173.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 43.8 mm -78.41 146.13 8.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 167.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.6 mt -135.17 165.19 31.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 177.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -138.67 146.41 50.4 Favored Pre-proline 0 C--O 1.235 0.32 0 C-N-CA 126.925 2.09 . . . . 0.0 107.009 -170.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -53.08 -28.43 40.86 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.38 2.72 . . . . 0.0 114.982 -175.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -66.69 -21.38 66.09 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 118.943 0.792 . . . . 0.0 112.359 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -117.96 -30.18 5.43 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.873 1.269 . . . . 0.0 111.894 -172.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 69.5 mt -50.5 -40.89 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 124.658 1.183 . . . . 0.0 109.89 170.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.81 -27.36 50.88 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.857 0.863 . . . . 0.0 113.254 -176.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -99.23 -43.22 6.7 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 174.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 95.0 mmm -72.1 -25.52 61.78 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.631 -0.668 . . . . 0.0 112.708 -169.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -80.0 1.01 29.22 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 172.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 23.3 ptt? -121.06 -3.12 9.59 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.407 0.683 . . . . 0.0 111.846 167.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 15.8 tpt -61.93 -29.27 70.11 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.213 0.915 . . . . 0.0 109.804 168.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.4 p -54.37 -28.55 43.92 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 127.988 2.515 . . . . 0.0 113.023 169.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.8 m 118.72 -52.38 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.446 1 C-N-CA 133.537 4.735 . . . . 0.0 104.091 -168.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -168.87 154.59 6.41 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.713 2.005 . . . . 0.0 107.449 168.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -140.45 -77.86 0.3 Allowed 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 168.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 36.3 mtt -164.44 133.82 2.92 Favored Pre-proline 0 C--N 1.329 -0.302 0 C-N-CA 129.376 3.071 . . . . 0.0 102.78 168.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -73.97 61.0 4.69 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.521 2.814 . . . . 0.0 110.631 177.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.6 mt -47.69 -12.46 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 129.608 3.163 . . . . 0.0 116.66 -168.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -52.48 -26.77 13.81 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.202 0.91 . . . . 0.0 112.199 168.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -63.53 -33.82 76.44 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.713 1.142 . . . . 0.0 111.671 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.6 tt -69.59 -46.39 66.42 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.0 mt -60.5 -49.49 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -67.18 -14.14 62.63 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -171.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -106.04 7.96 32.11 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.675 1.19 . . . . 0.0 111.668 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 26.6 tp -138.5 -27.86 0.85 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.785 0.834 . . . . 0.0 111.167 -173.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -59.35 -19.77 49.34 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.849 1.26 . . . . 0.0 111.494 168.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -64.39 -16.77 62.93 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.288 1.435 . . . . 0.0 111.361 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -125.75 -40.41 2.06 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.477 1.111 . . . . 0.0 111.426 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 36.5 mt -71.82 139.04 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.76 -38.89 93.42 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.361 0.981 . . . . 0.0 112.747 -177.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -147.22 135.95 22.06 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 118.662 1.231 . . . . 0.0 108.395 176.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.8 t -126.11 127.57 71.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.2 mt -130.24 155.31 41.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -168.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -136.13 147.8 47.92 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.4 tt -129.68 135.48 48.56 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.043 1.337 . . . . 0.0 108.167 171.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -118.13 158.91 14.48 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 125.112 1.339 . . . . 0.0 111.117 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 92.3 mt -136.31 129.73 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 C-N-CA 125.444 1.498 . . . . 0.0 107.593 -175.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -66.74 119.47 63.69 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 117.513 -1.232 . . . . 0.0 111.245 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.11 170.15 17.68 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 124.755 3.636 . . . . 0.0 113.449 173.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -137.82 -36.73 0.61 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.453 1.101 . . . . 0.0 112.028 168.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.1 pp -136.67 138.06 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 170.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 89.8 t -139.98 136.46 38.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 175.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 160.5 151.81 6.34 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -65.37 151.35 46.5 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.7 0.762 . . . . 0.0 111.079 -174.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 54.86 38.29 30.07 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.733 2.013 . . . . 0.0 112.061 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -121.6 149.54 53.05 Favored Pre-proline 0 C--O 1.237 0.439 0 C-N-CA 124.026 0.93 . . . . 0.0 109.451 173.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -78.0 158.37 30.72 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.831 2.354 . . . . 0.0 110.68 177.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 59.5 ttm -64.88 132.57 49.76 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 168.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.0 151.17 47.41 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 123.913 0.885 . . . . 0.0 111.209 177.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -57.59 -47.13 99.5 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 117.198 -1.382 . . . . 0.0 112.925 -174.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -67.92 -25.48 38.7 Favored 'Trans proline' 0 C--N 1.35 0.657 0 CA-C-N 122.105 1.787 . . . . 0.0 112.166 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 mp -76.96 -38.67 28.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -57.01 -46.88 81.98 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.977 0.808 . . . . 0.0 109.863 171.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -61.91 -39.22 91.25 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 122.639 0.376 . . . . 0.0 111.144 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.51 -49.9 71.7 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.755 0.422 . . . . 0.0 110.929 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 76.4 t -59.2 -40.78 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 118.634 0.652 . . . . 0.0 109.618 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -68.73 -28.93 67.26 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.921 0.782 . . . . 0.0 111.742 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 46.7 m -69.27 -46.79 66.39 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.558 -0.713 . . . . 0.0 109.527 173.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 96.3 t -59.39 -46.32 92.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 118.965 0.802 . . . . 0.0 108.968 176.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.562 ' CZ ' ' HE2' ' A' ' 31' ' ' LYS . 37.6 t80 -52.33 -57.93 8.25 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.317 1.047 . . . . 0.0 110.637 178.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -69.27 -29.95 67.95 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.025 0.83 . . . . 0.0 111.852 -176.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -61.43 -33.7 74.16 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 118.777 0.717 . . . . 0.0 110.881 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 52.7 mt -57.99 -17.2 15.79 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -177.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -79.46 -14.88 58.61 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 120.248 1.386 . . . . 0.0 112.793 177.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -135.23 -5.14 2.42 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.609 1.099 . . . . 0.0 113.328 -178.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -54.16 135.26 44.03 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 126.135 1.774 . . . . 0.0 109.048 174.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -143.96 151.41 39.73 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 167.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.01 -107.75 0.93 Allowed Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 -172.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -108.27 11.18 27.48 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.861 1.264 . . . . 0.0 112.463 -177.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 73.42 6.19 69.57 Favored Glycine 0 CA--C 1.528 0.887 0 O-C-N 121.379 -0.826 . . . . 0.0 113.395 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 73.17 5.71 66.91 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-N 119.024 1.412 . . . . 0.0 113.303 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -67.0 151.83 46.92 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 119.209 1.504 . . . . 0.0 108.83 170.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.62 155.77 40.14 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 123.811 0.844 . . . . 0.0 109.256 173.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -102.65 123.95 47.29 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.985 1.314 . . . . 0.0 108.196 -177.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 58.9 tp -56.05 129.31 39.35 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 126.226 1.81 . . . . 0.0 110.727 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -143.54 56.18 1.35 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.047 0.939 . . . . 0.0 110.139 178.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 6.9 t 53.78 51.69 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 125.201 1.401 . . . . 0.0 110.013 176.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -75.67 177.0 7.16 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.73 1.212 . . . . 0.0 110.913 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -145.32 153.25 41.05 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.048 1.739 . . . . 0.0 106.909 169.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 . . . . . 0 C--O 1.25 1.127 0 C-N-CA 124.781 1.232 . . . . 0.0 109.713 169.95 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.4 tpp . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 91.4 m -130.99 126.19 35.32 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 171.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -119.53 101.58 8.04 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 -175.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.1 m -89.88 141.36 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 29.3 tp -109.37 126.48 53.46 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 105.18 -2.155 . . . . 0.0 105.18 171.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 48.9 tp -114.61 97.38 6.25 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 177.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 93.2 m -71.78 140.12 49.31 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.84 169.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.1 t -140.26 141.84 32.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 148.0 -175.52 27.27 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 118.43 0.559 . . . . 0.0 112.153 177.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -136.79 117.78 14.28 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.057 1.343 . . . . 0.0 107.983 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.7 m -58.74 -11.55 3.29 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.477 2.311 . . . . 0.0 115.798 -170.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 23.4 ptp -131.97 12.35 4.74 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.805 1.184 . . . . 0.0 111.425 -177.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 27.7 mmm -89.45 24.54 2.22 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.64 0.776 . . . . 0.0 110.261 173.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.58 -139.15 16.3 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -63.42 -14.98 56.14 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.407 1.083 . . . . 0.0 112.108 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -61.39 -5.84 1.93 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.629 1.571 . . . . 0.0 113.324 174.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.64 16.89 28.48 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 120.537 -1.352 . . . . 0.0 113.412 174.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.37 -50.33 74.04 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.4 1.6 . . . . 0.0 111.578 -169.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.54 -55.22 31.19 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 117.718 -1.601 . . . . 0.0 111.144 176.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -48.73 -40.08 38.66 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 CA-C-N 120.849 2.325 . . . . 0.0 115.24 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.6 tp -71.19 -38.93 72.09 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 119.975 1.261 . . . . 0.0 110.464 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.3 tp -60.9 -46.36 90.95 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.066 0.394 . . . . 0.0 110.187 175.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.41 -39.92 81.02 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 123.85 0.86 . . . . 0.0 110.956 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -62.67 -49.36 75.42 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 118.815 0.734 . . . . 0.0 109.829 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -62.84 -44.51 95.95 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.558 0.343 . . . . 0.0 110.515 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 79.5 m -65.0 -39.64 93.76 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 118.21 0.459 . . . . 0.0 111.157 177.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.52 -37.54 87.9 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.039 0.836 . . . . 0.0 111.199 177.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.07 -38.8 79.23 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.226 0.61 . . . . 0.0 111.116 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.5 90.2 2.9 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.765 1.226 . . . . 0.0 109.191 -173.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -55.24 160.19 8.92 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 124.07 3.18 . . . . 0.0 114.0 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 32.1 mmtt -117.39 168.12 10.64 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.871 1.268 . . . . 0.0 109.768 174.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 37.52 -112.3 0.17 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 126.193 1.854 . . . . 0.0 111.564 176.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -139.13 36.27 2.11 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.852 1.261 . . . . 0.0 108.886 169.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -67.47 144.94 55.45 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 121.591 -0.693 . . . . 0.0 110.653 -175.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.1 t -103.16 103.5 15.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 168.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.8 t -71.36 136.97 24.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -176.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 54.9 mt -136.96 142.19 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 104.55 -2.389 . . . . 0.0 104.55 172.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -131.01 110.07 10.97 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -88.83 0.65 82.67 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 118.811 -0.994 . . . . 0.0 112.879 -178.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 56.9 -144.29 38.87 Favored Glycine 0 C--N 1.34 0.766 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -171.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.1 p -94.19 1.63 56.02 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.693 0.797 . . . . 0.0 112.629 -175.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.02 64.16 40.13 Favored Pre-proline 0 C--O 1.238 0.454 0 C-N-CA 124.798 1.239 . . . . 0.0 109.458 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -65.06 -14.35 44.78 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.194 2.596 . . . . 0.0 112.875 -173.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.7 tp10 -43.1 -41.74 3.73 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.087 1.755 . . . . 0.0 111.536 168.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -69.64 -17.41 63.51 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.048 0.939 . . . . 0.0 112.655 -175.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -117.79 0.8 12.06 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.797 0.839 . . . . 0.0 113.251 -168.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 73.5 mt -48.96 -38.9 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 125.147 1.379 . . . . 0.0 110.62 172.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.9 t -55.35 -42.02 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 123.955 0.902 . . . . 0.0 110.453 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.0 -40.77 91.41 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.954 0.501 . . . . 0.0 110.799 -176.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.5 mt -60.8 -49.31 85.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.975 0.91 . . . . 0.0 108.608 173.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -61.21 -36.02 78.77 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 118.386 -0.816 . . . . 0.0 111.857 -173.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -55.79 -30.19 60.94 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.871 0.76 . . . . 0.0 111.994 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 68.6 mt -87.67 -9.48 54.05 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.085 0.954 . . . . 0.0 112.377 -174.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 30.75 59.87 1.01 Allowed Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 126.588 1.955 . . . . 0.0 112.504 -168.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -57.45 155.59 30.03 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.02 2.48 . . . . 0.0 114.242 -169.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.3 m -72.77 -42.01 64.45 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.889 0.476 . . . . 0.0 109.802 170.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 50.3 mtm180 -142.7 160.62 39.95 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.439 0.696 . . . . 0.0 109.91 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 26.3 tp -141.17 138.86 33.69 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 124.645 1.178 . . . . 0.0 108.583 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 62.3 tp -127.62 114.54 17.5 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 176.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 mm -86.39 148.6 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 172.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.9 t -140.7 133.5 31.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 118.459 0.572 . . . . 0.0 109.634 171.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -161.95 173.84 13.91 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.266 2.226 . . . . 0.0 107.351 169.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.18 157.54 37.98 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.052 -1.03 . . . . 0.0 109.734 169.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.7 m -151.55 126.44 9.7 Favored 'General case' 0 CA--C 1.527 0.09 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -77.42 80.51 3.91 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.994 0.902 . . . . 0.0 110.261 175.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 74.0 mtm -75.4 -6.55 50.61 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.012 1.725 . . . . 0.0 112.345 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.0 21.02 76.74 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 123.87 0.747 . . . . 0.0 111.943 -172.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.5 mt -93.49 -172.65 2.97 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.132 1.373 . . . . 0.0 109.706 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -74.2 140.45 76.55 Favored Pre-proline 0 N--CA 1.468 0.437 0 CA-C-O 117.695 -1.145 . . . . 0.0 108.434 169.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -43.01 137.99 4.25 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.423 2.749 . . . . 0.0 113.445 172.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.05 1.59 74.39 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 118.587 -1.118 . . . . 0.0 113.689 176.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -67.12 147.22 53.41 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.926 1.863 . . . . 0.0 107.891 168.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 55.2 mt -124.97 139.81 49.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 -173.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 91.3 mmt-85 -147.26 152.46 38.35 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 118.765 0.712 . . . . 0.0 111.734 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 48.5 mm -80.51 142.53 13.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 166.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.2 mt -134.99 164.3 34.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 124.871 1.268 . . . . 0.0 107.844 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -135.05 145.78 55.77 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 126.884 2.074 . . . . 0.0 107.974 -169.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -55.32 -25.04 45.48 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.292 2.662 . . . . 0.0 115.229 -173.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -66.33 -21.16 66.25 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.157 0.89 . . . . 0.0 112.271 176.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -122.16 -29.8 4.14 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.655 1.182 . . . . 0.0 112.149 -170.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.0 mt -50.8 -40.36 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.15 1.38 . . . . 0.0 109.675 169.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.91 -29.18 59.66 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.409 1.084 . . . . 0.0 112.989 -176.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -99.45 -43.91 6.37 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 20.8 mmt -68.06 -31.4 71.01 Favored 'General case' 0 CA--C 1.523 -0.087 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -169.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -70.33 -45.65 65.76 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 118.766 0.712 . . . . 0.0 111.491 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -83.33 8.48 13.45 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 15.3 tpt -60.49 -26.53 66.89 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.174 0.897 . . . . 0.0 109.589 167.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 55.4 p -59.76 -15.86 23.37 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.963 1.705 . . . . 0.0 112.916 169.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.0 m 56.6 31.95 20.07 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.956 1.703 . . . . 0.0 109.845 -168.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -153.37 -60.05 0.14 Allowed 'General case' 0 C--N 1.345 0.37 0 O-C-N 121.411 -0.806 . . . . 0.0 112.724 -170.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -71.63 147.0 47.97 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 122.796 0.438 . . . . 0.0 109.884 -169.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 77.6 mtm -67.35 145.96 98.65 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 122.963 0.505 . . . . 0.0 109.981 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.8 81.44 1.89 Allowed 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 123.99 3.127 . . . . 0.0 110.139 177.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.2 mt -50.95 -8.47 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 127.257 2.223 . . . . 0.0 116.779 -169.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -52.48 -25.06 9.15 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.487 1.039 . . . . 0.0 112.128 167.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -59.11 -32.55 69.94 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.072 0.851 . . . . 0.0 111.529 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.8 tt -79.51 -44.6 20.91 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 85.0 mt -57.55 -42.39 81.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -59.63 -24.94 64.26 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -89.06 -4.0 58.5 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.151 0.98 . . . . 0.0 112.506 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -123.0 -30.87 3.71 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.449 1.022 . . . . 0.0 111.832 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -60.17 -20.66 59.59 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.103 0.961 . . . . 0.0 113.048 -176.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -69.62 -16.15 63.33 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.362 1.065 . . . . 0.0 112.094 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -140.2 -32.39 0.61 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.372 0.987 . . . . 0.0 113.621 -176.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 12.4 mt -69.53 138.78 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 170.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.62 -37.59 92.62 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.344 0.973 . . . . 0.0 112.483 -175.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -148.69 137.76 21.63 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 118.497 1.149 . . . . 0.0 108.462 175.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 45.2 t -129.63 124.45 59.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 25.8 mt -129.93 154.93 41.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -169.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -125.66 143.48 51.01 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 174.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.6 tt -122.23 124.08 42.95 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 169.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -110.71 156.73 15.39 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 57.7 mt -134.44 124.9 46.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 -176.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -64.89 118.14 45.81 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-O 117.448 -1.263 . . . . 0.0 110.447 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -76.18 171.68 17.66 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.703 2.935 . . . . 0.0 111.569 170.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -128.0 -31.96 2.34 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 125.765 1.626 . . . . 0.0 110.98 171.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -135.86 136.55 49.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.344 1.058 . . . . 0.0 108.161 175.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.9 t -140.79 132.2 29.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 174.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 162.83 154.76 7.75 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -70.11 153.18 43.48 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.898 0.856 . . . . 0.0 110.929 -171.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.9 t80 50.96 39.18 22.24 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.915 2.086 . . . . 0.0 112.222 -176.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.5 m-30 -120.29 148.04 46.42 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 123.793 0.837 . . . . 0.0 109.947 174.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -81.27 164.39 19.39 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.23 2.62 . . . . 0.0 111.162 177.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 52.0 ttm -72.74 140.54 47.85 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 168.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 71.4 p -81.25 159.81 24.42 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.374 1.07 . . . . 0.0 110.656 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.2 tm0? -51.04 -48.65 84.39 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-O 116.978 -1.487 . . . . 0.0 113.329 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -67.78 -30.01 34.55 Favored 'Trans proline' 0 C--N 1.352 0.731 0 CA-C-N 122.546 1.945 . . . . 0.0 112.368 -174.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.77 -35.88 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 119.092 0.86 . . . . 0.0 108.931 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -56.97 -47.13 81.49 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.46 1.027 . . . . 0.0 109.926 171.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -61.52 -42.49 98.9 Favored 'General case' 0 C--O 1.231 0.087 0 C-N-CA 122.995 0.518 . . . . 0.0 111.082 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.96 -48.47 80.23 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 119.04 -0.505 . . . . 0.0 110.952 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 55.5 t -60.01 -41.66 87.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 118.705 0.684 . . . . 0.0 109.617 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -69.58 -29.93 67.58 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.044 0.838 . . . . 0.0 111.568 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 38.0 m -69.58 -45.48 68.55 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.325 -0.86 . . . . 0.0 109.776 174.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 78.7 t -59.23 -47.15 91.29 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 175.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -52.08 -48.11 64.86 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.008 0.923 . . . . 0.0 110.811 177.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -64.0 -44.0 93.98 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 118.564 0.62 . . . . 0.0 110.991 177.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.6 tpp85 -64.11 -26.54 68.59 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 118.736 -0.65 . . . . 0.0 112.234 -175.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 61.0 mt -57.2 -23.68 49.39 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.412 1.006 . . . . 0.0 112.317 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -67.69 -19.03 65.12 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.325 0.966 . . . . 0.0 112.558 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -136.97 6.41 3.73 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.725 1.155 . . . . 0.0 113.361 -174.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 21.0 t90 -62.36 141.53 58.26 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 118.485 1.142 . . . . 0.0 108.822 172.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -151.3 70.34 0.97 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 80.69 -45.28 3.09 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.448 1.023 . . . . 0.0 110.945 -172.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -148.84 96.08 2.51 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 169.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -60.61 7.97 0.08 OUTLIER Glycine 0 CA--C 1.532 1.114 0 C-N-CA 125.865 1.698 . . . . 0.0 116.541 171.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 110.81 42.39 1.12 Allowed Glycine 0 CA--C 1.522 0.51 0 CA-C-N 120.034 1.917 . . . . 0.0 112.877 168.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -112.19 154.6 25.29 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 118.332 1.066 . . . . 0.0 110.121 169.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.81 151.13 39.09 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -91.98 120.47 32.67 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 59.0 tp -59.47 125.33 23.2 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.486 1.115 . . . . 0.0 109.794 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -139.82 -47.59 0.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.719 0.808 . . . . 0.0 111.133 173.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -164.09 -55.52 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 125.254 1.422 . . . . 0.0 109.022 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 47.91 31.83 2.52 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.822 2.049 . . . . 0.0 112.898 -170.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -139.48 27.74 2.27 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.395 1.878 . . . . 0.0 108.937 175.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 . . . . . 0 C--O 1.247 0.956 0 C-N-CA 126.913 2.085 . . . . 0.0 106.9 -176.806 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 tpt . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.4 m -137.47 135.54 36.92 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 172.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -129.94 118.53 21.8 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 105.056 -2.202 . . . . 0.0 105.056 -174.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.4 t -121.84 147.45 25.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.431 0.634 . . . . 0.0 109.995 -165.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 28.6 tp -116.27 127.95 55.16 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 56.8 tp -117.45 94.49 4.57 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 94.5 m -71.14 143.51 50.54 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.459 -0.791 . . . . 0.0 108.918 170.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.9 t -141.38 141.46 30.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 125.23 1.412 . . . . 0.0 107.655 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 143.38 176.34 17.33 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 124.494 1.045 . . . . 0.0 111.949 176.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -120.83 121.49 38.25 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 125.017 1.327 . . . . 0.0 108.124 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 m -59.07 -16.86 21.19 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.438 1.895 . . . . 0.0 115.342 -169.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -126.38 14.27 7.69 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.958 0.903 . . . . 0.0 111.03 -175.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.6 ttt -97.84 32.77 2.26 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.274 0.63 . . . . 0.0 109.586 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.2 -146.3 27.66 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -174.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -60.31 -17.39 42.45 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 126.028 1.731 . . . . 0.0 112.377 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -51.72 -28.03 13.75 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.022 1.329 . . . . 0.0 112.681 175.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.28 26.61 0.56 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.845 1.212 . . . . 0.0 114.456 178.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.77 -50.19 73.38 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 119.291 1.545 . . . . 0.0 110.297 -173.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.95 -56.69 23.33 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-O 117.75 -1.584 . . . . 0.0 111.111 175.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -48.78 -41.04 39.2 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 CA-C-N 120.972 2.386 . . . . 0.0 115.214 178.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.0 tp -71.24 -37.91 71.98 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-N 119.962 1.255 . . . . 0.0 110.605 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.6 tp -60.97 -48.35 82.23 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.308 0.504 . . . . 0.0 109.934 175.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.19 -40.01 88.56 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.773 0.829 . . . . 0.0 111.046 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.6 tp10 -61.06 -49.54 76.96 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 118.492 0.587 . . . . 0.0 109.535 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -63.51 -44.83 93.15 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 119.192 -0.433 . . . . 0.0 110.742 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 75.4 m -63.71 -42.25 97.99 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.716 0.689 . . . . 0.0 111.039 178.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.83 -41.15 99.21 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.417 0.553 . . . . 0.0 110.788 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.92 -32.86 72.78 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.379 0.672 . . . . 0.0 111.99 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.7 88.53 3.29 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 124.707 1.203 . . . . 0.0 109.014 -171.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -51.39 160.92 2.07 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 123.967 3.111 . . . . 0.0 114.329 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -135.75 164.26 28.31 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.473 1.509 . . . . 0.0 108.964 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 41.8 -120.18 2.03 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.491 1.52 . . . . 0.0 111.374 175.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -140.91 34.99 1.76 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.844 1.257 . . . . 0.0 109.443 170.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -69.3 162.21 27.68 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.636 0.774 . . . . 0.0 111.99 -174.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.2 t -116.61 119.13 61.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 103.728 -2.693 . . . . 0.0 103.728 165.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.4 t -88.1 136.79 22.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -172.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 73.0 mt -133.08 143.99 37.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 104.705 -2.332 . . . . 0.0 104.705 169.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -128.03 106.96 9.43 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 172.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.14 -2.98 80.63 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-O 118.929 -0.928 . . . . 0.0 112.807 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 56.83 -147.29 33.7 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 -168.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.6 p -86.61 10.38 15.71 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.732 -0.863 . . . . 0.0 111.876 177.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.76 59.76 17.19 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 125.138 1.375 . . . . 0.0 110.519 -175.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -67.75 -15.4 44.22 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.824 2.35 . . . . 0.0 113.355 -172.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -57.25 -30.75 64.91 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.824 0.738 . . . . 0.0 112.126 173.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.0 -28.46 70.11 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.185 0.594 . . . . 0.0 111.97 175.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.18 -4.12 36.19 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.954 1.301 . . . . 0.0 111.894 -169.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.8 mt -48.57 -43.73 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 124.265 1.026 . . . . 0.0 109.79 170.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 52.5 t -59.5 -38.73 76.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 118.591 0.632 . . . . 0.0 110.644 -177.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.69 -44.53 81.48 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 121.918 -0.489 . . . . 0.0 110.21 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 77.6 mt -60.02 -39.62 80.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 123.489 0.716 . . . . 0.0 109.507 176.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -65.8 -20.33 66.21 Favored 'General case' 0 N--CA 1.462 0.145 0 O-C-N 121.024 -1.048 . . . . 0.0 112.311 178.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -75.55 -48.18 23.56 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 120.122 1.328 . . . . 0.0 109.087 169.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.8 mt -66.04 -26.94 67.75 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.402 0.681 . . . . 0.0 112.368 -175.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 42.77 59.61 10.76 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 125.87 1.668 . . . . 0.0 110.863 -175.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -53.92 146.35 47.23 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.691 2.26 . . . . 0.0 113.413 -169.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.3 m -74.75 -35.1 62.6 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 167.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -147.98 152.5 37.58 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.78 1.232 . . . . 0.0 109.086 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 51.3 tp -140.9 141.37 34.57 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.433 1.093 . . . . 0.0 108.862 -177.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 58.8 tp -125.54 136.92 53.83 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 170.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.5 mt -121.17 143.67 32.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.5 t -140.58 135.41 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 118.586 0.63 . . . . 0.0 110.018 -173.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -162.9 170.37 18.27 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.727 2.411 . . . . 0.0 107.454 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.48 154.94 39.71 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 168.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.9 m -153.23 124.13 7.37 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -69.64 120.99 16.25 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 169.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 76.7 mtm -119.04 1.29 11.41 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.636 1.575 . . . . 0.0 110.704 -177.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.94 34.2 89.24 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 118.929 0.786 . . . . 0.0 111.577 -172.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.3 mt -111.54 -172.14 1.98 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.774 1.63 . . . . 0.0 109.446 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -75.28 140.18 72.62 Favored Pre-proline 0 N--CA 1.468 0.453 0 CA-C-O 117.456 -1.259 . . . . 0.0 108.681 173.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -43.64 136.55 6.55 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.198 2.599 . . . . 0.0 112.896 172.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.65 1.79 83.95 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-O 118.584 -1.12 . . . . 0.0 113.758 177.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -65.75 147.24 53.71 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 120.02 1.91 . . . . 0.0 108.68 168.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 66.9 mt -126.82 133.12 69.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 C-N-CA 125.403 1.481 . . . . 0.0 107.077 -172.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.3 mmt-85 -143.42 151.81 40.81 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.864 0.756 . . . . 0.0 109.691 174.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 48.7 mm -80.83 145.72 8.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 168.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 11.1 mt -131.81 123.39 51.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -175.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -76.81 140.69 67.51 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-O 117.87 -1.062 . . . . 0.0 109.716 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_exo -46.81 -35.24 17.4 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 124.264 3.309 . . . . 0.0 116.677 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -68.59 -23.96 64.53 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.648 0.658 . . . . 0.0 111.687 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -98.81 -31.46 11.86 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.279 1.431 . . . . 0.0 111.116 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 68.0 mt -50.11 -40.82 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.796 1.238 . . . . 0.0 109.569 169.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.93 -19.97 7.9 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.887 1.675 . . . . 0.0 114.327 -175.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -124.33 -37.0 2.58 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 118.72 0.691 . . . . 0.0 110.553 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 21.3 mmt -66.85 -29.43 69.34 Favored 'General case' 0 N--CA 1.46 0.063 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -175.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -69.35 -45.4 69.52 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 119.155 0.889 . . . . 0.0 110.487 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 21.7 ptp -78.31 8.02 5.61 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 118.923 -0.56 . . . . 0.0 112.468 176.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 50.0 tpp -61.24 -27.51 68.5 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.945 1.248 . . . . 0.0 109.743 168.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 68.4 p -62.16 -12.69 21.16 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.914 1.686 . . . . 0.0 113.008 169.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.8 m 57.48 30.6 18.93 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.919 1.687 . . . . 0.0 109.963 -168.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -152.64 -57.63 0.14 Allowed 'General case' 0 C--N 1.345 0.391 0 O-C-N 121.344 -0.847 . . . . 0.0 113.12 -172.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -67.46 146.35 54.08 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 122.838 0.455 . . . . 0.0 109.899 -169.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 94.8 mmm -67.13 148.95 98.73 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 123.228 0.611 . . . . 0.0 109.565 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -71.9 72.66 2.58 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 124.273 3.315 . . . . 0.0 109.433 171.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.7 mt -48.94 -11.47 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 128.532 2.733 . . . . 0.0 116.854 -168.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.04 -22.59 6.11 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.188 0.995 . . . . 0.0 112.608 168.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -59.51 -33.77 71.77 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.336 0.971 . . . . 0.0 111.755 175.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.9 tt -73.41 -44.49 58.26 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 74.4 mt -60.55 -42.29 90.93 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.107 0 C-N-CA 123.258 0.623 . . . . 0.0 109.63 -177.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -60.5 -24.37 65.25 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -176.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -85.03 -11.42 55.41 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.754 0.822 . . . . 0.0 112.063 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.4 mp -121.14 -31.28 4.16 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.32 1.448 . . . . 0.0 111.855 -168.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -60.57 -21.1 62.22 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.68 1.192 . . . . 0.0 112.611 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -71.78 -11.31 60.75 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.593 1.157 . . . . 0.0 111.694 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -134.35 -38.55 0.84 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.092 0.957 . . . . 0.0 112.138 -176.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 53.3 mt -72.17 139.96 18.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 174.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.08 -41.64 94.96 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.052 0.834 . . . . 0.0 111.972 -178.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -149.41 137.63 20.67 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 118.564 1.182 . . . . 0.0 108.612 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 41.4 t -131.13 123.98 54.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 19.9 mt -127.09 154.79 37.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 -171.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -129.74 141.84 50.81 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 173.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.1 tt -121.76 128.42 51.73 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 173.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -114.67 156.29 15.75 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 72.5 mt -131.98 128.09 59.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -177.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.1 tp60 -62.55 115.48 16.91 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 117.579 -1.201 . . . . 0.0 110.157 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -78.76 172.91 14.35 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.143 2.562 . . . . 0.0 111.552 171.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -137.29 -30.7 0.84 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 127.811 2.444 . . . . 0.0 111.045 173.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -129.74 124.14 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 -176.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.7 t -145.27 132.91 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 151.63 150.56 5.37 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -63.8 149.95 45.76 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 118.155 0.978 . . . . 0.0 110.901 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 57.95 43.62 21.03 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.601 1.96 . . . . 0.0 111.951 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -127.72 140.65 38.7 Favored Pre-proline 0 C--O 1.236 0.345 0 C-N-CA 124.116 0.967 . . . . 0.0 108.78 168.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -73.97 161.66 40.74 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.462 2.108 . . . . 0.0 110.041 170.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 52.1 ttm -70.27 139.49 52.17 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 168.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 33.1 p -76.32 156.49 33.31 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.134 0.974 . . . . 0.0 110.504 176.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.1 tm0? -49.32 -46.79 77.5 Favored Pre-proline 0 CA--C 1.544 0.733 0 CA-C-O 117.009 -1.472 . . . . 0.0 113.912 -178.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.46 -28.0 32.87 Favored 'Trans proline' 0 C--N 1.35 0.645 0 CA-C-N 122.616 1.97 . . . . 0.0 112.257 -175.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 mp -80.41 -35.55 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 119.358 0.981 . . . . 0.0 108.64 177.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -56.91 -47.23 81.03 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.405 1.002 . . . . 0.0 109.913 170.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -61.3 -41.81 97.6 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 123.303 0.641 . . . . 0.0 111.013 178.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.98 -48.99 77.89 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 119.121 -0.466 . . . . 0.0 110.929 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 56.0 t -59.48 -41.04 83.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 118.712 0.687 . . . . 0.0 109.728 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -68.94 -30.48 68.95 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.028 0.831 . . . . 0.0 111.483 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 32.9 m -69.41 -40.97 76.98 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.062 -1.024 . . . . 0.0 109.981 174.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 77.4 t -61.25 -50.08 81.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -56.28 -35.66 67.72 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.517 1.127 . . . . 0.0 112.156 177.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -67.9 -43.52 79.08 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.524 1.056 . . . . 0.0 110.685 171.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -58.91 -31.39 68.59 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 118.568 -0.729 . . . . 0.0 112.441 176.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.7 mp -56.52 -22.96 36.5 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.449 1.022 . . . . 0.0 111.973 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 -71.84 -16.3 62.15 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 119.449 1.022 . . . . 0.0 112.795 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -149.71 -0.36 0.41 Allowed Glycine 0 CA--C 1.533 1.213 0 N-CA-C 115.512 0.965 . . . . 0.0 115.512 -171.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 25.8 t90 -58.72 140.37 54.86 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.239 1.519 . . . . 0.0 109.022 170.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -138.49 10.63 2.72 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.44 1.096 . . . . 0.0 111.577 173.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 165.62 -47.93 0.28 Allowed Glycine 0 C--N 1.338 0.679 0 O-C-N 121.403 -0.811 . . . . 0.0 111.234 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -123.12 -24.36 4.73 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 54.86 26.27 40.09 Favored Glycine 0 CA--C 1.536 1.359 0 CA-C-N 119.267 0.94 . . . . 0.0 112.755 -172.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.38 -8.84 51.9 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 118.159 -1.356 . . . . 0.0 114.104 -176.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -69.23 145.46 53.15 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 120.362 2.081 . . . . 0.0 110.26 175.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.9 153.41 38.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.574 176.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -93.42 121.88 35.27 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 50.1 tp -56.47 124.45 18.22 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.663 1.585 . . . . 0.0 109.837 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.56 62.2 1.49 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.458 1.103 . . . . 0.0 109.006 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.6 t 52.86 42.01 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 125.463 1.505 . . . . 0.0 110.115 -176.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -73.01 157.67 36.92 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.001 0.92 . . . . 0.0 108.804 172.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -154.67 158.12 39.15 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.264 1.426 . . . . 0.0 107.685 169.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 . . . . . 0 C--O 1.248 1.005 0 C-N-CA 124.519 1.128 . . . . 0.0 108.062 175.843 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.482 1.135 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.8 m -134.97 138.05 43.65 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 173.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -137.85 101.01 4.33 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -168.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 56.3 t -93.93 146.69 6.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.556 0.693 . . . . 0.0 109.655 -169.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 58.5 tp -115.76 114.75 25.21 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 170.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 55.3 tp -103.59 102.29 12.16 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.456 1.102 . . . . 0.0 108.03 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 90.6 m -76.63 142.3 40.7 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 170.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.5 t -141.0 142.63 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 143.49 178.77 19.57 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -132.53 121.0 22.63 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 124.613 1.165 . . . . 0.0 108.443 177.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 m -58.58 -5.33 0.53 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.957 2.503 . . . . 0.0 116.391 -169.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -133.03 10.36 4.19 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.294 0.952 . . . . 0.0 111.446 -176.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 63.8 mtp -95.71 27.97 3.24 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.599 0.76 . . . . 0.0 110.581 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.6 -139.34 19.39 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 -177.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -62.9 -15.81 56.59 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.321 1.048 . . . . 0.0 112.148 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -58.29 -18.6 28.11 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.922 1.289 . . . . 0.0 112.755 174.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.54 19.67 0.86 Allowed Glycine 0 CA--C 1.535 1.3 0 O-C-N 120.626 -1.296 . . . . 0.0 114.237 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.85 -53.3 57.72 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 119.865 1.832 . . . . 0.0 111.157 -169.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.92 -53.93 41.7 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-O 117.953 -1.471 . . . . 0.0 111.21 176.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -50.57 -38.97 55.92 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 CA-C-N 120.907 2.353 . . . . 0.0 115.188 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.1 tp -70.3 -38.7 75.05 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 120.029 1.286 . . . . 0.0 110.243 177.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 51.1 tp -61.89 -48.89 78.43 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.001 0.364 . . . . 0.0 110.219 175.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.66 -41.05 80.73 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 124.302 1.041 . . . . 0.0 111.115 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -61.7 -48.74 79.4 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.771 0.714 . . . . 0.0 109.995 178.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -61.13 -46.24 91.38 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 122.817 0.447 . . . . 0.0 110.518 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 85.6 m -64.0 -40.38 96.23 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.278 0.49 . . . . 0.0 111.117 178.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.44 -38.9 92.92 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.334 0.516 . . . . 0.0 110.947 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.64 -37.65 76.86 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.3 0.64 . . . . 0.0 111.244 178.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.72 98.81 1.69 Allowed Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 125.122 1.369 . . . . 0.0 108.549 -172.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.52 167.36 25.64 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.305 2.004 . . . . 0.0 111.679 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -128.62 177.41 7.05 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.927 1.691 . . . . 0.0 108.654 177.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 41.16 -124.65 2.95 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.054 1.311 . . . . 0.0 112.317 175.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -141.44 37.91 1.69 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.25 1.42 . . . . 0.0 109.337 172.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -72.63 167.83 19.93 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.374 1.07 . . . . 0.0 111.85 -174.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.0 t -123.57 110.31 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 167.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.6 t -75.21 139.32 19.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -175.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 22.9 mm -134.59 147.95 29.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 169.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -130.72 112.2 12.87 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 176.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.52 -11.49 80.18 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 118.79 -1.005 . . . . 0.0 112.982 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.65 35.51 81.44 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 119.017 1.408 . . . . 0.0 113.667 170.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 66.92 10.26 7.49 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.772 1.629 . . . . 0.0 113.5 -177.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.79 53.68 4.84 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 125.341 1.457 . . . . 0.0 108.794 173.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -64.02 -24.63 66.79 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.488 2.125 . . . . 0.0 112.7 -169.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -63.49 -33.53 75.77 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.974 0.806 . . . . 0.0 111.741 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.52 -22.57 67.0 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.569 0.748 . . . . 0.0 111.552 174.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -105.59 -2.2 23.77 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.444 1.098 . . . . 0.0 112.653 -169.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.8 mt -47.24 -42.73 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.989 1.315 . . . . 0.0 110.372 173.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.3 t -56.42 -42.32 74.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.068 0.547 . . . . 0.0 110.167 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.12 -35.55 76.54 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.072 0.549 . . . . 0.0 111.525 -177.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 68.6 mt -63.83 -46.88 93.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 173.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 37.0 mtp180 -69.37 -22.43 63.73 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 117.888 -1.053 . . . . 0.0 112.624 -174.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -56.33 -32.45 64.67 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 120.535 1.516 . . . . 0.0 110.847 170.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 55.1 mt -86.64 -10.85 52.94 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.11 0.964 . . . . 0.0 112.773 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 28.68 61.85 0.72 Allowed Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 126.825 2.05 . . . . 0.0 112.54 -167.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.53 149.15 40.33 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.294 2.663 . . . . 0.0 113.873 -169.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.0 m -71.81 -37.59 70.36 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 168.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -147.97 156.61 42.86 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.059 0.944 . . . . 0.0 109.537 -176.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 41.7 tp -143.75 139.09 29.25 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 124.805 1.242 . . . . 0.0 108.653 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 57.1 tp -124.1 137.17 54.6 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 169.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.7 mt -120.58 143.21 33.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.4 t -140.58 134.03 33.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 118.442 0.565 . . . . 0.0 109.83 -175.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -161.87 172.57 15.86 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.241 2.217 . . . . 0.0 107.39 170.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.49 157.51 36.98 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 121.288 -0.883 . . . . 0.0 108.753 167.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.2 m -152.8 129.38 10.75 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -77.52 82.78 3.94 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 118.921 0.782 . . . . 0.0 109.731 176.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 77.5 mtm -76.82 -6.45 52.38 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.281 1.433 . . . . 0.0 111.806 -177.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.36 25.61 72.43 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.091 0.853 . . . . 0.0 111.752 -174.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 47.5 mt -107.84 -168.56 1.39 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.512 1.125 . . . . 0.0 109.873 -176.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -79.31 138.47 55.82 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-O 117.738 -1.125 . . . . 0.0 109.263 175.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -45.51 134.93 12.68 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.474 2.782 . . . . 0.0 113.864 177.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.13 1.82 90.17 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-O 118.597 -1.113 . . . . 0.0 113.238 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -64.1 145.79 55.32 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 119.767 1.784 . . . . 0.0 107.804 167.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 59.0 mt -126.74 137.33 58.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 -175.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.2 mmt-85 -147.59 150.19 33.98 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 118.792 0.724 . . . . 0.0 111.445 175.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 50.2 mm -72.97 149.38 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 164.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.6 mt -133.41 133.62 57.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -80.91 142.75 52.52 Favored Pre-proline 0 N--CA 1.471 0.614 0 CA-C-O 117.508 -1.234 . . . . 0.0 109.37 174.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -46.59 -37.48 20.35 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 123.997 3.131 . . . . 0.0 116.435 177.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -69.57 -22.32 63.54 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.552 0.614 . . . . 0.0 111.603 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -97.13 -34.1 11.26 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.956 1.303 . . . . 0.0 110.75 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.407 HD11 ' CB ' ' A' ' 110' ' ' PHE . 83.7 mt -50.81 -42.15 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 125.513 1.525 . . . . 0.0 109.111 169.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.55 -23.61 51.49 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.611 1.164 . . . . 0.0 113.571 -175.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -107.39 -40.76 5.27 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 123.184 0.593 . . . . 0.0 109.613 176.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 22.4 mmt -71.71 -29.49 64.62 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -169.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -71.09 -43.03 68.54 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 119.458 1.026 . . . . 0.0 110.981 175.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 28.9 ptm -81.21 10.74 4.98 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 176.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 51.3 tpp -61.78 -24.77 67.06 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.417 1.008 . . . . 0.0 109.862 168.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 45.0 p -62.16 -15.65 47.46 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.347 1.859 . . . . 0.0 112.81 169.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.6 m 60.57 22.03 11.81 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.139 1.776 . . . . 0.0 110.344 -168.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -142.15 -53.61 0.43 Allowed 'General case' 0 C--N 1.343 0.324 0 O-C-N 121.208 -0.932 . . . . 0.0 112.161 -169.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -69.61 147.88 50.11 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 118.272 0.487 . . . . 0.0 110.719 -168.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 12.7 tpt -61.76 140.92 95.34 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 171.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.96 81.34 1.95 Allowed 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 124.044 3.163 . . . . 0.0 109.686 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.8 mt -47.2 -11.12 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 128.326 2.65 . . . . 0.0 118.116 -168.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.06 -23.6 8.07 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.333 0.969 . . . . 0.0 112.821 168.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -59.19 -33.07 70.51 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.351 0.978 . . . . 0.0 111.883 175.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.6 tt -74.58 -43.23 56.63 Favored 'General case' 0 C--N 1.338 0.071 0 O-C-N 121.719 -0.613 . . . . 0.0 109.399 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 87.7 mt -61.73 -40.14 85.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.544 0.738 . . . . 0.0 109.728 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -57.39 -30.61 65.05 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.262 0.625 . . . . 0.0 112.264 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -84.74 -1.62 56.51 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.427 1.091 . . . . 0.0 112.27 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 70.7 mt -126.53 -26.13 3.33 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.457 1.103 . . . . 0.0 112.061 -175.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -58.69 -29.45 66.64 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.805 1.184 . . . . 0.0 111.82 170.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -66.97 -11.93 58.16 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.992 0.917 . . . . 0.0 113.132 173.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -129.84 -11.42 4.33 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.382 1.073 . . . . 0.0 113.701 -168.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 46.7 mt -132.33 143.41 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 125.488 1.515 . . . . 0.0 107.995 -169.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -68.52 -40.77 86.14 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-O 119.211 -0.772 . . . . 0.0 112.261 -175.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -147.46 138.75 23.77 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 118.686 1.243 . . . . 0.0 108.52 177.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 51.3 t -134.25 121.62 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 -176.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 18.2 mt -127.41 154.66 38.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 -170.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.407 ' CB ' HD11 ' A' ' 81' ' ' ILE . 4.8 t80 -130.32 144.19 51.23 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 174.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.3 tt -124.96 128.21 48.25 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 173.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -111.14 156.48 15.52 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 74.4 mt -133.44 126.39 52.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -66.12 117.27 41.21 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 117.368 -1.301 . . . . 0.0 110.296 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -76.84 172.06 16.88 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.515 2.81 . . . . 0.0 111.499 170.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -128.44 -32.27 2.21 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.882 1.673 . . . . 0.0 111.103 171.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -135.55 135.21 51.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 176.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.3 t -141.22 134.85 31.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 175.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 157.81 155.1 7.38 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 177.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -64.96 153.62 40.01 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.941 0.877 . . . . 0.0 111.339 -174.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 52.88 39.64 29.42 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.036 2.134 . . . . 0.0 112.127 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -123.41 148.76 56.32 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 123.828 0.851 . . . . 0.0 109.943 173.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -82.15 163.02 17.76 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.262 2.641 . . . . 0.0 111.184 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 53.1 ttm -71.47 139.41 49.6 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 168.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 72.5 p -79.65 159.27 26.79 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.356 1.063 . . . . 0.0 110.538 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.3 tp60 -53.06 -44.54 97.31 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 116.565 -1.683 . . . . 0.0 114.197 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -68.42 -30.46 29.65 Favored 'Trans proline' 0 C--N 1.352 0.717 0 CA-C-N 122.888 2.067 . . . . 0.0 112.176 -176.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.8 -35.45 16.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 119.026 0.83 . . . . 0.0 108.788 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -56.5 -46.85 80.29 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.318 0.963 . . . . 0.0 110.074 170.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -63.94 -37.98 89.41 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 123.039 0.536 . . . . 0.0 111.203 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.69 -47.28 78.97 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 119.108 -0.472 . . . . 0.0 111.045 175.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 76.5 t -61.5 -38.56 80.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 118.915 0.779 . . . . 0.0 109.688 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -63.65 -39.2 93.74 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 119.361 0.982 . . . . 0.0 110.926 174.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 41.2 m -64.76 -45.01 88.21 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.55 -0.719 . . . . 0.0 110.092 177.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 73.8 t -62.26 -44.48 99.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.32 0.648 . . . . 0.0 109.574 176.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -55.41 -47.44 75.9 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.032 0.933 . . . . 0.0 110.521 177.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -63.77 -38.98 93.14 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 121.827 -0.546 . . . . 0.0 111.248 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -61.12 -25.57 67.07 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 118.27 -0.872 . . . . 0.0 112.534 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 94.5 mt -57.7 -23.36 51.3 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.99 1.268 . . . . 0.0 112.195 178.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -84.4 0.56 48.98 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 118.973 0.806 . . . . 0.0 112.428 -178.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -151.15 -14.51 0.08 OUTLIER Glycine 0 CA--C 1.533 1.171 0 N-CA-C 115.331 0.892 . . . . 0.0 115.331 -174.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 24.8 t90 -57.85 142.25 46.49 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.969 1.384 . . . . 0.0 109.261 172.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -140.8 15.7 2.31 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.704 1.202 . . . . 0.0 110.184 177.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 149.89 -33.89 1.04 Allowed Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.876 1.227 . . . . 0.0 111.648 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -135.51 -28.14 1.14 Allowed 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -172.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 61.07 13.35 34.22 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-N 118.931 0.787 . . . . 0.0 115.038 175.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 83.96 2.18 89.61 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-O 118.411 -1.216 . . . . 0.0 112.984 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -72.36 160.68 31.95 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 119.92 1.86 . . . . 0.0 110.159 174.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.29 153.69 21.79 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 169.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -91.29 134.61 34.44 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 173.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 56.8 tp -62.36 127.23 30.36 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 175.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -150.66 79.34 1.33 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . 0.285 27.0 m 43.89 39.08 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 127.589 2.356 . . . . 0.0 114.158 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -70.27 166.21 20.62 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.12 0.968 . . . . 0.0 110.323 172.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -144.27 155.57 43.9 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.327 1.851 . . . . 0.0 106.533 171.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 . . . . . 0 C--O 1.247 0.974 0 C-N-CA 123.528 0.731 . . . . 0.0 109.578 169.763 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.7 tpp . . . . . 0 N--CA 1.483 1.19 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 51.0 m -101.7 100.89 11.31 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 170.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -84.54 147.03 27.25 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 170.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 79.8 t -137.35 146.91 27.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 36.1 tp -121.55 128.32 51.89 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 56.0 tp -118.83 95.98 5.06 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 89.1 m -70.39 142.96 52.03 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 169.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.8 t -140.64 142.08 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.314 1.446 . . . . 0.0 107.327 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 143.53 172.61 14.5 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 123.976 0.798 . . . . 0.0 112.059 175.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -110.2 118.56 36.67 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.537 1.135 . . . . 0.0 108.16 177.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -60.53 -13.88 16.55 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.235 1.814 . . . . 0.0 115.14 -170.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 26.0 ptm -127.94 18.13 6.68 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.584 1.153 . . . . 0.0 111.246 -173.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.2 ttt -110.72 37.95 2.63 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.101 0.864 . . . . 0.0 110.055 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.83 -141.37 26.24 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -61.35 -16.77 49.47 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.498 1.519 . . . . 0.0 112.198 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -60.51 -16.06 33.33 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.17 0.988 . . . . 0.0 112.127 174.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.64 17.16 2.77 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-O 118.35 -1.25 . . . . 0.0 113.649 174.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.09 -50.43 71.96 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 119.891 1.846 . . . . 0.0 111.123 -170.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.84 -54.96 32.59 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-O 117.789 -1.562 . . . . 0.0 110.825 175.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -48.51 -40.1 37.01 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 CA-C-N 120.758 2.279 . . . . 0.0 115.206 175.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.6 tp -71.4 -37.94 71.5 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.931 1.242 . . . . 0.0 110.466 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.8 tp -61.22 -46.89 88.58 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.235 0.47 . . . . 0.0 110.033 174.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.09 -40.74 86.2 Favored 'General case' 0 C--O 1.226 -0.159 0 C-N-CA 123.71 0.804 . . . . 0.0 111.036 178.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.8 tp10 -61.71 -49.52 76.12 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.601 0.637 . . . . 0.0 109.549 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -63.74 -45.6 89.12 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.87 0.468 . . . . 0.0 110.71 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 74.0 m -65.05 -37.84 88.87 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.703 0.683 . . . . 0.0 111.172 178.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.37 -40.38 95.73 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.263 0.938 . . . . 0.0 110.876 176.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.36 -34.05 75.38 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.277 0.631 . . . . 0.0 111.705 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.12 90.52 3.51 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 125.164 1.386 . . . . 0.0 108.792 -173.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -51.64 162.01 1.8 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 124.127 3.218 . . . . 0.0 114.486 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.417 ' HE2' ' CE1' ' A' ' 136' ' ' TYR . 36.7 mmtm -134.81 156.43 48.89 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 124.538 1.135 . . . . 0.0 110.052 -178.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 38.57 -111.45 0.17 Allowed Glycine 0 CA--C 1.527 0.817 0 C-N-CA 126.394 1.949 . . . . 0.0 113.096 170.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -137.74 9.68 2.86 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.392 1.477 . . . . 0.0 111.018 -171.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -81.77 126.41 31.8 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 121.33 -0.856 . . . . 0.0 111.205 -168.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.9 t -75.27 117.77 20.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 165.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.1 t -80.13 134.51 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -177.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 84.7 mt -133.54 146.19 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 170.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -127.57 110.47 12.74 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 173.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.5 -1.38 90.2 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 119.105 -0.83 . . . . 0.0 112.864 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 56.34 -147.57 31.24 Favored Glycine 0 C--N 1.339 0.737 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 -169.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.9 p -88.66 6.78 36.8 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.522 0.729 . . . . 0.0 112.155 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.37 58.2 20.24 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.179 1.392 . . . . 0.0 109.856 -177.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -68.68 -16.15 41.85 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.844 2.363 . . . . 0.0 113.237 -169.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -57.37 -31.07 65.41 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.479 0.711 . . . . 0.0 111.882 175.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.24 -28.26 69.04 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.256 0.622 . . . . 0.0 112.157 175.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.4 -2.48 45.46 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.967 1.307 . . . . 0.0 111.936 -169.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 87.9 mt -51.71 -43.72 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 123.923 0.889 . . . . 0.0 109.915 176.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.5 t -58.26 -41.05 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.265 0.626 . . . . 0.0 110.192 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.0 -44.96 75.36 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.241 0.473 . . . . 0.0 110.674 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.2 mt -59.11 -42.26 86.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -59.88 -31.17 69.54 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 118.061 -0.971 . . . . 0.0 111.847 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -59.97 -31.76 70.19 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.985 1.266 . . . . 0.0 111.133 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.6 mt -81.99 -13.0 58.04 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.176 0.99 . . . . 0.0 112.095 -175.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 72.8 mtp180 33.15 61.79 1.56 Allowed Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 126.552 1.941 . . . . 0.0 111.721 -169.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -53.88 143.2 61.14 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.008 2.472 . . . . 0.0 113.074 -169.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.4 m -72.81 -38.8 67.07 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 167.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 71.4 mtm180 -144.45 156.87 44.4 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 124.455 1.102 . . . . 0.0 108.969 176.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 45.6 tp -137.72 140.24 40.61 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.4 tp -126.24 136.38 52.73 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 174.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.0 mt -125.07 142.06 43.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 -174.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.1 t -141.56 133.77 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 118.806 0.73 . . . . 0.0 110.846 -174.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -161.36 172.21 16.96 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.565 2.346 . . . . 0.0 107.647 169.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.45 156.81 38.26 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.011 -1.056 . . . . 0.0 108.895 168.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.0 m -156.15 129.18 8.0 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 177.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -71.84 124.64 25.26 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 173.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 74.2 mtm -123.6 1.51 8.88 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.16 1.784 . . . . 0.0 110.766 -177.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.64 24.45 66.2 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-N 118.683 0.674 . . . . 0.0 112.423 -172.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.9 mt -95.74 -173.69 2.93 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.223 1.409 . . . . 0.0 109.333 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -73.38 140.4 79.27 Favored Pre-proline 0 N--CA 1.466 0.355 0 CA-C-O 117.72 -1.133 . . . . 0.0 108.18 170.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -44.23 136.59 8.07 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.258 2.639 . . . . 0.0 112.748 173.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.27 1.97 82.36 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-O 118.501 -1.166 . . . . 0.0 113.796 177.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -67.89 152.21 45.92 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 120.135 1.968 . . . . 0.0 108.257 168.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 51.5 mt -131.5 134.67 60.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -169.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.6 mmt-85 -147.01 148.85 32.11 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 118.721 0.691 . . . . 0.0 109.772 175.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 44.3 mm -73.79 152.85 7.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 166.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.9 mt -135.18 134.74 52.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 176.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -79.02 143.4 61.38 Favored Pre-proline 0 N--CA 1.472 0.661 0 CA-C-O 117.4 -1.286 . . . . 0.0 109.256 173.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo -45.47 -38.22 15.73 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 124.029 3.152 . . . . 0.0 116.439 176.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -68.04 -26.34 65.82 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.363 0.529 . . . . 0.0 111.523 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -94.35 -29.91 14.78 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.786 1.235 . . . . 0.0 111.232 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.487 HD11 ' HB3' ' A' ' 110' ' ' PHE . 59.9 mt -51.71 -45.59 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.15 1.38 . . . . 0.0 109.339 170.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -52.96 -31.35 40.0 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.292 1.037 . . . . 0.0 112.898 -177.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -96.8 -37.63 10.19 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.328 0.651 . . . . 0.0 110.328 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 24.8 mmt -80.64 -27.08 37.32 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 119.09 -0.481 . . . . 0.0 112.249 -170.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -64.8 -45.9 84.31 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 119.187 0.903 . . . . 0.0 110.286 175.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 20.2 ptt? -71.4 -7.63 48.51 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 45.0 tpp -59.18 -26.81 65.11 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.888 0.875 . . . . 0.0 112.106 -175.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 22.6 p -59.51 -55.53 33.36 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.163 0.985 . . . . 0.0 110.286 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -165.98 -46.51 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.776 1.63 . . . . 0.0 110.334 174.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -157.41 -44.39 0.07 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.728 0.811 . . . . 0.0 110.452 -179.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 47.8 -138.87 0.71 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.9 1.28 . . . . 0.0 110.567 176.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 71.0 mtm -139.66 144.15 38.07 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 169.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.21 55.48 5.08 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 124.233 3.289 . . . . 0.0 111.046 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.1 mt -48.68 -9.84 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 129.182 2.993 . . . . 0.0 117.836 -167.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.95 -20.34 6.01 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.31 0.959 . . . . 0.0 112.055 167.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -59.91 -27.18 66.52 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.557 1.071 . . . . 0.0 112.582 173.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.7 tt -63.35 -49.42 73.98 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 119.141 0.882 . . . . 0.0 108.909 172.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 84.1 mt -64.82 -43.21 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -63.54 -19.65 64.97 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -175.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -102.55 8.77 39.78 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.176 1.39 . . . . 0.0 111.781 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.6 tp -140.31 -25.77 0.78 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.826 0.851 . . . . 0.0 112.163 -170.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 50.5 pttt -56.01 -24.66 40.4 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.51 1.524 . . . . 0.0 112.271 172.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -62.4 -17.07 58.31 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.996 1.318 . . . . 0.0 112.635 -172.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -130.15 9.12 5.21 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.646 0.778 . . . . 0.0 112.584 -175.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 56.3 mt -122.96 143.14 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.894 1.278 . . . . 0.0 108.409 -175.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -73.43 -37.01 54.14 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.868 0.747 . . . . 0.0 112.027 -177.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -149.43 136.56 19.83 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 118.226 1.013 . . . . 0.0 108.508 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 43.8 t -122.24 128.92 75.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 171.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.8 mt -126.64 149.26 31.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 -169.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.487 ' HB3' HD11 ' A' ' 81' ' ' ILE . 60.0 t80 -131.31 144.46 51.28 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 169.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.1 tt -124.56 127.79 47.94 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.45 1.5 . . . . 0.0 107.045 174.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -109.77 155.82 15.9 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 78.4 mt -133.78 127.69 52.82 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 -178.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 69.1 tp60 -61.77 114.79 12.28 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-O 117.467 -1.254 . . . . 0.0 110.517 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -77.34 171.46 17.66 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.402 2.735 . . . . 0.0 111.188 170.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -138.24 -26.93 0.9 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 127.088 2.155 . . . . 0.0 111.536 173.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -136.77 120.12 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 -173.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.5 t -143.22 129.4 16.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 156.76 151.75 6.07 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -63.21 145.28 55.84 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.421 0.629 . . . . 0.0 110.765 -174.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 64.83 0.08 1.1 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 128.199 2.6 . . . . 0.0 113.834 -175.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 19.3 m-30 -77.28 142.51 67.88 Favored Pre-proline 0 C--O 1.237 0.418 0 CA-C-N 120.309 1.413 . . . . 0.0 109.133 174.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -73.61 158.29 47.58 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.48 2.12 . . . . 0.0 109.914 169.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 47.3 ttm -73.88 142.78 46.0 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 168.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 29.9 p -81.12 155.09 26.42 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.082 0.953 . . . . 0.0 110.798 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -53.69 -40.43 80.64 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-O 116.529 -1.7 . . . . 0.0 114.729 -178.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -63.68 -39.68 33.57 Favored 'Trans proline' 0 C--N 1.35 0.647 0 CA-C-N 122.819 2.043 . . . . 0.0 111.291 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.6 mp -73.21 -37.53 52.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -57.19 -47.06 82.21 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.35 0.977 . . . . 0.0 110.305 172.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -63.99 -39.25 93.7 Favored 'General case' 0 C--N 1.334 -0.095 0 C-N-CA 122.959 0.504 . . . . 0.0 110.903 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.59 -46.68 84.72 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 122.994 0.517 . . . . 0.0 111.095 176.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 52.7 t -59.94 -41.31 85.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -67.69 -27.88 67.21 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 118.843 0.747 . . . . 0.0 111.858 177.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 36.7 m -71.13 -41.86 69.95 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.366 -0.833 . . . . 0.0 109.952 174.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 98.2 t -62.73 -48.7 86.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 119.2 0.909 . . . . 0.0 108.761 173.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.417 ' CE1' ' HE2' ' A' ' 31' ' ' LYS . 18.0 t80 -50.91 -50.17 57.99 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.655 1.182 . . . . 0.0 111.301 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -73.18 -31.71 64.38 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.915 0.779 . . . . 0.0 111.988 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -61.3 -38.01 85.27 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.077 0.853 . . . . 0.0 110.642 176.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 75.7 mt -55.7 -20.48 14.47 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -174.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -72.57 -29.07 63.22 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.649 1.113 . . . . 0.0 112.352 177.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -131.13 1.87 5.44 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.544 1.069 . . . . 0.0 113.561 -171.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -52.21 136.9 29.44 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 126.297 1.839 . . . . 0.0 109.561 173.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -146.19 149.95 34.93 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 167.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 50.47 -118.21 5.9 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.157 0.884 . . . . 0.0 111.666 -177.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -76.47 -0.49 23.15 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.574 1.149 . . . . 0.0 113.134 -176.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 74.37 16.56 79.85 Favored Glycine 0 CA--C 1.527 0.811 0 O-C-N 121.347 -0.846 . . . . 0.0 113.066 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.66 -15.94 2.02 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-N 118.368 1.084 . . . . 0.0 113.471 -176.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -66.54 147.37 53.37 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.987 1.315 . . . . 0.0 109.412 174.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.88 155.65 37.26 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.784 0.834 . . . . 0.0 109.0 170.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -92.18 140.8 29.26 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 173.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 52.0 tp -64.44 117.25 7.03 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.969 1.308 . . . . 0.0 107.806 173.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -152.61 50.45 0.75 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.9 t 50.79 37.4 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 126.052 1.741 . . . . 0.0 111.241 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 51.03 34.18 10.34 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.116 1.767 . . . . 0.0 113.356 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -134.38 34.95 3.23 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.659 1.584 . . . . 0.0 109.846 174.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 . . . . . 0 C--O 1.252 1.212 0 C-N-CA 125.378 1.471 . . . . 0.0 109.87 169.895 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ttt . . . . . 0 N--CA 1.482 1.164 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 44.4 m -129.19 136.94 50.81 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 169.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -139.54 101.02 4.12 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -168.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 55.4 t -92.74 145.96 6.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -169.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 50.4 tp -119.76 98.19 5.99 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 172.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.9 tp -90.07 106.12 18.27 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -75.49 150.41 38.22 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 172.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.9 t -142.27 140.05 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 143.66 172.6 14.59 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.017 0.818 . . . . 0.0 112.135 176.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -116.67 120.25 38.05 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.92 1.288 . . . . 0.0 108.257 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 m -59.43 -13.72 9.69 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.644 1.977 . . . . 0.0 115.529 -169.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.1 ptt? -129.83 12.36 5.74 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 119.239 0.927 . . . . 0.0 111.485 -176.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.6 ttt -96.99 34.27 1.76 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.718 0.69 . . . . 0.0 110.002 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.37 -140.81 22.4 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -178.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -62.73 -15.98 55.47 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 124.387 1.075 . . . . 0.0 112.293 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -59.1 -17.81 29.79 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.961 1.304 . . . . 0.0 112.729 175.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.08 19.02 1.07 Allowed Glycine 0 CA--C 1.534 1.248 0 O-C-N 120.693 -1.254 . . . . 0.0 114.033 176.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.14 -49.98 73.69 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.572 1.686 . . . . 0.0 110.819 -170.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.68 -55.78 28.57 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.076 -1.402 . . . . 0.0 111.191 175.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -48.58 -42.75 35.17 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 CA-C-N 120.275 2.037 . . . . 0.0 115.487 176.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.6 tp -70.68 -37.15 73.6 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 120.217 1.371 . . . . 0.0 110.448 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 51.1 tp -61.41 -49.56 76.38 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.159 0.436 . . . . 0.0 110.108 175.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.79 -36.87 82.35 Favored 'General case' 0 C--O 1.227 -0.12 0 CA-C-O 118.594 -0.717 . . . . 0.0 111.774 178.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -60.59 -48.59 81.12 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 119.058 0.845 . . . . 0.0 109.682 176.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -62.01 -44.59 96.39 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 122.938 0.495 . . . . 0.0 110.605 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 75.0 m -62.62 -43.85 97.78 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 118.495 0.589 . . . . 0.0 111.023 177.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.44 -40.3 96.14 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.085 0.554 . . . . 0.0 110.787 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.21 -31.88 70.76 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.387 0.675 . . . . 0.0 111.951 177.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.73 93.09 2.17 Favored Pre-proline 0 CA--C 1.537 0.481 0 C-N-CA 124.93 1.292 . . . . 0.0 108.742 -171.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -55.64 158.13 14.0 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.819 2.346 . . . . 0.0 112.486 177.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -131.67 173.47 11.1 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.467 1.507 . . . . 0.0 108.892 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 37.93 -119.48 0.76 Allowed Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.216 1.389 . . . . 0.0 111.929 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -142.91 40.89 1.53 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.092 1.357 . . . . 0.0 108.592 169.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -76.54 165.06 25.31 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.705 0.764 . . . . 0.0 111.573 -170.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.3 t -120.41 84.41 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 104.478 -2.416 . . . . 0.0 104.478 167.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.2 p -64.97 143.57 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 O-C-N 121.596 -0.69 . . . . 0.0 109.386 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.2 mt -132.12 128.15 58.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -83.92 78.78 9.67 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.05 0.94 . . . . 0.0 109.312 172.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -66.35 -29.69 75.31 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.604 -0.599 . . . . 0.0 111.604 176.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 55.65 -140.03 41.44 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 175.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.9 p -88.18 1.54 54.19 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.726 0.81 . . . . 0.0 112.949 -171.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -145.18 61.46 7.97 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 124.583 1.153 . . . . 0.0 110.183 178.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -66.22 -15.37 48.06 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 122.679 2.253 . . . . 0.0 112.646 -175.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -47.88 -40.37 21.45 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.751 1.621 . . . . 0.0 111.011 169.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -64.65 -31.2 72.32 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 122.097 -0.377 . . . . 0.0 111.959 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -89.28 -9.17 51.61 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.2 1.0 . . . . 0.0 111.329 -169.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.7 mt -52.86 -40.07 34.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 123.811 0.845 . . . . 0.0 109.211 169.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.1 t -60.21 -40.84 84.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.041 0.537 . . . . 0.0 110.145 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.53 -47.49 63.56 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.836 0.454 . . . . 0.0 110.102 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 95.4 mt -53.55 -41.58 46.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.222 1.009 . . . . 0.0 110.079 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -66.34 -18.99 65.68 Favored 'General case' 0 CA--C 1.53 0.173 0 O-C-N 121.05 -1.031 . . . . 0.0 112.725 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -72.64 -40.7 66.21 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 120.228 1.376 . . . . 0.0 109.379 169.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 60.2 mt -73.72 -29.05 62.02 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.434 1.094 . . . . 0.0 111.934 -174.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 39.6 60.18 6.29 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 125.941 1.696 . . . . 0.0 111.877 -169.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.02 153.56 31.52 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.757 2.305 . . . . 0.0 114.043 -170.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.5 m -70.9 -37.81 72.98 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 168.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -148.59 155.5 41.18 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.038 0.935 . . . . 0.0 109.454 -174.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.6 tp -144.67 136.56 25.87 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.651 1.181 . . . . 0.0 108.347 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 58.5 tp -122.4 140.02 53.17 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 169.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.3 mt -124.06 143.17 38.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 41.4 t -141.07 135.33 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 118.571 0.623 . . . . 0.0 109.778 -173.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -163.96 171.8 14.79 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.52 2.328 . . . . 0.0 107.495 173.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.03 157.66 37.84 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.575 -0.703 . . . . 0.0 109.16 168.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.6 m -152.32 127.89 10.07 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -78.07 80.1 4.51 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 119.099 0.863 . . . . 0.0 110.222 176.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 73.7 mtm -75.47 -6.45 50.22 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.033 1.733 . . . . 0.0 112.379 -177.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.62 23.25 78.27 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-N 118.621 0.646 . . . . 0.0 111.822 -172.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.9 mt -100.33 -171.66 2.07 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.889 1.276 . . . . 0.0 109.948 -178.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -74.89 139.99 73.85 Favored Pre-proline 0 N--CA 1.468 0.451 0 CA-C-O 117.431 -1.271 . . . . 0.0 108.612 170.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -43.07 137.44 4.66 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.316 2.677 . . . . 0.0 113.31 172.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.45 0.58 79.32 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 118.641 -1.089 . . . . 0.0 113.646 176.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -65.05 146.57 54.83 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 119.82 1.81 . . . . 0.0 108.243 168.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.6 mt -125.94 138.44 54.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -175.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 91.0 mmt-85 -147.69 152.49 37.9 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 118.69 0.677 . . . . 0.0 111.442 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 37.3 mm -78.78 145.33 9.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 105.828 -1.915 . . . . 0.0 105.828 165.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.5 mt -129.61 124.14 58.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -76.8 140.68 67.56 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 117.859 -1.067 . . . . 0.0 109.586 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -47.42 -34.28 18.94 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 124.086 3.191 . . . . 0.0 116.581 179.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -67.74 -22.91 65.2 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.596 0.634 . . . . 0.0 111.806 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -101.54 -30.9 11.13 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.177 1.391 . . . . 0.0 111.35 -178.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 68.8 mt -50.41 -38.59 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.707 1.203 . . . . 0.0 109.547 169.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.22 -20.19 6.48 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.917 1.687 . . . . 0.0 114.285 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -124.76 -38.76 2.34 Favored 'General case' 0 C--N 1.334 -0.067 0 CA-C-N 118.811 0.732 . . . . 0.0 110.638 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 10.9 mmt -68.12 -24.48 65.02 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -172.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -74.78 -45.35 44.25 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 119.358 0.981 . . . . 0.0 111.066 173.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -78.56 6.23 9.13 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.732 -0.605 . . . . 0.0 112.583 177.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 50.4 tpp -58.7 -26.39 63.84 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.197 0.908 . . . . 0.0 110.115 168.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 42.4 p -59.22 -14.89 12.36 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.23 1.812 . . . . 0.0 113.059 169.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.7 m 61.4 23.25 13.53 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 126.325 1.85 . . . . 0.0 110.734 -168.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 59.8 m80 -147.43 -53.84 0.22 Allowed 'General case' 0 C--N 1.344 0.355 0 O-C-N 121.409 -0.807 . . . . 0.0 112.929 -171.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -68.23 150.0 48.83 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 118.155 0.434 . . . . 0.0 110.412 -169.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 90.8 mmm -63.12 150.53 88.51 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 171.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -73.06 82.32 1.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.708 2.939 . . . . 0.0 108.639 170.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 mt -50.05 -10.43 0.05 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 117.235 2.309 . . . . 0.0 117.235 -168.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.1 -21.13 4.37 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.093 0.957 . . . . 0.0 112.783 168.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -59.57 -29.49 67.97 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.453 1.024 . . . . 0.0 112.04 174.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.7 tt -76.62 -43.57 37.76 Favored 'General case' 0 C--N 1.338 0.103 0 O-C-N 121.399 -0.813 . . . . 0.0 109.667 175.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 77.7 mt -60.47 -43.93 95.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 C-N-CA 123.409 0.684 . . . . 0.0 109.299 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -60.79 -25.43 66.54 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -177.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -82.68 -3.09 55.82 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.879 0.872 . . . . 0.0 112.47 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.0 mt -134.89 -28.4 1.21 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.099 0.959 . . . . 0.0 112.626 -171.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -60.63 -22.04 63.38 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.149 0.98 . . . . 0.0 112.668 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -72.03 -10.25 59.52 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.623 1.169 . . . . 0.0 111.834 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -133.08 -42.57 0.88 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.433 1.093 . . . . 0.0 111.949 -173.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 29.0 mt -72.26 141.4 16.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -64.69 -41.86 97.5 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.119 0.866 . . . . 0.0 112.037 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -149.47 138.37 21.14 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.635 1.218 . . . . 0.0 108.906 176.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 54.0 t -131.28 124.98 56.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 16.9 mt -129.79 154.45 40.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -171.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -129.82 140.63 50.98 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 173.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.0 tt -120.09 129.72 54.32 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 174.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -112.58 156.55 15.52 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 68.8 mt -134.07 124.78 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 -177.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -65.28 118.1 46.69 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-O 117.423 -1.275 . . . . 0.0 110.363 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -77.15 172.05 16.77 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.656 2.904 . . . . 0.0 111.572 171.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -128.84 -31.96 2.14 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.785 1.634 . . . . 0.0 110.974 172.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.15 136.38 49.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.415 1.086 . . . . 0.0 108.269 175.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.1 t -141.1 134.36 31.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 175.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 159.7 151.55 6.2 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -64.71 157.98 25.91 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 117.642 0.721 . . . . 0.0 111.608 -175.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . 0.253 44.1 p90 44.37 41.4 4.49 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.333 2.253 . . . . 0.0 113.072 -174.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -121.51 148.41 50.12 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 123.95 0.9 . . . . 0.0 109.919 172.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -81.06 163.06 20.38 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.238 2.625 . . . . 0.0 111.259 177.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 54.2 ttm -72.22 139.66 48.28 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 168.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 68.3 p -80.6 159.88 25.28 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.365 1.066 . . . . 0.0 110.603 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.1 tm0? -51.23 -48.6 85.18 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-O 117.011 -1.471 . . . . 0.0 113.303 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -67.7 -29.64 35.65 Favored 'Trans proline' 0 C--N 1.352 0.727 0 CA-C-N 122.55 1.946 . . . . 0.0 112.423 -174.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -80.35 -35.32 15.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 119.046 0.839 . . . . 0.0 108.937 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -56.67 -46.78 80.93 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.418 1.008 . . . . 0.0 109.89 170.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -62.98 -38.57 91.66 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 122.961 0.504 . . . . 0.0 111.517 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.84 -46.74 80.62 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 119.193 -0.432 . . . . 0.0 111.017 176.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 73.8 t -62.25 -39.41 83.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 118.883 0.765 . . . . 0.0 109.81 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 34.6 tp10 -61.69 -40.98 96.92 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.031 0.832 . . . . 0.0 110.56 174.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 50.2 m -63.84 -45.87 87.59 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.06 0.544 . . . . 0.0 110.063 177.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 76.6 t -62.56 -44.17 99.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 118.831 0.741 . . . . 0.0 109.605 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -55.05 -46.95 75.4 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.317 1.047 . . . . 0.0 110.611 176.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -63.72 -39.7 94.94 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.659 0.663 . . . . 0.0 110.989 175.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.13 -26.06 67.43 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.421 0.688 . . . . 0.0 112.647 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 91.3 mt -57.11 -22.81 42.53 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.184 0.902 . . . . 0.0 112.231 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -81.43 -3.07 51.81 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.277 1.031 . . . . 0.0 112.166 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -152.01 -14.71 0.07 OUTLIER Glycine 0 CA--C 1.535 1.307 0 N-CA-C 115.962 1.145 . . . . 0.0 115.962 -172.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 15.7 t90 -59.71 141.66 54.7 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.573 1.686 . . . . 0.0 109.031 170.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -138.84 15.09 2.68 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.614 1.165 . . . . 0.0 111.407 173.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 156.53 -37.8 0.58 Allowed Glycine 0 CA--C 1.525 0.699 0 O-C-N 121.361 -0.837 . . . . 0.0 111.618 176.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -130.77 -26.76 2.18 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.781 0.659 . . . . 0.0 112.781 -174.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 57.45 17.08 24.36 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-N 118.675 0.671 . . . . 0.0 114.5 178.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.36 2.96 81.43 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-N 118.814 1.307 . . . . 0.0 113.531 -177.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -71.89 158.85 35.3 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 120.101 1.95 . . . . 0.0 110.153 175.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -80.81 149.71 29.47 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 171.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -88.98 123.07 32.97 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 173.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 62.9 tp -53.9 118.09 3.71 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.158 1.383 . . . . 0.0 109.925 177.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -151.66 102.85 2.9 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.642 0.777 . . . . 0.0 109.558 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . 0.263 33.9 m 40.64 46.56 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 127.27 2.228 . . . . 0.0 114.261 171.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -79.45 62.11 3.68 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.891 1.276 . . . . 0.0 109.924 -177.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 57.51 32.06 21.23 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.544 1.938 . . . . 0.0 112.271 -177.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 . . . . . 0 C--O 1.248 0.976 0 C-N-CA 126.676 1.99 . . . . 0.0 105.783 171.546 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.1 mtp . . . . . 0 N--CA 1.484 1.261 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.0 m -146.73 164.95 31.11 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.94 1.296 . . . . 0.0 107.82 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -144.44 133.34 22.56 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.8 m -132.92 154.73 40.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 124.002 0.921 . . . . 0.0 110.541 -169.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 30.6 tp -125.66 117.21 23.03 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 174.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 64.8 tp -104.74 97.52 7.39 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 96.9 m -73.15 143.73 47.16 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 169.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.0 t -142.16 144.47 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 175.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 147.64 174.48 19.6 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 124.653 1.121 . . . . 0.0 110.335 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -121.83 120.22 33.92 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 174.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 m -58.93 -12.95 5.13 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.446 1.898 . . . . 0.0 115.545 -169.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -129.61 12.82 5.91 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 119.321 0.964 . . . . 0.0 111.226 -177.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.8 ttt -94.32 32.17 1.59 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.868 0.758 . . . . 0.0 109.589 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.05 -145.12 26.75 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 -175.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -59.34 -18.06 34.88 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 125.952 1.701 . . . . 0.0 112.308 178.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -53.89 -25.58 20.77 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.819 1.248 . . . . 0.0 112.676 175.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.76 25.01 0.64 Allowed Glycine 0 CA--C 1.532 1.148 0 CA-C-O 118.7 -1.055 . . . . 0.0 114.277 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.08 -50.67 67.44 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 119.474 1.637 . . . . 0.0 110.432 -170.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.24 -55.64 29.0 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-O 117.881 -1.511 . . . . 0.0 110.98 175.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -50.65 -37.98 54.61 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 CA-C-N 121.106 2.453 . . . . 0.0 114.77 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.9 tp -71.75 -38.88 70.33 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 120.014 1.279 . . . . 0.0 110.509 176.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.1 tp -60.44 -47.65 85.19 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.341 0.518 . . . . 0.0 110.216 175.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.67 -40.96 85.05 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.479 1.111 . . . . 0.0 110.975 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.0 tp10 -61.97 -49.68 75.11 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-N 118.717 0.69 . . . . 0.0 109.693 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -63.64 -45.3 90.87 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.729 0.412 . . . . 0.0 110.81 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 75.5 m -65.32 -38.35 89.89 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.566 0.621 . . . . 0.0 111.094 178.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.91 -39.84 95.1 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.248 0.931 . . . . 0.0 110.906 176.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.41 -33.87 75.0 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.261 0.624 . . . . 0.0 111.805 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.47 91.08 3.35 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 125.141 1.376 . . . . 0.0 108.767 -173.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -51.66 161.32 2.13 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 124.035 3.157 . . . . 0.0 114.852 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.409 ' HE2' ' CE1' ' A' ' 136' ' ' TYR . 37.9 mmtm -137.98 158.78 43.63 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.345 1.458 . . . . 0.0 108.969 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 41.44 -120.15 1.86 Allowed Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.362 1.458 . . . . 0.0 111.737 175.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -136.79 16.26 3.09 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.685 1.194 . . . . 0.0 110.787 174.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 2.0 m95 -75.0 120.29 20.34 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 121.324 -0.86 . . . . 0.0 109.018 -170.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.7 t -71.02 111.12 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 168.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.3 t -71.33 138.33 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -177.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 98.5 mt -135.91 142.73 38.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 104.03 -2.581 . . . . 0.0 104.03 173.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -126.37 107.04 9.92 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 175.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.3 -11.38 71.29 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 118.523 -1.154 . . . . 0.0 113.391 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.17 34.64 80.7 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-N 119.425 1.612 . . . . 0.0 113.713 170.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 63.23 14.04 7.43 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.007 1.723 . . . . 0.0 114.242 -174.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.79 56.88 12.11 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 125.385 1.474 . . . . 0.0 108.057 169.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -68.58 -15.41 41.37 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.396 2.064 . . . . 0.0 113.128 -168.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -51.45 -34.14 33.99 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.086 0.857 . . . . 0.0 112.074 170.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.17 -26.4 68.31 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.215 0.606 . . . . 0.0 112.289 177.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -103.0 -5.66 23.18 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.956 1.302 . . . . 0.0 111.403 -170.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 73.9 mt -55.47 -41.63 64.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 119.112 0.869 . . . . 0.0 109.604 174.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.6 t -60.3 -41.21 86.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 118.524 0.602 . . . . 0.0 109.797 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.76 -45.19 83.47 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.87 0.468 . . . . 0.0 110.38 -178.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 90.2 mt -56.43 -48.38 80.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -63.02 -34.52 77.73 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 118.206 -0.902 . . . . 0.0 112.005 -174.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -58.01 -32.2 67.71 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.482 1.037 . . . . 0.0 111.537 175.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 78.9 mt -84.75 -8.65 58.75 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.174 0.99 . . . . 0.0 112.703 -175.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 27.74 62.26 0.64 Allowed Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 126.892 2.077 . . . . 0.0 112.794 -168.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.33 149.62 63.89 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.246 1.964 . . . . 0.0 113.543 -173.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.49 -26.43 35.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.784 168.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -145.21 151.32 38.22 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.811 0.844 . . . . 0.0 109.841 177.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 25.1 tp -140.91 141.31 34.56 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 125.551 1.54 . . . . 0.0 108.132 172.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 34.3 tp -129.34 138.88 51.81 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 171.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.8 mt -124.66 141.37 44.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 -174.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.9 t -140.86 133.47 30.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 118.728 0.694 . . . . 0.0 109.898 -174.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -161.28 172.44 16.63 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.442 2.297 . . . . 0.0 107.122 174.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.27 158.28 36.16 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.157 -0.965 . . . . 0.0 108.622 167.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.5 m -153.23 129.22 10.3 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 174.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -77.03 80.59 3.56 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.705 0.764 . . . . 0.0 109.94 175.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 76.3 mtm -76.46 -6.76 53.13 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.313 1.445 . . . . 0.0 112.241 -174.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.58 31.28 60.89 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -172.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 77.3 mt -110.97 -170.8 1.7 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.745 1.218 . . . . 0.0 109.722 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -81.14 140.82 49.61 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 117.668 -1.158 . . . . 0.0 108.84 174.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -46.51 132.94 16.34 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.198 2.599 . . . . 0.0 113.614 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.58 1.33 90.1 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 118.506 -1.164 . . . . 0.0 113.412 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -65.65 153.79 40.65 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 119.902 1.851 . . . . 0.0 108.49 168.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 62.3 mt -132.74 140.95 46.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -170.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 82.3 mmt-85 -149.44 152.98 36.59 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.365 0.666 . . . . 0.0 109.981 170.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 35.8 mm -77.29 145.33 10.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 165.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.3 mt -129.57 161.97 38.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 176.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -131.14 144.78 54.95 Favored Pre-proline 0 C--O 1.234 0.288 0 C-N-CA 126.519 1.928 . . . . 0.0 107.181 -171.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -54.28 -27.97 50.43 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 123.18 2.586 . . . . 0.0 115.139 -174.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -68.96 -19.98 64.18 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.948 0.794 . . . . 0.0 112.197 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -117.01 -30.88 5.56 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.164 1.386 . . . . 0.0 111.771 -171.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 65.6 mt -50.15 -40.87 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.268 1.427 . . . . 0.0 109.78 169.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.25 -26.13 37.92 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.822 1.249 . . . . 0.0 113.458 -176.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -108.14 -39.42 5.5 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 123.337 0.655 . . . . 0.0 110.021 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 21.4 mmt -69.21 -26.32 64.76 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -174.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -72.13 -46.37 56.83 Favored 'General case' 0 C--O 1.228 -0.052 0 CA-C-N 119.109 0.868 . . . . 0.0 110.799 174.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 27.6 ptm -74.94 9.23 2.01 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -176.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 76.7 mmm -53.88 -28.41 36.15 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.635 1.174 . . . . 0.0 111.977 171.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 30.9 p -76.56 32.69 0.13 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.361 1.864 . . . . 0.0 112.064 -178.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.4 m 68.87 -41.5 0.47 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 128.644 2.778 . . . . 0.0 112.081 -169.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -152.01 152.52 32.55 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.925 1.69 . . . . 0.0 107.084 169.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -163.44 175.37 10.85 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.828 1.251 . . . . 0.0 107.933 174.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 65.9 mtt -70.37 127.01 92.48 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 168.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -76.91 71.6 6.12 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 123.312 2.675 . . . . 0.0 108.603 173.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.1 mt -49.3 -14.86 0.1 Allowed 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 116.939 2.2 . . . . 0.0 116.939 -167.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.47 -20.31 4.62 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 117.878 -1.058 . . . . 0.0 113.02 168.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -54.77 -35.74 64.12 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 119.967 1.258 . . . . 0.0 111.517 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.8 tt -75.38 -44.09 46.7 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.329 0.652 . . . . 0.0 109.592 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 94.3 mt -62.95 -44.11 99.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -64.67 -17.65 64.26 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -171.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -109.6 13.68 23.76 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.306 1.043 . . . . 0.0 112.085 178.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 72.8 mt -129.5 -34.48 1.8 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.178 1.391 . . . . 0.0 110.783 177.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -57.5 -22.17 42.39 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.265 1.426 . . . . 0.0 112.693 176.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -70.16 -14.84 62.82 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.656 1.182 . . . . 0.0 111.931 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -137.52 -32.31 0.77 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.144 0.883 . . . . 0.0 113.045 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 32.5 mt -70.46 138.26 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 174.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -64.24 -42.87 97.71 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.268 0.937 . . . . 0.0 112.385 -176.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -144.75 134.62 23.72 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.664 1.232 . . . . 0.0 108.336 175.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 47.8 t -125.95 127.8 71.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 177.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.9 mt -130.84 153.29 38.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 -168.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -133.17 145.56 50.75 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 175.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.1 tt -127.87 133.46 49.34 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 171.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -114.16 157.06 15.22 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 80.8 mt -134.47 126.88 49.31 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -65.04 116.52 30.71 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-O 117.583 -1.199 . . . . 0.0 110.372 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -79.17 173.5 13.29 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.247 2.631 . . . . 0.0 111.789 171.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -136.71 -28.7 0.97 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.373 2.269 . . . . 0.0 111.382 172.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -132.42 119.63 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 -173.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.3 t -143.67 131.78 18.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 153.54 152.82 6.16 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -67.12 150.89 48.54 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.974 0.893 . . . . 0.0 111.27 -174.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 13.0 t80 51.69 40.67 27.9 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.839 2.055 . . . . 0.0 112.107 -174.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.4 m-30 -115.79 142.54 29.18 Favored Pre-proline 0 C--O 1.237 0.434 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 170.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -74.27 160.44 42.22 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.636 2.224 . . . . 0.0 110.46 170.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.1 ttm -74.69 141.98 44.49 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 169.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 39.9 p -79.53 157.42 27.42 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.426 1.091 . . . . 0.0 110.653 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -52.55 -42.47 88.39 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-O 116.579 -1.677 . . . . 0.0 114.721 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -70.81 -28.55 20.08 Favored 'Trans proline' 0 C--N 1.351 0.707 0 CA-C-N 123.043 2.123 . . . . 0.0 111.883 -175.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.23 -36.53 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -56.68 -45.93 81.43 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.297 0.953 . . . . 0.0 110.091 170.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -63.34 -41.6 98.89 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 123.064 0.546 . . . . 0.0 111.117 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.69 -47.09 85.13 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.833 0.453 . . . . 0.0 111.043 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.0 t -60.81 -42.33 91.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 177.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -68.26 -28.27 67.06 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.874 0.761 . . . . 0.0 111.602 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 42.9 m -69.03 -46.29 68.3 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.214 -0.929 . . . . 0.0 109.492 173.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 90.1 t -61.65 -43.43 97.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 119.111 0.869 . . . . 0.0 109.597 176.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.409 ' CE1' ' HE2' ' A' ' 31' ' ' LYS . 20.4 t80 -52.96 -46.12 68.07 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.209 1.004 . . . . 0.0 111.227 175.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -66.11 -42.43 89.23 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.628 0.649 . . . . 0.0 111.003 175.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -58.4 -37.31 75.05 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.882 0.873 . . . . 0.0 111.76 -175.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 72.1 mt -57.21 -18.59 16.49 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.154 0.982 . . . . 0.0 113.137 -175.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -77.29 -24.12 50.99 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.671 1.123 . . . . 0.0 112.431 177.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -139.14 3.0 2.7 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-N 118.93 0.786 . . . . 0.0 114.45 -169.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -54.43 133.74 45.71 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.699 1.6 . . . . 0.0 109.208 173.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -139.14 149.4 44.45 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 169.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 51.38 -121.67 12.86 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 123.995 0.807 . . . . 0.0 111.749 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -76.29 5.53 6.88 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.768 1.227 . . . . 0.0 112.957 -178.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 68.96 15.16 69.03 Favored Glycine 0 CA--C 1.528 0.856 0 O-C-N 121.068 -1.02 . . . . 0.0 112.529 -176.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 69.06 -9.47 2.07 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-N 118.642 1.221 . . . . 0.0 113.844 -174.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -68.81 156.44 38.37 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.103 1.451 . . . . 0.0 109.27 173.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -78.24 151.86 32.87 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 172.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -98.19 119.74 37.38 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 55.1 tp -57.05 130.42 46.04 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.262 1.425 . . . . 0.0 110.301 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.91 -50.4 0.65 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.073 0.949 . . . . 0.0 111.86 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 8.5 p -157.53 -0.97 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 123.74 0.816 . . . . 0.0 112.47 -169.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -63.95 155.05 32.13 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.337 -0.852 . . . . 0.0 111.617 -170.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -148.21 141.89 25.57 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 169.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 . . . . . 0 C--O 1.249 1.066 0 C-N-CA 124.791 1.236 . . . . 0.0 107.733 -175.966 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 N--CA 1.483 1.194 0 CA-C-O 118.616 -0.707 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.5 m -145.8 159.83 42.63 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.374 0.988 . . . . 0.0 108.413 -176.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -134.91 137.68 43.4 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 174.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 51.2 t -139.42 151.8 22.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 119.003 0.82 . . . . 0.0 109.921 -167.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 33.7 tp -126.2 129.86 49.82 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 126.069 1.748 . . . . 0.0 106.402 176.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.9 tp -117.31 100.95 8.03 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 124.915 1.286 . . . . 0.0 107.886 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 89.4 m -76.04 141.23 42.15 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 169.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 50.9 t -139.96 142.93 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 143.18 174.39 15.43 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.252 0.93 . . . . 0.0 111.709 176.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -118.32 120.16 36.8 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.7 1.2 . . . . 0.0 108.869 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -59.67 -15.97 23.12 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.356 1.862 . . . . 0.0 115.228 -170.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 27.7 ptm -126.88 14.47 7.42 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.206 1.003 . . . . 0.0 111.167 -175.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.2 ttt -101.78 31.58 3.78 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.41 0.684 . . . . 0.0 110.048 -177.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.29 -142.49 21.3 Favored Glycine 0 C--N 1.337 0.584 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -60.26 -17.68 43.82 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.784 1.234 . . . . 0.0 112.352 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -57.09 -19.75 21.36 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.88 1.272 . . . . 0.0 112.557 176.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.13 21.17 0.85 Allowed Glycine 0 CA--C 1.534 1.238 0 O-C-N 120.761 -1.212 . . . . 0.0 114.278 176.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.25 -53.18 58.86 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.588 1.694 . . . . 0.0 110.943 -170.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.59 -53.94 41.86 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 117.791 -1.561 . . . . 0.0 111.02 175.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -48.97 -41.02 40.63 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 CA-C-N 120.78 2.29 . . . . 0.0 115.217 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.7 tp -71.51 -37.74 71.19 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 120.265 1.393 . . . . 0.0 110.372 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.9 tp -61.91 -46.98 87.02 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.047 0.385 . . . . 0.0 110.252 175.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.53 -40.6 87.69 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 124.021 0.929 . . . . 0.0 111.111 177.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -60.94 -48.81 80.1 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 118.833 0.742 . . . . 0.0 109.789 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -62.34 -46.13 90.07 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 122.959 0.504 . . . . 0.0 110.569 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 79.6 m -64.57 -38.36 90.74 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.271 0.487 . . . . 0.0 111.219 178.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.54 -38.64 91.72 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.886 0.766 . . . . 0.0 110.988 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.36 -38.28 78.02 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.203 0.601 . . . . 0.0 111.157 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.32 94.57 2.16 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 125.205 1.402 . . . . 0.0 108.497 -173.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -56.01 159.67 11.75 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 123.526 2.817 . . . . 0.0 113.328 178.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -135.74 167.51 21.01 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 126.053 1.741 . . . . 0.0 108.336 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 44.23 -127.32 6.54 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.509 1.052 . . . . 0.0 111.831 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -136.16 9.89 3.26 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.854 1.261 . . . . 0.0 111.699 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -71.33 125.12 26.13 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 123.986 0.914 . . . . 0.0 109.252 -172.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 51.1 t -69.9 123.79 24.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 166.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.4 t -77.45 135.38 26.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -178.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.6 mm -130.65 145.9 34.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 104.292 -2.484 . . . . 0.0 104.292 168.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -134.33 107.92 7.9 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 177.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.54 -1.9 89.06 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 118.966 -0.908 . . . . 0.0 112.49 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 54.22 -145.1 27.23 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -169.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.8 p -89.71 13.75 13.48 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 122.01 -0.7 . . . . 0.0 111.869 177.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.54 58.63 10.42 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 124.995 1.318 . . . . 0.0 110.498 -177.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -72.25 -22.09 22.57 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.873 2.382 . . . . 0.0 112.967 -171.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.72 -36.19 78.22 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.847 0.749 . . . . 0.0 111.856 -177.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -65.0 -11.89 44.06 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.867 0.867 . . . . 0.0 112.931 175.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -113.75 -0.25 14.3 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.305 1.042 . . . . 0.0 112.29 -172.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 62.5 mt -48.17 -41.19 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 125.124 1.37 . . . . 0.0 110.732 174.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.0 t -56.77 -44.02 80.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.313 0.645 . . . . 0.0 110.198 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.32 93.03 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.974 0.51 . . . . 0.0 110.966 -177.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 64.7 mt -64.27 -45.53 95.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.1 mtp180 -64.89 -31.29 72.45 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.512 -176.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -57.92 -33.06 68.38 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.667 1.121 . . . . 0.0 111.558 174.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 33.0 mt -76.22 -8.23 56.61 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 118.571 -0.728 . . . . 0.0 112.778 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.1 mtp180 31.8 62.12 1.23 Allowed Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 126.994 2.118 . . . . 0.0 112.359 -169.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -55.07 142.67 76.63 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.835 2.357 . . . . 0.0 112.305 -172.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.2 m -81.68 -31.84 32.04 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.682 0.793 . . . . 0.0 108.913 168.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -142.55 150.76 40.82 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.611 1.564 . . . . 0.0 107.721 174.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 56.4 tp -138.81 142.89 38.7 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.645 1.178 . . . . 0.0 108.088 173.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 35.0 tp -128.49 138.93 52.52 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 173.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.1 mt -125.31 142.07 43.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 -175.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.4 t -140.83 134.11 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 118.593 0.633 . . . . 0.0 110.08 -174.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -161.52 171.18 18.54 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.252 2.221 . . . . 0.0 107.739 171.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.4 156.84 39.01 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.133 -0.979 . . . . 0.0 108.621 168.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.3 m -155.86 127.74 7.45 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 176.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -71.48 123.76 23.12 Favored 'General case' 0 N--CA 1.461 0.097 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 171.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 75.4 mtm -123.24 1.73 9.12 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.032 1.733 . . . . 0.0 110.705 -175.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.83 25.21 68.97 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-N 118.747 0.703 . . . . 0.0 112.332 -173.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.0 mt -99.92 -172.25 2.2 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.332 1.453 . . . . 0.0 109.292 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -75.36 140.22 72.34 Favored Pre-proline 0 N--CA 1.469 0.49 0 CA-C-O 117.539 -1.219 . . . . 0.0 108.667 173.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -43.43 136.32 6.1 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 123.343 2.695 . . . . 0.0 113.081 172.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.31 3.48 76.91 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 118.779 -1.012 . . . . 0.0 113.75 178.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -64.74 148.57 50.88 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 119.754 1.777 . . . . 0.0 108.581 168.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 76.5 mt -125.89 136.09 61.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 -173.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 90.1 mmt-85 -148.18 152.64 37.59 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 118.512 0.596 . . . . 0.0 111.101 175.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 41.5 mm -81.58 144.74 9.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 166.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.8 mt -126.79 129.33 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -73.5 139.14 77.86 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 118.185 -0.912 . . . . 0.0 109.36 172.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -45.37 -36.26 12.81 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 124.46 3.44 . . . . 0.0 116.4 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -66.67 -26.78 67.2 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.445 0.566 . . . . 0.0 111.687 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -97.7 -28.57 13.84 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.515 1.126 . . . . 0.0 111.149 -178.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 45.9 mt -51.04 -43.38 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.613 1.165 . . . . 0.0 110.229 170.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -52.99 -31.49 41.17 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.593 1.157 . . . . 0.0 112.804 -177.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -97.58 -42.33 7.72 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.314 0.646 . . . . 0.0 109.843 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 22.5 mmt -67.3 -33.38 75.17 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -171.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -62.43 -43.37 98.97 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 118.454 0.57 . . . . 0.0 110.655 176.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 27.8 ptm -80.43 15.61 1.58 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 26.2 mmt -74.0 -29.0 61.73 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.896 -1.127 . . . . 0.0 109.675 168.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 67.1 p -74.34 -45.87 44.4 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 122.937 0.495 . . . . 0.0 110.846 -173.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.5 p -164.82 -172.03 2.48 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 128.808 2.843 . . . . 0.0 105.194 -167.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -73.2 51.8 0.33 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.359 1.064 . . . . 0.0 109.448 167.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -65.34 161.05 20.43 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 126.985 2.114 . . . . 0.0 110.45 -171.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.2 mmt -63.3 136.27 96.62 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-O 118.402 -0.809 . . . . 0.0 109.075 172.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.87 61.48 6.33 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 123.946 3.097 . . . . 0.0 109.188 169.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.6 mt -52.63 -7.08 0.06 Allowed 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 128.016 2.526 . . . . 0.0 117.061 -167.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -52.84 -23.32 6.75 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.256 0.934 . . . . 0.0 112.045 167.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -60.64 -27.08 67.52 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.828 0.74 . . . . 0.0 112.583 175.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.5 tt -69.64 -43.78 71.95 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 119.023 0.829 . . . . 0.0 109.372 175.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 76.7 mt -61.95 -43.48 97.58 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.093 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -64.38 -16.46 62.33 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -105.54 16.98 24.6 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.33 1.452 . . . . 0.0 111.18 177.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.6 mt -136.06 -37.5 0.72 Allowed 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.703 1.201 . . . . 0.0 110.994 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -55.59 -22.32 21.63 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.569 1.148 . . . . 0.0 112.742 176.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -60.23 -24.71 65.08 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.504 1.522 . . . . 0.0 112.122 -177.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -134.05 7.42 3.7 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.681 0.792 . . . . 0.0 112.488 -171.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 76.5 mt -122.41 141.51 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.977 1.311 . . . . 0.0 108.291 -174.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.27 -39.64 81.88 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 123.864 0.745 . . . . 0.0 111.809 -176.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -147.38 132.86 18.65 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 118.307 1.054 . . . . 0.0 108.256 176.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 41.5 t -122.65 129.38 75.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 172.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 15.1 mt -129.24 148.68 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 -169.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -129.6 141.18 51.0 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 170.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.5 tt -123.53 127.98 49.11 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 175.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -109.48 155.63 16.0 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 83.4 mt -133.06 126.01 52.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.103 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -62.76 114.47 12.32 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-O 117.778 -1.106 . . . . 0.0 110.453 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -75.96 170.48 20.02 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.171 2.581 . . . . 0.0 111.111 170.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -129.75 -30.11 2.08 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.493 1.917 . . . . 0.0 111.025 169.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.1 pp -136.03 137.02 49.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 123.891 0.876 . . . . 0.0 109.025 176.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 75.7 t -146.36 139.64 20.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 153.9 151.51 5.78 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 108.776 -1.729 . . . . 0.0 108.776 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -64.27 149.11 48.73 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 118.086 0.943 . . . . 0.0 110.597 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.6 t80 58.43 46.08 15.7 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.292 1.837 . . . . 0.0 111.577 -175.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -132.81 147.27 64.8 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 123.853 0.861 . . . . 0.0 109.759 168.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -81.87 166.12 17.23 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.554 2.836 . . . . 0.0 110.827 176.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.1 ttm -70.0 134.64 48.52 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 169.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.04 159.66 31.46 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.557 1.143 . . . . 0.0 110.57 175.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.63 -46.39 99.59 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-O 117.233 -1.365 . . . . 0.0 113.538 -171.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -67.07 -26.8 42.74 Favored 'Trans proline' 0 C--N 1.35 0.615 0 CA-C-N 122.209 1.824 . . . . 0.0 112.593 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.24 -35.7 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -56.24 -46.79 79.45 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.138 0.881 . . . . 0.0 109.984 170.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -63.11 -38.09 89.8 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 122.722 0.409 . . . . 0.0 111.444 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.49 -47.78 77.67 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 122.033 -0.417 . . . . 0.0 111.056 175.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 71.4 t -61.21 -39.28 81.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 118.672 0.669 . . . . 0.0 109.719 178.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 32.6 tp10 -63.91 -39.09 93.36 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.13 0.877 . . . . 0.0 110.927 175.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 51.7 m -63.9 -48.07 78.08 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.763 -0.586 . . . . 0.0 109.854 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 79.2 t -60.3 -46.08 95.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -54.62 -48.78 71.82 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.05 0.94 . . . . 0.0 110.849 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -65.06 -38.16 89.91 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.456 0.571 . . . . 0.0 111.194 177.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -62.14 -29.25 70.21 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 118.367 -0.825 . . . . 0.0 111.552 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 83.9 mt -55.01 -21.28 11.54 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.3 0.954 . . . . 0.0 112.909 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -80.06 -21.94 42.84 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.309 0.959 . . . . 0.0 112.595 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -143.61 5.53 1.81 Allowed Glycine 0 CA--C 1.532 1.104 0 CA-C-N 118.859 0.754 . . . . 0.0 114.726 -169.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.8 t-105 -52.81 138.46 29.33 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.809 1.643 . . . . 0.0 109.266 171.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -141.52 145.34 35.05 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 170.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 58.09 -106.4 0.81 Allowed Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -174.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -110.2 14.28 22.86 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.28 1.432 . . . . 0.0 112.097 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 79.19 2.65 87.63 Favored Glycine 0 CA--C 1.526 0.748 0 O-C-N 121.535 -0.728 . . . . 0.0 112.65 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.32 6.13 64.6 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 118.965 1.382 . . . . 0.0 112.67 -176.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -67.22 148.8 51.3 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 118.829 1.315 . . . . 0.0 108.48 171.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.95 146.41 47.79 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -92.3 121.02 33.39 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 177.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 62.5 tp -55.12 130.52 42.27 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.791 1.637 . . . . 0.0 110.631 178.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -145.34 53.9 1.19 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.314 1.046 . . . . 0.0 109.522 176.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 57.1 t 71.75 -44.4 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 128.567 2.747 . . . . 0.0 113.026 176.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 53.47 30.92 11.28 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.693 1.997 . . . . 0.0 113.362 174.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -153.22 170.69 19.95 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.168 1.787 . . . . 0.0 108.217 169.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 . . . . . 0 C--O 1.246 0.917 0 C-N-CA 125.541 1.537 . . . . 0.0 106.889 178.376 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.3 mmt . . . . . 0 N--CA 1.484 1.254 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.6 m -135.09 93.17 2.96 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -174.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -78.5 143.58 36.47 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 169.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.432 HG21 ' HG3' ' A' ' 55' ' ' PRO . 78.4 t -136.77 149.11 26.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -175.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 37.0 tp -127.93 112.06 14.26 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.415 1.486 . . . . 0.0 107.066 -175.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 51.9 tp -101.45 97.22 7.71 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 125.129 1.372 . . . . 0.0 107.883 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 87.3 m -73.11 143.03 47.51 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 169.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.0 t -141.71 144.82 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 176.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.79 174.34 17.87 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -124.76 119.31 28.55 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.128 1.371 . . . . 0.0 107.846 176.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 m -60.44 -14.2 17.87 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.185 1.794 . . . . 0.0 115.313 -169.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 27.9 ptm -125.22 13.14 8.29 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.153 0.981 . . . . 0.0 111.067 -176.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.3 ttt -100.7 29.68 4.38 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.567 0.747 . . . . 0.0 109.83 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.78 -142.26 20.75 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -61.86 -17.04 55.02 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.592 1.157 . . . . 0.0 112.221 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -54.87 -24.53 23.67 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.433 1.493 . . . . 0.0 113.236 176.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.21 24.49 0.71 Allowed Glycine 0 CA--C 1.533 1.191 0 CA-C-O 118.575 -1.125 . . . . 0.0 114.447 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.31 -51.45 65.98 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 119.468 1.634 . . . . 0.0 110.826 -169.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.17 -54.8 34.33 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-O 117.809 -1.55 . . . . 0.0 111.021 175.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -50.22 -37.68 49.73 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 CA-C-N 121.085 2.442 . . . . 0.0 114.841 178.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.7 tp -71.05 -39.79 72.04 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 120.117 1.326 . . . . 0.0 110.546 176.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.7 tp -60.9 -46.74 89.43 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.225 0.466 . . . . 0.0 110.479 175.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.48 -41.74 90.51 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 124.222 1.009 . . . . 0.0 110.913 176.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -61.06 -48.36 82.09 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 118.932 0.787 . . . . 0.0 110.046 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -61.2 -47.55 85.6 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 122.917 0.487 . . . . 0.0 110.513 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 80.9 m -64.5 -38.16 90.06 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.252 0.478 . . . . 0.0 111.183 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.7 -38.45 91.05 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.857 0.753 . . . . 0.0 111.077 177.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.78 -37.58 76.39 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.349 0.659 . . . . 0.0 111.218 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.31 98.56 1.97 Allowed Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 125.448 1.499 . . . . 0.0 107.856 -174.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -56.08 167.39 2.48 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 123.93 3.087 . . . . 0.0 114.664 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.5 ' HE2' ' CZ ' ' A' ' 136' ' ' TYR . 71.4 mmtt -135.93 160.14 39.51 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 126.055 1.742 . . . . 0.0 107.858 176.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 42.29 -121.19 2.6 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.861 1.22 . . . . 0.0 111.867 175.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -137.25 15.76 3.0 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.036 1.734 . . . . 0.0 111.142 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 13.0 m95 -72.26 131.27 42.49 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.565 0.746 . . . . 0.0 110.243 -171.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.0 t -75.73 118.03 21.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 104.273 -2.491 . . . . 0.0 104.273 165.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.0 t -72.81 134.82 29.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.7 mm -133.33 148.1 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 171.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -135.45 113.82 11.53 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 176.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.04 -13.27 83.21 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 118.613 -1.104 . . . . 0.0 112.81 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.56 34.05 79.69 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-N 119.62 1.71 . . . . 0.0 113.784 172.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 61.87 14.03 5.98 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.951 1.7 . . . . 0.0 114.261 -172.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -135.54 58.05 23.0 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 125.807 1.643 . . . . 0.0 107.657 169.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -71.26 -25.41 22.05 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.018 1.812 . . . . 0.0 111.873 -169.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.42 -30.69 71.77 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.668 0.787 . . . . 0.0 111.867 -179.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -63.02 -15.34 56.1 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.029 0.932 . . . . 0.0 112.419 172.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -117.32 1.07 12.37 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.369 1.068 . . . . 0.0 112.568 -169.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 78.7 mt -48.82 -37.29 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.869 1.268 . . . . 0.0 110.512 171.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.8 t -55.93 -41.26 66.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 123.683 0.793 . . . . 0.0 110.333 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.78 -41.96 82.41 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 118.479 0.582 . . . . 0.0 110.562 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.6 mt -61.06 -41.57 89.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 176.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -67.33 -19.99 65.53 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 117.693 -1.146 . . . . 0.0 112.505 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -72.25 -44.97 62.06 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 120.655 1.57 . . . . 0.0 108.894 169.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 56.5 mt -69.04 -26.4 64.96 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 118.489 -0.767 . . . . 0.0 112.703 -176.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 37.43 63.65 3.19 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 125.778 1.631 . . . . 0.0 111.443 -169.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.432 ' HG3' HG21 ' A' ' 4' ' ' VAL . 53.1 Cg_exo -51.45 144.55 31.57 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.214 2.609 . . . . 0.0 113.774 -170.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.4 m -67.08 -42.18 85.1 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 167.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 73.0 mtm180 -144.08 153.82 42.57 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 124.769 1.228 . . . . 0.0 108.105 174.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 56.9 tp -133.16 137.01 46.07 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 35.0 tp -124.01 133.71 53.61 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.715 -1.958 . . . . 0.0 105.715 174.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.2 mt -122.22 139.75 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 -175.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.4 t -140.24 133.36 34.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 118.203 0.456 . . . . 0.0 109.828 -172.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -162.32 172.9 14.92 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.24 2.216 . . . . 0.0 107.397 176.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.73 157.73 37.4 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.112 -0.993 . . . . 0.0 108.326 167.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.0 m -154.66 130.18 9.86 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 174.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -74.55 124.19 26.17 Favored 'General case' 0 N--CA 1.461 0.105 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 172.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 77.1 mtm -122.18 0.44 9.57 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.547 1.539 . . . . 0.0 110.814 -175.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.55 24.83 68.19 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-N 118.576 0.626 . . . . 0.0 112.364 -172.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 58.8 mt -100.67 -169.61 1.74 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.964 1.305 . . . . 0.0 108.568 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -82.2 147.01 56.06 Favored Pre-proline 0 N--CA 1.471 0.62 0 CA-C-O 118.466 -0.778 . . . . 0.0 109.747 174.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -46.81 136.1 17.02 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.379 2.719 . . . . 0.0 112.348 176.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.56 1.87 90.3 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 118.483 -1.176 . . . . 0.0 113.45 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -64.53 148.54 50.5 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 119.906 1.853 . . . . 0.0 108.356 168.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 69.3 mt -128.76 135.95 61.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 -172.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 -148.7 150.84 33.87 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 118.666 0.666 . . . . 0.0 111.926 177.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 51.4 mm -79.45 143.61 12.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 166.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.8 mt -128.63 125.61 63.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -74.87 140.54 74.34 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.266 172.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -45.66 -34.57 11.69 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 124.369 3.379 . . . . 0.0 116.628 177.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -68.58 -24.99 64.66 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.57 0.623 . . . . 0.0 111.807 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -98.69 -30.37 12.49 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.865 1.266 . . . . 0.0 111.076 -177.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 63.7 mt -49.91 -40.91 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.692 1.197 . . . . 0.0 109.189 169.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.0 -19.72 19.99 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.161 1.384 . . . . 0.0 114.454 -174.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -117.91 -36.24 3.69 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 118.699 0.682 . . . . 0.0 110.084 176.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 38.4 mmt -69.19 -25.46 64.34 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -176.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -70.21 -47.15 62.71 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 119.164 0.893 . . . . 0.0 111.238 173.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 20.1 ptp -70.48 -13.4 62.1 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 118.608 -0.711 . . . . 0.0 112.881 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 27.9 ttt -58.49 -24.24 59.96 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.051 0.841 . . . . 0.0 111.663 175.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 44.0 p -61.85 -82.29 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.414 1.086 . . . . 0.0 110.082 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.3 p -155.7 54.31 0.6 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.556 2.343 . . . . 0.0 107.544 178.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 56.59 39.18 29.95 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.554 1.142 . . . . 0.0 112.52 -176.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -60.02 150.68 28.47 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 167.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -58.67 140.88 85.13 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 123.654 0.781 . . . . 0.0 109.735 -176.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -72.55 79.01 1.92 Allowed 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 125.101 3.868 . . . . 0.0 108.881 178.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 mt -50.87 -7.29 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 117.694 2.479 . . . . 0.0 117.694 -167.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -54.42 -21.79 10.71 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.21 -0.931 . . . . 0.0 112.192 167.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -60.0 -31.77 70.24 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.445 1.02 . . . . 0.0 111.751 174.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.9 tt -73.91 -45.71 48.9 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.758 0.708 . . . . 0.0 109.114 174.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 85.4 mt -57.22 -42.81 80.7 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -62.41 -21.58 65.5 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -85.42 -2.33 57.99 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.829 0.852 . . . . 0.0 112.226 177.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.442 ' HB3' HD12 ' A' ' 105' ' ' ILE . 2.4 mm? -129.95 -33.93 1.74 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.316 1.047 . . . . 0.0 112.51 -178.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 13.4 pttm -62.92 -19.72 64.5 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.658 0.783 . . . . 0.0 112.983 -171.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -72.09 -12.17 61.08 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.389 1.075 . . . . 0.0 111.814 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -133.26 -34.05 1.09 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.226 0.921 . . . . 0.0 112.915 -177.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.442 HD12 ' HB3' ' A' ' 101' ' ' LEU . 23.8 mt -67.87 143.19 15.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 171.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.81 -39.9 93.6 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 123.954 0.788 . . . . 0.0 112.39 -177.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -150.49 138.72 20.3 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 118.379 1.089 . . . . 0.0 108.442 174.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 39.0 t -122.41 132.07 71.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 174.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.2 mt -130.92 147.35 33.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 -169.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -132.68 140.74 48.27 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 175.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.9 tt -125.5 133.85 52.24 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 174.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -116.71 156.83 15.4 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 177.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 87.1 mt -134.39 127.53 50.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 -177.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -63.9 114.34 13.25 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 117.38 -1.295 . . . . 0.0 110.151 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -76.09 170.56 19.83 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.152 2.568 . . . . 0.0 111.154 170.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -128.81 -32.04 2.14 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.031 1.732 . . . . 0.0 110.986 171.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -135.58 136.23 50.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 177.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.4 t -141.73 135.55 30.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 176.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 157.47 150.73 5.8 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -66.14 152.67 44.25 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.78 0.8 . . . . 0.0 111.08 -176.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 25.0 t80 55.05 39.88 31.74 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.536 1.934 . . . . 0.0 111.648 -175.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -125.06 147.96 58.67 Favored Pre-proline 0 C--O 1.237 0.427 0 C-N-CA 123.669 0.787 . . . . 0.0 109.815 169.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -82.4 164.47 16.78 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.38 2.72 . . . . 0.0 111.087 176.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 53.0 ttm -71.83 138.0 47.97 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 168.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 71.5 p -78.41 159.49 28.28 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.153 0.981 . . . . 0.0 110.494 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.3 tp60 -53.09 -44.42 97.08 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-O 116.533 -1.699 . . . . 0.0 114.23 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -68.58 -30.53 28.45 Favored 'Trans proline' 0 C--N 1.351 0.683 0 CA-C-N 122.914 2.076 . . . . 0.0 112.164 -176.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.81 -35.31 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 119.021 0.828 . . . . 0.0 108.841 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -56.56 -46.64 80.63 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.3 0.955 . . . . 0.0 110.056 170.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -63.97 -37.14 86.33 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.055 0.542 . . . . 0.0 111.434 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.38 -47.25 77.02 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.919 -0.488 . . . . 0.0 111.17 175.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 78.9 t -61.74 -39.66 84.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 118.564 0.62 . . . . 0.0 109.525 177.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -61.37 -42.31 98.5 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.911 0.778 . . . . 0.0 110.534 174.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 52.2 m -62.19 -45.74 92.02 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.747 -0.596 . . . . 0.0 110.237 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 80.3 t -61.9 -47.53 92.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 176.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.5 ' CZ ' ' HE2' ' A' ' 31' ' ' LYS . 38.7 t80 -55.42 -49.66 71.82 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.913 0.885 . . . . 0.0 110.923 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 48.7 mm-40 -68.78 -23.35 64.29 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.734 -0.604 . . . . 0.0 112.102 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.18 -29.24 64.93 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.66 1.118 . . . . 0.0 111.583 175.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 67.6 mt -58.58 -20.38 46.34 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -168.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -83.81 -12.66 55.31 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 120.254 1.388 . . . . 0.0 113.297 177.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -131.56 -3.13 4.27 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.822 1.201 . . . . 0.0 113.092 -175.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 -56.62 111.94 1.14 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.428 1.891 . . . . 0.0 108.753 173.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -83.15 -36.0 25.11 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 122.66 0.384 . . . . 0.0 110.98 -177.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -165.79 -38.56 0.02 OUTLIER Glycine 0 CA--C 1.526 0.731 0 CA-C-O 118.804 -0.998 . . . . 0.0 112.377 -175.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -136.97 13.41 3.1 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.709 1.255 . . . . 0.0 113.015 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 61.43 12.74 33.94 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 119.188 -0.785 . . . . 0.0 114.437 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 65.61 8.45 39.7 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-N 118.793 1.297 . . . . 0.0 113.277 -173.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -72.03 143.3 49.19 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 119.335 1.567 . . . . 0.0 108.932 177.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.02 151.37 47.77 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.774 0.829 . . . . 0.0 109.527 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -92.59 123.98 36.28 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 62.0 tp -54.73 127.62 29.11 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.381 1.472 . . . . 0.0 109.741 176.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -141.83 34.36 1.59 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.545 1.138 . . . . 0.0 109.686 175.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.3 t 52.06 52.16 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 126.338 1.855 . . . . 0.0 110.391 175.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -56.06 150.0 14.6 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.568 0.747 . . . . 0.0 110.843 176.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -137.12 30.1 2.74 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.299 1.44 . . . . 0.0 109.128 175.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 . . . . . 0 C--O 1.251 1.182 0 C-N-CA 126.754 2.022 . . . . 0.0 108.154 -177.225 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.5 mmm . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 118.937 -0.554 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.9 m -143.09 151.87 41.22 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 -173.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -144.97 128.65 17.18 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 -171.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 70.8 t -124.0 148.61 28.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 121.409 0.623 . . . . 0.0 110.709 -167.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 33.7 tp -114.37 129.56 56.65 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.628 -1.989 . . . . 0.0 105.628 168.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.8 tp -120.63 100.82 7.35 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 92.7 m -75.33 143.03 43.11 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 171.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 51.9 t -141.01 142.04 30.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.285 1.434 . . . . 0.0 107.306 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 144.57 176.88 18.97 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.336 0.969 . . . . 0.0 111.873 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -126.55 122.54 35.42 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.8 1.24 . . . . 0.0 108.844 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 m -60.82 -15.33 29.0 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.572 1.949 . . . . 0.0 115.661 -169.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 25.8 ptm -127.4 11.01 6.82 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.074 0.95 . . . . 0.0 110.989 -176.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.6 ttt -88.68 14.32 10.33 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.225 1.01 . . . . 0.0 110.098 176.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.54 -140.96 15.34 Favored Glycine 0 C--N 1.337 0.637 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -60.44 -17.42 44.45 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.504 1.121 . . . . 0.0 112.224 176.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -55.81 -20.68 16.01 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.614 1.566 . . . . 0.0 113.207 174.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.44 21.5 0.7 Allowed Glycine 0 CA--C 1.534 1.253 0 O-C-N 120.823 -1.173 . . . . 0.0 114.286 177.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.4 -51.0 67.64 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 119.477 1.639 . . . . 0.0 110.788 -169.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.64 -54.91 33.74 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-O 117.76 -1.578 . . . . 0.0 111.073 175.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -49.75 -41.08 47.21 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 CA-C-N 120.826 2.313 . . . . 0.0 115.282 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.9 tp -71.34 -39.08 71.56 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 120.135 1.334 . . . . 0.0 110.267 178.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.8 tp -61.18 -46.15 91.69 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 122.055 -0.403 . . . . 0.0 110.314 175.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.14 -40.2 84.76 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 124.08 0.952 . . . . 0.0 111.167 177.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -61.41 -48.52 80.86 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 118.918 0.781 . . . . 0.0 109.866 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -61.87 -46.39 89.61 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.895 0.478 . . . . 0.0 110.506 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 80.1 m -64.59 -39.05 93.04 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.191 0.451 . . . . 0.0 111.209 178.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.47 -37.62 88.19 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.774 0.715 . . . . 0.0 111.052 177.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.88 -37.45 79.04 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.172 0.589 . . . . 0.0 111.058 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.0 96.24 1.72 Allowed Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 124.985 1.314 . . . . 0.0 108.553 -173.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -55.93 164.34 4.86 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.869 3.046 . . . . 0.0 113.969 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -134.02 166.1 23.51 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.383 1.473 . . . . 0.0 109.011 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 44.76 -113.25 0.82 Allowed Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.767 1.175 . . . . 0.0 111.418 175.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -144.57 8.94 1.35 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.795 1.238 . . . . 0.0 111.741 176.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 3.9 m95 -68.13 131.54 45.6 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.951 0.901 . . . . 0.0 110.201 -169.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 62.1 t -77.58 119.04 25.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 166.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.5 t -82.55 136.52 22.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -174.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 70.0 mt -133.74 145.29 33.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 169.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -129.58 107.91 9.82 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 175.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.98 -2.16 90.49 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-O 118.892 -0.949 . . . . 0.0 112.95 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 55.28 -144.93 31.88 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 108.441 -1.863 . . . . 0.0 108.441 -169.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.4 p -88.52 9.13 24.88 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.738 -0.86 . . . . 0.0 112.084 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -135.86 57.19 17.42 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 124.991 1.316 . . . . 0.0 110.493 -176.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -68.74 -14.37 39.02 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.735 2.29 . . . . 0.0 113.197 -171.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -55.48 -32.5 62.88 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.074 0.852 . . . . 0.0 112.001 173.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.99 -27.31 66.75 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.192 0.597 . . . . 0.0 112.119 176.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -99.38 -2.74 35.49 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.804 1.242 . . . . 0.0 111.458 -171.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 77.3 mt -54.56 -43.09 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 119.405 1.002 . . . . 0.0 109.641 175.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.3 t -61.6 -42.29 93.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 118.348 0.522 . . . . 0.0 109.737 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.68 -46.31 79.57 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 122.948 0.499 . . . . 0.0 110.666 -177.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 67.5 mt -55.16 -48.05 76.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 172.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -68.18 -23.28 64.83 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 117.865 -1.064 . . . . 0.0 112.778 -174.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -62.96 -37.56 87.57 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 120.519 1.509 . . . . 0.0 110.34 169.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 39.2 mt -77.19 -16.55 59.05 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.851 0.86 . . . . 0.0 111.917 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 26.89 64.6 0.56 Allowed Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 127.883 2.473 . . . . 0.0 113.538 -169.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -58.67 151.25 64.53 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.704 2.936 . . . . 0.0 113.912 -169.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.9 m -69.85 -36.1 75.25 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.085 0.954 . . . . 0.0 108.736 167.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -146.68 153.94 40.86 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.394 1.078 . . . . 0.0 110.402 -175.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 46.7 tp -142.77 136.85 29.28 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 125.301 1.44 . . . . 0.0 108.373 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 27.1 tp -125.32 135.33 52.36 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 172.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.5 mt -123.25 145.17 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 -172.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 44.0 t -141.06 135.53 32.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 118.74 0.7 . . . . 0.0 110.043 -175.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -163.99 172.26 14.13 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.598 2.359 . . . . 0.0 107.544 173.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.58 158.49 36.11 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.366 -0.834 . . . . 0.0 109.17 167.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.7 m -154.41 128.67 9.04 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -75.98 83.88 2.88 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 119.004 0.82 . . . . 0.0 109.925 174.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 74.6 mtm -77.44 -8.98 58.59 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.45 1.5 . . . . 0.0 112.212 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.04 29.26 67.1 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-N 118.914 0.779 . . . . 0.0 111.362 -171.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.3 mt -106.07 -172.36 2.07 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.965 1.306 . . . . 0.0 109.721 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -74.6 141.16 75.84 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-O 117.749 -1.12 . . . . 0.0 108.58 169.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -43.19 137.95 4.72 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 123.445 2.763 . . . . 0.0 113.395 172.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.29 1.02 79.94 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-O 118.625 -1.097 . . . . 0.0 113.82 176.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -68.2 149.34 49.64 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 119.875 1.838 . . . . 0.0 108.299 168.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 48.2 mt -128.82 135.07 63.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 125.607 1.563 . . . . 0.0 106.952 -172.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.2 mmt-85 -144.99 152.12 39.65 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.068 0.849 . . . . 0.0 109.653 175.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 42.6 mm -78.12 146.57 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 167.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.3 mt -128.49 118.18 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -71.88 139.85 83.15 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-O 117.926 -1.035 . . . . 0.0 109.172 174.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -47.56 -33.22 17.47 Favored 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 124.22 3.28 . . . . 0.0 116.654 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -67.95 -24.27 65.15 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.763 0.71 . . . . 0.0 111.641 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -100.64 -28.85 12.63 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.284 1.434 . . . . 0.0 111.307 -177.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.414 HG23 ' CD1' ' A' ' 85' ' ' PHE . 61.0 mt -49.34 -45.87 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.69 1.196 . . . . 0.0 109.044 169.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.68 -14.89 15.88 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.257 1.423 . . . . 0.0 113.969 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -126.2 4.89 7.08 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.226 1.01 . . . . 0.0 111.637 -177.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 20.9 mmt -121.64 -25.71 5.05 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -176.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.414 ' CD1' HG23 ' A' ' 81' ' ' ILE . 8.2 m-85 -73.79 -40.89 63.08 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.835 1.198 . . . . 0.0 111.449 -178.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.05 6.15 10.13 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.773 -0.58 . . . . 0.0 112.397 175.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 54.0 tpp -59.53 -26.13 65.08 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.573 1.079 . . . . 0.0 110.096 169.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 48.7 p -59.06 -14.05 8.65 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.207 1.803 . . . . 0.0 113.062 169.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.8 m 61.37 22.85 13.18 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.383 1.873 . . . . 0.0 110.751 -168.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 63.5 m80 -146.84 -55.08 0.25 Allowed 'General case' 0 C--N 1.346 0.42 0 O-C-N 121.349 -0.844 . . . . 0.0 112.804 -172.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -69.77 146.05 51.74 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 118.241 0.473 . . . . 0.0 110.399 -169.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 25.1 mmt -68.49 154.33 94.55 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 173.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.8 80.72 2.31 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 124.336 3.357 . . . . 0.0 109.876 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 mt -47.23 -11.72 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 127.994 2.518 . . . . 0.0 117.642 -168.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.06 -20.97 4.05 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.053 0.842 . . . . 0.0 112.641 168.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -58.39 -32.4 68.57 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.641 1.11 . . . . 0.0 112.083 174.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.4 tt -74.77 -43.5 54.51 Favored 'General case' 0 N--CA 1.462 0.125 0 O-C-N 121.623 -0.673 . . . . 0.0 109.669 176.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 74.5 mt -62.0 -40.28 86.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 123.946 0.898 . . . . 0.0 109.705 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.1 -27.89 65.99 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.505 0.722 . . . . 0.0 112.386 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -91.47 8.49 36.14 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.816 1.246 . . . . 0.0 111.943 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 88.4 mt -133.47 -29.81 1.34 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.223 1.009 . . . . 0.0 111.865 -176.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 45.0 mttm -56.16 -19.14 12.25 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.095 0.958 . . . . 0.0 112.779 170.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -59.02 -18.81 37.94 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.423 1.089 . . . . 0.0 112.205 175.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -138.23 -42.93 0.51 Allowed 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.868 0.867 . . . . 0.0 112.012 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 20.3 mt -68.62 133.4 31.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -173.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -75.97 -34.07 48.61 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.203 0.906 . . . . 0.0 112.432 -173.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -143.62 125.75 15.47 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.4 t -127.07 128.85 70.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 3.8 mt -131.55 150.11 33.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 -169.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -130.96 141.04 50.23 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 169.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.9 tt -120.62 128.74 53.3 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 174.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -111.94 156.23 15.7 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -178.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 62.6 mt -133.92 124.52 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 -176.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -65.47 117.84 44.7 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-O 117.389 -1.291 . . . . 0.0 110.4 -178.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -77.21 171.99 16.82 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.662 2.908 . . . . 0.0 111.485 170.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -128.11 -31.43 2.35 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.669 1.587 . . . . 0.0 111.073 170.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.1 pp -136.52 135.54 49.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.309 1.044 . . . . 0.0 108.751 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.3 t -143.77 145.92 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 176.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 173.28 -120.58 0.81 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -156.21 154.18 30.36 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.647 1.224 . . . . 0.0 108.33 175.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 3.0 t80 53.73 33.07 15.97 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.691 1.197 . . . . 0.0 110.861 -171.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 12.5 m-30 -118.96 140.38 28.57 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 124.816 1.246 . . . . 0.0 109.84 -173.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -82.72 165.22 15.81 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.433 2.755 . . . . 0.0 111.215 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.3 ttm -75.71 139.35 41.86 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 168.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 73.0 p -80.74 160.5 24.91 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.484 1.114 . . . . 0.0 110.475 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -53.1 -45.04 98.44 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-O 116.493 -1.718 . . . . 0.0 114.117 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -68.52 -30.56 28.83 Favored 'Trans proline' 0 C--N 1.35 0.653 0 CA-C-N 122.847 2.052 . . . . 0.0 112.215 -176.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -80.56 -35.47 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -56.3 -46.42 79.8 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.366 0.985 . . . . 0.0 109.946 170.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -64.05 -38.62 91.74 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 122.937 0.495 . . . . 0.0 111.254 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.53 -46.49 82.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 119.013 -0.518 . . . . 0.0 111.09 175.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 79.7 t -62.87 -38.92 83.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 119.147 0.885 . . . . 0.0 109.793 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -62.79 -42.29 99.64 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.396 0.998 . . . . 0.0 110.355 174.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 57.3 m -61.14 -49.75 75.97 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 71.1 t -60.66 -42.17 90.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 123.646 0.779 . . . . 0.0 109.893 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -57.1 -48.3 78.96 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.465 0.575 . . . . 0.0 110.575 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 63.9 mm-40 -64.53 -38.57 91.47 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.992 0.815 . . . . 0.0 110.895 175.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -63.92 -27.43 69.14 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 123.436 0.695 . . . . 0.0 112.414 -177.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 75.1 mt -59.11 -18.5 36.19 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.376 0.989 . . . . 0.0 112.16 175.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -91.44 2.11 56.65 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.149 0.886 . . . . 0.0 111.947 178.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -149.69 -3.74 0.26 Allowed Glycine 0 CA--C 1.535 1.323 0 CA-C-O 119.017 -0.879 . . . . 0.0 115.272 -173.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -53.94 144.13 19.74 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.169 1.387 . . . . 0.0 108.803 169.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.09 -27.51 1.61 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.282 1.433 . . . . 0.0 112.604 -169.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 178.4 -26.81 0.06 OUTLIER Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.15 1.357 . . . . 0.0 112.303 -176.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -145.52 4.78 1.04 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.792 1.296 . . . . 0.0 112.282 178.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 63.32 13.68 50.67 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.497 1.522 . . . . 0.0 112.495 -171.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 61.56 6.79 9.1 Favored Glycine 0 CA--C 1.538 1.508 0 CA-C-N 118.543 1.172 . . . . 0.0 112.914 -168.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -72.29 167.31 20.68 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.997 1.399 . . . . 0.0 109.076 172.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -88.75 148.56 23.89 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 170.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.6 121.9 29.77 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 174.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 52.3 tp -53.77 124.38 15.08 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.612 1.565 . . . . 0.0 109.793 178.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -139.3 57.28 1.65 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.638 1.175 . . . . 0.0 109.295 -175.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.5 t 53.2 40.18 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 125.429 1.492 . . . . 0.0 110.048 -175.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -72.76 152.38 41.64 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.22 1.008 . . . . 0.0 108.395 172.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -141.2 150.7 43.04 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 169.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 . . . . . 0 C--O 1.247 0.965 0 C-N-CA 124.545 1.138 . . . . 0.0 108.161 179.039 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.485 1.309 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 24.6 m -102.71 86.32 2.73 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -177.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -75.78 145.58 40.64 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 168.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.412 HG21 ' HG3' ' A' ' 55' ' ' PRO . 69.6 t -136.33 148.38 27.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 39.3 tp -123.36 119.15 29.24 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.9 tp -109.95 96.91 6.54 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 99.4 m -71.29 142.39 50.48 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 169.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.3 t -140.82 143.12 29.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 177.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.02 174.54 17.36 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -122.71 121.05 35.43 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.365 1.466 . . . . 0.0 107.422 177.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 m -59.56 -14.78 14.52 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.934 1.693 . . . . 0.0 115.495 -169.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -128.86 14.12 6.35 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.839 0.856 . . . . 0.0 111.243 -176.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.2 ttt -97.73 30.6 2.9 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 118.682 0.674 . . . . 0.0 109.898 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.26 -142.39 20.45 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -178.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -61.2 -17.31 52.48 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.593 1.157 . . . . 0.0 112.111 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -56.63 -19.97 18.84 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.217 1.407 . . . . 0.0 112.871 174.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.36 20.26 0.77 Allowed Glycine 0 CA--C 1.534 1.258 0 O-C-N 120.691 -1.256 . . . . 0.0 114.311 177.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.8 -52.7 63.14 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 119.571 1.685 . . . . 0.0 110.862 -169.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.62 -54.81 34.55 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-O 117.88 -1.511 . . . . 0.0 111.214 175.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -49.67 -40.76 46.75 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 CA-C-N 120.818 2.309 . . . . 0.0 115.077 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 65.6 tp -70.65 -39.27 73.72 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-N 119.963 1.256 . . . . 0.0 110.311 178.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.0 tp -61.28 -46.87 88.54 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.065 0.393 . . . . 0.0 110.348 175.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.38 -42.23 86.58 Favored 'General case' 0 C--O 1.227 -0.125 0 C-N-CA 124.134 0.974 . . . . 0.0 110.829 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -60.72 -49.15 78.68 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.476 0.58 . . . . 0.0 110.0 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -61.75 -49.83 74.83 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 122.99 0.516 . . . . 0.0 110.723 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 75.7 m -64.02 -37.79 88.71 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.549 0.613 . . . . 0.0 111.399 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.46 -40.65 96.12 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.112 0.869 . . . . 0.0 111.073 176.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.64 -33.05 73.34 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.511 0.724 . . . . 0.0 111.704 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.44 96.08 2.66 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.544 1.537 . . . . 0.0 107.762 -173.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -53.31 159.5 5.87 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 123.439 2.759 . . . . 0.0 113.939 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -134.53 155.54 50.23 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.638 1.575 . . . . 0.0 108.085 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 40.71 -119.08 1.32 Allowed Glycine 0 CA--C 1.532 1.104 0 C-N-CA 125.128 1.346 . . . . 0.0 111.88 176.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -137.14 14.87 3.04 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.913 1.685 . . . . 0.0 111.309 177.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -72.52 128.17 34.77 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.337 0.655 . . . . 0.0 109.791 -173.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.2 t -72.86 120.45 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 166.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.0 t -76.22 133.72 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 24.4 mm -133.15 147.94 31.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 104.967 -2.235 . . . . 0.0 104.967 171.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -134.7 114.06 12.32 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 177.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.79 -16.28 76.19 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 118.654 -1.081 . . . . 0.0 113.003 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 57.95 39.0 91.14 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-N 119.264 1.532 . . . . 0.0 113.722 170.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . 0.252 75.3 p 60.71 14.29 4.95 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.502 2.321 . . . . 0.0 114.69 -173.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.2 56.29 6.22 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 125.632 1.573 . . . . 0.0 108.995 172.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -67.05 -28.75 41.11 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.395 2.063 . . . . 0.0 112.258 -169.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.59 -36.19 77.96 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.592 0.757 . . . . 0.0 111.892 -178.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -64.43 -13.59 52.2 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.702 0.801 . . . . 0.0 112.574 176.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -112.66 -0.36 15.12 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.314 1.046 . . . . 0.0 112.38 -172.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 87.5 mt -50.01 -36.92 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 124.577 1.151 . . . . 0.0 110.518 172.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 51.3 t -56.41 -40.82 69.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 123.646 0.778 . . . . 0.0 110.455 178.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.46 -41.85 83.99 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.498 0.59 . . . . 0.0 110.504 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 51.1 mt -61.91 -40.29 86.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -66.23 -20.25 66.06 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 117.785 -1.103 . . . . 0.0 112.528 176.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -72.45 -43.94 63.07 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 120.677 1.581 . . . . 0.0 109.097 169.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 49.0 mt -68.75 -27.91 66.33 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 118.671 -0.681 . . . . 0.0 112.568 -177.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 39.12 64.74 3.69 Favored Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 125.589 1.556 . . . . 0.0 111.306 -169.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.412 ' HG3' HG21 ' A' ' 4' ' ' VAL . 51.6 Cg_exo -49.69 141.04 28.23 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.269 2.646 . . . . 0.0 113.402 -172.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.1 m -66.99 -41.29 87.01 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 167.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.2 mtm-85 -146.72 149.97 34.47 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.115 1.766 . . . . 0.0 106.789 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 52.9 tp -134.59 137.76 43.99 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 33.6 tp -125.6 133.8 52.13 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 175.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.4 mt -121.96 142.38 38.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -174.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.5 t -141.01 133.56 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 118.764 0.711 . . . . 0.0 110.056 -174.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -161.42 171.24 18.55 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.39 2.276 . . . . 0.0 107.464 172.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.54 156.28 39.6 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.951 -1.093 . . . . 0.0 108.583 168.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.8 m -155.9 132.56 10.38 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -78.13 122.73 26.01 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 73.5 mtm -121.43 1.49 10.14 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.209 1.803 . . . . 0.0 110.699 -176.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.24 18.17 60.24 Favored Glycine 0 CA--C 1.537 1.412 0 CA-C-N 118.676 0.671 . . . . 0.0 112.579 -171.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.6 mt -87.47 -176.1 5.47 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.487 1.515 . . . . 0.0 109.744 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -76.08 140.26 69.76 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-O 117.871 -1.062 . . . . 0.0 108.818 171.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -45.86 134.93 14.0 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.417 2.744 . . . . 0.0 113.71 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.01 2.27 88.54 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.574 -1.126 . . . . 0.0 113.359 177.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -65.99 151.93 45.72 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 119.867 1.833 . . . . 0.0 108.025 168.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 81.0 mt -128.12 141.91 45.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -171.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 84.2 mmt-85 -151.04 154.19 36.55 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 123.326 0.651 . . . . 0.0 110.858 172.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 35.8 mm -81.6 144.68 9.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 165.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.7 mt -125.53 128.12 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 176.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -72.87 140.1 80.67 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-O 118.084 -0.96 . . . . 0.0 109.655 173.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -46.98 -32.55 13.05 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 124.356 3.37 . . . . 0.0 116.79 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -67.49 -26.48 66.38 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.778 0.717 . . . . 0.0 111.782 178.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -101.66 -25.08 13.99 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.991 1.316 . . . . 0.0 111.446 -176.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.443 HD11 ' HB3' ' A' ' 110' ' ' PHE . 45.0 mt -50.17 -41.21 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.54 1.136 . . . . 0.0 109.512 169.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.33 -30.67 52.11 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.53 1.132 . . . . 0.0 113.15 -177.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -100.38 -39.16 8.12 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.052 0.541 . . . . 0.0 110.06 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 26.1 mmt -73.47 -27.85 61.62 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 121.714 -0.616 . . . . 0.0 112.256 -173.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -68.59 -49.95 55.39 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 118.838 0.745 . . . . 0.0 110.306 171.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 27.6 ptm -63.21 -20.78 65.74 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.206 0.912 . . . . 0.0 111.911 -178.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 10.7 tpt -58.4 -25.28 61.93 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.935 0.894 . . . . 0.0 112.249 173.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 82.4 p -68.99 -7.08 32.07 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 119.378 0.99 . . . . 0.0 113.136 176.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.4 m 118.68 81.33 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 130.929 3.692 . . . . 0.0 108.188 169.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 24.5 m80 56.29 26.58 10.68 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.914 1.686 . . . . 0.0 113.388 176.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -63.17 157.42 22.5 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.222 1.009 . . . . 0.0 109.543 172.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 63.4 mtt -67.43 146.22 98.65 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -76.61 73.46 5.2 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 124.285 3.323 . . . . 0.0 109.827 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.1 mt -51.85 -6.83 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 117.363 2.357 . . . . 0.0 117.363 -168.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -54.08 -19.42 4.89 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.437 1.017 . . . . 0.0 112.243 166.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -59.35 -28.46 66.87 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.608 1.095 . . . . 0.0 112.125 173.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.7 tt -70.78 -45.6 64.41 Favored 'General case' 0 N--CA 1.463 0.18 0 O-C-N 121.334 -0.854 . . . . 0.0 109.625 173.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 90.0 mt -61.5 -42.11 92.66 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.137 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -60.38 -24.85 65.43 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -85.89 0.11 53.94 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.921 0.888 . . . . 0.0 112.453 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 65.3 mt -135.89 -31.34 0.93 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.21 1.004 . . . . 0.0 112.401 -171.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -59.29 -21.84 60.29 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.895 1.278 . . . . 0.0 112.712 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -71.44 -13.06 61.71 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.513 1.125 . . . . 0.0 111.916 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -134.67 -32.98 0.97 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.219 0.918 . . . . 0.0 112.983 -176.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 53.7 mt -68.55 143.58 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 172.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -67.17 -41.66 92.05 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 123.96 0.791 . . . . 0.0 112.236 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -150.63 143.15 24.42 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 118.582 1.191 . . . . 0.0 108.999 173.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.0 t -127.66 129.44 70.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 177.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.6 mt -129.93 148.86 33.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 -169.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.443 ' HB3' HD11 ' A' ' 81' ' ' ILE . 77.3 t80 -132.86 142.38 48.91 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 171.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.4 tt -122.44 127.8 50.09 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.434 1.494 . . . . 0.0 107.124 174.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -109.16 156.09 15.78 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 77.8 mt -133.93 126.98 51.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -61.28 114.95 12.19 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-O 117.346 -1.311 . . . . 0.0 110.34 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -76.52 171.4 18.13 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.184 2.589 . . . . 0.0 111.174 170.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -129.59 -31.81 1.98 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.915 1.686 . . . . 0.0 111.041 171.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -135.84 135.85 50.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 124.282 1.033 . . . . 0.0 108.215 176.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.6 t -141.58 135.4 30.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 158.4 151.16 5.99 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 178.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -65.99 153.33 42.45 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.844 0.831 . . . . 0.0 111.344 -175.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 54.62 38.79 30.55 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.92 2.088 . . . . 0.0 112.141 -176.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -123.4 148.32 55.06 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 123.961 0.904 . . . . 0.0 109.996 172.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -81.74 163.83 18.48 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.19 2.594 . . . . 0.0 111.161 176.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 52.2 ttm -72.24 138.94 47.84 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 168.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 68.8 p -79.07 159.27 27.61 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.153 0.981 . . . . 0.0 110.529 178.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -52.9 -44.1 95.63 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-O 116.569 -1.681 . . . . 0.0 114.277 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -68.67 -31.26 26.49 Favored 'Trans proline' 0 C--N 1.351 0.667 0 CA-C-N 122.892 2.069 . . . . 0.0 112.215 -176.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.09 -35.28 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -56.3 -46.02 80.0 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.196 0.907 . . . . 0.0 110.172 170.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -64.15 -37.92 89.2 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 122.987 0.515 . . . . 0.0 111.41 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.58 -47.33 79.08 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 121.944 -0.473 . . . . 0.0 110.986 175.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 72.4 t -62.71 -39.37 84.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 118.552 0.615 . . . . 0.0 109.789 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -60.31 -43.26 96.51 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.022 0.828 . . . . 0.0 110.265 173.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 55.2 m -61.52 -47.5 85.33 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.959 -0.463 . . . . 0.0 109.971 178.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 87.8 t -61.44 -45.65 98.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 118.552 0.615 . . . . 0.0 109.648 178.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -54.4 -48.84 71.11 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.802 0.841 . . . . 0.0 110.71 177.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 48.2 mm-40 -65.58 -37.34 86.37 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.642 0.656 . . . . 0.0 111.41 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.1 -35.54 71.6 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.545 0.738 . . . . 0.0 111.843 -178.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 77.6 mt -59.07 -16.88 21.27 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -172.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -77.52 -20.34 54.39 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 120.042 1.292 . . . . 0.0 112.54 177.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -145.76 5.81 1.35 Allowed Glycine 0 CA--C 1.532 1.145 0 CA-C-O 119.393 -0.67 . . . . 0.0 114.713 -169.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -52.06 138.19 25.81 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.647 1.579 . . . . 0.0 108.907 170.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -143.61 145.78 32.76 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 170.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 53.59 -121.27 16.94 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 123.971 0.796 . . . . 0.0 111.581 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -75.33 5.09 6.07 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.71 1.204 . . . . 0.0 112.916 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 70.8 13.76 72.28 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 124.213 0.911 . . . . 0.0 112.398 -174.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.54 -4.5 3.88 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-N 118.413 1.107 . . . . 0.0 113.526 -172.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -71.82 152.22 42.84 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 119.094 1.447 . . . . 0.0 109.023 174.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -76.7 148.08 37.02 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 174.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -91.3 120.54 32.27 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 176.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 44.9 tp -55.89 124.31 17.2 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.819 1.647 . . . . 0.0 109.883 177.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.98 -42.51 0.16 Allowed 'General case' 0 C--O 1.233 0.189 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -177.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 16.4 t -151.27 -47.9 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 118.711 0.687 . . . . 0.0 110.172 -169.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 57.83 28.79 16.51 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.487 1.915 . . . . 0.0 113.128 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -143.35 162.67 35.12 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.377 1.871 . . . . 0.0 107.357 174.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 . . . . . 0 C--O 1.25 1.111 0 C-N-CA 125.897 1.679 . . . . 0.0 107.035 179.86 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ttt . . . . . 0 N--CA 1.483 1.209 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.8 m -104.04 93.77 5.03 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 -177.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -77.38 151.99 34.6 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 169.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.6 t -138.02 148.19 25.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -175.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 31.7 tp -122.71 119.55 31.01 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.3 tp -109.02 97.68 7.27 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 125.405 1.482 . . . . 0.0 107.487 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 87.7 m -73.53 143.17 46.63 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 169.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.8 t -140.21 142.11 32.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 142.37 178.92 18.83 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 124.214 0.912 . . . . 0.0 111.861 177.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -127.95 123.59 35.23 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.768 1.227 . . . . 0.0 108.619 177.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 m -58.74 -16.05 14.93 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.631 1.972 . . . . 0.0 115.461 -169.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.0 ptp -128.7 15.98 6.42 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 119.197 0.908 . . . . 0.0 111.259 -178.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 11.3 tpt -92.19 25.48 2.89 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.621 0.768 . . . . 0.0 109.397 176.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.75 -142.64 20.21 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -176.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -61.0 -16.82 47.68 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.695 1.198 . . . . 0.0 112.221 178.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -55.58 -20.56 13.87 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.483 1.513 . . . . 0.0 112.906 173.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.14 17.91 0.94 Allowed Glycine 0 CA--C 1.534 1.257 0 O-C-N 120.789 -1.194 . . . . 0.0 114.437 177.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.19 -51.29 69.63 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 119.566 1.683 . . . . 0.0 110.838 -170.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.77 -55.96 27.52 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-O 117.794 -1.559 . . . . 0.0 111.136 175.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -49.77 -40.78 47.66 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 CA-C-N 120.784 2.292 . . . . 0.0 115.113 178.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 62.6 tp -70.61 -39.89 73.51 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 119.862 1.21 . . . . 0.0 109.986 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.2 tp -61.47 -46.37 90.33 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.443 0.297 . . . . 0.0 110.388 176.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.69 -42.6 88.93 Favored 'General case' 0 C--O 1.227 -0.127 0 C-N-CA 123.838 0.855 . . . . 0.0 110.883 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -60.93 -48.98 79.3 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 118.616 0.643 . . . . 0.0 109.871 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -63.62 -48.69 76.28 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 123.016 0.526 . . . . 0.0 110.907 -178.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 93.0 m -65.39 -34.56 78.6 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.732 0.696 . . . . 0.0 111.478 178.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.99 -40.64 95.26 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.689 1.132 . . . . 0.0 110.848 174.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.14 -33.05 72.83 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.434 0.693 . . . . 0.0 111.8 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.57 89.54 4.42 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.394 1.478 . . . . 0.0 108.548 -174.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -52.6 155.8 9.7 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.955 3.103 . . . . 0.0 113.606 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -133.37 156.65 47.27 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.635 1.174 . . . . 0.0 109.479 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 40.84 -111.95 0.3 Allowed Glycine 0 CA--C 1.527 0.844 0 C-N-CA 125.85 1.691 . . . . 0.0 112.612 172.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -138.04 9.91 2.8 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.145 1.378 . . . . 0.0 111.295 -173.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 1.5 m95 -85.07 123.07 30.18 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 121.286 -0.884 . . . . 0.0 110.753 -168.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.7 t -70.68 119.88 17.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 166.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.6 t -74.04 132.6 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.1 mm -133.98 148.0 30.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 172.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -135.61 111.66 9.6 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.23 -1.99 88.05 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-O 118.991 -0.894 . . . . 0.0 112.727 179.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 56.16 -147.52 30.63 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -169.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 p -90.08 10.95 22.31 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.841 0.856 . . . . 0.0 111.94 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.83 55.17 7.43 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.267 1.427 . . . . 0.0 109.77 -177.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -66.36 -20.35 55.06 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.825 2.35 . . . . 0.0 113.479 -169.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.3 pm0 -61.6 -30.39 70.65 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 119.05 0.841 . . . . 0.0 111.911 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.02 -25.85 67.89 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.373 0.669 . . . . 0.0 112.084 175.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -102.84 -2.51 27.79 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.106 0.962 . . . . 0.0 113.06 -168.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.9 mt -48.52 -40.4 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.518 1.127 . . . . 0.0 110.288 174.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.1 t -56.19 -40.26 64.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.926 0.89 . . . . 0.0 110.582 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.32 -42.26 83.94 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 118.318 0.508 . . . . 0.0 110.398 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 35.3 mt -64.97 -37.48 80.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.38 -21.05 66.05 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 117.855 -1.069 . . . . 0.0 112.397 175.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -70.91 -39.74 72.57 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 120.613 1.552 . . . . 0.0 109.745 170.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 59.5 mt -70.48 -26.55 63.67 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.499 0.72 . . . . 0.0 112.187 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 40.89 65.71 4.08 Favored Pre-proline 0 N--CA 1.472 0.668 0 C-N-CA 125.698 1.599 . . . . 0.0 110.932 -171.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -52.14 137.4 54.39 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 123.253 2.635 . . . . 0.0 112.79 -169.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.0 m -69.53 -38.67 77.61 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 167.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -144.45 157.7 44.11 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 124.889 1.276 . . . . 0.0 107.885 171.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 53.5 tp -136.74 136.16 38.72 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 32.5 tp -123.67 134.92 53.66 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 175.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.0 mt -123.29 141.82 42.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 -173.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 44.6 t -140.87 134.36 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 118.773 0.715 . . . . 0.0 110.642 -174.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -162.82 171.22 17.04 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.783 2.433 . . . . 0.0 107.481 172.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.75 157.69 37.59 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 120.989 -1.069 . . . . 0.0 108.54 167.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.0 m -156.2 127.79 7.23 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 175.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -70.74 124.21 23.74 Favored 'General case' 0 C--O 1.23 0.058 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 172.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 73.6 mtm -122.39 2.2 9.66 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.142 1.777 . . . . 0.0 110.562 -177.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.11 24.64 68.9 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-N 118.66 0.664 . . . . 0.0 112.195 -172.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.6 mt -98.04 -172.71 2.42 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.398 1.479 . . . . 0.0 109.24 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -79.6 140.4 55.37 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-O 117.746 -1.121 . . . . 0.0 108.931 173.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -45.64 134.0 13.26 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.343 2.695 . . . . 0.0 113.705 178.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.49 2.08 89.27 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-O 118.254 -1.303 . . . . 0.0 113.345 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -66.29 150.24 49.15 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 120.156 1.978 . . . . 0.0 107.728 167.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 34.4 mt -131.52 135.14 59.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -169.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.4 mmt-85 -146.6 153.3 40.17 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.504 0.593 . . . . 0.0 109.984 176.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 29.4 mm -83.0 143.36 12.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 167.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.6 mt -126.11 124.17 65.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -71.39 141.09 85.33 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.419 173.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -46.99 -32.5 13.01 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 124.133 3.222 . . . . 0.0 116.594 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -67.19 -25.54 66.18 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.803 0.728 . . . . 0.0 111.799 177.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -101.42 -26.21 13.67 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.915 1.286 . . . . 0.0 111.447 -177.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.429 HD11 ' HB3' ' A' ' 110' ' ' PHE . 51.6 mt -50.19 -41.36 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.478 1.111 . . . . 0.0 109.109 168.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.39 -22.1 18.44 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.425 1.49 . . . . 0.0 114.075 -177.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -115.2 -33.75 5.24 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 118.68 0.673 . . . . 0.0 110.387 177.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 23.3 mmt -72.28 -28.51 63.15 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -177.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.404 ' CD1' HG23 ' A' ' 81' ' ' ILE . 2.1 m-85 -66.39 -46.29 77.12 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 119.241 0.928 . . . . 0.0 110.92 176.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -69.55 1.34 4.16 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 -178.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 87.2 mmm -62.7 -40.06 95.94 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 166.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 63.4 p -72.2 134.69 45.8 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 169.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.6 m -49.47 114.61 1.08 Allowed 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.813 1.645 . . . . 0.0 111.428 -166.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 30.1 m170 55.78 20.77 4.24 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.422 1.489 . . . . 0.0 113.905 173.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -67.51 148.0 52.07 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.369 -0.832 . . . . 0.0 109.471 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 26.4 mmt -72.19 151.36 92.37 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -74.9 74.56 3.91 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 124.321 3.347 . . . . 0.0 109.433 175.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.83 -6.78 0.06 Allowed 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 -167.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -55.46 -17.31 4.93 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 120.997 -1.065 . . . . 0.0 112.179 166.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -59.29 -32.15 69.77 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 120.155 1.343 . . . . 0.0 111.924 173.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.3 tt -67.59 -48.92 65.46 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 174.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 74.5 mt -61.27 -45.31 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -174.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.56 -21.08 66.56 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.014 -1.054 . . . . 0.0 113.38 -174.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -91.84 5.64 49.18 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.149 0.98 . . . . 0.0 111.852 177.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 40.5 tp -140.89 -32.88 0.55 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.593 0.757 . . . . 0.0 112.311 -169.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.0 pttm -61.68 -25.28 67.31 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 125.63 1.572 . . . . 0.0 112.62 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -62.6 -18.04 61.41 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.315 1.046 . . . . 0.0 112.275 -175.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -114.12 6.21 16.27 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.231 1.012 . . . . 0.0 112.155 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 79.9 mt -120.6 146.42 25.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.848 1.259 . . . . 0.0 108.522 -171.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -75.19 -36.25 46.22 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.774 0.702 . . . . 0.0 112.143 -177.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -152.12 141.05 21.11 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.107 0.954 . . . . 0.0 108.679 175.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.6 t -124.99 135.23 64.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 171.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.0 mp -129.49 149.72 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 -177.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.429 ' HB3' HD11 ' A' ' 81' ' ' ILE . 43.2 t80 -130.75 141.8 50.39 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 169.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.4 tt -120.28 130.54 54.52 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.313 1.445 . . . . 0.0 107.544 173.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -111.41 155.01 16.4 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 176.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 77.1 mt -133.24 127.37 54.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -60.93 114.63 10.98 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-O 117.351 -1.309 . . . . 0.0 110.179 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -76.2 171.5 17.99 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.158 2.572 . . . . 0.0 111.116 170.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -129.42 -31.56 2.04 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.053 1.741 . . . . 0.0 111.012 171.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -135.85 136.03 50.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.237 1.015 . . . . 0.0 108.309 176.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.8 t -141.45 134.84 30.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 175.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 159.47 153.94 7.06 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -69.52 153.46 43.47 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.882 0.849 . . . . 0.0 110.775 -173.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.4 t80 51.8 39.16 25.02 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.846 2.058 . . . . 0.0 112.296 -176.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 23.0 m-30 -121.97 147.63 49.34 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 124.067 0.947 . . . . 0.0 109.961 173.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -81.15 164.09 19.77 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.153 2.568 . . . . 0.0 111.15 177.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.3 ttm -72.59 139.41 47.44 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 168.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 68.6 p -79.08 159.36 27.55 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.191 0.996 . . . . 0.0 110.522 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.2 tp60 -52.87 -44.26 95.88 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-O 116.579 -1.677 . . . . 0.0 114.232 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -68.78 -30.55 27.08 Favored 'Trans proline' 0 C--N 1.35 0.647 0 CA-C-N 122.869 2.06 . . . . 0.0 112.295 -176.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.97 -35.26 15.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 119.072 0.851 . . . . 0.0 108.706 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -56.29 -46.91 79.56 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.136 0.88 . . . . 0.0 109.977 169.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -63.28 -38.27 90.5 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.037 0.535 . . . . 0.0 111.248 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.35 -47.14 80.44 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 121.967 -0.458 . . . . 0.0 111.133 176.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.5 t -61.4 -41.27 89.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 118.581 0.628 . . . . 0.0 109.655 177.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -62.36 -33.86 75.55 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.863 0.865 . . . . 0.0 111.074 175.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 44.3 m -69.52 -46.23 67.02 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.462 -0.774 . . . . 0.0 109.926 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 92.3 t -61.97 -44.35 98.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 119.203 0.911 . . . . 0.0 109.592 178.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -53.37 -43.82 68.09 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.32 1.048 . . . . 0.0 111.172 176.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -68.73 -45.02 72.61 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.527 0.603 . . . . 0.0 111.119 175.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -58.7 -36.66 74.58 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.133 0.573 . . . . 0.0 111.221 -174.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 56.9 mt -56.27 -19.06 12.47 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -175.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -72.92 -25.65 61.12 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 120.09 1.314 . . . . 0.0 112.211 176.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -132.21 1.8 4.99 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.416 1.008 . . . . 0.0 113.72 -173.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -54.42 113.0 1.11 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.342 1.857 . . . . 0.0 109.09 175.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -80.09 -43.45 21.73 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.621 0.368 . . . . 0.0 110.721 -177.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -168.77 -39.2 0.02 OUTLIER Glycine 0 CA--C 1.529 0.91 0 CA-C-O 118.822 -0.988 . . . . 0.0 112.671 -178.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -113.38 3.73 16.01 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 118.406 1.103 . . . . 0.0 112.209 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 61.3 15.8 46.54 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.187 0.899 . . . . 0.0 113.832 -176.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 63.99 2.22 6.3 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-N 118.625 1.212 . . . . 0.0 113.574 -171.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -75.17 148.55 39.49 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 119.202 1.501 . . . . 0.0 108.818 177.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.87 148.47 42.29 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.196 176.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -92.15 119.85 32.19 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 60.4 tp -56.66 124.31 17.9 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.024 1.729 . . . . 0.0 110.104 178.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -145.78 44.34 1.27 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.103 0.961 . . . . 0.0 110.653 -174.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 4.5 t 52.72 49.11 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 125.295 1.438 . . . . 0.0 109.792 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -65.14 163.14 15.59 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.933 0.893 . . . . 0.0 111.108 176.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -143.15 163.49 32.75 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.804 1.642 . . . . 0.0 107.892 177.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 . . . . . 0 C--O 1.248 0.989 0 C-N-CA 125.659 1.583 . . . . 0.0 106.891 177.395 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.6 mmt . . . . . 0 N--CA 1.484 1.23 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 15.2 m -145.6 139.11 26.43 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -176.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -136.54 97.07 3.47 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 -172.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.8 m -86.41 150.72 3.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 123.758 0.823 . . . . 0.0 110.04 -172.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 52.6 tp -115.32 124.51 51.47 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 171.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 67.2 tp -112.95 97.41 6.51 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 92.2 m -72.97 141.97 47.78 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 169.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.4 t -141.23 142.03 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 125.216 1.407 . . . . 0.0 107.734 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 148.91 178.04 23.61 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 123.971 0.796 . . . . 0.0 112.272 175.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -124.93 117.17 23.46 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 125.387 1.475 . . . . 0.0 107.908 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 m -56.13 -21.63 23.63 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 126.5 1.92 . . . . 0.0 115.339 -170.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 25.7 ptp -123.91 20.48 9.2 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.665 0.666 . . . . 0.0 110.794 -174.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.9 ttt -102.34 29.23 5.31 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.38 1.072 . . . . 0.0 110.29 179.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.33 -142.07 21.83 Favored Glycine 0 N--CA 1.441 -1.021 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -63.17 -15.44 56.89 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.37 1.068 . . . . 0.0 112.223 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -56.17 -21.49 23.24 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.15 1.38 . . . . 0.0 112.987 175.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.33 21.29 0.69 Allowed Glycine 0 CA--C 1.534 1.246 0 CA-C-O 118.491 -1.172 . . . . 0.0 114.475 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.1 -51.88 67.27 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 119.545 1.673 . . . . 0.0 110.758 -169.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.28 -55.32 30.81 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 117.502 -1.721 . . . . 0.0 111.423 177.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -50.47 -40.14 54.23 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 CA-C-N 120.921 2.36 . . . . 0.0 115.076 178.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.6 tp -71.07 -39.48 72.18 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 119.878 1.217 . . . . 0.0 110.039 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 51.1 tp -61.53 -48.85 79.13 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 176.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.26 -41.7 80.14 Favored 'General case' 0 C--O 1.227 -0.107 0 C-N-CA 124.054 0.942 . . . . 0.0 111.283 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -60.77 -49.1 78.86 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.661 0.664 . . . . 0.0 109.897 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -62.66 -47.74 82.37 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 122.983 0.513 . . . . 0.0 110.702 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 73.8 m -64.74 -37.95 89.33 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.574 0.624 . . . . 0.0 111.458 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.81 -40.91 97.77 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.991 0.814 . . . . 0.0 110.806 176.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.67 -32.53 72.42 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.483 0.713 . . . . 0.0 111.837 178.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.86 92.6 2.85 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 125.268 1.427 . . . . 0.0 108.461 -172.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -53.8 158.85 7.8 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.34 2.693 . . . . 0.0 113.567 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.424 ' HE2' ' CE1' ' A' ' 136' ' ' TYR . 74.7 mmtt -129.36 166.39 19.61 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.481 1.512 . . . . 0.0 108.474 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 41.17 -124.37 2.88 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.478 1.513 . . . . 0.0 112.139 175.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -138.47 35.98 2.26 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.185 1.394 . . . . 0.0 109.028 170.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -70.49 167.02 19.25 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.146 0.978 . . . . 0.0 111.441 -175.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 68.7 t -122.29 101.95 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 168.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.9 t -72.43 136.91 24.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -175.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 90.9 mt -135.33 142.31 40.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 172.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -127.01 105.29 8.5 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.55 -6.36 80.76 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 118.973 -0.904 . . . . 0.0 112.69 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 54.22 -140.7 35.42 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 -169.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.4 p -93.2 7.89 42.43 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.624 0.77 . . . . 0.0 112.469 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.72 64.22 42.52 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 124.875 1.27 . . . . 0.0 109.528 177.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -65.17 -15.63 51.15 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.668 2.245 . . . . 0.0 112.183 -177.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -46.92 -42.37 17.55 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.703 1.601 . . . . 0.0 111.161 168.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.96 -27.29 68.73 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.93 -5.43 41.4 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.854 1.261 . . . . 0.0 111.33 -169.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.8 mt -52.86 -44.9 49.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 118.919 0.781 . . . . 0.0 109.18 171.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.7 t -60.99 -42.29 92.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.22 -44.69 87.48 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 123.192 0.597 . . . . 0.0 110.854 -177.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 72.9 mt -55.39 -48.15 77.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.091 0.956 . . . . 0.0 108.504 173.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 49.7 mtp180 -67.83 -19.17 65.03 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 117.598 -1.192 . . . . 0.0 113.135 -176.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -58.97 -27.39 65.33 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 121.023 1.738 . . . . 0.0 110.977 171.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 58.6 mt -95.93 -9.52 31.05 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.582 1.153 . . . . 0.0 112.33 -172.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 48.7 mmm-85 32.85 58.48 1.47 Allowed Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 126.423 1.889 . . . . 0.0 111.764 -169.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -56.09 152.49 37.14 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.073 2.515 . . . . 0.0 114.867 -168.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.1 m -71.97 -39.06 69.6 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.089 0.955 . . . . 0.0 109.244 168.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -148.67 160.12 43.46 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.633 0.773 . . . . 0.0 111.126 -177.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 24.1 tp -141.91 139.52 32.57 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 125.304 1.442 . . . . 0.0 109.074 177.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 54.4 tp -124.17 135.98 53.86 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 168.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.9 mt -119.49 144.97 26.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -178.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 46.3 t -139.92 133.68 36.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 123.148 0.579 . . . . 0.0 109.649 -175.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -162.65 171.68 16.52 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 127.335 2.254 . . . . 0.0 107.245 173.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.07 155.31 40.58 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 167.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.1 m -153.86 135.56 14.44 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 177.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -81.09 84.45 6.51 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.945 0.793 . . . . 0.0 109.873 176.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -69.48 -8.88 50.79 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.698 0.799 . . . . 0.0 112.121 173.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.36 24.89 76.39 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 119.434 1.016 . . . . 0.0 111.634 -171.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 98.0 mt -100.01 -173.26 2.39 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.232 1.413 . . . . 0.0 110.477 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -69.66 139.76 89.01 Favored Pre-proline 0 N--CA 1.467 0.407 0 CA-C-O 117.606 -1.188 . . . . 0.0 108.72 169.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -43.04 138.92 3.88 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.544 2.829 . . . . 0.0 113.57 172.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.17 0.27 76.42 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 118.6 -1.111 . . . . 0.0 113.679 176.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -65.72 154.78 38.0 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 119.794 1.797 . . . . 0.0 108.815 168.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 77.4 mt -134.7 132.87 54.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 125.825 1.65 . . . . 0.0 106.699 -170.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.2 mmt-85 -143.39 148.11 35.69 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.291 0.95 . . . . 0.0 109.733 177.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 47.1 mm -77.92 144.68 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 169.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -135.5 165.63 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 124.777 1.231 . . . . 0.0 108.205 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -139.42 146.16 47.21 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 127.086 2.155 . . . . 0.0 107.619 -169.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -54.12 -27.97 48.88 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.399 2.733 . . . . 0.0 115.088 -174.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -67.29 -20.02 65.57 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.862 0.755 . . . . 0.0 112.123 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -119.85 -31.2 4.56 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.91 1.284 . . . . 0.0 111.84 -171.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 67.2 mt -50.74 -39.98 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.373 1.469 . . . . 0.0 109.938 169.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.45 -28.28 53.36 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.359 1.064 . . . . 0.0 113.129 -177.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -102.24 -43.83 5.6 Favored 'General case' 0 C--O 1.23 0.078 0 C-N-CA 123.202 0.601 . . . . 0.0 109.53 176.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 21.2 mmt -69.06 -28.76 66.83 Favored 'General case' 0 C--O 1.23 0.057 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -169.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -68.06 -48.36 65.82 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 119.038 0.835 . . . . 0.0 110.724 175.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 28.8 ptm -80.64 9.86 5.59 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 15.1 tpt -60.8 -27.37 67.98 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.432 1.015 . . . . 0.0 109.488 167.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 45.4 p -59.81 -15.56 21.59 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.096 1.758 . . . . 0.0 112.9 169.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.9 m 56.78 31.34 19.31 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.941 1.696 . . . . 0.0 109.961 -168.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -153.52 -54.58 0.11 Allowed 'General case' 0 C--N 1.345 0.404 0 O-C-N 121.393 -0.817 . . . . 0.0 112.988 -171.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -70.5 150.92 45.66 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 118.113 0.415 . . . . 0.0 110.321 -169.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 26.3 mmt -68.34 145.47 97.39 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 123.31 0.644 . . . . 0.0 109.632 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -73.83 76.58 2.87 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 124.463 3.442 . . . . 0.0 109.057 176.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.3 mt -52.03 -7.56 0.06 Allowed 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 117.087 2.255 . . . . 0.0 117.087 -167.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -52.78 -23.24 6.46 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.318 -0.864 . . . . 0.0 112.278 167.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -58.83 -34.4 71.49 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.396 0.998 . . . . 0.0 111.593 175.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.3 tt -75.83 -44.29 41.73 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 86.7 mt -60.96 -42.0 91.18 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.175 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -60.84 -26.01 67.04 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.853 0.751 . . . . 0.0 112.606 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -85.06 -3.57 58.84 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.753 0.821 . . . . 0.0 112.211 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 80.3 mt -130.01 -26.59 2.37 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.22 1.008 . . . . 0.0 111.946 -173.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -63.44 -23.11 67.26 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.221 -0.924 . . . . 0.0 112.286 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -80.09 -6.06 57.0 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.148 0.979 . . . . 0.0 111.789 175.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -132.51 -3.06 3.38 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.689 1.195 . . . . 0.0 113.038 -168.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.3 mt -134.85 143.41 37.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 126.549 1.94 . . . . 0.0 106.163 -175.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -70.37 -37.15 70.2 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-O 119.464 -0.631 . . . . 0.0 112.539 -172.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -146.53 130.88 17.59 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 -177.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 48.6 t -132.12 124.31 52.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 21.3 mt -130.19 156.68 42.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 -169.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -130.82 147.47 52.48 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 174.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.8 tt -126.37 126.5 43.99 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 170.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -107.69 156.16 15.98 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 82.5 mt -131.82 126.32 56.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 71.1 tp60 -64.64 116.03 25.44 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-O 117.201 -1.381 . . . . 0.0 110.438 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -76.51 170.59 19.64 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.268 2.645 . . . . 0.0 111.377 170.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -128.08 -31.9 2.32 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.978 1.711 . . . . 0.0 110.984 171.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.1 pp -137.14 139.77 43.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 124.369 1.068 . . . . 0.0 108.531 178.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 92.8 t -143.22 138.55 26.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 175.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 163.01 140.06 2.78 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 175.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -74.1 42.71 0.15 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.806 2.042 . . . . 0.0 113.759 -169.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -161.39 26.1 0.13 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.608 1.563 . . . . 0.0 110.731 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -135.04 153.24 78.33 Favored Pre-proline 0 CA--C 1.536 0.421 0 O-C-N 121.517 -0.74 . . . . 0.0 112.15 -174.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -83.75 166.1 13.52 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.601 2.867 . . . . 0.0 110.854 172.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.4 ttm -69.83 140.87 53.32 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 168.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 71.7 p -81.32 160.45 24.17 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.509 1.124 . . . . 0.0 110.682 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 6.9 tm0? -50.91 -48.81 83.32 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-O 117.004 -1.474 . . . . 0.0 113.351 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -67.53 -29.3 37.26 Favored 'Trans proline' 0 C--N 1.352 0.753 0 CA-C-N 122.575 1.955 . . . . 0.0 112.573 -175.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -81.63 -34.76 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 119.134 0.879 . . . . 0.0 108.865 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -56.65 -46.61 80.95 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 119.183 0.901 . . . . 0.0 109.782 169.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -62.36 -38.74 90.7 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 123.092 0.557 . . . . 0.0 111.525 177.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.41 -46.93 81.13 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 122.036 -0.415 . . . . 0.0 111.094 176.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 62.7 t -62.38 -40.32 87.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 118.81 0.732 . . . . 0.0 109.782 178.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -61.48 -40.06 93.17 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.625 0.648 . . . . 0.0 110.52 174.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 49.5 m -63.94 -46.92 82.6 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.785 -0.626 . . . . 0.0 109.962 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 85.4 t -58.83 -47.6 88.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 119.209 0.913 . . . . 0.0 109.133 177.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.424 ' CE1' ' HE2' ' A' ' 31' ' ' LYS . 24.4 t80 -53.83 -46.87 71.31 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.939 0.896 . . . . 0.0 111.2 177.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -72.36 -4.96 33.05 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 178.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.38 -11.4 10.57 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.17 1.388 . . . . 0.0 109.452 -175.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 59.5 mt -59.72 -25.45 64.83 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 119.348 -2.095 . . . . 0.0 111.449 170.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -81.33 -1.05 43.83 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.668 1.187 . . . . 0.0 113.555 177.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -137.4 -19.29 0.6 Allowed Glycine 0 CA--C 1.532 1.138 0 CA-C-N 119.182 0.901 . . . . 0.0 114.476 -172.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 17.1 t90 -60.26 149.62 32.74 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 118.422 1.111 . . . . 0.0 110.527 172.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.48 -2.36 2.47 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.391 1.876 . . . . 0.0 111.646 -175.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 150.93 -25.28 1.02 Allowed Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.725 1.631 . . . . 0.0 111.616 -173.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -142.79 -29.75 0.55 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.563 1.182 . . . . 0.0 112.652 -177.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 56.74 29.0 57.74 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.025 1.298 . . . . 0.0 113.751 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 78.76 4.87 88.39 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-O 118.204 -1.331 . . . . 0.0 114.265 173.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -87.74 150.87 23.33 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 119.874 1.837 . . . . 0.0 110.049 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.36 144.65 44.33 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -87.88 119.81 28.59 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 48.4 tp -57.96 137.91 56.35 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.322 1.449 . . . . 0.0 110.255 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -137.19 -63.9 0.58 Allowed 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.253 0.621 . . . . 0.0 111.431 173.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 8.1 p -156.26 9.0 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 C-N-CA 124.243 1.017 . . . . 0.0 111.121 -173.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -68.43 146.13 53.47 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.188 -0.945 . . . . 0.0 109.472 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -143.5 163.84 32.01 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.617 1.567 . . . . 0.0 108.109 177.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 . . . . . 0 C--O 1.252 1.204 0 C-N-CA 125.166 1.386 . . . . 0.0 109.874 173.491 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 44.4 m -128.2 135.98 50.46 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 170.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -137.81 96.68 3.27 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 -168.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 49.1 t -88.42 143.56 10.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-O 121.518 0.675 . . . . 0.0 109.357 -170.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.2 tp -113.22 108.67 17.59 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 169.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.1 tp -98.09 103.14 15.06 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 99.8 m -77.58 141.67 39.4 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 169.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 54.3 t -140.84 141.67 31.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 152.73 176.48 25.34 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-N 118.44 0.563 . . . . 0.0 112.9 174.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -120.15 115.65 24.08 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.73 1.612 . . . . 0.0 108.494 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -66.5 -10.39 44.18 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 -170.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 21.9 ptp -117.34 2.0 12.46 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.912 1.233 . . . . 0.0 111.267 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.3 ttt -95.75 39.85 1.13 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 122.087 0.946 . . . . 0.0 109.227 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 57.66 -121.83 27.13 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 124.327 0.965 . . . . 0.0 110.759 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -61.43 -19.67 62.22 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.096 0.959 . . . . 0.0 112.502 -174.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -65.61 -13.02 58.23 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.614 0.765 . . . . 0.0 112.274 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.19 17.4 1.4 Allowed Glycine 0 CA--C 1.531 1.039 0 O-C-N 120.743 -1.223 . . . . 0.0 113.097 176.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.26 -52.22 65.67 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.604 1.702 . . . . 0.0 110.821 -169.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.59 -55.6 29.02 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-O 117.745 -1.586 . . . . 0.0 111.024 175.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -49.73 -40.98 47.27 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 CA-C-N 120.878 2.339 . . . . 0.0 115.217 177.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.7 tp -71.98 -36.66 69.85 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 119.876 1.216 . . . . 0.0 110.408 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 49.4 tp -61.74 -49.94 74.41 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.332 0.515 . . . . 0.0 109.936 174.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.73 -39.49 77.43 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.923 0.889 . . . . 0.0 111.102 177.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.9 tp10 -62.05 -49.48 75.82 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 118.778 0.717 . . . . 0.0 109.87 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -62.24 -44.49 96.43 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.816 0.446 . . . . 0.0 110.614 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 84.9 m -63.64 -42.34 98.15 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.298 0.499 . . . . 0.0 110.997 178.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.18 -39.53 94.91 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.309 0.504 . . . . 0.0 111.046 178.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.37 -36.36 76.75 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.258 0.623 . . . . 0.0 111.486 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.01 91.61 2.43 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 124.8 1.24 . . . . 0.0 108.877 -171.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -55.65 163.26 5.51 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.633 2.889 . . . . 0.0 113.811 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -133.71 174.42 10.46 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 126.033 1.733 . . . . 0.0 108.87 176.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 40.1 -125.4 2.46 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.228 1.394 . . . . 0.0 112.336 177.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -141.25 38.4 1.73 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.319 1.447 . . . . 0.0 109.169 172.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -74.93 168.38 20.05 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.341 1.057 . . . . 0.0 111.904 -172.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 67.9 t -120.38 105.6 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 167.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.0 t -70.44 137.77 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -178.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.0 mm -134.59 148.21 29.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 169.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -130.66 109.81 10.92 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 175.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.22 -1.91 88.12 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 118.868 -0.962 . . . . 0.0 112.833 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 60.93 -146.5 47.54 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -170.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.8 p -94.44 -1.78 53.02 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.15 0.98 . . . . 0.0 112.917 -172.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.66 70.0 31.07 Favored Pre-proline 0 C--O 1.235 0.303 0 C-N-CA 125.138 1.375 . . . . 0.0 107.993 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -66.1 -12.42 35.37 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.777 2.318 . . . . 0.0 112.77 -169.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.8 tp10 -44.57 -41.15 6.3 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.592 1.557 . . . . 0.0 110.938 168.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -62.86 -23.71 67.45 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -177.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -113.86 -2.22 13.68 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -168.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 79.6 mt -50.59 -37.7 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.154 0.981 . . . . 0.0 110.311 172.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 53.1 t -55.92 -40.28 61.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 123.852 0.861 . . . . 0.0 110.395 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.81 -43.29 84.19 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.431 0.56 . . . . 0.0 110.406 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.3 mt -62.36 -39.5 84.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -65.91 -18.99 65.71 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 117.724 -1.131 . . . . 0.0 112.513 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -69.19 -42.95 75.14 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 120.702 1.592 . . . . 0.0 109.241 169.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.4 mt -72.6 -25.75 61.44 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.648 0.779 . . . . 0.0 112.447 -175.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 38.22 60.32 4.83 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.703 1.601 . . . . 0.0 111.929 -169.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.37 151.02 38.73 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.862 2.374 . . . . 0.0 113.501 -170.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.6 m -71.66 -37.28 70.81 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 168.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -147.4 155.86 42.34 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.201 1.0 . . . . 0.0 109.31 -176.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 37.1 tp -144.51 136.22 25.79 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.63 1.172 . . . . 0.0 108.633 -177.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 56.9 tp -122.14 137.85 54.67 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 169.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.2 mt -122.21 143.19 35.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 -177.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.9 t -140.97 134.07 31.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 118.294 0.497 . . . . 0.0 110.013 -174.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -161.92 173.15 14.9 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 127.11 2.164 . . . . 0.0 107.456 169.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.69 156.58 39.29 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.055 -1.028 . . . . 0.0 109.906 169.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.8 m -152.92 129.49 10.74 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -178.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -79.85 83.63 5.75 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 119.031 0.832 . . . . 0.0 109.561 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 74.9 mtm -77.26 -7.28 55.7 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.583 1.553 . . . . 0.0 112.018 -177.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.33 26.67 72.98 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 123.816 0.722 . . . . 0.0 111.672 -172.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.4 mt -104.88 -171.24 1.88 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.936 1.294 . . . . 0.0 110.004 -177.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -73.66 140.2 78.17 Favored Pre-proline 0 N--CA 1.468 0.467 0 CA-C-O 117.47 -1.252 . . . . 0.0 108.676 171.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -42.96 137.59 4.37 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.303 2.668 . . . . 0.0 113.378 172.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.66 2.74 76.87 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 118.692 -1.06 . . . . 0.0 113.7 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -66.11 148.1 52.34 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.743 1.771 . . . . 0.0 108.348 168.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 64.7 mt -129.13 136.32 59.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -173.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 89.4 mmt-85 -145.9 151.16 37.41 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 118.8 0.727 . . . . 0.0 110.703 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 49.0 mm -75.9 144.09 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 167.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.409 HG22 ' H ' ' A' ' 77' ' ' ASP . 1.4 mt -133.64 165.79 30.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 124.55 1.14 . . . . 0.0 107.989 177.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.409 ' H ' HG22 ' A' ' 76' ' ' ILE . 5.9 t70 -135.63 145.89 55.12 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 127.116 2.166 . . . . 0.0 107.681 -170.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -54.46 -26.6 45.54 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.395 2.73 . . . . 0.0 115.147 -174.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -66.51 -21.37 66.17 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.012 0.824 . . . . 0.0 112.273 177.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -120.39 -28.52 4.99 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.708 1.203 . . . . 0.0 112.14 -171.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 72.0 mt -51.23 -39.78 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.845 1.258 . . . . 0.0 109.743 169.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.9 -28.6 51.91 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.53 1.132 . . . . 0.0 113.261 -177.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -100.9 -44.27 5.81 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 123.068 0.547 . . . . 0.0 109.657 175.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 21.3 mmt -67.26 -26.77 66.73 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -171.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.435 ' CE2' HD12 ' A' ' 94' ' ' LEU . 4.7 m-85 -76.85 -43.33 36.64 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.741 0.701 . . . . 0.0 111.502 174.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 22.0 ptt? -71.15 -17.79 62.53 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.102 0.864 . . . . 0.0 112.044 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 14.4 tpt -55.35 -27.22 45.78 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.347 1.059 . . . . 0.0 112.229 173.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 75.9 p -59.67 -31.15 69.29 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.63 0.772 . . . . 0.0 112.501 176.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.3 m 139.07 -41.89 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.605 1 C-N-CA 133.43 4.692 . . . . 0.0 105.849 -168.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -166.66 -46.25 0.02 OUTLIER 'General case' 0 C--N 1.347 0.481 0 C-N-CA 123.414 0.686 . . . . 0.0 112.144 174.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 42.77 -105.72 0.07 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.681 1.592 . . . . 0.0 108.332 -165.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 17.3 mmt -149.34 141.79 15.38 Favored Pre-proline 0 N--CA 1.452 -0.364 0 N-CA-C 104.036 -2.579 . . . . 0.0 104.036 168.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -74.83 59.05 4.95 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.786 2.991 . . . . 0.0 110.613 175.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.435 HD12 ' CE2' ' A' ' 85' ' ' PHE . 18.8 mt -47.86 -14.36 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 129.148 2.979 . . . . 0.0 116.903 -168.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -52.42 -24.94 8.71 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.406 1.003 . . . . 0.0 112.578 168.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -59.18 -33.05 70.48 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 119.32 0.964 . . . . 0.0 111.803 176.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.6 tt -75.61 -41.77 53.49 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 -177.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 92.2 mt -61.4 -48.59 88.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -61.7 -29.44 70.1 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.392 0.542 . . . . 0.0 112.395 -177.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -82.28 -2.69 53.41 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.002 0.921 . . . . 0.0 113.246 178.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 64.4 mt -133.08 -25.71 1.77 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.676 1.125 . . . . 0.0 112.549 -174.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -59.02 -21.62 59.34 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.353 1.061 . . . . 0.0 112.862 177.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -72.8 -11.19 60.51 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.415 1.086 . . . . 0.0 112.051 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -133.09 -42.54 0.88 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.349 1.06 . . . . 0.0 111.733 -173.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 28.2 mt -73.65 140.42 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 175.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.05 -40.89 95.34 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.185 0.897 . . . . 0.0 112.141 -177.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -148.49 137.14 21.47 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 118.633 1.216 . . . . 0.0 108.429 177.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.8 t -131.9 123.06 50.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -178.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 18.2 mt -129.54 155.39 41.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 -171.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -127.99 147.13 50.49 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 175.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.6 tt -129.1 130.36 46.39 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 172.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -115.19 156.96 15.31 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 77.6 mt -133.49 127.53 53.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 125.215 1.406 . . . . 0.0 107.269 -176.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 69.1 tp60 -67.25 117.6 48.05 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-O 117.607 -1.187 . . . . 0.0 111.129 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.35 175.04 11.78 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 124.27 3.313 . . . . 0.0 111.887 170.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -134.12 -29.16 1.29 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.257 1.423 . . . . 0.0 112.78 175.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.2 pp -132.29 4.22 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 119.362 0.983 . . . . 0.0 113.408 -171.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 8.5 p -38.43 118.49 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 125.929 1.692 . . . . 0.0 113.713 -167.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 170.31 158.37 14.09 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -175.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -67.17 152.56 45.53 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.996 0.919 . . . . 0.0 111.647 -173.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 56.32 41.76 28.67 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.883 2.073 . . . . 0.0 112.046 177.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -127.33 152.59 76.46 Favored Pre-proline 0 C--O 1.236 0.356 0 C-N-CA 124.287 1.035 . . . . 0.0 109.176 172.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -77.76 157.57 31.58 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.031 2.487 . . . . 0.0 109.875 168.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 56.5 ttm -66.25 136.64 56.14 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 169.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 18.1 p -77.75 154.45 31.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.588 0.709 . . . . 0.0 111.318 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -49.33 -47.25 77.17 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-O 116.916 -1.516 . . . . 0.0 113.443 -177.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -66.98 -28.13 42.11 Favored 'Trans proline' 0 C--N 1.351 0.69 0 CA-C-N 122.46 1.914 . . . . 0.0 112.407 -177.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 mp -78.12 -37.81 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 119.29 0.95 . . . . 0.0 108.564 177.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -57.28 -47.42 81.51 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.44 1.018 . . . . 0.0 110.074 172.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.18 -41.81 97.46 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 123.347 0.659 . . . . 0.0 111.053 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.94 -47.82 81.58 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 118.997 -0.525 . . . . 0.0 111.15 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.2 t -59.22 -41.21 83.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 118.886 0.766 . . . . 0.0 109.467 178.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -69.49 -27.83 65.54 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.861 0.755 . . . . 0.0 111.776 177.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 40.1 m -72.2 -42.39 65.86 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 120.982 -1.074 . . . . 0.0 109.944 174.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 88.0 t -61.18 -44.38 98.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 174.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -54.31 -47.04 72.91 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.163 0.985 . . . . 0.0 110.875 175.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -62.73 -40.72 98.09 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 118.869 0.758 . . . . 0.0 111.461 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -60.32 -25.39 65.76 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 118.368 -0.825 . . . . 0.0 112.463 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 93.0 mt -57.18 -22.66 42.07 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.852 1.205 . . . . 0.0 112.421 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -79.13 -9.45 59.56 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.731 0.812 . . . . 0.0 112.411 -178.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -150.99 -10.85 0.1 OUTLIER Glycine 0 CA--C 1.535 1.291 0 N-CA-C 115.884 1.114 . . . . 0.0 115.884 -171.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 17.7 t90 -58.17 139.53 54.69 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 119.175 1.487 . . . . 0.0 108.772 170.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -137.65 14.07 2.94 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.007 1.323 . . . . 0.0 111.058 172.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 158.05 -34.58 0.52 Allowed Glycine 0 CA--C 1.527 0.801 0 C-N-CA 123.866 0.746 . . . . 0.0 111.762 177.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -133.64 -26.32 1.61 Allowed 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -171.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 58.73 13.7 19.18 Favored Glycine 0 CA--C 1.537 1.423 0 N-CA-C 115.389 0.916 . . . . 0.0 115.389 176.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 85.14 1.27 88.58 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-N 118.793 1.296 . . . . 0.0 113.239 -178.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -74.57 165.87 24.49 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 119.721 1.76 . . . . 0.0 110.685 176.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -90.55 153.4 20.38 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 170.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -91.79 123.12 34.94 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 177.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 58.3 tp -59.02 116.75 4.02 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.986 1.314 . . . . 0.0 109.809 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -149.56 55.62 0.97 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.088 0.955 . . . . 0.0 109.379 -174.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . 0.272 35.1 m 42.62 47.84 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 127.017 2.127 . . . . 0.0 113.292 178.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -61.61 149.9 37.87 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.623 1.169 . . . . 0.0 110.916 176.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -142.09 31.34 1.58 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.461 1.504 . . . . 0.0 109.352 -178.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 . . . . . 0 C--O 1.25 1.079 0 C-N-CA 126.261 1.824 . . . . 0.0 108.486 -177.637 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 N--CA 1.482 1.15 0 N-CA-C 110.705 -0.109 . . . . 0.0 110.705 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.42 158.34 44.04 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -146.68 138.13 24.37 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -176.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 88.4 t -135.47 146.2 30.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 121.425 0.631 . . . . 0.0 110.284 -168.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 17.1 tp -115.03 126.94 55.31 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 104.889 -2.263 . . . . 0.0 104.889 168.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.8 tp -116.29 99.36 7.15 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 87.9 m -72.68 142.76 48.25 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 169.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.4 t -143.79 144.75 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 147.17 172.17 17.11 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -121.96 114.37 20.88 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 123.818 0.847 . . . . 0.0 109.138 -176.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -59.87 -11.76 6.17 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.624 1.97 . . . . 0.0 115.197 -170.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 22.5 ptp -127.72 10.13 6.54 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 119.212 0.915 . . . . 0.0 111.303 -178.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.4 ttt -98.04 31.33 2.75 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.072 0.851 . . . . 0.0 109.665 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.22 -140.49 20.67 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -178.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -62.04 -16.92 55.38 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.681 1.192 . . . . 0.0 112.389 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -58.19 -16.55 14.07 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.89 1.276 . . . . 0.0 112.995 176.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.32 21.86 0.84 Allowed Glycine 0 CA--C 1.535 1.324 0 O-C-N 120.288 -1.507 . . . . 0.0 114.451 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.94 -50.55 70.37 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 119.522 1.661 . . . . 0.0 111.363 -169.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.26 -54.43 37.96 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 117.555 -1.692 . . . . 0.0 111.322 177.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -48.37 -41.72 35.3 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 CA-C-N 120.656 2.228 . . . . 0.0 115.1 175.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 64.3 tp -72.54 -37.59 68.23 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.848 1.204 . . . . 0.0 110.706 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.6 tp -61.74 -45.95 91.74 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.605 0.639 . . . . 0.0 109.998 174.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.89 -38.55 86.05 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.903 0.881 . . . . 0.0 111.09 179.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.4 tp10 -61.86 -49.08 77.69 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 118.7 0.682 . . . . 0.0 109.541 178.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -63.84 -44.85 91.95 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.781 0.432 . . . . 0.0 110.501 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 73.3 m -63.69 -39.47 94.39 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.487 0.585 . . . . 0.0 111.444 177.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.22 -37.51 87.73 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.89 0.768 . . . . 0.0 111.113 177.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.48 -36.65 76.74 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.089 0.556 . . . . 0.0 111.245 178.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.71 98.51 1.53 Allowed Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 125.023 1.329 . . . . 0.0 108.163 -173.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -55.14 169.18 1.02 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 124.316 3.344 . . . . 0.0 114.983 -178.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.54 ' HE2' ' CZ ' ' A' ' 136' ' ' TYR . 14.9 mmtm -140.52 158.9 43.31 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.758 1.623 . . . . 0.0 108.28 -177.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 42.79 -126.33 4.71 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.007 1.289 . . . . 0.0 111.95 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -136.53 12.1 3.21 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.036 1.334 . . . . 0.0 111.164 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -73.64 131.03 41.22 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.942 0.897 . . . . 0.0 108.806 -173.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 97.5 t -69.85 112.86 5.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 166.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.3 t -71.56 133.16 32.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 60.4 mt -132.84 145.13 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 104.258 -2.497 . . . . 0.0 104.258 169.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -128.42 98.48 5.06 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 177.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.43 -14.07 71.54 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-O 119.136 -0.814 . . . . 0.0 112.121 175.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 51.71 -135.66 33.66 Favored Glycine 0 C--N 1.34 0.795 0 CA-C-N 118.208 1.004 . . . . 0.0 110.591 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.6 t -88.4 7.21 33.69 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.109 0.964 . . . . 0.0 111.554 -175.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.47 60.56 5.61 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.666 1.186 . . . . 0.0 110.12 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -69.7 -18.2 37.41 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.723 2.282 . . . . 0.0 112.929 -169.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -56.66 -31.69 64.65 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.44 0.696 . . . . 0.0 112.267 177.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.47 -30.32 69.6 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.296 0.639 . . . . 0.0 111.982 176.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -94.16 -6.4 44.96 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.022 0.929 . . . . 0.0 111.496 -169.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.2 mt -53.19 -43.85 50.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 118.964 0.802 . . . . 0.0 109.2 173.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.0 t -61.14 -42.11 92.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 122.981 0.512 . . . . 0.0 110.012 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.0 -46.87 73.21 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 122.923 0.489 . . . . 0.0 110.689 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.6 mt -55.09 -45.72 77.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.258 1.023 . . . . 0.0 109.179 174.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -60.86 -30.96 70.44 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 117.846 -1.073 . . . . 0.0 112.357 -177.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -59.46 -30.73 68.73 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 120.083 1.31 . . . . 0.0 111.265 176.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 56.5 mt -87.07 -9.06 56.37 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.666 1.186 . . . . 0.0 112.374 -173.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 27.34 61.73 0.6 Allowed Pre-proline 0 N--CA 1.475 0.811 0 C-N-CA 127.084 2.154 . . . . 0.0 112.229 -168.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.22 142.99 66.05 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.75 2.3 . . . . 0.0 114.203 -169.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.2 m -74.39 -30.37 61.92 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 168.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -146.54 151.66 37.7 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.007 0.923 . . . . 0.0 110.023 177.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 46.0 tp -141.24 136.11 31.36 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.674 1.59 . . . . 0.0 107.83 174.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 20.8 tp -126.8 133.42 50.79 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 105.674 -1.972 . . . . 0.0 105.674 172.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.4 mt -119.36 144.7 27.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -172.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.6 t -140.46 134.76 34.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 118.557 0.617 . . . . 0.0 109.875 -174.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -161.4 175.94 11.66 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 127.347 2.259 . . . . 0.0 107.082 172.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.44 160.4 30.28 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 120.805 -1.184 . . . . 0.0 108.494 167.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.0 m -156.29 125.27 6.02 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -70.72 122.3 19.57 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 169.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 77.1 mtm -122.46 1.39 9.56 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.53 1.532 . . . . 0.0 110.896 -175.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.87 26.05 71.01 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 118.568 0.622 . . . . 0.0 112.071 -173.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 74.9 mt -103.68 -171.1 1.88 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.479 1.512 . . . . 0.0 109.026 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -81.29 138.67 48.5 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-O 117.649 -1.167 . . . . 0.0 109.34 176.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -45.32 132.72 12.13 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.417 2.745 . . . . 0.0 113.814 177.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.95 3.22 90.65 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 118.502 -1.166 . . . . 0.0 113.241 179.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -64.58 145.71 55.73 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 119.895 1.847 . . . . 0.0 107.664 167.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 41.7 mt -126.72 138.84 53.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 -173.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 -148.94 148.96 30.41 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 118.236 0.471 . . . . 0.0 111.764 -179.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 41.3 mm -76.11 144.63 11.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 165.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.4 mt -135.38 163.79 34.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 176.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -136.72 145.73 52.32 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 126.36 1.864 . . . . 0.0 107.688 -170.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -52.17 -28.1 32.28 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.448 2.766 . . . . 0.0 115.197 -174.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -66.53 -23.23 66.2 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.817 0.735 . . . . 0.0 112.567 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -117.41 -29.51 5.81 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.659 1.184 . . . . 0.0 111.701 -173.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 53.5 mt -50.14 -41.02 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.322 1.449 . . . . 0.0 110.12 169.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.8 -24.43 57.25 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -173.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -103.34 -44.15 5.23 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 172.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 33.8 mmt -65.04 -34.44 78.43 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -170.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -66.79 -22.12 66.03 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -178.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -121.29 30.68 6.68 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.773 0.829 . . . . 0.0 111.208 174.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 15.1 tpt -61.38 -31.94 71.85 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 167.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.1 t -102.06 161.2 13.86 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.111 1.764 . . . . 0.0 107.547 169.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.6 p -76.02 37.44 0.15 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.631 1.972 . . . . 0.0 112.523 -176.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -145.62 177.86 8.57 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.862 1.265 . . . . 0.0 110.714 -167.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 52.75 -157.0 0.16 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.991 1.716 . . . . 0.0 110.765 -178.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 66.4 mtt -140.23 153.3 68.82 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 125.445 1.498 . . . . 0.0 107.672 176.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -70.94 72.86 1.98 Allowed 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 124.581 3.521 . . . . 0.0 110.822 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.5 mt -50.63 -6.36 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 129.228 3.011 . . . . 0.0 117.343 -168.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.12 -26.43 16.57 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 119.298 0.954 . . . . 0.0 111.614 167.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -60.36 -34.46 73.9 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.827 0.74 . . . . 0.0 111.604 176.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.5 tt -77.22 -43.35 33.93 Favored 'General case' 0 C--N 1.338 0.087 0 C-N-CA 123.334 0.654 . . . . 0.0 109.374 177.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 85.8 mt -59.78 -43.75 92.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -178.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -61.98 -23.94 66.72 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -84.71 0.68 49.59 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.723 0.809 . . . . 0.0 112.314 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 84.5 mt -133.58 -35.7 0.99 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.071 0.948 . . . . 0.0 111.626 -173.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -58.83 -22.77 59.42 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.307 1.043 . . . . 0.0 113.07 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -71.32 -13.37 61.85 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.061 0.944 . . . . 0.0 111.988 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -134.84 -30.35 1.09 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.175 0.898 . . . . 0.0 112.931 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 28.9 mt -69.19 138.92 21.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 174.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -63.95 -42.86 98.15 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 123.763 0.697 . . . . 0.0 112.442 -177.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -146.94 134.14 20.53 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.404 1.102 . . . . 0.0 108.367 177.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.8 t -126.09 133.59 68.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 176.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.9 mp -132.01 154.66 40.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 -176.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -128.69 146.52 50.86 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 170.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.0 tt -126.94 132.73 50.78 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 170.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -118.58 159.28 14.43 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 124.571 1.081 . . . . 0.0 110.853 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 82.1 mt -133.85 126.14 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 -177.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -62.48 115.42 16.42 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-O 117.463 -1.256 . . . . 0.0 110.199 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -75.45 171.13 18.83 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 123.394 2.73 . . . . 0.0 111.196 169.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -125.21 -30.91 3.12 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 125.867 1.667 . . . . 0.0 110.734 170.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -136.01 134.32 50.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 176.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.3 t -140.27 135.49 36.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 174.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 158.08 150.8 5.86 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -66.9 154.42 41.05 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.952 0.882 . . . . 0.0 111.522 -175.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 54.81 38.65 30.6 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.048 2.139 . . . . 0.0 112.273 -176.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -124.79 149.09 61.53 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 123.899 0.88 . . . . 0.0 110.281 172.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -83.13 165.16 14.98 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.437 2.758 . . . . 0.0 111.461 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.4 ttm -72.73 139.92 47.47 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 168.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 82.4 p -80.64 159.82 25.24 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.816 1.246 . . . . 0.0 110.549 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.3 tp60 -53.78 -44.79 98.61 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-O 116.675 -1.631 . . . . 0.0 114.298 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -68.29 -30.47 30.49 Favored 'Trans proline' 0 C--N 1.351 0.71 0 CA-C-N 122.86 2.057 . . . . 0.0 112.034 -176.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.6 mp -78.94 -35.79 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -56.82 -46.36 81.71 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.549 1.068 . . . . 0.0 110.044 171.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -63.21 -41.67 99.18 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 122.965 0.506 . . . . 0.0 111.07 178.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.98 -47.97 82.44 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 118.958 -0.544 . . . . 0.0 110.974 176.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 76.5 t -60.76 -40.01 83.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 118.98 0.809 . . . . 0.0 109.705 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -69.93 -30.62 68.06 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.583 1.083 . . . . 0.0 111.551 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 28.1 m -68.68 -46.87 67.94 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.36 -0.837 . . . . 0.0 109.443 173.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 53.9 t -58.73 -45.52 91.07 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.163 0 C-N-CA 123.875 0.87 . . . . 0.0 109.152 176.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.54 ' CZ ' ' HE2' ' A' ' 31' ' ' LYS . 33.5 t80 -52.37 -48.64 65.47 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.275 1.03 . . . . 0.0 110.861 177.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -64.39 -38.74 92.11 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.568 0.622 . . . . 0.0 110.838 176.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 9.2 tpp85 -65.46 -23.25 66.87 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 118.145 -0.931 . . . . 0.0 112.862 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -59.2 -17.27 26.23 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 120.431 1.469 . . . . 0.0 111.036 172.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -91.97 -2.07 56.94 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 120.167 1.349 . . . . 0.0 112.706 176.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -152.43 13.44 0.7 Allowed Glycine 0 CA--C 1.531 1.06 0 CA-C-N 119.083 0.856 . . . . 0.0 114.922 -169.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 6.7 t90 -58.07 140.93 51.55 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.567 1.183 . . . . 0.0 108.347 169.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -138.35 10.48 2.75 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -168.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 140.97 -34.28 1.95 Allowed Glycine 0 CA--C 1.524 0.637 0 C-N-CA 124.186 0.898 . . . . 0.0 112.211 175.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -136.86 20.62 3.05 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.644 1.178 . . . . 0.0 109.983 177.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 59.47 7.04 5.19 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.802 1.668 . . . . 0.0 115.17 -175.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.76 -0.2 29.46 Favored Glycine 0 CA--C 1.538 1.496 0 CA-C-N 119.364 1.582 . . . . 0.0 112.025 -168.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -80.72 169.78 17.16 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.891 1.276 . . . . 0.0 109.835 172.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -87.69 155.46 19.92 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 169.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -88.53 125.72 34.91 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 174.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 67.7 tp -54.87 127.37 28.31 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.941 1.296 . . . . 0.0 109.785 176.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -142.16 36.47 1.54 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.934 0.894 . . . . 0.0 109.598 171.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.8 t 53.03 52.79 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 126.198 1.799 . . . . 0.0 110.296 174.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -54.25 149.39 9.89 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.486 0.714 . . . . 0.0 110.489 174.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -154.17 169.18 24.2 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.402 1.481 . . . . 0.0 108.543 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 . . . . . 0 C--O 1.247 0.921 0 C-N-CA 125.953 1.701 . . . . 0.0 106.972 178.854 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ptm . . . . . 0 N--CA 1.484 1.243 0 CA-C-O 120.629 0.252 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.5 m -136.37 152.33 50.52 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 173.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -150.37 141.63 23.22 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -169.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 74.0 t -135.73 145.52 31.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 123.3 0.64 . . . . 0.0 109.986 -170.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 25.8 tp -114.14 124.89 53.2 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 169.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 56.7 tp -114.2 96.26 5.7 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 178.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 91.5 m -72.54 142.22 48.48 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.131 169.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.4 t -140.4 142.94 30.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 125.176 1.39 . . . . 0.0 107.517 178.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 144.76 172.26 15.14 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 124.657 1.122 . . . . 0.0 111.442 176.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -113.77 121.14 43.16 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 107.832 -1.174 . . . . 0.0 107.832 174.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -59.2 -13.63 8.09 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.401 1.88 . . . . 0.0 115.423 -169.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.0 ptt? -130.78 12.79 5.31 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.976 0.91 . . . . 0.0 111.172 -176.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.9 ttt -92.95 35.24 1.06 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.816 0.734 . . . . 0.0 109.311 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.28 -143.89 30.08 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -173.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -60.24 -18.01 45.79 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 126.016 1.726 . . . . 0.0 112.445 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -54.02 -26.96 29.06 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.649 1.18 . . . . 0.0 112.57 176.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.18 27.83 0.68 Allowed Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.643 -1.087 . . . . 0.0 114.165 178.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.45 -47.97 74.32 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 119.45 1.625 . . . . 0.0 110.253 -172.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.03 -55.82 28.78 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 117.692 -1.616 . . . . 0.0 111.071 174.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -48.21 -41.82 34.07 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 CA-C-N 121.01 2.405 . . . . 0.0 115.372 176.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.3 tp -70.78 -38.28 73.38 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.889 1.222 . . . . 0.0 110.495 178.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.4 tp -61.99 -46.6 88.51 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.936 -0.477 . . . . 0.0 110.291 175.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.35 -40.57 82.55 Favored 'General case' 0 C--O 1.227 -0.088 0 C-N-CA 124.025 0.93 . . . . 0.0 110.978 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -60.72 -48.82 80.1 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 118.594 0.634 . . . . 0.0 109.821 178.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -63.37 -48.8 76.4 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.171 0.589 . . . . 0.0 110.515 -178.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 70.7 m -64.32 -36.74 85.11 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.45 0.568 . . . . 0.0 111.449 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.74 -37.56 88.02 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.166 0.894 . . . . 0.0 111.151 176.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.75 -34.27 75.31 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.18 0.592 . . . . 0.0 111.406 178.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.72 98.89 1.87 Allowed Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 125.325 1.45 . . . . 0.0 108.156 -174.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -54.89 161.02 6.82 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 123.483 2.789 . . . . 0.0 113.854 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.427 ' HE2' ' CE1' ' A' ' 136' ' ' TYR . 72.8 mmtt -135.08 162.21 33.13 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.912 1.685 . . . . 0.0 108.137 178.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 43.53 -121.73 3.56 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.96 1.267 . . . . 0.0 111.614 176.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -134.07 10.7 3.89 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.672 1.189 . . . . 0.0 111.136 174.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -72.86 117.71 14.91 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 121.469 -0.77 . . . . 0.0 109.31 -169.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 89.4 t -67.98 118.31 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 167.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.1 t -73.9 134.13 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -177.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 56.1 mt -132.45 141.34 45.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 103.875 -2.639 . . . . 0.0 103.875 169.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -125.98 106.19 9.45 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 175.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.36 -1.89 82.63 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 118.997 -0.89 . . . . 0.0 112.919 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 56.52 -146.99 33.04 Favored Glycine 0 C--N 1.34 0.76 0 N-CA-C 108.17 -1.972 . . . . 0.0 108.17 -168.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.2 p -88.5 10.49 20.06 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.772 -0.84 . . . . 0.0 111.867 177.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.37 57.96 15.91 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 125.151 1.38 . . . . 0.0 110.393 -176.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -68.87 -14.29 38.52 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.834 2.356 . . . . 0.0 112.978 -171.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -56.7 -32.21 65.25 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.05 0.841 . . . . 0.0 112.03 175.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -61.64 -27.88 68.98 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.4 0.68 . . . . 0.0 112.258 175.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -98.25 -1.88 40.89 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.945 1.298 . . . . 0.0 111.575 -169.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.7 mt -53.86 -42.4 52.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 118.866 0.757 . . . . 0.0 109.783 175.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 43.2 t -61.08 -41.04 87.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 118.378 0.535 . . . . 0.0 110.065 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.33 -43.91 84.82 Favored 'General case' 0 N--CA 1.456 -0.159 0 O-C-N 121.842 -0.536 . . . . 0.0 110.757 -177.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 63.3 mt -58.84 -48.99 84.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 173.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -60.82 -35.88 77.66 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 118.163 -0.922 . . . . 0.0 111.947 -174.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -57.07 -29.73 63.7 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.521 1.055 . . . . 0.0 111.794 177.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 55.2 mt -87.15 -9.78 54.39 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.883 0.873 . . . . 0.0 112.457 -177.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 29.14 61.06 0.78 Allowed Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 126.768 2.027 . . . . 0.0 112.464 -168.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -56.33 145.99 75.16 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.86 2.374 . . . . 0.0 112.589 -171.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.8 m -73.13 -30.35 63.55 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.938 0.895 . . . . 0.0 108.937 168.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -145.36 151.88 38.99 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.28 1.032 . . . . 0.0 109.954 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 41.9 tp -143.17 134.0 25.35 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.329 1.452 . . . . 0.0 107.862 176.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 23.5 tp -126.65 135.27 50.97 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 172.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.0 mt -121.33 143.76 32.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 -171.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.5 t -142.14 135.64 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 119.117 0.871 . . . . 0.0 110.296 -175.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -164.89 170.93 14.73 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 127.372 2.269 . . . . 0.0 107.871 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.82 155.42 37.59 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 121.437 -0.789 . . . . 0.0 108.963 168.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.2 m -154.67 125.08 6.88 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -72.66 121.75 20.3 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 172.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 74.2 mtm -121.53 1.73 10.11 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.168 1.787 . . . . 0.0 110.709 -176.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.43 23.87 67.06 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 118.686 0.675 . . . . 0.0 112.317 -172.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.0 mt -96.2 -174.32 3.05 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.315 1.446 . . . . 0.0 109.43 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -73.7 140.43 78.22 Favored Pre-proline 0 N--CA 1.467 0.393 0 CA-C-O 117.645 -1.169 . . . . 0.0 108.286 170.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -44.29 137.52 7.73 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.216 2.611 . . . . 0.0 112.962 173.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.41 2.32 79.24 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 118.695 -1.058 . . . . 0.0 113.83 176.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -67.12 147.85 52.6 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.911 1.855 . . . . 0.0 108.23 168.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 70.4 mt -124.39 135.92 62.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -172.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.3 mmt-85 -145.26 147.76 32.74 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 118.853 0.751 . . . . 0.0 110.513 176.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 42.3 mm -78.05 142.81 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 167.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.7 mt -129.02 136.38 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 119.98 1.264 . . . . 0.0 108.729 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -80.66 141.29 51.83 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 124.536 1.134 . . . . 0.0 109.761 175.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -47.62 -34.35 20.37 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 124.162 3.241 . . . . 0.0 116.216 178.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -66.54 -26.27 67.05 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.528 0.604 . . . . 0.0 111.719 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -101.09 -29.05 12.36 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.541 1.137 . . . . 0.0 111.094 -176.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.405 HD11 ' HB3' ' A' ' 110' ' ' PHE . 24.9 mt -49.34 -41.08 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.317 1.447 . . . . 0.0 110.839 169.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.9 -24.4 15.97 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.138 1.375 . . . . 0.0 113.601 -177.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -113.61 -37.35 4.62 Favored 'General case' 0 C--O 1.228 -0.063 0 C-N-CA 123.304 0.642 . . . . 0.0 110.381 175.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 22.3 mmt -66.89 -31.86 72.74 Favored 'General case' 0 C--N 1.334 -0.096 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -173.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -63.77 -53.02 57.5 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 119.053 0.842 . . . . 0.0 109.869 174.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.55 4.82 17.17 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -176.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 14.3 tpt -60.31 -26.64 66.68 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.323 -0.861 . . . . 0.0 110.021 168.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 65.6 p -62.5 -13.39 30.02 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.511 1.524 . . . . 0.0 113.042 169.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.6 m 61.22 21.85 12.26 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.462 1.905 . . . . 0.0 110.54 -168.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -142.88 -58.05 0.43 Allowed 'General case' 0 C--N 1.344 0.369 0 O-C-N 121.046 -1.034 . . . . 0.0 112.101 -170.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -68.43 149.37 49.4 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 123.168 0.587 . . . . 0.0 110.002 -169.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 64.3 mtt -77.5 149.93 78.94 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-O 118.404 -0.808 . . . . 0.0 109.522 -175.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -73.88 56.23 3.53 Favored 'Trans proline' 0 CA--C 1.538 0.684 1 C-N-CA 125.683 4.256 . . . . 0.0 112.667 -177.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.3 mt -49.66 -1.06 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 130.36 3.464 . . . . 0.0 118.822 -168.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.49 -25.92 39.72 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 120.006 1.276 . . . . 0.0 110.762 166.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -62.03 -29.64 70.42 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.618 0.767 . . . . 0.0 112.171 174.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.2 tt -74.68 -45.86 41.69 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.175 0.898 . . . . 0.0 108.858 174.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 98.5 mt -58.59 -42.14 83.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -178.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.11 -23.88 64.2 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -87.94 -1.77 58.19 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.993 0.917 . . . . 0.0 112.449 178.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -123.63 -34.93 2.98 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.102 0.961 . . . . 0.0 111.789 178.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -60.68 -21.78 63.21 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.859 0.864 . . . . 0.0 113.063 -173.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -72.34 -12.11 60.99 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.079 0.952 . . . . 0.0 112.012 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -136.31 -32.62 0.85 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.265 0.939 . . . . 0.0 113.082 -178.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 15.3 mt -69.6 138.83 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 172.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -65.91 -41.14 95.58 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.111 0.862 . . . . 0.0 112.397 -176.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -145.9 137.57 25.04 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 118.582 1.191 . . . . 0.0 109.113 175.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.5 t -130.22 129.4 65.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.9 mp -130.52 154.12 40.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -174.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.405 ' HB3' HD11 ' A' ' 81' ' ' ILE . 78.5 t80 -133.35 144.5 49.65 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 168.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.3 tt -126.32 123.31 37.74 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.641 1.576 . . . . 0.0 106.966 177.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -109.65 155.6 16.01 Favored Glycine 0 C--N 1.334 0.436 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 64.6 mt -133.97 124.19 46.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 -173.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.7 tp60 -61.64 115.94 17.9 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-O 117.547 -1.216 . . . . 0.0 110.619 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -79.12 172.47 14.77 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.308 2.672 . . . . 0.0 111.582 170.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -135.95 -29.2 1.03 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 127.263 2.225 . . . . 0.0 111.317 173.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -132.97 120.42 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 -173.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 64.5 t -143.56 132.62 20.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 153.54 152.39 6.03 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -67.73 150.15 49.04 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.882 0.849 . . . . 0.0 111.441 -173.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 14.2 t80 51.24 41.41 27.86 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.884 2.074 . . . . 0.0 112.101 -173.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.3 m-30 -115.19 142.9 29.29 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 169.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.03 159.44 44.54 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.596 2.197 . . . . 0.0 110.531 171.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.7 ttm -73.98 142.45 45.83 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 168.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 37.3 p -81.71 157.61 24.52 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.367 1.067 . . . . 0.0 110.701 178.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -52.1 -42.6 86.67 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-O 116.52 -1.705 . . . . 0.0 114.697 -178.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.37 -29.07 21.53 Favored 'Trans proline' 0 C--N 1.35 0.628 0 CA-C-N 123.087 2.138 . . . . 0.0 111.878 -176.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.63 -36.11 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -56.52 -46.15 80.74 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.166 0.893 . . . . 0.0 109.986 170.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -64.61 -37.83 88.9 Favored 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 123.302 0.641 . . . . 0.0 111.435 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.25 -47.24 80.39 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 121.933 -0.479 . . . . 0.0 110.706 175.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 61.0 t -62.6 -39.91 86.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 118.643 0.656 . . . . 0.0 109.842 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -60.7 -42.88 98.09 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.136 0.88 . . . . 0.0 110.283 173.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 54.2 m -61.35 -48.76 79.82 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 79.3 t -60.39 -45.97 95.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 118.762 0.71 . . . . 0.0 109.654 179.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.427 ' CE1' ' HE2' ' A' ' 31' ' ' LYS . 19.3 t80 -54.06 -49.7 68.4 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.92 0.888 . . . . 0.0 110.578 177.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -69.83 -26.8 64.4 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.525 -0.734 . . . . 0.0 112.114 178.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -73.48 -24.36 60.18 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.23 -0.919 . . . . 0.0 112.065 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 33.4 mt -61.1 -21.94 64.17 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.393 0.997 . . . . 0.0 113.454 -172.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -88.69 -1.94 58.34 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.833 1.197 . . . . 0.0 112.794 176.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -137.58 5.83 3.5 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.479 1.037 . . . . 0.0 113.754 -172.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -59.4 139.49 57.01 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.405 1.082 . . . . 0.0 108.259 169.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -143.88 23.11 1.74 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.572 0.749 . . . . 0.0 111.315 -170.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 146.08 -34.65 1.41 Allowed Glycine 0 C--N 1.339 0.704 0 O-C-N 121.427 -0.796 . . . . 0.0 112.64 171.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -153.33 16.4 0.54 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.221 1.008 . . . . 0.0 111.327 173.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 69.23 3.1 36.3 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.652 1.12 . . . . 0.0 114.246 -177.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.81 10.25 60.82 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-N 119.422 1.611 . . . . 0.0 112.09 -170.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -69.63 167.7 16.38 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 118.371 1.085 . . . . 0.0 109.133 170.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -89.42 147.08 24.23 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 172.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -93.22 119.91 32.92 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 44.1 tp -60.82 126.56 27.86 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.913 1.285 . . . . 0.0 109.797 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.31 56.38 1.61 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.35 1.06 . . . . 0.0 109.207 -179.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 6.5 t 50.79 51.96 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 125.434 1.493 . . . . 0.0 109.007 -173.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 -64.77 136.51 56.99 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.234 1.014 . . . . 0.0 109.77 -176.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -146.19 163.56 35.03 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.179 1.792 . . . . 0.0 107.416 175.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 . . . . . 0 C--O 1.25 1.108 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 176.34 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 119.062 -0.494 . . . . 0.0 110.82 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.2 m -143.51 152.14 41.11 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 -172.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -140.1 139.2 35.79 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 53.1 t -124.87 141.1 46.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.624 0.726 . . . . 0.0 109.541 -170.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 34.8 tp -107.42 128.1 54.18 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 168.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 56.5 tp -116.18 97.81 6.27 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 177.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 93.2 m -73.18 142.19 47.38 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 170.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.8 t -140.34 141.58 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 125.31 1.444 . . . . 0.0 107.274 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.74 174.94 18.39 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 123.988 0.804 . . . . 0.0 112.219 175.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -117.13 121.25 40.74 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.94 1.296 . . . . 0.0 108.25 176.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 m -59.39 -14.87 13.55 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.458 1.903 . . . . 0.0 115.524 -169.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -130.0 13.98 5.75 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.983 0.913 . . . . 0.0 111.282 -175.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.9 ttt -97.24 34.42 1.78 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.599 0.636 . . . . 0.0 109.756 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.86 -140.95 22.98 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -177.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -62.77 -15.77 55.04 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.474 1.11 . . . . 0.0 112.279 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -59.4 -16.51 23.56 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.035 1.334 . . . . 0.0 112.669 174.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.64 17.84 1.47 Allowed Glycine 0 CA--C 1.533 1.208 0 O-C-N 120.568 -1.332 . . . . 0.0 114.01 175.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.45 -51.16 68.61 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 119.682 1.741 . . . . 0.0 111.032 -169.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.84 -55.18 31.82 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-O 117.806 -1.552 . . . . 0.0 110.984 175.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -48.96 -40.94 40.63 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 CA-C-N 120.687 2.243 . . . . 0.0 115.298 176.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.9 tp -71.97 -37.84 69.85 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 120.254 1.388 . . . . 0.0 110.443 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.2 tp -62.18 -45.63 92.53 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.899 -0.501 . . . . 0.0 110.315 175.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.43 -40.55 87.13 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 123.894 0.878 . . . . 0.0 111.023 177.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.4 tp10 -60.85 -48.66 80.77 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.792 0.723 . . . . 0.0 109.661 178.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -62.28 -46.69 87.65 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.062 0.545 . . . . 0.0 110.639 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 81.1 m -64.98 -37.89 89.17 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.267 0.485 . . . . 0.0 111.237 179.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.66 -37.83 88.93 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.853 0.751 . . . . 0.0 111.107 176.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.13 -37.95 78.57 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.204 0.602 . . . . 0.0 111.092 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.63 95.81 2.03 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 125.166 1.386 . . . . 0.0 108.489 -173.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -55.78 164.32 4.67 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 123.813 3.009 . . . . 0.0 114.182 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.421 ' HE2' ' CZ ' ' A' ' 136' ' ' TYR . 21.0 mmtt -131.56 167.54 19.22 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.625 1.57 . . . . 0.0 109.058 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 40.08 -116.63 0.75 Allowed Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.048 1.309 . . . . 0.0 111.513 175.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -140.65 28.45 1.98 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.62 1.168 . . . . 0.0 109.843 169.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -73.58 125.66 28.5 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.372 -0.83 . . . . 0.0 109.514 -173.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.9 t -78.14 115.32 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 104.103 -2.555 . . . . 0.0 104.103 166.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.4 t -75.77 136.2 25.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -175.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.9 mm -131.38 145.35 35.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 103.972 -2.603 . . . . 0.0 103.972 169.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -132.85 103.79 6.26 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 178.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.5 -4.54 87.44 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-O 118.855 -0.969 . . . . 0.0 112.743 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 54.71 -143.72 31.75 Favored Glycine 0 C--N 1.34 0.754 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 -169.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.2 p -89.67 6.74 40.04 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.985 -0.714 . . . . 0.0 112.41 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.28 64.59 47.22 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 124.866 1.266 . . . . 0.0 109.749 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -64.51 -16.39 54.94 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.732 2.288 . . . . 0.0 112.505 -177.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -47.71 -42.28 24.72 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.51 1.524 . . . . 0.0 111.164 169.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.26 -24.99 66.67 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.015 0.526 . . . . 0.0 112.342 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.04 -3.8 31.27 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 125.071 1.348 . . . . 0.0 111.821 -169.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 84.0 mt -51.2 -41.09 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.866 0.866 . . . . 0.0 110.423 175.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 49.0 t -58.46 -42.04 83.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 118.844 0.747 . . . . 0.0 110.319 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.39 -32.99 73.45 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.212 0.605 . . . . 0.0 111.227 -175.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 58.5 mt -67.33 -50.57 61.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 170.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -66.65 -33.24 75.22 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 118.247 -0.882 . . . . 0.0 112.464 -169.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -62.91 -20.74 65.46 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.979 1.263 . . . . 0.0 112.03 178.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 62.5 mt -86.03 -10.18 55.47 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.391 1.076 . . . . 0.0 113.067 174.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 28.91 61.79 0.75 Allowed Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 127.231 2.212 . . . . 0.0 112.856 -167.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -58.05 150.38 65.21 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.383 2.722 . . . . 0.0 113.549 -169.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.3 m -71.13 -36.27 72.03 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.221 1.009 . . . . 0.0 109.359 168.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 21.3 mtm180 -144.52 162.2 37.17 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.346 1.059 . . . . 0.0 110.199 179.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.5 tp -146.19 134.8 22.16 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 125.256 1.422 . . . . 0.0 107.836 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 37.7 tp -125.78 131.1 52.55 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 173.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.0 mt -115.95 143.2 26.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -175.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.5 t -140.27 134.07 34.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 118.64 0.654 . . . . 0.0 109.91 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -161.7 173.46 14.64 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.275 2.23 . . . . 0.0 107.304 170.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.89 157.78 35.88 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 166.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.3 m -154.6 124.47 6.67 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 176.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -71.57 125.63 27.56 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 172.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 72.9 mtm -127.01 1.96 6.54 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.445 1.898 . . . . 0.0 110.427 -175.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.66 23.74 67.36 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-N 118.693 0.679 . . . . 0.0 112.553 -172.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.2 mt -96.41 -172.47 2.53 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.251 1.421 . . . . 0.0 109.41 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -76.02 139.33 69.18 Favored Pre-proline 0 N--CA 1.468 0.426 0 CA-C-O 117.669 -1.158 . . . . 0.0 108.338 171.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -43.38 137.5 5.41 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.411 2.741 . . . . 0.0 113.131 172.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.93 2.11 81.0 Favored Glycine 0 CA--C 1.534 1.234 0 CA-C-O 118.528 -1.151 . . . . 0.0 113.739 176.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -66.57 144.16 56.6 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 119.909 1.855 . . . . 0.0 107.786 168.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 51.8 mt -121.05 140.71 44.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 -174.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 90.3 mmt-85 -148.4 147.67 29.46 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 118.522 0.601 . . . . 0.0 112.131 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 50.6 mm -77.94 143.28 13.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 164.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.6 mt -128.57 123.84 60.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 176.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -75.16 139.89 72.83 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-O 117.739 -1.124 . . . . 0.0 109.433 175.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_exo -46.75 -36.39 19.33 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 124.235 3.29 . . . . 0.0 116.609 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -69.32 -25.83 64.42 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 118.532 0.605 . . . . 0.0 111.38 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -93.35 -34.46 13.48 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.87 1.268 . . . . 0.0 110.985 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 71.6 mt -48.78 -46.48 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.901 1.28 . . . . 0.0 108.956 169.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.46 -19.54 37.63 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.609 1.164 . . . . 0.0 114.002 -174.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -115.01 -25.34 8.18 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.469 0.708 . . . . 0.0 110.867 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 22.7 mmt -80.5 -36.68 32.98 Favored 'General case' 0 C--O 1.231 0.079 0 CA-C-N 118.238 0.472 . . . . 0.0 112.005 -178.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.64 -37.7 88.48 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 118.906 0.775 . . . . 0.0 112.584 -169.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -63.27 -10.43 15.95 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 178.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.6 ttt -62.14 -23.0 66.31 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.501 1.046 . . . . 0.0 111.064 172.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 55.9 p -76.86 47.51 0.52 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.348 1.059 . . . . 0.0 111.107 169.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.5 m 61.62 65.67 0.92 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.971 1.708 . . . . 0.0 111.931 174.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 21.0 t-80 58.84 32.59 22.38 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.673 1.589 . . . . 0.0 111.986 175.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -60.84 159.85 10.52 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 123.784 0.834 . . . . 0.0 110.004 169.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 26.4 mmt -64.18 145.59 98.01 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 123.149 0.579 . . . . 0.0 109.969 178.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -75.25 78.33 2.99 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 124.708 3.605 . . . . 0.0 108.213 174.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.2 mt -48.89 -11.2 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 117.435 2.383 . . . . 0.0 117.435 -167.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -53.73 -20.04 4.99 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.333 -0.854 . . . . 0.0 112.554 167.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -58.88 -31.3 68.45 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.517 1.053 . . . . 0.0 111.71 174.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.4 tt -72.95 -45.95 55.2 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 174.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 83.8 mt -58.84 -39.48 77.43 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 123.196 0.599 . . . . 0.0 109.881 -177.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -58.33 -24.72 60.58 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.677 0.671 . . . . 0.0 112.805 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -89.79 -6.71 55.68 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.231 1.012 . . . . 0.0 112.086 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -118.63 -28.15 5.72 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.252 1.021 . . . . 0.0 111.703 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -63.46 -24.18 67.72 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 119.379 0.991 . . . . 0.0 112.403 -175.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -79.27 -4.78 52.33 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.47 1.108 . . . . 0.0 111.843 176.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -134.33 -1.81 2.85 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.33 1.452 . . . . 0.0 112.688 -168.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 20.0 mt -137.29 145.41 29.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 126.094 1.758 . . . . 0.0 107.15 -173.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -71.46 -37.68 62.41 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-O 119.236 -0.758 . . . . 0.0 112.45 -174.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -146.75 135.37 22.09 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.56 1.18 . . . . 0.0 108.076 174.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.2 t -124.68 132.62 71.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 175.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 5.4 mt -133.49 152.29 34.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 -168.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -130.43 142.02 50.51 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 169.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.8 tt -124.31 129.05 50.05 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 174.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -112.88 156.46 15.59 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 77.6 mt -132.75 123.71 49.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -178.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -60.63 115.94 15.95 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-O 117.43 -1.271 . . . . 0.0 110.439 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -76.05 171.53 17.97 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.59 2.86 . . . . 0.0 111.416 170.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -127.96 -32.45 2.31 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.976 1.71 . . . . 0.0 110.932 171.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.69 137.03 47.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.296 1.038 . . . . 0.0 108.333 176.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 90.1 t -141.41 134.93 30.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 175.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 159.21 150.93 5.96 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -65.29 152.55 43.47 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.865 0.84 . . . . 0.0 111.308 -175.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 54.87 38.96 31.21 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.852 2.061 . . . . 0.0 112.09 -177.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -123.14 148.41 54.53 Favored Pre-proline 0 C--O 1.237 0.399 0 C-N-CA 123.987 0.915 . . . . 0.0 109.794 172.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.99 162.5 20.67 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.164 2.576 . . . . 0.0 111.13 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 52.5 ttm -71.43 138.91 49.45 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 168.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 67.4 p -79.85 159.51 26.43 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.285 1.034 . . . . 0.0 110.496 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 21.8 tp60 -53.03 -44.8 97.93 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 116.565 -1.683 . . . . 0.0 114.101 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -68.63 -30.53 28.09 Favored 'Trans proline' 0 C--N 1.351 0.695 0 CA-C-N 122.912 2.076 . . . . 0.0 112.144 -176.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.6 mp -80.05 -35.61 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 118.971 0.805 . . . . 0.0 108.889 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -56.26 -46.56 79.62 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.354 0.979 . . . . 0.0 109.941 170.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -63.92 -38.58 91.6 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.024 0.53 . . . . 0.0 111.319 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.9 -46.19 82.75 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 119.097 -0.478 . . . . 0.0 111.164 175.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 71.8 t -62.68 -39.5 84.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 118.994 0.816 . . . . 0.0 109.658 178.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -62.35 -42.46 99.41 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.191 0.905 . . . . 0.0 110.508 173.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 59.0 m -61.48 -49.4 76.93 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 72.7 t -60.09 -44.25 94.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 123.539 0.736 . . . . 0.0 109.642 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.421 ' CZ ' ' HE2' ' A' ' 31' ' ' LYS . 43.1 t80 -55.96 -48.59 75.53 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.184 0.594 . . . . 0.0 110.631 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 60.0 mm-40 -64.89 -39.09 93.0 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.038 0.836 . . . . 0.0 110.903 176.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -62.3 -29.42 70.42 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 118.732 -0.651 . . . . 0.0 112.263 -177.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 76.8 mt -57.52 -21.78 40.19 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.11 0.868 . . . . 0.0 112.389 177.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -81.49 -13.6 57.96 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.105 0.866 . . . . 0.0 112.21 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -134.79 -9.88 1.67 Allowed Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.215 0.912 . . . . 0.0 114.342 -171.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 17.5 t90 -55.18 141.83 33.53 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.177 1.391 . . . . 0.0 109.253 171.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -145.08 12.28 1.39 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.085 0.954 . . . . 0.0 112.705 -178.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 159.96 -36.16 0.46 Allowed Glycine 0 CA--C 1.529 0.919 0 O-C-N 121.653 -0.654 . . . . 0.0 112.264 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -148.5 -17.03 0.33 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.318 1.047 . . . . 0.0 112.495 -175.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 67.89 7.93 51.21 Favored Glycine 0 CA--C 1.531 1.043 0 O-C-N 121.257 -0.902 . . . . 0.0 113.661 177.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 76.61 5.5 83.15 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 118.319 -1.267 . . . . 0.0 112.728 -174.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -71.06 157.64 37.86 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 119.98 1.89 . . . . 0.0 109.794 175.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.28 144.68 30.45 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 172.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -81.42 123.97 29.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 170.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 67.0 tp -53.53 121.08 7.01 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.004 0.922 . . . . 0.0 109.914 176.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -150.38 29.38 0.71 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.911 1.285 . . . . 0.0 109.346 173.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . 0.332 24.6 m 42.94 28.92 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 128.512 2.725 . . . . 0.0 114.31 -169.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 36.96 56.08 1.22 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 129.821 3.248 . . . . 0.0 113.561 168.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -133.92 24.35 3.93 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.804 1.242 . . . . 0.0 111.098 174.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 . . . . . 0 C--O 1.247 0.96 0 C-N-CA 126.744 2.017 . . . . 0.0 106.82 178.127 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.8 ttm . . . . . 0 N--CA 1.482 1.15 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 27.6 m -133.19 139.8 47.22 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 169.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -142.44 117.44 9.99 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -171.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.41 HG23 HD13 ' A' ' 58' ' ' LEU . 1.4 m -108.76 146.48 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 123.977 0.911 . . . . 0.0 109.78 -169.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 54.7 tp -119.47 104.35 10.25 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 179.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.3 tp -93.71 97.61 10.56 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 98.5 m -72.89 140.83 47.79 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 169.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.5 t -141.0 141.84 30.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 125.063 1.345 . . . . 0.0 107.768 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.59 176.68 19.72 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.248 0.928 . . . . 0.0 111.862 176.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -118.84 121.55 40.28 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.737 1.215 . . . . 0.0 108.253 176.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -59.97 -14.67 17.06 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.65 1.98 . . . . 0.0 115.469 -169.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.8 ptt? -126.91 13.53 7.35 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.115 0.966 . . . . 0.0 111.065 -177.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 27.0 ttt -97.68 33.54 2.04 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.038 0.835 . . . . 0.0 110.25 -177.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.46 -139.71 21.96 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -178.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -63.26 -15.47 57.25 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.251 1.02 . . . . 0.0 111.977 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -59.79 -16.61 29.31 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.933 1.293 . . . . 0.0 112.651 174.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.1 17.63 1.32 Allowed Glycine 0 CA--C 1.534 1.221 0 O-C-N 120.562 -1.336 . . . . 0.0 114.015 175.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.83 -53.3 59.58 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 119.562 1.681 . . . . 0.0 111.096 -169.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.83 -55.04 32.03 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-O 117.812 -1.549 . . . . 0.0 111.152 176.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -49.44 -39.63 44.7 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 CA-C-N 120.787 2.294 . . . . 0.0 115.381 177.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.8 tp -71.18 -38.86 72.11 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 120.083 1.311 . . . . 0.0 110.394 177.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 52.5 tp -61.21 -47.58 85.46 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 122.002 -0.436 . . . . 0.0 110.277 175.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.71 -41.04 85.4 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.862 0.865 . . . . 0.0 111.082 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -60.94 -48.52 81.42 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 118.858 0.753 . . . . 0.0 109.963 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -61.47 -47.15 87.02 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 122.907 0.483 . . . . 0.0 110.668 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 75.7 m -63.88 -40.69 97.12 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.209 0.459 . . . . 0.0 110.938 179.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.8 -39.63 94.72 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.383 0.538 . . . . 0.0 111.094 178.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.18 -35.9 76.76 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.374 0.669 . . . . 0.0 111.457 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.23 95.71 2.11 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 125.086 1.354 . . . . 0.0 108.296 -172.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -55.45 165.53 3.19 Favored 'Trans proline' 0 CA--C 1.537 0.625 0 C-N-CA 123.674 2.916 . . . . 0.0 114.445 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.443 ' HE2' ' CZ ' ' A' ' 136' ' ' TYR . 68.5 mmtt -133.3 170.77 14.96 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 126.327 1.851 . . . . 0.0 108.215 176.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 38.16 -121.93 1.1 Allowed Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.366 1.46 . . . . 0.0 112.307 177.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -140.22 38.21 1.92 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.242 1.417 . . . . 0.0 108.763 169.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -71.59 160.93 31.82 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.912 0.885 . . . . 0.0 111.565 -172.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 98.8 t -115.12 99.26 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 167.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.8 t -68.17 138.3 22.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -178.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 87.7 mt -136.23 141.16 42.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 172.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -125.64 104.36 8.34 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 177.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.22 -4.02 83.02 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.939 -0.923 . . . . 0.0 112.835 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 54.61 -143.8 31.2 Favored Glycine 0 C--N 1.341 0.82 0 N-CA-C 108.427 -1.869 . . . . 0.0 108.427 -169.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.0 p -91.46 10.98 25.47 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 122.064 -0.668 . . . . 0.0 111.891 177.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.52 58.57 21.02 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 125.352 1.461 . . . . 0.0 110.131 -177.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -70.24 -15.44 35.29 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.61 2.207 . . . . 0.0 113.784 -169.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -55.89 -32.07 63.4 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.22 0.918 . . . . 0.0 111.877 174.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.17 -28.59 68.05 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.284 0.634 . . . . 0.0 112.036 177.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -96.45 -3.29 43.71 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.386 1.075 . . . . 0.0 111.607 -170.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 90.0 mt -54.72 -41.74 57.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 118.898 0.772 . . . . 0.0 109.386 173.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.0 t -61.79 -41.7 91.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 O-C-N 121.869 -0.519 . . . . 0.0 110.063 178.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.38 -44.88 86.18 Favored 'General case' 0 N--CA 1.457 -0.1 0 O-C-N 121.972 -0.455 . . . . 0.0 110.512 -178.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 80.8 mt -57.11 -47.89 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.787 0.835 . . . . 0.0 109.237 173.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -60.58 -34.65 74.5 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 118.131 -0.938 . . . . 0.0 112.048 -174.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -57.82 -31.24 66.41 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.481 1.037 . . . . 0.0 111.638 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 70.1 mt -86.26 -12.18 50.29 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.319 1.048 . . . . 0.0 112.339 -174.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 30.53 60.09 0.98 Allowed Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 126.512 1.925 . . . . 0.0 112.57 -168.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -56.78 154.79 30.05 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.923 2.416 . . . . 0.0 114.766 -170.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.7 m -74.83 -37.28 62.32 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.401 1.08 . . . . 0.0 109.874 169.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 36.2 mtm180 -144.03 159.66 42.21 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.355 1.062 . . . . 0.0 109.872 -177.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.41 HD13 HG23 ' A' ' 4' ' ' VAL . 30.8 tp -147.38 141.81 26.41 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.748 1.219 . . . . 0.0 108.472 176.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.5 123.59 26.89 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 177.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.4 mm -98.79 144.4 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 175.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.9 t -137.56 132.9 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 119.093 0.86 . . . . 0.0 110.0 175.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -160.91 173.5 15.21 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.35 2.26 . . . . 0.0 107.222 169.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.09 157.34 37.04 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.071 -1.018 . . . . 0.0 109.181 168.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.9 m -156.23 127.15 6.89 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 176.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -71.55 124.55 24.92 Favored 'General case' 0 C--O 1.231 0.096 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 172.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 76.2 mtm -122.15 0.8 9.66 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.805 1.642 . . . . 0.0 111.058 -176.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.03 34.22 88.25 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 119.162 0.892 . . . . 0.0 111.5 -171.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.5 mt -109.53 -176.66 3.07 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.405 1.482 . . . . 0.0 109.676 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -70.34 141.22 88.24 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-O 117.988 -1.006 . . . . 0.0 108.832 170.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -42.99 138.12 4.15 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.53 2.82 . . . . 0.0 113.453 172.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.41 3.14 70.23 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-O 118.733 -1.037 . . . . 0.0 113.451 175.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -66.25 148.6 51.6 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 120.101 1.951 . . . . 0.0 108.335 168.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 65.3 mt -124.44 134.5 66.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 -172.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.1 mmt-85 -143.16 151.08 40.26 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.934 0.788 . . . . 0.0 109.747 173.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 50.7 mm -79.11 145.53 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 169.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.1 mt -132.81 163.42 37.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 124.612 1.165 . . . . 0.0 107.89 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -133.07 144.93 54.83 Favored Pre-proline 0 C--O 1.236 0.345 0 C-N-CA 126.868 2.067 . . . . 0.0 107.617 -170.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -54.81 -27.04 50.81 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 123.24 2.626 . . . . 0.0 115.141 -173.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -66.76 -20.58 65.98 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.006 0.821 . . . . 0.0 112.249 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -119.25 -31.1 4.77 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.794 1.238 . . . . 0.0 111.875 -171.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 79.7 mt -50.77 -40.58 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.09 1.356 . . . . 0.0 109.869 170.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.02 -25.59 31.38 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.7 1.2 . . . . 0.0 113.446 -176.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -111.35 -35.66 5.78 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.362 0.665 . . . . 0.0 110.215 177.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 22.1 mmt -67.1 -29.71 69.53 Favored 'General case' 0 C--N 1.334 -0.1 0 O-C-N 121.757 -0.589 . . . . 0.0 112.412 -178.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -71.72 -42.67 67.05 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 119.095 0.861 . . . . 0.0 111.598 177.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 19.0 ptp -66.47 -9.01 29.98 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.134 0.879 . . . . 0.0 113.01 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 24.0 mmt -58.04 -28.98 64.99 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.318 0.963 . . . . 0.0 110.987 168.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 74.5 p -79.92 51.16 1.29 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.675 1.19 . . . . 0.0 110.64 177.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.0 m 58.58 67.91 0.88 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.662 1.985 . . . . 0.0 111.958 178.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 57.3 34.64 25.03 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.556 1.542 . . . . 0.0 111.936 174.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -61.17 159.47 11.94 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.794 0.838 . . . . 0.0 110.653 174.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 17.1 ptt? -61.14 138.93 94.46 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 124.366 1.066 . . . . 0.0 110.587 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -79.57 72.86 6.3 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 124.691 3.594 . . . . 0.0 109.827 -175.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -46.33 -13.24 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 128.124 2.57 . . . . 0.0 117.782 -168.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -52.8 -22.02 4.86 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.979 0.911 . . . . 0.0 112.957 168.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -56.86 -32.37 65.74 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 119.402 1.001 . . . . 0.0 111.664 176.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.5 tt -73.23 -44.32 59.75 Favored 'General case' 0 C--N 1.339 0.118 0 O-C-N 121.845 -0.535 . . . . 0.0 109.58 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 98.0 mt -60.31 -45.4 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -64.32 -21.25 66.55 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -175.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -88.17 1.58 54.08 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.245 1.018 . . . . 0.0 112.425 177.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 79.1 mt -135.52 -33.3 0.88 Allowed 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.042 0.937 . . . . 0.0 112.128 -171.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 15.9 pttm -59.85 -20.63 58.15 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.471 1.108 . . . . 0.0 112.676 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -68.2 -17.2 64.26 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.45 1.1 . . . . 0.0 111.813 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -136.51 -31.18 0.88 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.066 0.848 . . . . 0.0 113.12 -177.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 30.4 mt -69.65 140.89 17.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 172.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -62.58 -42.56 99.68 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 124.105 0.86 . . . . 0.0 112.218 -177.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -149.5 142.28 24.64 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 118.742 1.271 . . . . 0.0 109.221 175.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 43.5 t -134.06 121.36 38.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 21.5 mt -127.91 154.45 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 C-N-CA 125.094 1.358 . . . . 0.0 107.914 -171.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -125.04 145.14 50.05 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 174.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.7 tt -125.12 128.0 47.75 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 171.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -113.35 155.44 16.3 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 73.9 mt -131.98 126.92 57.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 -178.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.8 tp60 -61.36 114.87 12.07 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-O 117.282 -1.342 . . . . 0.0 110.062 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -76.31 170.28 20.3 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.917 2.412 . . . . 0.0 111.041 170.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -130.04 -32.06 1.86 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.924 1.69 . . . . 0.0 111.014 172.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -135.43 136.04 51.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 175.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 90.9 t -141.55 134.87 30.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 175.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 158.83 149.04 5.39 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -68.67 157.5 36.1 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 122.065 0.936 . . . . 0.0 111.353 -173.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 14.1 t80 48.88 41.38 18.47 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.769 2.028 . . . . 0.0 112.391 -172.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -123.73 148.39 56.2 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 124.067 0.947 . . . . 0.0 109.759 170.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -81.44 160.88 19.75 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.053 2.502 . . . . 0.0 111.157 177.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 52.0 ttm -70.05 138.22 51.92 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 168.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 68.7 p -78.06 158.98 28.98 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 123.967 0.907 . . . . 0.0 110.459 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -52.84 -44.46 96.24 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-O 116.629 -1.653 . . . . 0.0 114.211 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -68.22 -31.86 28.15 Favored 'Trans proline' 0 C--N 1.351 0.702 0 CA-C-N 122.906 2.074 . . . . 0.0 112.065 -176.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.92 -33.91 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 119.074 0.852 . . . . 0.0 108.872 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -56.89 -46.63 81.76 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.477 1.035 . . . . 0.0 110.059 169.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -63.65 -37.01 85.73 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 122.977 0.511 . . . . 0.0 111.228 178.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.56 -49.31 73.94 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 119.172 -0.442 . . . . 0.0 110.895 175.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 75.8 t -61.46 -38.37 79.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 118.743 0.701 . . . . 0.0 109.837 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -61.61 -43.24 99.22 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.09 0.859 . . . . 0.0 110.486 173.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 29.2 m -63.31 -43.46 97.78 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.602 -0.687 . . . . 0.0 110.331 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 78.2 t -62.01 -45.71 98.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 123.3 0.64 . . . . 0.0 109.406 176.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.443 ' CZ ' ' HE2' ' A' ' 31' ' ' LYS . 48.7 t80 -56.68 -48.06 78.47 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.788 0.835 . . . . 0.0 110.624 178.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -66.62 -26.85 67.28 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.589 -0.695 . . . . 0.0 112.17 178.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -68.0 -23.54 65.02 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 119.203 0.91 . . . . 0.0 112.694 176.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.44 -24.25 66.41 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -169.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -82.87 -2.74 55.59 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.649 1.113 . . . . 0.0 112.966 178.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -136.39 -18.36 0.72 Allowed Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.378 0.99 . . . . 0.0 114.143 -172.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 51.1 t90 -57.11 140.87 48.02 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 118.707 1.254 . . . . 0.0 109.78 172.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -146.02 17.18 1.4 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.513 1.125 . . . . 0.0 110.543 170.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 162.43 -48.2 0.34 Allowed Glycine 0 C--N 1.34 0.802 0 O-C-N 121.193 -0.942 . . . . 0.0 111.104 178.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -125.02 -23.36 4.25 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 55.68 26.43 46.4 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 119.507 1.048 . . . . 0.0 112.636 -172.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 78.82 -8.24 44.79 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.292 -1.282 . . . . 0.0 113.994 -176.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -69.73 147.44 50.51 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 120.192 1.996 . . . . 0.0 110.312 176.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -76.22 155.75 34.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.325 176.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -97.56 121.78 39.86 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.789 1.236 . . . . 0.0 107.756 -178.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 52.3 tp -58.28 123.76 17.17 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.564 1.546 . . . . 0.0 110.044 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -141.62 62.89 1.44 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.422 1.089 . . . . 0.0 108.998 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.6 t 52.64 43.72 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 125.554 1.542 . . . . 0.0 110.066 -176.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -71.09 155.4 40.83 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.917 0.887 . . . . 0.0 108.846 172.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -144.79 158.97 43.59 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.806 1.642 . . . . 0.0 106.821 170.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 . . . . . 0 C--O 1.248 0.977 0 C-N-CA 124.376 1.071 . . . . 0.0 108.61 -177.295 . . . . . . . . 0 0 . 1 stop_ save_